Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,embryonic skeletal system development (GO:0048706),-0.7181829938165794,-2.1319887134046476,0.0,0.005860937805042359,0.006,14/35,5.58%,SULF1;COL1A1;PDGFRA;HOXC4;OSR1;HOXB3;PCSK5;HOXA3;HOXB4;SULF2;RBP4;DYNC2I1;WNT9A;SIX1
prerank,collagen fibril organization (GO:0030199),-0.5926987714812957,-2.105637465785805,0.0,0.004395703353781769,0.009,42/88,9.00%,COL1A2;COL3A1;COL5A2;COL4A5;ADAMTS2;COL1A1;COL4A6;COL5A1;COL8A1;COL12A1;COL22A1;COL25A1;COL4A3;LOXL1;COL4A4;COL6A2;PLOD2;COL26A1;COL6A3;COL6A1;COL8A2;COL13A1;COL18A1;COL11A1;COL23A1;COL15A1;LOXL3;TGFBR1;P4HA1;SERPINH1;COL20A1;CYP1B1;TLL1;COL16A1;LOX;ATP7A;COL27A1;COL9A2;DPT;LUM;COL5A3;ITGB4
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.8093634001285416,-2.0851054645005744,0.0,0.0052097224933709855,0.014,10/17,11.22%,ATP1A2;CACNA1C;ANK2;KCNJ2;CACNA2D1;CACNA1G;SLC8A1;CACNA1D;TRPM4;CACNB2
prerank,dermatan sulfate metabolic process (GO:0030205),-0.8828109940754347,-2.069618377839064,0.0,0.006593555030672654,0.025,5/13,5.32%,UST;DSE;DCN;BGN;CSPG4
prerank,dermatan sulfate biosynthetic process (GO:0030208),-0.8897857960179295,-2.044204627275761,0.0,0.007423854553053655,0.036,5/12,5.32%,UST;DSE;DCN;BGN;CSPG4
prerank,regulation of smoothened signaling pathway (GO:0008589),-0.6331453726563452,-2.013766431087401,0.0,0.01383832537301668,0.075,20/50,10.24%,ZIC1;GLI3;GPC3;FGFR2;DCDC2;TULP3;GAS1;SMO;FBXL17;IFT81;SUFU;GLIS2;RORA;GLI1;MGRN1;IFT122;EVC;FUZ;ARMC9;BTRC
prerank,skeletal system development (GO:0001501),-0.5206125722525471,-2.0131356549845862,0.0,0.012000967886515305,0.076,49/148,13.52%,BMP6;COL1A2;SULF1;IGF1;SOX5;FBN1;COL1A1;GLI2;BMP5;BMP7;EXT1;FGFR2;CDH11;PCSK5;ITGB8;PKD1;NPR3;MMP14;GJA1;WWOX;MMP16;SULF2;COL13A1;RBP4;CREB3L2;SH3PXD2B;TGFBR1;TNFRSF11B;SUFU;PRELP;PAPSS2;IGF2;TLL1;AKAP13;GNAS;ATP7A;COL9A2;PTH1R;MYOC;SOX6;EVC;PAPSS1;PTHLH;CHRD;PKDCC;BMP2;P3H1;COMP;CMKLR1
prerank,ureteric bud development (GO:0001657),-0.7964862160680877,-1.9980449895767578,0.0,0.013431315803222073,0.096,14/17,14.08%,BMP7;GPC3;FGFR2;BMP4;OSR1;SLIT2;SALL1;FOXC1;PKD2;SIX1;BMP2;ROBO2;NPNT;WNT11
prerank,mesonephric tubule development (GO:0072164),-0.8241754226321518,-1.9964648449991709,0.0,0.012481626807034652,0.1,13/15,14.08%,BMP7;FGFR2;BMP4;OSR1;SLIT2;PKD1;SALL1;FOXC1;PKD2;SIX1;ROBO2;NPNT;WNT11
prerank,establishment of endothelial barrier (GO:0061028),0.8026544428558102,1.988414235447675,0.0,0.0476871018486882,0.045,15/29,8.46%,PECAM1;TJP1;PPP1R16B;ROBO4;PDE2A;RAPGEF2;TJP2;F11R;RAPGEF1;RAPGEF3;PDE4D;MARVELD2;RAP1B;SOX18;MSN
prerank,retinoid metabolic process (GO:0001523),-0.5750375063435553,-1.979577524430118,0.0,0.015433802886611546,0.132,17/71,8.31%,GPC6;ALDH1A1;LRP1;ALDH1A2;SDC2;GPC3;RBP1;CYP26B1;ABCA4;RBP4;DHRS3;GPC4;AKR1B1;CYP1B1;SCPEP1;SDC4;APOE
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.7734871876171366,-1.9332190417791315,0.002403846153846154,0.03578724144594046,0.284,7/16,8.05%,IGF1;IGFBP2;IGFBP5;BMP5;IGFBP6;IGFBP4;IGFBP3
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.83877853137688,1.9310894880821479,0.0,0.12987125609855507,0.206,5/19,6.62%,SLCO1C1;PDGFB;APP;KLF2;KLF4
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.7678634542465209,-1.9237239583253813,0.0,0.03866590913048778,0.325,9/16,12.39%,FOXD1;BMP4;FGF1;SALL1;FGF2;PKD2;SIX1;BMP2;NPNT
prerank,angiogenesis involved in wound healing (GO:0060055),0.8983127490963388,1.9216493298465958,0.0,0.11126990431360578,0.252,6/11,4.60%,NDNF;KDR;ADIPOR2;CD34;PRCP;GATA2
prerank,hemopoiesis (GO:0030097),0.6378983873400947,1.913872840311474,0.0,0.10196922842113113,0.298,18/87,5.28%,FLT1;MECOM;KITLG;TEK;PDGFB;KDR;CD34;TGFB2;NOTCH4;RASGRP4;TIRAP;FLT4;SNRK;ZFPM1;ZBTB16;PLD4;ETV6;TAL1
prerank,positive regulation of developmental growth (GO:0048639),0.6921264723537631,1.9066966938043415,0.0,0.09720051823626231,0.341,15/49,12.73%,PLCB1;SEMA7A;INSR;MACF1;NTN1;NEDD4L;AGRN;ITSN2;DBNL;RASAL1;TWF2;SMURF1;CPNE5;SYT4;CPNE6
prerank,eye development (GO:0001654),-0.5801124897635692,-1.9047585934883358,0.0,0.04861572769054366,0.42,14/54,6.73%,CACNA1C;PBX1;FBN1;COL5A2;SMOC1;COL5A1;EFEMP1;LAMA1;RBP4;SH3PXD2B;FOXC1;PBX4;PBX3;MEIS1
prerank,bile acid and bile salt transport (GO:0015721),0.7822834757368341,1.9038663600586168,0.0,0.08455159902249679,0.355,6/24,7.31%,SLCO1C1;ABCC4;SLCO2B1;NCOA1;ABCB11;NCOA2
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.7084529379441226,-1.9000243465329996,0.0,0.04863182916803005,0.435,12/22,20.44%,TIMP2;TIMP3;PTPN3;ADAM9;APOE;SNX9;SNX33;NRDC;PACSIN3;ADRA2A;TIMP4;ADAM8
prerank,ceramide biosynthetic process (GO:0046513),0.7095129418887421,1.8945200209550028,0.0,0.09334496532083644,0.431,7/40,2.46%,SGMS1;ST8SIA4;ST6GALNAC3;ST8SIA6;SGMS2;DEGS2;CERS4
prerank,monocyte chemotaxis (GO:0002548),0.7301055649401647,1.8758085890792455,0.0,0.12555912454840773,0.568,4/32,2.32%,FLT1;PDGFB;IL6R;TNFRSF11A
prerank,membrane lipid biosynthetic process (GO:0046467),0.6618097093608055,1.873592464032754,0.0,0.11577932292813893,0.583,15/58,5.14%,SGMS1;CERT1;SGPP2;ELOVL7;ST8SIA6;SGMS2;DEGS2;ACER2;SPNS2;CERS4;PPM1L;PRKD2;PRKD1;PRKD3;ACER1
prerank,glycerolipid catabolic process (GO:0046503),0.8203513650081306,1.8724416303160127,0.0,0.10612916709303798,0.588,5/19,6.04%,GPCPD1;ABHD2;PLA2G4B;PNPLA6;GDPD1
prerank,extracellular structure organization (GO:0043062),-0.46096028796106575,-1.8715456161885664,0.0,0.07208953500202102,0.597,80/204,9.00%,COL1A2;LAMA2;COL3A1;FBN1;COL5A2;SMOC1;COL4A5;THSD4;ADAMTS2;ADAMTSL3;ADAMTS12;COL1A1;ITGA9;DCN;COL4A6;COL5A1;COL8A1;COL22A1;ADAMTS10;COL4A3;NID1;VTN;LOXL1;ADAMTS6;COL4A4;COL6A2;BGN;ELN;COL6A3;ADAMTSL5;COL6A1;LAMA1;COL8A2;ITGB5;ITGB8;VIT;MFAP5;ITGA10;MMP14;SMOC2;MMP16;LAMC3;COL13A1;COL18A1;FBLN5;COL11A1;THBS1;COL23A1;CDH1;DDR1;COL15A1;DAG1;TGFBR1;SH3PXD2A;ECM2;ADAMTS17;ADAMTS5;NID2;ITGA11;ADAMTSL4;FGF2;SPP1;TNC;ST7;ADAMTS15;ADAMTSL1;COL16A1;LOX;ATP7A;COL27A1;MMP2;TGFBI;ADAMTS16;SPARC;ITGA5;COL9A2;ADAM19;LUM;COL5A3;ITGB4
prerank,external encapsulating structure organization (GO:0045229),-0.4578148372655244,-1.8711363598949333,0.0,0.06776709337080228,0.597,79/205,9.00%,COL1A2;LAMA2;COL3A1;FBN1;COL5A2;SMOC1;COL4A5;THSD4;ADAMTS2;ADAMTSL3;ADAMTS12;COL1A1;ITGA9;DCN;COL4A6;COL5A1;COL8A1;COL22A1;ADAMTS10;COL4A3;NID1;VTN;LOXL1;ADAMTS6;COL4A4;COL6A2;BGN;ELN;COL6A3;ADAMTSL5;COL6A1;LAMA1;COL8A2;ITGB5;ITGB8;VIT;MFAP5;ITGA10;MMP14;SMOC2;MMP16;LAMC3;COL13A1;COL18A1;FBLN5;COL11A1;THBS1;COL23A1;CDH1;DDR1;COL15A1;DAG1;SH3PXD2A;ECM2;ADAMTS17;ADAMTS5;NID2;ITGA11;ADAMTSL4;FGF2;SPP1;TNC;ST7;ADAMTS15;ADAMTSL1;COL16A1;LOX;ATP7A;COL27A1;MMP2;TGFBI;ADAMTS16;SPARC;ITGA5;COL9A2;ADAM19;LUM;COL5A3;ITGB4
prerank,regulation of cell junction assembly (GO:1901888),0.7597278055040265,1.8640920911631647,0.0,0.11345287287018661,0.642,11/27,7.11%,PRKCH;OCLN;TJP1;CLDN5;RAPGEF2;F11R;MEF2C;RAPGEF1;APLNR;SNAI2;RAP1B
prerank,maintenance of blood-brain barrier (GO:0035633),0.7279612052042891,1.8553396315807034,0.0016207455429497568,0.1242908505630703,0.686,12/30,4.06%,OCLN;SLC1A1;MFSD2A;PECAM1;ESAM;TJP1;CLDN5;JAM2;TJP2;F11R;ACTB;LSR
prerank,extracellular matrix organization (GO:0030198),-0.44632878345645044,-1.8549124593097925,0.0,0.08153598769955987,0.686,97/276,9.00%,COL1A2;LAMA2;COL3A1;FBN1;COL5A2;SMOC1;COL4A5;THSD4;ADAMTS2;ADAMTSL3;ADAMTS12;COL1A1;ITGA9;DCN;GSN;COL4A6;COL5A1;COL8A1;COL12A1;TIMP2;COL22A1;ADAMTS10;COL25A1;COL4A3;NID1;VTN;LOXL1;ADAMTS6;COL4A4;COL6A2;BGN;ELN;PLOD2;COL26A1;COL6A3;ADAMTSL5;COL6A1;LAMA1;COL8A2;ITGB5;ITGB8;VIT;MFAP5;ITGA10;MMP14;SMOC2;MMP16;LAMC3;COL13A1;COL18A1;FBLN5;COL11A1;THBS1;COL23A1;SH3PXD2B;CDH1;DDR1;COL15A1;LOXL3;DAG1;TGFBR1;P4HA1;SH3PXD2A;ECM2;ADAMTS17;ADAMTS5;NID2;ITGA11;SERPINH1;ADAMTSL4;FGF2;SCUBE1;SPP1;COL20A1;TNC;CYP1B1;ST7;TLL1;CTSL;ADAMTS15;ADAMTSL1;COL16A1;LOX;ATP7A;COL27A1;MMP2;TGFBI;ADAMTS16;SPARC;ITGA5;COL9A2;ADAM19;DPT;KLK2;LUM;COL5A3;ITGB4
prerank,heme catabolic process (GO:0042167),0.8386817471327427,1.8469984748809343,0.0,0.12465321455888098,0.743,2/14,1.05%,ABCG2;SLCO2B1
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.8386817471327427,1.8469984748809343,0.0,0.12465321455888098,0.743,2/14,1.05%,ABCG2;SLCO2B1
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.7357115594056126,-1.846236678417248,0.008771929824561403,0.08791406707563539,0.731,7/16,9.98%,ATP1A2;CACNA1C;ANK2;DMD;CAMK2D;SLC8A1;PRKACA
prerank,sphingolipid metabolic process (GO:0006665),0.6003996237245797,1.8434465813653642,0.0,0.12432467120267929,0.768,36/108,15.17%,SGMS1;ST6GALNAC3;CERT1;SGPP2;ELOVL7;ESYT2;SGMS2;DEGS2;ACER2;SPNS2;CERS4;PPM1L;PRKD2;PRKD1;PRKD3;ACER1;NEU4;ESYT1;GAL3ST1;SPTLC2;CERKL;ELOVL5;ENPP2;GLB1;ORMDL1;ORMDL3;ELOVL6;GLTP;B4GALNT1;HACD2;CERK;DEGS1;NEU2;SPTLC1;FA2H;CLN8
prerank,cardiac muscle cell action potential (GO:0086001),-0.6315490620508509,-1.8356116653179542,0.0,0.09629417990214333,0.78,9/30,7.60%,ATP1A2;CACNA1C;ANK2;DMD;KCNJ2;CACNA2D1;CACNA1G;SLC8A1;CACNA1D
prerank,organic hydroxy compound transport (GO:0015850),0.7011602816367234,1.8354752480451233,0.0015527950310559005,0.13481752464137114,0.809,7/36,7.31%,SLCO1C1;ABCC4;SLCO2B1;NCOA1;OSBP;ABCB11;NCOA2
prerank,glycosaminoglycan catabolic process (GO:0006027),-0.5630453258040106,-1.8316296203994864,0.0,0.09709620297020174,0.802,20/55,12.56%,GPC6;DCN;SDC2;OGN;CEMIP;FMOD;GPC3;BGN;CEMIP2;GPC4;FGF2;PRELP;CSPG4;SDC4;LUM;OMD;ARSB;SLC9A1;HEXA;GNS
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.6948812348017943,-1.8313947597127722,0.004651162790697674,0.09289121267198089,0.803,8/20,11.35%,ATP1A2;CACNA1C;ANK2;DMD;CAMK2D;SLC8A1;PRKACA;SLC9A1
prerank,sulfur compound catabolic process (GO:0044273),-0.5973115502842603,-1.8278445659870257,0.0,0.09328659339692422,0.824,12/38,12.56%,DCN;OGN;FMOD;BGN;PRELP;CSPG4;GGT5;LUM;OMD;ARSB;HEXA;GNS
prerank,regulation of interleukin-4 production (GO:0032673),0.7706964005993198,1.8267863386862377,0.0,0.14735851622579615,0.844,5/21,8.56%,LEF1;SLC7A5;ZFPM1;LGALS9;FOXP3
prerank,organic anion transport (GO:0015711),0.6240391002549831,1.8262911074539026,0.0,0.14075022850611632,0.849,9/76,2.52%,SLCO1C1;ABCC4;ABCG2;CA4;ABCC6;SLCO2B1;SLC39A8;SLC16A2;LRRC8C
prerank,neutral amino acid transport (GO:0015804),0.7242134785603664,1.8253810346082178,0.00322061191626409,0.13537156011917645,0.851,5/28,2.92%,SLC6A6;SLC7A5;SLC1A1;SLC38A5;SLC43A2
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.8654263563783051,1.8159796364860747,0.0017953321364452424,0.1525479949563887,0.893,3/10,3.22%,NAMPT;KDR;NOD2
prerank,cellular response to interleukin-4 (GO:0071353),0.883643386172007,1.813454013778698,0.0018315018315018315,0.15151646544831426,0.901,3/10,5.64%,LEF1;JAK3;TCF7
prerank,amide transport (GO:0042886),0.7220322084420474,1.8090154796400268,0.004739336492890996,0.15569792634542684,0.916,5/26,1.99%,CERT1;ABCG2;PLTP;AQP11;SLC38A5
prerank,regulation of JNK cascade (GO:0046328),0.5850926044883034,1.8069247834694018,0.0,0.15439857212803765,0.922,19/101,5.21%,IGF1R;MECOM;PLCB1;MFHAS1;DAB2IP;MAP4K2;TNFRSF19;APP;ANKRD6;SH3RF1;TIRAP;FLT4;PHLPP1;TPD52L1;NOD2;MEN1;DUSP3;WNT7A;CCR7
prerank,response to interleukin-4 (GO:0070670),0.8829636682391274,1.8029941210336602,0.001851851851851852,0.1569700435852653,0.936,3/10,5.64%,LEF1;JAK3;TCF7
prerank,relaxation of cardiac muscle (GO:0055119),-0.7673853701621565,-1.7944149606320756,0.004338394793926247,0.14011038999155612,0.921,6/13,7.21%,ATP1A2;GSN;CAMK2D;KCNJ2;SLC8A1;P2RX4
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.7562828606204024,-1.7934052538514116,0.002145922746781116,0.13533068195670725,0.923,5/13,4.64%,BMP6;BMPR1A;BMP4;TGFBR1;DAB2
prerank,diterpenoid metabolic process (GO:0016101),-0.5478105149234933,-1.7891470505379097,0.0,0.13659892377618726,0.931,15/55,11.40%,GPC6;ALDH1A1;LRP1;SDC2;GPC3;RBP1;ABCA4;RBP4;DHRS3;GPC4;AKR1B1;SDC4;APOE;PECR;AKR1B10
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.7723635998721299,1.7891198053532682,0.0,0.19091074646487596,0.976,7/19,5.18%,PRKCH;OCLN;TJP1;CLDN5;F11R;IKBKB;SNAI2
prerank,ureteric bud morphogenesis (GO:0060675),-0.7086732718362336,-1.7858176202756362,0.002257336343115124,0.13713091659233725,0.941,9/16,17.54%,BMP4;SALL1;FGF2;PKD2;SIX1;BMP2;NPNT;WNT11;PAX2
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.7022266114112033,1.7840117420440422,0.0016181229773462784,0.19917755142038013,0.983,11/34,5.30%,FLT1;SEMA6A;KDR;DAB2IP;FLT4;PRKD2;NOTCH1;PRKD1;RAMP2;DLL4;GAB1
prerank,sphingolipid biosynthetic process (GO:0030148),0.6059334274220702,1.7806226113608565,0.0,0.20220984637335787,0.986,15/71,5.44%,SGMS1;CERT1;SGPP2;ELOVL7;SGMS2;DEGS2;ACER2;SPNS2;CERS4;PPM1L;PRKD2;PRKD1;PRKD3;ACER1;TLCD3B
prerank,kidney development (GO:0001822),-0.532846267524767,-1.7799734516711996,0.0,0.14301411816871878,0.959,19/65,8.11%,SULF1;GLI2;WNT4;BMP7;BMP4;KANK2;OSR1;PCSK5;PKD1;GREB1L;SULF2;SALL1;FOXC1;TGFBR1;ARL3;PYGO1;SIX1;ACE;AGTR1
prerank,regulation of epithelial cell migration (GO:0010632),0.6402445698561144,1.7777162940409952,0.0,0.2031774924510598,0.99,17/51,8.73%,PTPRG;DAB2IP;MACF1;BMPR2;TGFB2;DOCK1;MCC;PTK2;EVL;VIL1;PLCG1;RREB1;INSL3;RAB11A;PTPRR;PTN;ENPP2
prerank,positive regulation of neuron migration (GO:2001224),0.8535115672923719,1.776356398438392,0.001841620626151013,0.19956509827213315,0.991,4/11,2.61%,SEMA6A;DAB2IP;RAPGEF2;ARHGEF2
prerank,hematopoietic stem cell proliferation (GO:0071425),0.8412231268403734,1.7762695716693147,0.007155635062611807,0.19304821088816468,0.991,3/11,5.19%,MECOM;CD34;ETV6
prerank,activation of adenylate cyclase activity (GO:0007190),-0.5943715931586673,-1.7742617905473195,0.00273224043715847,0.14767470076633515,0.964,7/35,5.06%,LGR4;ADCY5;ADCY1;ADCY9;EDNRA;ADCY2;ADCY7
prerank,ganglioside biosynthetic process (GO:0001574),0.8038236148035849,1.7738376452095088,0.0019083969465648854,0.19405410216943877,0.994,5/15,1.98%,ST8SIA4;ST6GALNAC3;ST8SIA6;ST3GAL1;B4GALT5
prerank,endodermal cell differentiation (GO:0035987),-0.6086484939937562,-1.773613203869479,0.0025380710659898475,0.1439971788307821,0.966,12/31,10.48%,COL8A1;COL12A1;VTN;COL6A1;ITGB5;MMP14;COL11A1;CTR9;MMP2;ITGA5;LAMB1;ITGAV
prerank,glycerophospholipid catabolic process (GO:0046475),0.720320012075339,1.7721507803475445,0.006349206349206349,0.19271423207202582,0.995,7/27,8.73%,GPCPD1;PLA2G4B;PNPLA6;INPP5F;GDPD1;LIPC;ENPP2
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.7512417746348761,-1.7713564746324286,0.0020876826722338203,0.14346273316120353,0.971,5/13,11.81%,DCN;BGN;CSPG4;ARSB;HEXA
prerank,embryonic eye morphogenesis (GO:0048048),-0.774025484903647,-1.7710367261118707,0.004310344827586207,0.13968568435350953,0.972,10/11,22.65%,FBN1;EFEMP1;MFAP5;KDM2B;FBN2;LRP6;MFAP2;TBX2;RARG;ALDH1A3
prerank,cardiac muscle cell contraction (GO:0086003),-0.6871928755875858,-1.7699863150475494,0.004464285714285714,0.1374267812411495,0.973,7/19,7.60%,CACNA1C;GSN;CAMK2D;KCNJ2;CACNA2D1;CACNA1G;CACNA1D
prerank,negative regulation of blood pressure (GO:0045776),0.8131269715025656,1.7695723454318788,0.007285974499089253,0.1946531539677917,0.996,5/13,4.91%,BMPR2;NOS3;PRCP;NOS2;NPPA
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.7384071290515203,-1.7692671194155454,0.006741573033707865,0.1345943646440788,0.974,6/14,10.13%,SULF1;SULF2;THBS1;FGF2;CREB3L1;FUZ
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.5497553238143195,-1.7663384833660154,0.0,0.13540490134884625,0.976,16/53,17.11%,EYA2;EYA1;EGFR;EYA4;DDX5;PLA2R1;PRKCD;FBH1;ATM;FXR2;SPRED1;TMEM161A;FMR1;NSMCE1;ERCC6;HIC1
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.6393973841008376,-1.7648096105447983,0.005089058524173028,0.1336852004102519,0.976,5/23,7.01%,ATP1A2;ANK2;CAMK2D;CACNA2D1;DIAPH1
prerank,cellular component maintenance (GO:0043954),0.8262235008591778,1.7641148854375517,0.0035398230088495575,0.20459497514055458,0.997,3/12,6.12%,IGF1R;INSR;FYN
prerank,myeloid cell differentiation (GO:0030099),0.6411006014650735,1.7633411854440266,0.0015600624024961,0.20135842519209007,0.997,13/47,7.78%,MFHAS1;RASGRP4;TIRAP;SNRK;JAK3;ZFPM1;LYN;ZBTB16;KLF1;SLC25A5;TAL1;CDKN2B;KAT6A
prerank,dendritic spine organization (GO:0097061),0.720717483282597,1.7621165815628534,0.004991680532445923,0.1992599350296841,0.997,6/26,6.12%,IGF1R;SHANK3;INSR;WNT7A;DIP2A;FYN
prerank,relaxation of muscle (GO:0090075),-0.7566371576590596,-1.7602390851449023,0.0,0.13765063650453652,0.979,6/13,7.21%,ATP1A2;GSN;CAMK2D;KCNJ2;SLC8A1;P2RX4
prerank,vascular transport (GO:0010232),0.596997494553021,1.7589846433339709,0.0,0.20322548119645095,0.997,16/81,3.12%,SLCO1C1;SLC6A6;SLC7A5;TFRC;ABCC4;SLC7A1;ABCG2;SLC1A1;SLC2A1;MFSD2A;ATP8A1;INSR;SLCO2B1;SLC16A2;SLC38A5;SLC22A8
prerank,transport across blood-brain barrier (GO:0150104),0.5928669863486685,1.7551492875996768,0.0,0.2093586593480202,0.997,16/83,3.12%,SLCO1C1;SLC6A6;SLC7A5;TFRC;ABCC4;SLC7A1;ABCG2;SLC1A1;SLC2A1;MFSD2A;ATP8A1;INSR;SLCO2B1;SLC16A2;SLC38A5;SLC22A8
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.6037457872950956,1.753527271320879,0.0,0.20893350515374515,0.997,39/70,21.25%,MYO10;WASF2;DOCK1;ELMO1;PTK2;ARPC4;LYN;ELMO2;ACTB;PLCG1;GRB2;HSP90AB1;BAIAP2;FYN;MAPK3;YES1;WIPF2;NCKAP1;HCK;ARPC3;PAK1;ACTG1;CYFIP1;RAC1;SYK;PIK3CB;NCKAP1L;NCK1;MAPK1;ACTR2;PRKCE;FCGR3A;CRK;WIPF1;ARPC1B;MYO1C;PLCG2;VAV1;ARPC2
prerank,protein targeting to ER (GO:0045047),0.570496995151794,1.7529124746331224,0.0,0.20523209630730646,0.997,68/99,32.36%,SEC62;RPL38;RPL13;RPS29;RPL36A;ZFAND2A;RPL3;RPSA;SRP14;RPL27;SGTB;RPS7;RPL9;RPLP2;RPL18;RPL13A;RPS11;RPL8;RPS27;RPL19;GET3;RPS9;EDEM1;RPL11;SPCS2;RPS15;RPL37;RPS28;RPS10;RPS25;RPL37A;RPL15;RPL17;RPL23;RPL34;RPS18;RPL21;SPCS1;RPS4X;RPS21;RPL18A;RPL10A;RPL24;SRPRA;RPL7A;ZFAND2B;RPL4;RPS2;RPL32;RPL6;SEC63;RPS20;RPL14;RPS13;RPL26;RPS19;RPS6;RPS14;RPS15A;RPS24;RPS23;RPS12;RPL12;RPL41;RPS3;RPS16;RPL27A;RPL10
prerank,blood vessel morphogenesis (GO:0048514),0.630998150546442,1.7501152955389803,0.0030581039755351682,0.2088383251173221,0.998,20/54,8.54%,FLT1;SLC1A1;EGFL7;KDR;ENG;RASIP1;CAV1;TBX1;SOX17;FLT4;ID1;CDH2;APLNR;RAMP2;SMAD7;COL4A1;SOX18;TGFB1;LRP5;CCM2
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.7352159528795642,1.7468967178631458,0.00530035335689046,0.21326329033445765,0.999,3/21,3.41%,SLC39A10;PRKCH;PRKD2
prerank,amino acid import (GO:0043090),0.73375815247019,1.7466514524855241,0.00684931506849315,0.20920031914422044,0.999,6/21,1.66%,SLC6A6;SLC7A5;SLC7A1;SLC1A1;SH3BP4;SLC16A2
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.6883325117708614,-1.745635200080298,0.006276150627615063,0.16014616542967092,0.99,6/15,11.35%,IGF1;ROCK2;CAMK2D;PRKCA;PARP1;SLC9A1
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.6446775926021828,-1.7431668372134768,0.002421307506053269,0.16066167228734535,0.99,11/23,15.19%,GLI3;ENPP1;GPC3;TULP3;SUFU;GLIS2;MGRN1;IFT122;BTRC;KIF7;PTCH2
prerank,positive regulation of lymphocyte migration (GO:2000403),0.8137235328559443,1.7421901325723834,0.010582010582010581,0.21692097054671655,0.999,3/12,1.56%,CXCL12;JAM2;APP
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.5973192102452909,1.7404192558542635,0.001447178002894356,0.21751180687200708,0.999,39/71,21.25%,MYO10;WASF2;DOCK1;ELMO1;PTK2;ARPC4;LYN;ELMO2;ACTB;PLCG1;GRB2;HSP90AB1;BAIAP2;FYN;MAPK3;YES1;WIPF2;NCKAP1;HCK;ARPC3;PAK1;ACTG1;CYFIP1;RAC1;SYK;PIK3CB;NCKAP1L;NCK1;MAPK1;ACTR2;PRKCE;FCGR3A;CRK;WIPF1;ARPC1B;MYO1C;PLCG2;VAV1;ARPC2
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.6459412562913145,-1.7396241942102508,0.004796163069544364,0.1628288746605999,0.992,10/20,9.17%,IGF1;LRP1;BMPR1A;PDGFRB;IGFBP5;VTN;SLIT2;ACE;IGFBP3;CCN4
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.7261043506705225,1.7376386234886212,0.006825938566552901,0.2205252748765886,0.999,7/21,11.78%,SLC39A10;PRKCH;LYN;CD19;ELF2;CBFB;PRKCB
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.7153057746574114,1.737518875221519,0.0053285968028419185,0.2161354747438054,0.999,5/23,7.43%,PIK3R6;CADM1;LGALS9;PVR;CD160
prerank,cardiac conduction system development (GO:0003161),-0.6235464126344155,-1.7370409937650866,0.004914004914004914,0.16356900590905718,0.993,7/24,5.95%,NOTCH2;BMPR1A;GJB6;BMP4;GJA1;CACNA1G;TBX18
prerank,ceramide transport (GO:0035627),0.8069613983440985,1.7353030234266904,0.007054673721340388,0.21858702137290983,0.999,2/12,0.51%,CERT1;PLTP
prerank,lipid transport (GO:0006869),0.5669035932011577,1.7345679547587156,0.0013679890560875513,0.2161138871015018,0.999,20/97,7.47%,SLCO1C1;ABCC4;CERT1;MFSD2A;PLTP;ATP8A1;SLCO2B1;SPNS2;PPARD;NCOA1;SCARB1;OSBP;ABCG1;PRELID2;PITPNC1;PITPNA;ABCA3;ABCB11;NCOA2;CHKA
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.535713559803795,1.7292187412856532,0.001288659793814433,0.22743703724259456,0.999,33/138,9.16%,PTPRG;FLT1;IGF1R;TEK;MPZL1;KDR;INSR;TIE1;BMPR2;FES;RASGRP4;FLT4;NEDD9;PTK2;MTSS1;RAPGEF1;JAK3;ZAP70;MERTK;LYN;NPPA;CD4;EPHA4;FYN;YES1;RET;HCK;EPHB4;PTN;SHC3;CD8B;LIFR;NPR1
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.7956546179922329,1.7290727135671455,0.018148820326678767,0.22351463882770622,0.999,4/12,8.84%,IGF1R;INSR;IRGM;FYCO1
prerank,cell junction assembly (GO:0034329),0.5626480731816363,1.7286845040362475,0.0,0.22025041148444857,0.999,25/100,9.79%,SPOCK2;DNM3;ITGA6;SHANK3;TJP1;CLDN5;LIMS2;ADGRL3;GJC1;PLXND1;CDH2;ACTB;CDH20;CTNND1;CDH8;DBNL;DCHS1;CDH19;PKP4;OPHN1;SLITRK1;GPM6A;NRXN1;DNER;ACTG1
prerank,positive regulation of JNK cascade (GO:0046330),0.5928969957606163,1.725205659759366,0.00430416068866571,0.22633665401727843,1.0,14/70,5.21%,PLCB1;MFHAS1;DAB2IP;MAP4K2;TNFRSF19;APP;ANKRD6;SH3RF1;TIRAP;FLT4;TPD52L1;NOD2;WNT7A;CCR7
prerank,regulation of protein import into nucleus (GO:0042306),-0.5777642610874772,-1.7242644349120049,0.0027100271002710027,0.18476249056139632,0.996,13/36,14.82%,ZIC1;SMAD3;BMP4;MDFIC;APOD;CDH1;PRKCD;SUFU;FLNA;UBR5;PSEN1;BAG3;PIK3R1
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.5898427388236993,1.7234657480795799,0.001451378809869376,0.22725590892824413,1.0,39/73,21.25%,MYO10;WASF2;DOCK1;ELMO1;PTK2;ARPC4;LYN;ELMO2;ACTB;PLCG1;GRB2;HSP90AB1;BAIAP2;FYN;MAPK3;YES1;WIPF2;NCKAP1;HCK;ARPC3;PAK1;ACTG1;CYFIP1;RAC1;SYK;PIK3CB;NCKAP1L;NCK1;MAPK1;ACTR2;PRKCE;FCGR3A;CRK;WIPF1;ARPC1B;MYO1C;PLCG2;VAV1;ARPC2
prerank,positive regulation of axon extension (GO:0045773),0.7187934224238919,1.7228968290099607,0.008038585209003215,0.22448910731013022,1.0,5/22,8.42%,SEMA7A;MACF1;NTN1;DBNL;TWF2
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.7020206349887208,-1.7222736449286176,0.0069605568445475635,0.18492189082496743,0.996,4/14,7.12%,ANK2;ACTN2;ATP1B3;ATP1B2
prerank,membrane depolarization during action potential (GO:0086010),-0.6257699836802154,-1.7220782630919178,0.010666666666666666,0.18116658525276286,0.996,7/26,7.60%,ATP1A2;CACNA1C;SCN7A;KCNJ2;CACNA1G;SLC8A1;CACNA1D
prerank,regulation of angiogenesis (GO:0045765),0.5161693736064189,1.7209252386855365,0.0,0.22586147858880962,1.0,40/192,7.43%,FLT1;TEK;ETS1;PTPRM;SEMA6A;CLDN5;PIK3R6;KDR;PPP1R16B;TIE1;DAB2IP;CD34;TGFB2;NOS3;STAB1;COL4A2;RGCC;PLXND1;SP100;CD40;AMOT;APLNR;PRKD2;PRKD1;RAMP2;VASH1;RAPGEF3;PLCG1;SARS1;HHEX;CTNNB1;GATA2;TSPAN12;FGF16;GAB1;RHOB;STAT1;KLF4;GTF2I;CD160
prerank,renal system development (GO:0072001),-0.5349075719367302,-1.7137784737418587,0.0,0.19549779663334474,0.998,18/52,8.11%,SULF1;GLI2;WNT4;BMP4;PCSK5;PKD1;GREB1L;SULF2;RBP4;SALL1;FOXC1;TGFBR1;ARL3;PYGO1;SIX1;TBX18;ACE;AGTR1
prerank,purine ribonucleotide transport (GO:0015868),0.7757769831840209,1.7129852013045364,0.005415162454873646,0.2455200432246944,1.0,3/16,2.52%,ABCC4;ABCC6;LRRC8C
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.6635240042213683,1.7099443354177848,0.012779552715654952,0.2508033672797662,1.0,12/33,10.25%,HIP1;HIP1R;BCAR3;PLAUR;AFAP1L2;CCDC88A;FBXW7;SHKBP1;TGFA;CNOT9;ADAM17;PTK6
prerank,skeletal system morphogenesis (GO:0048705),-0.5525542513128417,-1.7099310706153035,0.007407407407407408,0.20011846527661298,0.998,18/42,16.66%,PDGFRA;HOXC4;FGFR2;HOXB3;CYP26B1;HOXA3;HOXB4;WWOX;DYNC2I1;TGFBR1;SIX1;SFRP4;FUZ;FBN2;SKI;HOXA9;LRP6;RFLNA
prerank,T-helper cell differentiation (GO:0042093),0.7833698473056568,1.7090319048376015,0.009174311926605505,0.2494759417666497,1.0,2/14,3.22%,LEF1;ZFPM1
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.5821563851358942,1.7074870919987708,0.001445086705202312,0.24959632031441054,1.0,17/67,6.96%,FLT1;IGF1R;TEK;PDGFB;KDR;INSR;FES;FLT4;PTK2;JAK3;ZAP70;LYN;EPHA4;AATK;FYN;MAPK3;HCK
prerank,adenine nucleotide transport (GO:0051503),0.7633828659114045,1.7062164801048652,0.005291005291005291,0.24946325550283413,1.0,4/17,5.14%,ABCC4;ABCC6;LRRC8C;SLC25A5
prerank,smooth muscle contraction (GO:0006939),-0.7061219354497746,-1.7054106364201742,0.007194244604316547,0.2056849405059431,0.998,7/14,9.67%,ROCK2;MYLK;EDNRA;SLC8A1;MYH11;BDKRB2;ACTA2
prerank,negative regulation of reproductive process (GO:2000242),-0.6748614358596111,-1.7016121799686263,0.004901960784313725,0.20922716625305468,0.999,3/17,3.02%,SULF1;IGF1;GJA1
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.766007755887243,1.6984225349886037,0.005309734513274336,0.2695777723930819,1.0,4/15,7.28%,PLTP;SCARB1;ABCG1;LIPC
prerank,positive regulation of vasculature development (GO:1904018),0.5600070220840797,1.6978021891348665,0.0013458950201884253,0.26744073397477747,1.0,18/94,5.40%,FLT1;TEK;ETS1;PIK3R6;KDR;TIE1;CD34;NOS3;CD40;APLNR;PRKD2;PRKD1;RAMP2;RAPGEF3;PLCG1;GATA2;GAB1;RHOB
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.6487881209905274,1.6969976986189181,0.007861635220125786,0.2659729081500804,1.0,6/36,4.47%,LEF1;PLCB1;FZD6;FZD4;CALM1;CTNNB1
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.6015916382093867,1.6960588644754098,0.0029985007496251873,0.2647063414566463,1.0,25/54,14.80%,ETS1;PDGFB;KDR;NOS3;RGCC;MEF2C;CD40;ACVRL1;PRKD2;PRKD1;VASH1;PLCG1;TMSB4X;PRCP;GATA2;TGFB1;ADAM17;AGTR2;HSPB1;HIF1A;ATP5F1A;PPARG;CSNK2B;SP1;NUS1
prerank,phospholipid catabolic process (GO:0009395),0.7124607796844411,1.6948228878331542,0.004815409309791332,0.26493859228249267,1.0,5/24,8.73%,GPCPD1;PLA2G4B;PNPLA6;GDPD1;ENPP2
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.7955006926930914,1.6931321675664919,0.007233273056057866,0.26629967799592946,1.0,6/13,5.24%,KDR;ENG;NOTCH4;CTNNB1;DLL4;COL4A1
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.4383568555234536,-1.6926814743685663,0.0,0.22572750740808972,1.0,36/152,12.61%,RNF220;WLS;SULF1;EGFR;ZEB2;LGR4;COL1A1;PTK7;GPC3;FGFR2;WNT5B;RSPO3;LRRK1;KANK1;SULF2;SALL1;LYPD6;TBL1XR1;DAAM2;PLEKHA4;RSPO2;DACT1;SFRP4;TNKS2;PSME4;UBR5;AXIN1;SMURF2;PPM1B;TRPM4;PSME3;CAPRIN2;LRRK2;BMP2;SCEL;SKI
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.7663867517087501,1.6926607107237286,0.01981981981981982,0.26365178024603264,1.0,3/13,3.22%,NAMPT;KDR;NOD2
prerank,ceramide metabolic process (GO:0006672),0.6077810401510705,1.6891620617087402,0.005805515239477504,0.27166796381576147,1.0,16/49,15.17%,SGMS1;ST6GALNAC3;SGMS2;DEGS2;ACER2;CERS4;ACER1;TLCD3B;SPTLC2;ORMDL1;ORMDL3;CERK;DEGS1;SPTLC1;FA2H;CLN8
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.5587741136578014,1.6879496150901336,0.0,0.271758502298193,1.0,16/93,5.21%,PLCB1;MFHAS1;DAB2IP;TGFB2;MAP4K2;TNFRSF19;APP;XDH;ANKRD6;SH3RF1;TIRAP;FLT4;TPD52L1;NOD2;WNT7A;CCR7
prerank,neurotransmitter uptake (GO:0001504),-0.7315191003217325,-1.6860758711752957,0.013303769401330377,0.23579310325864292,1.0,2/12,0.94%,ATP1A2;SLC1A3
prerank,negative regulation of cell junction assembly (GO:1901889),-0.6035373247014206,-1.6828539168790537,0.009779951100244499,0.2391848718237787,1.0,11/25,13.59%,PHLDB2;ARHGAP6;ROCK2;APOD;THBS1;ACE;ITGB1BP1;DMTN;ROBO2;BCAS3;PTEN
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.669539656894956,-1.682180919867807,0.008988764044943821,0.2363336979621492,1.0,7/16,11.35%,IGF1;ROCK2;CAMK2D;TRPC3;PRKCA;PARP1;SLC9A1
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.6539494922955441,1.6814348200815705,0.013029315960912053,0.2899524412675707,1.0,11/34,5.21%,FLT1;TEK;PDGFB;DAB2IP;PTK2;PIK3R3;NOD2;PIK3IP1;PRKD1;CD19;CCR7
prerank,modified amino acid transport (GO:0072337),-0.6709689224539359,-1.681195498132115,0.00975609756097561,0.23439994208755943,1.0,4/15,6.16%,SLC6A13;SLC16A12;PDPN;SLC5A6
prerank,endothelial cell development (GO:0001885),0.689113241209035,1.6797088459831275,0.006546644844517185,0.2916325569617618,1.0,12/25,8.46%,PECAM1;PPP1R16B;ROBO4;PDE2A;RAPGEF2;RAPGEF1;RAPGEF3;PDE4D;MARVELD2;RAP1B;SOX18;MSN
prerank,regulation of gastrulation (GO:0010470),-0.6693982065816861,-1.6797000657747396,0.01126126126126126,0.23338696674607354,1.0,4/14,7.67%,PHLDB2;OSR1;DAG1;PHLDB1
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.7499635420037155,1.6771120981356717,0.010810810810810811,0.29626880297482877,1.0,2/16,0.95%,IGF1R;INSR
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.653002535072228,-1.677095587271772,0.004914004914004914,0.23485356642859553,1.0,10/19,9.45%,TGFBR3;BMPR1A;FGFR2;ZFPM2;RBP4;TGFBR1;RBPJ;FGF2;GLI1;VGLL4
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.6626603950048595,1.675768820574953,0.02023608768971332,0.2971188893217577,1.0,9/30,12.39%,DACH1;BMPR2;ACVRL1;MEN1;TERF2;HNRNPC;DCP2;ACD;TERF1
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.6956336777601786,-1.6750996987600282,0.016203703703703703,0.2355031372571566,1.0,5/13,3.47%,FSTL1;FBN1;NBL1;LTBP1;GREM2
prerank,digestive tract development (GO:0048565),-0.5734991845800452,-1.6733920303531546,0.004878048780487805,0.235693427445632,1.0,13/32,7.96%,GLI3;CLMP;RARB;GLI2;FGFR2;COBL;PCSK5;PKD1;SMO;SALL1;KIT;GLI1;CHD8
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.7466960053285907,-1.6729415987656957,0.015486725663716814,0.23239818004146034,1.0,5/10,8.49%,PID1;APPL2;ENPP1;SELENOS;GRB10
prerank,phospholipid transport (GO:0015914),0.6040268661011624,1.672647801293403,0.004484304932735426,0.3039663805498369,1.0,15/52,9.76%,ATP10A;MFSD2A;PLTP;ATP8A1;ATP11B;SCARB1;ABCG1;ATP11A;PRELID2;PITPNC1;PITPNA;ABCA3;ABCA7;ATP11C;ATP10B
prerank,nuclear migration (GO:0007097),-0.7206887734595632,-1.6718181930522953,0.013513513513513514,0.23122073311904182,1.0,7/13,16.75%,DOCK7;SYNE2;CLMN;SYNE3;PCM1;FBXW11;SUN2
prerank,regulation of acrosome reaction (GO:0060046),0.834957603035798,1.6706369692485745,0.012259194395796848,0.3066018983922097,1.0,1/10,0.22%,PLCB1
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.8046670511129509,1.6701944278454088,0.017921146953405017,0.3043989333535634,1.0,2/10,1.57%,PRKCH;TRIM16
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.6672992718815143,-1.6632582742709423,0.011389521640091117,0.24755011881636538,1.0,8/16,6.56%,IGF1;TGFBR3;BMPR1A;FGFR2;ZFPM2;RBPJ;FGF2;GLI1
prerank,organic acid transport (GO:0015849),0.5561231500985088,1.6628163977238286,0.0013458950201884253,0.32729273584692953,1.0,11/94,2.92%,SLCO1C1;SLC6A6;ABCC4;SLC7A1;ABCG2;MFSD2A;SLCO2B1;PPARD;SLC38A5;NCOA1;SLC43A2
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.6890594061416214,-1.66268497017983,0.011013215859030838,0.2448569571884363,1.0,9/13,20.83%,ADHFE1;IDH2;D2HGDH;GOT1;PHYH;GPT2;L2HGDH;IDH1;GOT2
prerank,regulation of cell projection organization (GO:0031344),0.7532630183160378,1.6615994240909537,0.026465028355387523,0.3279403335858886,1.0,3/13,3.36%,MFSD2A;MACF1;NTNG2
prerank,aminoglycan biosynthetic process (GO:0006023),-0.5195080629567206,-1.6612296389346206,0.005813953488372093,0.24406162045532948,1.0,14/49,9.30%,GPC6;SDC2;B3GALT1;EXT1;GPC3;HS3ST3A1;HS2ST1;GPC4;PXYLP1;HS3ST3B1;HS6ST1;HS6ST2;SDC4;NDST2
prerank,tight junction assembly (GO:0120192),0.6115801403561472,1.6602668930264388,0.01059001512859304,0.3282546728850393,1.0,10/49,7.13%,OCLN;PECAM1;ESAM;CLDN5;F11R;PARD3;RAMP2;LSR;MARVELD2;CLDN14
prerank,lung development (GO:0030324),-0.5609675206938995,-1.6588691662526842,0.008,0.2455922002822588,1.0,11/33,6.24%,GLI2;ERRFI1;PDPN;FGFR2;BMP4;FGF1;PKD1;RBP4;LOXL3;FGF2;RCN3
prerank,positive regulation of cell motility (GO:2000147),0.49628053092872343,1.6567653270028007,0.002398081534772182,0.3368786228312635,1.0,35/205,7.33%,LEF1;SPOCK2;FLT1;IGF1R;SEMA3C;ITGA6;SEMA7A;PECAM1;SEMA6A;TJP1;PDGFB;KDR;INSR;PODXL;CXCL12;PDGFD;CAV1;NTN1;NEDD9;SEMA6B;PTK2;PIK3R3;TIAM1;NOTCH1;RIPOR1;VIL1;SEMA4F;SNAI2;CCR7;ACTN4;FAM107A;ADAM10;RET;SEMA6D;SPAG9
prerank,peptide catabolic process (GO:0043171),-0.6148599569019503,-1.656336358391055,0.012224938875305624,0.24798899273504624,1.0,8/23,13.64%,CPQ;ANPEP;GGT5;ACE;ENPEP;NPEPPS;IDE;CTSH
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.6258979684199127,-1.6562223025237999,0.022004889975550123,0.24432784474770336,1.0,7/21,9.98%,ATP1A2;CACNA1C;ANK2;DMD;CAMK2D;SLC8A1;PRKACA
prerank,carboxylic acid transport (GO:0046942),0.5945731688065452,1.6552860428445209,0.005865102639296188,0.33830125885962214,1.0,7/55,1.99%,SLC6A6;SLC7A5;SLC7A1;SLC1A1;SLC16A4;SLC16A2;SLC38A5
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.5127318364809876,1.6528126947807764,0.0,0.34398035347865596,1.0,28/151,9.84%,SGMS1;CERT1;MFSD2A;SGPP2;ELOVL7;SGMS2;DEGS2;ACER2;SPNS2;B4GALT5;GCH1;CERS4;ALAS1;PPM1L;PRKD2;PRKD1;PRKD3;SLC44A5;ACER1;MGST2;GSTA4;SPTLC2;CHKA;GPHN;ELOVL5;HPGDS;GSTK1;LPCAT3
prerank,chordate embryonic development (GO:0043009),-0.5164675204759954,-1.6524844383373498,0.003289473684210526,0.24948058590130306,1.0,16/55,6.88%,SULF1;ALDH1A2;COL1A1;BMP5;BMP7;FGFR2;ARNT2;PCSK5;PKD1;SULF2;RBP4;TGFBR1;PKD2;IGF2;DACT1;ZNF568
prerank,protein localization to cilium (GO:0061512),-0.5618009353711274,-1.6507979717870356,0.01092896174863388,0.25000747828983716,1.0,12/32,17.45%,TULP3;INVS;WDR35;ARL3;ZNF423;IFT122;BBS9;EHD1;RAB29;WDR19;SNX10;TULP1
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.6120662488940352,-1.6501558017124398,0.01643192488262911,0.24769022977578264,1.0,7/21,9.72%,BMP6;BMPR1A;BMP4;TGFBR1;DAB2;CCN3;TGFB3
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.5453138904794984,1.6494113899929996,0.007052186177715092,0.3520607795298163,1.0,60/87,32.36%,RPL38;RPL13;RPS29;RPL36A;RPL3;RPSA;SRP14;RPL27;RPS7;RPL9;RPLP2;RPL18;RPL13A;RPS11;RPL8;RPS27;RPL19;RPS9;RPL11;RPS15;RPL37;RPS28;RPS10;RPS25;RPL37A;RPL15;RPL17;RPL23;RPL34;RPS18;RPL21;RPS4X;RPS21;RPL18A;RPL10A;RPL24;RPL7A;ZFAND2B;RPL4;RPS2;RPL32;RPL6;SEC63;RPS20;RPL14;RPS13;RPL26;RPS19;RPS6;RPS14;RPS15A;RPS24;RPS23;RPS12;RPL12;RPL41;RPS3;RPS16;RPL27A;RPL10
prerank,receptor internalization (GO:0031623),0.5952932864371884,1.6484064761651003,0.009554140127388535,0.3515953904763731,1.0,12/44,8.27%,TFRC;DNM3;CAV1;RAB31;RAMP2;CALCRL;GRB2;RAMP3;GTF2H2;DNM2;AP2M1;CXCR2
prerank,positive regulation of angiogenesis (GO:0045766),0.5348999409490194,1.6483291099538344,0.0013157894736842105,0.34783741311352645,1.0,34/108,14.43%,FLT1;TEK;ETS1;TJP1;PIK3R6;KDR;TIE1;CD34;NOS3;CD40;APLNR;PRKD2;PRKD1;RAMP2;RAPGEF3;PLCG1;GATA2;GAB1;RHOB;KLF4;PKM;PGF;BTG1;SMAD1;HSPB1;HIF1A;PRKCB;TNFSF12;HIPK2;ADAM12;CDH5;PDCD6;SP1;ANGPTL4
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.8039330845874777,1.6453371860947064,0.02394106813996317,0.3550700667364052,1.0,4/11,2.49%,TJP1;RAPGEF2;TJP2;F11R
prerank,embryonic hemopoiesis (GO:0035162),0.7686166288323004,1.6452722673062485,0.012658227848101266,0.3512888344114681,1.0,4/12,5.28%,KITLG;KDR;ZFPM1;TAL1
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.5880645749281638,1.6452502516115097,0.020155038759689922,0.3473873697186772,1.0,20/48,11.79%,ETS1;JCAD;PDGFB;KDR;NOS3;CD40;PRKD2;PRKD1;HDAC9;HDAC7;PLCG1;TMSB4X;GATA2;TGFB1;MAP3K3;ADAM17;PIK3C2A;HSPB1;HIF1A;ATP5F1A
prerank,mesoderm development (GO:0007498),0.7019410882605985,1.6452349281580372,0.01232394366197183,0.3435387836016726,1.0,5/18,6.96%,TIE1;TBX1;TBX3;MESD;HCK
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.53015154519795,-1.6451547466550278,0.009615384615384616,0.25632983870876436,1.0,17/40,12.50%,BMP6;BMPR1A;WNT4;BMP7;BMP4;OSR1;WNT6;ADGRV1;ANO6;KL;CCN1;SLC8A1;TGFB3;CEBPB;PKDCC;BMP2;FBN2
prerank,retinoic acid metabolic process (GO:0042573),-0.6712436795426355,-1.6449881842141802,0.022271714922048998,0.253138717130344,1.0,3/14,6.81%,ALDH1A2;CYP26B1;SCPEP1
prerank,cartilage development (GO:0051216),-0.512085664182177,-1.6447727413935394,0.00558659217877095,0.2500387704541642,1.0,15/49,9.26%,SULF1;SOX5;BMP4;WNT5B;OSR1;ITGB8;PKD1;SULF2;CREB3L2;SLC39A14;FGF2;RUNX2;ATP7A;CCN3;SOX6
prerank,eye morphogenesis (GO:0048592),-0.6254501716046065,-1.6445353857311327,0.019230769230769232,0.2470811784994266,1.0,9/19,13.80%,FBN1;COL5A2;COL5A1;EFEMP1;MFAP5;IFT122;FBN2;SKI;NF1
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.7453576045956627,-1.644409514762849,0.013015184381778741,0.24386656723526945,1.0,7/10,18.77%,HOXB4;ACE;MLLT3;LMBR1L;SFRP1;BATF;SP7
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.707824214254252,1.6437750791964842,0.02155887230514096,0.34502627231883476,1.0,6/20,12.29%,PLCB1;AGRN;GNAQ;LYPD1;CHRM3;GNB1
prerank,positive regulation of interferon-gamma production (GO:0032729),0.5866543563155271,1.6436272041497824,0.006568144499178982,0.3417612394054113,1.0,11/48,12.59%,SLC7A5;IL1R1;ZFPM1;PDE4D;TLR3;LGALS9;TLR7;PDE4B;EBI3;TLR8;CYRIB
prerank,positive regulation of T cell activation (GO:0050870),0.5705070423989321,1.6434346861222697,0.007462686567164179,0.3386646112072704,1.0,16/62,15.57%,TFRC;SLC7A1;JAK3;NOD2;ZAP70;CD6;CCR7;CCDC88B;LGALS9;TNFSF11;PNP;CYRIB;IL15;NCKAP1L;VCAM1;NCK1
prerank,cAMP biosynthetic process (GO:0006171),-0.7393583951733929,-1.6418840656308946,0.012958963282937365,0.24656082190801487,1.0,5/10,5.06%,ADCY5;ADCY1;ADCY9;ADCY2;ADCY7
prerank,bicellular tight junction assembly (GO:0070830),0.6138016141011349,1.6406270625655066,0.015384615384615385,0.34477623523105433,1.0,9/46,7.13%,OCLN;PECAM1;ESAM;CLDN5;F11R;PARD3;RAMP2;MARVELD2;CLDN14
prerank,positive regulation of isotype switching (GO:0045830),0.7430605578726757,1.640609316437855,0.0216998191681736,0.3412004127122154,1.0,4/15,7.94%,TFRC;CD40;SHLD1;TGFB1
prerank,positive regulation of cellular component movement (GO:0051272),0.6909512722599227,1.6391091662808128,0.00819672131147541,0.3432689230814592,1.0,6/24,6.02%,SPOCK2;ETS1;NTN1;LYN;CCR7;ACTN4
prerank,histone H3 acetylation (GO:0043966),0.6075107289144213,1.6387496374286958,0.021035598705501618,0.3408911272754438,1.0,12/40,14.09%,LEF1;TRIM16;YEATS2;BRCA2;KAT6A;NAA60;BRD1;BRPF1;JADE2;POLE3;BRPF3;PHF14
prerank,positive regulation of cell adhesion (GO:0045785),0.5514297424916261,1.638119471706969,0.011494252873563218,0.33981460201425184,1.0,16/74,6.61%,NDNF;FRMD5;PDGFB;CXCL12;TGFB2;MAGI1;STX3;ADGRG1;PTPRJ;PRKD2;TGM2;SMAD7;CCR7;EPHA4;RSU1;RET
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.6772624129124027,1.63683643395448,0.024390243902439025,0.3408198091506825,1.0,7/26,10.81%,OCLN;FES;CLIP1;CDK5RAP2;PAK1;AKAP9;RAC1
prerank,alanine transport (GO:0032328),0.8108279630109693,1.636715709023956,0.022944550669216062,0.3378174587344837,1.0,1/10,0.07%,SLC6A6
prerank,negative regulation of epithelial cell migration (GO:0010633),0.627924050846852,1.6363290425650943,0.023923444976076555,0.3358590427864319,1.0,9/33,4.99%,PTPRG;PTPRM;DAB2IP;MCC;SP100;ACVRL1;EVL;VASH1;DLL4
prerank,heart morphogenesis (GO:0003007),0.5810089572001141,1.6360838126139645,0.0125,0.33345161205083973,1.0,11/50,3.41%,INSR;ENG;TGFB2;NOS3;TBX1;TBX3;SOX17;PTK2;ACVRL1;ZFPM1;NOTCH1
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.6339225302695222,-1.6334025505062337,0.02027027027027027,0.2645474201595809,1.0,4/18,5.98%,IGF1;IGFBP2;IL18;IGF2
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.6123653321521026,1.6328789703883217,0.011475409836065573,0.341443983532169,1.0,7/36,6.71%,SGMS1;DAB2IP;FAS;TPD52L1;PTPMT1;PPIA;CRADD
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.555331908877917,1.632528298383157,0.004322766570605188,0.33968279708830307,1.0,13/75,4.60%,TEK;EGFL7;JCAD;PDGFB;KDR;PPP1R16B;BMPR2;FLT4;APLNR;PRKD2;PRKD1;PLCG1;GATA2
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.5943275800890769,1.6300879495774598,0.01059001512859304,0.34462265457580865,1.0,17/47,11.15%,IGF1R;DAB2IP;TGFB2;FAS;PHLPP1;FOXO1;NOD2;PPIA;MAPK3;LGALS9;GREM1;SEMA4C;PDCD10;MID1;AGER;MAP4K4;ARL6IP5
prerank,regulation of vasculogenesis (GO:2001212),0.7488921658733216,1.6290321717012415,0.03163444639718805,0.34510453031967164,1.0,4/14,1.71%,KDR;CD34;RAPGEF2;XDH
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.7054076483975045,-1.6276000616404973,0.01020408163265306,0.2750342747312877,1.0,2/12,3.22%,NUPR1;IL18
prerank,regulation of protein neddylation (GO:2000434),0.7844254625399467,1.6273824428190158,0.01651376146788991,0.3471894108347325,1.0,6/10,13.29%,EPAS1;DCUN1D3;COPS9;HIF1A;DCUN1D1;RPL11
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.6692552121111329,-1.627312916462787,0.017467248908296942,0.2719038141791033,1.0,8/15,20.44%,ADAM9;APOE;SNX9;SNX33;NRDC;PACSIN3;ADRA2A;ADAM8
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.7083801881711073,-1.6266848298652954,0.022222222222222223,0.27005983548428947,1.0,4/12,11.02%,ANK2;ANXA6;DIAPH1;PTK2B
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.759061003384789,1.6261323223839295,0.013059701492537313,0.34841835032748203,1.0,3/12,0.97%,PROM1;MYO1E;PODXL
prerank,regulation of cardiac conduction (GO:1903779),-0.5009724136316609,-1.6242039744731394,0.006097560975609756,0.2729218324471968,1.0,14/54,10.04%,ATP1A2;ANK2;ITPR1;STIM1;SLC8A3;DMPK;ASPH;ABCC9;ATP1B3;TMEM65;ATP1B2;SLC8A1;PRKACA;ITPR2
prerank,regulation of interleukin-13 production (GO:0032656),0.7532363869390355,1.624149437980713,0.018018018018018018,0.35227764385391463,1.0,3/13,6.29%,LEF1;TNFRSF21;LGALS9
prerank,response to axon injury (GO:0048678),-0.6273373419974166,-1.6240792899935097,0.02823529411764706,0.26957840933656857,1.0,6/18,21.99%,DPYSL3;APOD;P2RX4;SARM1;GAP43;TYROBP
prerank,receptor metabolic process (GO:0043112),0.567996210575033,1.6237531134319216,0.0076103500761035,0.3503572295204202,1.0,16/53,12.14%,TFRC;DNM3;CAV1;RAB31;RAMP2;CALCRL;GRB2;RAMP3;REP15;DNM2;TGFB1;AP2M1;CXCR2;SMURF1;SH3GLB1;SYK
prerank,cellular response to fatty acid (GO:0071398),-0.7045685159603352,-1.622872432572025,0.021739130434782608,0.26966419046741774,1.0,2/12,2.50%,PID1;IRS1
prerank,cellular zinc ion homeostasis (GO:0006882),0.6512346281412257,1.6207886589877536,0.013311148086522463,0.35753900494756347,1.0,11/26,13.76%,SLC39A10;SLC39A8;SLC30A1;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X
prerank,clathrin coat assembly (GO:0048268),0.7292839814047549,1.6204141931813054,0.019963702359346643,0.355642143688412,1.0,5/15,12.02%,HIP1;HIP1R;FCHO2;PIK3C2A;EPS15
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.7059169698108174,-1.6203777668958077,0.025806451612903226,0.2726300842769395,1.0,8/12,16.09%,PARP8;PARP3;TNKS2;PARP6;PARP11;PARP1;PARP12;TIPARP
prerank,regulation of T cell proliferation (GO:0042129),0.5683744229093328,1.6196398594119525,0.004531722054380665,0.35517058947970437,1.0,12/61,15.57%,TFRC;SLC7A1;JAK3;TNFRSF21;CD6;CCDC88B;FOXP3;PNP;IL15;NCKAP1L;VCAM1;NCK1
prerank,regulation of endothelial cell proliferation (GO:0001936),0.5374435581238852,1.6169575309987976,0.0028089887640449437,0.3614892364102874,1.0,16/88,3.64%,TEK;PTPRM;EGFL7;PDGFB;KDR;PPP1R16B;TIE1;BMPR2;XDH;CAV1;FLT4;RGCC;ACVRL1;PRKD2;PRKD1;VASH1
prerank,positive regulation of interleukin-12 production (GO:0032735),0.6277415470398233,1.6159115637249806,0.027914614121510674,0.36199848082362196,1.0,9/31,12.14%,PLCB1;TIRAP;CD40;CCR7;TLR3;LGALS9;IRF5;AGER;SYK
prerank,regulation of transmembrane transport (GO:0034762),0.6303256827321757,1.6151182413681056,0.026272577996715927,0.36187792824390624,1.0,5/31,3.92%,OCLN;SLC2A1;CTTNBP2NL;NEDD4L;ACTB
prerank,epithelial cell morphogenesis (GO:0003382),-0.6460302948970512,-1.6145746813704314,0.014251781472684086,0.2843269583958354,1.0,6/17,13.44%,COL22A1;COL18A1;COL15A1;MET;DACT2;RILPL2
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.4293689013416499,-1.6143410898282442,0.004484304932735426,0.28145447310760646,1.0,28/129,12.60%,RNF220;WLS;EGFR;ZEB2;LGR4;COL1A1;PTK7;GPC3;FGFR2;LRRK1;KANK1;LYPD6;TBL1XR1;DAAM2;PLEKHA4;DACT1;SFRP4;TNKS2;PSME4;UBR5;AXIN1;SMURF2;PPM1B;TRPM4;PSME3;CAPRIN2;LRRK2;SCEL
prerank,apical junction assembly (GO:0043297),0.5874038002384553,1.6138359984461255,0.012066365007541479,0.3633377329071354,1.0,10/53,7.13%,OCLN;PECAM1;ESAM;CLDN5;F11R;PARD3;RAMP2;MARVELD2;PKN2;CLDN14
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.6811780068591974,1.6131015821624777,0.027164685908319185,0.3625629889202644,1.0,5/20,13.49%,FAR2;FASN;ACSL3;SLC25A1;HSD17B8
prerank,ameboidal-type cell migration (GO:0001667),0.5847252072261611,1.6102028879615864,0.007429420505200594,0.3692190699902724,1.0,15/51,9.48%,SEMA3C;SEMA7A;SEMA6A;SRGAP2;TBX1;SEMA6B;PKN3;AMOT;SEMA4F;PKN1;NANOS1;PKN2;SEMA6D;SEMA4C;PHACTR4
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.49050723355630504,1.6094727430294902,0.0013003901170351106,0.36881407493613105,1.0,31/149,11.78%,TFRC;PRKCH;APP;CAV1;NFKBIA;TIRAP;TRIM25;TNFRSF11A;TRIM14;ARHGEF2;NOD1;CD40;NOD2;PRKD2;PRKD1;IKBKB;PPIA;LGALS9;RPS6KA5;AIM2;CRNN;PIDD1;IRAK2;TNFSF11;MALT1;UBE2V1;LAMTOR5;AGER;S100A8;ZBTB7A;PRKCB
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.5689702071667356,1.6089756310405514,0.004398826979472141,0.3675856310428951,1.0,9/63,6.14%,TFRC;SLC7A1;TIRAP;MEF2C;CD40;JAK3;CD6;CD38;CCDC88B
prerank,regulation of muscle contraction (GO:0006937),-0.56996196662466,-1.608323854641595,0.0175,0.2940004555299225,1.0,7/26,8.70%,ATP1A2;PLCE1;TPM1;PPP1R12B;ANXA6;KCNB2;MYL9
prerank,vesicle transport along actin filament (GO:0030050),0.6994054929005048,1.6072645970507988,0.016245487364620937,0.37061044989241226,1.0,5/19,6.02%,MYO1D;MYO1E;FNBP1L;MYO6;ACTN4
prerank,nitric oxide mediated signal transduction (GO:0007263),0.7066035186879301,1.6067238940172104,0.034722222222222224,0.369412122831656,1.0,5/16,5.32%,NDNF;NOS3;DDAH1;NOS2;KCNC2
prerank,innate immune response (GO:0045087),0.47680409836930654,1.6064710038348506,0.0,0.3671857747872139,1.0,46/217,14.16%,MFHAS1;PGLYRP1;APP;FES;GCH1;TRIM25;TRIM14;B2M;PTK2;SERINC3;SP100;CD40;ADAM15;DEFA6;NOD2;IFIH1;NLRC5;ZAP70;LYN;SERINC5;IKBKB;ADAR;NOS2;CFD;TLR3;NRROS;FYN;YES1;HCK;IRF5;BST2;IRGM;SHMT2;MALT1;PTK6;AGER;CYBB;TLR8;SYK;PPARG;TNK2;RNF187;SLPI;CYLD;TRIM39;BCL10
prerank,regulation of neuron projection arborization (GO:0150011),0.7365431351505284,1.606380168911423,0.025454545454545455,0.3645486158686441,1.0,4/15,3.36%,MFSD2A;MACF1;FZD4;NTNG2
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.6762580333269299,-1.6058827736266077,0.017391304347826087,0.2968852299126751,1.0,4/14,13.73%,MOXD1;DAGLA;SLC5A7;SLC22A2
prerank,metanephros development (GO:0001656),-0.5727564791920653,-1.605843967957309,0.01728395061728395,0.2935125849226736,1.0,12/26,17.54%,FOXD1;BMP7;BMP4;OSR1;PKD1;PKD2;SIX1;ROBO2;CTSH;NF1;SIX4;PAX2
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.5510679498946498,1.605762996386167,0.01002865329512894,0.36368461126209956,1.0,24/67,12.37%,FLT1;KDR;DAB2IP;WASF2;DOCK1;ELMO1;FLT4;PTK2;PRKD2;PRKD1;PXN;ELMO2;BAIAP2;FYN;NCKAP1;PGF;CYFIP1;SHB;CYBB;RAC1;HSPB1;CLEC14A;NCF4;PIK3CB
prerank,mesonephros development (GO:0001823),-0.7109502095587056,-1.6048554984648178,0.020134228187919462,0.2924967255922577,1.0,4/11,2.23%,BMP7;BMP4;OSR1;FGF1
prerank,regulation of extracellular matrix disassembly (GO:0010715),-0.651943480534082,-1.604720893044179,0.036093418259023353,0.28959470908286006,1.0,5/15,8.56%,LRP1;PDPN;DDR1;FAP;DPP4
prerank,insulin receptor signaling pathway (GO:0008286),0.5567396726607177,1.6045220124480484,0.0014367816091954023,0.3649992665707853,1.0,17/69,10.47%,IGF1R;GRB14;NAMPT;INSR;BCAR3;FOXO1;PIK3R3;ATP6V0A1;GRB2;GAB1;BAIAP2;SOS1;AP3S1;SORBS1;CAV2;PIK3C2A;GRB7
prerank,positive regulation of microtubule polymerization (GO:0031116),0.6401303994823319,1.6042089202037273,0.03454231433506045,0.3631781824137877,1.0,9/28,15.38%,OCLN;FES;CLIP1;CDK5RAP2;PAK1;AKAP9;RAC1;GIT1;CKAP5
prerank,regulation of GTPase activity (GO:0043087),0.4955144544910343,1.6022251665521428,0.0,0.36678090392707846,1.0,46/177,11.94%,CHN2;ITGA6;DOCK9;FGD5;LRCH1;SRGAP2;DAB2IP;RASIP1;RAPGEF2;SH3BP4;ARHGAP27;NET1;BCAR3;F11R;PTK2;AGRN;PLXND1;CD40;RAPGEF1;SNX13;RAPGEF3;PRKG1;TGM2;TBC1D2;USP6NL;MAPRE2;EPHA4;RSU1;RAP1GDS1;OCRL;RASGRP2;STMN3;FICD;PKP4;ARHGEF5;PIN1;ARHGEF7;CAV2;FGD6;TBC1D10B;FERMT2;CCL1;MAP4K4;PLXNB3;HRAS;TBC1D30
prerank,monocarboxylic acid transport (GO:0015718),0.5833393100711478,1.6004407373992204,0.014925373134328358,0.3701096655919219,1.0,7/51,2.80%,SLCO1C1;ABCC4;ABCG2;SLCO2B1;SLC16A4;SLC16A2;NCOA1
prerank,regulation of chemokine production (GO:0032642),0.5912182786966583,1.599366368519821,0.030015797788309637,0.3711724836600104,1.0,10/36,11.75%,APP;IL6R;SIGIRR;SNAI2;TLR3;LGALS9;TLR7;ADAM17;AGER;HIF1A
prerank,regulation of neuron migration (GO:2001222),0.6426189540987337,1.5992818280046746,0.029459901800327332,0.3686065391930758,1.0,7/26,3.36%,SEMA6A;SRGAP2;DAB2IP;RAPGEF2;ADGRG1;ARHGEF2;NTNG2
prerank,regulation of DNA biosynthetic process (GO:2000278),0.6287341817322647,1.598202173676117,0.023140495867768594,0.3697180777467325,1.0,7/27,3.79%,DACH1;PDGFB;BMPR2;RGCC;ACVRL1;PRKD2;HMBOX1
prerank,carbohydrate derivative transport (GO:1901264),0.7022596875964705,1.5978186584683625,0.02040816326530612,0.3680947553623576,1.0,5/18,6.47%,MFSD2A;PLTP;SCARB1;ABCG1;SLC10A7
prerank,zinc ion transmembrane transport (GO:0071577),0.6673118870547645,1.5974248034122982,0.027586206896551724,0.3667059217338367,1.0,3/22,3.00%,SLC39A10;SLC39A8;SLC30A1
prerank,positive regulation of cell migration (GO:0030335),0.47104986518566583,1.597068091104368,0.0011695906432748538,0.36517338255469173,1.0,56/253,11.13%,LEF1;FLT1;IGF1R;SEMA3C;ITGA6;SEMA7A;PECAM1;SEMA6A;TJP1;PDGFB;KDR;INSR;PODXL;DAB2IP;BMPR2;CXCL12;TGFB2;RAPGEF2;PDGFD;DOCK1;CAV1;NEDD9;SEMA6B;ARHGEF2;PTK2;PIK3R3;TIAM1;NOTCH1;RIPOR1;VIL1;PLCG1;RREB1;SEMA4F;SNAI2;GAB1;ACTN4;FAM107A;INSL3;ADAM10;RET;RAB11A;SEMA6D;SPAG9;TGFB1;ARHGEF7;ENPP2;PAK1;SEMA4C;ACTG1;ADAM17;PDCD10;CBLL1;GRB7;FERMT2;PPP3CA;MAP4K4
prerank,ganglioside metabolic process (GO:0001573),0.6795324893516919,1.5969910947374366,0.03152364273204904,0.362774498673108,1.0,3/20,1.10%,ST8SIA4;ST6GALNAC3;ST8SIA6
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.704189678156379,1.5965923404248994,0.03626943005181347,0.36166027442753196,1.0,9/17,16.15%,TGFB2;NOD2;LYN;SEMA4C;PDCD10;MID1;ARL6IP5;INAVA;KLHDC10
prerank,glycosaminoglycan metabolic process (GO:0030203),-0.48956431627461305,-1.594413794952942,0.014492753623188406,0.3139004142775496,1.0,19/54,15.11%,GPC6;SDC2;EXT1;GPC3;HS3ST3A1;HS2ST1;GPC4;PXYLP1;HS3ST3B1;HS6ST1;HS6ST2;SDC4;NDST2;HEXA;GNS;NDST1;B3GAT1;HGSNAT;HPSE2
prerank,cellular response to drug (GO:0035690),0.6499937052546413,1.5933502078245898,0.021922428330522766,0.36956956476336805,1.0,7/25,8.49%,TFRC;ACER2;MEF2C;KCNQ1;AIM2;KCNH2;PDE4B
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.724141632211897,-1.593346843549505,0.01939655172413793,0.31347334386154335,1.0,3/11,2.30%,EGFR;BMP4;DDX5
prerank,cellular transition metal ion homeostasis (GO:0046916),0.5262031358890427,1.5930401397118255,0.008344923504867872,0.36795889590601777,1.0,9/91,4.06%,SLC39A10;TFRC;SLC40A1;ABCG2;SLC39A8;APP;ATOX1;SLC30A1;SLC31A1
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.6470011916741238,1.5930136022390577,0.02711864406779661,0.3654212171540793,1.0,5/24,4.60%,TEK;NDNF;KDR;RAMP2;GATA2
prerank,glucose transmembrane transport (GO:1904659),0.6873965117499277,1.5914670995889306,0.037037037037037035,0.367978085886641,1.0,3/18,5.20%,SLC2A1;PPARD;SORT1
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.5815860200004734,-1.5909981316841664,0.03359173126614987,0.31642623556234184,1.0,6/24,10.93%,PID1;LEPR;PPARGC1A;GFPT1;GFPT2;COQ10A
prerank,embryonic organ morphogenesis (GO:0048562),-0.5292544593580264,-1.5900420986271835,0.005571030640668524,0.3156943184009501,1.0,13/42,5.58%,FBN1;PDGFRA;EFEMP1;HOXC4;FGFR2;HOXB3;HOXA3;MFAP5;HOXB4;RBP4;DYNC2I1;RBPMS2;SIX1
prerank,calcium ion transmembrane transport (GO:0070588),-0.4489378097983194,-1.5893407258287704,0.003436426116838488,0.31423239482697535,1.0,25/86,12.68%,SLC24A3;TRPM3;CACNA1C;NALCN;MCU;PKD1;SLC8A3;ANO6;CACNA2D1;TRPC3;PKD2;CACNA1G;TRPM6;SLC35G1;SLC8B1;SLC8A1;P2RX4;CACNA1D;TRPC6;ITGAV;TRPM4;AFG3L2;TRPC4;SLC24A5;TRPC4AP
prerank,peptidyl-tyrosine modification (GO:0018212),0.5619254530273182,1.588447876331548,0.005865102639296188,0.3757070997011958,1.0,15/56,6.96%,FLT1;TEK;PDGFB;KDR;INSR;FES;FLT4;PTK2;JAK3;ZAP70;LYN;EPHA4;TPST2;FYN;HCK
prerank,oligosaccharide metabolic process (GO:0009311),0.5900983087670791,1.5882441353788306,0.0121580547112462,0.37392240071040683,1.0,14/46,14.36%,ST8SIA4;ST6GALNAC3;ST3GAL6;ST8SIA6;FUT8;NEU4;FUT9;B3GALT4;ST6GALNAC4;MAN1B1;MANBA;B3GALT2;NEU2;MAN2B1
prerank,sulfation (GO:0051923),-0.7081350486092457,-1.587825001704261,0.029473684210526315,0.3154618598362959,1.0,1/11,0.06%,UST
prerank,neural crest cell development (GO:0014032),0.5878150477069366,1.5871081603916175,0.0136986301369863,0.3753531206701881,1.0,15/44,14.53%,SEMA3C;SEMA7A;SEMA6A;TBX1;SEMA6B;CDH2;SEMA4F;SNAI2;SEMA6D;SEMA4C;PHACTR4;SOX10;SOX11;PDCD6;SEMA3G
prerank,positive regulation of tissue remodeling (GO:0034105),-0.7258517687693623,-1.587044468295356,0.032119914346895075,0.3141976780854024,1.0,2/10,3.22%,ROCK2;IL18
prerank,regulation of vasculature development (GO:1901342),0.6411126176255528,1.585696197514497,0.03204047217537943,0.3774939336083857,1.0,6/26,4.65%,ETS1;PLXND1;SP100;VASH1;CTNNB1;TSPAN12
prerank,odontogenesis (GO:0042476),-0.5311973551855003,-1.5842654153445805,0.01876675603217158,0.3186681426706885,1.0,9/35,3.80%,COL1A2;GLI2;EDA;FGFR2;BMP4;OSR1;WNT6;BCOR;FOXC1
prerank,synapse assembly (GO:0007416),0.5454128901610338,1.5840887678844917,0.008955223880597015,0.3802958369748186,1.0,14/67,9.65%,SPOCK2;DNM3;SHANK3;ADGRL3;PLXND1;FGF13;CDH2;WNT7A;DBNL;GRID2;SLITRK1;GPM6A;NRXN1;DNER
prerank,embryonic digestive tract development (GO:0048566),-0.6049908515629758,-1.583937187197885,0.02745995423340961,0.31637986773370413,1.0,8/18,5.48%,GLI3;RARB;PDGFRA;GLI2;FGFR2;PCSK5;SALL1;RBPMS2
prerank,cotranslational protein targeting to membrane (GO:0006613),0.5192911792263826,1.5836965495182276,0.009762900976290097,0.3790219666343336,1.0,62/91,32.36%,SEC62;RPL38;RPL13;RPS29;RPL36A;RPL3;RPSA;SRP14;RPL27;RPS7;RPL9;RPLP2;RPL18;RPL13A;RPS11;RPL8;RPS27;RPL19;RPS9;RPL11;RPS15;RPL37;RPS28;RPS10;RPS25;RPL37A;RPL15;RPL17;RPL23;RPL34;RPS18;RPL21;RPS4X;RPS21;RPL18A;RPL10A;RPL24;SRPRA;RPL7A;RPL4;RPS2;RPL32;RPL6;SEC63;RPS20;RPL14;RPS13;RPL26;RPS19;RPS6;RPS14;SSR1;RPS15A;RPS24;RPS23;RPS12;RPL12;RPL41;RPS3;RPS16;RPL27A;RPL10
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.504183473116334,-1.583286326890399,0.0028169014084507044,0.31487589330151045,1.0,16/43,12.11%,IGF1;BMPR1A;PDGFRB;IGFBP5;BMP4;GJA1;IL18;THBS1;FGF2;RBPMS2;MMP2;FOXJ2;CCN4;CDH13;ADAMTS1;MFN2
prerank,respiratory tube development (GO:0030323),-0.5551298704056965,-1.581941651299613,0.015345268542199489,0.3154743509101336,1.0,9/28,4.75%,GLI2;PDPN;FGFR2;BMP4;FGF1;PCSK5;RBP4;LOXL3;FGF2
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.6625346972242396,-1.581692379495235,0.03611738148984198,0.3129350058705617,1.0,4/13,12.31%,BMP5;DKK3;APOE;BMP2
prerank,early endosome to Golgi transport (GO:0034498),-0.6937496706863856,-1.5809615109137145,0.03023758099352052,0.3115194830039841,1.0,7/11,22.40%,STX5;SNX8;RAB6A;LMAN1;TRAPPC10;SURF4;TMED9
prerank,positive regulation of locomotion (GO:0040017),0.6435198771094611,1.5808159730092173,0.01751592356687898,0.38640648213677165,1.0,6/27,7.94%,SPOCK2;PDGFB;NTN1;STX3;CCR7;TGFB1
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.5583970630834159,-1.5808052419286494,0.019230769230769232,0.3089250518219876,1.0,10/27,22.88%,EGFR;BMP4;DDX5;AGO2;TNRC6B;FMR1;LIMD1;EIF4G1;AJUBA;MAP2K1
prerank,zinc ion homeostasis (GO:0055069),0.622596995037764,1.5802068157113927,0.024350649350649352,0.385805564275692,1.0,11/28,13.76%,SLC39A10;SLC39A8;SLC30A1;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.6071018643258775,1.5801842393259735,0.03015873015873016,0.38330431519774805,1.0,13/36,12.37%,NOSTRIN;NOS3;CAV1;DDAH1;GCH1;SCARB1;CALM1;DNM2;TERF2;LYPLA1;AGTR2;HIF1A;PIK3CB
prerank,regulation of interleukin-2 production (GO:0032663),0.5855840444762546,1.5796363949044974,0.01615508885298869,0.3826582867550251,1.0,12/43,12.24%,SPTBN1;CD34;PRKD2;HDAC7;HOMER2;PDE4D;CD4;PDE4B;FOXP3;MALT1;PNP;TNFAIP3
prerank,regulation of striated muscle contraction (GO:0006942),-0.5500567893728556,-1.578971924777948,0.027906976744186046,0.3104115781502289,1.0,6/27,9.98%,ATP1A2;ANK2;SLC8A3;DMD;P2RX4;PRKACA
prerank,regulation of B cell proliferation (GO:0030888),0.5826611953279379,1.5782690484522803,0.013657056145675266,0.3845937243380158,1.0,7/44,5.80%,TFRC;TIRAP;MEF2C;CD40;LYN;TNFRSF21;CD38
prerank,intraciliary retrograde transport (GO:0035721),-0.6748811198869228,-1.5759682990872517,0.015151515151515152,0.3155044259762466,1.0,6/12,14.45%,WDR35;DYNC2I1;DYNC2H1;IFT122;DYNC2I2;WDR19
prerank,regulation of T cell migration (GO:2000404),0.6789179365508499,1.5756730831477568,0.03664921465968586,0.39091827868058376,1.0,4/18,2.15%,LRCH1;CXCL12;APP;CD200
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.6218048143856765,-1.5750556574806336,0.03587443946188341,0.3116065266347521,1.0,8/16,13.59%,PHLDB2;ARHGAP6;APOD;THBS1;ITGB1BP1;DMTN;BCAS3;PTEN
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.6218048143856765,-1.5750556574806336,0.03587443946188341,0.3116065266347521,1.0,8/16,13.59%,PHLDB2;ARHGAP6;APOD;THBS1;ITGB1BP1;DMTN;BCAS3;PTEN
prerank,cardiac muscle contraction (GO:0060048),-0.5456744997468547,-1.5725258155593087,0.005208333333333333,0.315331234772536,1.0,7/34,10.26%,ATP1A2;GSN;TPM1;DMD;CAMK2D;SLC8A1;GAA
prerank,positive regulation of vasculogenesis (GO:2001214),0.7719416759262179,1.5724776002689067,0.045871559633027525,0.39943920959626655,1.0,3/10,1.44%,KDR;CD34;RAPGEF2
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.5469514281824159,-1.572287859401783,0.012195121951219513,0.3130174931433734,1.0,10/31,5.58%,PDGFRA;HOXC4;FGFR2;OSR1;HOXB3;HOXA3;HOXB4;DYNC2I1;TGFBR1;SIX1
prerank,negative regulation of angiogenesis (GO:0016525),0.5168069157829878,1.5716087722706233,0.010144927536231883,0.3998640236848541,1.0,20/84,7.43%,TEK;PTPRM;SEMA6A;CLDN5;DAB2IP;TGFB2;EPN2;STAB1;COL4A2;RGCC;AMOT;VASH1;KLF2;SARS1;HHEX;CTNNB1;STAT1;KLF4;GTF2I;CD160
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.5430780677500642,1.5703209784670886,0.0103397341211226,0.40146607142488255,1.0,10/72,3.86%,FLT1;IGF1R;TEK;PDGFB;KDR;INSR;TGFB2;PDGFD;PTK2;LYN
prerank,negative regulation of wound healing (GO:0061045),-0.5495963628222068,-1.569444036252403,0.019553072625698324,0.3174405794039915,1.0,9/28,8.31%,PHLDB2;TFPI;VTN;SLC12A2;CASK;FGF2;THBD;CD109;APOE
prerank,skin development (GO:0043588),-0.45780763544965364,-1.569118754051919,0.006134969325153374,0.3154072559992341,1.0,22/65,14.36%,COL1A2;COL3A1;COL5A2;COL1A1;COL5A1;ERRFI1;PKD1;ADAM9;ANXA1;TXNIP;ATP7A;MET;JAG1;COL5A3;ITGB4;CLDN1;GATA6;BCR;DACT2;SCEL;SLC2A10;CASP3
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.565749305720496,-1.568712522456586,0.019464720194647202,0.31355137236285174,1.0,8/25,8.71%,ANK2;ACTN2;SLC6A9;DMD;WNK4;ATP1B3;ATP1B2;TRPC6
prerank,keratan sulfate catabolic process (GO:0042340),-0.6943596554743541,-1.567867371878306,0.03837953091684435,0.3130892043532896,1.0,7/11,12.56%,OGN;FMOD;PRELP;LUM;OMD;HEXA;GNS
prerank,modulation by symbiont of entry into host (GO:0052372),0.6917962528998295,1.5664937213982253,0.03502626970227671,0.411832644190691,1.0,3/16,2.37%,CAV1;TRIM25;TRIM14
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.7149727779895083,1.5661537588451475,0.04569420035149385,0.41049322731465465,1.0,2/14,6.72%,TFRC;SHLD1
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.6939718837676844,1.5646034746517816,0.028368794326241134,0.41333683319140224,1.0,5/18,12.29%,PLCB1;AGRN;GNAQ;CHRM3;GNB1
prerank,camera-type eye morphogenesis (GO:0048593),-0.7083898627423548,-1.5638979440749756,0.030434782608695653,0.320216399870478,1.0,6/10,20.14%,KDM2B;IFT122;SKI;NF1;LRP6;TBX2
prerank,phospholipid biosynthetic process (GO:0008654),0.5927982836101614,1.5629790529794205,0.027243589743589744,0.416390892090442,1.0,3/36,1.86%,SGMS1;SGMS2;MBOAT1
prerank,neural crest cell migration (GO:0001755),0.5964955310643928,1.5623559388226609,0.019969278033794162,0.41612539190027475,1.0,9/36,9.48%,SEMA3C;SEMA7A;SEMA6A;TBX1;SEMA6B;SEMA4F;SEMA6D;SEMA4C;PHACTR4
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.6985265458901652,-1.5621790237621636,0.03248259860788863,0.3218888736611422,1.0,1/10,0.02%,ATP1A2
prerank,cellular response to increased oxygen levels (GO:0036295),0.7469972661493797,1.5620521157051122,0.0497335701598579,0.4146244425193996,1.0,3/11,2.97%,CAV1;FAS;FOXO1
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.7558598389911637,1.5618471997916594,0.04174573055028463,0.41280771547142187,1.0,2/10,1.56%,SHANK3;APP
prerank,respiratory system development (GO:0060541),-0.5276709986391962,-1.5609306456110101,0.02610966057441253,0.32222416758591577,1.0,8/32,4.75%,GLI2;PDPN;FGFR2;BMP4;FGF1;RBP4;LOXL3;FGF2
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.6932259514181005,1.5598822135644421,0.03731343283582089,0.41705153082936564,1.0,3/16,1.10%,ST8SIA4;ST6GALNAC3;ST8SIA6
prerank,vasculogenesis (GO:0001570),0.6176354351883393,1.5598705537499402,0.02218430034129693,0.41460029384775926,1.0,12/32,8.54%,EGFL7;KDR;ENG;RASIP1;CAV1;SOX17;APLNR;NOTCH1;RAMP2;SOX18;TGFB1;CCM2
prerank,sulfate transport (GO:0008272),-0.6400155700374193,-1.5598605178744727,0.0365296803652968,0.3221915824119622,1.0,3/14,2.76%,SLC13A4;SLC26A7;SLC26A2
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.7043258288836052,-1.5595335833024866,0.041304347826086954,0.32020590831451506,1.0,7/11,16.09%,PARP8;PARP3;PARP4;PARP6;PARP11;PARP12;TIPARP
prerank,N-glycan processing (GO:0006491),0.663975855098611,1.5590669776880564,0.03583617747440273,0.41488811454239005,1.0,3/18,1.97%,ST8SIA4;ST8SIA6;FUT8
prerank,cytoplasmic translation (GO:0002181),0.513554825879776,1.5578722176656161,0.009655172413793104,0.4164045463859364,1.0,61/91,32.36%,RPL38;RPL13;RPS29;RPL36A;RPL3;RPSA;RPL27;RPS7;RPL9;RPL18;RPL13A;RPS11;RPL8;RPS27;RPL19;RPS9;RPL11;RPL22L1;RPS15;RPL37;RPS28;RPS10;RPS25;EIF3M;EIF4A1;RPL37A;RWDD1;RPL15;RPL17;RPL23;RPL34;RPS18;RPL21;RPS4X;RPS21;RPL18A;RPL10A;RPL24;RPL7A;RPL4;RPS2;RPL32;RPL6;RPS20;RPL14;RPS13;RPL26;RPS19;RPS6;RPS14;RPS15A;RPS24;RPS23;RPS12;RPL12;RPL41;DRG1;RPS3;RPS16;RPL27A;RPL10
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.4431153468365628,1.557671713739913,0.0,0.41463103549993113,1.0,93/390,12.58%,PTPRG;FLT1;IGF1R;GRB14;TEK;PLCB1;MPZL1;NAMPT;PDGFB;KDR;INSR;TIE1;WASF2;RAPGEF2;PDGFD;DOCK1;FES;RASGRP4;ELMO1;ANKS1A;FLT4;BCAR3;NEDD9;COL4A2;PTPRJ;PTK2;MTSS1;KALRN;ARPC4;FOXO1;RAPGEF1;PIK3R3;TIAM1;PRKD2;PRKD1;ATP6V0A1;ZAP70;MERTK;PXN;LYN;ELMO2;ACTB;STMN1;SOCS2;GRB2;FGF16;SORT1;CD4;GAB1;BAIAP2;EPHA4;FYN;SOS1;MAPK3;YES1;RET;NCKAP1;HCK;EPHB4;EFNA1;TIAL1;AP3S1;ANKS1B;SORBS1;AP2M1;PLAT;ARPC3;ARHGEF7;SHC3;CD8B;CAV2;PAK1;PGF;ACTG1;CYFIP1;PTK6;PIK3C2A;SHB;GRB7;DDIT4;CYBB;RAC1;NCBP2;GRIN2B;APH1A;GSK3A;HRAS;SYK;NCF4;TNK2;PIK3CB;GDF15;AP2B1
prerank,adherens junction organization (GO:0034332),0.5641649906115295,1.5574217775724453,0.021341463414634148,0.4130395348483687,1.0,15/48,7.09%,TJP1;CADM1;CDH2;RAMP2;ACTB;NECTIN4;SMAD7;CDH20;CTNNB1;CTNND1;CDH8;PIP5K1C;PVR;DCHS1;CDH19
prerank,cellular response to sterol (GO:0036315),-0.6532865205844197,-1.5572963372991264,0.031180400890868598,0.3235022436204101,1.0,8/13,20.83%,INSIG2;SMO;RORA;GRAMD1B;GRAMD1C;LRP6;GRAMD1A;PTCH1
prerank,L-amino acid transport (GO:0015807),0.6293458460719243,1.557257596307918,0.028286189683860232,0.41118777629887915,1.0,5/28,5.09%,SLC7A5;SLC7A1;SLC1A1;SLC38A5;SLC1A2
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.6319369258830208,1.5570060719659342,0.03529411764705882,0.40952861933984774,1.0,8/27,5.21%,FLT1;TEK;PDGFB;PTK2;NOD2;PRKD1;CD19;CCR7
prerank,filopodium assembly (GO:0046847),0.6997588591125214,1.5555617538190634,0.04215851602023609,0.4121289305139796,1.0,5/16,3.88%,DNM3;FGD5;SRGAP2;SPATA13;PPP1R9B
prerank,neuron remodeling (GO:0016322),0.7646256036588779,1.554483965320967,0.043151969981238276,0.41347481265428987,1.0,3/10,2.07%,APP;SCARF1;ANKS1A
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.5942310483578274,1.5517386864059886,0.04118616144975288,0.421072760955967,1.0,7/33,10.93%,LEF1;FES;CTNNBIP1;CD4;TNFSF11;CASP8;ZFP36L1
prerank,positive regulation of DNA repair (GO:0045739),-0.48953350467831414,-1.5505676103175854,0.021021021021021023,0.3379889553538083,1.0,4/46,2.08%,EYA2;EYA1;EGFR;EYA4
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.4968881356857224,1.5502674681167687,0.01098901098901099,0.42404740699757704,1.0,58/110,28.19%,RPL38;RPL13;RPS29;RPL36A;RPL3;RNPS1;RPSA;RPL27;EIF3E;RPS7;RPL9;RPLP2;RPL18;MAGOHB;RPL13A;HELZ2;NCBP2;RPS11;RPL8;RPS27;RPL19;RPS9;RPL11;RPS15;RPL37;PNRC2;RPS28;RPS10;RPS25;RPL37A;RPL15;RPL17;RPL23;RPL34;RBM8A;RPS18;UPF2;RPL21;RPS4X;NCBP1;RPS21;RPL18A;RPL10A;PABPC1;RPL24;RPL7A;RPL4;UPF3B;RPS2;RPL32;RPL6;UPF1;RPS20;RPL14;RPS13;RPL26;RPS19;PPP2R1A
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.7166013413614665,-1.550045698498004,0.02231237322515213,0.33655621326316154,1.0,7/10,25.10%,SETD7;SETD4;SETD2;SETD6;KMT5A;EEF1AKMT2;SMYD2
prerank,eye photoreceptor cell differentiation (GO:0001754),0.7295515417470937,1.5488533204927237,0.038817005545286505,0.42660437632903286,1.0,2/12,2.16%,PROM1;NKD1
prerank,positive regulation of B cell proliferation (GO:0030890),0.6218378128527896,1.548426898878254,0.0272,0.4258322532522233,1.0,5/29,5.80%,TFRC;TIRAP;MEF2C;CD40;CD38
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.6394595007709745,1.5483832325653077,0.042444821731748725,0.4235950087072765,1.0,9/25,10.25%,HIP1;HIP1R;BCAR3;PLAUR;AFAP1L2;CCDC88A;SHKBP1;CNOT9;PTK6
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.5622265716629342,-1.5478221110293762,0.02557544757033248,0.33980522601906743,1.0,6/23,5.58%,BMP4;WNT5B;GJA1;SMO;FGF2;SIX1
prerank,cardiac muscle tissue development (GO:0048738),-0.476156550225675,-1.5475924075798537,0.0058823529411764705,0.33770851740584235,1.0,13/50,6.20%,NOTCH2;BMPR1A;GJB6;SGCD;BMP5;BMP7;BMP4;GJA1;RBP4;CACNA1G;NDUFV2;TBX18;AKAP13
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.6321563563331423,1.5459686552532106,0.037953795379537955,0.42955594367389266,1.0,7/24,9.35%,SEMA3C;SEMA7A;SEMA6A;SEMA6B;SEMA4F;SEMA6D;SEMA4C
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.6441409920049048,1.5457939426988856,0.03914590747330961,0.4276984244564725,1.0,3/22,5.73%,SLC7A5;NOD2;TRIL
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.6250437038555183,-1.545059256885365,0.033936651583710405,0.3419039219277556,1.0,6/16,14.70%,ANK2;GBF1;SEC16B;LRRK2;SEC16A;DDRGK1
prerank,regulation of leukocyte activation (GO:0002694),0.7124600212524378,1.5446622799517975,0.05344827586206897,0.4294849574962519,1.0,3/14,3.86%,MFHAS1;CD200;LYN
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.6601929142583343,-1.5445729395426178,0.01598173515981735,0.34048582501282365,1.0,7/13,6.56%,TGFBR3;BMPR1A;FGFR2;ZFPM2;RBPJ;FGF2;GLI1
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.6174341321479074,-1.543904496218689,0.04326923076923077,0.3394264447493532,1.0,7/15,20.83%,GGT5;ALDH4A1;PRODH;GGACT;SARDH;ABHD16A;GOT2
prerank,regulation of actomyosin structure organization (GO:0110020),-0.649222635745203,-1.5439021997447364,0.0467706013363029,0.3367325840767392,1.0,6/13,11.35%,ROCK2;ASAP3;ALMS1;AKAP13;FHOD1;SLC9A1
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.5824613648196658,-1.5434936196981912,0.04672897196261682,0.33508873545206747,1.0,5/20,4.75%,SULF1;SMOC2;SULF2;THBS1;FGF2
prerank,myelination (GO:0042552),0.5599982535353888,1.5430026305986053,0.03225806451612903,0.4328487433236935,1.0,20/46,18.78%,MPZ;CMTM8;B4GALT5;MAL;PLLP;PARD3;TNFRSF21;BCAS1;GAL3ST1;NFASC;ABCD1;EIF2B2;SOX10;DEGS1;PMP22;MBP;ARHGEF10;MAL2;TPPP;ABCD2
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.6581729638150089,-1.542935456511397,0.04086021505376344,0.3339513520164761,1.0,8/13,21.33%,DDO;ASPA;ACOT8;GOT1;GLUL;QPRT;GOT2;MTHFS
prerank,limb development (GO:0060173),-0.5408205983945193,-1.5427137492733158,0.02577319587628866,0.33192292990468575,1.0,7/28,9.95%,SMOC1;GLI3;PCSK5;SALL1;RSPO2;IFT122;IQCE
prerank,regulation of trophoblast cell migration (GO:1901163),-0.6428218816482296,-1.5425423911008473,0.04009433962264151,0.32976791980755643,1.0,7/14,19.61%,GJA1;SYDE1;AGO2;SMURF2;ACVR1B;C1QBP;ARHGDIB
prerank,positive regulation of lipid kinase activity (GO:0090218),0.6132633622833416,1.5424212071373775,0.024509803921568627,0.4323104877237865,1.0,8/29,5.21%,FLT1;TEK;PDGFB;PTK2;NOD2;PRKD1;CD19;CCR7
prerank,diol metabolic process (GO:0034311),0.6567971585762149,1.5411386687637707,0.04280821917808219,0.4344763897013317,1.0,5/19,4.40%,SGPP2;DEGS2;NOS3;GCH1;CALM1
prerank,regulation of cell communication (GO:0010646),-0.5184139258049887,-1.5411258646390482,0.034031413612565446,0.3306806728246991,1.0,9/35,8.19%,ANK2;CXADR;GRK5;GRK3;CAMK2D;ANXA1;TBX18;SLC8A1;TSPYL2
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.618547499210852,1.5410794704024313,0.04455445544554455,0.43236414774981413,1.0,8/26,13.42%,NOD1;NOD2;IFIH1;IRAK2;UBE2V1;CASP8;TNFAIP3;CYLD
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.6323836134337029,-1.5410158655340864,0.052752293577981654,0.3284197219542675,1.0,5/14,10.02%,IRS1;PPARGC1A;IRS2;NNMT;SLC45A3
prerank,negative regulation of anoikis (GO:2000811),0.7030172755937669,1.5409295432030303,0.05350553505535055,0.4306434490534056,1.0,7/14,11.37%,CAV1;PTK2;NOTCH1;SNAI2;MCL1;PTRH2;TLE1
prerank,cellular potassium ion homeostasis (GO:0030007),-0.6458192671543238,-1.5405789745734058,0.04308390022675737,0.3269786354392053,1.0,5/13,7.12%,ATP1A2;SLC12A2;KCNJ2;ATP1B3;ATP1B2
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.5007044072704383,1.5396363656330065,0.015027322404371584,0.43269730542310725,1.0,17/100,6.24%,FLT1;IGF1R;TEK;PDGFB;KDR;INSR;PPP1R16B;DAB2IP;TGFB2;PDGFD;PTK2;PIK3IP1;LYN;GAB1;PIP5K1C;ENTPD5;MAPK3
prerank,positive regulation of hydrolase activity (GO:0051345),0.4896570005762847,1.5395575183660553,0.005141388174807198,0.43073000302031933,1.0,31/137,11.94%,ITGA6;DOCK9;SRGAP2;RAPGEF2;ARHGAP27;NET1;CD200;BCAR3;F11R;AGRN;CD40;RAPGEF1;SNX13;RAPGEF3;TGM2;TBC1D2;CALM1;USP6NL;MAPRE2;RSU1;RAP1GDS1;RASGRP2;PKP4;PIN1;ARHGEF7;CAV2;FERMT2;CCL1;MAP4K4;HRAS;TBC1D30
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.6596615273176907,1.5395167260314582,0.044444444444444446,0.42856446492324995,1.0,7/20,9.35%,SEMA3C;SEMA7A;SEMA6A;SEMA6B;SEMA4F;SEMA6D;SEMA4C
prerank,positive regulation of bone mineralization (GO:0030501),-0.5152391431093936,-1.5388173465105828,0.017391304347826087,0.3289341997225452,1.0,15/35,12.50%,BMP6;BMPR1A;WNT4;BMP7;BMP4;OSR1;ADGRV1;ANO6;KL;CCN1;SLC8A1;TGFB3;PKDCC;BMP2;FBN2
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),-0.4011199482369544,-1.537944120087929,0.0043859649122807015,0.3286611320748568,1.0,27/142,12.26%,ATP1A2;CACNA1C;LPAR1;PLCE1;ADCY5;PDGFRA;SMAD3;CD55;CCR9;EDNRA;ADRA1B;TRPC3;SLC35G1;SLC8B1;DLG4;SLC8A1;BDKRB2;AGTR1;PTGDR;TRPC6;PTGFR;PRKACA;TRPM4;CLN3;ESR1;TRPC4;ABL1
prerank,sodium-independent organic anion transport (GO:0043252),0.762006760407821,1.5377846772399033,0.03171641791044776,0.4323765141887186,1.0,3/10,1.66%,SLCO1C1;SLCO2B1;SLC16A2
prerank,regulation of monooxygenase activity (GO:0032768),0.6464608104115753,1.5376341222770906,0.03459637561779242,0.43066885409602634,1.0,7/23,8.87%,NOSTRIN;NOS3;CAV1;DDAH1;CALM1;DNM2;LYPLA1
prerank,synaptic membrane adhesion (GO:0099560),-0.654364403069098,-1.5361977186044093,0.041758241758241756,0.3306042968484004,1.0,4/14,4.60%,GPC6;PTPRF;PTPRS;GPC4
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.533759705762323,1.534865859858993,0.020172910662824207,0.4379054359819236,1.0,21/65,12.26%,HIP1;DAB2IP;ITGA1;HIP1R;BCAR3;PLAUR;AFAP1L2;PTPRJ;RHBDF2;PTPN12;DUSP3;GRB2;CCDC88A;SHKBP1;TGFA;ARHGEF7;CNOT9;PTK6;EPS15;HGS;CEACAM1
prerank,microtubule depolymerization (GO:0007019),0.6611575080318597,1.5346888219685295,0.0528169014084507,0.4362234910062936,1.0,7/17,15.38%,STMN1;NCKAP5;KIF2A;STMN3;STMN4;NCKAP5L;CKAP5
prerank,hemidesmosome assembly (GO:0031581),0.7188641595312179,1.533911924244073,0.06569343065693431,0.43676494308593394,1.0,1/11,0.31%,ITGA6
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.7358000281961291,1.5325939028103768,0.06088560885608856,0.43885385869782795,1.0,5/12,7.23%,CAV1;GJD3;CALM1;PDE4D;SRI
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.6267479558726556,-1.532524866192517,0.02654867256637168,0.33714652568300235,1.0,5/14,2.24%,LRP1;BMPR1A;IGFBP5;SLIT2;TPM1
prerank,amino acid import across plasma membrane (GO:0089718),0.650384996034354,1.5315064788325523,0.03986710963455149,0.4403035248994873,1.0,6/24,1.94%,SLC6A6;SLC7A5;SLC7A1;SLC1A1;SLC16A2;SLC6A5
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.6028337613544231,1.5312782635428603,0.029950083194675542,0.4389099126954482,1.0,9/30,12.24%,BCL2L1;NOS3;FAS;TNFSF10;ARHGEF2;RFFL;FAIM;CASP8;TNFAIP3
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.5645964512007396,1.5303828804158865,0.021103896103896104,0.4396870097428978,1.0,12/45,11.20%,APP;TRIM16;NOD2;GBP5;LGALS9;AIM2;P2RX7;MALT1;CASP8;AGER;TLR8;HSPB1
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.5770114471996567,1.5290838880179214,0.01800327332242226,0.44178041386056527,1.0,8/39,4.60%,TEK;NDNF;KDR;RGCC;CD40;RAMP2;PLCG1;GATA2
prerank,glycoprotein metabolic process (GO:0009100),0.5471281261285801,1.52838642075625,0.026785714285714284,0.44186918041989726,1.0,15/53,14.36%,ST8SIA4;ST6GALNAC3;ST8SIA6;FUT8;B4GALT5;OGA;NEU4;STT3B;HIF1A;FBXO6;MGAT4B;MAN1B1;MANBA;NEU2;MAN2B1
prerank,negative regulation of interleukin-10 production (GO:0032693),0.6775781576621034,1.5267771399364212,0.05786618444846293,0.4449758113308708,1.0,6/16,12.21%,JAK3;TNFRSF21;FOXP3;TRIB2;AGER;VSIR
prerank,granulocyte differentiation (GO:0030851),0.6611175618693725,1.5258207135633193,0.04529616724738676,0.4462175235033367,1.0,2/18,5.28%,LEF1;TAL1
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.6401550489866548,1.5250073870003535,0.04576271186440678,0.4467109657532102,1.0,8/23,12.88%,FAR2;ELOVL7;ACSL5;ACSL6;ELOVL5;ACSL3;ELOVL6;HACD2
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.5091515818498118,1.5241770267255947,0.018731988472622477,0.4475707960744031,1.0,18/75,7.43%,TEK;PTPRM;SEMA6A;CLDN5;DAB2IP;TGFB2;STAB1;COL4A2;RGCC;AMOT;VASH1;SARS1;HHEX;CTNNB1;STAT1;KLF4;GTF2I;CD160
prerank,positive regulation of lipid localization (GO:1905954),-0.6830159163200351,-1.5233963523098484,0.042352941176470586,0.3585081859296925,1.0,2/11,3.90%,LRP1;IKBKE
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.5449352003065829,-1.5231835403882157,0.027227722772277228,0.3564982181198967,1.0,8/26,10.98%,ANK2;ACTN2;FHL1;DLG1;ATP1B3;ATP1B2;CACNA1D;WWP2
prerank,cellular response to BMP stimulus (GO:0071773),-0.4444236402938832,-1.5229873334930346,0.017123287671232876,0.35451696413595507,1.0,15/66,6.69%,BMP6;TGFBR3;BMPR1A;ADAMTS12;SMAD3;BMP5;BMP7;BMP4;DDX5;SMAD6;RGMA;RGMB;RUNX2;TMEM100;SMAD9
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.596597191294233,1.5228115029882436,0.03541315345699832,0.4499836099977279,1.0,5/29,3.66%,KANK3;SHANK3;TJP1;HIP1R;SSH2
prerank,mesenchymal to epithelial transition (GO:0060231),-0.6908313679541614,-1.5225733873670089,0.058426966292134834,0.3532081005346095,1.0,3/10,6.29%,BMP4;SALL1;FZD7
prerank,fat cell differentiation (GO:0045444),-0.45815315429003983,-1.5224432452924859,0.01744186046511628,0.35110594550394597,1.0,17/57,14.95%,PID1;WNT5B;SMAD6;OSBPL8;PPARGC1A;FAM120B;PER2;ATF5;C1QTNF3;CLIP3;BBS9;MKKS;NR4A1;EP300;METRNL;MAFB;TMEM120A
prerank,receptor-mediated endocytosis (GO:0006898),0.469717744235451,1.5213551504661769,0.006693440428380187,0.45299070599774544,1.0,31/132,12.58%,TFRC;DNM3;INSR;STAB1;ARHGAP27;SCARF1;CAV1;FNBP1L;HIP1R;RAB31;SCARB1;RAMP2;CALCRL;DNAJC13;GRB2;PIKFYVE;RAMP3;PIP5K1C;INPP5F;LRP1B;DNM2;FCHO2;AP2M1;CXCR2;CAV2;LRP2;AMN;CD163;EPS15;SYK;AP2B1
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.4761064583291476,-1.520082459545585,0.03067484662576687,0.35476434138097307,1.0,18/46,15.69%,ALDH1A1;LGR4;DOCK7;PLCL1;NPR3;FOXC2;ADAMTS5;ZNF423;RBPJ;ACOT11;TLE3;NOVA1;PLCL2;STK11;RHEB;PCTP;TLR4;NRDC
prerank,regulation of phospholipase activity (GO:0010517),-0.6915583728559187,-1.5182047808586723,0.05508474576271186,0.3576528759641821,1.0,3/10,9.08%,LRP1;FGFR2;PDPK1
prerank,regulation of blood circulation (GO:1903522),-0.5150788548071055,-1.5179417437925198,0.02666666666666667,0.3558532387077615,1.0,12/34,15.15%,CELF2;TPM1;DMPK;CAMK2D;KCNMB2;PER2;ACE;BDKRB2;AGTR1;DES;FXYD1;ACE2
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.7223879136587305,1.5162550700951902,0.06261859582542695,0.4681248059649202,1.0,2/11,0.22%,IGF1R;PLCB1
prerank,positive regulation of interleukin-4 production (GO:0032753),0.6722538917056389,1.5157209887331031,0.05432937181663837,0.46768119014527887,1.0,2/17,6.29%,SLC7A5;LGALS9
prerank,regulation of establishment of cell polarity (GO:2000114),-0.6021113615494453,-1.5154304798327451,0.03982300884955752,0.3601131465965753,1.0,6/16,12.60%,ROCK2;GSN;KANK1;RIPOR2;PTK2B;BCAS3
prerank,positive regulation of interleukin-17 production (GO:0032740),0.6273469523265545,1.5153512786893577,0.05419580419580419,0.4669277504418363,1.0,6/22,13.26%,SLC7A5;NOD2;TGFB1;CCL1;RFTN1;IL15
prerank,regulation of cell migration (GO:0030334),0.4341926161151768,1.5142613803174911,0.0,0.46860018908487083,1.0,58/382,6.61%,LEF1;FLT1;IGF1R;SEMA3C;ITGA6;SEMA7A;LIMCH1;DACH1;PECAM1;FRMD5;SEMA6A;TJP1;CLDN5;PDGFB;KDR;SRGAP3;SRGAP2;INSR;PODXL;SRGAP1;MACF1;ROBO4;ENG;CXCL12;PDGFD;PRR5L;CAV1;NKD1;NEDD9;SEMA6B;SPATA13;PTPRJ;PTK2;PLXND1;ADAM15;AMOT;ACVRL1;PIK3R3;TIAM1;NTNG2;NOTCH1;DUSP3;RIPOR1;VIL1;TMSB4X;SMAD7;GNA12;FGF16;SEMA4F;SNAI2;RHOB;EPHA4;ACTN4;FAM107A;KIF2A;RFFL;ADAM10;RET
prerank,regulation of anoikis (GO:2000209),0.6461686641498117,1.5137898443849955,0.05653710247349823,0.46811274907870254,1.0,7/19,11.37%,CAV1;PTK2;NOTCH1;SNAI2;MCL1;PTRH2;TLE1
prerank,catecholamine biosynthetic process (GO:0042423),0.73047396565443,1.513127831882698,0.05321100917431193,0.46824437365140353,1.0,4/11,7.15%,DDC;TGFB2;GCH1;INSM1
prerank,actin filament organization (GO:0007015),0.4692196377076433,1.5128325632807316,0.008871989860583017,0.467085158652353,1.0,34/151,10.95%,FLII;HIP1;MYO1D;MYO1E;RHOBTB1;SHROOM4;NEBL;SHROOM1;ELMO1;HIP1R;NEDD9;ARHGEF2;ARPC4;CD2AP;EVL;PLS3;PPP1R9B;ELMO2;VIL1;MYO6;RFLNB;EPS8;RHOB;BAIAP2;TPM3;ARHGAP25;ACTN1;TMOD1;CAPG;MYO1F;ARHGAP17;CLRN1;RAC1;TPM4
prerank,regulation of potassium ion transport (GO:0043266),-0.5205829604260771,-1.5126563996714408,0.025252525252525252,0.3656308172866732,1.0,7/31,7.60%,ANK2;ACTN2;FHL1;KCNIP3;CD63;DLG1;CACNA1D
prerank,cellular response to exogenous dsRNA (GO:0071360),0.7195029708090008,1.5125849953695374,0.07850467289719626,0.46579515227818613,1.0,4/12,6.99%,CAV1;IFIH1;ZCCHC3;RALB
prerank,cellular response to copper ion (GO:0071280),0.6801174949283587,1.5123087898607652,0.06440071556350627,0.46460633931756307,1.0,11/16,25.50%,MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;DAXX;SNCA;AOC1
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.609750363792787,-1.511869689882666,0.056074766355140186,0.36532518969245453,1.0,7/15,16.43%,PIEZO2;ADGRV1;COL11A1;KIT;MKKS;TMEM120A;PDZD7
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.6665220019122552,1.5118033335375192,0.06878306878306878,0.4643075080772902,1.0,5/15,8.56%,TGFB2;JAK3;SMAD7;TGFB1;FOXP3
prerank,glycolipid metabolic process (GO:0006664),0.5577092521189893,1.5114852168942796,0.029940119760479042,0.46334121123779576,1.0,12/47,14.06%,ST6GALNAC3;ST3GAL6;ST8SIA6;ESYT2;NEU4;ESYT1;GLB1;GLTP;B4GALNT1;ST6GALNAC4;CERK;NEU2
prerank,regulation of interleukin-17 production (GO:0032660),0.5878337424754964,1.5114193323695413,0.04304635761589404,0.4614803109826225,1.0,9/31,15.04%,SLC7A5;NOD2;TGFB1;FOXP3;CCL1;VSIR;RFTN1;IL15;NCKAP1L
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.6032502732162572,1.51091801387822,0.06368330464716007,0.4610475710552718,1.0,7/29,11.37%,LEF1;MEN1;CTNNB1;TCF7;TLE4;AXIN2;TLE1
prerank,bone development (GO:0060348),-0.4980620302509849,-1.5105120810297903,0.010666666666666666,0.3667216319222142,1.0,10/39,6.76%,RANBP3L;SULF1;FGFR2;CYP26B1;GJA1;SULF2;SH3PXD2B;AKAP13;SFRP4;GNAS
prerank,response to progesterone (GO:0032570),0.6495310612034413,1.5099516899344785,0.07781456953642384,0.4625286187395726,1.0,3/18,1.79%,ABHD2;TGFB2;CAV1
prerank,neutrophil migration (GO:1990266),0.5233503152928547,1.509676341653131,0.029985007496251874,0.46132723533685427,1.0,11/58,12.14%,BSG;PECAM1;TGFB2;PIKFYVE;PIP5K1C;PPIA;CXCR2;PDE4B;CCL1;S100A8;SYK
prerank,protein glycosylation (GO:0006486),0.47435749995331294,1.5096333728471614,0.014925373134328358,0.4594359479512295,1.0,36/125,17.45%,ST8SIA4;ST3GAL6;EOGT;AQP11;ST8SIA6;SLC39A8;ST3GAL1;GALNT18;FUT8;B4GALT5;ST6GALNAC2;B3GNT2;OGA;STT3B;FUT9;ENTPD5;GAL3ST1;COG3;PLOD3;NPC1;B3GALT4;MGAT4B;PLOD1;B3GALT2;DPAGT1;SERP2;DAD1;NUS1;POFUT1;GCNT2;DPM3;B3GNT3;MGAT2;POMGNT1;POGLUT1;DOLPP1
prerank,amino sugar metabolic process (GO:0006040),0.7350922504300209,1.5092353349875973,0.0661764705882353,0.4586848754471324,1.0,3/10,7.56%,CSGALNACT1;ST3GAL1;ST6GAL1
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.5924542260277766,-1.5080354282504058,0.06235565819861432,0.37076292554697965,1.0,6/17,6.64%,FSTL1;SULF1;SLIT2;CASK;TWSG1;SFRP4
prerank,secondary palate development (GO:0062009),0.6834611570666103,1.5079162474494738,0.055248618784530384,0.4610655062429432,1.0,3/14,4.29%,LEF1;TGFB2;WNT7A
prerank,cAMP metabolic process (GO:0046058),-0.6314290095420804,-1.5078009542299733,0.056179775280898875,0.368999727745498,1.0,7/13,12.16%,ADCY5;ADCY1;ADCY9;ADCY2;ADCY7;PTHLH;ADCY6
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.6323242394469758,1.5073268594890887,0.0378657487091222,0.46107258962174036,1.0,9/24,11.13%,TEK;KDR;PTPRJ;DUSP3;MAPRE2;IQSEC1;RAC1;FERMT2;MAP4K4
prerank,positive regulation of integrin activation (GO:0033625),0.7238230298895572,1.5066238231435574,0.05415162454873646,0.46139695844375145,1.0,4/11,10.94%,RASIP1;PIEZO1;RAP1B;FERMT2
prerank,positive regulation of cell junction assembly (GO:1901890),0.5337246927333101,1.5054501714909092,0.0258751902587519,0.46329381171753253,1.0,19/56,17.38%,TEK;CLDN5;KDR;CAV1;PTPRJ;WNT7A;CLSTN1;GRID2;NRXN1;LRRC4B;RAC1;FERMT2;MAP4K4;EPHB1;CNTNAP2;NLGN1;IL1RAP;PPM1F;NRP1
prerank,cellular response to peptide (GO:1901653),0.5352979717850864,1.5048715039817984,0.03508771929824561,0.4632910717093822,1.0,12/56,6.34%,IGF1R;CACNA1A;APP;CAV1;ARHGEF2;NOD1;NOD2;CYP11B1;CYP11A1;EPHA4;FYN;ATP1A3
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.601446909580884,1.5039356155821322,0.04966887417218543,0.464470607451113,1.0,10/29,13.49%,ELOVL7;FASN;ACSL5;ACSL6;ELOVL5;ACSL3;ELOVL6;SLC25A1;HACD2;HSD17B8
prerank,prostanoid biosynthetic process (GO:0046457),-0.6032974934973615,-1.5037209272841099,0.04434589800443459,0.37763204747795953,1.0,4/15,6.06%,PTGDS;PTGIS;PTGS1;PTGES
prerank,glycosaminoglycan biosynthetic process (GO:0006024),-0.42404505653382446,-1.500366531953751,0.014652014652014652,0.38415957371155096,1.0,28/95,9.89%,GPC6;UST;DSE;DCN;ANGPT1;SDC2;OGN;CEMIP;FMOD;EXT1;GPC3;BGN;HS3ST3A1;ST3GAL4;HS2ST1;CHST15;GPC4;PRELP;CSPG4;PXYLP1;HS3ST3B1;HS6ST1;HS6ST2;SDC4;LUM;OMD;NDST2;B4GALT1
prerank,spinal cord development (GO:0021510),-0.6429898471276537,-1.4996628119113706,0.07327586206896551,0.3834664448093461,1.0,5/12,4.80%,GLI2;VIT;PKD1;LOXL3;PKD2
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.5610031811861751,1.4992970402118102,0.06210191082802548,0.47815356741750886,1.0,11/39,6.03%,TGFB2;EPN2;NOS3;NOTCH4;JAG2;TSPAN5;NOD2;TSPAN14;NOTCH1;DLL4;MAML2
prerank,regulation of interleukin-10 production (GO:0032653),0.5503350850563627,1.498974746877193,0.0304,0.47727336747533383,1.0,10/44,12.21%,CD34;JAK3;NOD2;TNFRSF21;LGALS9;FOXP3;TRIB2;AGER;SYK;VSIR
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.7077297084566575,1.4988759131729472,0.05913978494623656,0.47565173362544166,1.0,4/13,4.43%,DAB2IP;EPN2;MMRN2;HHEX
prerank,regulation of plasminogen activation (GO:0010755),-0.644921475367999,-1.498239579514611,0.06638115631691649,0.3846791866879415,1.0,6/12,23.05%,THBS1;CLEC3B;SERPINE2;CTSZ;SERPINE1;RUNX1
prerank,intestinal absorption (GO:0050892),0.7089686290441233,1.4978096670547674,0.054481546572934976,0.47743903179313557,1.0,3/13,5.26%,TJP2;F11R;KCNQ1
prerank,ATP transport (GO:0015867),0.7297050309679641,1.4971802756995574,0.07879924953095685,0.4775013776421475,1.0,2/10,5.14%,ABCC6;SLC25A5
prerank,amino acid transport (GO:0006865),0.5477054794983183,1.497118426066913,0.04054054054054054,0.47565433530772766,1.0,6/49,2.92%,SLC6A6;SLC7A5;SLC7A1;SH3BP4;SLC38A5;SLC43A2
prerank,positive regulation of cellular component organization (GO:0051130),0.4757921388416235,1.4968272836453165,0.02266666666666667,0.4745720712121943,1.0,13/107,6.07%,IGF1R;ATP10A;TFRC;SHANK3;INSR;DAB2IP;TGFB2;TIRAP;NEDD4L;RAPGEF3;FNIP2;TAL1;BIK
prerank,defense response to symbiont (GO:0140546),0.4948452462143519,1.4963906345173472,0.03328509406657019,0.4740104744728939,1.0,23/92,11.18%,BCL2L1;SERINC3;IFNAR2;CD40;IFIH1;NLRC5;IRF2;SERINC5;SAMHD1;NT5C3A;TLR3;STAT1;TLR7;BST2;RTP4;AGBL5;BNIP3L;ZMYND11;OASL;DDIT4;PDE12;RNASE1;TLR8
prerank,positive regulation of MAPK cascade (GO:0043410),0.43908907357639765,1.496242626309519,0.0059594755661501785,0.47255782561959203,1.0,47/245,11.15%,FLT1;IGF1R;TEK;SEMA7A;MFHAS1;PIK3R6;JCAD;PDGFB;KDR;INSR;DAB2IP;TGFB2;RAPGEF2;PDGFD;APP;TBX1;PDE8A;TIRAP;FLT4;BCAR3;TPD52L1;PTPRJ;CD40;NOD2;PRKD2;NOTCH1;RAMP3;CCR7;CD4;MAPK3;LGALS9;ADRA2B;FBXW7;RET;HTR2A;TGFB1;IQGAP1;ABCA7;CAV2;TNFSF11;SEMA4C;PDCD10;MID1;AGER;FERMT2;CCL1;ARL6IP5
prerank,positive regulation of ruffle assembly (GO:1900029),0.6864654077262422,1.496070487184122,0.08043875685557587,0.4712441095719348,1.0,6/13,16.00%,EPS8;EPS8L2;PLEKHM1;HRAS;FAM98A;NLGN1
prerank,negative regulation of metabolic process (GO:0009892),-0.4521791362479116,-1.4958187882055178,0.025559105431309903,0.3893641395225897,1.0,17/54,14.30%,ALDH1A1;LGR4;DOCK7;PLCL1;NPR3;FOXC2;ADAMTS5;ZNF423;RBPJ;ACOT11;TLE3;NOVA1;PLCL2;STK11;RHEB;PCTP;TLR4
prerank,cell-cell junction organization (GO:0045216),0.5027576381262023,1.495697639644639,0.022727272727272728,0.4705012308028469,1.0,19/79,7.94%,OCLN;TJP1;CLDN5;CADM1;LIMS2;TGFB2;GJC1;TJP2;CDH2;NECTIN4;CDH20;CTNND1;CDH8;MARVELD2;PVR;DCHS1;CDH19;PKP4;TGFB1
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.590041765578838,-1.4953749604064077,0.04279279279279279,0.3881844698454329,1.0,4/17,5.33%,PID1;NUPR1;HDAC4;PPARA
prerank,regulation of developmental growth (GO:0048638),0.5922964845354144,1.495233236855282,0.04569420035149385,0.4701082881121735,1.0,4/29,1.56%,PLCB1;MFSD2A;INSR;APP
prerank,JNK cascade (GO:0007254),0.558825711751308,1.495211446305034,0.04654895666131621,0.4682780707936326,1.0,6/40,3.22%,SH2D3C;MAP4K2;TNFRSF19;MAP4K3;NOD1;NOD2
prerank,Rap protein signal transduction (GO:0032486),0.7421736109146411,1.4949787035444329,0.06445672191528545,0.46713233758963496,1.0,4/10,7.11%,RAPGEF2;RAPGEF1;RAPGEF3;RAP1B
prerank,regulation of cell-cell adhesion (GO:0022407),0.564264079341326,1.4948066611993642,0.04019292604501608,0.4657806095636699,1.0,8/39,7.94%,PTPRG;PODXL;MAGI1;PTK2;SMAD7;FUT9;PTPRR;TGFB1
prerank,glucose import (GO:0046323),0.6839401445929926,1.4946251231177134,0.07092198581560284,0.46457185418029234,1.0,2/13,5.20%,SLC2A1;SORT1
prerank,neuron maturation (GO:0042551),0.6594179645486933,1.4946214679052692,0.0663265306122449,0.46269099647106043,1.0,4/18,2.07%,APP;SCARF1;B4GALT5;ANKS1A
prerank,glycoprotein biosynthetic process (GO:0009101),0.5063717209387566,1.4942830565847023,0.02170767004341534,0.46188083822147413,1.0,11/79,7.05%,ST8SIA4;CSGALNACT1;ST3GAL6;ST8SIA6;BMPR2;B4GALT5;ST6GALNAC2;CHST11;B3GNT2;FUT9;COG3
prerank,response to exogenous dsRNA (GO:0043330),0.6561652766915737,1.4941723297257075,0.06822262118491922,0.4603885501473157,1.0,7/18,12.31%,CAV1;IFIH1;TLR3;ZCCHC3;RALB;SLC3A2;RFTN1
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.6700481412794589,1.4937897943890475,0.08163265306122448,0.45985382546121817,1.0,4/15,6.99%,MFSD2A;SCARB1;FBXW7;NR1H2
prerank,amino acid transmembrane transport (GO:0003333),0.5535914439066201,1.4936569738153107,0.0395738203957382,0.45849064617985597,1.0,5/45,1.99%,SLC6A6;SLC7A5;SLC7A1;SLC16A2;SLC38A5
prerank,peptide metabolic process (GO:0006518),-0.4287987379844066,-1.4935864248353394,0.009554140127388535,0.39076009912204884,1.0,19/75,17.15%,CPQ;AEBP1;MGAT3;PCSK5;DMD;ANPEP;GSTT1;BACE2;ACE;ENPEP;NPEPPS;CPXM1;CPXM2;IDE;PSEN1;GSTA3;GSTM2;HM13;PARL
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.5769326307776503,1.4919614421968181,0.039936102236421724,0.4622234605228894,1.0,14/32,10.33%,JCAD;KDR;MMRN2;NOTCH1;HDAC9;HDAC7;STARD13;GATA2;DLL4;CARD10;KLF4;MAP3K3;PDCD10;PIK3C2A
prerank,regulation of BMP signaling pathway (GO:0030510),-0.43059523722218096,-1.4915180573183728,0.024734982332155476,0.3940712731306468,1.0,17/73,6.69%,FSTL1;SULF1;BMPR1A;FOXD1;NBL1;CRIM1;BMP4;BMPER;SMAD6;HTRA3;TWSG1;ZNF423;RBPJ;RBPMS2;CCN1;SFRP4;SMAD9
prerank,acylglycerol biosynthetic process (GO:0046463),-0.5447810261328039,-1.4907623445484597,0.05181347150259067,0.3936230250440636,1.0,7/23,15.27%,PLCE1;AGMO;MOGAT3;GK;LPGAT1;GPAT3;PNPLA3
prerank,negative regulation of DNA binding (GO:0043392),0.5933560753665595,1.4895796110410915,0.053833605220228384,0.4680682946993224,1.0,3/28,2.87%,LEF1;NFKBIA;SP100
prerank,glycerophospholipid metabolic process (GO:0006650),0.5105999779685495,1.4874826059460986,0.031161473087818695,0.4731081394500697,1.0,10/75,6.37%,GPCPD1;PLCB1;DGKH;PLA2G4B;PLCG1;SERINC5;PNPLA6;GDPD1;ABCA3;PIGM
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.5943057066823778,-1.4872096306493676,0.06277056277056277,0.40107987012435836,1.0,4/16,5.33%,APPL2;APOD;ADCY7;PPARA
prerank,cellular response to dsRNA (GO:0071359),0.6731165845934908,1.4872081785085673,0.08064516129032258,0.4720963399538468,1.0,5/15,10.76%,CAV1;IFIH1;ZCCHC3;RALB;PDE12
prerank,regulation of glucose import (GO:0046324),-0.5210413596894495,-1.4866374430346496,0.047979797979797977,0.4001778387934632,1.0,12/30,8.49%,PID1;PRKAG2;IGF1;APPL2;ENPP1;IRS1;RHOQ;OSBPL8;PRKCI;IRS2;SELENOS;GRB10
prerank,heart looping (GO:0001947),0.5537332397847373,1.486085374089524,0.03571428571428571,0.47386283112790967,1.0,7/39,3.41%,ENG;ZIC3;TBX3;SOX17;MEF2C;APLNR;NOTCH1
prerank,L-serine metabolic process (GO:0006563),0.7393630052458346,1.4846076619707935,0.08151093439363817,0.4767012572997395,1.0,4/10,9.86%,SERINC3;SERINC5;SHMT2;CBS
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.7346233847876782,1.4846019888117863,0.0784313725490196,0.4748614432729054,1.0,3/10,4.03%,DGKH;PARD3;PRKD3
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.7243594873816531,1.4840936123145694,0.08363636363636363,0.47477910093268827,1.0,3/10,1.71%,SEMA6A;DAB2IP;XDH
prerank,negative regulation of axon extension (GO:0030517),0.5932110731646233,1.4839906830143372,0.040584415584415584,0.4733237537094304,1.0,8/30,9.35%,SEMA3C;SEMA7A;SEMA6A;SEMA6B;DIP2B;SEMA4F;SEMA6D;SEMA4C
prerank,camera-type eye development (GO:0043010),-0.5345402107902307,-1.4839059977789402,0.044854881266490766,0.4053575603996628,1.0,11/25,17.54%,CACNA1C;FBN1;EFEMP1;LAMA1;CYP1B1;IFT122;FBN2;SKI;NF1;TSKU;PAX2
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.4834835219411363,1.483587971056951,0.0199468085106383,0.47277755486524103,1.0,20/94,11.68%,PLCB1;IL1R1;NFKBIA;NOD1;NOD2;PELI1;MAP3K8;IKBKB;ST18;MAPK3;RPS6KA5;PSMB3;PSMD11;PSMC6;IRAK2;MAP3K3;PSME2;UBE2V1;TOLLIP;PSMD8
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.6028004719522884,-1.4828027286622638,0.05952380952380952,0.4058997241872171,1.0,5/14,10.75%,SEC24D;SEC24A;SAR1A;SEC31A;SEC23A
prerank,cellular response to type I interferon (GO:0071357),0.5597869284202466,1.4823165587368308,0.05221518987341772,0.473298633055939,1.0,12/41,9.61%,IFNAR1;SP100;IFNAR2;IRF2;ADAR;SAMHD1;IRF9;XAF1;STAT1;IRF5;BST2;OASL
prerank,type I interferon signaling pathway (GO:0060337),0.5597869284202466,1.4823165587368308,0.05221518987341772,0.473298633055939,1.0,12/41,9.61%,IFNAR1;SP100;IFNAR2;IRF2;ADAR;SAMHD1;IRF9;XAF1;STAT1;IRF5;BST2;OASL
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.5221352444265156,-1.4822077426250755,0.04030226700251889,0.4050618439987911,1.0,9/28,14.82%,ZIC1;SMAD3;CDH1;PRKCD;FLNA;UBR5;PSEN1;BAG3;PIK3R1
prerank,growth hormone receptor signaling pathway (GO:0060396),0.6704349138429598,1.4821005468569048,0.07773851590106007,0.4722552698311538,1.0,5/14,4.18%,PTK2;JAK3;PXN;LYN;SOCS2
prerank,lung epithelium development (GO:0060428),-0.684527970956915,-1.4812479476956562,0.06837606837606838,0.40522265067131724,1.0,4/10,6.24%,ERRFI1;BMP4;PKD1;RCN3
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.6061034740506068,1.4811107793821268,0.061258278145695365,0.47360892207780264,1.0,5/27,1.99%,SLC7A5;SLC7A1;SLC1A1;SLC6A5;SLC38A5
prerank,regulation of protein localization to nucleus (GO:1900180),0.5481055568682814,1.4809240878132501,0.0380517503805175,0.472465435169394,1.0,10/43,11.79%,TFRC;MFHAS1;WWTR1;CARD10;LIMK2;TGFB1;PIN1;LAMTOR5;FERMT2;ORMDL3
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.6696197103224565,1.4800861004210468,0.06108202443280977,0.4733901526574614,1.0,4/15,10.03%,ENTPD1;AK4;ENTPD5;CMPK1
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.6710494941215507,-1.479959142055664,0.08114035087719298,0.4063349575256313,1.0,6/10,24.17%,EMC8;EMC7;EMC2;EMC1;EMC3;EMC4
prerank,membrane organization (GO:0061024),0.43890904182174095,1.4798279838525328,0.0037267080745341614,0.472422594806967,1.0,60/227,16.60%,TFRC;DNM3;CERT1;HIP1;SPTBN1;EPN2;REEP1;FNBP1L;AGFG1;HIP1R;DYSF;FZD4;ARPC4;ATP2C1;ACTB;GRB2;SNX3;CD4;PIP5K1C;CCDC88A;OCRL;CNTN2;DNM2;CHRNB1;GRIN3B;FCHO2;CHMP1B;AP2M1;RTP4;ARPC3;TGFA;NPC1;ATP10B;ACTG1;LPCAT3;PIK3C2A;LEMD3;HSPA8;LRP2;SH3GLB1;EPS15;HGS;GLTP;SNAP29;AP2B1;MITD1;SUN1;IL7R;SGCZ;SH3KBP1;M6PR;PLEKHA3;AMPH;RTP3;ACTR2;SYNJ1;PDCD6IP;REEP3;SPAST;ANK3
prerank,response to molecule of bacterial origin (GO:0002237),0.5054577729454329,1.4789140920669581,0.027941176470588237,0.47364611363197184,1.0,18/69,13.00%,NOS3;TIRAP;IFNAR1;GCH1;TNFRSF11A;PELI1;NOS2;NOCT;PALM3;CD6;LGALS9;IRF5;ADAM17;S100A8;TNFAIP3;CYRIB;HMGB2;SLPI
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.7095659490492026,1.4788059676883736,0.06095238095238095,0.4722375908604491,1.0,4/12,11.50%,MFSD2A;ACSL3;LPCAT3;MTTP
prerank,copper ion homeostasis (GO:0055070),0.655001276156276,1.4786829199443956,0.06937394247038917,0.470865670966642,1.0,4/17,5.11%,APP;ATOX1;SLC31A1;XIAP
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.7139868342640201,1.4784723764596728,0.09210526315789473,0.46976495395138823,1.0,3/11,3.86%,MFHAS1;TIRAP;LYN
prerank,chondrocyte differentiation (GO:0002062),-0.5030405644737639,-1.4775850540578088,0.04155844155844156,0.41051566651726756,1.0,11/32,9.26%,SULF1;SOX5;BMP4;WNT5B;OSR1;SULF2;CREB3L2;SLC39A14;RUNX2;CCN3;SOX6
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.44972703953504645,-1.47602044614587,0.03459119496855346,0.41254875328885443,1.0,15/51,12.61%,FSTL1;FBN1;BMPR1A;NBL1;CRIM1;BMPER;SMAD6;HTRA3;GREM2;RBPMS2;SMAD9;SMURF2;CHRD;BMP2;SKI
prerank,phospholipid translocation (GO:0045332),0.6036151258848294,1.4756708594455792,0.05747126436781609,0.4769862316547807,1.0,9/28,9.76%,ATP10A;MFSD2A;ATP8A1;ATP11B;ATP11A;ABCA7;P2RX7;ATP11C;ATP10B
prerank,muscle cell differentiation (GO:0042692),0.5808155653111204,1.4747611422259022,0.043548387096774194,0.4783299964437373,1.0,7/32,2.77%,SYNE1;NEBL;TMEM204;MRTFB;TBX1;MRTFA;MEF2C
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.7084913850505419,1.4745697886110778,0.06764168190127971,0.4771661804325605,1.0,3/11,4.40%,NOS3;GCH1;CALM1
prerank,dendrite self-avoidance (GO:0070593),0.6406637006851991,1.473178845925926,0.07387387387387387,0.4800692746238199,1.0,4/16,6.87%,BSG;ROBO4;DSCAML1;CNTN2
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.46406207633350477,1.4731582789017303,0.015544041450777202,0.4784240817931147,1.0,33/140,9.35%,CHN2;MCF2L;ARHGAP31;ARHGEF3;ARAP3;SRGAP3;SRGAP2;SRGAP1;ARAP2;RASGRF2;NET1;PLEKHG5;ARHGEF2;KALRN;TIAM1;FAM13A;ABR;CD2AP;STARD13;TGM2;RHOB;DEPDC7;OCRL;ARHGAP23;SOS1;ARHGAP25;ARHGEF12;PREX1;ARHGEF5;OPHN1;ARHGEF7;ARHGAP4;ARHGDIA
prerank,positive regulation of cytokine production (GO:0001819),0.42528772954914273,1.4720950496955765,0.003500583430571762,0.4800389661682429,1.0,52/292,12.80%,SLC7A5;PLCB1;SPTBN1;CADM1;CD34;APP;IL1R1;IL6R;TIRAP;FLT4;CD200;AFAP1L2;ARHGEF2;RGCC;NOD1;LRRFIP1;CD40;NOD2;ZFPM1;PRKD2;IFIH1;GBP5;CTNNB1;NOS2;PDE4D;POU2AF1;CD6;HYAL2;CCR7;CD4;TLR3;MRE11;CCDC88B;LGALS9;IRF5;TLR7;TGFB1;PDE4B;MALT1;EBI3;ADAM17;LAMTOR5;AGER;CCL1;PNP;TLR8;HIF1A;SYK;C1QTNF4;RFTN1;CYRIB;RAB1A
prerank,lipid modification (GO:0030258),0.5515923186438441,1.4718989980823631,0.05993690851735016,0.47895480628214604,1.0,7/37,6.76%,SGPP2;DGKH;MBOAT1;CYP2E1;PLPP6;DGKI;DGKE
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5633356012932881,1.4708368828912801,0.05741626794258373,0.4806106149236483,1.0,16/33,14.37%,MMRN2;RGCC;MEF2C;ACVRL1;NOTCH1;VASH1;STARD13;DLL4;CARD10;KLF4;TGFB1;PDCD10;AGTR2;PPARG;CSNK2B;HDAC5
prerank,divalent inorganic cation homeostasis (GO:0072507),0.6032823513532631,1.4708027331605316,0.07413793103448275,0.4790049684522469,1.0,2/25,1.79%,TMTC2;CAV1
prerank,regulation of smooth muscle cell proliferation (GO:0048660),-0.46200467688066554,-1.4704001126650257,0.04507042253521127,0.425820115606151,1.0,15/46,12.28%,IGF1;PDGFRB;OGN;IGFBP5;BMP4;ELN;APOD;IL18;THBS1;RBPMS2;IGFBP3;CCN4;CDH13;MFN2;XRCC5
prerank,calcium ion transport (GO:0006816),-0.40386278016478083,-1.4690252760268756,0.01694915254237288,0.4272029568714355,1.0,29/113,13.02%,SLC24A3;TRPM3;CACNA1C;ANK2;NALCN;ITPR1;PKD1;STIM1;SLC8A3;ANO6;RAMP1;CACNA2D1;TRPC3;PKD2;CACNA1G;TRPM6;SLC8A1;P2RX4;CACNA1D;TRPC6;ITGAV;TRPM4;CACNB2;TRPC4;SLC24A5;TRPC4AP;PANX1;PSEN1;ORAI2
prerank,energy reserve metabolic process (GO:0006112),-0.5602516788470688,-1.4687419035827451,0.046798029556650245,0.4252871390800359,1.0,8/19,10.86%,PID1;PRKAG2;LEPR;PHKB;PYGM;GFPT1;PPP1R3C;GFPT2
prerank,stabilization of membrane potential (GO:0030322),-0.5890238470994813,-1.4671094307110808,0.06428571428571428,0.4272499439614115,1.0,2/16,2.97%,KCNK2;KCNK5
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.3913126748295432,-1.4670792957568966,0.0176678445229682,0.4248786933898667,1.0,36/108,12.73%,TRABD2B;WLS;SULF1;LRP1;PTK7;GPC3;FGFR2;RNF43;DCDC2;RSPO3;MDFIC;KANK1;WWOX;SULF2;SALL1;DAAM2;RSPO2;FZD7;DACT1;SFRP4;CTNND2;PRKN;FOXL1;GRB10;NXN;AXIN1;VGLL4;BTRC;CDK14;CXXC4;ESR1;LRRK2;BMP2;SKI;EMD;PSEN1
prerank,oogenesis (GO:0048477),0.6625329768165072,1.4664491156992525,0.07664233576642336,0.4917197184513859,1.0,4/15,7.81%,NANOS3;NANOS2;NANOS1;PTN
prerank,striated muscle cell development (GO:0055002),0.6858700351494824,1.4656839784323001,0.08912655971479501,0.4924416585386715,1.0,2/14,1.55%,FLII;PGM5
prerank,B cell activation (GO:0042113),0.498694323614177,1.464596658806016,0.02275960170697013,0.49443036112894834,1.0,23/68,17.53%,TPD52;PTPRJ;MEF2C;CD40;JAK3;HDAC9;ZAP70;HHEX;SLC25A5;KLF6;CD79A;MALT1;ADAM17;CASP8;ZBTB7A;PRKCB;HDAC5;VCAM1;LAT2;DNAJB9;MSH2;ITGA4;ADGRG3
prerank,smoothened signaling pathway (GO:0007224),-0.5041684126543707,-1.464268462296375,0.056338028169014086,0.43070078283321284,1.0,10/32,17.49%,GLI3;GLI2;CC2D2A;SMO;EVC2;GLI1;DYRK2;PTCH2;STIL;TMEM231
prerank,anterior/posterior pattern specification (GO:0009952),-0.45636032131176124,-1.4639641592580597,0.03581267217630854,0.42904173782499,1.0,17/53,13.79%,WLS;HOXC4;HOXC6;HOXB3;PCSK5;HOXA3;HOXA5;HOXB4;HOXB6;TGFBR1;HOXA7;HEYL;BMP2;SKI;HOXB5;HOXC5;HOXA9
prerank,fatty acid biosynthetic process (GO:0006633),0.5103218772572921,1.463662305292949,0.0513950073421439,0.49581769680257576,1.0,12/63,13.80%,ABHD2;ELOVL7;TECRL;CYP2E1;LIPC;ELOVL5;ABCD1;ELOVL6;HACD2;HSD17B8;LTA4H;DEGS1
prerank,acylglycerol metabolic process (GO:0006639),0.5610314799856595,1.4636266899853336,0.07020280811232449,0.49419404469779876,1.0,6/37,7.91%,ABHD2;DGKH;CAV1;DGKI;DGKE;AWAT2
prerank,protein localization to cell-cell junction (GO:0150105),0.6636353810697665,1.4631701325217505,0.07092198581560284,0.494073586327027,1.0,5/15,4.06%,TJP1;TJP2;F11R;ACTB;LSR
prerank,positive regulation by host of viral transcription (GO:0043923),0.6662925282092301,1.4628828809581864,0.08318264014466546,0.49323527588102767,1.0,3/15,9.06%,LEF1;JUN;CHD1
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.5465834910897646,1.462726950770355,0.04501607717041801,0.4920551983805414,1.0,10/38,12.24%,BCL2L1;NOS3;FAS;TNFSF10;ARHGEF2;SP100;RFFL;FAIM;CASP8;TNFAIP3
prerank,smooth muscle cell differentiation (GO:0051145),0.6870301069054937,1.461553826008034,0.08941605839416059,0.4940635656977736,1.0,5/12,3.35%,TMEM204;MRTFB;MRTFA;MEF2C;APLNR
prerank,positive regulation of cellular metabolic process (GO:0031325),0.4820689630204251,1.4613712515456974,0.027510316368638238,0.4929026989943227,1.0,18/98,7.94%,SLCO1C1;PDGFB;INSR;XDH;FASN;PPARD;NFKBIA;IFNAR1;IL10RB;WNT7A;GRB2;RAMP3;INPP5F;TBC1D5;KLF4;ACACB;NR1H2;TGFB1
prerank,regulation of integrin activation (GO:0033623),0.6702216745827172,1.461199972703515,0.07042253521126761,0.49173588453968636,1.0,4/15,10.94%,RASIP1;PIEZO1;RAP1B;FERMT2
prerank,protein secretion (GO:0009306),-0.4454187431655231,-1.460134763268524,0.03503184713375796,0.43758357680019644,1.0,10/56,9.93%,WLS;PCSK5;STEAP3;TANGO2;ABCA1;ANXA1;RCN3;ARFGAP3;TANGO6;CANX
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.5170448396359069,1.4601201692069998,0.042042042042042045,0.4933854174932282,1.0,11/59,6.87%,HMCN1;PTPRM;BSG;PECAM1;CADM1;ROBO4;CDH2;DSCAML1;NECTIN4;PVR;CNTN2
prerank,nitrogen compound transport (GO:0071705),0.4629629547287719,1.4597483834290328,0.01804123711340206,0.4928806049303661,1.0,25/141,11.31%,SLC6A6;SLC7A5;SLC7A1;CERT1;ABCG2;SLC6A2;SLC38A5;ATP11B;SLC43A2;RAMP2;CALCRL;RAMP3;SLC52A2;CMTM6;SEC14L1;LRP1B;SCAMP1;CHMP1B;SLC3A2;SLC52A3;SLC18A1;LRP2;AMN;ARL6IP5;SLC7A7
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.5671000215729627,-1.4593679466055094,0.08428246013667426,0.4375014462840749,1.0,3/18,2.30%,EGFR;BMP4;DDX5
prerank,regulation of glucose metabolic process (GO:0010906),-0.4923089793164063,-1.459187510185411,0.043010752688172046,0.435668500619699,1.0,8/34,10.02%,PDK1;IRS1;OGT;IRS2;RORA;PRKN;SELENOS;SLC45A3
prerank,determination of heart left/right asymmetry (GO:0061371),0.5357722923457172,1.4585013912870601,0.043343653250773995,0.4952132697785555,1.0,7/42,3.41%,ENG;ZIC3;TBX3;SOX17;MEF2C;APLNR;NOTCH1
prerank,cardiac atrium morphogenesis (GO:0003209),0.6514488897736828,1.4579230143954796,0.08093525179856115,0.49545637402336756,1.0,6/16,4.99%,ENG;BMPR2;TGFB2;ZFPM1;NOTCH1;DLL4
prerank,endothelial cell proliferation (GO:0001935),0.6442252806776292,1.4573236045462143,0.07208872458410351,0.4957490845959049,1.0,4/17,3.16%,TEK;CD34;BMPR2;ACVRL1
prerank,embryonic heart tube morphogenesis (GO:0003143),0.5323655968146277,1.456809049737258,0.04434250764525994,0.49556316393521116,1.0,7/43,3.41%,ENG;ZIC3;TBX3;SOX17;MEF2C;APLNR;NOTCH1
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.5673529873169598,-1.454310346921026,0.05592841163310962,0.4470538846681338,1.0,2/17,1.83%,BMP6;CD55
prerank,positive regulation of dendrite extension (GO:1903861),0.6362283845614017,1.4541482471538425,0.0913978494623656,0.5021584505637641,1.0,10/17,20.46%,NEDD4L;ITSN2;RASAL1;SMURF1;CPNE5;SYT4;CPNE6;RIMS2;UNC13A;PLAA
prerank,regulation of heart contraction (GO:0008016),-0.40593093037710215,-1.4535441300450525,0.010344827586206896,0.446823650672815,1.0,16/90,7.21%,ATP1A2;CELF2;ANK2;ITPR1;TPM1;STIM1;SLC8A3;DMPK;ASPH;CAMK2D;ABCC9;ATP1B3;TMEM65;ATP1B2;SLC8A1;P2RX4
prerank,lipid translocation (GO:0034204),0.6183127473356743,1.4518362719254942,0.07885906040268456,0.5081720204450103,1.0,7/21,9.76%,ATP10A;ATP8A1;ATP11B;ATP11A;ABCA7;ATP11C;ATP10B
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.5486174986209803,-1.4517310073252443,0.052884615384615384,0.4495478842605704,1.0,7/21,7.95%,SULF1;EXT1;SULF2;HS2ST1;HS3ST3B1;HS6ST1;HS6ST2
prerank,lamellipodium assembly (GO:0030032),0.5925150831272965,1.4510239189542338,0.06678082191780822,0.5092545618148206,1.0,9/26,10.81%,PARVB;ABLIM1;SRGAP2;S1PR1;SPATA13;CCDC88A;ARHGEF7;CYFIP1;RAC1
prerank,positive regulation of interleukin-8 production (GO:0032757),0.5184599052326923,1.4507752674044785,0.05071315372424723,0.5083443713203686,1.0,15/49,14.16%,TIRAP;AFAP1L2;NOD1;NOD2;PRKD2;NOS2;HYAL2;TLR3;LGALS9;TLR7;LAMTOR5;TLR8;SYK;RAB1A;BCL10
prerank,Rac protein signal transduction (GO:0016601),0.6418432533915799,1.45076160603896,0.07867132867132867,0.5066834100154874,1.0,7/18,10.81%,ELMO1;TIAM1;EPS8;DBNL;NCKAP1;CYFIP1;RAC1
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.5485472238930209,-1.4505898057406112,0.06053268765133172,0.45029937452948393,1.0,9/19,21.84%,DDO;ASPA;ALDH7A1;GOT1;PHYKPL;HYKK;PIPOX;GOT2;AASS
prerank,transition metal ion transport (GO:0000041),0.5640241827964755,1.4493336406440382,0.07298136645962733,0.5098528172318942,1.0,6/35,4.06%,TFRC;SLC39A8;ATOX1;SLC30A1;ATP2C1;SLC31A1
prerank,negative regulation of defense response to virus (GO:0050687),-0.6570056604948303,-1.4481179434019806,0.06941431670281996,0.4551357970125829,1.0,5/10,20.98%,PPM1B;PCBP2;C1QBP;MUL1;TARBP2
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),-0.5435273234378387,-1.4467884663586263,0.058823529411764705,0.4566620972474761,1.0,7/22,11.35%,IGF1;ROCK2;CAMK2D;P2RX4;PRKCA;PARP1;SLC9A1
prerank,axon extension (GO:0048675),-0.5326349186111217,-1.446583846265792,0.06510416666666667,0.4546795809562297,1.0,11/23,22.06%,ALCAM;AUTS2;SLIT2;ULK2;SPG11;PPP3CB;USP9X;SEMA5A;MAP1B;SEMA3F;CDK5
prerank,regulation of dendrite extension (GO:1903859),0.6291058734035495,1.4463738055424586,0.08944543828264759,0.5179847186436966,1.0,10/18,20.46%,NEDD4L;ITSN2;RASAL1;SMURF1;CPNE5;SYT4;CPNE6;RIMS2;UNC13A;PLAA
prerank,pteridine-containing compound metabolic process (GO:0042558),0.6686033772530855,1.4454344900455995,0.07918968692449356,0.5193490786859881,1.0,3/13,4.40%,NOS3;GCH1;CALM1
prerank,regulation of Notch signaling pathway (GO:0008593),0.49164158783676704,1.4453825160525218,0.04028776978417266,0.5178292451977277,1.0,16/76,6.50%,EGFL7;TGFB2;EPN2;NOS3;NOTCH4;JAG2;TSPAN5;PRAG1;NOD2;TSPAN14;NOTCH1;MFNG;GATA2;DLL4;MAML2;FBXW7
prerank,positive regulation of signaling receptor activity (GO:2000273),0.5519233095355625,1.4451886613182843,0.06403940886699508,0.5167607059893525,1.0,11/36,17.38%,SHANK3;ADRA2B;FBXW7;BUD31;TGFA;GREM1;ADAM17;HIF1A;EDN1;NRP1;CCR2
prerank,stress-activated MAPK cascade (GO:0051403),0.5012069923320396,1.4448768933418947,0.0481203007518797,0.5161029604333205,1.0,14/61,10.93%,SH2D3C;MAP4K2;TNFRSF19;MAP4K3;NOD1;NOD2;MAP3K8;IKBKB;MAPK3;LGALS9;CCM2;IRAK2;UBE2V1;ZFP36L1
prerank,cellular response to mechanical stimulus (GO:0071260),0.5307499122394884,1.4440338716725256,0.0686427457098284,0.517184129912434,1.0,14/46,14.16%,PDE2A;FAS;F11R;CD40;MAP3K1;PIEZO1;TLR3;MAPK3;CRADD;TLR7;CASP8;TLR8;SOX9;BCL10
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.7026680120283968,1.4440019681930845,0.08103130755064457,0.5155994570204919,1.0,5/10,6.29%,CXCL12;RAPGEF2;LYN;CCR7;LGALS9
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.621685567357008,-1.4438711054118216,0.08528784648187633,0.4607574688338381,1.0,7/12,18.74%,DMD;WNK4;ATP1B3;ATP1B2;FXYD1;WNK1;WNK3
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.598814609938341,1.4429788765115443,0.08940397350993377,0.5172574149584354,1.0,4/22,3.86%,MFHAS1;DAB2IP;TIRAP;LYN
prerank,acylglycerol catabolic process (GO:0046464),0.576703540081153,1.442494077893238,0.07980456026058631,0.5171834920502214,1.0,4/30,9.49%,ABHD2;LIPE;LIPC;FABP5
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.5594500968680532,1.442327289111138,0.05799373040752351,0.516085726986386,1.0,9/35,6.27%,FLT1;PTPRM;XDH;CAV1;RGCC;MEF2C;VASH1;DLL4;STAT1
prerank,regulation of glucose transmembrane transport (GO:0010827),0.6264373741436976,1.4421900420756775,0.08521739130434783,0.5148725333542121,1.0,2/18,0.45%,OCLN;SLC2A1
prerank,cellular response to insulin stimulus (GO:0032869),0.4568307758781301,1.440979260745887,0.017310252996005325,0.5173209315686066,1.0,31/124,14.37%,IGF1R;GRB14;TBC1D4;NAMPT;INSR;BCAR3;RAB31;FOXO1;PIK3R3;HDAC9;ATP6V0A1;GRB2;GAB1;BAIAP2;DENND4C;SOS1;SLC25A33;AP3S1;PKM;SORBS1;CAV2;PIK3C2A;GRB7;ZFP36L1;GSK3A;CEACAM1;PPARG;SH2B2;LPIN3;PDE3B;HDAC5
prerank,defense response to bacterium (GO:0042742),0.46151114275296135,1.4399177798479073,0.0286493860845839,0.5193153877476011,1.0,20/105,13.00%,PGLYRP1;STAB1;IL6R;TIRAP;NOD1;GBP7;DEFA6;NOD2;GBP4;NOS2;TLR3;IRGM;PPP1R11;ADAM17;S100A8;SYK;LPO;RAB1A;HMGB2;SLPI
prerank,positive regulation of proteolysis (GO:0045862),-0.4403728646072578,-1.439640118824161,0.022099447513812154,0.4710417008791889,1.0,22/55,21.75%,CCBE1;CYFIP2;ASPH;OGT;ADAM9;RCN3;APOE;SNX9;PERP;BTRC;TBC1D10A;CTSH;ATP5IF1;FBXW11;NKD2;SNX33;NRDC;PACSIN3;CLN6;ADRA2A;ADAM8;AURKAIP1
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.6118362935590154,-1.4396302073825897,0.08167770419426049,0.4685545851230425,1.0,7/13,18.62%,NUPR1;TMEM39A;LRRK2;SCFD1;FEZ1;PHF23;SMCR8
prerank,negative regulation of protein processing (GO:0010955),-0.6171838080582378,-1.4393316084471348,0.07674418604651163,0.46700877841809896,1.0,7/12,19.20%,GAS1;THBS1;SNX12;LRRK2;SERPINE2;CTSZ;SERPINE1
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.538762573416089,-1.438679543002701,0.058004640371229696,0.4664150670873108,1.0,9/21,12.11%,IGF1;BMPR1A;IGFBP5;GJA1;FGF2;MMP2;FOXJ2;ADAMTS1;MFN2
prerank,negative regulation of immune effector process (GO:0002698),-0.6077985814412037,-1.4382267243802365,0.07889125799573561,0.46548158211522617,1.0,4/13,16.41%,CD55;ENPP3;CD300A;GRN
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.631545560868582,1.437857477325212,0.0880281690140845,0.5246219328631343,1.0,3/16,5.18%,BCL2L1;CXCL12;SNAI2
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.5573860756660528,1.43769488021071,0.057660626029654036,0.5235912105135199,1.0,5/33,4.60%,TEK;NDNF;KDR;RAMP2;GATA2
prerank,response to lipid (GO:0033993),0.46409150758084605,1.4374333488003677,0.029045643153526972,0.5228586331952179,1.0,26/105,13.65%,NOS3;ACER2;TRIM16;PPARD;TIRAP;IFNAR1;GCH1;TNFRSF11A;FOXO1;PELI1;ABCG1;SOCS2;CTNNB1;NOS2;NOCT;PALM3;CD6;LGALS9;TGFB1;ADAM17;S100A8;PAQR7;PPARG;HMGB2;SLPI;SOX9
prerank,regulation of axon extension (GO:0030516),0.5493568544396574,1.4371740013878285,0.06334841628959276,0.522117976991818,1.0,7/37,8.42%,SEMA7A;MACF1;NTN1;DIP2B;DBNL;DNM2;TWF2
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.5265261597695632,1.4366065708363758,0.060995184590690206,0.5223996913170454,1.0,5/49,2.68%,SGMS1;BCL2L1;CAV1;PLAUR;PTPMT1
prerank,negative regulation of complement activation (GO:0045916),-0.6526874253140122,-1.4364920691932215,0.0970464135021097,0.46788807891808365,1.0,2/10,1.83%,SERPING1;CD55
prerank,regulation of fatty acid oxidation (GO:0046320),-0.5729623469831797,-1.43613354600129,0.08314087759815242,0.4664631780042347,1.0,4/16,5.33%,PRKAG2;APPL2;PPARGC1A;PPARA
prerank,MAPK cascade (GO:0000165),0.4203858190622548,1.4353749370657398,0.005668934240362812,0.5249036562820397,1.0,50/295,9.34%,KITLG;TEK;RASGRP3;SHANK3;RASAL2;SPTBN1;PDGFB;KDR;BCL2L1;DAB2IP;RAPGEF2;RASGRF2;RASGRP4;PTK2;MEF2C;DUSP7;JAK3;FGF13;MEN1;MAP3K8;IKBKB;GRB2;CALM1;FGF16;ZDHHC9;CAMKK2;IL17RD;FYN;SOS1;MAPK3;LGALS9;ABHD17A;RET;PSMB3;LRRC7;RASAL1;PSMD11;RGL2;TGFB1;SPTAN1;MARK3;CCM2;PSMC6;TGFA;SHC3;LYPLA1;PPP1CB;PAK1;MAP3K3;PSME2
prerank,positive regulation of macrophage activation (GO:0043032),-0.5691152898935967,-1.4348020569489328,0.07317073170731707,0.46780803316195785,1.0,4/17,14.30%,LBP;THBS1;TNIP2;TLR4
prerank,intraciliary transport involved in cilium assembly (GO:0035735),-0.47403612019804403,-1.4346126966521773,0.06232294617563739,0.4659046851756632,1.0,12/37,14.45%,IFT80;WDR35;DYNC2I1;IFT81;IFT74;DYNC2H1;IFT122;IFT57;CLUAP1;PCM1;DYNC2I2;WDR19
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.5187615685187825,-1.4343894621467312,0.07542579075425791,0.46410991337915375,1.0,7/26,15.59%,IGF1;FHL2;EFHB;STIMATE;SLC9A1;DYRK2;HOMER3
prerank,organic substance transport (GO:0071702),0.4617599909275077,1.4342726041335385,0.019867549668874173,0.5268222242649503,1.0,24/121,11.15%,ABCG2;MFSD2A;PLTP;ATP8A1;SLCO2B1;SPNS2;SLC6A2;RAMP2;CALCRL;ABCG1;RAMP3;CMTM6;ABCA3;LRP1B;CHKA;SCAMP1;CHMP1B;ABCA7;TAP2;SLC18A1;LRP2;ABCD1;AMN;ARL6IP5
prerank,defense response to virus (GO:0051607),0.46957198173386644,1.434119525726863,0.0442225392296719,0.525747566214742,1.0,23/100,11.18%,BCL2L1;SERINC3;IFNAR2;CD40;IFIH1;NLRC5;IRF2;SERINC5;SAMHD1;NT5C3A;TLR3;STAT1;TLR7;BST2;RTP4;AGBL5;BNIP3L;ZMYND11;OASL;DDIT4;PDE12;RNASE1;TLR8
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.5537867258649896,1.4328770451370616,0.08943089430894309,0.5280003559865718,1.0,16/31,25.15%,PPP1R13B;HIP1R;PPP3CC;YWHAH;YWHAQ;CASP8;ZNF205;GSK3A;PPP3R1;YWHAZ;YWHAB;BAK1;BBC3;SFN;PMAIP1;CHCHD10
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.4840420685007432,1.4324441227193685,0.04107648725212465,0.5278005578026714,1.0,17/73,10.15%,TFRC;SH2D3C;APP;CAV1;BCAR3;PRKD2;PRKD1;RAPGEF3;FNIP2;RAMP3;HSP90AB1;TGFB1;IRGM;PAK1;AKAP9;CNOT9;PDCD10
prerank,positive regulation of GTPase activity (GO:0043547),0.4396350035087892,1.4321330717541507,0.01835985312117503,0.5272245890559625,1.0,38/188,8.89%,ITGA6;DOCK9;TBC1D4;SRGAP2;RAPGEF2;ARHGAP27;ARHGEF15;NET1;BCAR3;F11R;TBC1D14;AGRN;TBC1D22A;CD40;SIPA1L2;RAPGEF1;SIPA1;TIAM1;ABR;TBC1D12;RALGAPA1;SNX13;RAPGEF3;TGM2;TBC1D2;CCR7;USP6NL;MAPRE2;RSU1;RAP1GDS1;TBC1D5;RASGRP2;ARHGAP25;PKP4;ARHGEF5;PIN1;ARHGEF7;CAV2
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.6278381499126902,-1.4320175422502612,0.07900677200902935,0.4684655481089286,1.0,5/11,19.69%,WNT4;BMP5;BMP2;STAR;NR1H4
prerank,regulation of endothelial cell migration (GO:0010594),0.47984013636780987,1.4319874562545618,0.03894297635605007,0.5261216824281321,1.0,17/85,5.40%,TEK;ETS1;PTPRM;KDR;DAB2IP;BMPR2;FLT4;PTK2;SP100;SCARB1;ACVRL1;PRKD2;PRKD1;VASH1;PRCP;DLL4;RHOB
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.5187802094552009,-1.4316958274222324,0.053488372093023255,0.4670539122378353,1.0,11/25,15.46%,ERRFI1;SLC6A9;SNX6;CBLB;PPARA;TSG101;EPHB2;CNRIP1;ZFYVE28;ACE2;GPRC5A
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.5512564161236322,-1.4309196832363662,0.05707196029776675,0.4668676532051617,1.0,7/20,7.19%,ATP1A2;SLC12A2;KCNJ2;ATP1B3;LACC1;ATP1B2;SLC8A1
prerank,positive regulation of transferase activity (GO:0051347),0.4447332850115389,1.4307675979484167,0.022280471821756225,0.5285797018454401,1.0,24/142,8.18%,FLT1;IGF1R;TEK;KDR;INSR;TIE1;FLT4;CD200;DCUN1D3;MERTK;HMBOX1;SERINC5;CTNNB1;HSP90AB1;CD4;EPHA4;MRE11;MAPK3;FBXW7;RET;KLF4;EPHB4;TGFB1;PIN1
prerank,neuron migration (GO:0001764),0.5193923651837734,1.4303961486809587,0.059541984732824425,0.5280954935780582,1.0,15/48,10.81%,NDNF;RAPGEF2;ADGRL3;SH3RF1;NAV1;MEF2C;FGF13;GPM6A;DISC1;SPOCK1;DNER;DCX;DDIT4;CEP85L;RAC1
prerank,BMP signaling pathway (GO:0030509),-0.4263395372709436,-1.429551204640273,0.028070175438596492,0.46852025785300055,1.0,14/62,6.69%,BMP6;TGFBR3;BMPR1A;SMAD3;BMP5;BMP7;BMP4;DDX5;SMAD6;RGMA;RGMB;RUNX2;TMEM100;SMAD9
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.6772866724097284,1.4294628915076364,0.11444652908067542,0.5294875804279782,1.0,3/11,6.99%,MFSD2A;SCARB1;NR1H2
prerank,amide biosynthetic process (GO:0043604),0.5231891850592604,1.4294387204128516,0.055891238670694864,0.5279858878635092,1.0,11/47,15.17%,SGMS1;SGMS2;DEGS2;CERS4;TLCD3B;SPTLC2;SLC25A15;DEGS1;SPTLC1;FA2H;CLN8
prerank,phosphatidylcholine metabolic process (GO:0046470),0.4883751643302347,1.428521863324179,0.04694167852062589,0.5292788335648262,1.0,14/70,13.27%,MFSD2A;MBOAT1;PLA2G4B;SLC44A5;ABCA3;NR1H2;LIPC;CHKA;ENPP2;LPCAT3;CEPT1;PNPLA8;CSNK2B;LPIN3
prerank,endocrine system development (GO:0035270),-0.5518454352703187,-1.428034744808333,0.056074766355140186,0.47073679095036997,1.0,11/21,19.21%,GLI2;WNT4;DKK3;SALL1;TGFBR1;SIX1;FOXE1;NF1;WNT11;MDK;HOXD3
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.6404255218606543,1.427932153393949,0.10627177700348432,0.5297190489827702,1.0,5/16,4.99%,JCAD;PPP1R16B;APLNR;GATA2;DLL4
prerank,defense response to protozoan (GO:0042832),0.663599327318173,1.42779116715867,0.09157509157509157,0.5286256561885453,1.0,3/12,3.23%,CD40;GBP7;GBP4
prerank,cellular response to growth factor stimulus (GO:0071363),0.4418669225705088,1.4277125717469639,0.01858736059479554,0.5273490757881704,1.0,29/151,5.18%,FLT1;NDNF;SEMA6A;PDGFB;KDR;DAB2IP;BMPR2;PDE2A;RAPGEF2;TBX1;PDE8A;FLT4;MEF2C;RAPGEF1;PTPN12;ACVRL1;PRKD2;NOTCH1;PRKD1;RAMP2;DUSP3;VIL1;PLCG1;WNT7A;SMAD7;CTNNB1;DLL4;HYAL2;SNAI2
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.680760891577545,1.4272422594665057,0.10299625468164794,0.5273678350107793,1.0,5/11,12.37%,RAPGEF2;MEF2C;LYN;LGALS9;PIK3CB
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.6389058374121019,1.4271017662087848,0.11070110701107011,0.5262910539934117,1.0,3/16,6.99%,MFSD2A;SCARB1;NR1H2
prerank,microtubule polymerization or depolymerization (GO:0031109),0.5817279625021432,1.4264799126255818,0.08448275862068966,0.5267574566348494,1.0,11/24,17.88%,FGF13;STMN1;NCKAP5;KIF2A;STMN3;STMN4;PIN1;NCKAP5L;CKAP5;TRPV4;TPPP
prerank,regulation of cellular component biogenesis (GO:0044087),0.5390086806626574,1.426327368243231,0.08282208588957055,0.5257006827059386,1.0,10/39,8.46%,TJP1;TIE1;DAB2IP;RAPGEF2;RAPGEF1;NOTCH1;RAP1B;INSM1;IRGM;MSN
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.44390429047666446,1.4263165277039749,0.02929936305732484,0.5241961801572983,1.0,19/150,6.61%,IGF1R;KITLG;TEK;HIP1;MFHAS1;PDGFB;INSR;ENG;PTPRJ;PTK2;GRB2;CD19;FGF16;RAMP3;HSP90AB1;CCR7;GAB1;FYN;RET
prerank,regulation of macrophage cytokine production (GO:0010935),0.6720038108767725,1.4261266701879673,0.08823529411764706,0.5233482683005776,1.0,2/13,1.29%,SEMA7A;TGFB2
prerank,regulation of isotype switching (GO:0045191),0.6476951919405304,1.426048063289837,0.11091234347048301,0.5221189050195839,1.0,2/14,6.72%,TFRC;SHLD1
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.6406650284938548,1.425992442539416,0.10664335664335664,0.5207878542504626,1.0,3/14,1.79%,NOTCH4;XDH;CAV1
prerank,glutamate receptor signaling pathway (GO:0007215),0.5474702484262629,1.4251716637860994,0.06721311475409836,0.5219160050505087,1.0,13/37,16.73%,PLCB1;APP;GNAQ;HOMER2;GRID2;HOMER1;GRIN3B;GRIA4;GRIN2B;GRIK2;GRIK1;GRM7;GRM8
prerank,response to muramyl dipeptide (GO:0032495),0.6788498755604797,1.4250445971785346,0.10261194029850747,0.5208417486113882,1.0,4/12,7.27%,ARHGEF2;NOD1;NOD2;IRF5
prerank,heart contraction (GO:0060047),-0.4716711452847542,-1.424883014998448,0.041884816753926704,0.477791541441766,1.0,7/41,10.26%,ATP1A2;SGCD;TPM1;DMD;SLC8A1;ACE;GAA
prerank,regulation of interferon-gamma production (GO:0032649),0.48249354038424136,1.423649716043553,0.04380664652567976,0.5238000715167477,1.0,14/71,12.59%,SLC7A5;IL1R1;ZFPM1;PDE4D;CCR7;TLR3;LGALS9;TLR7;PDE4B;FOXP3;EBI3;TLR8;VSIR;CYRIB
prerank,negative regulation of GTPase activity (GO:0034260),0.595637727457456,1.4231333337172671,0.08561643835616438,0.5239824911112795,1.0,7/22,11.71%,LRCH1;DAB2IP;SH3BP4;F11R;FICD;PLXNB3;HRAS
prerank,protein O-linked glycosylation (GO:0006493),0.4611213584050801,1.4221722642020478,0.03954802259887006,0.5254104004537169,1.0,11/96,4.52%,TMTC2;EOGT;ST8SIA6;ST3GAL1;GALNT18;B4GALT5;ST6GALNAC2;MUC3A;MUC3B;B3GNT2;OGA
prerank,positive regulation of B cell activation (GO:0050871),0.5146214113315302,1.4219126372876736,0.06240713224368499,0.5246968716775557,1.0,7/50,6.72%,TFRC;TIRAP;MEF2C;CD40;NOD2;CD38;SHLD1
prerank,positive regulation of interleukin-1 production (GO:0032732),0.5105486073235067,1.421670840385678,0.044657097288676235,0.5241171068815778,1.0,12/51,11.20%,APP;TRIM16;NOD2;GBP5;LGALS9;AIM2;P2RX7;MALT1;CASP8;AGER;TLR8;HSPB1
prerank,modulation by host of symbiont process (GO:0051851),0.5504668111694239,1.4216005124069757,0.08771929824561403,0.5228565493456103,1.0,1/31,0.03%,LEF1
prerank,spliceosomal complex assembly (GO:0000245),-0.4407217589152886,-1.4215040502817173,0.03038674033149171,0.4858018341589644,1.0,9/46,12.20%,CELF2;SRSF5;LUC7L3;DDX1;SRSF6;GCFC2;RBM5;PRPF19;LUC7L2
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.6641943026235739,1.4213364992734965,0.10382513661202186,0.5222308017455272,1.0,5/13,12.88%,ELOVL7;TECRL;ELOVL5;ELOVL6;HACD2
prerank,regulation of cell-substrate adhesion (GO:0010810),0.5225064893690624,1.4211848162369243,0.0729483282674772,0.5211912994798461,1.0,13/42,14.99%,NDNF;PDGFB;FZD4;PTK2;CORO2B;NOTCH1;RSU1;ATXN3;SPOCK1;RAC1;PIK3CB;MINK1;GCNT2
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.4378248654720463,1.4209888613925712,0.023809523809523808,0.5203257902946126,1.0,26/159,7.13%,MPZ;HMCN1;PTPRM;BSG;PECAM1;CLDN5;CADM1;ROBO4;TGFB2;ADGRL3;CDH2;DSCAML1;ATP2C1;NECTIN4;PCDHGB4;CDH20;CD6;CDH8;GRID2;PVR;CNTN2;FAT4;SLITRK3;DCHS1;CDH19;CLDN14
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.6208617865785693,1.4205663394891175,0.12660550458715597,0.520189857891954,1.0,3/16,7.43%,CADM1;PVR;CD160
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.6421767217497041,1.4205396797163787,0.08657243816254417,0.5188190034186799,1.0,2/15,1.57%,PRKCH;TRIM16
prerank,regulation of MAPK cascade (GO:0043408),0.43870239806854366,1.4188810138850714,0.026515151515151516,0.5227069349085037,1.0,29/157,9.07%,FLT1;IGF1R;TEK;JCAD;PDGFB;KDR;INSR;DAB2IP;CAV1;FAS;TBX1;FLT4;BCAR3;PHLPP1;PTPRJ;DUSP3;LYN;CD4;PAK5;MAPK3;ADRA2B;RET;ARHGEF5;IQGAP1;ABCA7;P2RX7;CAV2;GREM1;PAK1
prerank,lipid phosphorylation (GO:0046834),0.6862081811998512,1.4187920438960153,0.11214953271028037,0.5215283547039307,1.0,4/10,12.19%,DGKH;DGKI;DGKE;DGKZ
prerank,positive regulation of interleukin-6 production (GO:0032755),0.48535155229160104,1.4187175501476486,0.05530642750373692,0.5203085241786056,1.0,18/68,15.16%,APP;IL6R;TIRAP;ARHGEF2;NOD2;IFIH1;NOS2;POU2AF1;HYAL2;TLR3;LGALS9;TLR7;AGER;TLR8;SYK;C1QTNF4;BCL10;INAVA
prerank,carboxylic acid metabolic process (GO:0019752),0.5527211949132429,1.4185230584707442,0.07290015847860538,0.519454193424411,1.0,6/33,9.32%,CSGALNACT1;SLC2A1;ST3GAL1;GLYAT;ST6GAL1;TBXAS1
prerank,Golgi to plasma membrane transport (GO:0006893),0.5156793626710243,1.418449688338198,0.0724191063174114,0.5182607731422582,1.0,10/47,11.54%,SPTBN1;MACF1;EXOC6B;RAB31;EXOC6;STXBP6;RAB34;EXOC4;AMN;EXOC2
prerank,negative regulation of T cell differentiation (GO:0045581),-0.6460514174253051,-1.4172672481477657,0.08541666666666667,0.49613553268196375,1.0,2/10,1.84%,GLI3;BMP4
prerank,B cell proliferation (GO:0042100),0.6287573879497451,1.416839481239621,0.08743169398907104,0.5216954447686656,1.0,4/17,8.31%,MEF2C;CD40;CD19;CD79A
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.6409482924610762,-1.4158298642666804,0.09151785714285714,0.4981228111198137,1.0,3/10,3.97%,ATP1A2;OSR1;CAMK2D
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.6105963311456972,1.415322245020163,0.13285457809694792,0.5250529209260142,1.0,3/17,7.43%,CADM1;PVR;CD160
prerank,negative regulation of neuron projection development (GO:0010977),-0.424191410383122,-1.41524391790228,0.026865671641791045,0.4974294001347182,1.0,13/56,13.59%,DPYSL3;LPAR1;PTPN9;EFNB2;KANK1;PTPRS;APOE;CBFA2T2;STX1B;ADCY6;RAB29;MYLIP;PTEN
prerank,inorganic ion transmembrane transport (GO:0098660),-0.6299030939772291,-1.4150462305954892,0.08928571428571429,0.49567660457436363,1.0,4/12,14.96%,PKD2;ABCC9;TRPM4;KCNJ8
prerank,positive regulation of interleukin-2 production (GO:0032743),0.5728290972689858,1.414625161738393,0.08952702702702703,0.5257806532919281,1.0,7/25,11.16%,SPTBN1;PRKD2;PDE4D;CD4;PDE4B;MALT1;PNP
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.6052945230557666,-1.4141397898207702,0.09839816933638444,0.49589422811228023,1.0,7/13,15.43%,LARGE1;MGAT3;RENBP;PGM3;CHST3;NAGK;CHST1
prerank,regulation of DNA repair (GO:0006282),-0.45855661398578085,-1.4139469633848705,0.06111111111111111,0.4940165869718442,1.0,4/44,2.08%,EYA2;EYA1;EGFR;EYA4
prerank,response to copper ion (GO:0046688),0.6044095723867906,1.4136139543013273,0.1111111111111111,0.5275024512225116,1.0,12/20,25.50%,MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;LOXL2;DAXX;SNCA;AOC1
prerank,sodium ion transport (GO:0006814),-0.401164709966697,-1.4122747046419573,0.02158273381294964,0.49659642691254635,1.0,17/85,7.19%,ATP1A2;SLC24A3;NALCN;SLC6A13;SCN7A;SLC6A12;SLC8A3;SLC6A9;SLC12A2;ANO6;PKD2;ATP1B3;SLC5A5;SLC6A1;SLC5A6;SLC9B2;SLC8A1
prerank,iron ion transmembrane transport (GO:0034755),0.7048574086939835,1.412183903827016,0.10775047258979206,0.5303839093160441,1.0,2/10,1.25%,SLC40A1;SLC39A8
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.5550760836027283,-1.411745556244142,0.08863636363636364,0.49587127801953906,1.0,3/17,4.69%,ANK2;SNTA1;CACNA2D1
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.395276197299239,1.4116181767187728,0.002136752136752137,0.5306760815656533,1.0,88/509,12.51%,FLT1;IGF1R;TFRC;KITLG;TEK;HIP1;MFHAS1;JCAD;PDGFB;KDR;INSR;BCL2L1;DAB2IP;ENG;TGFB2;TNFRSF19;RAPGEF2;PDGFD;APP;CAV1;TBX1;TIRAP;FLT4;PLEKHG5;TRIM25;BCAR3;TRIM14;TNFSF10;PTPRJ;PTK2;NOD1;CD40;NOD2;PELI1;PRKD2;PRKD1;ATP2C1;VWF;LYN;TGM2;IKBKB;GRB2;CD19;FGF16;RAMP3;HSP90AB1;CCR7;CD4;GAB1;TLR3;WDR59;ACTN4;FYN;LGALS9;ZCCHC3;ADRA2B;RET;BIRC3;TLR7;BST2;TGFB1;IQGAP1;TGFA;CAV2;TNFSF11;MAP3K3;MALT1;NDFIP2;OASL;UBE2V1;SCHIP1;CASP8;BRD4;LAMTOR5;SHARPIN;AGER;RAC1;FERMT2;LRP2;S100A8;HRAS;PRKCB;RPTOR;GPR89A;C1QTNF4;PIK3CB;SOX11;GDF15
prerank,negative regulation of DNA metabolic process (GO:0051053),0.5800104864082579,1.411128236108068,0.09966216216216216,0.5307802039522852,1.0,3/24,3.16%,DACH1;BMPR2;ACVRL1
prerank,positive regulation of T cell migration (GO:2000406),0.6091347758949204,1.4107416978367249,0.10732538330494037,0.5305555863190634,1.0,4/20,10.02%,CXCL12;APP;ADAM10;ADAM17
prerank,cellular copper ion homeostasis (GO:0006878),0.6489001788251885,1.4095727279366883,0.09726962457337884,0.5328441770397748,1.0,3/14,4.06%,APP;ATOX1;SLC31A1
prerank,negative regulation of cytokine production (GO:0001818),0.43028051396256867,1.408811897038695,0.025974025974025976,0.5339127460418983,1.0,36/163,12.26%,LEF1;CD34;CD200;TRIM25;RGCC;SRGN;JAK3;ZFPM1;IFIH1;SIGIRR;HDAC9;HDAC7;NLRC5;RNF125;TNFRSF21;TMSB4X;SARS1;HOMER2;CCR7;ATP2B1;LGALS9;RPS6KA5;KLF4;N4BP1;CD200R1;PIN1;FOXP3;PPP1R11;TRIB2;AGER;RAC1;ABCD1;TLR8;VSIR;TNFAIP3;CEACAM1
prerank,hippo signaling (GO:0035329),0.572462612943191,1.4087596493594088,0.07885906040268456,0.5326506578719586,1.0,7/26,7.08%,TJP1;TEAD4;TJP2;AMOT;WWTR1;FAT4;DCHS1
prerank,xenobiotic transport (GO:0042908),0.625217232013425,1.4083599935423463,0.10286677908937605,0.5325046178181004,1.0,2/17,0.39%,SLC7A5;ABCG2
prerank,actin filament-based transport (GO:0099515),0.6053312360747644,1.4081508726422327,0.08561020036429873,0.531709026848643,1.0,5/21,6.02%,MYO1D;MYO1E;FNBP1L;MYO6;ACTN4
prerank,hepaticobiliary system development (GO:0061008),-0.5413064659821984,-1.406392716735389,0.0947867298578199,0.509768594362358,1.0,5/20,7.94%,TGFBR3;WNT4;COBL;PKD2;MET
prerank,negative regulation of binding (GO:0051100),0.4664979312782932,1.4059646737205265,0.049786628733997154,0.5371668495054501,1.0,13/81,9.18%,LEF1;PDGFB;CAV1;NFKBIA;CTNNBIP1;NES;SP100;ZFPM1;ACTB;RALB;JUN;PIN1;DISC1
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.627897120809779,1.405295808220763,0.11678832116788321,0.5379172729811246,1.0,6/16,11.69%,BMPR2;DDAH1;PRCP;NPPA;KLK1;GSK3A
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.6230887710187779,-1.4049566269294773,0.10022779043280182,0.5116543928682306,1.0,5/11,8.07%,PDK1;MAP3K5;PRKCD;CYP1B1;PRODH
prerank,protein modification process (GO:0036211),0.46814585123261004,1.4033149730205696,0.05805515239477504,0.5429658288805418,1.0,23/76,19.40%,ST8SIA4;ST3GAL6;ST3GAL1;STK38;YES1;LCMT1;PLAT;FBXL2;DUSP12;CHRM3;UBA3;MANBA;FBXW2;MAN2B1;UBE2D3;MMP15;LOXL2;MCRS1;FBXO2;SEPHS1;ERO1A;USP25;CPE
prerank,regulation of inflammatory response (GO:0050727),0.4212902942790184,1.402330221670864,0.017478152309612985,0.5446502503138108,1.0,32/190,12.29%,TEK;ETS1;SEMA7A;MFHAS1;PDE2A;APP;IL1R1;PPARD;NFKBIA;CD200;BCL6B;NOD2;TMSB4X;XIAP;HYAL2;MGST2;TLR3;KLF4;HCK;BIRC3;TLR7;NLRP6;CD200R1;LPCAT3;BRD4;SHARPIN;CCL1;S100A8;USP18;DDT;TNFAIP3;PPARG
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.5460962208175765,-1.4022121144098776,0.09420289855072464,0.5179478842733596,1.0,10/18,22.45%,ASPA;NAALAD2;ASPG;MTHFD1;MTHFR;GOT1;SLC25A12;NIT2;GOT2;NAT8L
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.6174693233203821,1.4013436865307096,0.0984182776801406,0.5462219709827516,1.0,6/19,11.13%,TEK;KDR;PTPRJ;RAC1;FERMT2;MAP4K4
prerank,positive regulation of chromatin organization (GO:1905269),0.6551269371522828,1.4005844733275132,0.1198501872659176,0.5471426935236839,1.0,6/12,21.79%,TAL1;TERF2;ACD;TERF1;SIN3A;DAXX
prerank,triglyceride biosynthetic process (GO:0019432),-0.5413711323998135,-1.4001764254894236,0.0851581508515815,0.52162346464877,1.0,6/18,15.27%,AGMO;MOGAT3;GK;LPGAT1;GPAT3;PNPLA3
prerank,embryonic limb morphogenesis (GO:0030326),-0.46027210922506673,-1.3997252770677413,0.06914893617021277,0.520588122332979,1.0,7/34,4.42%,CACNA1C;GLI3;AFF3;OSR1;CYP26B1;SALL1;WDPCP
prerank,positive regulation of blood coagulation (GO:0030194),-0.5575733413817313,-1.399412695894533,0.0827250608272506,0.5192082922658052,1.0,6/17,12.21%,ST3GAL4;THBS1;F3;ANO6;THBD;DMTN
prerank,cellular biogenic amine metabolic process (GO:0006576),0.6689501354700738,1.3993849202119053,0.11753731343283583,0.5494917908316455,1.0,2/12,0.85%,DDC;MAOA
prerank,endoderm formation (GO:0001706),-0.47108898796560117,-1.398964353700617,0.07161803713527852,0.5183094031654013,1.0,11/35,10.48%,COL8A1;COL12A1;VTN;COL6A1;ITGB5;MMP14;COL11A1;MMP2;ITGA5;LAMB1;ITGAV
prerank,regulation of interleukin-12 production (GO:0032655),0.5063845507323327,1.3987866313602682,0.07401574803149606,0.5498575441055829,1.0,11/47,12.14%,PLCB1;TIRAP;CD40;JAK3;CCR7;TLR3;LGALS9;IRF5;AGER;TLR8;SYK
prerank,base conversion or substitution editing (GO:0016553),0.6650578415887138,1.3981433524022382,0.1371841155234657,0.5504137797021067,1.0,5/11,24.11%,ADAR;ADAD1;NUDT16;METTL3;ADARB2
prerank,lipid oxidation (GO:0034440),0.6428161059214457,1.397063971034408,0.12734082397003746,0.5522419786020448,1.0,3/12,11.95%,ADIPOR2;ACOX1;ADIPOR1
prerank,cell-cell junction assembly (GO:0007043),0.4832114445458686,1.396905426522243,0.0673352435530086,0.551305264931772,1.0,17/63,7.67%,TJP1;CLDN5;GJD3;GJC1;CDH2;RAMP2;ACTB;SMAD7;CDH20;CTNNB1;CTNND1;CDH8;PIP5K1C;PKN2;DCHS1;CDH19;PKP4
prerank,membrane lipid metabolic process (GO:0006643),0.5799248976014038,1.3964114046793432,0.09965034965034965,0.551390613868658,1.0,9/22,14.15%,ST3GAL6;B4GALT4;ACER1;MGST2;GAL3ST1;CERKL;ST6GALNAC4;CERK;SPTLC1
prerank,anion transmembrane transport (GO:0098656),0.48684687428712425,1.3963821568951669,0.07164179104477612,0.5500931379529556,1.0,10/67,5.14%,SLC7A5;SLC7A1;SLC1A1;SLC39A8;SLC6A5;SLC38A5;LRRC8B;LRRC8C;SLC1A2;SLC25A5
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.5871484467682018,-1.395483092571082,0.11486486486486487,0.5262145325960531,1.0,7/13,25.08%,DDX5;PLA2R1;ATM;SPRED1;HIC1;MSX1;ATR
prerank,membrane repolarization (GO:0086009),-0.5671320996499845,-1.3953790889842328,0.09006928406466513,0.5241384522890935,1.0,4/15,7.12%,ATP1A2;KCNJ2;ATP1B3;ATP1B2
prerank,regulation of kinase activity (GO:0043549),0.45783367577203055,1.394797196544773,0.044349070100143065,0.5536282608733357,1.0,15/89,7.06%,FLT1;IGF1R;TEK;KDR;INSR;TIE1;FLT4;NLRC5;MERTK;CD4;CAMKK2;EPHA4;MRE11;RET;EPHB4
prerank,protein autophosphorylation (GO:0046777),0.4285577309262708,1.394631437904715,0.0299625468164794,0.5527676476902575,1.0,25/157,10.25%,FLT1;IGF1R;TEK;KDR;INSR;FES;FLT4;PTK2;STK10;PRKD2;PRKD1;LYN;PIKFYVE;CAMKK2;EPHA4;AATK;MAPK3;HCK;EPHB4;MARK3;PAK1;MAP3K3;EIF2AK4;STK33;PTK6
prerank,regulation of activated T cell proliferation (GO:0046006),-0.47910817402420797,-1.3944413586341902,0.08353808353808354,0.524589134378949,1.0,4/30,5.98%,IGF1;IGFBP2;IL18;IGF2
prerank,regulation of cholesterol efflux (GO:0010874),0.5465243688864547,1.39395967243309,0.0832,0.5533531164312419,1.0,8/30,12.29%,PLTP;CAV1;NFKBIA;ABCA3;NR1H2;ABCA7;NAXE;PPARG
prerank,regulation of calcium ion import (GO:0090279),0.6075929091428868,1.3935884061519992,0.11428571428571428,0.5530474911817763,1.0,5/21,6.12%,PDGFB;CXCL12;SLC30A1;CTNNB1;FYN
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.5218325777250472,-1.3935249655448738,0.07159353348729793,0.5251190015459476,1.0,8/21,13.46%,ADCY5;ADCY1;ADCY9;ADCY2;ADCY7;GUCY1A1;ADCY6;GUCY1B1
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.5334291107309357,1.3932701710214528,0.08280254777070063,0.5527176655734687,1.0,11/35,11.25%,SEMA3C;SEMA7A;SEMA6A;SEMA6B;PLXND1;SEMA4F;SEMA6D;SEMA4C;ARHGDIA;RAC1;PLXNB3
prerank,activation of phospholipase C activity (GO:0007202),-0.4831954831373927,-1.3925740963649362,0.0665024630541872,0.5259014259484326,1.0,4/29,2.87%,ARHGAP6;LPAR1;EGFR;EDNRA
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.6342661990692935,1.3919510776314123,0.10357815442561205,0.5556439973392234,1.0,4/14,10.29%,RAPGEF2;PKIG;PRKAR2B;PRKAR2A
prerank,positive regulation of secretion (GO:0051047),0.6707269983038917,1.3915978057826817,0.14312267657992564,0.5553682105854344,1.0,4/11,17.18%,ABCB11;ACSL3;NPR1;TRH
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.5263508960458877,1.3911147234133299,0.08196721311475409,0.5555359520257973,1.0,11/39,13.13%,MYO1D;MYO1E;FNBP1L;MYO6;ACTN4;KIF1A;BICDL1;MYO1F;SYT4;RAB1A;F8A1
prerank,regulation of cellular protein metabolic process (GO:0032268),0.5062514532126654,1.3909672976706582,0.078125,0.5546321468783357,1.0,11/47,13.12%,NANOS3;APP;NFKBIA;WNT7A;KLF4;NR1H2;TGFB1;CYFIP1;EIF4E;PUM3;SSH1
prerank,heart development (GO:0007507),-0.3562908564855232,-1.3900074730069583,0.009259259259259259,0.5314220843717186,1.0,38/150,8.79%,CACNA1C;COL3A1;TGFBR3;FBN1;NTRK3;PLCE1;GLI2;CXADR;SGCD;BMP5;MICAL2;BMP7;ADAP2;GPC3;BMP4;ZFPM2;OSR1;PCSK5;PKD1;PDLIM7;RBP4;SALL1;SH3PXD2B;FOXC2;BCOR;FOXC1;TGFBR1;PKD2;NDUFV2;SCUBE1;PDLIM2;AKAP13;PDLIM4;FOXL1;KDM6B;MTHFD1;POU6F1;IFT122
prerank,regulation of microtubule polymerization (GO:0031113),0.5263843337434735,1.3895305963683102,0.10766721044045677,0.5579388373391284,1.0,10/40,13.96%,OCLN;FES;STMN1;CLIP1;CDK5RAP2;PAK1;AKAP9;RAC1;MAPRE3;CDH5
prerank,positive regulation of MAP kinase activity (GO:0043406),0.4783239085299393,1.3883373647474175,0.0641399416909621,0.5602270578992006,1.0,9/66,3.22%,FLT1;PIK3R6;PDGFB;DAB2IP;PDGFD;TNFRSF11A;TPD52L1;CD40;NOD2
prerank,regulation of interleukin-6 production (GO:0032675),0.45067863198282954,1.3882977827662153,0.04775687409551375,0.5589438429505047,1.0,24/96,15.16%,APP;IL6R;TIRAP;CD200;AFAP1L2;ARHGEF2;NOD2;IFIH1;NOS2;POU2AF1;HYAL2;TLR3;LGALS9;TLR7;CD200R1;AGER;TLR8;SYK;TNFAIP3;C1QTNF4;BCL10;FOXJ1;NCKAP1L;INAVA
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.5734336294324791,1.388243693648869,0.1035653650254669,0.557712442865705,1.0,5/25,9.25%,SLC7A5;B2M;NOD2;CD160;MALT1
prerank,cell junction organization (GO:0034330),0.47662686704689666,1.3881449078916765,0.08333333333333333,0.5566533198692314,1.0,16/71,9.79%,OCLN;TJP1;APBB2;LIMS2;TGFB2;APP;TJP2;AGRN;PPFIBP1;ACTB;MARVELD2;TGFB1;OPHN1;PIN1;ELFN1;ACTG1
prerank,actin filament depolymerization (GO:0030042),-0.6049906813194033,-1.387813480270205,0.09713024282560706,0.536029442306739,1.0,3/11,1.64%,MICAL3;GSN;MICAL2
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.6299062179070758,1.3876767244210062,0.12641509433962264,0.5568124625012907,1.0,2/13,6.08%,ETS1;FUT9
prerank,epithelial tube morphogenesis (GO:0060562),0.5365093249630976,1.3874729264398733,0.09822866344605476,0.5560413779627025,1.0,12/32,9.07%,PODXL;RASIP1;SOX17;MTSS1;MEF2C;ACVRL1;PRKD2;CTNNB1;COL4A1;RHOB;CCM2;PAK1
prerank,metanephric mesenchyme development (GO:0072075),-0.622490992274579,-1.38694505233732,0.12121212121212122,0.5364006015228635,1.0,4/10,5.58%,WNT4;OSR1;PKD2;SIX1
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.5520809344850046,1.3861348309897021,0.0998389694041868,0.558857746835583,1.0,4/30,4.82%,FLT1;KDR;FLT4;PLD4
prerank,cellular response to glucagon stimulus (GO:0071377),-0.5480162524886241,-1.385728793311408,0.10284463894967177,0.5378053082815514,1.0,8/17,13.35%,ADCY5;ADCY1;ADCY9;ADCY2;ADCY7;PRKACA;ADCY6;CYSLTR2
prerank,cyclooxygenase pathway (GO:0019371),-0.6251702962739234,-1.3856271318129438,0.12311015118790497,0.5357980616838178,1.0,4/10,6.06%,PTGDS;PTGIS;PTGS1;PTGES
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.643538467113177,1.3849860959908094,0.12252252252252252,0.5597017437880973,1.0,4/13,5.23%,PLCB1;JAK3;GRB2;CD4
prerank,cellular response to interleukin-15 (GO:0071350),0.643538467113177,1.3849860959908094,0.12252252252252252,0.5597017437880973,1.0,4/13,5.23%,PLCB1;JAK3;GRB2;CD4
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.4481013609981449,1.3844799285527007,0.049664429530201344,0.5599358324233891,1.0,21/93,10.53%,TFRC;SH2D3C;APP;CAV1;CNKSR3;BCAR3;PRKD2;PRKD1;RAPGEF3;FNIP2;SMAD7;PDE4D;RAMP3;HSP90AB1;TGFB1;IRGM;PAK1;AKAP9;CNOT9;PDCD10;DDIT4
prerank,positive regulation of protein phosphorylation (GO:0001934),0.3944674773297542,1.3842049545267308,0.014492753623188406,0.5594214255169049,1.0,64/348,10.15%,TFRC;TEK;LIMCH1;PECAM1;PDGFB;SH2D3C;KDR;INSR;ENG;BMPR2;TGFB2;RAPGEF2;PDGFD;APP;CAV1;FAS;TBX1;IL6R;PDE8A;FLT4;BCAR3;LRP8;PLAUR;PTPRJ;ARHGEF2;PTK2;NIBAN1;CD40;ACVRL1;PIK3R3;APLNR;PRKD2;PRKD1;MMD;LYN;RAPGEF3;FNIP2;CALM1;FGF16;RAMP3;HSP90AB1;CCR7;CD4;CAMKK2;MRE11;LIMK2;PPIA;MAPK3;RPS6KA5;RALB;EFNA1;TGFB1;IRGM;PIN1;IQGAP1;ENPP2;PAK1;CCND3;PGF;AKAP9;CNOT9;AXIN2;ADAM17;PDCD10
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.5074745770458602,1.3841247621338666,0.0941358024691358,0.5583244494284084,1.0,10/46,10.94%,TEK;PARVB;SRGAP2;LAMA5;NTNG2;PXN;PARVG;EFNA1;RAC1;FERMT2
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.5235834932299432,1.383915039272049,0.09006211180124224,0.5575455572940072,1.0,9/39,12.37%,EFR3B;ITPKB;PIK3R3;SOCS2;SOCS5;PIK3C3;PIK3C2A;PIP4K2A;PIK3CB
prerank,neuron projection organization (GO:0106027),0.6227416656646863,1.3834874484308683,0.1267605633802817,0.5574534010400126,1.0,4/15,11.09%,INSR;APP;ATP1A3;ABCD1
prerank,positive regulation of phosphorylation (GO:0042327),0.4109765193195916,1.382433711593812,0.017878426698450536,0.5593272083162125,1.0,46/240,10.02%,FLT1;IGF1R;TFRC;TEK;ITGA6;LIMCH1;PECAM1;KDR;INSR;TIE1;ENG;APP;FAS;TBX1;PDE8A;FLT4;PLAUR;PTK2;NIBAN1;CD40;PIK3R3;MERTK;LYN;FGF16;CD4;CAMKK2;EPHA4;MRE11;LIMK2;PPIA;ENTPD5;MAPK3;RET;RALB;EPHB4;EFNA1;TGFB1;IRGM;PIN1;P2RX7;PAK1;CCND3;PFKFB3;PGF;AXIN2;ADAM17
prerank,wound healing (GO:0042060),-0.41010959207457626,-1.3820445329485824,0.03115264797507788,0.5448421218807746,1.0,13/62,6.29%,IGF1;COL3A1;PDGFRA;SMAD3;FGF1;TPM1;DCBLD2;MYOF;AHNAK2;TGFBR1;FGF2;ANXA6;FZD7
prerank,positive regulation of ion transport (GO:0043270),-0.43471896680422606,-1.3819923843346327,0.06997084548104957,0.5426526448107293,1.0,11/48,11.67%,ANK2;ACTN2;FHL1;MYLK;ANO6;DLG1;P2RX4;CACNA1D;TRPC6;CACNB2;GPD1L
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.5493832758756837,1.3818720422037172,0.10570469798657718,0.5597495145426974,1.0,4/26,5.34%,MFHAS1;CAV1;TIRAP;TLR3
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.5990399264023716,-1.3816179632314247,0.10561797752808989,0.5415851788252828,1.0,2/12,6.33%,INSIG2;KDELR3
prerank,cellular response to ketone (GO:1901655),-0.46253521861908437,-1.381252865446643,0.07792207792207792,0.5403969120672103,1.0,7/35,8.79%,ROCK2;ADCY5;ADCY1;ADCY2;AR;SPP1;PTGFR
prerank,somite development (GO:0061053),-0.6175511416988613,-1.379926914453342,0.10467706013363029,0.5420156877097614,1.0,4/11,8.65%,MEOX2;SMO;LOXL3;MTHFD1
prerank,organophosphate ester transport (GO:0015748),0.5626645524569007,1.3797025061574988,0.13220338983050847,0.565303861102969,1.0,6/24,6.10%,PLTP;SCARB1;PRELID2;PITPNC1;PITPNA;ABCA3
prerank,positive regulation of chemokine production (GO:0032722),0.5015135922676972,1.3796310725370509,0.10223642172523961,0.5641477337944203,1.0,10/44,12.14%,APP;IL6R;TIRAP;TLR3;LGALS9;TLR7;ADAM17;AGER;HIF1A;SYK
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.4897192582188235,-1.3795010224230253,0.06527415143603134,0.5410851035162936,1.0,12/27,19.58%,ANK2;DMD;CAMK2D;CACNB4;PRKACA;CACNB2;JPH1;CACNB1;AHNAK;JPH2;ADRA2A;CACNB3
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.5870612637109192,1.3791828811626123,0.11764705882352941,0.5642423526538132,1.0,7/18,10.33%,JCAD;KDR;HDAC9;HDAC7;GATA2;MAP3K3;PIK3C2A
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),-0.3346426034004841,-1.379123304192646,0.012658227848101266,0.5398975044858194,1.0,66/248,15.81%,RNF220;BICC1;RBMS3;WLS;EGFR;ZEB2;LGR4;GLI3;COL1A1;IGFBP2;PTK7;DKK3;GPC3;FGFR2;IGFBP6;LRRK1;KANK1;INVS;AMFR;LYPD6;DAB2;TBL1XR1;IGFBP4;DAAM2;PLEKHA4;FZD7;DACT1;GLI1;SFRP4;CTNND2;PRKN;PFDN5;TMEM64;TLE3;TNKS2;CHD8;PSME4;APOE;MLLT3;UBR5;AXIN1;SMURF2;CUL3;FUZ;PPM1B;STK11;BTRC;CDK14;TRPM4;PSME3;CAPRIN2;LRRK2;BMP2;SCEL;EMD;PSEN1;DVL2;WNK1;WNT11;LMBR1L;DDX3X;NKD2;UBE2B;TLE2;LIMD1;LRP6
prerank,positive regulation of protein modification process (GO:0031401),0.4138668829415497,1.3786425810228513,0.026159334126040427,0.5645738293717542,1.0,41/203,10.81%,TFRC;TEK;LIMCH1;PECAM1;KDR;INSR;PPP1R16B;ENG;APP;FAS;TBX1;PDE8A;FLT4;PLAUR;PTK2;NIBAN1;CD40;PIK3R3;LYN;RAPGEF3;CALM1;FGF16;CD4;CAMKK2;LIMK2;PPIA;MAPK3;PPP2R5A;RALB;EFNA1;TGFB1;IRGM;PIN1;ASPSCR1;PAK1;CCND3;PGF;AXIN2;ADAM17;AGER;RAC1
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.6213444469815588,1.3780382758229754,0.12585034013605442,0.5650148525878488,1.0,2/15,1.29%,STOX2;TGFB2
prerank,positive regulation of cholesterol transport (GO:0032376),0.5624596270624966,1.3776399610896897,0.07768595041322314,0.564913935793006,1.0,8/27,12.29%,PLTP;CAV1;NFKBIA;ABCA3;NR1H2;ABCA7;LPCAT3;PPARG
prerank,positive regulation of potassium ion transport (GO:0043268),-0.4630342344106233,-1.3774747012204376,0.052486187845303865,0.5428745162119193,1.0,7/38,6.12%,ANK2;ACTN2;FHL1;KCNMB2;KCNJ2;DLG1;FLNA
prerank,innate immune response in mucosa (GO:0002227),0.6684681790103573,1.3773279164190944,0.13246268656716417,0.5645321929047085,1.0,2/10,4.55%,DEFA6;NOS2
prerank,positive regulation of cell differentiation (GO:0045597),0.4095111177917572,1.3771404673980991,0.028268551236749116,0.5637780691473955,1.0,30/237,5.11%,LEF1;SLC6A6;PRKCH;KITLG;PLCB1;KDR;CD34;BMPR2;TGFB2;RAPGEF2;ZHX3;FES;PPARD;IL6R;CTNNBIP1;ARHGEF2;RGCC;MEF2C;ACVRL1;RPS6KA1;TIAM1;CDH2;PRKD1;MMD;ZBTB16;CTNNB1;NOCT;CREB1;WWTR1;HSP90AB1
prerank,positive regulation of endothelial cell migration (GO:0010595),0.45812735480690187,1.3765416572008995,0.06789250353606789,0.5643173132910074,1.0,15/84,5.40%,TEK;ETS1;PDGFB;KDR;BMPR2;NOS3;FLT4;CD40;SCARB1;PRKD2;PRKD1;PLCG1;TMSB4X;GATA2;RHOB
prerank,regulation of protein dephosphorylation (GO:0035304),0.5245099197499056,1.3761715601274294,0.07938931297709924,0.5640805218927682,1.0,11/37,14.06%,MFHAS1;PPP1R16B;CALM1;PPP1R2;PPIA;PPP2R5A;TGFB1;PIN1;NSMF;CDH5;PPP1R8
prerank,endoderm development (GO:0007492),0.6351029727327837,1.3761048905156574,0.14018691588785046,0.5629397828214162,1.0,4/13,16.42%,SOX17;SOX7;DUSP1;LHX1
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.49160928462064796,-1.3757046048056008,0.10722610722610723,0.5461753763782962,1.0,6/25,5.95%,CACNA1C;ANK2;CXADR;CAMK2D;DLG1;TBX18
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.5318826811629561,1.3751674403103302,0.10256410256410256,0.5645108300113808,1.0,9/33,12.29%,ETS1;PDGFB;TGFB2;GATA2;KLF4;TGFB1;JUN;HIF1A;PPARG
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.5765356487534161,-1.3739798464796202,0.11751662971175167,0.5491666026321593,1.0,6/13,15.46%,ERRFI1;SNX6;CBLB;TSG101;ZFYVE28;GPRC5A
prerank,T cell homeostasis (GO:0043029),0.6729504446259686,1.3739491436408702,0.15254237288135594,0.5668971359956204,1.0,4/10,15.04%,FAS;JAK3;FOXP3;NCKAP1L
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.6646627480466202,1.3736250377683215,0.13978494623655913,0.5665288245664296,1.0,4/10,8.93%,FAS;LYN;MAPK3;GREM1
prerank,hexose transmembrane transport (GO:0008645),0.5673883960636041,1.3730204179251044,0.12305025996533796,0.5671202154937411,1.0,2/21,1.87%,SLC2A1;PPARD
prerank,negative regulation of chemotaxis (GO:0050922),0.5370329871840528,1.3729852551628603,0.11556982343499198,0.565879722682908,1.0,8/31,7.22%,SEMA3C;SEMA7A;SEMA6A;SEMA6B;NOTCH1;DUSP3;SEMA4F;SEMA6D
prerank,endocardial cushion development (GO:0003197),0.5899529997700425,1.3729443041635618,0.116751269035533,0.5646567161719892,1.0,7/21,4.39%,ENG;BMPR2;TGFB2;NOS3;ACVRL1;NOTCH1;FOXF1
prerank,positive regulation of cellular process (GO:0048522),0.3838172067384909,1.3729395781316698,0.003161222339304531,0.563371404941814,1.0,89/565,12.64%,LEF1;FLT1;IGF1R;SLC6A6;KITLG;ETS1;MFSD2A;FRMD5;TJP1;CLDN5;NAMPT;PDGFB;KDR;INSR;AQP11;CXCL12;TGFB2;ACER2;PDGFD;CAV1;FASN;TBX1;IL6R;TBX3;CNOT6L;FLT4;STX3;TNFRSF11A;ADGRG1;PTPRJ;GNAI2;PTK2;RPS6KA1;TIAM1;PRKD2;NOTCH1;PARD3;MERTK;LYN;TGM2;OSMR;GATA2;WWTR1;FGF16;RAMP3;HSP90AB1;SLC25A5;CCR7;TAL1;EPHA4;ACTN4;SLC25A33;ADAM10;ACACB;HCK;INSM1;PTN;TGFB1;CXCR2;ABCA7;CST7;P2RX7;LRP5;TGFA;GREM1;LIFR;PAK1;COPS9;PGF;AXIN2;ADAM17;PDCD10;PTK6;CDCA7L;CDC6;CNTF;RAC1;ZFP36L1;PPP3CA;S100A8;HRAS;RPTOR;BRAT1;CNOT6;RPS9;SOX11;TGFBR2;RNF187;DERL2
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.5765028877343554,1.372707076792279,0.10998307952622674,0.5628167447964869,1.0,10/24,14.31%,DAB2IP;EPN2;TMEM204;MMRN2;PRKD2;HHEX;HIF1A;PRKCB;HGS;PDCD6
prerank,positive regulation of kinase activity (GO:0033674),0.4414773585154705,1.372517857246992,0.05408970976253298,0.5621200224226953,1.0,17/107,7.06%,FLT1;IGF1R;TEK;KDR;INSR;TIE1;RAPGEF2;FLT4;PTK2;MMD;MERTK;CCR7;CD4;EPHA4;MRE11;RET;EPHB4
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.6154410789754617,-1.3714337464642266,0.1310483870967742,0.552666979620291,1.0,3/10,5.33%,NUPR1;HDAC4;PPARA
prerank,negative regulation of glycolytic process (GO:0045820),-0.6154410789754617,-1.3714337464642266,0.1310483870967742,0.552666979620291,1.0,3/10,5.33%,NUPR1;HDAC4;PPARA
prerank,cellular response to fluid shear stress (GO:0071498),0.6479091863980413,1.3711972880418486,0.14779270633397312,0.5649148312598309,1.0,4/12,6.62%,MTSS1;MEF2C;KLF2;KLF4
prerank,regulation of trans-synaptic signaling (GO:0099177),0.5239355087252173,1.3709072750749813,0.10339256865912763,0.5644951103983427,1.0,12/33,16.04%,CACNA1A;LRP8;ABR;BTBD9;GRID2;PXK;FABP5;GRIK5;GRIK2;GRIK1;NLGN1;LRRC4C
prerank,regulation of histone methylation (GO:0031060),-0.5762196709960538,-1.370338225903391,0.13186813186813187,0.5537334923616569,1.0,10/13,34.08%,CTR9;NNMT;MTHFR;PAF1;AASS;NSD1;TET1;TTLL12;PIH1D1;JARID2
prerank,regulation of osteoblast differentiation (GO:0045667),-0.39133277087091517,-1.3701527984725743,0.03308823529411765,0.5520135125267673,1.0,29/82,13.27%,BMP6;RANBP3L;IGF1;SMOC1;BMPR1A;WNT4;CRIM1;BMP7;FGFR2;BMP4;DDX5;SMAD6;SUFU;RUNX2;CCN1;TMEM64;LRP3;YAP1;CCN4;TWIST2;PRKACA;TRPM4;CHRD;IFITM1;BMP2;NPNT;FBN2;SKI;TWIST1
prerank,cell-matrix adhesion (GO:0007160),-0.38345955054643166,-1.3700434885909902,0.031914893617021274,0.5500674285181866,1.0,21/95,6.99%,ITGBL1;COL3A1;ADAMTS12;VTN;ACTN2;ITGB5;ITGB8;PKD1;ITGA10;COL13A1;FBLN5;VCL;DDR1;ECM2;CD63;ADAM9;NID2;ITGA11;THBS3;EMILIN1;MSLN
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.44496096776814853,1.369999758710929,0.0674931129476584,0.5661528740903086,1.0,23/101,12.53%,FLT1;PIK3R6;PDGFB;DAB2IP;RAPGEF2;PDGFD;CCNY;TPD52L1;RGCC;CD40;NOD2;CALM1;RALB;TGFB1;IRGM;TNFSF11;CCND3;ADAM17;PDCD10;FERMT2;HRAS;RPTOR;MAPRE3
prerank,regulation of cellular component organization (GO:0051128),0.42893807805948964,1.3694006730423756,0.05064935064935065,0.5665689016230031,1.0,20/135,8.15%,TFRC;HIP1;TJP1;DAB2IP;LTBP4;RAPGEF2;NET1;HIP1R;RAPGEF1;SOCS2;PAK5;WFDC1;FAM107A;RASGRP2;RAP1B;EGLN2;INSM1;MARK4;IRGM;OPHN1
prerank,amino sugar biosynthetic process (GO:0046349),-0.5817792420135983,-1.368971893300788,0.13129102844638948,0.5511873107878101,1.0,8/12,28.53%,GFPT1;RENBP;GFPT2;PGM3;NAGK;UAP1;UAP1L1;GNPDA1
prerank,carbohydrate transport (GO:0008643),0.6738809884861244,1.3689180277055792,0.14951456310679612,0.566715547608187,1.0,2/11,4.61%,AQP11;AQP7
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.5236010503935729,-1.3673129165874613,0.1026252983293556,0.554100842905844,1.0,6/19,17.67%,IRS1;PRKCD;PPARA;IRS2;TWIST1;ANGPTL3
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.47154205323959864,-1.36723703178732,0.09669811320754718,0.5520948045865914,1.0,8/30,7.60%,CACNA1C;ANK2;SNTA1;GJA1;KCNJ2;CACNA2D1;CACNA1G;CACNA1D
prerank,renal water homeostasis (GO:0003091),-0.5058989547847111,-1.3671823205097529,0.09411764705882353,0.550014351543088,1.0,8/23,12.16%,ADCY5;ADCY1;ADCY9;ADCY2;RAB11FIP2;ADCY7;PRKACA;ADCY6
prerank,negative regulation of lipid catabolic process (GO:0050995),0.6040648913140118,1.367177553514399,0.1332116788321168,0.5710051320652617,1.0,1/17,0.47%,MFSD2A
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.5586554811857409,1.3661187821251624,0.13643926788685523,0.5728213973341583,1.0,7/24,13.42%,NOD1;NOD2;IRAK2;UBE2V1;CASP8;TNFAIP3;CYLD
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.5106869889406835,-1.364292367065767,0.1066350710900474,0.5567812455114136,1.0,7/22,14.62%,AEBP1;MAP1S;AKAP13;APOE;EFEMP2;ABL1;MAP2
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.5047241460056389,-1.3636728610036213,0.10874704491725769,0.5564022695838913,1.0,5/21,7.60%,ANK2;SNTA1;CACNA2D1;FLNA;CACNA1D
prerank,regulation of lymphocyte migration (GO:2000401),0.674578884422943,1.3631652857997474,0.1381957773512476,0.580911856514763,1.0,3/10,8.46%,JAM2;STK10;MSN
prerank,negative regulation of interleukin-2 production (GO:0032703),0.59659878641273,1.3627016399591523,0.12612612612612611,0.5811094290115087,1.0,5/18,12.24%,CD34;HDAC7;HOMER2;FOXP3;TNFAIP3
prerank,cellular response to lipid (GO:0071396),-0.3401447986220414,-1.361416931401187,0.01092896174863388,0.5612606834697238,1.0,27/191,8.30%,ATP1A2;PID1;EGFR;ROCK2;ADCY5;EPHA3;TFPI;PTK7;AXL;ADCY1;WNT5B;IRS1;LBP;WNT6;ADCY2;ADAM9;WNT9A;AR;CTR9;SPP1;RORA;FZD7;PABPN1;LCOR;SELENOS;TNIP2;ATM
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.5250700295001508,1.361209459808633,0.10084033613445378,0.5846418166261096,1.0,11/35,11.71%,TEK;ESAM;TJP1;FES;F11R;RAPGEF3;BAIAP2;HCK;ARHGDIA;ABI3;HRAS
prerank,adipose tissue development (GO:0060612),0.6563481775856715,1.3611092057948302,0.12522686025408347,0.5836471759322607,1.0,3/11,8.45%,NAMPT;SPTLC2;LRP5
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.5998674255089975,-1.3610058746155282,0.1300639658848614,0.5601924667388304,1.0,5/11,25.99%,XPO5;FMR1;LIMD1;AJUBA;STAT3
prerank,positive regulation of cholesterol efflux (GO:0010875),0.5794104960011758,1.3609650386525032,0.10961214165261383,0.5828703506412868,1.0,6/21,8.34%,PLTP;CAV1;NFKBIA;ABCA3;NR1H2;ABCA7
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.6138036228412503,1.3609079754866733,0.14211438474870017,0.5817300997746033,1.0,1/15,0.16%,PRKCH
prerank,alpha-amino acid catabolic process (GO:1901606),-0.4753778012493972,-1.3604416400331383,0.08413461538461539,0.5595767048487478,1.0,11/29,20.83%,DDO;ACADSB;ALDH4A1;PRODH;THNSL2;KYAT1;SARDH;FAH;KYNU;KMO;GOT2
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.5650002480409585,1.36036982255031,0.12203389830508475,0.5821315450098287,1.0,9/23,14.68%,MYO10;CCDC88A;CCDC88B;KIF1A;MAP6D1;TUBB;HOOK1;F8A1;TUBA1A
prerank,melanocyte differentiation (GO:0030318),-0.5988399236735005,-1.3603379842402694,0.11060948081264109,0.5577313026090998,1.0,7/11,19.29%,LRMDA;ENPP1;KIT;MITF;SLC24A5;MREG;USP13
prerank,cellular response to interleukin-1 (GO:0071347),0.42426913803394745,1.3601182134127134,0.04182509505703422,0.5816631429607109,1.0,25/143,11.75%,PLCB1;DAB2IP;IL1R1;NFKBIA;NOD1;CD40;NOD2;PELI1;MAP3K8;IKBKB;HYAL2;ST18;MAPK3;RPS6KA5;PSMB3;PSMD11;PSMC6;IRAK2;MAP3K3;PSME2;UBE2V1;TOLLIP;CCL1;PSMD8;HIF1A
prerank,epithelial cell-cell adhesion (GO:0090136),-0.5871434082859074,-1.3599781382286564,0.14782608695652175,0.5566818324865135,1.0,5/11,7.90%,ITGB5;KIT;VCL;PLEKHA7;CCN3
prerank,polyol metabolic process (GO:0019751),0.49831321917404225,1.3597666030305198,0.09767441860465116,0.5813745451687361,1.0,13/46,11.51%,PLCB1;PLCB4;ITPKB;INPP5D;PLCG1;CALM1;PLD4;OCRL;PLCH2;NUDT3;PLCH1;IPMK;INPP1
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.5878030076385713,1.3593127602158612,0.12869565217391304,0.5815159683071675,1.0,4/17,6.61%,PODXL;TGFB2;PIEZO1;RET
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.4341951066141283,1.3588328810810777,0.050666666666666665,0.5817665161563016,1.0,40/113,22.86%,TFRC;DAB2IP;RASIP1;UNC13B;TIRAP;GBP5;PIEZO1;FNIP2;TAL1;BIK;GTF2H2;RAP1B;TGFB1;PSMC6;CAPG;MMP1;FERMT2;SH3GLB1;GTF2H4;SYK;TERF1;FSCN1;CDH5;RBX1;MPP7;SUMO1;IL5;TPPP;RPA1;SLF1;SKAP1;BAK1;DDB1;GTF2H3;ERCC4;RACK1;HRK;SNCA;PSMC3;LCP1
prerank,histone lysine demethylation (GO:0070076),-0.48137883216562427,-1.3586372418025447,0.10913705583756345,0.5586740545491354,1.0,12/25,23.33%,KDM7A;KDM2A;KDM3B;KDM5B;KDM6B;KDM2B;PHF8;KDM1A;RIOX2;PHF2;KDM4D;HR
prerank,iron ion homeostasis (GO:0055072),0.4744029863124143,1.3583796194761277,0.06896551724137931,0.5818952786929581,1.0,4/58,2.45%,TFRC;SLC40A1;ABCG2;B2M
prerank,regulation of protein kinase B signaling (GO:0051896),0.40941217965111815,1.3581703324336045,0.0488997555012225,0.5812296193480817,1.0,23/193,6.61%,IGF1R;KITLG;TEK;HIP1;MFHAS1;PDGFB;INSR;ENG;XDH;PHLPP1;PTPRJ;PTK2;GRB2;CD19;FGF16;RAMP3;HSP90AB1;HYAL2;CCR7;GAB1;FYN;PLEKHA1;RET
prerank,cell chemotaxis (GO:0060326),0.47180757840078685,1.3581341902531634,0.08359133126934984,0.580077370304237,1.0,7/60,5.21%,LEF1;DOCK4;PDGFB;CXCL12;PLEKHG5;ELMO2;CCR7
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.5953423587021465,1.3577595830949925,0.1261101243339254,0.5799891865796317,1.0,7/18,12.88%,ELOVL7;ACSL5;ACSL6;ELOVL5;ACSL3;ELOVL6;HACD2
prerank,positive regulation of histone deacetylation (GO:0031065),0.631215057469461,1.3576414724030457,0.181651376146789,0.5790418415502239,1.0,3/12,3.42%,APLNR;PRKD2;PRKD1
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.5073635416998437,1.3570277373689006,0.096875,0.5796946048955214,1.0,14/42,18.98%,TEK;UTRN;KDR;PTPRJ;CCR7;RAC1;FERMT2;MAP4K4;RIN2;PPM1F;NRP1;EPHA1;CDK6;SKAP1
prerank,positive regulation of epithelial cell migration (GO:0010634),0.445410279146682,1.3569260863023882,0.07362784471218206,0.5787740760913868,1.0,18/92,7.67%,TEK;ETS1;KDR;BMPR2;TGFB2;DOCK1;FLT4;SCARB1;PRKD2;PRKD1;VIL1;PLCG1;RREB1;RHOB;MAPRE2;INSL3;RAB11A;IQSEC1
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.465502641934418,1.356807375770865,0.08806818181818182,0.5779015590906657,1.0,13/70,10.94%,TEK;PARVB;SRGAP2;MEF2C;LAMA5;NTNG2;PXN;PARVG;ACTN1;EFNA1;OPHN1;RAC1;FERMT2
prerank,sodium ion transmembrane transport (GO:0035725),-0.38266893879943276,-1.3564878946006496,0.04067796610169491,0.562760254443824,1.0,16/84,7.19%,ATP1A2;SLC24A3;NALCN;SLC6A13;SCN7A;SLC6A12;SLC8A3;SLC6A9;SLC12A2;ANO6;SLC9A2;PKD2;ATP1B3;SLC6A1;ATP1B2;SLC8A1
prerank,neutrophil chemotaxis (GO:0030593),0.47570073337089847,1.3564544545767279,0.0962406015037594,0.5777926855383059,1.0,10/53,12.14%,BSG;TGFB2;PIKFYVE;PIP5K1C;PPIA;CXCR2;PDE4B;CCL1;S100A8;SYK
prerank,positive regulation of calcium ion import (GO:0090280),0.6421150069741465,1.3562734098557532,0.15263157894736842,0.5771232833356383,1.0,3/12,5.01%,PDGFB;CXCL12;RAMP3
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.5838155594677348,-1.3560677654436486,0.13445378151260504,0.5598100767955227,1.0,5/12,12.21%,FBLN1;EFNA5;KANK1;ITGB1BP1;DMTN
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.5838155594677348,-1.3560677654436486,0.13445378151260504,0.5598100767955227,1.0,5/12,12.21%,FBLN1;EFNA5;KANK1;ITGB1BP1;DMTN
prerank,arachidonic acid secretion (GO:0050482),-0.6021503406470219,-1.3551461444640691,0.14573991031390135,0.5581963153709116,1.0,3/10,7.97%,ANXA1;ACE;BDKRB2
prerank,arachidonate transport (GO:1903963),-0.6021503406470219,-1.3551461444640691,0.14573991031390135,0.5581963153709116,1.0,3/10,7.97%,ANXA1;ACE;BDKRB2
prerank,regulation of metal ion transport (GO:0010959),-0.5546144898333549,-1.3540216995563548,0.11727078891257996,0.559477218805637,1.0,7/16,7.82%,ANK2;SLC30A10;STIM1;IL16;CACNA2D1;DLG1;BCL2
prerank,regulation of intracellular signal transduction (GO:1902531),0.3834881874716899,1.35358219891272,0.007641921397379912,0.5841232640607291,1.0,76/420,11.30%,SGMS1;CHN2;MCF2L;TEK;ARHGAP31;ARHGEF3;ARAP3;SRGAP3;SRGAP2;PPP1R16B;DAB2IP;SRGAP1;PPP1R13B;PDE2A;ARAP2;RASGRF2;NET1;NFKBIA;PLEKHG5;PHLPP1;ARHGEF2;PTPMT1;KALRN;TIAM1;FAM13A;ABR;PRKD2;STARD13;VWF;MOB3B;LYN;PEX5L;TMSB4X;GNA12;XIAP;PHF20;RHOB;PIP5K1C;DEPDC7;MRE11;OCRL;ARHGAP23;SOS1;ENTPD5;PAK5;MAPK3;RFFL;ARHGAP25;ARHGEF12;BIRC3;JMY;PRKAR2B;KAT6A;CRNN;PREX1;ARHGEF5;OPHN1;PIN1;PIDD1;DNA2;ARHGEF7;TNFSF11;PAK1;ARHGAP4;ARHGDIA;PRKAR2A;PRKAB1;ARHGAP17;DDIT4;AGER;RAC1;FBXL2;IER3;MAP4K4;HSPB1;PIP4K2A
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.5559011056980722,-1.3534531239771432,0.12444444444444444,0.5590807255891072,1.0,5/15,5.32%,UST;DSE;DCN;BGN;CSPG4
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.5562204992392918,-1.3533550470991853,0.11974789915966387,0.5571850007878243,1.0,6/15,6.64%,GPC3;WNT5B;RSPO3;DAAM2;DACT1;SFRP4
prerank,myotube cell development (GO:0014904),-0.6134003780592592,-1.353333252699866,0.12742980561555076,0.5551377077452763,1.0,3/10,12.61%,IGF1;SIX1;SKI
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.5356932435976757,1.3532217324718034,0.13162118780096307,0.5839340716284781,1.0,7/27,11.69%,EFHC2;MBOAT1;NTNG2;CCDC88A;HOMER1;DISC1;GSK3A
prerank,regulation of ossification (GO:0030278),0.5179824905697067,1.3530069971968524,0.12125984251968504,0.5832688637083159,1.0,8/36,4.59%,SGMS2;BMPR2;TGFB2;S1PR1;MEF2C;NOTCH1;ZBTB16;NOTUM
prerank,carnitine shuttle (GO:0006853),-0.5999866272595367,-1.3528461853842375,0.10619469026548672,0.5545086137992425,1.0,2/11,1.32%,PRKAG2;PRKAA2
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.4428692619994038,-1.3527181064647316,0.08673469387755102,0.5528854581219826,1.0,9/38,11.22%,CACNA1C;ANK2;CAMK2D;KCNJ2;CACNA2D1;CACNA1G;CACNA1D;TRPM4;CACNB2
prerank,regulation of hydrolase activity (GO:0051336),0.4659905331980003,1.352694943847151,0.08633093525179857,0.5829497805153205,1.0,17/71,11.25%,CHN2;FGD5;DAB2IP;RASIP1;ARHGAP27;CAV1;PTK2;PLXND1;PRKG1;EPHA4;OCRL;STMN3;CFAP100;ARHGEF5;FGD6;TBC1D10B;PLXNB3
prerank,icosanoid secretion (GO:0032309),0.6352309862667129,1.3526329908618409,0.15167548500881833,0.5818754325139488,1.0,2/12,4.55%,ABCC4;NOS2
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.6484926839536852,1.3524824355496508,0.1614678899082569,0.5810847403149002,1.0,3/11,4.04%,SEMA6A;EPN2;KLF2
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.4641514268610833,1.3524245762870257,0.06921944035346098,0.5799908682427958,1.0,15/70,12.36%,BCL2L1;DAB2IP;TGFB2;FAS;IL6R;SORT1;TLR3;CRADD;MCL1;TGFB1;P2RX7;DEDD2;CASP8;GSK3A;TNFSF12
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.4639544937982394,1.3523645002784235,0.08504398826979472,0.5789576497652544,1.0,18/66,8.89%,PTPRM;AQP11;DAB2IP;TGFB2;XDH;CAV1;MCC;B2M;RGCC;MTSS1;VASH1;SNAI2;CDKN2B;STAT1;FBXW7;BRCA2;TGFB1;CAV2
prerank,dephosphorylation (GO:0016311),0.41946560184568693,1.3522786677547594,0.044416243654822336,0.5779696520536712,1.0,24/147,11.19%,PTPRG;PTPRM;PTPRB;SGPP2;CTTNBP2NL;PTPRJ;DUSP23;PPM1L;DUSP7;PTPN12;SSH2;DUSP3;PLPP6;PPP3CC;PPP4R1;PPP2R5A;PTPRR;MTMR6;PTPN5;PPP1CB;ACP4;PPP3CA;DUSP12;DUSP1
prerank,connective tissue development (GO:0061448),-0.4409469500819214,-1.3521290566861102,0.09302325581395349,0.5525902106634714,1.0,10/35,10.07%,SULF1;SOX5;ITGB8;PKD1;SULF2;CREB3L2;SH3PXD2B;ATP7A;SOX6;SLC39A13
prerank,negative regulation of endothelial cell migration (GO:0010596),0.5106775337040287,1.3518884258561714,0.11128526645768025,0.5779790003877374,1.0,15/36,14.66%,PTPRM;DAB2IP;RGCC;MEF2C;SP100;ACVRL1;NOTCH1;VASH1;DLL4;TGFB1;AGTR2;PPARG;CSNK2B;DNAJA4;SYNJ2BP
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.6114940882891979,1.3518151123152709,0.1436265709156194,0.5769801117295181,1.0,4/15,6.24%,IGF1R;KDR;AATK;MAPK3
prerank,positive regulation of developmental process (GO:0051094),0.4190259893349324,1.3518145878375996,0.04630788485607009,0.575765416757456,1.0,18/164,5.11%,SLC6A6;TFRC;PLCB1;SHANK3;PDGFB;KDR;INSR;DAB2IP;BMPR2;B4GALT5;LRP8;FZD4;RPS6KA1;RAPGEF3;VIL1;ZBTB16;RREB1;HSP90AB1
prerank,heterochromatin organization (GO:0070828),0.6092542660658657,1.3516325050052538,0.15625,0.5751313448332447,1.0,1/14,0.11%,MECOM
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.541776793036252,-1.351609564535204,0.10688836104513064,0.5519776028844261,1.0,3/16,5.39%,AUTS2;BCOR;CTR9
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.5896955124183377,-1.3515496867307795,0.13815789473684212,0.5501358417114481,1.0,8/11,28.53%,GFPT1;RENBP;GFPT2;PGM3;NAGK;UAP1;UAP1L1;GNPDA1
prerank,sister chromatid segregation (GO:0000819),-0.46804604452285004,-1.3514603267484413,0.10344827586206896,0.5483473225125978,1.0,15/31,26.83%,TOP2B;KLHL22;ZWINT;SMC4;CENPK;LATS1;TUBG1;KIF18A;NUSAP1;TOP2A;KNSTRN;KIFC1;NSL1;SGO1;CDCA8
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.6280154655620651,1.3510028058666035,0.14160839160839161,0.5758378674861199,1.0,6/14,19.73%,DAB2IP;FICD;DNAJB9;COPS5;BFAR;BAK1
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.5763601405791873,-1.350649729387022,0.12954545454545455,0.5487087544316311,1.0,2/12,0.75%,NOTCH2;DOCK11
prerank,cellular iron ion homeostasis (GO:0006879),0.4774970987910019,1.3504565581115902,0.07541478129713423,0.5762039351259393,1.0,3/55,0.39%,TFRC;SLC40A1;ABCG2
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.41488584267025586,1.3502068781110863,0.0567741935483871,0.575723311343213,1.0,24/151,8.34%,TEK;SEMA7A;MFHAS1;PDGFB;KDR;RAPGEF2;PDGFD;APP;PDE8A;TIRAP;FLT4;TNFRSF11A;NOD2;PRKD2;NOTCH1;RAMP3;CCR7;CD4;MAPK3;LGALS9;FBXW7;HTR2A;TGFB1;ABCA7
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.444390525199633,-1.3492839229243019,0.06722689075630252,0.5509066850373332,1.0,14/37,13.59%,IGF1;BMPR1A;IGFBP5;TPM1;GJA1;FGF2;MMP2;FOXJ2;SOD2;EFEMP2;TGFB3;ADAMTS1;MFN2;PTEN
prerank,regulation of p38MAPK cascade (GO:1900744),0.5179213316230625,1.3485673703091074,0.11075949367088607,0.5794173115713416,1.0,9/35,13.77%,MFHAS1;DAB2IP;XDH;PHLPP1;LGALS9;AGER;DUSP1;CYLD;MINK1
prerank,nitric oxide biosynthetic process (GO:0006809),0.6302244438305007,1.3479083959742302,0.15467625899280577,0.5801723301042553,1.0,3/13,4.55%,NOS3;GCH1;NOS2
prerank,development of primary male sexual characteristics (GO:0046546),0.5205491852830396,1.3478387177719673,0.10078740157480315,0.5791623148246215,1.0,7/34,11.00%,KITLG;TGFB2;LHFPL2;BIK;COL9A3;NCOA4;LRP2
prerank,regulation of cell motility (GO:2000145),0.4255673161280027,1.3477903320852642,0.057692307692307696,0.5781102672642785,1.0,28/121,12.59%,SPOCK2;FRMD5;MACF1;ROBO4;FES;NTN1;SPATA13;PLXND1;AMOT;PRAG1;TMSB4X;FGF16;CCR7;RHOB;PKN1;INPP5F;KIF2A;PKN2;TGFB1;TMSB10;PIN1;ENPP2;RAC1;PLXNB3;ABI3;SLK;CEACAM1;CYRIB
prerank,positive regulation of protein import (GO:1904591),-0.4710079371342428,-1.3477147146413142,0.09844559585492228,0.5536875003048228,1.0,9/30,14.82%,ZIC1;SMAD3;CDH1;PRKCD;FLNA;UBR5;PSEN1;BAG3;PIK3R1
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.6451886956113104,1.3474106301754458,0.13693693693693693,0.578041548745346,1.0,2/10,3.89%,PODXL;PIEZO1
prerank,protein oxidation (GO:0018158),-0.5980606230737239,-1.3472735260561246,0.12526539278131635,0.5529457371123236,1.0,3/11,6.67%,LOXL1;LOXL3;LOX
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.40144127782281713,-1.3472728716333384,0.06397306397306397,0.5509458497422337,1.0,21/65,14.25%,FBN1;LDLRAD4;LTBP1;SMAD3;SMAD6;HTRA3;SNX6;TGFBR1;PPARA;ASPN;EMILIN1;TGFB1I1;CD109;PDPK1;SMURF2;SPRED1;VASN;FBN2;SKI;HTRA4;SLC2A10
prerank,histone H4 acetylation (GO:0043967),0.4897412984375797,1.3468459443838758,0.08709175738724728,0.5786571970544592,1.0,10/47,16.38%,LEF1;TRIM16;PHF20;BRCA2;NAA60;JADE2;TRRAP;MCRS1;MSL2;HCFC1
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.42513715685475095,1.3466710979145013,0.05714285714285714,0.5779508893479245,1.0,25/124,11.39%,PTPRM;FRY;RAPGEF2;APP;FRYL;STX3;MAP4;LYN;PPP1R9B;STMN1;CCR7;TBC1D24;PLEKHA1;STMN3;RAB11A;STMN4;MARK4;OPHN1;GPM6A;CYFIP1;BICDL1;TBC1D23;AGER;RAC1;CEP78
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.5461436058695996,1.3453184304347852,0.14401294498381878,0.5807934409306067,1.0,6/26,7.18%,NOS3;ACER2;GCH1;NOS2;ACER1;SPTLC2
prerank,retinol metabolic process (GO:0042572),-0.5583818694876107,-1.345262516438814,0.13870246085011187,0.5551316662272973,1.0,3/14,5.92%,RBP4;DHRS3;CYP1B1
prerank,negative regulation of cell-matrix adhesion (GO:0001953),-0.46032469946850796,-1.3451799985400623,0.0979381443298969,0.5533596698377043,1.0,13/32,13.59%,PHLDB2;ARHGAP6;APOD;THBS1;CASK;HOXA7;JAG1;MYOC;SEMA3E;ITGB1BP1;DMTN;BCAS3;PTEN
prerank,cell-substrate junction assembly (GO:0007044),0.5183825099910122,1.3451121771496262,0.12292358803986711,0.5802977224223107,1.0,6/33,10.94%,ITGA6;THSD1;ACTN1;SORBS1;ARHGEF7;FERMT2
prerank,microtubule bundle formation (GO:0001578),0.5036668705486539,1.3445502041342445,0.10869565217391304,0.5808622231840235,1.0,15/42,17.88%,NAV1;CLIP1;RP1;NCKAP5;MARK4;TTLL3;CDK5RAP2;DCX;RSPH4A;RSPH1;FOXJ1;NCKAP5L;SPAST;CCDC66;TPPP
prerank,nitric oxide metabolic process (GO:0046209),0.6242945015592949,1.3439179605013547,0.1504424778761062,0.5815652241565096,1.0,3/14,4.55%,NOS3;GCH1;NOS2
prerank,defense response to Gram-positive bacterium (GO:0050830),0.5012558429137667,1.3434525346239878,0.1035031847133758,0.581870672650575,1.0,7/40,10.02%,PGLYRP1;TIRAP;GBP7;DEFA6;GBP4;PPP1R11;ADAM17
prerank,inositol phosphate metabolic process (GO:0043647),0.49287013024771686,1.3431432223014588,0.1069182389937107,0.5816180762710205,1.0,13/46,11.51%,PLCB1;PLCB4;ITPKB;INPP5D;PLCG1;CALM1;PLD4;OCRL;PLCH2;NUDT3;PLCH1;IPMK;INPP1
prerank,negative regulation of dephosphorylation (GO:0035305),0.5794486316971612,1.3421841929313059,0.14285714285714285,0.5834698328390745,1.0,2/18,0.95%,MFHAS1;PPP1R16B
prerank,potassium ion homeostasis (GO:0055075),-0.49529602587597715,-1.3421248877040037,0.10869565217391304,0.560661371773156,1.0,6/23,7.12%,ATP1A2;SLC12A2;KCNJ2;ATP1B3;SLC12A7;ATP1B2
prerank,artery development (GO:0060840),0.5601744234581173,1.342060961772991,0.11774744027303755,0.5826276108415552,1.0,7/23,4.30%,ENG;BMPR2;PDE2A;TBX1;ACVRL1;APLNR;SMAD7
prerank,anterograde trans-synaptic signaling (GO:0098916),0.39678274056831375,1.3420425674797536,0.03855421686746988,0.5815243758515272,1.0,53/224,17.52%,MPZ;SLC1A1;CACNA1A;HCRTR1;SLC6A2;SLC6A5;UNC13B;RPS6KA1;CALM1;PDE7B;SLC1A2;CAMKK2;SYPL1;PRKACB;SLC12A6;ATXN3;HOMER1;CHRNB1;HTR2A;PRKAR2B;GABRB1;HCRTR2;GRIA4;KCNQ3;APBA2;NRXN1;AKAP9;PRKAR2A;EXOC4;NPY5R;CHRM3;GRIN2B;GABRQ;CPNE6;PCDHB14;GRIK2;SDCBP;CPLX1;GRIK1;MINK1;MYCBPAP;HTR4;GABRG1;SYNJ2BP;GRM7;AMPH;MAPK1;NLGN1;PMP22;GABRG3;MBP;SST;GABRA1
prerank,regulation of neuroinflammatory response (GO:0150077),-0.520197708604086,-1.3419962731745692,0.12582781456953643,0.5590218296904688,1.0,4/19,5.15%,IGF1;NUPR1;IL18;DAGLA
prerank,aminoglycan catabolic process (GO:0006026),-0.4666049020668341,-1.3419653954113444,0.11311053984575835,0.557115857880966,1.0,8/28,15.11%,GPC6;SDC2;GPC3;GPC4;SDC4;GNS;HGSNAT;HPSE2
prerank,C4-dicarboxylate transport (GO:0015740),0.6169964294595449,1.34194319217566,0.16757741347905283,0.5806853809963588,1.0,2/14,5.09%,SLC1A1;SLC1A2
prerank,muscle organ development (GO:0007517),-0.4083555632894555,-1.3418050053257977,0.07932011331444759,0.5556494646835992,1.0,17/54,10.96%,LAMA2;IGF1;SGCD;LARGE1;FHL1;COL6A3;DMD;SPEG;ITGA11;MKX;MRAS;CHD2;VAMP5;POU6F1;SOX6;EVC;TAGLN
prerank,cellular defense response (GO:0006968),-0.4424798204646053,-1.341062385087832,0.09428571428571429,0.5557881068126741,1.0,7/40,11.02%,DCDC2;LBP;CCR9;LSP1;ADORA2A;ZNF148;PTK2B
prerank,calcium-mediated signaling (GO:0019722),-0.3740614048481627,-1.3410228187049944,0.05673758865248227,0.5539239734088361,1.0,23/93,12.21%,CACNA1C;ANK2;EGFR;PLCE1;MCU;NUDT4;CCR9;ADGRL1;DMPK;SLC8A1;P2RX4;AGTR1;PTGFR;PDPK1;PRKACA;TRPM4;PPP3CB;SPHK1;STIMATE;SLC9A1;RCAN3;LRRK2;DMTN
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.5582165323757615,-1.3408200129734529,0.15964523281596452,0.5525630468511777,1.0,8/13,28.53%,GFPT1;RENBP;GFPT2;PGM3;NAGK;UAP1;UAP1L1;GNPDA1
prerank,heme biosynthetic process (GO:0006783),0.5547645762603816,1.3405956464841546,0.16188870151770657,0.5834570704377364,1.0,3/22,8.65%,ABCG2;ALAS1;CPOX
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.5200929448274055,1.3404722607403914,0.13848631239935588,0.5826460875579895,1.0,7/32,13.27%,MFSD2A;SLC44A5;CHKA;LPCAT3;CEPT1;CSNK2B;LPIN3
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.5407283765330305,1.3389247662044872,0.1206611570247934,0.585998497113032,1.0,10/26,10.93%,DAB2IP;PDE8A;PTPN12;DUSP3;VIL1;PLCG1;SNAI2;IQGAP1;ZPR1;ZFP36L1
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.6153692546246152,-1.3382973996604968,0.14439655172413793,0.5561287999957615,1.0,5/10,18.25%,PRKCD;SMPD3;SIRT3;NSMAF;PLA2G6
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.6153692546246152,-1.3382973996604968,0.14439655172413793,0.5561287999957615,1.0,5/10,18.25%,PRKCD;SMPD3;SIRT3;NSMAF;PLA2G6
prerank,nucleoside catabolic process (GO:0009164),-0.6003812676562819,-1.3377849060022622,0.12931034482758622,0.5557206913583133,1.0,6/11,15.21%,DPYD;NT5E;UPB1;UPP2;DERA;NT5C1A
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.5529096022967054,1.3375450795950876,0.13322091062394603,0.5889742633604534,1.0,7/24,10.29%,PDE2A;RAPGEF2;APLNR;PEX5L;PDE4D;PRKAR2B;PRKAR2A
prerank,retinal metabolic process (GO:0042574),-0.5779468557631064,-1.3367650790414314,0.14699331848552338,0.556805991530365,1.0,7/12,34.31%,ABCA4;CYP1B1;RDH10;ALDH1A3;RDH13;ALDH8A1;DHRS13
prerank,negative regulation of cartilage development (GO:0061037),-0.5629790565661565,-1.3364304897994415,0.1280353200883002,0.5559166875183884,1.0,6/13,14.08%,ADAMTS12;EFEMP1;TGFBR1;WNT9A;PTHLH;WNT11
prerank,cytosolic calcium ion transport (GO:0060401),-0.4712149703741433,-1.3361865109763789,0.10194174757281553,0.5547615963849545,1.0,13/28,20.42%,CACNA1C;MCU;CACNA2D1;SLC35G1;SLC8A1;AFG3L2;JPH1;ATP2A3;ATP2B3;JPH2;CACNB3;MICU1;ATP2A2
prerank,positive regulation of cell growth (GO:0030307),0.4338147820470494,1.3354579778721838,0.07024793388429752,0.5941030762740741,1.0,23/96,13.14%,SEMA7A;MFSD2A;MACF1;TGFB2;NTN1;NEDD4L;RPS6KA1;ITSN2;DBNL;SLC25A33;ADAM10;RASAL1;TWF2;SMURF1;ADAM17;CPNE5;S100A8;SYT4;RPTOR;BRAT1;DERL2;CPNE6;SDCBP
prerank,regulation of cytokine production (GO:0001817),0.4200640806268075,1.3339661791161936,0.06763925729442971,0.5973681634396281,1.0,23/126,10.68%,CADM1;AFAP1L2;BCL6B;RGCC;SRGN;IFIH1;HDAC9;LYN;NOS2;MOG;PLD4;SNAI2;CCR7;TRIL;CCDC88B;ATP2B1;LGALS9;RPS6KA5;N4BP1;FOXP3;PPP1R11;CASP8;NLRP4
prerank,histone acetylation (GO:0016573),0.4545103206634983,1.333685575921663,0.0975254730713246,0.5970196811710011,1.0,12/69,13.64%,LEF1;TRIM16;PHF20;YEATS2;BRCA2;KAT6A;NAA60;BRD1;BRPF1;JADE2;POLE3;BRPF3
prerank,visual system development (GO:0150063),-0.4437458908146289,-1.3336319872637887,0.09792284866468842,0.5603250568100343,1.0,8/37,6.73%,PBX1;SMOC1;RBP4;SH3PXD2B;FOXC1;PBX4;PBX3;MEIS1
prerank,regulation of bone mineralization (GO:0030500),-0.41046283179676235,-1.3335333780559764,0.07333333333333333,0.5586293859434059,1.0,21/55,13.27%,BMP6;BMPR1A;WNT4;BMP7;ENPP1;BMP4;OSR1;ADGRV1;ANO6;BCOR;KL;ECM1;CCN1;SLC8A1;TGFB3;TRPM4;PTK2B;PKDCC;BMP2;FBN2;TWIST1
prerank,regulation of protein phosphorylation (GO:0001932),0.3905327799048096,1.3332863308885796,0.0461361014994233,0.5970409851642605,1.0,48/256,10.81%,TFRC;TEK;OCLN;LIMCH1;PECAM1;KDR;INSR;DAB2IP;ENG;APP;PRR5L;XDH;FAS;TBX1;PDE8A;FLT4;PLAUR;PTK2;NIBAN1;CD40;PIK3R3;MEN1;LYN;FNIP2;WWTR1;FGF16;CD4;CAMKK2;CCDC88A;LIMK2;PPIA;FYN;MAPK3;PPP2R5A;RALB;INSM1;EFNA1;TGFB1;IRGM;PIN1;PAK1;CCND3;PGF;AXIN2;ADAM17;BRD4;AGER;RAC1
prerank,regulation of MAP kinase activity (GO:0043405),0.4380628988768865,1.3331803616615163,0.09318497913769123,0.5962324271124861,1.0,14/92,5.12%,FLT1;PIK3R6;PDGFB;DAB2IP;PDGFD;TPD52L1;STK38;PTPRJ;CD40;DUSP7;NOD2;LYN;FGF16;HYAL2
prerank,cellular response to alcohol (GO:0097306),-0.42428443635287233,-1.3330161474415145,0.08695652173913043,0.5582609709844853,1.0,16/42,22.29%,ADCY5;ADCY1;SMO;CDH1;ADCY2;ADCY7;GRAMD1B;PTGFR;GRAMD1C;ADCY6;LRP6;SFRP1;BRCA1;GRAMD1A;PTCH1;KLF9
prerank,cilium-dependent cell motility (GO:0060285),0.5482266450033996,1.3329229820805657,0.14309484193011648,0.5957879966693919,1.0,6/22,12.72%,EFHC2;DNAH3;DRC1;CFAP54;DNAAF2;DNAH8
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.5798994017008071,1.332115292318653,0.1592920353982301,0.5969042707796478,1.0,2/18,1.52%,SLC39A8;JAM2
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.5409681655216237,-1.3318661058802523,0.13948497854077252,0.5597559842888082,1.0,6/16,15.21%,DPYSL3;DPYD;NT5E;UPB1;UPP2;NT5C1A
prerank,negative regulation of JNK cascade (GO:0046329),0.5178834661884348,1.33181243186569,0.12459546925566344,0.596769846225138,1.0,8/31,14.99%,MECOM;MEN1;DUSP3;NPPA;ZMYND11;CYLD;HIPK3;DNAJA1
prerank,positive regulation of growth (GO:0045927),0.46073087186979544,1.331616400219193,0.09009009009009009,0.5961934244001234,1.0,16/64,14.09%,PLCB1;MFSD2A;INSR;TGFB2;RPS6KA1;SLC25A33;ADAM10;ZPR1;ADAM17;S100A8;RPTOR;BRAT1;RFTN1;DERL2;SDCBP;AKAP6
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.5832886500996032,1.3314380534805932,0.1634782608695652,0.5955754951663011,1.0,5/18,9.61%,RNF125;SEC14L1;ZCCHC3;BIRC3;OASL
prerank,cellular macromolecule catabolic process (GO:0044265),0.484007803496522,1.3311198708396597,0.10380116959064327,0.5953054712108089,1.0,19/49,23.18%,DAB2IP;DENND3;OGA;NEU4;STT3B;UBE2G1;DFFB;FBXO6;MANBA;PPP1R8;NEU2;SND1;FBXO2;UBE2G2;RNASEH2C;XRN2;NCBP1;RNASE6;RIPK1
prerank,positive regulation of immune system process (GO:0002684),0.591558442644693,1.330260624262789,0.16485507246376813,0.5966456246552897,1.0,5/16,15.04%,TGFB2;LGALS9;PIK3CB;IL15;NCKAP1L
prerank,positive regulation of fatty acid oxidation (GO:0046321),-0.568650627184754,-1.3300637801235449,0.1479028697571744,0.5631087400694835,1.0,4/12,5.57%,IRS1;PPARGC1A;PPARA;IRS2
prerank,import into cell (GO:0098657),0.5072905647881651,1.3299948886609605,0.10785824345146379,0.5962420537851929,1.0,5/41,2.52%,SLC6A6;SLC7A5;SLC7A1;SLC16A2;LRRC8C
prerank,purine nucleotide catabolic process (GO:0006195),0.6119865618775706,1.3297739586916901,0.17235188509874327,0.5958064957857958,1.0,4/13,11.16%,XDH;HINT1;NT5C2;PNP
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.4065336299172844,-1.3293593368243646,0.06962025316455696,0.5632486211362088,1.0,11/56,4.64%,BMP6;BMPR1A;LDLRAD4;BMP5;BMP7;BMP4;BMPER;SMAD6;TGFBR1;TWSG1;DAB2
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.5894814424069407,-1.3291241066092074,0.15575620767494355,0.562023944764624,1.0,6/10,30.00%,ADGRV1;PDZD7;TSKU;PLS1;WHRN;IFT88
prerank,natural killer cell activation (GO:0030101),-0.4801238099928864,-1.3289351237324023,0.10327455919395466,0.5608139941411268,1.0,3/23,7.54%,PBX1;AXL;ELF4
prerank,I-kappaB phosphorylation (GO:0007252),0.650144088213568,1.3286908126060941,0.16923076923076924,0.5979988183571999,1.0,3/10,7.31%,DAB2IP;TLR3;TLR7
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.6117939548369875,-1.3278074396410755,0.1554524361948956,0.562262556173622,1.0,4/10,10.02%,IRS1;IRS2;PTH1R;SLC45A3
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.636169826016259,1.3276788956638772,0.1694915254237288,0.5997893803030289,1.0,4/11,9.37%,JAK3;SMAD7;FOXP3;SOCS5
prerank,regulation of phospholipid metabolic process (GO:1903725),0.6500920921119733,1.3272747602269326,0.1774193548387097,0.5999088045398742,1.0,5/10,18.87%,MFSD2A;ABCA3;DNAJC19;MTMR2;MTMR1
prerank,dicarboxylic acid metabolic process (GO:0043648),-0.40189900754364893,-1.3271545039404593,0.0847953216374269,0.5622086740562228,1.0,22/52,22.32%,ME1;ME2;ADHFE1;ACOT8;IDH2;MTHFD1;MTHFR;MDH2;D2HGDH;ALDH18A1;GOT1;PHYH;GCLC;GPT2;L2HGDH;MTHFD2;MTHFD1L;IDH1;NIT2;GOT2;MTHFS;FPGS
prerank,nucleotide catabolic process (GO:0009166),0.582066858464777,1.3271342890640865,0.15411558669001751,0.5991855162295576,1.0,5/16,11.16%,XDH;SAMHD1;NT5C2;NUDT3;PNP
prerank,telomere maintenance via recombination (GO:0000722),-0.5819387940675217,-1.3266269682444065,0.1648590021691974,0.5617767107369575,1.0,6/11,19.35%,SMC6;TEP1;ERCC1;RAD50;NSMCE2;TPRKB
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.5919914180775504,1.3256449091266604,0.15808170515097691,0.6026622933794266,1.0,6/17,12.26%,PTPRJ;DUSP3;UBASH3A;CD160;DGKZ;CEACAM1
prerank,regulation of macrophage migration (GO:1905521),0.6438998470861979,1.3252995010222615,0.17996289424860853,0.6025686775783035,1.0,3/10,7.98%,MTUS1;CD200;CD200R1
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.4193407861725562,1.325283868769941,0.06048906048906049,0.6014491172846351,1.0,20/124,12.58%,LEF1;PLCB1;FZD6;FZD4;TIAM1;WNT7A;CALM1;CTNNB1;PSMB3;PSMD11;AP2M1;PSMC6;PSME2;SMURF1;RAC1;PPP3CA;PSMD8;PPP3R1;GNB1;AP2B1
prerank,prostaglandin biosynthetic process (GO:0001516),-0.51144092554415,-1.325226677945226,0.14385150812064965,0.5639718029364688,1.0,4/18,6.06%,PTGDS;PTGIS;PTGS1;PTGES
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.5221000994412368,-1.3245505428557756,0.13378684807256236,0.5640574255333036,1.0,7/17,14.33%,BMP4;FGF2;TMEM100;SFRP4;ATOH8;NKX6-1;AHI1
prerank,mitochondrion morphogenesis (GO:0070584),-0.579713760022345,-1.3242102762135917,0.140625,0.563194487987267,1.0,1/11,0.14%,PID1
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.3503437732559862,-1.323863057169701,0.028037383177570093,0.5624393419773492,1.0,22/128,6.69%,BMP6;COL1A2;COL3A1;TGFBR3;BMPR1A;APPL2;SMAD3;BMP5;BMP7;BMP4;DDX5;SMAD6;ITGB5;RGMA;RGMB;TGFBR1;TWSG1;ADAM9;RUNX2;TMEM100;ARHGEF18;SMAD9
prerank,positive regulation of protein sumoylation (GO:0033235),-0.6016085113338775,-1.3236061004322444,0.16033755274261605,0.5613518411057509,1.0,5/10,25.03%,HDAC4;PIAS1;MUL1;UBA2;RWDD3
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.47199921188978405,-1.323333553816219,0.14285714285714285,0.5603443465003728,1.0,2/22,1.80%,ALDH1A2;RBP1
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.5758426892397682,-1.3223250832291578,0.15336134453781514,0.5614171459270186,1.0,2/12,2.90%,DPYSL3;DPYD
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.3929280998434913,-1.3218752817717572,0.06811145510835913,0.5608728416915697,1.0,10/61,9.63%,EYA2;EYA1;EGFR;PDGFRB;EYA4;SMOC2;FGF2;PARP3;PML;RTEL1
prerank,positive regulation of T cell proliferation (GO:0042102),0.46609268876633847,1.3215581006078587,0.10973724884080371,0.6115374192932186,1.0,14/55,15.57%,TFRC;SLC7A1;JAK3;CD6;CCDC88B;EBI3;AGER;PNP;SYK;IL27RA;IL15;NCKAP1L;VCAM1;NCK1
prerank,positive regulation of protein processing (GO:0010954),-0.5077960706466722,-1.3213757838272657,0.12831858407079647,0.5604796605684801,1.0,3/19,3.33%,GSN;CCBE1;CLEC3B
prerank,regulation of synapse maturation (GO:0090128),0.6458797118962095,1.320879414475945,0.1893939393939394,0.6123896100673755,1.0,7/10,19.31%,DAB2IP;ARHGEF15;NRXN1;CAMK2B;YWHAZ;NEUROD2;ANAPC2
prerank,activation of protein kinase A activity (GO:0034199),-0.5350446440798717,-1.320337933638904,0.141280353200883,0.5617076455878497,1.0,7/16,12.16%,ADCY5;ADCY1;ADCY9;ADCY2;ADCY7;PRKACA;ADCY6
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.604500988315404,1.3202585947449759,0.1847246891651865,0.6131649689508787,1.0,2/13,1.56%,SHANK3;APP
prerank,error-prone translesion synthesis (GO:0042276),0.5557407252415594,1.319333883472676,0.14482758620689656,0.6147104172773171,1.0,1/21,0.27%,POLK
prerank,protein localization to cell junction (GO:1902414),0.5532845653147443,1.3192139966256906,0.1634782608695652,0.6139101926531388,1.0,3/22,1.91%,TJP1;HEG1;TJP2
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.6296916662171403,1.318957706997305,0.15892857142857142,0.6135096112965734,1.0,1/12,1.02%,DAB2IP
prerank,transferrin transport (GO:0033572),0.5166432284135685,1.3180996577401567,0.15397350993377484,0.6149360931816171,1.0,5/33,7.14%,TFRC;ATP6V0A1;MCOLN1;REP15;DNM2
prerank,protein ADP-ribosylation (GO:0006471),-0.46286480387438206,-1.317445285370456,0.12436548223350254,0.5684703961671357,1.0,11/28,16.09%,PARP8;PARP3;SIRT3;TNKS2;PARP4;PARP6;PARP11;PARP1;SIRT2;PARP12;TIPARP
prerank,synaptic vesicle endocytosis (GO:0048488),0.5120971887394479,1.316766978783131,0.14573643410852713,0.6177132041826093,1.0,7/33,8.15%,DNM3;STX1A;ITSN2;PIP5K1C;DNM2;FCHO2;OPHN1
prerank,positive regulation of protein secretion (GO:0050714),-0.3813233246998012,-1.316609347037276,0.07987220447284345,0.5691518127302122,1.0,14/69,10.90%,BMP6;WLS;IGF1;MCU;FRMD4A;NLGN2;RBP4;ADAM9;IRS2;NNAT;C1QTNF3;EZR;TGFB3;AACS
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.5232283011693503,1.3165180925205788,0.1644518272425249,0.6172847422643101,1.0,9/28,15.16%,NOD1;NOD2;IRGM;IRAK2;UBE2V1;CASP8;TNFAIP3;CYLD;INAVA
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.4967903019165771,1.3160664166463119,0.13884555382215288,0.61733940832959,1.0,8/38,7.56%,PDGFB;APP;CAV1;LRP8;NEDD9;HYAL2;EPHA4;EFNA1
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.3729271853842744,-1.3159260412213478,0.039735099337748346,0.5692459100837093,1.0,14/86,4.64%,BMP6;SULF1;BMPR1A;ZEB2;FOXD1;BMP5;BMP7;BMP4;THBS1;TGFBR1;TWSG1;ZNF423;RBPJ;DAB2
prerank,sodium ion homeostasis (GO:0055078),-0.49276465515820284,-1.3152205873721396,0.1223021582733813,0.5694754252089259,1.0,5/21,7.19%,ATP1A2;SLC12A2;ATP1B3;ATP1B2;SLC8A1
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.5521041507571932,-1.314943304869521,0.16414686825053995,0.5684863154053862,1.0,3/12,8.31%,ROCK2;FLOT2;APOE
prerank,negative regulation of calcium ion transport (GO:0051926),-0.5365515350545741,-1.3148239721699377,0.15261958997722094,0.5669812254607487,1.0,1/15,0.02%,ATP1A2
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),-0.4466454577326002,-1.3147977561250286,0.12755102040816327,0.5652681598082625,1.0,14/33,19.74%,APPL2;PKD1;STXBP4;GLI1;PSME3;MN1;PTEN;PAF1;TCIM;PLK5;DDRGK1;ID2;PTPN6;EZH2
prerank,protein localization to cell surface (GO:0034394),-0.4717692297823375,-1.3143153294080387,0.13106796116504854,0.5648723015351451,1.0,7/26,10.23%,ANK2;ANGPT1;FBLN5;VCL;FLNA;GGA2;PRRT1
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.469844272626888,1.313946074863398,0.11703703703703704,0.6227721134527472,1.0,15/55,14.16%,BCL2L1;DAB2IP;CAV1;FAS;TPD52L1;TNFSF10;HYAL2;CRADD;DEDD2;AGTR2;S100A8;TNFSF12;CYLD;TRIM39;BCL10
prerank,regulation of osteoblast proliferation (GO:0033688),-0.5129645649437804,-1.3138617535743171,0.155902004454343,0.5643541441183466,1.0,7/17,18.66%,FGFR2;NPR3;CCN1;MN1;BMP2;SFRP1;TMEM119
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.43670524817434764,1.3134936564815658,0.09714285714285714,0.6229266879788163,1.0,9/75,6.01%,PLCB1;RGS12;RGS3;RASGRP4;GIT2;PPP1R9B;CALM1;RAMP3;GNG7
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.5813730759172129,1.3133300860020096,0.1743119266055046,0.622269368230647,1.0,13/18,26.75%,UNC13B;CDH8;GRID2;GRIK5;GRIK2;GRIK1;SLC17A6;UNC13A;GRIA2;GRIK3;GRID1;SLC17A8;NAPB
prerank,positive regulation of ossification (GO:0045778),-0.4297960587049327,-1.3132149202047925,0.10736196319018405,0.5643943560117576,1.0,15/39,12.50%,BMP6;BMPR1A;WNT4;BMP7;BMP4;OSR1;ADGRV1;ANO6;KL;CCN1;SLC8A1;TGFB3;PKDCC;BMP2;FBN2
prerank,response to lipopolysaccharide (GO:0032496),0.406186352737529,1.3129558860782742,0.07133592736705577,0.6222062089053497,1.0,25/138,14.16%,DAB2IP;NOS3;TIRAP;IFNAR1;GCH1;TNFRSF11A;MEF2C;SCARB1;DEFA6;NOD2;PELI1;NOS2;NOCT;PALM3;CD6;LGALS9;IRGM;PDE4B;ADAM17;S100A8;TNFAIP3;HMGB2;SLPI;GIT1;BCL10
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.5725824191293747,-1.3126036468119322,0.15766738660907129,0.5627495205122384,1.0,3/12,11.35%,IGF1;STIMATE;SLC9A1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.5725824191293747,-1.3126036468119322,0.15766738660907129,0.5627495205122384,1.0,3/12,11.35%,IGF1;STIMATE;SLC9A1
prerank,mitochondrial fission (GO:0000266),0.5787187094697318,1.312470944666744,0.1872852233676976,0.62262220064961,1.0,2/16,7.14%,DNM3;DNM2
prerank,regulated exocytosis (GO:0045055),0.40041961546750193,1.3113803429018491,0.059393939393939395,0.6247597952173595,1.0,28/173,10.36%,ABCC4;PECAM1;RAB11FIP1;PDGFB;TGFB2;APP;LHFPL2;RAB31;STX1A;SELENOP;SRGN;VWF;LYN;TMSB4X;CALM1;CFD;PIP5K1C;SYT7;ACTN4;CTSW;STXBP1;ACTN1;TGFB1;QSOX1;CDC37L1;SCG3;DNAJC5;ARHGAP17
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.584482351481153,1.3112652871979362,0.17869415807560138,0.6238776462297138,1.0,2/16,7.13%,CLDN5;CLDN14
prerank,muscle contraction (GO:0006936),-0.34885096100521873,-1.3099625104455994,0.058091286307053944,0.5686341970634713,1.0,30/126,12.95%,CALD1;ROCK2;ACTN2;MYLK;SNTA1;TPM1;ITGB5;SNTB1;MYOF;EDNRA;DMD;VCL;ASPH;PABPN1;GNAO1;SLC8A1;MYH11;BDKRB2;MYL9;LMOD1;ACTA2;TPM2;TMOD3;ARHGEF11;DES;DTNA;MYOM1;TLN1;EMD;FXYD1
prerank,positive regulation of phospholipase C activity (GO:0010863),-0.42887367273046595,-1.3096899412188587,0.11466666666666667,0.5676929527635585,1.0,9/40,4.75%,ARHGAP6;LPAR1;NTRK3;EGFR;PDGFRB;PDGFRA;EDNRA;KIT;FGF2
prerank,protein trimerization (GO:0070206),-0.5364730818651565,-1.3096248387109644,0.1759465478841871,0.5644369005660915,1.0,3/14,5.09%,SCARA5;SLC1A5;CLYBL
prerank,protein homotrimerization (GO:0070207),-0.5364730818651565,-1.3096248387109644,0.1759465478841871,0.5644369005660915,1.0,3/14,5.09%,SCARA5;SLC1A5;CLYBL
prerank,neuron development (GO:0048666),0.40785381088583994,1.3095194468255116,0.0759651307596513,0.6280906905671989,1.0,25/141,10.55%,PTPRM;FRY;TGFB2;RAPGEF2;APP;B4GALT5;FRYL;STX3;MEF2C;MAP4;LYN;PPP1R9B;STMN1;TBC1D24;RP1;STMN3;RAB11A;INSM1;STMN4;OPHN1;GPM6A;BICDL1;TBC1D23;DCX;AGER
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.5659997922208623,1.3093755035637324,0.17128027681660898,0.6273709858225035,1.0,3/18,4.13%,FLT1;MEF2C;PLCG1
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.4447899302973278,1.3090761006850187,0.1279887482419128,0.627186569911372,1.0,11/73,11.68%,KITLG;LMO2;GATA2;TAL1;PSMB3;PSMD11;TCF12;PSMC6;PSME2;CBFB;PSMD8
prerank,lamellipodium organization (GO:0097581),0.521739139760397,1.3090151035955881,0.12941176470588237,0.6262278301771382,1.0,8/29,10.81%,PARVB;ABLIM1;S1PR1;SPATA13;CCDC88A;ARHGEF7;CYFIP1;RAC1
prerank,regulation of protein localization to membrane (GO:1905475),-0.4687917163710949,-1.3080309413130173,0.11081794195250659,0.567314433180582,1.0,9/28,11.12%,GPC6;GSN;GPC3;MMP14;GPC4;AR;PRKN;SLC5A3;CLN3
prerank,miRNA metabolic process (GO:0010586),-0.49559016337584094,-1.3079357400754323,0.14180929095354522,0.5658735450768397,1.0,8/20,24.46%,TUT4;AGO2;XPO5;DDX17;BCDIN3D;TARBP2;PARN;DROSHA
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.4007668668349442,1.3068882931669066,0.0778061224489796,0.6317377826544743,1.0,46/163,18.98%,INPP5D;PTPRJ;MEF2C;PRKD2;ZAP70;TNFRSF21;PLCG1;IKBKB;PDE4D;MOG;CD19;CD4;CD38;FYN;PLEKHA1;PSMB3;PSMD11;CD79A;PDE4B;PSMC6;PAK1;MALT1;PSME2;EIF2B1;DENND1B;EIF2B2;PSMD8;PRKCB;SYK;RFTN1;PIK3CB;SH2B2;LCP2;PSMB10;BCL10;NCKAP1L;CARD11;NCK1;PSMA8;LAT2;SKP1;SPPL3;PAK2;PSMD9;RBCK1;SKAP1
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.49013660422961713,-1.3067114584345851,0.13705583756345177,0.5675666065162923,1.0,6/20,14.70%,IGF1;FOXC1;NIBAN2;TWIST1;EP300;DDRGK1
prerank,neuron projection development (GO:0031175),0.40200895546939547,1.3065985650286114,0.06765067650676507,0.6314400453410819,1.0,32/168,11.13%,PTPRM;FRY;SHANK3;SRGAP2;DAB2IP;RAPGEF2;APP;FRYL;STX3;MAP4;LYN;PPP1R9B;STMN1;WNT7A;TBC1D24;EPHA4;DIP2A;DBNL;NCKAP1;STMN3;RAB11A;DNM2;STMN4;OPHN1;GPM6A;PAK1;SLC9A6;ZPR1;BICDL1;TBC1D23;AGER;MAP4K4
prerank,regulation of cell growth (GO:0001558),0.3897460753393944,1.3065963965455265,0.06385542168674699,0.6302833014398841,1.0,41/204,12.64%,TFRC;MFSD2A;APBB2;BMPR2;TGFB2;LTBP4;SH3BP4;NET1;SOX17;DCUN1D3;PTPRJ;SMARCA2;SIPA1;ADAM15;ACVRL1;RPS6KA1;CCDC85B;PPP1R9B;SOCS2;KIF26A;HYAL2;SLC25A33;PAK5;WFDC1;FAM107A;RASGRP2;ADAM10;EGLN2;BST2;TGFB1;NPR1;SPOCK1;ADAM17;BTG1;AGTR2;S100A8;RPTOR;BRAT1;NAIF1;CEACAM1;DERL2
prerank,response to interferon-gamma (GO:0034341),0.4508662265986836,1.3059885278985988,0.11094890510948906,0.6310076543664428,1.0,12/67,11.07%,GCH1;SP100;CD40;GBP7;GBP4;GBP5;STAT1;LGALS9;BST2;RPL13A;PDE12;CCL1
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.5108978691410092,-1.3055187049264998,0.13559322033898305,0.5694613099159304,1.0,6/17,1.51%,IGF1;DOCK5;PDGFRB;DOCK7;IGFBP5;VTN
prerank,cellular response to zinc ion (GO:0071294),0.5737695201364471,1.305500017462247,0.18558558558558558,0.6312860425912654,1.0,8/15,13.76%,MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X
prerank,axon guidance (GO:0007411),0.3956913758790744,1.3051447043480282,0.061957868649318466,0.6311931158268478,1.0,39/201,9.35%,SEMA3C;PTPRM;SEMA7A;BSG;SHANK3;SEMA6A;SPTBN1;ROBO4;CXCL12;NTN1;SEMA6B;KLF7;PTK2;PLXND1;LAMA5;TMEFF1;NOTCH1;DSCAML1;EVL;PLCG1;GRB2;SEMA4F;GAB1;EPHA4;DOK4;FYN;SOS1;MAPK3;RPS6KA5;RET;CNTN2;EPHB4;SEMA6D;EFNA1;OPHN1;SPTAN1;SHC3;NRXN1;SEMA4C
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.49021065124499386,1.3048226952424247,0.15639810426540285,0.6309988808623828,1.0,6/41,4.30%,TJP1;PODXL;MAGI1;PLAUR;PIEZO1;SMAD7
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.5272466785409935,1.3046588806198913,0.16091954022988506,0.6303662988126827,1.0,11/25,19.27%,HSP90AB1;EPHA4;EFNA1;OPHN1;RPS7;HIPK2;F8A1;RPL11;TRIM39;PRKCG;RPL23
prerank,positive regulation of defense response (GO:0031349),0.4349027124577985,1.3046247151528674,0.0988857938718663,0.629356681574808,1.0,15/89,13.26%,ETS1;PDE2A;APP;NFKBIA;MEF2C;GBP5;HYAL2;MGST2;TLR3;TLR7;CCL1;TLR8;S100A8;DDT;IL15
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.3492344040726496,-1.3045701015618318,0.058365758754863814,0.5705467482886581,1.0,26/104,12.61%,BMPR1A;LDLRAD4;NBL1;SMAD3;CRIM1;BMPER;MAGI2;SMAD6;HTRA3;SNX6;TGFBR1;PPARA;RBPMS2;ASPN;SMAD9;EMILIN1;TGFB1I1;CD109;CCN3;PDPK1;SMURF2;SPRED1;VASN;CHRD;BMP2;SKI
prerank,regulation of actin filament-based movement (GO:1903115),-0.5850171450708751,-1.3040158221156175,0.1762208067940552,0.5702540404083729,1.0,2/10,1.62%,ANK2;PDPN
prerank,response to X-ray (GO:0010165),-0.5372325071718012,-1.3040125087605239,0.18666666666666668,0.5685634530993031,1.0,5/14,12.28%,ANXA1;IKBIP;ATM;NUCKS1;XRCC5
prerank,cellular response to hexose stimulus (GO:0071331),0.5383238187359995,1.3036538725459064,0.16825396825396827,0.6311648201552612,1.0,2/23,2.01%,IGF1R;UNC13B
prerank,regulation of sprouting angiogenesis (GO:1903670),0.5105445832890002,1.303193379063221,0.15309446254071662,0.6314710945122047,1.0,11/33,12.37%,SEMA6A;TJP1;PPP1R16B;EPN2;KLF2;FGF16;KLF4;PKM;SMAD1;CEACAM1;PIK3CB
prerank,chemical synaptic transmission (GO:0007268),0.37662598207208603,1.3030005409769363,0.05753739930955121,0.6309447882550896,1.0,66/284,17.52%,MPZ;SLC1A1;CACNA1A;HCRTR1;SLC6A2;SLC6A5;UNC13B;STX1A;RPS6KA1;CALM1;PDE7B;CDH8;SLC1A2;CAMKK2;TBC1D24;SYPL1;PRKACB;SLC12A6;GRID2;ATXN3;HOMER1;STXBP1;CHRNB1;HTR2A;PRKAR2B;GABRB1;HCRTR2;GRIA4;KCNQ3;APBA2;NRXN1;AKAP9;DNAJC5;PRKAR2A;EXOC4;HSPA8;NPY5R;CHRM3;GRIN2B;SHISA6;GABRQ;CPNE6;PCDHB14;GRIK5;GRIK2;SDCBP;CPLX1;GRIK1;MINK1;SLC17A6;MYCBPAP;HTR4;GABRG1;SYNJ2BP;GRM7;ERC1;AMPH;MAPK1;NLGN1;FCHSD1;PMP22;CRHBP;GABRG3;MBP;SST;GABRA1
prerank,vasculature development (GO:0001944),0.5684125002293423,1.3027122796697868,0.19926873857404023,0.6307220221395579,1.0,9/16,9.77%,BMPR2;NOTCH4;FLT4;ACVRL1;APLNR;FOXF1;FBXW7;SOX18;STRA6
prerank,regulation of programmed cell death (GO:0043067),0.39468640170501795,1.3023554791674268,0.06633291614518148,0.6306478705680567,1.0,22/161,9.25%,MECOM;HIP1;PPP1R13B;ACER2;FAS;TNFRSF25;LRP8;PHLPP1;JAK3;TGM2;ACTN4;STAT1;TOX3;CRADD;ACTN1;LCMT1;BIRC3;MARK4;PIDD1;TRIM24;BNIP3L;MALT1
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.33675037506359473,-1.3020337759298013,0.035856573705179286,0.5725578050973523,1.0,23/140,12.57%,CACNA1C;LPAR1;PLCE1;ADCY5;PDGFRA;CD55;CCR9;EDNRA;ADRA1B;CACNA2D1;TRPC3;DLG4;SLC8A1;P2RX4;BDKRB2;AGTR1;PTGDR;PTGFR;TRPM4;ESR1;JPH1;ABL1;LPAR4
prerank,apoptotic DNA fragmentation (GO:0006309),0.58732014131862,1.3018216296326297,0.1891891891891892,0.6311277450941802,1.0,8/16,18.52%,FOXL2;CECR2;DFFB;HMGB2;DNASE2;EXOG;ENDOG;DICER1
prerank,vasodilation (GO:0042311),0.6065559263707754,1.3016772180606004,0.19243986254295534,0.6304076307419487,1.0,3/13,10.52%,NOS3;KLF2;AGTR2
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.49331752949111335,1.3010057352865807,0.12944983818770225,0.631463407580494,1.0,7/36,11.19%,MECOM;FOXO1;MEN1;DUSP3;PPIA;ZMYND11;DUSP1
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.541584520025661,1.300903031108231,0.15625,0.6307090292683567,1.0,2/21,0.95%,MFHAS1;PPP1R16B
prerank,purine ribonucleotide biosynthetic process (GO:0009152),-0.4120706181314132,-1.3003331675943128,0.09497206703910614,0.5757690226102888,1.0,16/48,17.16%,ADCY5;AMPD3;ADCY1;ADCY9;SLC26A2;ADCY2;ADCY7;PAPSS2;GUCY1A1;DCAKD;PAPSS1;ADCY6;GUCY1B1;IMPDH2;GMPS;ADSL
prerank,regulation of stress fiber assembly (GO:0051492),-0.3753362823889044,-1.3001818318803229,0.05921052631578947,0.5745250753594704,1.0,24/74,10.46%,PHLDB2;ARHGAP6;LPAR1;ROCK2;ARHGAP28;PPM1E;CCN2;ARHGEF10L;ARAP1;ASAP3;TPM1;CARMIL1;TGFBR1;S100A10;ALMS1;CGNL1;ARHGEF18;FHOD1;MET;PFN2;MYOC;TGFB3;ITGB1BP1;TMEFF2
prerank,cytokine-mediated signaling pathway (GO:0019221),0.362874220362523,1.2999177580297867,0.014846235418875928,0.6326521399885662,1.0,99/532,12.52%,PLCB1;PDGFB;MAOA;BCL2L1;ADIPOR2;CXCL12;IL1R1;NFKBIA;IL6R;TNFRSF25;IFNAR1;TRIM25;LRP8;STX3;TNFRSF11A;S1PR1;INPP5D;B2M;PTPRJ;STX1A;NOD1;LAMA5;SP100;IFNAR2;CD40;FOXO1;RAPGEF1;JAK3;NOD2;PELI1;IL10RB;MAP3K8;TMSB4X;SOCS2;IRF2;OSMR;IKBKB;ADAR;GRB2;SAMHD1;NOS2;CD4;PITPNA;ST18;IRF9;ACTN4;PPIA;XAF1;FYN;SOS1;MAPK3;STAT1;RPS6KA5;AIM2;MCL1;PSMB3;IL13RA2;HCK;RAP1B;IRF5;BIRC3;IL4R;BST2;PSMD11;TGFB1;CXCR2;MSN;PSMC6;IRAK2;CEBPD;LIFR;TNFSF11;MAP3K3;PSME2;SOCS5;OASL;EBI3;TALDO1;ADAM17;UBE2V1;MMP1;EIF5A;MID1;CNTF;TOLLIP;HSPA8;CCL1;PLVAP;TNFRSF4;IL20RB;PSMD8;HIF1A;ADIPOR1;SYK;CEACAM1;TNFSF12;PIK3CB;IL27RA;POU2F1
prerank,positive regulation of lipid transport (GO:0032370),-0.5530231804517217,-1.2996496923904253,0.1561822125813449,0.574311393736872,1.0,3/12,8.31%,LRP1;SPP1;APOE
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.5292953969577834,1.2993855444934719,0.16351118760757316,0.6330790445471491,1.0,6/20,12.70%,EPAS1;DCUN1D3;HSP90AB1;UBQLN1;HIF1A;DCUN1D1
prerank,positive regulation of cell population proliferation (GO:0008284),0.36900487550642636,1.2990868152494157,0.02918918918918919,0.6328826854661755,1.0,51/423,9.10%,LEF1;FLT1;IGF1R;PRKCH;KITLG;TJP1;CLDN5;NAMPT;PDGFB;KDR;INSR;AQP11;TGFB2;ACER2;PDGFD;TBX1;IL6R;TBX3;CNOT6L;FLT4;STX3;TNFRSF11A;GNAI2;PTK2;MEF2C;NES;NOD2;TIAM1;NOTCH1;LYN;OSMR;WWTR1;FGF16;DLL4;SLC25A5;SLC25A33;STAT1;ADAM10;HCK;INSM1;BST2;PTN;TGFB1;CXCR2;LRP5;TGFA;GREM1;LIFR;PAK1;MAP3K3;COPS9
prerank,negative regulation of cell projection organization (GO:0031345),-0.39384595906739234,-1.298963022879509,0.08383233532934131,0.5746419677145795,1.0,13/48,13.59%,DPYSL3;LPAR1;PTPN9;EFNB2;KANK1;PTPRS;APOE;CBFA2T2;STX1B;ADCY6;RAB29;MYLIP;PTEN
prerank,metal ion homeostasis (GO:0055065),0.4934135089621227,1.2987227434092798,0.1383147853736089,0.6328795125045403,1.0,6/40,9.50%,TMTC2;CAV1;SLC12A6;SLC12A9;KCNH2;LETM1
prerank,negative regulation of developmental process (GO:0051093),0.44340165828235645,1.2982378885227166,0.09523809523809523,0.6332426911541092,1.0,9/69,3.90%,TFRC;NOS3;NOTCH4;ARHGEF15;TBX1;KLF7;NOTCH1;VASH1;RAPGEF3
prerank,actin filament polymerization (GO:0030041),-0.4559029133025349,-1.29787685730155,0.12949640287769784,0.5762682591595168,1.0,4/29,2.37%,ARHGAP6;GAS7;GSN;COBL
prerank,actin cytoskeleton reorganization (GO:0031532),-0.39114320408304515,-1.297854447808025,0.09876543209876543,0.5746518132298696,1.0,16/63,9.10%,AUTS2;PARVA;GSN;CXADR;PTK7;MCU;SIPA1L1;NRK;KIT;DTNBP1;ANXA1;FLNA;PHACTR1;SYDE1;PDLIM4;EZR
prerank,iron ion transport (GO:0006826),0.47482647758684465,1.297773883054883,0.14923076923076922,0.6335042001361124,1.0,6/47,7.14%,TFRC;SLC40A1;ATP6V0A1;MCOLN1;REP15;DNM2
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.5365895978349751,1.296972413254744,0.15619694397283532,0.6348080371054124,1.0,1/24,0.27%,POLK
prerank,regulation of endocytic recycling (GO:2001135),-0.5667598682373772,-1.2969660202048778,0.15056179775280898,0.5755936455736279,1.0,5/11,16.69%,ACTN2;ATP9A;EHD1;RAB11B;EHD2
prerank,carboxylic acid catabolic process (GO:0046395),-0.5461008277993281,-1.296824417684806,0.18082788671023964,0.574352027682603,1.0,8/12,28.82%,ACOT8;PON3;RENBP;NAGK;BCKDK;NPL;GNPDA1;IL4I1
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.6057778594907448,1.2966414844451528,0.2067137809187279,0.6346032173309416,1.0,3/12,1.71%,SEMA6A;DAB2IP;XDH
prerank,transepithelial transport (GO:0070633),0.5895393942876525,1.2960841245560621,0.17562724014336917,0.6351944077454291,1.0,3/15,5.09%,ABCG2;SLC1A1;SLC1A2
prerank,negative regulation of cell adhesion (GO:0007162),0.4440446182481018,1.296037318481121,0.11320754716981132,0.6342117540825986,1.0,20/72,12.20%,SEMA6A;PODXL;ACER2;FZD4;PTK2;CORO2B;PLXND1;SIPA1;ACVRL1;NOTCH1;SNAI2;ADAM10;NEXMIF;TGFB1;SPOCK1;ARHGDIA;CBLL1;DUSP1;PLXNB3;RND1
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.49876333194937034,1.295845389840735,0.16775244299674266,0.6336607791092578,1.0,8/33,7.56%,TGFB2;ACER2;PTK2;LYN;SNAI2;RET;NEXMIF;EFNA1
prerank,cell part morphogenesis (GO:0032990),-0.5445267209602592,-1.2956462870280716,0.1425339366515837,0.5761641626867076,1.0,1/13,0.14%,PID1
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.47767876307844814,-1.2954108809603768,0.15296803652968036,0.5735724301887563,1.0,3/21,2.08%,EYA2;EYA1;EYA4
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.47767876307844814,-1.2954108809603768,0.15296803652968036,0.5735724301887563,1.0,3/21,2.08%,EYA2;EYA1;EYA4
prerank,sulfur compound transport (GO:0072348),0.5273880145764877,1.2951980814225774,0.16306156405990016,0.6345378736766788,1.0,2/27,0.39%,SLC6A6;ABCG2
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.4342477573314668,-1.2951019250158247,0.13144329896907217,0.5727803571281267,1.0,10/33,13.59%,OGN;IGFBP5;TPM1;APOD;SOD2;IGFBP3;EFEMP2;TGFB3;MFN2;PTEN
prerank,mRNA splice site selection (GO:0006376),-0.44748666087625083,-1.2948803434917764,0.11655011655011654,0.5717185290397193,1.0,6/30,14.03%,CELF2;SRSF5;LUC7L3;SRSF6;LUC7L2;PSIP1
prerank,negative regulation of vascular permeability (GO:0043116),0.614320540514202,1.2944630319777668,0.17870036101083034,0.635714698945774,1.0,5/12,3.59%,CLDN5;PDE2A;DDAH1;PTPRJ;RAMP2
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.6141046194872173,1.2940713546328344,0.2040072859744991,0.635805634678703,1.0,4/10,16.82%,CAV1;KCNRG;ANK3;SUMO1
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.5315817482282206,-1.2938794995824463,0.1547085201793722,0.5729178341339478,1.0,4/15,3.80%,GLI2;EDA;WNT6;FOXC1
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.4429168137403158,1.2938092840575803,0.12162162162162163,0.6355115810994431,1.0,9/67,5.70%,NDNF;UTRN;PDGFB;LIMS2;DOCK1;NEDD9;RREB1;CCR7;RSU1
prerank,sodium ion export across plasma membrane (GO:0036376),-0.5486452678264686,-1.293746018414602,0.18552036199095023,0.5716752055906914,1.0,4/13,11.35%,ATP1A2;ATP1B3;ATP1B2;SLC9A1
prerank,regulation of immune effector process (GO:0002697),-0.41264410165871535,-1.2936592743001918,0.10541310541310542,0.570298109109207,1.0,4/41,1.95%,SERPING1;VTN;CD55;CFH
prerank,regulation of cell population proliferation (GO:0042127),0.35978951027841727,1.2935645933982338,0.007329842931937173,0.6351445658904107,1.0,83/691,9.10%,LEF1;FLT1;IGF1R;TFRC;KITLG;ETS1;TJP1;CLDN5;NAMPT;PDGFB;KDR;INSR;AQP11;DAB2IP;ENG;BMPR2;TGFB2;NOS3;RAPGEF2;SH3BP4;ACER2;PDGFD;APP;JAG2;FES;DDAH1;TBX1;ITGA1;IL6R;TBX3;CNOT6L;FLT4;CD200;STX3;TNFRSF11A;ADGRG1;PTPRJ;GNAI2;ARHGEF2;PTK2;BCL6B;RGCC;SMARCA2;ACVRL1;TIAM1;NOTCH1;MEN1;LYN;PPP1R9B;OSMR;HHEX;CTNNB1;IGFBP7;SOX7;WWTR1;FGF16;DLL4;XIAP;SLC25A5;BTG4;ST18;CCDC88A;CDKN2B;SLC25A33;STAT1;ADAM10;KLF4;HCK;INSM1;PTN;TGFB1;JUN;CXCR2;TMEM115;CDCA7;LRP5;FOXP3;TGFA;ADAMTS8;GREM1;LIFR;PAK1;COPS9
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.5676184440447208,1.2934269082457674,0.17962962962962964,0.6344834051125547,1.0,4/17,6.96%,TEK;FES;BAIAP2;HCK
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.41442843108670413,-1.2931384899595062,0.11142061281337047,0.5701104109282563,1.0,9/44,7.12%,ANK2;ACTN2;WNK4;ANO6;KCNMB2;KCNJ2;ATP1B3;FLNA;ATP1B2
prerank,maintenance of protein location in nucleus (GO:0051457),0.5606654865577987,1.2928895732908838,0.18458781362007168,0.6351042161509695,1.0,3/20,2.87%,SYNE1;ARL2BP;SP100
prerank,vesicle organization (GO:0016050),0.4819675282669886,1.2926024459981773,0.1498422712933754,0.6349325662636733,1.0,10/46,12.02%,CD34;CAV1;FNBP1L;ALS2CL;SRGN;DNAJC13;SORT1;CAV2;HOOK1;EPS15
prerank,regulation of neuron projection development (GO:0010975),0.3945436334862814,1.292600178365076,0.07475490196078431,0.6338413536293853,1.0,35/163,11.69%,ITGA6;NDNF;MFSD2A;SHANK3;DAB2IP;EFHC2;RAPGEF2;FES;SCARF1;MBOAT1;RAPGEF1;PRAG1;CDH2;NTNG2;PRKD1;LYN;SNX3;EPHA4;CCDC88A;FUT9;CSMD3;RET;KIF1A;LRRC7;PTN;TWF2;PAK1;DISC1;SPOCK1;SERPINI1;PTK6;ACP4;PLXNB3;ABI3;GSK3A
prerank,mesenchyme morphogenesis (GO:0072132),0.579254696737178,1.2925109963539307,0.17422867513611615,0.6330158471973503,1.0,5/17,3.41%,ENG;TGFB2;NOS3;ACVRL1;NOTCH1
prerank,atrioventricular valve development (GO:0003171),0.5878939333704487,1.2919390418444163,0.1724770642201835,0.633589586440003,1.0,5/14,3.41%,BMPR2;TGFB2;ZFPM1;APLNR;NOTCH1
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.3945659247991586,1.291518007053154,0.07828282828282829,0.6337401947700544,1.0,83/168,28.19%,CNOT6L;MTPAP;RPL38;RPL13;RPS29;RPL36A;RPL3;RNPS1;RPSA;RPL27;PAN3;EIF3E;RPS7;RPL9;RPLP2;RPL18;CNOT9;MAGOHB;RPL13A;PAN2;PDE12;HELZ2;ZFP36L1;DCP2;NCBP2;RPS11;RPL8;RPS27;CNOT6;RPL19;DXO;RPS9;DCP1B;RPL11;RPS15;RPL37;PNRC2;RPS28;RPS10;RPS25;RPL37A;XRN1;RPL15;EXOSC10;NBAS;RPL17;RPL23;CNOT11;RPL34;RBM8A;RPS18;EXOSC9;UPF2;XRN2;RPL21;PELO;CNOT4;RPS4X;NCBP1;EXOSC8;RPS21;RPL18A;RPL10A;DCPS;PABPC1;RPL24;RPL7A;ZC3H12A;RPL4;UPF3B;RPS2;RPL32;RPL6;UPF1;RPS20;RPL14;AGO1;NBDY;RPS13;RPL26;RPS19;RC3H2;PPP2R1A
prerank,negative regulation of cell activation (GO:0050866),0.588059107258721,1.291490186893879,0.1912280701754386,0.6327505780929735,1.0,3/14,2.15%,PDGFB;NOS3;CD200
prerank,neural tube development (GO:0021915),-0.5335518802174196,-1.2911916735599935,0.15681818181818183,0.5741732290363531,1.0,4/15,6.41%,ALDH1A2;PKD1;PKD2;DACT1
prerank,erythrocyte differentiation (GO:0030218),0.4808816220287572,1.290543007010139,0.14715189873417722,0.6344439800128692,1.0,8/44,5.28%,MFHAS1;ALAS1;JAK3;ZFPM1;LYN;KLF1;SLC25A5;TAL1
prerank,fatty acid elongation (GO:0030497),0.6011860886265544,1.2904695043183454,0.20626151012891344,0.6335760086806723,1.0,5/13,12.88%,ELOVL7;ELOVL5;ABCD1;ELOVL6;HACD2
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.5583853202131824,1.2904128940933803,0.2033898305084746,0.6326729680478322,1.0,6/18,6.32%,CD200;LRP8;PRKD2;PRKD1;CRTC1;RPS6KA5
prerank,negative regulation of locomotion (GO:0040013),0.5962795360035873,1.2899196469045129,0.18571428571428572,0.6330947647950609,1.0,3/12,8.18%,FRMD5;DUSP3;PIN1
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.5160533998917384,1.289569594213789,0.1648,0.633108592574673,1.0,8/28,12.77%,SHANK3;APP;EPHA4;FAM107A;PTN;EIF2AK4;AGER;CALB2
prerank,inhibitory synapse assembly (GO:1904862),0.6087853887789391,1.289087584908785,0.2046783625730994,0.6334611531077259,1.0,6/11,26.19%,FGF13;GABRA1;GABRB2;CBLN4;GABRA2;GABRG2
prerank,regulation of complement activation (GO:0030449),-0.4142602119378477,-1.2889436166029866,0.12640449438202248,0.5789698518764168,1.0,4/40,1.95%,SERPING1;VTN;CD55;CFH
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.48148072679253345,-1.2888905702453177,0.17067307692307693,0.5774505435726425,1.0,5/21,6.64%,ROCK2;ERRFI1;BMP4;CTSL;SFRP4
prerank,protein hydroxylation (GO:0018126),-0.5320053491069623,-1.2888608751938002,0.17312072892938496,0.5759096486133078,1.0,7/15,13.30%,PLOD2;ASPH;P3H3;EGLN3;P3H2;OGFOD1;P3H1
prerank,regulation of cell adhesion (GO:0030155),0.40159326695560876,1.2887208301940252,0.09893048128342247,0.633484614848857,1.0,29/129,11.25%,FRMD5;PODXL;CXCL12;FES;STX3;CYTH1;ADGRG1;PTPRJ;PTK2;PLXND1;SIPA1;ACVRL1;PRKD2;LYN;TGM2;CCR7;EPHA4;RSU1;ATXN3;ADAM10;RET;EFNA1;PKP4;PPP1CB;ARHGDIA;CBLL1;PPP3CA;DUSP1;PLXNB3
prerank,thyroid hormone generation (GO:0006590),-0.5713185187985812,-1.2877141668586154,0.18552036199095023,0.5775970578203895,1.0,3/10,13.15%,CPQ;SLC5A5;FOXE1
prerank,negative chemotaxis (GO:0050919),0.5126673792236026,1.2872893342789296,0.1444805194805195,0.6366324074290656,1.0,7/33,7.22%,SEMA3C;SEMA7A;SEMA6A;NTN1;SEMA6B;SEMA4F;SEMA6D
prerank,carbohydrate biosynthetic process (GO:0016051),0.5511602821107013,1.2868400689199118,0.18030050083472454,0.6369430221270106,1.0,4/21,6.08%,ST3GAL6;ST8SIA6;FUT8;FUT9
prerank,cellular response to oxidative stress (GO:0034599),-0.34403847845289054,-1.2868084624291531,0.056768558951965066,0.5784451750399954,1.0,26/118,12.26%,EGFR;PDGFRA;PRKAA2;MGAT3;CPEB2;TPM1;PLA2R1;PRKCD;PPARGC1A;PKD2;STX2;SOD3;SOD2;GPX8;NOX4;SELENOS;SLC25A24;FOXO3;ARNT;CYBA;PARP1;CHUK;TMEM161A;MPV17;LRRK2;ABL1
prerank,blood circulation (GO:0008015),-0.40067187342130994,-1.2866670104687012,0.12275449101796407,0.5772101182941856,1.0,18/49,13.46%,ROCK2;SERPING1;COL4A3;SGCD;ELN;MEOX2;MYOF;SCPEP1;GUCY1A1;ACE;BDKRB2;AGTR1;ADORA2A;ITGB1BP1;ADCY6;HTR7;GCLC;GUCY1B1
prerank,cellular response to cytokine stimulus (GO:0071345),0.36274878448391645,1.286595923593323,0.03369565217391304,0.636625713472277,1.0,75/416,12.52%,LEF1;ST3GAL6;MAOA;LRCH1;BCL2L1;DAB2IP;CXCL12;PDE2A;IL1R1;IL6R;IFNAR1;LRP8;STX3;S1PR1;INPP5D;PTPRJ;ARHGEF2;STX1A;LAMA5;IFNAR2;CD40;FOXO1;RAPGEF1;JAK3;GBP7;PTPN12;GBP4;SIGIRR;IL10RB;GBP5;TNFRSF21;SOCS2;OSMR;IKBKB;GRB2;NOS2;HYAL2;CCR7;CD4;TCF7;FYN;SOS1;STAT1;LGALS9;AIM2;MCL1;IL13RA2;HCK;IRF5;IL4R;TGFB1;IRGM;CRNN;IRAK2;PTPN5;CEBPD;LIFR;TNFSF11;SOCS5;EBI3;RPL13A;MMP1;CNTF;PDE12;HSPA8;ZFP36L1;CCL1;DUSP1;IL20RB;GSK3A;HIF1A;SYK;PIK3CB;IL27RA;POU2F1
prerank,phagosome-lysosome fusion (GO:0090385),0.6249453430776788,1.2862465862352914,0.23076923076923078,0.6365482053279088,1.0,4/10,7.88%,PIKFYVE;SYT7;RAB39A;RAB34
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.583877212265127,-1.2858782445615082,0.19517543859649122,0.5777244912009136,1.0,1/10,2.75%,TUT4
prerank,potassium ion transport (GO:0006813),-0.3435979418773378,-1.2857057187297352,0.06808510638297872,0.576635867517738,1.0,19/120,11.35%,ATP1A2;SLC24A3;KCNK2;NALCN;SLC1A3;KCNK5;KCNMB2;SLC9A2;KCNJ2;PKD2;ABCC9;ATP1B3;KCNQ4;KCNB2;SLC9A9;KCNJ13;KCNQ5;TMEM175;SLC9A1
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.46391872851446386,1.2851175644275814,0.1404833836858006,0.6387827909317944,1.0,13/54,16.12%,IVNS1ABP;CAV1;DCUN1D3;SMAD7;CTNNB1;N4BP1;COPS9;UBXN1;TNFAIP3;RPL11;DNAJA1;BAG2;SIRT7
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.49696379548694636,1.2849900489135642,0.16666666666666666,0.6381376854144336,1.0,2/32,3.19%,PGLYRP1;DEFA6
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.530392655688751,1.284426439563508,0.17983193277310924,0.6386569684505842,1.0,5/24,10.05%,BCL2L1;AQP11;NR1H2;LPCAT3;UBXN1
prerank,negative regulation of heart contraction (GO:0045822),-0.560099112014248,-1.284289732840344,0.17608695652173914,0.5790461238874287,1.0,1/11,0.02%,ATP1A2
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.5154044091175762,-1.2836095026971808,0.1789709172259508,0.5793875151311585,1.0,6/15,15.43%,LARGE1;MGAT3;RENBP;CHST3;NAGK;CHST1
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.4742863283542219,-1.2833807035971556,0.1628440366972477,0.5784477990845984,1.0,3/23,2.24%,TGFBR3;FGFR2;TPM1
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.43664598214167616,-1.2829230480354161,0.1279373368146214,0.5780683524624497,1.0,7/32,5.33%,PID1;IGF1;ZBTB20;PRKAA2;NUPR1;PPARGC1A;PPARA
prerank,regulation of exosomal secretion (GO:1903541),-0.49019011924021827,-1.2827870589017836,0.16625916870415647,0.5768685259936651,1.0,5/19,8.00%,ATP9A;SMPD3;TSG101;PRKN;SDC4
prerank,protein targeting (GO:0006605),0.40214491091765564,1.2827460049710482,0.10973936899862825,0.6425283506965881,1.0,41/118,21.73%,AQP11;RASSF9;ZDHHC14;PARD3;TOMM22;PIKFYVE;ZDHHC9;ZDHHC20;ZFAND2A;ZDHHC19;SRP14;TIMM13;RTP4;ZDHHC18;AP1S3;ZDHHC22;TIMM10;AP4S1;DNAJC19;EDEM1;SDCBP;RPL11;HACL1;SPCS2;NACAD;AKAP6;MFF;RTP3;NLGN1;ZDHHC21;PEX16;TOMM7;VPS37A;LONP2;MYO1C;VPS37B;TOMM5;SPCS1;GABARAP;PEX6;VPS37C
prerank,synapse organization (GO:0050808),0.40765893370606676,1.2825170877721521,0.09236947791164658,0.6421592483839805,1.0,23/125,10.18%,SPOCK2;DNM3;SHANK3;APBB2;APP;ADGRL3;UNC13B;AGRN;PLXND1;CDH2;PPFIBP1;DBNL;CNTN2;SLITRK3;GPHN;PIN1;SLITRK1;GPM6A;NRXN1;DNER;ELFN1;CYFIP1;LRRC4B
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.5319826826030479,1.2820766053900252,0.17391304347826086,0.6423029045051017,1.0,12/23,24.49%,NLRC5;HSP90AB1;STAT1;NR1H2;IRGM;PPARG;SUMO1;IFNGR1;PARP9;SOCS1;IFNGR2;PARP14
prerank,negative regulation of cell migration (GO:0030336),0.4009182102987212,1.279801803848256,0.10695876288659793,0.6479219932349387,1.0,23/137,7.48%,PTPRG;LIMCH1;DACH1;CLDN5;SRGAP3;SRGAP2;DAB2IP;SRGAP1;ENG;MCC;ADGRG1;PTPRJ;ADAM15;ACVRL1;EVL;DUSP3;SMAD7;HYAL2;RHOB;EPHA4;NEXMIF;PTPRR;BST2
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.5678323988665469,1.2793563846491753,0.1945945945945946,0.6481414296570692,1.0,10/15,30.91%,ARPC4;JMY;ARPC3;ACTR2;ARPC1B;ARPC2;WHAMM;ARPC5;WASHC1;ARPC1A
prerank,retina homeostasis (GO:0001895),0.5342323614256992,1.279226114709587,0.214168039538715,0.6474849464269926,1.0,6/23,11.20%,B2M;ACTB;POTEF;POC1B;ACTG1;HSPB1
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.49995185330993325,1.2791447526022843,0.15408320493066255,0.6466511883428919,1.0,2/34,3.22%,SLC7A5;NOD2
prerank,regulation of chondrocyte differentiation (GO:0032330),-0.46550659348732626,-1.2788589506232528,0.15365239294710328,0.5859345158899684,1.0,8/24,12.17%,SOX5;ADAMTS12;EFEMP1;TGFBR1;WNT9A;SOX6;PTHLH;PKDCC
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.5747431896010103,1.2787911218441141,0.19748653500897667,0.6467092294421898,1.0,4/14,9.25%,TIRAP;TLR3;CARD10;MALT1
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.486757327826463,1.2784124195239803,0.14838709677419354,0.6466901888860364,1.0,8/37,7.08%,HMCN1;CADM1;NECTIN4;CD6;GRID2;PVR;FAT4;DCHS1
prerank,positive regulation of histone methylation (GO:0031062),-0.4666873555092125,-1.2783369090075778,0.14745308310991956,0.585834353266253,1.0,3/24,5.39%,AUTS2;OGT;CTR9
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.5370314643087578,1.278051521768238,0.18074324324324326,0.6467563188228336,1.0,5/22,8.93%,PDGFB;PDGFD;CALM1;MRE11;GREM1
prerank,sphingoid metabolic process (GO:0046519),0.5937601502631996,1.277837492822447,0.21195652173913043,0.646330749382926,1.0,2/12,1.20%,SGPP2;DEGS2
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.5963273883344388,1.2778062603110585,0.2014519056261343,0.6453510296643261,1.0,3/13,15.83%,PRR5L;GTPBP1;ZC3HAV1
prerank,response to amyloid-beta (GO:1904645),0.4710698536526917,1.2774044535874103,0.17425431711145997,0.6454505778236903,1.0,7/44,6.34%,IGF1R;CACNA1A;APP;RAMP3;EPHA4;FYN;ATP1A3
prerank,positive regulation of vascular permeability (GO:0043117),0.6029977707675744,1.2770603921320804,0.19925512104283055,0.6453856710876993,1.0,4/12,1.91%,OCLN;TJP1;PDE2A;TJP2
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.4749588214537188,-1.2769662313361694,0.18313253012048192,0.5882005500395618,1.0,8/24,10.47%,IGF1;ENPP1;IRS1;IRS2;IGF2;SELENOS;PPP1R3B;PPP1R3C
prerank,granulocyte chemotaxis (GO:0071621),0.4464330176762369,1.276941237402876,0.15037593984962405,0.6447002873824925,1.0,10/55,12.14%,BSG;TGFB2;PIKFYVE;PIP5K1C;PPIA;CXCR2;PDE4B;CCL1;S100A8;SYK
prerank,negative regulation of hormone secretion (GO:0046888),0.6305923877384032,1.2769394498747642,0.2045028142589118,0.6436502869144428,1.0,1/10,0.73%,RAB11FIP1
prerank,potassium ion transmembrane transport (GO:0071805),-0.3385017925859798,-1.2768134795813428,0.06862745098039216,0.5870363751736901,1.0,17/135,7.12%,ATP1A2;SLC24A3;KCNK2;NALCN;SLC1A3;KCNT2;KCNK5;SLC12A2;SLC9A2;KCNJ2;PKD2;ABCC9;ATP1B3;KCNQ4;SLC12A7;KCNB2;ATP1B2
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.3773360858756961,1.27669927425952,0.058394160583941604,0.6433015611091156,1.0,40/234,11.78%,TFRC;PRKCH;APP;CAV1;NFKBIA;TIRAP;CD200;TRIM25;LRP8;TNFRSF11A;TRIM14;FZD4;ARHGEF2;RGCC;NOD1;CD40;NOD2;PRKD2;PRKD1;IKBKB;CTNNB1;CRTC1;PPIA;LGALS9;RPS6KA5;AIM2;BUD31;JMY;CRNN;ARHGEF5;PIDD1;IRAK2;TNFSF11;MALT1;UBE2V1;LAMTOR5;AGER;S100A8;ZBTB7A;PRKCB
prerank,gland development (GO:0048732),-0.3888506867372604,-1.276384873230721,0.09880239520958084,0.5866583421655639,1.0,19/59,14.08%,TGFBR3;GLI2;WNT4;DKK3;FGFR2;COBL;SALL1;TGFBR1;PKD2;ANXA1;SIX1;IGSF3;MET;EZR;TGFB3;FOXE1;NF1;ZBTB1;WNT11
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.5170125410315065,1.275644988720722,0.19773095623987033,0.6453818063023607,1.0,4/27,6.99%,PRKCH;NFKBIA;ABCG1;NR1H2
prerank,regulation of protein metabolic process (GO:0051246),0.4679990867581328,1.2753931579514517,0.16129032258064516,0.6450692266454174,1.0,8/44,8.34%,LTBP4;APP;PLAUR;NEDD4L;KLF2;HSP90AB1;KLF4;ABCA7
prerank,response to nitric oxide (GO:0071731),0.5911483749764508,1.2750296390280498,0.21206581352833637,0.6450843725188621,1.0,4/13,12.90%,FOXO1;CCR7;KCNC2;EGLN1
prerank,regulation of DNA binding (GO:0051101),0.4705833296663775,1.2746062167267813,0.15707620528771385,0.6453174732554616,1.0,11/44,13.34%,LEF1;NFKBIA;PLAUR;SP100;TGFB1;JUN;ZBTB7A;PPARG;HMGB2;CSNK2B;EDF1
prerank,positive regulation of cellular senescence (GO:2000774),0.6200870874486409,1.2743736149726939,0.19923371647509577,0.6449230492330603,1.0,4/10,16.37%,B2M;HMGA1;ABI3;HMGA2
prerank,regulation of ERAD pathway (GO:1904292),0.5903858816437884,1.274124865651279,0.20656370656370657,0.6445985170849782,1.0,5/11,18.99%,AQP11;ATXN3;UBXN1;BAG6;USP25
prerank,positive regulation of cellular protein localization (GO:1903829),0.44024513366570334,1.2740160293297826,0.138328530259366,0.6438329676768878,1.0,14/69,11.79%,TFRC;STX3;WWTR1;HSP90AB1;CARD10;CCDC88A;LIMK2;FYN;MARK4;TGFB1;ABCA7;LAMTOR5;FERMT2;ORMDL3
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.5943587636981058,1.2738616921389148,0.218018018018018,0.643306023214408,1.0,5/11,22.62%,CAV1;ADIPOR1;HGS;SH2B3;SOCS1
prerank,cellular sodium ion homeostasis (GO:0006883),-0.5232149966905724,-1.2735713422157247,0.18223234624145787,0.5930546262083478,1.0,5/15,7.19%,ATP1A2;SLC12A2;ATP1B3;ATP1B2;SLC8A1
prerank,axonogenesis (GO:0007409),0.3815936402736747,1.2731622822189463,0.07246376811594203,0.6442718026054033,1.0,46/237,9.57%,SEMA3C;SEMA7A;BSG;SHANK3;SEMA6A;SPTBN1;ROBO4;CXCL12;APP;B4GALT5;SEMA6B;KLF7;PTK2;LAMA5;NTNG2;NOTCH1;PARD3;DSCAML1;EVL;ACTB;PLCG1;WNT7A;GRB2;SEMA4F;HSP90AB1;GAB1;BAIAP2;EPHA4;DOK4;FYN;SOS1;MAPK3;RPS6KA5;RET;CNTN2;SLITRK3;EPHB4;SEMA6D;EFNA1;OPHN1;SLITRK1;SPTAN1;SHC3;NRXN1;SEMA4C;SLC9A6
prerank,positive regulation of protein depolymerization (GO:1901881),0.5962298986648078,1.2729198526259828,0.21493624772313297,0.6439406491134656,1.0,4/11,18.20%,NES;VIL1;TRPV4;WDR1
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.5953458392003544,1.272765940101255,0.20825852782764812,0.6433739171958035,1.0,7/14,20.21%,KDR;FLT4;GAB1;PGF;NUS1;NRP1;MYO1C
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.3791313462781472,1.2726678197678307,0.06930693069306931,0.6426115711200334,1.0,31/214,8.34%,TEK;SEMA7A;SEMA6A;MFHAS1;PDGFB;KDR;DAB2IP;RAPGEF2;PDGFD;APP;CNKSR3;PDE8A;TIRAP;FLT4;NOD2;PRKD2;NOTCH1;DUSP3;LYN;RAMP3;CCR7;CD4;MAPK3;LGALS9;FBXW7;PTPRR;HTR2A;TGFB1;ARHGEF5;PIN1;ABCA7
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.6095141769834725,1.2726037387399949,0.2290909090909091,0.6417627929372518,1.0,6/11,13.65%,TBX1;CTNNBIP1;STAT1;LRP5;TGFBR2;SOX9
prerank,positive regulation of multicellular organismal process (GO:0051240),0.3678781416791245,1.2719953650001363,0.04740406320541761,0.6426701174794542,1.0,22/308,4.78%,LEF1;IGF1R;TFRC;PRKCH;PLCB1;EPAS1;PDGFB;CADM1;ADIPOR2;GATM;BMPR2;TGFB2;TRIM16;CAV1;B4GALT5;RGCC;UCP2;TIAM1;ZBTB16;RREB1;CTNNB1;WWTR1
prerank,positive regulation of leukocyte activation (GO:0002696),-0.49518481804019365,-1.271992931949743,0.16703786191536749,0.5958411155703759,1.0,4/18,14.30%,LBP;THBS1;TNIP2;TLR4
prerank,acidic amino acid transport (GO:0015800),0.5596699912316316,1.2717879271155361,0.19753086419753085,0.6422104624953884,1.0,2/17,0.40%,SLC6A6;SLC1A1
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.5325741481733699,-1.2709497077553096,0.1891304347826087,0.5971826748313761,1.0,3/13,3.02%,CACNA1C;ANK2;GJA1
prerank,sensory organ development (GO:0007423),-0.38464379630680773,-1.27074042306205,0.13836477987421383,0.5962049373913036,1.0,8/51,6.73%,PBX1;SMOC1;RBP4;SH3PXD2B;FOXC1;PBX4;PBX3;MEIS1
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.5790300122525922,-1.2703941727297399,0.21106557377049182,0.59561327011331,1.0,5/10,15.21%,DPYD;NT5E;UPB1;UPP2;NT5C1A
prerank,central nervous system neuron development (GO:0021954),0.5721427800926983,1.2701807046881513,0.2,0.6459827922883533,1.0,3/15,5.11%,RAPGEF2;B4GALT5;HSP90AB1
prerank,synaptic vesicle cycle (GO:0099504),0.4984677032030659,1.2688759774317009,0.17886178861788618,0.6488537871289645,1.0,8/30,16.00%,STX1A;WNT7A;PIP5K1C;SYT7;DNAJC5;CPLX1;SLC17A6;NLGN1
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.5308557331039712,1.2687900317354717,0.18425460636515914,0.6480884072259168,1.0,2/22,1.71%,MFHAS1;XDH
prerank,Ras protein signal transduction (GO:0007265),0.3988483928387631,1.2686626220165735,0.10700132100396301,0.6474262635510505,1.0,33/137,10.09%,RASGRP3;ARHGEF3;RAPGEF2;NTN1;ELMO1;PLEKHG5;GRAP;ADGRG1;RAPGEF1;TIAM1;PRKD1;RAPGEF3;RIPOR1;GRB2;RREB1;EPS8;GNA12;RHOB;CDC42EP3;EPS8L2;DBNL;SOS1;RASGRP2;NCKAP1;RALB;RAP1B;RGL2;JUN;SHC3;ARHGAP4;ARHGDIA;PHACTR4;CYFIP1
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.5011474810377703,1.2684929956484194,0.17520661157024794,0.6469595422527676,1.0,10/30,12.88%,ELOVL7;TECRL;ABCD4;ACOX1;ACSL6;ELOVL5;ABCD1;ELOVL6;SLC27A2;HACD2
prerank,negative regulation of response to stimulus (GO:0048585),0.44088461206195695,1.2684078051954277,0.15201192250372578,0.646195965065161,1.0,15/60,10.25%,AQP11;CD34;DDAH1;KLF7;YBX1;LYN;KIF26A;KLF4;NR1H2;TERF2;FOXP3;MAP3K3;SOCS5;LPCAT3;PTK6
prerank,epithelial to mesenchymal transition (GO:0001837),0.4618002860994822,1.2683148211683473,0.1534954407294833,0.6454538989994294,1.0,8/47,5.18%,LEF1;ENG;TGFB2;NOTCH4;TBX3;NOTCH1;CTNNB1;SNAI2
prerank,regulation of myelination (GO:0031641),0.5219595721778213,1.2681235452849544,0.19830508474576272,0.6450640278452197,1.0,9/25,18.52%,JAM2;PARD3;TNFRSF21;PTN;CST7;ZPR1;PTPRZ1;TPPP;DICER1
prerank,response to peptide (GO:1901652),0.49154189284527183,1.2679771304142997,0.15798045602605862,0.6445134189525198,1.0,9/33,11.22%,CACNA1A;NOD2;RAMP3;FYN;STAT1;IRF5;EIF2B1;AGER;EIF2B2
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.5018476584846624,1.2679711250796717,0.188135593220339,0.6435253908451865,1.0,4/29,7.43%,CADM1;NOS2;PVR;CD160
prerank,regulation of cellular respiration (GO:0043457),0.5597949342483503,1.267625225110712,0.19137931034482758,0.6434648411499659,1.0,4/17,8.10%,IFNAR1;IL10RB;NOS2;SHMT2
prerank,regulation of cytoplasmic translation (GO:2000765),-0.5282440435874679,-1.2675467549014443,0.18501170960187355,0.6020227137627372,1.0,6/14,23.08%,CPEB1;CPEB2;YBX3;FMR1;RBM24;CPEB4
prerank,rRNA catabolic process (GO:0016075),0.5636872299641786,1.2673988917302965,0.2286212914485166,0.6431184270097512,1.0,8/16,22.32%,DEDD2;TRIR;DIS3L;XRN1;EXOSC10;EXOSC9;PELO;EXOSC8
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.5582831892994765,1.2673672146647668,0.21968365553602812,0.6422176534200952,1.0,1/16,0.24%,ETS1
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.5583924167297285,-1.2670145324861526,0.17777777777777778,0.6020528512556969,1.0,7/12,30.40%,ANO1;TRPM4;PPP3CB;STX4;PLA2G6;BAIAP3;GPLD1
prerank,response to glucagon (GO:0033762),-0.49069656097541947,-1.2664343770655486,0.1564625850340136,0.6021702300799969,1.0,8/19,13.35%,ADCY5;ADCY1;ADCY9;ADCY2;ADCY7;PRKACA;ADCY6;CYSLTR2
prerank,glutamine family amino acid catabolic process (GO:0009065),0.586993169678263,1.2660994049953056,0.20246478873239437,0.6447621352241493,1.0,3/13,4.55%,NOS3;DDAH1;NOS2
prerank,establishment of epithelial cell polarity (GO:0090162),0.537064422870695,1.2658857765970504,0.19725557461406518,0.6444420629049377,1.0,5/19,8.46%,CYTH1;PARD3;CYTH3;OPHN1;MSN
prerank,positive regulation of protein kinase activity (GO:0045860),0.39589258871103583,1.265600123179382,0.0998719590268886,0.6442596252823481,1.0,30/148,13.77%,PDGFB;INSR;DAB2IP;TGFB2;RAPGEF2;IL6R;LRP8;NEDD9;PTK2;MMD;CALM1;HSP90AB1;CCR7;CD4;EPHA4;CCDC88A;PAK5;RALB;EFNA1;IRGM;IQGAP1;PAK1;PDCD10;MAP4K4;RPTOR;TGFBR2;MAPRE3;LCP2;STK3;MINK1
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.5288541998852929,-1.2653075941331804,0.19222462203023757,0.6036791577591728,1.0,7/14,20.68%,DPYD;NT5E;UPB1;UPP2;NT5C1A;UMPS;ERH
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.577412195332305,1.2652964427385927,0.20871143375680581,0.6442220251258575,1.0,5/15,4.96%,KDR;PRKD2;PRKD1;TMSB4X;FGF16
prerank,photoreceptor cell development (GO:0042461),0.5875170501329153,1.2650548905113614,0.2276707530647986,0.6439622016292106,1.0,3/14,10.16%,MFSD2A;RP1;DCX
prerank,dendritic spine morphogenesis (GO:0060997),0.5723945061594244,1.264599265312979,0.2040072859744991,0.644411379888002,1.0,3/15,5.88%,SHANK3;WNT7A;DIP2A
prerank,alpha-amino acid metabolic process (GO:1901605),-0.41483062531582837,-1.2645147284025569,0.12461059190031153,0.6042647334024169,1.0,22/45,22.45%,ASPA;ATP7A;NAALAD2;ASPG;NOX4;MTHFD1;MTHFR;OAT;ALDH18A1;GOT1;GLUL;SLC25A12;GLS;GLS2;KYAT3;GPT2;DDAH2;KYAT1;KMO;GOT2;PYCR3;NAT8L
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.4525173512382207,-1.264422505906356,0.14039408866995073,0.6029497152098602,1.0,6/26,14.98%,ATP1A2;THADA;PKD2;GNB5;FMR1;GSTM2
prerank,cellular response to interferon-gamma (GO:0071346),0.4145579535575642,1.2641228964416908,0.13811420982735723,0.6448014208137419,1.0,17/88,11.07%,TRIM25;B2M;SP100;GBP7;GBP4;GBP5;IRF2;IRF9;STAT1;LGALS9;HCK;IRF5;OASL;RPL13A;MID1;PDE12;CCL1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.5880640425520648,1.264020987728111,0.21092278719397364,0.644083689534377,1.0,3/14,9.61%,TLR3;ZCCHC3;OASL
prerank,negative regulation of lymphocyte migration (GO:2000402),0.6060728924068712,1.2637776179368454,0.21083172147001933,0.643746307833706,1.0,3/10,7.98%,LRCH1;CD200;CD200R1
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.511531346293107,1.2635446891628934,0.20279720279720279,0.6434845409637214,1.0,7/25,15.04%,ETS1;TAL1;STAT1;HIF1A;BRD1;HMGB2;NCKAP1L
prerank,epithelial cell differentiation (GO:0030855),-0.3546340093789524,-1.263496375635788,0.08650519031141868,0.604053077771423,1.0,15/88,8.22%,FSTL1;MAF;FGFR2;BMP4;DAB2;SCUBE1;ANXA4;ANXA1;SIX1;FZD7;GLI1;CNN3;KDM6B;JAG1;BDH2
prerank,response to cAMP (GO:0051591),0.4873976079307597,1.2627536381409714,0.178125,0.6448044567949405,1.0,11/37,14.09%,PDE2A;RAPGEF2;RAPGEF1;RAPGEF3;KCNQ1;STAT1;RAP1B;AKAP9;ZFP36L1;HCN2;AKAP6
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.49429928806882356,-1.2624396678242789,0.19294117647058823,0.605594719019195,1.0,8/17,13.77%,NOTCH2;BMPR1A;BMP4;RBPJ;HEYL;JAG1;BMP2;SNAI1
prerank,regulation of fibrinolysis (GO:0051917),-0.5412354359036855,-1.2620900259159433,0.20398009950248755,0.605078562634386,1.0,3/13,7.03%,THBS1;FAP;THBD
prerank,regulation of membrane repolarization (GO:0060306),0.5792370681613102,1.2615311564587548,0.2247787610619469,0.6472217076050868,1.0,6/13,14.09%,CAV1;NEDD4L;KCNQ1;KCNH2;AKAP9;AKAP6
prerank,endothelial tube morphogenesis (GO:0061154),0.6200504188515482,1.261200796992317,0.20074349442379183,0.6472017613932936,1.0,7/10,13.25%,ACVRL1;PRKD2;STARD13;CTNNB1;RHOB;CCM2;CSNK2B
prerank,autonomic nervous system development (GO:0048483),0.5617064871080195,1.260785711807764,0.2195540308747856,0.6473872706525254,1.0,6/17,17.38%,KIF26A;PHOX2A;PHACTR4;SOX10;SOX11;NRP1
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.38819791840711326,1.2592798545436739,0.11325611325611326,0.6507856908081648,1.0,17/152,6.81%,ADGRL4;ADGRE5;WASF2;ADGRL2;PDE2A;ADGRL3;S1PR1;ADGRG1;GNAI2;GNAQ;RAMP2;CALCRL;GNA12;RAMP3;PRKACB;INSL3;ADCY4
prerank,T cell proliferation (GO:0042098),0.5792295639896546,1.2589106392004137,0.20864661654135339,0.6508620431120896,1.0,3/13,11.46%,CADM1;MSN;TNFRSF4
prerank,regulation of embryonic development (GO:0045995),0.4826064955045152,1.2583230101393228,0.19086460032626426,0.6515915173105702,1.0,4/34,2.13%,PLCB1;INSR;B4GALT5;SOX17
prerank,negative regulation of neurogenesis (GO:0050768),0.4837825489176888,1.2580000117886645,0.19101123595505617,0.6515113869077996,1.0,7/34,9.35%,RAPGEF2;B2M;NOTCH1;WNT7A;PTN;YWHAH;ARHGDIA
prerank,regulation of transport (GO:0051049),0.4818009434484465,1.2576761754780739,0.18341307814992025,0.6514560211089837,1.0,12/36,14.99%,ICA1;FES;EPB41;ACTB;MYO6;RAB11A;ACTG1;REEP5;ARL6IP5;WWC1;DISP3;DNAJA1
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.40164166590551625,1.257634004842452,0.12313937753721245,0.6505866784224421,1.0,13/110,6.81%,ADGRL4;ADGRE5;ADGRL2;RAPGEF2;ADGRL3;S1PR1;ADGRG1;GNAQ;RAMP2;CALCRL;RAMP3;ADRA2B;ADCY4
prerank,positive regulation of DNA recombination (GO:0045911),0.5094337196891056,1.2575914388262628,0.2025518341307815,0.6497413468112152,1.0,6/27,17.78%,TFRC;SHLD1;PRDM9;WDR48;ACTR2;FANCB
prerank,stem cell development (GO:0048864),0.5618128729325531,1.2575119568575777,0.1916376306620209,0.6490084110567972,1.0,7/16,21.44%,CDH2;WNT7A;SNAI2;SOX11;PDCD6;KBTBD8;PEF1
prerank,regulation of interleukin-1 beta production (GO:0032651),0.43218343521023983,1.2573740746691575,0.16114457831325302,0.6483873648715446,1.0,16/66,15.16%,APP;TRIM16;NOD2;GBP5;CCR7;LGALS9;AIM2;P2RX7;MALT1;CASP8;AGER;TLR8;HSPB1;TNFAIP3;GIT1;INAVA
prerank,platelet degranulation (GO:0002576),0.40470110719983826,1.2570884526980746,0.11333333333333333,0.6482184466804427,1.0,21/118,9.90%,ABCC4;PECAM1;PDGFB;TGFB2;APP;LHFPL2;SELENOP;SRGN;VWF;LYN;TMSB4X;CALM1;CFD;ACTN4;CTSW;STXBP1;ACTN1;TGFB1;QSOX1;CDC37L1;SCG3
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.513622499034778,1.2567507421191377,0.20654044750430292,0.647222395294127,1.0,8/23,17.60%,PPP1R13B;PPP3CC;YWHAH;YWHAQ;CASP8;PPP3R1;YWHAZ;YWHAB
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.513622499034778,1.2567507421191377,0.20654044750430292,0.647222395294127,1.0,8/23,17.60%,PPP1R13B;PPP3CC;YWHAH;YWHAQ;CASP8;PPP3R1;YWHAZ;YWHAB
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.5718673207209637,1.256697054586046,0.2382608695652174,0.6464214566317796,1.0,5/14,20.00%,ENTPD1;ENTPD5;NUDT9;NUDT1;NUDT16
prerank,water transport (GO:0006833),0.6018026830062664,1.2564456015222933,0.2456813819577735,0.6462111122191517,1.0,2/12,4.61%,AQP11;AQP7
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.47985250557916526,-1.2555230016701087,0.18362282878411912,0.6219913935375315,1.0,11/23,24.73%,SELENOS;HSP90B1;SYVN1;AUP1;SEC16A;LMAN1;SURF4;SEC61B;DERL1;TMED9;UFD1
prerank,acyl-CoA biosynthetic process (GO:0071616),0.5642747578180085,1.2551226978073728,0.20175438596491227,0.6491041355456906,1.0,5/16,15.75%,FASN;DIP2A;SLC25A1;HSD17B8;ACAT1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.45546315470289106,-1.2549480524161005,0.15121951219512195,0.6221581851679953,1.0,5/24,5.92%,SULF1;CCBE1;SULF2;RORA;CYP1B1
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.5620658839365862,1.2542554140274846,0.24428822495606328,0.6506377460351669,1.0,1/15,0.26%,TENT4A
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.6020516443530713,1.253773263286032,0.23597678916827852,0.6510543375318979,1.0,5/10,21.38%,SVIP;DERL2;UBAC2;UBE2G2;UBE2J1
prerank,ncRNA 3'-end processing (GO:0043628),-0.5116690386599594,-1.2534880363794245,0.20649651972157773,0.6247121877466293,1.0,9/14,36.81%,INTS8;INTS2;ERI1;PTCD1;TOE1;INTS6L;INTS5;SSB;ELAC2
prerank,peptidyl-lysine methylation (GO:0018022),-0.44813951680243613,-1.2534727319824062,0.16666666666666666,0.623147931738337,1.0,13/26,29.52%,SMYD3;EHMT2;SETD7;SETD4;EEF2KMT;TRMT112;SETD2;SETD6;KMT5A;EEF1AKMT2;SMYD2;METTL21C;ANTKMT
prerank,regulation of Rho protein signal transduction (GO:0035023),0.42930612013141417,1.253360717833256,0.14425770308123248,0.6512021358456577,1.0,20/72,10.81%,ARHGEF3;RASIP1;HEG1;NET1;F11R;ADGRG1;ARHGEF2;LPAR6;PRAG1;STARD13;STMN1;EPS8;P2RY10;EPS8L2;GPR17;OPHN1;ARHGDIA;KCTD10;PDCD10;RAC1
prerank,erythrocyte development (GO:0048821),0.6079453027263505,1.2530770010425174,0.23333333333333334,0.6510433100306681,1.0,5/10,18.67%,ALAS1;ZBTB7A;NCKAP1L;LYAR;SH2B3
prerank,regulation of stem cell proliferation (GO:0072091),-0.497104987342144,-1.2530515331486975,0.18295739348370926,0.6227858493629984,1.0,5/17,11.64%,FBLN1;GJA1;ACE;YAP1;KDM1A
prerank,regulation of cholesterol storage (GO:0010885),0.5720567418459215,1.2509035066798813,0.23893805309734514,0.6563402175937177,1.0,6/15,13.87%,PPARD;SCARB1;ABCG1;NR1H2;PPARG;MSR1
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.5746219580781347,1.2507534729779062,0.22162162162162163,0.6557956704147896,1.0,2/15,3.18%,DDC;SMOX
prerank,regulation of axon regeneration (GO:0048679),0.5880114577699022,1.2502072192491374,0.2306338028169014,0.6564033262834692,1.0,6/12,13.52%,SCARF1;EPHA4;INPP5F;PTN;CNTF;STK24
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.5103292504522756,-1.250128576776488,0.20666666666666667,0.6294677105359396,1.0,2/15,1.83%,GLI3;CD55
prerank,regulation of apoptotic process (GO:0042981),0.3475767530157542,1.2493784320988066,0.020042194092827006,0.657899970892825,1.0,83/676,9.35%,LEF1;IGF1R;TFRC;MCF2L;TEK;ITGA6;RNF144B;HIP1;ARHGEF3;TJP1;KDR;BCL2L1;DAB2IP;PPP1R13B;RASGRF2;ACER2;FAS;NET1;UNC13B;NFKBIA;SH3RF1;TBX3;FLT4;HIP1R;TNFRSF25;PLEKHG5;LRP8;PHLPP1;PLAUR;DCUN1D3;TNFSF10;ARHGEF2;PTK2;MEF2C;RYBP;KALRN;FOXO1;JAK3;FOXL2;RPS6KA1;TIAM1;ABR;TGM2;SOCS2;IKBKB;PTMA;CTNNB1;XIAP;RHOB;CAT;CD38;MRE11;ACTN4;PPIA;SOS1;GRID2;STAT1;ADAM10;TOX3;CRADD;MCL1;ARHGEF12;HCK;RNPS1;ACTN1;LCMT1;EGLN2;DNM2;IRF5;BIRC3;JMY;JUN;PREX1;RHBDD1;ARHGEF5;PIDD1;PRDM9;ARHGEF7;TRIM24;GREM1;BNIP3L;MALT1;ARHGDIA
prerank,protein phosphorylation (GO:0006468),0.3521416658214449,1.2492818394002736,0.048859934853420196,0.6571901537555117,1.0,62/478,8.08%,FLT1;IGF1R;PRKCH;TEK;ERG;PDGFB;KDR;INSR;DAB2IP;BMPR2;TGFB2;MAP4K2;APP;CDK17;FES;MAP4K3;FLT4;STK38;PKN3;PTK2;LIPE;SNRK;JAK3;ACVRL1;RPS6KA1;PRAG1;MAP3K1;STK10;PRKD2;PRKD1;CDK19;ZAP70;MERTK;LYN;FNIP2;PRKG1;IKBKB;SMAD7;PPP4R1;MAST4;CREB1;TLR3;CAMKK2;PKN1;EPHA4;LIMK2;PRKACB;AATK;FYN;PAK5;MAPK3;RPS6KA5;ADAM10;RET;PKN2;HCK;EPHB4;PXK;TLR7;MARK4;TGFB1;MAP3K6
prerank,positive regulation of insulin secretion (GO:0032024),-0.41770922177450326,-1.2482920997236036,0.17158176943699732,0.6332671217264153,1.0,9/36,10.98%,MCU;NLGN2;RBP4;IRS2;NNAT;ANO1;TRPM4;AACS;PPP3CB
prerank,cobalamin metabolic process (GO:0009235),0.5374252425312187,1.2474359639954415,0.22580645161290322,0.6614632760267064,1.0,8/17,24.55%,ABCD4;AMN;MMAA;LMBRD1;TCN2;MMACHC;MMADHC;CD320
prerank,rRNA metabolic process (GO:0016072),0.3798929103693299,1.247425288827198,0.10796915167095116,0.6605274902962748,1.0,68/160,27.94%,RPL38;RPL13;RPL36A;RPL3;RPL27;SNU13;WDR74;DHX37;RPS7;RPL9;RPLP2;RPL18;DEDD2;PDCD11;RPL13A;WDR36;MPHOSPH10;UTP3;PWP2;RPL8;RPS27;RPL19;RPS9;MRM2;NOL9;RPL11;RPS15;RPL37;TRIR;RPS28;ESF1;UTP11;RPS25;NOC4L;RPL37A;DIS3L;LYAR;NOL8;XRN1;RPL15;EXOSC10;RRP12;RPL17;RPL23;RPL34;WDR75;EXOSC9;XRN2;RPL21;NVL;DDX54;EXOSC8;RPL18A;RPL10A;RPL24;RPL7A;RPL4;BYSL;RPS2;RPL32;TBL3;RPL6;RPL14;HEATR1;DDX10;UTP4;RPL26;RPS19
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.46251122337548245,1.2473762538269877,0.18461538461538463,0.6597071762467926,1.0,9/41,10.02%,PDGFB;LRP8;NEDD9;EPHA4;FYN;FBXW7;EFNA1;TGFA;ADAM17
prerank,canonical Wnt signaling pathway (GO:0060070),0.42543645398889407,1.247330616546493,0.1563380281690141,0.6588788889035601,1.0,8/68,5.75%,LEF1;FZD6;CAV1;FZD4;WNT7A;CTNNB1;TCF7;FRAT2
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.3954418481346105,1.2472603437338463,0.13147410358565736,0.6581210520812416,1.0,22/114,12.36%,NFKBIA;TNFRSF25;TNFRSF11A;CD40;TMSB4X;IKBKB;ST18;ACTN4;STAT1;AIM2;PSMB3;BIRC3;PSMD11;PSMC6;TNFSF11;PSME2;ADAM17;EIF5A;PLVAP;TNFRSF4;PSMD8;TNFSF12
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.5838334279096211,1.2471038182046943,0.2309090909090909,0.6576031997755984,1.0,3/11,8.04%,CAV1;NEDD4L;KCNH2
prerank,brain morphogenesis (GO:0048854),0.5921921363979563,1.247010206432404,0.25471698113207547,0.6569231570262247,1.0,1/12,0.50%,SHANK3
prerank,positive regulation of establishment of protein localization (GO:1904951),0.5472469737792243,1.2470066372276332,0.24655172413793103,0.655977075660354,1.0,6/18,18.03%,CORO2B;CCT3;CCT5;CEP135;PTP4A3;CCT7
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.5429027814291049,1.246951946773573,0.23809523809523808,0.6551734305055232,1.0,5/19,7.38%,TJP1;NOTCH4;RGCC;NOTCH1;NEXMIF
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.6049286870612219,1.2468233831571314,0.22007722007722008,0.6546276016011533,1.0,4/11,5.21%,CXCL12;NOD2;MERTK;CCR7
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.49969490951090106,1.2462493327806468,0.2032520325203252,0.65525045554602,1.0,3/30,2.29%,SPTBN1;MACF1;RAB31
prerank,regulation of sister chromatid cohesion (GO:0007063),0.5838272955917363,1.2461480522269879,0.23694029850746268,0.6546050680684576,1.0,6/12,21.87%,CTNNB1;AXIN2;CTCF;RAD21;DDX11;WAPL
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.5787020222649024,1.2457403398570195,0.24444444444444444,0.654786101336053,1.0,4/13,16.79%,JAK3;PIGU;IL7R;CRLF2
prerank,apoptotic process (GO:0006915),0.3752452363620411,1.245661938489533,0.10869565217391304,0.654065865386817,1.0,23/203,6.83%,HIP1;SEMA6A;BCL2L1;TNFRSF19;APP;FAS;PPARD;TBX1;NFKBIA;ELMO1;MAL;TNFRSF25;MAGI3;FOXO1;ADAM15;TNFRSF21;ZBTB16;RHOB;PPIA;BIK;PAK5;CASP7;NCKAP1
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.4130840676855104,1.2450603513790188,0.14957264957264957,0.6547107291688035,1.0,26/86,18.62%,OCLN;APP;FES;EVL;VIL1;CLIP1;CCR7;BAIAP2;CDC42EP3;NCKAP1;HCK;CDK5RAP2;PAK1;AKAP9;RAC1;NCKAP1L;NCK1;FCHSD1;EDN1;TRPV4;BIN1;PROX1;WDR1;PRKCE;COLGALT1;TENM1
prerank,fatty acid transport (GO:0015908),0.5354209128947888,1.2448651925312608,0.22495606326889278,0.6543245664175464,1.0,2/17,1.87%,MFSD2A;PPARD
prerank,histone modification (GO:0016570),-0.33712683212299516,-1.2446464596181361,0.09634551495016612,0.6423206030425421,1.0,21/109,15.01%,EYA2;EYA1;EYA4;HDAC4;PRKCD;BAZ1B;TBL1XR1;EHMT2;MIER3;MAP3K12;KAT6B;SGF29;MORF4L2;HUWE1;USP3;PRMT8;EP300;SIRT2;BRD8;MRGBP;UBE2B
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.5132860842479336,-1.2439380458246205,0.18620689655172415,0.6427816612236392,1.0,3/16,4.31%,AUTS2;ARHGAP24;OGT
prerank,regulation of defense response (GO:0031347),0.41809459976845353,1.2439248747407912,0.1685878962536023,0.6560050887551633,1.0,15/76,10.19%,SEMA7A;IL1R1;TIRAP;LRP8;BCL6B;NOD2;TMSB4X;SAMHD1;XIAP;HCK;N4BP1;BIRC3;NLRP6;CASP8;BRD4
prerank,negative regulation of cell differentiation (GO:0045596),-0.3168862635069638,-1.2425197220495174,0.031914893617021274,0.6451225017477811,1.0,41/181,11.28%,RANBP3L;COL5A2;EGFR;LDLRAD4;ADAMTS12;COL5A1;EFEMP1;SMAD3;CRIM1;BMP5;BMP7;ENPP1;BMP4;ZFPM2;OSR1;SMAD6;ADGRV1;TGFBR1;ABCA1;WNT9A;SUFU;PPARA;CTR9;RORA;IGF2;DTX1;MEIS1;TMEM64;RUNX1T1;JAG1;LRP3;YAP1;TWIST2;ANKRD26;SPRED1;ITGAV;TRPM4;VASN;PTK2B;PTHLH;CHRD
prerank,replicative senescence (GO:0090399),-0.535123081474067,-1.2420598802297675,0.20408163265306123,0.6447917369597734,1.0,5/12,25.08%,PLA2R1;ATM;SERPINE1;WNT16;ATR
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.35873951654048686,-1.2419447330792361,0.08333333333333333,0.6435520782236022,1.0,22/79,12.61%,SULF1;BMPR1A;ADAMTS12;NBL1;CRIM1;BMPER;SLIT2;SMAD6;HTRA3;SULF2;THBS1;CASK;FGF2;RBPMS2;SMAD9;EMILIN1;SMURF2;CREB3L1;NIBAN2;CHRD;BMP2;SKI
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.47894512185552685,-1.2413242261664421,0.20803782505910165,0.6438462963024604,1.0,4/19,11.01%,IGF1;FLOT2;APOE;RTN1
prerank,glycine transport (GO:0015816),0.610830427644498,1.241143276156723,0.24665391969407266,0.6627959930309608,1.0,2/10,1.99%,SLC6A5;SLC38A5
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.4388563725792134,-1.2411431192797122,0.1658291457286432,0.642773933193833,1.0,14/27,25.10%,DDX5;PLA2R1;ATM;SPRED1;KDM1A;TWIST1;SNAI1;CD44;HIC1;KMT5A;YJU2;MSX1;ATR;SMYD2
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.5343775556845726,1.2404580803401575,0.23885918003565063,0.6638566381491364,1.0,8/19,20.57%,TERF2;HNRNPC;DCP2;ACD;TERF1;XRN1;EXOSC10;PINX1
prerank,endothelial cell differentiation (GO:0045446),0.5817811491311412,1.2403599182308624,0.24471830985915494,0.6632005494454176,1.0,5/12,7.35%,KDR;TIE1;BMPR2;ACVRL1;SOX18
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.5090923837971049,1.239695686923806,0.23013245033112584,0.6641463063525568,1.0,2/24,2.73%,ABCG2;ALAS1
prerank,nucleotide metabolic process (GO:0009117),-0.44948382547219495,-1.239343561301859,0.19329896907216496,0.646415643707172,1.0,4/23,5.16%,FHIT;NMNAT2;ME1;ENPP3
prerank,potassium ion import across plasma membrane (GO:1990573),-0.40524839785909655,-1.239261259041259,0.15151515151515152,0.6450384858420126,1.0,11/41,15.79%,ATP1A2;SLC12A2;KCNJ2;ABCC9;ATP1B3;SLC12A7;ATP1B2;KCNJ13;SLC12A4;KCNJ8;KCNJ15
prerank,glutamate metabolic process (GO:0006536),-0.4592802814609239,-1.2392503702402753,0.1964735516372796,0.643474252240699,1.0,11/19,22.32%,PRODH;OAT;ALDH18A1;GOT1;GCLC;GLUL;GLS;GLS2;GOT2;MTHFS;FPGS
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.3511294420020336,-1.239177608203878,0.12420382165605096,0.6420942675102532,1.0,22/80,20.66%,SAMD4A;PLD1;ROCK2;SLC2A13;THBS1;PRKCD;SMPD3;PLXNB2;SIRT3;FXR2;NSMAF;EIF3C;FMR1;CASP3;DDX3X;LARP6;YTHDF1;PLA2G6;LRRTM3;RPS6KB1;CIRBP;PIWIL2
prerank,diol biosynthetic process (GO:0034312),0.5573310121025217,1.2382915151724483,0.2424778761061947,0.6671907745318251,1.0,6/15,14.50%,ACER2;GCH1;ACER1;SPTLC2;SPTLC1;QDPR
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.6101654031398142,1.2382283929659896,0.23800738007380073,0.6664433900043218,1.0,3/11,4.82%,SLC19A3;NT5C3A;TPK1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.4804266765770802,-1.2380274176497026,0.1853546910755149,0.6437408070385229,1.0,1/19,0.34%,IGF1
prerank,actin polymerization or depolymerization (GO:0008154),-0.38456873019370574,-1.2379939540510738,0.14016172506738545,0.6422370414568892,1.0,10/50,7.43%,ARHGAP6;MICAL3;GAS7;GSN;MICAL2;COBL;SVIL;VILL;DIAPH1;ABI2
prerank,cellular response to amyloid-beta (GO:1904646),0.48176959672743147,1.237779927890651,0.19614147909967847,0.6667501634848757,1.0,6/35,6.34%,IGF1R;CACNA1A;APP;EPHA4;FYN;ATP1A3
prerank,cellular metal ion homeostasis (GO:0006875),-0.3406320628111244,-1.2377781882721175,0.10227272727272728,0.6413142788737751,1.0,16/102,8.24%,ATP1A2;SLC24A3;ANK2;ATP13A5;SLC41A1;STIM1;SLC8A3;SLC12A2;DMPK;ATP13A3;KCNJ2;ATP1B3;SLC8B1;ATP1B2;SLC8A1;PTH1R
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.47322629994722176,1.2377163482093951,0.19611021069692058,0.6659681547097903,1.0,9/38,10.81%,INSR;CD34;CAV1;DDAH1;KLF2;HSP90AB1;KLF4;AGTR2;RAC1
prerank,keratan sulfate biosynthetic process (GO:0018146),0.49397254386979766,1.2374769769382383,0.21788617886178863,0.6656734235912612,1.0,5/26,4.25%,ST3GAL6;ST3GAL1;B4GALT5;B4GALT4;B3GNT2
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.43168682370760464,1.237408877544989,0.16235632183908047,0.6649180739467634,1.0,11/67,6.13%,MYO10;PPP1R16B;PODXL;CAV1;TBC1D14;TBC1D22A;TBC1D2;CCR7;USP6NL;TBC1D24;TBC1D5
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.46476457184059305,1.2357611377638331,0.21870047543581617,0.6687256326976188,1.0,8/33,15.04%,ETS1;FES;TAL1;STAT1;HIF1A;BRD1;HMGB2;NCKAP1L
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.5089322779293456,-1.2348863995803,0.2,0.6481435865063938,1.0,5/15,17.54%,BMP4;SMO;SIX1;SIX4;PAX2
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.4675052193477417,1.2342728890827641,0.2132701421800948,0.6719780012678649,1.0,12/39,22.10%,POLK;NTHL1;GTF2H2;GTF2H4;FAN1;RBX1;RPA1;POLD1;DDB1;GTF2H3;RFC2;ERCC4
prerank,B cell receptor signaling pathway (GO:0050853),0.47561530577961053,1.2341601767653019,0.21986970684039087,0.6713197178017248,1.0,11/32,15.63%,MEF2C;CD19;CD38;PLEKHA1;CD79A;PRKCB;SYK;RFTN1;SH2B2;NCKAP1L;LAT2
prerank,urogenital system development (GO:0001655),-0.5458389167230224,-1.2340907884193881,0.2328159645232816,0.6487704678790226,1.0,3/11,7.27%,OSR1;ANXA1;EPHB2
prerank,male gonad development (GO:0008584),0.47646313569668686,1.2339919709671174,0.21540880503144655,0.6708528120307703,1.0,6/34,11.00%,KITLG;TGFB2;BIK;COL9A3;NCOA4;LRP2
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.5874896035209866,1.2337749689349824,0.22644927536231885,0.6705465951246519,1.0,5/11,16.60%,PLAUR;LYN;TNFSF11;SYK;ANK3
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.4536490652007546,-1.233105387087803,0.17848970251716248,0.6500733023809055,1.0,7/22,14.06%,MDFIC;APOD;SUFU;ITGB1BP1;LRRK2;DMTN;LMAN1
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.4840380085097711,1.2330082454348998,0.19934640522875818,0.6718015327038734,1.0,9/29,18.50%,CXCL12;JAM2;CCR7;LGALS9;AGER;CCL1;GAS6;CCR2;MOSPD2
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.5435057860257476,-1.2323730928514058,0.22321428571428573,0.650732841933164,1.0,6/11,14.50%,P4HA1;EGLN3;P4HTM;P3H2;OGFOD1;P4HB
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),-0.39600284905269634,-1.2320860311813615,0.1239193083573487,0.6499689930469731,1.0,11/46,15.64%,ZIC1;SMAD3;CDH1;PRKCD;FLNA;UBR5;EMD;PSEN1;BAG3;PIK3R1;CAMK1
prerank,neuron projection extension (GO:1990138),-0.41428630006916933,-1.2318034486684002,0.18316831683168316,0.6492585121513147,1.0,9/32,14.82%,ALCAM;AUTS2;IMPACT;ULK2;FLRT1;SPG11;PPP3CB;CDKL3;USP9X
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.3756746371395144,1.2317522052904102,0.13583441138421734,0.6744180839669512,1.0,27/158,10.42%,TFRC;TNFRSF19;TIRAP;PLEKHG5;TRIM25;TRIM14;TNFSF10;NOD1;CD40;NOD2;PELI1;PRKD1;ATP2C1;IKBKB;CCR7;CD4;LGALS9;BIRC3;BST2;MAP3K3;MALT1;NDFIP2;UBE2V1;CASP8;BRD4;LAMTOR5;SHARPIN
prerank,positive regulation of protein binding (GO:0032092),0.4418209568444133,1.231530546121804,0.16920731707317074,0.6741095877283895,1.0,12/56,8.50%,CLDN5;RAPGEF2;APP;CAV1;HIP1R;B2M;EPB41;TIAM1;MEN1;RALB;PIN1;MARK3
prerank,B cell differentiation (GO:0030183),0.4483291927150063,1.2314851777044036,0.1933028919330289,0.6732911046913781,1.0,16/46,17.53%,TPD52;PTPRJ;JAK3;HDAC9;HHEX;SLC25A5;KLF6;CD79A;ADAM17;ZBTB7A;HDAC5;VCAM1;DNAJB9;MSH2;ITGA4;ADGRG3
prerank,inorganic cation transmembrane transport (GO:0098662),-0.296119947266397,-1.2311523091490006,0.03333333333333333,0.6495801949648939,1.0,31/268,5.45%,ATP1A2;SLC24A3;TRPM3;CACNA1C;KCNK2;NALCN;SLC6A13;SLC1A3;SLC41A1;SCN7A;SCARA5;SLC6A12;PKD1;SLC30A10;KCNK5;SLC8A3;SLC6A9;SLC12A2;ANO6;SLC39A14;SLC9A2;KCNJ2;TRPC3;PKD2;CACNA1G;TRPM6;ABCC9;ATP6V0A4;ATP1B3;SLC6A1;KCNQ4
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.37177903337706447,1.2306440733276234,0.1060419235511714,0.6748376359285468,1.0,29/182,8.25%,SLC7A5;OCLN;CLDN5;PDGFB;KDR;CD34;ENG;TGFB2;APP;XDH;MEF2C;ANKRD13A;ACVRL1;APLNR;NOTCH1;RIN3;NOS2;GATA2;NOCT;DLL4;HSP90AB1;DIP2A;LGALS9;FBXW7;ADAM10;KLF4;HINFP;TGFB1;TERF2
prerank,response to cytokine (GO:0034097),0.3866445425828857,1.2304820453287466,0.14285714285714285,0.6743647384267396,1.0,28/141,9.01%,LEF1;BCL2L1;APP;IL1R1;MAP4K3;IL6R;GCH1;TNFRSF11A;SP100;IFNAR2;CD40;JAK3;PTPN12;SIGIRR;OSMR;ADAR;CCR7;XAF1;STAT1;LGALS9;ADAM10;MCL1;BST2;CRNN;SHMT2;IRAK2;PTPN5;LIFR
prerank,gluconeogenesis (GO:0006094),-0.39999522981740837,-1.2301216929246943,0.14910025706940874,0.6509854248203856,1.0,12/39,22.12%,RBP4;SLC39A14;PPARGC1A;PER2;MDH2;GOT1;SLC25A12;ALDOA;ENO2;GOT2;PGK1;ENO3
prerank,negative regulation of cell motility (GO:2000146),0.40003510332738396,1.2298884718197511,0.15485564304461943,0.6750811044953701,1.0,15/108,5.69%,LIMCH1;DACH1;FRMD5;CLDN5;SRGAP3;SRGAP2;SRGAP1;ENG;PTPRJ;ADAM15;ACVRL1;DUSP3;SMAD7;RHOB;EPHA4
prerank,response to ketone (GO:1901654),0.5062330052962944,1.2297484921465167,0.23214285714285715,0.6745430408695517,1.0,5/24,7.94%,ABHD2;TGFB2;CAV1;CCR7;TGFB1
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.434580859099281,-1.2293801316297104,0.20843091334894615,0.6514892604202734,1.0,3/26,2.08%,EYA2;EYA1;EYA4
prerank,protein localization to cell periphery (GO:1990778),0.3865544385735156,1.2291788206513232,0.13583441138421734,0.6751841005221572,1.0,25/133,11.37%,EFR3B;BSG;SPTBN1;RAPGEF2;TSPAN5;CAV1;F11R;FGF13;TSPAN14;RAMP2;IKBKB;RAMP3;DENND4C;MAP7;STXBP1;RAB11A;FCHO2;RAB34;TMEM88;SMURF1;PACS1;ZDHHC22;RAB3B;RAB40C;EHD4
prerank,positive regulation of embryonic development (GO:0040019),0.5222597763227231,1.2291292860967915,0.2614601018675722,0.6743975872638531,1.0,2/19,1.98%,PLCB1;B4GALT5
prerank,positive regulation of response to external stimulus (GO:0032103),0.39019202896281296,1.2290946775379914,0.1423027166882277,0.6735627960162381,1.0,20/128,11.24%,ETS1;PDGFB;PDE2A;APP;SCARF1;NFKBIA;STX3;GBP5;HYAL2;MGST2;TLR3;ZCCHC3;TLR7;PTN;TGFB1;OASL;CNTF;CCL1;TLR8;S100A8
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.5344332966019494,1.2290747637035635,0.23898305084745763,0.6726967202472118,1.0,5/19,4.65%,SEMA6A;JCAD;DAB2IP;XDH;TSPAN12
prerank,negative regulation of mitochondrion organization (GO:0010823),0.4712456680172502,1.2288252702637865,0.2238562091503268,0.6724395657994627,1.0,5/33,10.27%,TFRC;BCL2L1;SLC25A5;VAT1;GHITM
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.5113859959898422,-1.2288170170926078,0.21330275229357798,0.6516369618731749,1.0,3/13,8.96%,TNRC6A;AGO2;TNRC6B
prerank,entry into host (GO:0044409),0.5640502281991314,1.2285573223185373,0.24156305506216696,0.67229616439593,1.0,6/13,10.39%,GRB2;CTNNB1;CTNND1;CD4;PPIA;CBLL1
prerank,negative regulation of MAPK cascade (GO:0043409),0.40457140908675077,1.2281978020542317,0.17270194986072424,0.6723622131037262,1.0,16/87,8.39%,SEMA6A;DAB2IP;CAV1;CNKSR3;STK38;PTPRJ;FOXO1;DUSP7;DUSP3;LYN;HYAL2;PPIA;PTPRR;PIN1;ABCA7;P2RX7
prerank,sterol transport (GO:0015918),0.5242896924222858,1.2277180236522485,0.2292768959435626,0.6727593280246813,1.0,4/19,13.87%,CAV1;OSBP;NPC1;MSR1
prerank,negative regulation of protein catabolic process (GO:0042177),-0.40410010694548915,-1.2275607965255892,0.1585014409221902,0.6535950518354354,1.0,8/40,6.74%,EGFR;TIMP2;TIMP3;PTPN3;MDM4;SNX12;FLNA;SNRNP70
prerank,negative regulation of apoptotic process (GO:0043066),0.3456817568753866,1.2273562919651264,0.06652126499454744,0.6728106624133995,1.0,99/444,18.03%,LEF1;IGF1R;TFRC;PRKCH;TEK;NDNF;RNF144B;TJP1;KDR;BCL2L1;CAV1;FAS;TBX1;NFKBIA;SH3RF1;TBX3;FLT4;PLAUR;PTK2;MEF2C;FOXO1;RPS6KA1;NOTCH1;MERTK;SOCS2;IKBKB;PTMA;CTNNB1;XIAP;SNAI2;CAT;CD38;MRE11;MAPK3;ADAM10;RETREG1;KLF4;TOX3;MCL1;HCK;POU3F4;BIRC3;RHBDD1;PIDD1;PRDM9;GREM1;BNIP3L;MALT1;ARHGDIA;FOXQ1;MGMT;PDCD10;LAMTOR5;KLHL20;PTRH2;CNTF;THOC6;LRP2;MAP4K4;HSPB1;TLE1;UFM1;CIAPIN1;NAA16;HIGD1A;MAEA;MAG;SOX9;CFL1;PIM2;AREL1;ANGPTL4;PRDX5;HIPK3;DNAJA1;NCKAP1L;UNC5B;PLK2;ERC1;OPN3;DSTYK;MAPK1;MSH2;PTPRZ1;PROC;HMGA2;YWHAZ;COPS5;DNAJB6;GAS6;TRIAP1;SERPINB9;CBL;TFAP2A;UBE2Z;BFAR;HSPA9;PAK2;PRKCG
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.4495380162439451,1.2273557806938826,0.2175226586102719,0.6718944287542359,1.0,8/43,7.99%,ETS1;PDGFB;TGFB2;PPARD;GATA2;KLF4;TGFB1;JUN
prerank,regulation of immune response (GO:0050776),0.3854423993512728,1.2270874369510094,0.14566929133858267,0.6717014661950979,1.0,25/135,12.14%,CD34;TGFB2;CLEC2D;TIRAP;CD200;LRP8;B2M;CD40;LYN;ICAM2;SAMHD1;CD19;PILRA;XIAP;PVR;N4BP1;BIRC3;CD160;CD200R1;FOXP3;CD8B;CASP8;DENND1B;KIR3DL2;SYK
prerank,regulation of calcium ion transport (GO:0051924),-0.37988077523598385,-1.2265603400169836,0.15249266862170088,0.6549306582168396,1.0,13/54,8.86%,ANK2;MYLK;STIM1;IL16;CACNA2D1;PKD2;EFHB;SLC8B1;P2RX4;CACNA1D;BCL2;TRPC6;SARAF
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.47660634772918564,-1.226525803255138,0.20044543429844097,0.6535108456450147,1.0,9/18,29.96%,EHMT2;SETD7;SETD4;SETD2;EEF1AKMT2;SMYD2;SETMAR;SETD1B;KMT2A
prerank,protein localization to membrane (GO:0072657),0.37146043167799664,1.2264400593374034,0.13681592039800994,0.6726039329716212,1.0,37/187,12.31%,EFR3B;BSG;SHANK3;SPTBN1;RAPGEF2;TSPAN5;CAV1;F11R;AGRN;FGF13;TSPAN14;RAMP2;IKBKB;RAMP3;DENND4C;ABHD17A;MAP7;STXBP1;RAB11A;LRRC7;FCHO2;PTN;RAB34;TMEM88;NPC1;NRXN1;SMURF1;PACS1;ZDHHC22;RAB3B;FERMT2;RAB40C;EHD4;NUP54;SH3GLB1;HGS;RFTN1
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.4868799921583944,-1.2258466348338186,0.20794392523364486,0.6540862276297154,1.0,6/17,9.98%,ATP1A2;CACNA1C;GJA1;ATP1B2;SLC8A1;PRKACA
prerank,nucleotide-sugar metabolic process (GO:0009225),0.5852552622458327,1.2256595185593624,0.23486238532110093,0.6739089589969322,1.0,2/12,1.97%,CSGALNACT1;FUT8
prerank,anion transport (GO:0006820),0.4846416238156517,1.2254597066466675,0.2016260162601626,0.6734917932651726,1.0,4/33,2.52%,ABCG2;SLCO2B1;LRRC8B;LRRC8C
prerank,regulation of erythrocyte differentiation (GO:0045646),0.4660514078136228,1.2253358579156135,0.21859706362153344,0.6729199840051374,1.0,10/35,15.04%,ETS1;ZFPM1;LYN;TAL1;STAT1;ZFP36L1;HIF1A;BRD1;HMGB2;NCKAP1L
prerank,positive regulation of immunoglobulin production (GO:0002639),0.48060169171019707,1.2252830786792,0.20361990950226244,0.6721583668093499,1.0,1/31,0.14%,TFRC
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.592949499173568,1.2250481757029243,0.2581227436823105,0.6719184966156729,1.0,2/10,5.72%,RNF125;SEC14L1
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.5184514820318269,-1.2241664043860863,0.212253829321663,0.6573578769512497,1.0,2/13,1.84%,GLI2;BMP4
prerank,positive regulation of protein polymerization (GO:0032273),0.42591552176551406,1.2241039095822277,0.18960244648318042,0.6736934113875972,1.0,20/65,18.62%,OCLN;FES;EVL;CLIP1;CCR7;BAIAP2;CDC42EP3;NCKAP1;HCK;CDK5RAP2;PAK1;AKAP9;RAC1;NCKAP1L;NCK1;FCHSD1;BIN1;TPPP;PRKCE;TENM1
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.5606779324660199,1.2236485735095897,0.22634508348794063,0.6740444333360037,1.0,1/14,0.33%,SEMA7A
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.5242065626904082,1.223512566312992,0.22448979591836735,0.6735140758215836,1.0,10/21,17.86%,NES;CTNNB1;DLL4;DCT;INSM1;DISC1;LRP2;DISP3;TOX;PROX1
prerank,cellular component assembly (GO:0022607),0.35712432806700695,1.2233743893155462,0.10844748858447488,0.6729892500761578,1.0,58/253,16.60%,OCLN;SLC2A1;PARVB;SPTBN1;LIMS2;SHROOM1;FAS;MAGI1;NEDD9;CD40;PARD3;CD2AP;PLS3;ACTB;VIL1;WNT7A;EPS8;BAIAP2;CARD10;RP1;ABCA3;FAM107A;PARVG;NCKAP1;CLDN14;TTLL3;TGFB1;OPHN1;QSOX1;CAPG;ACTG1;CYFIP1;PDCD10;DCX;RSPH4A;RAC1;FERMT2;ACD;PEX14;FSCN3;CHAF1A;RANBP9;RSPH1;SOX9;FSCN1;FOXJ1;RHOV;SH3BGR;NCKAP1L;ELOB;NLGN1;HAS3;APC;CHAF1B;BAG6;IL1RAP;YWHAZ;ANK3
prerank,negative regulation of growth (GO:0045926),0.3870570529988247,1.222797164279791,0.16535433070866143,0.6736511526038264,1.0,30/121,13.76%,APBB2;BMPR2;TGFB2;SH3BP4;SOX17;DCUN1D3;PTPRJ;SMARCA2;SIPA1;ADAM15;ACVRL1;CCDC85B;NOTCH1;PPP1R9B;HYAL2;WFDC1;BST2;TGFB1;NPR1;BTG1;AGTR2;NAIF1;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.6136509400046766,1.2213200557169608,0.24772313296903462,0.6766418997386161,1.0,7/10,30.25%,SMAD7;FOXP3;MALT1;NFKBID;ZC3H12A;RC3H2;NFKBIZ
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.4287038780326132,1.2211841257709948,0.17194570135746606,0.6761354175383489,1.0,23/59,23.18%,DAB2IP;NFKBIA;IKBKB;TLR3;BIRC3;TLR7;FAIM;IRAK2;SHARPIN;TLR8;BCL10;ERC1;CARD11;NKIRAS1;RELB;TBK1;RBCK1;AZI2;TBKBP1;TICAM2;TRAF6;RIPK1;PRDX4
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.46841556894280023,1.2209396858605712,0.20569620253164558,0.6759077493847409,1.0,10/39,9.07%,KDR;TIE1;ENG;RASIP1;NOTCH4;CTNNB1;DLL4;COL4A1;LRP5;PAK1
prerank,mitotic chromosome condensation (GO:0007076),0.49204131294038295,1.2207629039332735,0.21669341894060995,0.6755136249743054,1.0,8/26,18.92%,TENT4A;NCAPH;MCPH1;NCAPG;CSNK2B;TTN;SET;NCAPH2
prerank,regulation of ATP biosynthetic process (GO:2001169),-0.48329448188246804,-1.2193475767166124,0.22972972972972974,0.6700566795009006,1.0,3/16,5.33%,PID1;PPARGC1A;PPARA
prerank,positive regulation of dendritic spine development (GO:0060999),0.5271235167982404,1.2193051222862257,0.24315068493150685,0.6785876220799648,1.0,3/20,6.17%,SHANK3;LRP8;DBNL
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.5844374909187442,1.2192528976959491,0.26737967914438504,0.6778170937712159,1.0,4/11,8.93%,TGFB2;MEF2C;TGFB1;GREM1
prerank,carbohydrate derivative catabolic process (GO:1901136),0.5275384196334807,1.2191342676789605,0.2551369863013699,0.6772366629608495,1.0,9/18,20.27%,SAMHD1;OGA;NEU4;STT3B;FBXO6;MANBA;NEU2;FBXO2;AOAH
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.4632512706723413,1.2189590027350556,0.2347417840375587,0.6768077415932512,1.0,11/37,22.10%,POLK;NTHL1;GTF2H2;GTF2H4;RBX1;RPA1;POLD1;DDB1;GTF2H3;RFC2;ERCC4
prerank,positive regulation of interleukin-10 production (GO:0032733),0.47202975908839434,1.2188637118206844,0.2296416938110749,0.6761991644696781,1.0,5/30,15.16%,CD34;NOD2;LGALS9;SYK;INAVA
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.40232236923384546,-1.218665503509186,0.1883656509695291,0.670478383461426,1.0,16/35,24.36%,DDX5;PPARGC1B;AR;NR3C2;UBR5;YAP1;DDX17;ESR1;PGR;CALCOCO1;RNF14;ESR2;GPER1;NEDD4;UBE3A;ZMIZ1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.5044504402469187,1.2185169256641941,0.24253075571177504,0.6763144293635817,1.0,3/24,5.18%,BCL2L1;CXCL12;SNAI2
prerank,positive regulation of dephosphorylation (GO:0035306),0.48957669325970715,1.2180789298553445,0.22698412698412698,0.6765922120187489,1.0,8/27,13.96%,PPP1R16B;CALM1;PPIA;PPP2R5A;TGFB1;PIN1;NSMF;CDH5
prerank,purine ribonucleotide catabolic process (GO:0009154),0.5158652400594671,1.2179586643394191,0.23793103448275862,0.6760320300121909,1.0,8/21,11.16%,PDE2A;XDH;HPRT1;PDE4D;HINT1;NT5C2;NUDT3;PNP
prerank,negative regulation of hydrolase activity (GO:0051346),0.4379428941734128,1.217554038374256,0.21846153846153846,0.6762557677817896,1.0,11/49,12.94%,LRCH1;DAB2IP;SH3BP4;F11R;FICD;TERF2;CST7;PLXNB3;HRAS;EGLN1;PPP1R35
prerank,neuropeptide signaling pathway (GO:0007218),0.43195405686939325,1.2168314036482892,0.19411764705882353,0.6774372403520145,1.0,14/58,19.77%,RAPGEF2;HCRTR1;NPPA;SORT1;SORCS1;HCRTR2;CYSLTR1;PPY;RXFP3;OPRD1;SSTR1;NTS;CPE;GLRA2
prerank,response to fatty acid (GO:0070542),-0.47918206418155496,-1.2166725590728589,0.2044334975369458,0.6747847091399122,1.0,2/17,2.50%,PID1;IRS1
prerank,carbohydrate homeostasis (GO:0033500),0.423552728165462,1.2162755635873934,0.18658892128279883,0.6781109630817138,1.0,5/67,5.05%,IGF1R;INSR;ADIPOR2;KLF7;CYP11B1
prerank,protein polyglutamylation (GO:0018095),0.5801125178894728,1.2161094465966182,0.2573913043478261,0.6776613485987413,1.0,2/11,5.36%,TTLL7;TTLL5
prerank,protein catabolic process (GO:0030163),0.4262751267739547,1.2158867276760807,0.19827586206896552,0.6774612320078534,1.0,20/59,18.27%,DAB2IP;DENND3;OGA;NEU4;STT3B;UBE2G1;TRIM24;HSPA8;CEACAM1;FBXO6;MANBA;NEU2;CLN8;PSMA8;ATE1;BAG6;FBXO2;UBE2G2;USE1;SIAH1
prerank,"base-excision repair, AP site formation (GO:0006285)",0.5440909164534031,1.2158500222249962,0.266304347826087,0.6766696690484895,1.0,6/17,12.39%,NTHL1;TERF2;MPG;SMUG1;ACD;TERF1
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.5940037863517845,1.2155832785225276,0.2676056338028169,0.6765339606132192,1.0,5/10,17.37%,DAB2IP;EPHA4;EFNA1;RGP1;NELL1
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.36687064417752174,-1.2154078955418228,0.1686046511627907,0.6770231579138426,1.0,8/57,6.12%,LPAR1;ADCY5;ADCY1;ADCY9;AKAP12;ADCY2;ADCY7;FLNA
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.46948064558809094,1.2151001354509368,0.23659305993690852,0.6769956773842448,1.0,7/35,9.65%,DAB2IP;RASIP1;TGFB2;HEG1;STMN1;STMN3;KCTD10
prerank,positive regulation of response to wounding (GO:1903036),0.4947043736777177,1.215032070977636,0.23255813953488372,0.6763074346900929,1.0,8/24,11.71%,OCLN;SCARF1;PTK2;INSL3;PTN;ACTG1;CNTF;HRAS
prerank,positive regulation of lamellipodium organization (GO:1902745),0.4780427512305933,1.2149745421791955,0.2304,0.6756010968293584,1.0,11/32,10.81%,OCLN;WASF2;VIL1;RREB1;NCKAP1;TWF2;ARHGEF7;ENPP2;CYFIP1;CLRN1;RAC1
prerank,regulation of cell differentiation (GO:0045595),0.3754646625317981,1.214834348222984,0.14522292993630573,0.6751522448420672,1.0,20/148,8.98%,SPOCK2;SLC6A6;LTBP4;NOTCH4;FES;TBX1;PTK2;BCL6B;RPS6KA1;TIAM1;SMAD7;HSP90AB1;SNAI2;KLF4;INSM1;TGFB1;YWHAH;CDK5RAP2;GREM1;CEBPD
prerank,lymphocyte differentiation (GO:0030098),0.4100600938368563,1.2147667946943104,0.1853448275862069,0.6744611604862399,1.0,25/68,17.53%,JAG2;TPD52;PTPRJ;JAK3;HDAC9;ZAP70;HHEX;DLL4;SLC25A5;CD4;KLF6;CD79A;ADAM17;ZBTB7A;GPR89A;GPR89B;HDAC5;TOX;VCAM1;IKZF1;DNAJB9;MSH2;ITGA4;RELB;ADGRG3
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.5242349254853808,1.2145012049514567,0.2126126126126126,0.6743425991226579,1.0,4/20,11.69%,BCL2L1;FAS;MCL1;GSK3A
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.49593148402842324,-1.2143592179747384,0.21797752808988763,0.6784733240027606,1.0,2/14,5.39%,AUTS2;CTR9
prerank,positive regulation of metabolic process (GO:0009893),0.39149268033300744,1.2139901317391184,0.15595075239398085,0.6748629360813774,1.0,12/103,7.46%,IGF1R;EPAS1;INSR;ADIPOR2;GATM;CAV1;FASN;UCP2;OXTR;ACACB;YBX2;IL4R
prerank,atrial septum morphogenesis (GO:0060413),0.5886012272406194,1.213290677481921,0.24858757062146894,0.6758615596772563,1.0,3/10,3.22%,BMPR2;TGFB2;ZFPM1
prerank,positive regulation of interferon-alpha production (GO:0032727),0.5161187266386017,1.2128822403483794,0.23725834797891038,0.6761522284973837,1.0,6/19,11.18%,IFIH1;TLR3;STAT1;IRF5;TLR7;TLR8
prerank,proteoglycan biosynthetic process (GO:0030166),0.48232476351415654,1.212259374563012,0.2193126022913257,0.6770532814948494,1.0,4/31,2.85%,CSGALNACT1;BMPR2;EXTL3;CHST11
prerank,regulation of multicellular organismal development (GO:2000026),0.4975851259085906,1.2121680507110981,0.2547008547008547,0.6764110420821938,1.0,4/25,9.93%,INSR;SOX17;PTN;MYSM1
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.5840805137832158,1.211804799105867,0.25985663082437277,0.6764901339527236,1.0,5/11,24.38%,NPPA;AKAP6;KCNIP2;ALG10B;LRRC55
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.480868898128189,1.2111550648727099,0.2413223140495868,0.6774069007868041,1.0,4/29,5.11%,IFNAR2;NLRC5;SAMHD1;HSP90AB1
prerank,protein localization to plasma membrane (GO:0072659),0.3832054827019136,1.2110458786356633,0.16294349540078842,0.6768503684965651,1.0,25/129,11.37%,EFR3B;BSG;SPTBN1;RAPGEF2;TSPAN5;F11R;FGF13;TSPAN14;RAMP2;IKBKB;RAMP3;DENND4C;CCDC88A;MAP7;STXBP1;RAB11A;FCHO2;RAB34;TMEM88;SMURF1;PACS1;ZDHHC22;RAB3B;RAB40C;EHD4
prerank,cellular response to cAMP (GO:0071320),0.4888226100507276,1.211012924170656,0.22167487684729065,0.6760785032324877,1.0,12/30,17.80%,PDE2A;RAPGEF2;RAPGEF1;RAPGEF3;KCNQ1;RAP1B;AKAP9;ZFP36L1;HCN2;AKAP6;CRHBP;SLC26A3
prerank,leukocyte cell-cell adhesion (GO:0007159),0.4999969243063773,1.2108309471393839,0.2461799660441426,0.6757402918011168,1.0,8/24,20.41%,PECAM1;F11R;MSN;SYK;VCAM1;ITGA4;TNIP1;SEMA4D
prerank,regulation of interleukin-8 production (GO:0032677),0.40985504548821083,1.2101706684010827,0.18862275449101795,0.676683270465936,1.0,17/69,14.16%,TIRAP;AFAP1L2;NOD1;NOD2;PRKD2;TMSB4X;NOS2;HYAL2;TLR3;LGALS9;KLF4;TLR7;LAMTOR5;TLR8;SYK;RAB1A;BCL10
prerank,O-glycan processing (GO:0016266),0.42729530328309784,1.209741966213691,0.20808383233532934,0.6770670914770254,1.0,7/54,7.56%,ST3GAL1;B4GALT5;ST6GALNAC2;MUC3A;MUC3B;B3GNT2;ST6GAL1
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.45716215921968817,1.209657304910976,0.22919937205651492,0.6764612929691705,1.0,7/40,4.78%,LEF1;TGFB2;RGCC;TIAM1;NOTCH1;CTNNB1;WWTR1
prerank,negative regulation of nuclear division (GO:0051784),-0.5277296236437375,-1.2095808291449572,0.24411134903640258,0.6911227901811222,1.0,6/11,23.54%,BMP7;BMP4;TOM1L2;NME6;AURKAIP1;TOM1L1
prerank,negative regulation of phosphorylation (GO:0042326),-0.339709619069594,-1.2093085452294785,0.1678082191780822,0.6903747554829965,1.0,16/85,8.05%,PID1;PTPN13;NTRK3;PLPP3;FBLN1;BMP7;BMP4;NUPR1;SLIT2;HDAC4;IMPACT;PPARA;IRS2;PRKN;EPHB2;IGFBP3
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.5372850633053075,-1.2085013119581813,0.2535496957403651,0.6912226486211933,1.0,4/10,10.86%,GFPT1;PFKP;HK2;GFPT2
prerank,microvillus organization (GO:0032528),0.5574167250836992,1.208193290598202,0.28222996515679444,0.6797183055883066,1.0,5/13,14.83%,RAPGEF2;RAP1B;MAP4K4;MINK1;STK26
prerank,positive regulation of inflammatory response (GO:0050729),0.3987221114490811,1.2080564350541927,0.18571428571428572,0.6792622782527786,1.0,9/86,7.31%,ETS1;PDE2A;APP;NFKBIA;OSMR;HYAL2;MGST2;TLR3;TLR7
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.5149050519500924,-1.2080473162806034,0.24263038548752835,0.6910217919350349,1.0,4/13,11.21%,CYFIP2;ASPH;PERP;TBC1D10A
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.5383488123858042,1.2076803247970223,0.28846153846153844,0.6794583752876214,1.0,7/16,24.49%,CAV1;INPP5F;ADIPOR1;HGS;SH2B3;SOCS1;PARP14
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.4411927770142036,-1.2076425840253566,0.20149253731343283,0.6905980098775548,1.0,11/26,19.69%,ADCY5;EFNA5;STXBP4;ANO1;CDK16;TRPM4;PPP3CB;STX4;PLA2G6;ADRA2A;NR1H4
prerank,liver development (GO:0001889),-0.4173618710623593,-1.2075771056213602,0.1925,0.6892264335817249,1.0,7/32,9.91%,TGFBR3;WNT4;COBL;PKD2;ANXA1;MET;CEBPB
prerank,negative regulation of viral process (GO:0048525),0.43258466342324525,1.2074788242965628,0.2113323124042879,0.6791770370682717,1.0,16/57,18.44%,TRIM14;IFIH1;BTBD17;PPIA;STAT1;N4BP1;BST2;OASL;BANF1;SLPI;ZC3HAV1;TRIM26;MBL2;TRIM11;PROX1;TNIP1
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.4488421715955576,-1.207323632791104,0.1927710843373494,0.6884216132110123,1.0,4/22,7.11%,UGGT2;MAN1C1;AMFR;MAN1A2
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.38270048468306034,-1.206673410180408,0.17563739376770537,0.6887522604641272,1.0,15/43,12.50%,BMP6;IGF1;BMPR1A;WNT4;BMP7;BMP4;RUNX2;CCN1;LRP3;YAP1;CCN4;IFITM1;BMP2;NPNT;FBN2
prerank,regulation of peptide hormone secretion (GO:0090276),0.41544387867356924,1.2060109642437484,0.2108345534407028,0.6821997359726134,1.0,9/67,5.78%,SLC2A1;CACNA1A;STX1A;RAPGEF3;NOS2;KCNC2;RAPGEF4;SYT7;KCNG2
prerank,peptidyl-lysine trimethylation (GO:0018023),-0.419152115085404,-1.2058493867847915,0.21040189125295508,0.6897243914263438,1.0,12/26,29.96%,OGT;CTR9;SETD4;KMT5C;EEF2KMT;SETD5;KMT5B;SETD2;METTL21C;SETD1B;ANTKMT;KMT2A
prerank,membrane fusion (GO:0061025),0.4681271755953718,1.205517690602851,0.23615635179153094,0.6825989180652543,1.0,2/33,2.18%,DNM3;DYSF
prerank,negative regulation of viral genome replication (GO:0045071),0.4503741822187509,1.2046802810893955,0.2310177705977383,0.6842009816005947,1.0,13/40,18.44%,IFIH1;BTBD17;N4BP1;BST2;OASL;BANF1;TASOR;SETDB1;SLPI;ZC3HAV1;HMGA2;PROX1;TNIP1
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.5061609022134091,-1.2046646051921972,0.2330508474576271,0.6915347786742028,1.0,7/13,23.89%,IRS1;IGF2;SNX5;ECHDC3;ZBTB7B;PRKCZ;C1QTNF12
prerank,negative regulation of proteolysis (GO:0045861),-0.4023463205868371,-1.2039130182376405,0.17708333333333334,0.6920768422893283,1.0,8/34,11.89%,TIMP2;TIMP3;PTPN3;GAS1;SNX12;ECM1;CLN3;LRRK2
prerank,regulation of multicellular organism growth (GO:0040014),0.5406835989321386,1.2033496191267357,0.27167630057803466,0.6871093731787443,1.0,2/15,1.56%,MFSD2A;APP
prerank,T cell receptor signaling pathway (GO:0050852),0.37683598855088607,1.2030367370079795,0.17564102564102563,0.6870872710155538,1.0,45/138,23.67%,INPP5D;PTPRJ;PRKD2;ZAP70;TNFRSF21;PLCG1;IKBKB;PDE4D;MOG;CD4;FYN;PSMB3;PSMD11;PDE4B;PSMC6;PAK1;MALT1;PSME2;EIF2B1;DENND1B;EIF2B2;PSMD8;RFTN1;PIK3CB;LCP2;PSMB10;BCL10;CARD11;NCK1;PSMA8;SKP1;SPPL3;PAK2;PSMD9;RBCK1;SKAP1;FYB2;PLCG2;CUL1;PSMD1;PSMC3;TRAT1;TRAF6;PSMD10;NFKBID
prerank,regulation of cellular protein localization (GO:1903827),-0.38068940321147127,-1.2025647145250664,0.17765042979942694,0.6945344805531117,1.0,5/45,4.60%,GPC6;PRKAA2;GPC3;GBF1;GPC4
prerank,protein polymerization (GO:0051258),-0.3694752398289911,-1.202262448968098,0.1524390243902439,0.6938218134548724,1.0,9/55,9.16%,ARHGAP6;GAS7;GSN;COBL;HDGFL3;DIAPH1;PRKN;RNF135;MAP7D3
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.46767855008981196,-1.2021846168560701,0.19913419913419914,0.6924412279326916,1.0,6/20,23.89%,WNT4;C1QTNF3;EP300;BCKDK;NCOR1;C1QTNF12
prerank,neuromuscular process controlling balance (GO:0050885),0.5886783120139022,1.2002102931889664,0.25314183123877915,0.6940854659721203,1.0,4/12,12.00%,PCDH15;NRXN1;CLRN1;CDH23
prerank,regulation of protein binding (GO:0043393),0.3851553933080758,1.2001436943789834,0.17437252311756934,0.6934063824986625,1.0,14/114,3.92%,CLDN5;PDGFB;RAPGEF2;APP;CAV1;HIP1R;CTNNBIP1;B2M;NES;EPB41;ZFPM1;TIAM1;MEN1;ACTB
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.5631970042373683,1.199969870382955,0.2697841726618705,0.6929682724869366,1.0,7/14,10.15%,MMRN2;NOTCH1;STARD13;DLL4;CARD10;KLF4;PDCD10
prerank,cell proliferation in forebrain (GO:0021846),-0.5312454830213893,-1.199793651273924,0.26595744680851063,0.6980947107537614,1.0,4/10,13.98%,DOCK7;NUMBL;AKNA;PCM1
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.35513816917147967,1.1997905483124376,0.14233576642335766,0.692577268911988,1.0,37/208,12.24%,TFRC;DAB2IP;TNFRSF19;TIRAP;PLEKHG5;TRIM25;TRIM14;TNFSF10;NOD1;CD40;NOD2;PELI1;PRKD1;ATP2C1;IKBKB;CCR7;CD4;STAT1;LGALS9;BIRC3;BST2;PIDD1;MAP3K3;MALT1;NDFIP2;ZMYND11;OTUD7A;UBE2V1;CASP8;BRD4;LAMTOR5;SHARPIN;HSPB1;TLE1;PRKCB;GPR89A;TNFAIP3
prerank,regulation of microtubule-based process (GO:0032886),-0.39743755608573345,-1.1994198615416756,0.18356164383561643,0.6976324102748388,1.0,11/36,14.35%,PHLDB2;EPHA3;PRKAA2;EFNA5;DIAPH1;ATF5;PHLDB1;BICD1;MAP6;MEMO1;KLHL42
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.5668879917316323,1.1988441904538112,0.2587800369685767,0.6943721899376283,1.0,3/11,15.91%,RTP4;LPO;RTP3
prerank,chondroitin sulfate metabolic process (GO:0030204),0.46946883624079266,1.198591290340454,0.23154362416107382,0.6942085669209705,1.0,3/30,2.85%,CSGALNACT1;NDNF;CHST11
prerank,tetrapyrrole metabolic process (GO:0033013),0.5137685475613227,1.198532593331683,0.2736842105263158,0.6935170396168616,1.0,8/18,24.55%,ABCD4;AMN;MMAA;LMBRD1;TCN2;MMACHC;MMADHC;CD320
prerank,negative regulation of actin filament polymerization (GO:0030837),0.4913469935101545,1.1983173638046636,0.2593220338983051,0.6932544535431622,1.0,9/22,13.12%,KANK3;HIP1R;SSH2;VIL1;TMSB4X;TMSB10;TWF2;CYRIB;SSH1
prerank,protein O-linked mannosylation (GO:0035269),0.524808600151947,1.1981349798857612,0.27090909090909093,0.6929417303037765,1.0,1/18,0.08%,TMTC2
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.49686794129239886,-1.198042795396119,0.22737306843267108,0.7003138660989747,1.0,4/14,4.45%,ADAMTS12;EFEMP1;TGFBR1;WNT9A
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.5176705402822823,-1.1978875202576391,0.26490066225165565,0.699174758416879,1.0,6/12,33.31%,UCK2;UPP2;UMPS;UCK1;UCKL1;DCK
prerank,regulation of glycolytic process (GO:0006110),-0.3539783940027557,-1.197534071037907,0.13015873015873017,0.6987481889273146,1.0,9/68,5.33%,PRKAG2;IGF1;ZBTB20;PRKAA2;NUPR1;HDAC4;OGT;SEH1L;PPARA
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.5366880077576442,1.197489128340068,0.2744755244755245,0.6938435270764571,1.0,9/15,25.13%,ZFAND2A;SRP14;EDEM1;SPCS2;SPCS1;RAB3GAP1;RYR2;SRPRA;ZFAND2B
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.49947616982012305,1.1973789603210925,0.2564102564102564,0.6924118102114681,1.0,6/22,9.99%,ZDHHC14;ZDHHC9;ZDHHC20;ZDHHC19;ZDHHC18;ZDHHC22
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.49947616982012305,1.1973789603210925,0.2564102564102564,0.6924118102114681,1.0,6/22,9.99%,ZDHHC14;ZDHHC9;ZDHHC20;ZDHHC19;ZDHHC18;ZDHHC22
prerank,regulation of epithelial cell differentiation (GO:0030856),0.5295527194925486,1.1973526282491362,0.2624356775300172,0.6916253411468165,1.0,3/17,2.51%,CAV1;APOLD1;KLF7
prerank,neuromuscular process (GO:0050905),0.5327971953775331,1.1972147894569227,0.25252525252525254,0.6911260323740533,1.0,3/16,9.77%,GCH1;NRXN1;STRA6
prerank,phosphorylation (GO:0016310),0.3404709374670171,1.1970446584883483,0.10444444444444445,0.6907250146510321,1.0,105/384,18.84%,PRKCH;ERG;PDGFB;INSR;BMPR2;TGFB2;DGKH;MAP4K2;APP;CDK17;MAP4K3;STK38;PKN3;LIPE;SNRK;JAK3;ACVRL1;PRAG1;MAP3K1;STK10;PRKD2;PRKD1;CDK19;ZAP70;MERTK;LYN;FNIP2;PRKG1;IKBKB;PPP4R1;CREB1;CAMKK2;DGKI;PKN1;LIMK2;PRKACB;AATK;FYN;PAK5;MAPK3;RPS6KA5;ADAM10;RET;DGKE;PKN2;HCK;PXK;MARK4;CERKL;TGFB1;MAP3K6;MARK3;PAK1;EIF2AK4;TRIB2;PTK6;PRKAB1;TOLLIP;HK1;MAP4K4;GSK3A;PRKCB;SYK;DGKZ;TNK2;PIK3CB;TGFBR2;PANK3;HIPK2;CERK;STK24;STK3;MINK1;CAMK2B;PIM2;SGK1;TBCK;HIPK3;VRK1;STK26;CTBP1;NEK3;PLK2;GRK6;SGK3;SGK2;ACVR1;MAPK1;YWHAZ;GAS6;ALK;SIK2;MAP3K11;PRKG2;CDK11B;PAK2;PRKCG;TBK1;WNK2;PRKCE;CCNT1;RSKR;CSNK1G2;CDK6;CDK18
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.5848165536801953,1.1969364020883266,0.28308823529411764,0.6893199552367023,1.0,4/10,11.97%,ALKBH2;MGMT;MPG;ASCC3
prerank,DNA dealkylation (GO:0035510),0.5848165536801953,1.1969364020883266,0.28308823529411764,0.6893199552367023,1.0,4/10,11.97%,ALKBH2;MGMT;MPG;ASCC3
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.4474102774098522,1.1968358577589482,0.2144,0.6887317927286433,1.0,7/35,12.37%,HIP1;HIP1R;B2M;MKLN1;RAC1;TNK2;PIK3CB
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.5730163385906404,1.1967111813637357,0.27617328519855594,0.6882278591346038,1.0,4/11,6.29%,FAS;PLAUR;ST18;LGALS9
prerank,axoneme assembly (GO:0035082),0.4757896003696197,1.196459874477896,0.25368248772504093,0.6880696392985426,1.0,10/30,16.83%,RP1;TTLL3;DRC1;DCX;RSPH4A;DNAAF2;RSPH1;FOXJ1;DNAAF3;TTC12
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.490980909879555,1.1963933107626545,0.2512998266897747,0.6874013723735269,1.0,6/26,10.52%,INSR;DDAH1;KLF2;HSP90AB1;KLF4;AGTR2
prerank,negative regulation of programmed cell death (GO:0043069),0.3425720315371509,1.1963413484706225,0.08968609865470852,0.6866910178404579,1.0,44/355,11.20%,LEF1;IGF1R;MECOM;TFRC;TEK;RNF144B;TJP1;KDR;BCL2L1;FAS;NFKBIA;SH3RF1;TBX3;FLT4;PLAUR;PTK2;FOXO1;RPS6KA1;SOCS2;IKBKB;PTMA;CTNNB1;XIAP;CAT;CD38;MRE11;ADAM10;MCL1;HCK;BIRC3;RHBDD1;PIDD1;PRDM9;GREM1;BNIP3L;MALT1;ARHGDIA;MGMT;PDCD10;KLHL20;THOC6;LRP2;MAP4K4;HSPB1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.4968739080047095,1.1956679816491613,0.24825174825174826,0.6876746907715465,1.0,6/25,10.52%,INSR;DDAH1;KLF2;HSP90AB1;KLF4;AGTR2
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.5399913834529165,1.1954999602295409,0.29246935201401053,0.6864776485367432,1.0,4/15,10.93%,NANOS3;NANOS2;NANOS1;ZFP36L1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.5399913834529165,1.1954999602295409,0.29246935201401053,0.6864776485367432,1.0,4/15,10.93%,NANOS3;NANOS2;NANOS1;ZFP36L1
prerank,lymphocyte migration (GO:0072676),0.461456241972662,1.1954205633022457,0.2552504038772213,0.6858378086592468,1.0,5/32,11.07%,S1PR1;ZAP70;RET;MSN;CCL1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.3971572250516853,1.1949524617356846,0.20203488372093023,0.6862278150089751,1.0,18/72,16.98%,KANK3;SHANK3;HIP1R;ARHGEF2;FGF13;SSH2;STMN1;TWF2;PFDN4;PFDN2;HSPA8;CYRIB;ATXN7;SSH1;CDH5;PFDN1;APC;CAMSAP2
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.559105633322536,1.1949464598070152,0.2851851851851852,0.6854050304544991,1.0,4/13,7.23%,CAV1;CALM1;PDE4D;SRI
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.4515547838716083,1.1945660424989055,0.24126455906821964,0.6856137405453969,1.0,8/39,7.94%,PODXL;NOTCH4;PTK2;RGCC;NOTCH1;KLF4;NEXMIF;TGFB1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.5427086459891677,-1.1942951716558092,0.27467811158798283,0.7054166307203605,1.0,4/10,24.80%,TULP1;CEP250;CACNA2D4;CNGB1
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.5427086459891677,-1.1942951716558092,0.27467811158798283,0.7054166307203605,1.0,4/10,24.80%,TULP1;CEP250;CACNA2D4;CNGB1
prerank,histone H3-K36 demethylation (GO:0070544),-0.531792053798451,-1.1940386788159068,0.26939655172413796,0.704583059128522,1.0,5/10,16.33%,KDM7A;KDM2A;KDM2B;PHF8;RIOX2
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.4916536363162682,1.1938020078332603,0.2793388429752066,0.686835323435089,1.0,4/23,12.90%,MBOAT1;PLA2G4B;LPCAT3;PNPLA8
prerank,regulation of response to cytokine stimulus (GO:0060759),0.4970495557464438,1.193797771720729,0.26362038664323373,0.6860110979398973,1.0,5/19,10.34%,IFIH1;KLF4;IRAK2;LIFR;CBFB
prerank,protein export from nucleus (GO:0006611),-0.42324677607606687,-1.1937417577964615,0.22305764411027568,0.7038790939262373,1.0,6/27,13.31%,RANBP3L;PKD1;RANBP17;XPO5;XPO6;STRADA
prerank,activin receptor signaling pathway (GO:0032924),-0.49053026928564314,-1.193645732975011,0.2523148148148148,0.7026151153289473,1.0,7/15,29.88%,SMAD3;TGFBR1;ACVR1B;INHBB;INHBA;SMAD2;AMHR2
prerank,regulation of viral entry into host cell (GO:0046596),0.4677252411540228,1.193306431478402,0.25967741935483873,0.6865083765362517,1.0,6/30,6.29%,LY6E;TRIM25;TRIM14;SNX3;CD4;LGALS9
prerank,phagolysosome assembly (GO:0001845),0.5598239392055249,1.193189372953546,0.2840690978886756,0.685979964849927,1.0,4/12,7.88%,PIKFYVE;SYT7;RAB39A;RAB34
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.4428257310897205,-1.1931407773387228,0.2555831265508685,0.7009901561724007,1.0,7/20,12.47%,ACADSB;IVD;MCCC2;AUH;HIBADH;BCKDHB;HIBCH
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.4428257310897205,-1.1931407773387228,0.2555831265508685,0.7009901561724007,1.0,7/20,12.47%,ACADSB;IVD;MCCC2;AUH;HIBADH;BCKDHB;HIBCH
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.5460686047501162,-1.1930634172711458,0.25957446808510637,0.6996462230882724,1.0,5/11,8.42%,WNT5B;RSPO3;DAB2;PLEKHA4;MLLT3
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.4018329182911712,1.1927496589657325,0.19912152269399708,0.6863320081682106,1.0,13/69,12.30%,APP;TIRAP;PTPRJ;ARHGEF2;NOD2;IFIH1;TLR3;LGALS9;AGER;HSPB1;SYK;DDT;C1QTNF4
prerank,ear morphogenesis (GO:0042471),-0.46334310862987166,-1.1920120757386805,0.22982885085574573,0.701169966667562,1.0,5/20,7.27%,ZIC1;FGFR2;OSR1;SIX1;EPHB2
prerank,positive regulation of biosynthetic process (GO:0009891),-0.3833742754340163,-1.1917911162514807,0.19571045576407506,0.700326371656169,1.0,11/40,14.99%,ZBTB20;WNT4;BMP4;PPARA;APOE;TGFB3;CREB3L1;SLC5A3;CYBA;TLR4;LARP6
prerank,lymphocyte mediated immunity (GO:0002449),-0.5142569460210956,-1.1916938809827071,0.2838983050847458,0.6990290503318136,1.0,2/12,8.12%,CD55;JAG1
prerank,protein localization to organelle (GO:0033365),-0.3127025631829645,-1.1913391345693678,0.11555555555555555,0.6985734522518064,1.0,37/133,17.81%,ANK2;COL1A1;BMP7;BMP4;TULP3;LMNA;LAMP2;WDR35;GBF1;OBSL1;ARL3;ZNF423;SIX1;DCP1A;DDX1;BICD1;IFT122;STX5;BBS9;ARL1;EHD1;TOR1AIP1;LRRK2;RAB6A;EMD;AUP1;TRAM2;PAF1;DDX3X;DDRGK1;OPTN;SIX4;SEC61B;VAMP2;SNX10;TULP1;GET1
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.47275957583523054,-1.1913311446705204,0.24764150943396226,0.6970727872788723,1.0,5/17,4.99%,ATP1A2;TFPI;BMP7;BMP4;AR
prerank,regulation of humoral immune response (GO:0002920),-0.37195166435719945,-1.1911067945718943,0.18911174785100288,0.6962157053933252,1.0,4/44,1.95%,SERPING1;VTN;CD55;CFH
prerank,small GTPase mediated signal transduction (GO:0007264),0.3848272234876836,1.190726306575917,0.18493150684931506,0.6909974818208149,1.0,24/103,12.92%,RASGRP3;ARHGAP31;RAPGEF2;NTN1;GRAP;TIAM1;ABR;PRKD1;GRB2;RREB1;CCDC88A;SOS1;RASGRP2;RALB;RGL2;JUN;SHC3;RAC1;HRAS;GNB1;TNK2;RAPGEF5;RIN2;SETDB1
prerank,regulation of innate immune response (GO:0045088),0.4254022647243462,1.190677391989577,0.22585438335809807,0.6902997269618,1.0,13/57,12.24%,TIRAP;LRP8;IFNAR2;GBP5;SAMHD1;XIAP;HSP90AB1;N4BP1;BIRC3;CASP8;TLR8;USP18;TNFAIP3
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.5338676319061479,1.1906445027834986,0.27289048473967686,0.6895631729208083,1.0,7/16,14.80%,GCH1;SCARB1;TERF2;AGTR2;HIF1A;PIK3CB;NUS1
prerank,pancreas development (GO:0031016),0.5572528739076807,1.190322187576818,0.2692307692307692,0.689590587772553,1.0,2/12,4.39%,ZIC3;FOXF1
prerank,positive regulation of oxidoreductase activity (GO:0051353),-0.45222861083453914,-1.1901909486187312,0.23608017817371937,0.6974134582069493,1.0,6/18,12.26%,POR;ATP7A;SIRT3;AGTR1;FXN;ABL1
prerank,response to alcohol (GO:0097305),-0.4252893918459196,-1.189524101178488,0.24173027989821882,0.6978977235752442,1.0,3/27,3.92%,TGFBR3;SLIT2;TGFBR1
prerank,cellular response to reactive oxygen species (GO:0034614),-0.356816034077438,-1.1890823949038072,0.2046783625730994,0.6977575152801455,1.0,13/59,12.26%,EGFR;PDGFRA;TPM1;MAP3K5;IMPACT;PRKCD;PKD2;ANXA1;CYP1B1;FXN;CHUK;MPV17;ABL1
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),-0.26940294524837133,-1.18776980804467,0.01818181818181818,0.7001568089578998,1.0,119/572,15.52%,BMP6;FOXP2;PRDM6;FHL2;AEBP1;NR2F2;ZEB2;GLI3;RARB;ZFHX3;GLI2;GLIS3;SMAD3;FOXP4;FGFR2;BMP4;KANK2;ZFPM2;OSR1;DDX5;NR6A1;FNIP1;THRB;HDAC4;CUX1;FRK;PER3;MXI1;WWOX;SALL1;IMPACT;NR1D2;ZHX2;FOXC2;DNMT3A;BCOR;FOXC1;KCNIP3;SUFU;HOXA7;RBPJ;DAB2;TBL1XR1;EHMT2;MIER3;MDM4;AR;DLG1;PER2;GLIS2;PPARA;PHF21A;CTR9;ZMYM5;IGF2;CBX7;ZNF25;BCL6;DACT1;ZNF568;LCOR;NFATC4;PRKN;ATN1;CHD3;ZEB1;CBX5;CHD8;MED25;MITF;KDM2B;POU6F1;YAP1;USP2;EZR;SMURF2;PCGF2;FOXO3;CXXC5;CEBPB;URI1;EZH1;CRY2;ZNF148;WWP2;PARP1;NR2F1;GATA6;ESR1;RXRA;KDM1A;NFX1;ZNF219;BMP2;SKI;PSEN1;ZBTB4;E4F1;FOXE1;TWIST1;ZNF3;NKX6-1;PAF1;PEX2;SNAI1;GZF1;ZBTB1;EP300;SIRT2;BAG3;NFIB;IFI27;USP9X;CBX6;ZBTB7B;MAP2K5;PHF12;LDB1;LDB2
prerank,organelle fusion (GO:0048284),-0.43605781281726896,-1.1875065549653827,0.2340909090909091,0.699384237789517,1.0,7/22,16.30%,MIGA2;EEA1;MIEF1;AFG3L2;MFN2;MIEF2;STX4
prerank,cardiac ventricle development (GO:0003231),0.5162503741059593,1.186647226450761,0.26475548060708265,0.6988156001757397,1.0,6/20,9.80%,ENG;PDE2A;NOTCH1;DLL4;STRA6;HECTD1
prerank,striated muscle contraction (GO:0006941),-0.3691675289550835,-1.1854837311789932,0.21865889212827988,0.7038323908882198,1.0,10/53,16.13%,ATP1A2;TPM1;DMD;SLC8A1;GAA;ARHGEF11;DTNA;TNNT3;STAC3;ALDOA
prerank,Golgi organization (GO:0007030),-0.31774860325503645,-1.1853559744413236,0.12648221343873517,0.7027017607881407,1.0,31/112,15.88%,RAB30;GBF1;OBSL1;TANGO2;ARHGAP21;GOLGB1;FAM174B;FBXW8;GOLGA2;DYNC2H1;PI4K2B;STX5;CUL7;SEC16B;COG4;ARL1;HUWE1;ATP8B2;PRMT5;LRRK2;GORASP2;RAB29;BCAS3;PLEKHM2;ATP8B1;SEC16A;STX16;LMAN1;PLK5;SURF4;OPTN
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.45205143037660556,1.1848475711385098,0.2370486656200942,0.7029208390368876,1.0,12/37,22.11%,ENTPD1;ENTPD5;DFFB;NUDT9;PPP1R8;SND1;NUDT1;RNASEH2C;NUDT16;XRN2;NCBP1;RNASE6
prerank,protein targeting to membrane (GO:0006612),0.39226779186542643,1.1841423589490507,0.21961932650073207,0.7041164135781036,1.0,27/83,21.73%,AQP11;ZDHHC14;PARD3;SEC62;PIKFYVE;ZDHHC9;ZDHHC20;ZDHHC19;SRP14;SGTB;RTP4;ZDHHC18;ZDHHC22;ABCD1;PEX14;GET3;SDCBP;NACAD;RTP3;ZDHHC21;PEX16;VPS37A;ABCD2;ACBD5;MYO1C;VPS37B;VPS37C
prerank,negative regulation of receptor internalization (GO:0002091),0.5555077293280333,1.1838778936065213,0.28884826325411334,0.7039884019054027,1.0,5/12,19.45%,ANKRD13A;RIN3;SDCBP;MTMR2;LRPAP1
prerank,positive regulation of behavior (GO:0048520),0.5731169638187029,1.1838021383083812,0.2821497120921305,0.7033491248836887,1.0,3/10,16.00%,MEF2C;STRA6;NLGN1
prerank,negative regulation of gene expression (GO:0010629),0.3437682025694614,1.1837984713904603,0.1296928327645051,0.7025191628767191,1.0,58/302,13.14%,SLC7A5;OCLN;CLDN5;PDGFB;KDR;CD34;ENG;TGFB2;NANOS3;APP;XDH;RGCC;MEF2C;SRGN;ACVRL1;APLNR;NOTCH1;YBX1;HDAC9;NANOS2;NOS2;GATA2;NOCT;DLL4;ENC1;MRPL13;DIP2A;NANOS1;ATP2B1;LGALS9;RPS6KA5;PTBP3;FBXW7;ADAM10;KLF4;N4BP1;HINFP;TGFB1;TERF2;FOXP3;NDFIP2;PPP1R11;KDM4A;CNOT9;RPL13A;PDCD10;GRB7;PTRH2;TASOR;DCP2;HRAS;HIF1A;DXO;SOX11;BTG2;SETDB1;PAIP2;HELLS
prerank,fluid transport (GO:0042044),0.5652924826025354,1.1837322795305356,0.28810408921933084,0.7018527988051432,1.0,2/12,4.61%,AQP11;AQP7
prerank,positive regulation of programmed cell death (GO:0043068),0.3471543336744201,1.1836696396904576,0.13904982618771727,0.7011771059721424,1.0,36/272,8.71%,MCF2L;ITGA6;ARHGEF3;DAB2IP;RASGRF2;FAS;NET1;UNC13B;HIP1R;PLEKHG5;DCUN1D3;TNFSF10;ARHGEF2;RYBP;KALRN;FOXO1;FOXL2;TIAM1;ABR;TGM2;CTNNB1;NOS2;RHOB;SOS1;CRADD;ARHGEF12;RNPS1;DNM2;IRF5;JMY;MARK4;JUN;PREX1;ARHGEF5;PIDD1;ARHGEF7
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.4486383971506389,-1.1832250223874217,0.23471882640586797,0.7074682086741142,1.0,13/21,30.91%,DCDC2;SMO;GLI1;EVC;ARMC9;KIF7;SFRP1;TTC23;STK36;PDCL;TXNDC15;ULK3;SHH
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.4427791550100092,-1.1828209069541322,0.21768707482993196,0.7071823384678296,1.0,8/19,23.76%,ENPP1;SLC26A2;PAPSS2;PAPSS1;TPST1;ABHD14B;SULT1A1;SLC35B2
prerank,neuron apoptotic process (GO:0051402),0.5169487034014545,1.1826506613000773,0.27491408934707906,0.7031298852617784,1.0,3/19,4.08%,APP;FAS;TNFRSF21
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.38916842814530817,-1.1823797107793603,0.20540540540540542,0.7069787402533436,1.0,8/37,11.82%,PHLDB2;EPHA3;PRKAA2;EFNA5;PHLDB1;BICD1;MAP6;SKA2
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.37729448275645994,-1.1815319731402367,0.19469026548672566,0.7079705926242356,1.0,8/45,4.64%,BMP6;BMPR1A;BMP5;BMP7;BMP4;TGFBR1;TWSG1;DAB2
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.5272696927837156,1.1813252778815722,0.28846153846153844,0.7059872868089458,1.0,8/15,18.70%,KCNQ1;ATP1A1;KCNH2;KCNN2;KCNJ5;KCNJ3;KCNIP2;KCNA5
prerank,dorsal/ventral pattern formation (GO:0009953),-0.4536593401417054,-1.1808160844025157,0.2639225181598063,0.7085774468367313,1.0,3/20,1.28%,BMPR1A;GLI2;NBL1
prerank,protein neddylation (GO:0045116),0.5520528068422955,1.1803399434409185,0.315884476534296,0.7078631652704879,1.0,4/13,14.48%,DCUN1D3;UBA3;DCUN1D1;RBX1
prerank,epithelial structure maintenance (GO:0010669),-0.5141612857593809,-1.180189138398231,0.2648305084745763,0.7088533738605195,1.0,2/11,3.20%,CXADR;RBP4
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.45414696429331813,1.1797549849464286,0.24336973478939158,0.7086825138869034,1.0,3/35,2.89%,FAR2;FASN;HMGCS2
prerank,protein mannosylation (GO:0035268),0.4997707771521073,1.1796984533267796,0.26758147512864494,0.7079954786448104,1.0,1/22,0.08%,TMTC2
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.49783051178073395,1.17931772751543,0.24829931972789115,0.7081993733687834,1.0,6/22,12.26%,PTPRJ;DUSP3;UBASH3A;CD160;DGKZ;CEACAM1
prerank,regulation of epithelial cell proliferation (GO:0050678),0.38979752750165353,1.179186081372929,0.21770682148040638,0.7077420181238262,1.0,14/85,6.10%,SGPP2;TIE1;AQP11;DAB2IP;TGFB2;TBX1;MCC;B2M;MTSS1;ACVRL1;NOD2;PRKD1;FGF16;CDKN2B
prerank,positive regulation of ERAD pathway (GO:1904294),0.540718684084241,1.1790682478912686,0.276,0.7072484798405438,1.0,4/13,16.40%,CAV1;ATXN3;UBQLN1;BAG6
prerank,negative regulation of catabolic process (GO:0009895),-0.3778918364869942,-1.178861035315593,0.1797752808988764,0.7112631336697292,1.0,7/47,6.12%,EGFR;NUPR1;HDAC4;MDM4;SNX12;PPARA;FLNA
prerank,positive regulation of neuron projection development (GO:0010976),0.3924059307793765,1.178858145290246,0.23601637107776263,0.706991453317578,1.0,19/85,10.25%,ITGA6;NDNF;DAB2IP;RAPGEF2;FES;SCARF1;LRP8;RAPGEF1;PRKD1;LYN;SNX3;FUT9;DBNL;RET;LRRC7;PTN;TWF2;SERPINI1;PTK6
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.4426306351289401,-1.1788138732399658,0.25,0.7099117469266203,1.0,6/20,6.64%,GSN;PLA2R1;THBS1;ANO6;PRKCI;SFRP4
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.45199313452222933,-1.1784134441948204,0.24744897959183673,0.7096044257193198,1.0,8/20,15.51%,HOXA5;CTR9;MEIS1;PTK2B;PAF1;HOXA9;MAFB;LDB1
prerank,cognition (GO:0050890),0.4368909457389829,1.1782920675901536,0.24566929133858267,0.7077028803856048,1.0,7/42,10.09%,MFSD2A;SHROOM4;APP;GPR155;FAM107A;STRA6;CYFIP1
prerank,regulation of axonogenesis (GO:0050770),-0.3651034491982518,-1.17813788305503,0.1846590909090909,0.708903158620375,1.0,13/51,14.32%,ROBO1;PLXNA2;TIAM2;SLIT2;SIPA1L1;KIF13B;NGF;PLXNB2;MAP6;CHN1;ROBO2;PTEN;BRSK1
prerank,negative regulation of cell growth (GO:0030308),0.37849346141807183,1.1780430550258938,0.19787516600265603,0.7075872761964249,1.0,22/121,10.52%,APBB2;BMPR2;TGFB2;SH3BP4;SOX17;DCUN1D3;PTPRJ;SMARCA2;SIPA1;ADAM15;ACVRL1;FGF13;DIP2B;CCDC85B;PPP1R9B;HYAL2;WFDC1;BST2;TGFB1;NPR1;BTG1;AGTR2
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.5444908556945164,1.177841005175384,0.29545454545454547,0.7072553808932137,1.0,7/13,21.38%,SVIP;DERL2;EDEM1;UBAC2;UBE2G2;BRSK2;UBE2J1
prerank,endocardial cushion morphogenesis (GO:0003203),0.5244133286981304,1.1775848770422295,0.284452296819788,0.707114284461076,1.0,5/18,3.41%,ENG;TGFB2;NOS3;ACVRL1;NOTCH1
prerank,monosaccharide transmembrane transport (GO:0015749),-0.47597124027335924,-1.1773504194241549,0.2608695652173913,0.7097885867808776,1.0,4/16,14.25%,SLC2A12;SLC45A3;SLC5A3;SLC2A10
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.4329513188991249,1.1772970268352148,0.23065476190476192,0.7070141047880742,1.0,16/45,20.03%,TRIM25;B2M;SP100;IRF2;IRF9;STAT1;HCK;IRF5;OASL;MID1;CAMK2B;VCAM1;TRIM26;TRIM68;CAMK2G;IFNGR1
prerank,gliogenesis (GO:0042063),0.5263056310585972,1.177085577148329,0.28256880733944956,0.7067722807859793,1.0,4/15,10.21%,TGFB2;CDH2;MMP24;METRN
prerank,regulation of keratinocyte proliferation (GO:0010837),-0.4392038970822006,-1.1769468906629164,0.2553699284009546,0.7095364691663181,1.0,5/22,8.91%,NOTCH2;FGFR2;CASK;STXBP4;SRSF6
prerank,epidermis development (GO:0008544),-0.355619817604153,-1.1765815857508406,0.17151162790697674,0.7090818972569216,1.0,11/56,12.99%,SVEP1;CCN2;FGFR2;EMP1;FLOT2;CRABP2;GLI1;PTHLH;GATA6;SCEL;LAMC2
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.45204756495191695,1.1760716990758662,0.24082934609250398,0.7088567888527758,1.0,7/35,12.08%,CAV1;JAK3;NOTCH1;IL10RB;PIGU;ADIPOR1;HGS
prerank,negative regulation of signal transduction (GO:0009968),-0.28470647190540266,-1.175368423933178,0.1223021582733813,0.7111535209658829,1.0,50/249,10.98%,PID1;TRABD2B;SULF1;LRP1;EGFR;LGR4;GLI3;ADAMTS12;DCN;IGFBP5;BMP5;DKK3;ENPP1;GPC3;KANK2;RNF43;CYP26B1;TULP3;IRS1;MMP14;KANK1;APOD;NOTCH3;WWOX;SULF2;THBS1;PRKCD;ARRB1;SUFU;FGF2;GLIS2;DACT1;SFRP4;MGRN1;EMILIN1;BCL2;IGFBP3;TNS2;GRB10;NXN;IFT122;BEND6;VGLL4;QARS1;PIP4K2C;CREB3L1;BTRC;NIBAN2;RPGRIP1L;WWP2
prerank,regulation of biomineral tissue development (GO:0070167),0.4830479192134007,1.1753519537604238,0.2765273311897106,0.7100490637066966,1.0,6/26,7.94%,SGMS2;NOS3;S1PR1;NOTCH1;NOTUM;TGFB1
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.4238006018081175,-1.1752981240915348,0.2425,0.7098645462605817,1.0,7/25,6.47%,SULF1;BMPR1A;FOXD1;BMP4;ZNF423;RBPJ;CCN1
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.3234247244739017,-1.17500337680602,0.14444444444444443,0.7092685275767359,1.0,26/95,14.25%,TGFBR3;ZEB2;LDLRAD4;SMAD3;DKK3;SMAD6;HTRA3;THBS1;SNX6;TGFBR1;DAB2;PPARA;ASPN;EMILIN1;TGFB1I1;CD109;PDPK1;SMURF2;STK11;SPRED1;VASN;SKI;GIPC1;EP300;HTRA4;SLC2A10
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.37848646899278265,1.1748987520125267,0.19363762102351315,0.710493621018752,1.0,31/119,16.72%,EFR3B;PIK3R6;ITPKB;INPP5D;PIK3R3;SOCS2;PIKFYVE;PIGU;PIP5K1C;OCRL;INPP5F;PLEKHA1;PIGM;MTMR6;PGAP4;SOCS5;PIGF;PIK3C3;PIK3C2A;PIP4K2A;RAB4A;PIK3CB;MTMR12;CDIPT;PIK3R5;MTMR2;PLEKHA3;DPM3;SYNJ1;TTC7B;INPP5E
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.5166950027684883,-1.1746065647248414,0.2713347921225383,0.7089292686682486,1.0,4/11,8.12%,BMPR1A;BMP4;ZFPM2;JAG1
prerank,reverse cholesterol transport (GO:0043691),0.541704041443532,1.1745734191136612,0.2912966252220249,0.7105645180504087,1.0,3/13,7.28%,SCARB1;ABCG1;LIPC
prerank,heart trabecula morphogenesis (GO:0061384),0.5151308415468367,1.1745110984110076,0.26791808873720135,0.7098837674659129,1.0,6/18,4.99%,TEK;ENG;TGFB2;S1PR1;NOTCH1;DLL4
prerank,cellular response to glucose stimulus (GO:0071333),0.4742719655284177,1.1734271016472235,0.26517571884984026,0.7121099445234047,1.0,2/30,2.01%,IGF1R;UNC13B
prerank,response to interferon-alpha (GO:0035455),0.5303289549685859,1.1732740630902563,0.29553264604810997,0.711702146278287,1.0,7/16,13.21%,IFNAR1;IFNAR2;ADAR;BST2;KLHL20;PDE12;RO60
prerank,positive regulation of JUN kinase activity (GO:0043507),0.48081884982937484,1.173273749242228,0.26666666666666666,0.7108736222430386,1.0,4/23,9.07%,DAB2IP;TNFRSF11A;ARHGEF5;PAK1
prerank,vasoconstriction (GO:0042310),-0.5154721294884004,-1.173165521671871,0.28216704288939054,0.7116024403870604,1.0,3/11,9.67%,EDNRA;SLC8A1;ACTA2
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.3623326253895692,-1.172806909356606,0.20161290322580644,0.7110989814119192,1.0,18/52,23.69%,CELF2;DDX5;FXR2;SRRM4;NOVA1;SRSF6;DDX17;RBM5;FMR1;NSRP1;RBFOX1;SAP18;TRA2B;ZC3H10;MBNL2;RBM24;KHDRBS3;CELF6
prerank,synaptic vesicle recycling (GO:0036465),0.4678230732614035,1.1726877659293304,0.250788643533123,0.7116338422267364,1.0,10/31,16.18%,STX1A;WNT7A;TBC1D24;PIP5K1C;SYT7;FCHO2;OPHN1;AMPH;NLGN1;SYNJ1
prerank,hydrogen peroxide catabolic process (GO:0042744),0.5540277183042227,1.1725412843722698,0.2832699619771863,0.7112445157187474,1.0,3/11,14.44%,PXDN;CAT;PRDX5
prerank,regulation of gluconeogenesis (GO:0006111),-0.41801586511349176,-1.1724947317571413,0.24379232505643342,0.7106116306066399,1.0,6/27,14.04%,OGT;PPARGC1A;C1QTNF3;SELENOS;NNMT;EP300
prerank,positive regulation of axonogenesis (GO:0050772),0.4374088034494769,1.172095134705426,0.2537764350453172,0.7116082290185547,1.0,11/43,11.25%,SEMA7A;MACF1;NTN1;PLXND1;TIAM1;DBNL;SLITRK1;TWF2;ARHGDIA;METRN;PLXNB3
prerank,positive regulation of translation (GO:0045727),-0.32706653850073647,-1.1720378943781777,0.1773049645390071,0.7106006768196184,1.0,40/94,30.20%,SAMD4A;PLD1;THBS1;PLXNB2;AGO2;YBX3;FXR2;MRPS27;RMND1;EIF3C;FMR1;HABP4;DDX3X;LARP6;YTHDF1;RPUSD4;JMJD4;C1QBP;RCC1L;USP16;FASTKD3;RPS6KB1;CIRBP;PIWIL2;FASTKD2;EIF4A3;POLDIP3;RPS27L;ERBB2;CDC123;HNRNPD;LARP4;MPV17L2;VIM;BCL3;BOLL;DHX36;EIF5A2;UPF3A;RPUSD3
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.3818405680460493,-1.1715105458294983,0.21584699453551912,0.7106297196929734,1.0,6/44,5.75%,PRKAG2;CYP7B1;INSIG2;CYP27A1;PER2;ACOT8
prerank,translation (GO:0006412),0.35195804561917704,1.171345974680441,0.17274939172749393,0.7127940813742012,1.0,106/208,31.19%,SARS2;SARS1;ZAR1L;RPL38;MRPL13;RPL13;RPS29;MRPL10;RPL36A;RPL3;YARS2;RPSA;RPL27;RPS7;RPL9;RPLP2;RPL18;GTPBP1;RPL13A;GARS1;MRPL57;RPS11;RPL8;RPS27;RPL19;RPS9;MRPL28;EEFSEC;RPL11;RPL22L1;RPS15;RPL37;SRBD1;RPS28;GATC;RPS10;RPS25;MRPS2;EEF1D;RPL37A;MRPL9;COPS5;RWDD1;RPL15;TNIP1;FARSB;MRPL16;MRPL23;RPL17;RPL23;RPL34;RPS18;APEH;MRPS18A;RPL21;RPS4X;ABCE1;CARS1;DHPS;RPS21;RPL18A;GTPBP2;RPL10A;EEF1B2;IARS2;NARS1;RSL24D1;RPL24;MRPL27;MRPL41;PTCD3;RPL7A;MRPL51;HARS1;NDUFA7;RPL4;MRPS33;RPS2;RPL32;RPL6;MRPL37;MRPL2;RPS20;RPL14;RPS13;MRPS18C;RPL26;QRSL1;RPS19;EEF1G;VARS1;LARS2;MARS2;MRPS34;MRPS12;RPS6;RPS14;RPS15A;RPS24;RPS23;EEF1E1;RPS12;MRPS28;RPL12;MRPS24;EEF1A1
prerank,microvillus assembly (GO:0030033),0.5304416510870694,1.1708591017742067,0.29965156794425085,0.7132538027984989,1.0,5/14,14.83%,RAPGEF2;RAP1B;MAP4K4;MINK1;STK26
prerank,glycogen catabolic process (GO:0005980),-0.48061459205509405,-1.1707172906780152,0.2847380410022779,0.7115995836988113,1.0,10/15,23.20%,PYGB;PHKB;PYGM;GAA;PHKA2;AGL;PHKG2;PHKA1;PHKG1;PYGL
prerank,dopamine metabolic process (GO:0042417),0.5155191073830516,1.1705779306145185,0.29422382671480146,0.7131963544127532,1.0,3/18,2.21%,MAOA;TGFB2;GCH1
prerank,sphingosine metabolic process (GO:0006670),0.5026953953076275,1.1703432353367607,0.2874779541446208,0.7130277352116333,1.0,4/17,7.18%,SGPP2;ACER2;ACER1;SPTLC2
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.5001847122556463,-1.1699485184043497,0.28270042194092826,0.7124202668398026,1.0,2/13,3.22%,AXL;IL18
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),-0.47851964139600417,-1.1699288642431194,0.27230046948356806,0.7110278497183603,1.0,11/16,37.60%,PDK1;RORA;PRKN;BCKDK;PDK3;SIRT1;FOXK1;FOXK2;GNB3;MLYCD;PDK2
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.5720851485646792,1.1699116606853937,0.29922779922779924,0.7134060184318795,1.0,3/10,7.33%,CD40;LYN;BTLA
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.3976661756147134,1.1693451495794536,0.23728813559322035,0.7140744901445666,1.0,13/75,8.22%,MFSD2A;APP;KLF7;MEF2C;NTNG2;PARD3;DSCAML1;ACTB;WNT7A;BAIAP2;SLITRK3;OPHN1;SLITRK1
prerank,regulation of viral genome replication (GO:0045069),0.40947574193018393,1.1691245527510183,0.24,0.7138365558568684,1.0,17/56,18.44%,IFIH1;FKBP6;ADAR;BTBD17;PPIA;PKN2;N4BP1;BST2;OASL;BANF1;PDE12;NR5A2;SLPI;ZC3HAV1;RAD23A;PROX1;TNIP1
prerank,mitochondrion localization (GO:0051646),-0.45001406606087313,-1.1689565169045613,0.251131221719457,0.712256509983028,1.0,10/19,28.55%,TRAK1;MARK1;LRRK2;MFN2;MUL1;TLE6;HAP1;MFN1;MARK2;ATCAY
prerank,regulation of histone modification (GO:0031056),-0.49664738396977137,-1.1679624843976095,0.2757847533632287,0.7138440328094203,1.0,7/13,19.16%,IGF2;AKAP8L;NNMT;MTHFR;SETD5;MYOCD;FLCN
prerank,glycogen biosynthetic process (GO:0005978),0.5549064276489009,1.167576571898933,0.3179297597042514,0.7164457901483804,1.0,4/12,16.35%,GBE1;PGM2L1;NHLRC1;UGP2
prerank,glucan biosynthetic process (GO:0009250),0.5549064276489009,1.167576571898933,0.3179297597042514,0.7164457901483804,1.0,4/12,16.35%,GBE1;PGM2L1;NHLRC1;UGP2
prerank,regulation of cell morphogenesis (GO:0022604),0.4596674241139533,1.1670755875457397,0.275974025974026,0.7169343399371918,1.0,7/30,10.94%,MFSD2A;MACF1;NTNG2;VIL1;STRIP1;PDZD8;FERMT2
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.4369105360600898,-1.1668488462132491,0.26914660831509846,0.715486316173873,1.0,4/23,7.31%,NUPR1;HDAC4;PPARA;C1QTNF3
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.5080894217347021,-1.166619371799994,0.2823275862068966,0.7147114304275243,1.0,2/12,7.17%,IL18;IL17D
prerank,organelle transport along microtubule (GO:0072384),-0.39926454296921216,-1.1662015009449775,0.2520107238605898,0.7144329880138455,1.0,13/31,24.61%,TRAK1;ARHGAP21;MAP1S;BICD1;DYNC1I1;CLN3;RAB6A;FBXW11;RHOT1;BORCS5;HTT;COPG1;HAP1
prerank,inorganic anion transport (GO:0015698),-0.3639572634752194,-1.165470970729322,0.21450151057401812,0.7151599476969358,1.0,9/53,6.32%,SLC13A4;SLC4A10;ENPP1;SLC26A7;ANO6;CLCN2;ENPP3;SLC5A5;ANO1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.3116162403150795,-1.1652657422922257,0.1686746987951807,0.7143238175514302,1.0,16/112,4.37%,COL1A2;COL3A1;SOX5;TGFBR3;BMPR1A;APPL2;WNT4;SMAD3;PDE3A;SMAD6;ITGB5;WWOX;CLEC3B;TGFBR1;TWSG1;ADAM9
prerank,organelle disassembly (GO:1903008),-0.39500123046000873,-1.1650700595505374,0.2553763440860215,0.7134851709887016,1.0,10/33,14.70%,GBF1;ULK2;ATG2B;MCTS1;GOLGA2;TEX264;STX5;PLK5;UFC1;DDRGK1
prerank,peptide biosynthetic process (GO:0043043),0.3604797916442722,1.1645239090801858,0.19440914866581957,0.7231131681514102,1.0,67/153,27.94%,SARS1;ZAR1L;RPL38;MRPL13;RPL13;RPS29;MRPL10;RPL36A;RPL3;YARS2;RPSA;RPL27;RPS7;RPL9;RPLP2;RPL18;RPL13A;RPS11;RPL8;RPS27;RPL19;RPS9;MRPL28;RPL11;RPS15;RPL37;SRBD1;RPS28;RPS10;RPS25;RPL37A;MRPL9;COPS5;RPL15;TNIP1;FARSB;MRPL23;RPL17;RPL23;RPL34;RPS18;MRPS18A;RPL21;RPS4X;DHPS;RPS21;RPL18A;RPL10A;RSL24D1;RPL24;MRPL27;MRPL41;RPL7A;MRPL51;HARS1;RPL4;MRPS33;RPS2;RPL32;RPL6;MRPL37;RPS20;RPL14;RPS13;MRPS18C;RPL26;RPS19
prerank,long-chain fatty acid import into cell (GO:0044539),0.5642438582367396,1.163903816877174,0.29844961240310075,0.7239737438168486,1.0,3/10,12.21%,SLC2A1;ACSL3;SLC27A2
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.48796605859699516,1.1639006271909522,0.27882960413080893,0.7231509835116329,1.0,4/21,6.66%,DAB2IP;TGFB2;CD2AP;ARHGAP25
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.564311995331368,1.1636976983452993,0.3215613382899628,0.7229092221958525,1.0,3/10,7.38%,ACER2;SNAI2;NEXMIF
prerank,regulation of calcium-mediated signaling (GO:0050848),-0.42086418173154566,-1.1633728816764501,0.26932668329177056,0.716988058150182,1.0,5/25,13.52%,ITPR1;P2RX4;CDH13;LRRK2;CMKLR1
prerank,pulmonary valve morphogenesis (GO:0003184),-0.4651334910211196,-1.1629611817333043,0.26376146788990823,0.7167331501646373,1.0,7/17,8.12%,ROBO1;NOTCH2;BMP4;SLIT2;SMAD6;HEYL;JAG1
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.4096427130079664,-1.1628214074110166,0.24345549738219896,0.7156655602558034,1.0,9/28,9.81%,PID1;APPL2;ENPP1;IRS1;KANK1;PRKCD;TNS2;GRB10;PIP4K2C
prerank,regulation of dephosphorylation (GO:0035303),0.5130445102726829,1.162392321333341,0.2942176870748299,0.7255927069810734,1.0,1/15,0.95%,PPP1R16B
prerank,neurotrophin signaling pathway (GO:0038179),0.48137022814888214,1.1621169592431846,0.28347826086956524,0.7254827652837458,1.0,6/21,10.53%,RAPGEF2;RAPGEF1;GRB2;SORT1;SOS1;DDIT4
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.29538692567225244,-1.1620246989599474,0.1,0.7164104921892352,1.0,34/173,14.90%,ANK2;CD55;SEC24D;CAPZB;SEC24A;GBF1;USO1;GOLGB1;COPA;NRBP2;KDELR3;COPZ2;COPB1;ARFGAP1;ARFGAP3;GOLGA2;ERGIC3;SAR1A;TRAPPC3;STX5;SEC31A;CUL3;SEC16B;DYNC1I1;COG4;SEC23A;GOLT1A;RAB29;ERGIC1;SCFD1;SEC16A;LMAN1;CTSZ;DCTN6
prerank,keratan sulfate metabolic process (GO:0042339),0.44904134574771765,1.1619139735666182,0.27129337539432175,0.725182616211367,1.0,5/31,4.25%,ST3GAL6;ST3GAL1;B4GALT5;B4GALT4;B3GNT2
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.4325161338545952,1.1613624073654298,0.270516717325228,0.7257916946600127,1.0,2/42,2.24%,POLK;TRIM25
prerank,cellular glucose homeostasis (GO:0001678),0.4330109049970157,1.1610451651627542,0.26324237560192615,0.7258811399740173,1.0,3/41,2.97%,IGF1R;UNC13B;FOXO1
prerank,positive regulation of response to stimulus (GO:0048584),0.4306734191331337,1.1607279174990184,0.2390625,0.7259174658171734,1.0,10/40,16.37%,TGFB2;B2M;IFIH1;HOMER1;HMGA1;ABI3;IL15;NSMCE4A;CDKN2AIP;HMGA2
prerank,ribosomal small subunit assembly (GO:0000028),0.5043025394241348,1.1605716494744196,0.29764065335753176,0.7255434952821882,1.0,6/16,14.11%,ABT1;RPSA;PWP2;RPS27;RPS15;RPS28
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.49912695380388844,1.1605252166202924,0.301056338028169,0.7248260430555618,1.0,6/20,5.18%,ENG;TGFB2;TBX3;ACVRL1;NOTCH1;SNAI2
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.3922470591905898,1.1603563892111974,0.2590448625180897,0.7244449791989104,1.0,16/75,12.37%,DAB2IP;RASIP1;HEG1;STK38;PTPRJ;DUSP7;MEN1;PKIG;LYN;HHEX;HYAL2;PRKAR2B;LRP5;PRKAR2A;DUSP1;PIK3CB
prerank,ion homeostasis (GO:0050801),-0.40913878938784043,-1.1602026536708117,0.2469733656174334,0.7201313003723581,1.0,8/30,14.94%,SLC4A10;FHL1;WNK4;CAMK2D;SLC4A7;SLC4A2;WNK1;SLC4A3
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.4676012100647615,1.1584507869779095,0.29692832764505117,0.7287943209576858,1.0,6/25,14.97%,APP;ANKRD13A;RIN3;RAC1;SDCBP;MTMR2
prerank,response to chemokine (GO:1990868),0.537941950836294,1.1583562684773505,0.3148479427549195,0.7281911619317578,1.0,2/13,1.28%,LRCH1;CXCL12
prerank,regulation of mast cell degranulation (GO:0043304),0.5335411826062483,1.1575266395219896,0.3212996389891697,0.729587749840893,1.0,5/14,12.14%,FES;LYN;LGALS9;UNC13D;SYK
prerank,regulation of insulin secretion (GO:0050796),-0.31669006659380355,-1.1573746286812059,0.17624521072796934,0.7271095656969004,1.0,22/101,10.98%,CACNA1C;ADCY5;ITPR1;MCU;IRS1;EFNA5;NLGN2;RBP4;PER2;STXBP4;IRS2;SLC8B1;NNAT;PRKN;CACNA1D;CCN3;DPP4;CDK16;PRKCA;ITPR2;AACS;PPP3CB
prerank,negative regulation of synaptic transmission (GO:0050805),0.4730053457026827,1.1572202115601953,0.29519071310116085,0.7296150550231695,1.0,7/23,15.14%,SLC30A1;SLC24A2;STXBP1;PNKD;TMEM25;MTMR2;PLK2
prerank,cation transmembrane transport (GO:0098655),0.42907906576611393,1.1571499223950343,0.2646616541353383,0.7289924865563688,1.0,4/44,1.99%,SLC7A5;SLC7A1;SLC6A5;SLC38A5
prerank,protein autoubiquitination (GO:0051865),-0.348818289527882,-1.1569320605678934,0.2302839116719243,0.7269508817497461,1.0,12/61,12.07%,RNF220;SH3RF3;AMFR;SH3RF2;PRKN;LRSAM1;DDB2;CUL3;RNF10;WWP2;NFX1;RNF181
prerank,protein localization to vacuole (GO:0072665),0.5336511369222784,1.1561698271010896,0.31123388581952116,0.7308708544029087,1.0,5/13,15.78%,SH3BP4;LAMTOR5;SH3GLB1;LMBRD1;LAMTOR4
prerank,negative regulation of protein binding (GO:0032091),0.38958312084821345,1.1558549583275286,0.23413897280966767,0.7308886670353791,1.0,14/71,13.00%,PDGFB;CAV1;CTNNBIP1;B2M;NES;ADAM15;ZFPM1;ACTB;RALB;PIN1;DISC1;PEX14;MITD1;SLPI
prerank,establishment of protein localization to membrane (GO:0090150),0.400772431032633,1.1555378910908312,0.2689450222882615,0.7309621131672455,1.0,17/66,13.69%,AQP11;REEP1;ZDHHC14;PARD3;PIKFYVE;ZDHHC9;ZDHHC20;RAB11A;GRIN3B;ZDHHC19;RTP4;NPC1;ZDHHC18;ZDHHC22;RFTN1;SDCBP;NACAD
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.3997087479860942,-1.1550280692930115,0.25547445255474455,0.7310289268681672,1.0,7/31,4.61%,TGFBR3;BMPR1A;FGFR2;ZFPM2;TPM1;TGFBR1;RBPJ
prerank,dicarboxylic acid transport (GO:0006835),-0.41026965258987014,-1.1550057220595198,0.2344632768361582,0.7296618084005092,1.0,6/28,4.34%,SLC1A3;SLC13A3;PDPN;SLC26A7;GJA1;SLC22A6
prerank,integrin-mediated signaling pathway (GO:0007229),-0.3333486083529376,-1.1546747732909406,0.20743034055727555,0.7291408850694608,1.0,21/73,12.26%,ITGBL1;COL3A1;PLPP3;FBLN1;ITGB5;ITGB8;ITGA10;TEC;ADAM9;ITGA11;DAB2;COL16A1;ITGA5;FYB1;ITGB4;CUL3;ITGB1BP1;ITGAV;PTK2B;ADAMTS1;ABL1
prerank,heterocycle biosynthetic process (GO:0018130),0.5305692210198366,1.1545105669134628,0.32451499118165783,0.732910284138886,1.0,2/14,7.49%,GCH1;GPHN
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.422558913461474,1.154448944549855,0.2716417910447761,0.7322637051807611,1.0,11/45,18.00%,NANOS3;APP;NANOS1;TDRD7;CYFIP1;EIF4E;PUM3;ZC3H7A;GCNT2;ATG14;TRIM71
prerank,cardiac cell development (GO:0055006),-0.5130159022902807,-1.1541139977049644,0.28964059196617337,0.7293770789963918,1.0,4/11,8.12%,CXADR;SLC8A1;MYH11;JAG1
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3484909405674219,1.1537178437858975,0.22250639386189258,0.7334281246833185,1.0,46/190,14.33%,BCL2L1;DAB2IP;PDE2A;SH3BP4;XDH;CAV1;PHLPP1;PLAUR;PTPRJ;TNFAIP8L1;PIK3IP1;APLNR;CD2AP;HDAC7;DUSP3;LYN;TMSB4X;PDE4D;HYAL2;STAT1;PLEKHA1;RFFL;ARHGAP25;MCL1;ABCA7;P2RX7;MARK3;ZMYND11;OTUD7A;CASP8;DEPDC5;DDIT4;DUSP1;TLE1;GSK3A;ADIPOR1;TNFAIP3;PIK3CB;CYRIB;WWC1;TMEM127;CYLD;TRIM39;EPM2A;PDCD6;PDE3B
prerank,negative regulation of histone methylation (GO:0031061),-0.5130018474531302,-1.1534673565599443,0.31277533039647576,0.7298756346062565,1.0,6/10,34.08%,BCOR;KDM1A;BRCA1;AASS;MTF2;JARID2
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.41911162949088115,1.153316920308921,0.2730210016155089,0.7337393418797623,1.0,12/46,19.11%,PLCB1;PITPNA;PPIA;RAP1B;MSN;PSME2;TALDO1;CFL1;RALA;HSPA9;PAK2;BOLA2
prerank,contractile actin filament bundle assembly (GO:0030038),-0.4647319729082844,-1.1528549627795686,0.2937219730941704,0.7287479424360452,1.0,5/15,15.42%,ITGB5;ARRB1;PHACTR1;CUL3;ZYX
prerank,stress fiber assembly (GO:0043149),-0.4647319729082844,-1.1528549627795686,0.2937219730941704,0.7287479424360452,1.0,5/15,15.42%,ITGB5;ARRB1;PHACTR1;CUL3;ZYX
prerank,regulation of actin filament polymerization (GO:0030833),0.390751000009247,1.1525224218389736,0.25914634146341464,0.7350588358030794,1.0,13/69,8.42%,KANK3;ESAM;HIP1R;EVL;SSH2;VIL1;CCR7;BAIAP2;CDC42EP3;DBNL;NCKAP1;HCK;TWF2
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),-0.49552243269296253,-1.1524497605064672,0.2950108459869848,0.7271311152430168,1.0,3/12,15.59%,FHL2;DYRK2;HOMER3
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),-0.49552243269296253,-1.1524497605064672,0.2950108459869848,0.7271311152430168,1.0,3/12,15.59%,FHL2;DYRK2;HOMER3
prerank,tryptophan metabolic process (GO:0006568),-0.5072291573222039,-1.1522437537697277,0.297008547008547,0.7263443972896305,1.0,6/11,29.97%,ATP7A;KYAT1;KYNU;KMO;IL4I1;HAAO
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.4456576406524251,1.1521142090389398,0.26677577741407527,0.7353923761103457,1.0,10/33,16.53%,PTPRJ;PRKD2;DUSP3;UBASH3A;CD160;DGKZ;CEACAM1;BCL10;CARD11;TESPA1
prerank,blood vessel diameter maintenance (GO:0097746),-0.3818733137063486,-1.1520274798594812,0.2231638418079096,0.7255852317194188,1.0,12/34,15.15%,ROCK2;EDNRA;KCNMB2;PER2;SCPEP1;ACE;BDKRB2;AGTR1;ITGB1BP1;ADCY6;GCLC;ACE2
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.45151011703122856,1.1519627135896124,0.2750809061488673,0.7349867579187993,1.0,12/32,14.72%,PPP1R16B;ITGA1;CALM1;HSP90AB1;PPIA;PPP2R5A;TGFB1;PIN1;AGTR2;NSMF;CDH5;PPP1R15B
prerank,ventricular septum morphogenesis (GO:0060412),-0.4187039761877787,-1.1518607864263395,0.2627551020408163,0.7246596003766921,1.0,8/27,6.39%,ROBO1;TGFBR3;BMPR1A;BMP4;ZFPM2;SLIT2;TGFBR1;HEYL
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.4810216857820582,-1.1517601755683966,0.30337078651685395,0.7235759776637344,1.0,7/15,19.74%,STXBP4;GLI1;KLHL18;CUL3;PAF1;DDRGK1;EZH2
prerank,mucosal immune response (GO:0002385),0.5238116299702369,1.1517038558297568,0.3092224231464738,0.7348894663363323,1.0,2/15,4.55%,DEFA6;NOS2
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.4592209678745915,1.1516293834456188,0.3037300177619893,0.734264833494294,1.0,4/27,12.59%,ETS1;CCDC88B;TNFSF11;CYRIB
prerank,regulation of dendritic spine development (GO:0060998),0.4980428064003879,1.1514306173069706,0.3119584055459272,0.7339899029933936,1.0,3/19,6.95%,SHANK3;MEF2C;KIF1A
prerank,COPII-coated vesicle budding (GO:0090114),-0.3341255219890587,-1.1513575023236757,0.22340425531914893,0.7233383448890426,1.0,16/68,15.06%,SEC24D;SEC24A;USO1;GOLGA2;SAR1A;TRAPPC3;STX5;SEC31A;CUL3;SEC16B;SEC23A;SCFD1;SEC16A;LMAN1;CTSZ;TRAPPC10
prerank,inner ear morphogenesis (GO:0042472),-0.43378016300617805,-1.1513240626313215,0.2702078521939954,0.7220424620491025,1.0,6/22,7.27%,ZIC1;FGFR2;SIX1;TTC39C;TBX18;EPHB2
prerank,"wound healing, spreading of cells (GO:0044319)",-0.4163487048004289,-1.1511968607813228,0.2639593908629442,0.7210279588743076,1.0,8/24,10.46%,COL5A1;PDPN;ARHGAP24;DDR1;FLNA;CCN1;ITGA5;TMEFF2
prerank,cellular response to organic substance (GO:0071310),0.369018044382238,1.151177266838934,0.22823218997361477,0.7338087371535864,1.0,20/116,8.85%,LEF1;SLC1A1;PDGFB;BMPR2;NCOA1;PTPN12;ACVRL1;SIGIRR;RAMP2;SOCS2;CTNNB1;RAMP3;CYP11B1;CCR7;KLF4;NCOA2;TGFB1;CRNN;TWF2;PTPN5
prerank,nervous system development (GO:0007399),0.3251177894848613,1.1508652737886218,0.15308370044052863,0.7338678926817013,1.0,68/429,12.85%,SPOCK2;ST8SIA4;MPZ;DNM3;SLC2A1;SHANK3;SEMA6A;ZIC3;ADGRL3;MAL;TBX3;PCDH1;SEMA6B;NAV1;MEF2C;NES;PLXND1;KALRN;FGF13;CDH2;PCDHA11;DSCAML1;EVL;MERTK;ZBTB16;MOG;WWTR1;PCDHAC1;SEMA4F;DBNL;ATXN3;NCKAP1;FAT4;STMN3;DCHS1;PCDHA1;MARK4;PTN;NAV2;TGFB1;NFASC;DPYSL2;OPHN1;SLITRK1;GPM6A;CDK5RAP2;APBA2;CAPG;SPOCK1;NRXN1;DNER;SERPINI1;RITA1;DCX;THOC6;MOBP;VXN;EIF2B2;CHRM3;PCDHB12;RBM45;HMGCR;SOX10;RAPGEF5;FEZ2;CPNE6;EPHB1;PCDHB14
prerank,ion transport (GO:0006811),-0.31440400064641505,-1.1501621887293716,0.16532258064516128,0.7225861485536622,1.0,21/111,9.47%,SLC24A3;TRPM3;SLC1A3;PIEZO2;SLC26A7;SLC26A2;SLC8A3;SLC12A2;WNK4;ANO6;SLC9A2;SLC5A5;SLC12A7;SLC8B1;ANO1;SLC20A2;SLC8A1;TRPC6;SLC4A2;SLC9A9;GLRB
prerank,L-glutamate transmembrane transport (GO:0015813),0.5560695132771655,1.1496053875862164,0.31645569620253167,0.7365944925756028,1.0,2/10,5.09%,SLC1A1;SLC1A2
prerank,negative regulation of mRNA processing (GO:0050686),-0.4692659394539366,-1.1493590692885485,0.291196388261851,0.7236285937140536,1.0,7/15,20.67%,SRSF6;SRSF4;PCBP4;SAP18;C1QBP;U2AF2;SRSF10
prerank,muscle cell migration (GO:0014812),-0.5288714426760677,-1.1491886896846801,0.32172131147540983,0.7227171434253897,1.0,6/10,22.54%,DDR1;SIX1;CCN3;ITGB1BP1;ITGB3;THBS4
prerank,regulation of B cell activation (GO:0050864),0.46319142402501173,1.1490026618998372,0.3018867924528302,0.7374100123400541,1.0,8/25,20.19%,NOD2;CD19;ZFP36L1;TNFAIP3;FOXJ1;SH3KBP1;SAMSN1;ZFP36L2
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.3742325159710238,-1.148381813586028,0.24860335195530725,0.7236627061691437,1.0,7/39,9.93%,STEAP3;TANGO2;ABCA1;RCN3;ARFGAP3;TANGO6;CANX
prerank,cholesterol transport (GO:0030301),0.41739304411700995,1.1482924217514303,0.3052147239263804,0.7386505910146266,1.0,7/45,9.00%,CAV1;SCARB1;OSBP;ABCG1;LIPC;ABCA7;NPC1
prerank,megakaryocyte differentiation (GO:0030219),0.5462137523384517,1.147586787028293,0.33583489681050654,0.739811422845041,1.0,3/11,6.10%,ZFPM1;TAL1;CDKN2B
prerank,hydrogen peroxide metabolic process (GO:0042743),0.48451735951452135,1.1474273548623377,0.29930795847750863,0.7394589242757118,1.0,5/19,14.44%,PXDN;ACOX1;CAT;MAOB;PRDX5
prerank,fibrinolysis (GO:0042730),0.538252632856749,1.1468455717444617,0.30864197530864196,0.7402521266094344,1.0,2/13,8.59%,PLAUR;PLAT
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.5361993903800056,1.1467848865041923,0.3248175182481752,0.739608437323052,1.0,7/13,22.14%,ATF6B;ABCA7;PPP1R15B;NCK1;DNAJB9;BFAR;RACK1
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.4399253308232689,1.1467673659144706,0.2755267423014587,0.7388416922091633,1.0,7/33,12.37%,IGF1R;PLEKHA1;CD160;HTR2A;PIK3C2A;ZFP36L1;PIK3CB
prerank,cGMP metabolic process (GO:0046068),0.5468384922490304,1.1465221605709668,0.3233082706766917,0.7387804198037984,1.0,4/12,13.22%,PDE2A;NPPA;NPR1;NPR2
prerank,negative regulation of protein metabolic process (GO:0051248),-0.3541774674178967,-1.146426207503062,0.23714285714285716,0.7280476181876008,1.0,16/48,19.78%,EGFR;MDM4;SNX12;FLOT2;FLNA;PFDN5;APOE;LDLR;ITGAV;AZIN1;IRAK3;SIRT2;CRYAB;INHBB;ITGB3;MAD2L1
prerank,phosphate-containing compound metabolic process (GO:0006796),0.3449294831645727,1.1463906828858463,0.20248447204968945,0.7383234135127488,1.0,37/198,13.29%,PLCB1;PTPRB;PLCB4;ITPKB;GPD2;INPP5D;DUSP23;PLA2G4B;DUSP3;PLCG1;CALM1;PLD4;LIMK2;OCRL;MAPK3;CERKL;TGFB1;PGM2L1;PLCH2;PAK1;PFKFB3;NUDT3;ACP4;TOLLIP;HK1;PPP3CA;DUSP12;PLCH1;PIP4K2A;IPMK;INPP1;TNK2;PIK3CB;PANK3;DUSP16;G6PC3;CERK
prerank,transcription by RNA polymerase III (GO:0006383),0.4565560303775223,1.146243092137655,0.30434782608695654,0.7379316494984476,1.0,6/27,14.82%,IVNS1ABP;GTF3A;GTF3C5;RO60;SNAPC1;CRCP
prerank,lipoprotein transport (GO:0042953),-0.5192198642723954,-1.1460250758215005,0.3080260303687636,0.7277626555327976,1.0,1/10,0.53%,LRP1
prerank,phosphate ion homeostasis (GO:0055062),-0.5180973744602138,-1.1458639191756164,0.3054298642533937,0.7268650284952203,1.0,2/10,6.64%,ENPP1;SFRP4
prerank,synaptic vesicle exocytosis (GO:0016079),0.43227514966426267,1.1451850905352212,0.28125,0.7399461729905015,1.0,9/40,13.36%,UNC13B;STX3;STX1A;PIP5K1C;SYT7;DNAJC5;STX19;SNAP29;CPLX1
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.38239896479369423,1.1443497597383436,0.24963715529753266,0.7414224719565004,1.0,13/73,12.30%,APP;TIRAP;PTPRJ;ARHGEF2;NOD2;IFIH1;TLR3;LGALS9;AGER;HSPB1;SYK;DDT;C1QTNF4
prerank,calcium ion transport into cytosol (GO:0060402),-0.4306162029866736,-1.1443161470875753,0.2803970223325062,0.7299755725580912,1.0,4/21,12.06%,CACNA1C;CACNA2D1;SLC8A1;JPH1
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.36473022929355653,1.1440500538243459,0.2074966532797858,0.7414106148766286,1.0,27/118,13.10%,ETS1;SHANK3;TBX1;FLT4;NEDD4L;MEF2C;PLXND1;SP100;CDH2;VASH1;LZTS1;CTNNB1;TSPAN12;EPHA4;KIF1A;INF2;TGFB1;PAK1;STRIP1;PDZD8;FERMT2;ABI3;TNFAIP3;CEACAM1;CYRIB;EGLN1;NSMF
prerank,regulation of AMPA receptor activity (GO:2000311),0.4760851382756662,1.1435320780817413,0.296551724137931,0.7420439490351239,1.0,6/25,16.00%,SHANK3;MEF2C;SHISA6;CNIH3;MINK1;NLGN1
prerank,organelle fission (GO:0048285),0.4699751990205536,1.1435314684921671,0.29233226837060705,0.7412382552793855,1.0,1/24,0.16%,DNM3
prerank,cellular response to interleukin-12 (GO:0071349),0.4108183263163299,1.1434074079972705,0.2838709677419355,0.7407897560847345,1.0,12/48,19.11%,PLCB1;PITPNA;PPIA;RAP1B;MSN;PSME2;TALDO1;CFL1;RALA;HSPA9;PAK2;BOLA2
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.4489514434926952,1.1433607290221108,0.2917341977309562,0.7401322696023585,1.0,10/31,16.00%,SHANK3;LRP8;EPHA4;DBNL;KIF1A;EFNA1;ABI3;CFL1;CAMK2B;NLGN1
prerank,positive regulation of reproductive process (GO:2000243),0.44803146492014645,1.1429761176125632,0.3052147239263804,0.7403766258768506,1.0,2/31,1.62%,PLCB1;LHFPL2
prerank,serine family amino acid biosynthetic process (GO:0009070),0.5336801609875224,1.1429218633243494,0.32575757575757575,0.7397166200716847,1.0,3/12,9.86%,SERINC3;SERINC5;CBS
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.4406667857632303,1.1428755484803068,0.2711598746081505,0.739033934341539,1.0,3/36,2.29%,SPTBN1;MACF1;RAB31
prerank,negative regulation of inflammatory response (GO:0050728),0.34529672437576253,1.142788647248749,0.21528662420382166,0.7384665514884593,1.0,37/182,14.52%,TEK;MFHAS1;PPARD;CD200;RHBDF2;RAMP2;CALCRL;LYN;PLCG1;CREB1;RAMP3;PRKACB;FYN;INSL3;YES1;KLF4;ADCY4;HCK;PRKAR2B;CD200R1;NPS;CALCB;LPCAT3;ADAM17;PRKAR2A;ADCYAP1R1;SHARPIN;CYSLTR1;CD163;SYK;TNFAIP3;PPARG;GNB1;CDH5;GIT1;RXFP2;HTR4
prerank,mammary gland development (GO:0030879),0.48880228015869576,1.1427698626202647,0.31141868512110726,0.7377298304590176,1.0,4/21,5.83%,NOTCH4;CAV1;TBX3;OXTR
prerank,cellular response to radiation (GO:0071478),0.4267191161002948,1.1423182971979637,0.288135593220339,0.7381458350124559,1.0,13/40,22.12%,NET1;GRB2;RHOB;OPN5;GPR52;OPN3;EEF1D;RRH;HUS1;NSMCE3;RAD9B;INO80;RAD1
prerank,regulation of focal adhesion assembly (GO:0051893),0.4061266748664448,1.142252300394806,0.27439024390243905,0.7375495987092993,1.0,8/54,3.74%,TEK;LIMCH1;KDR;MACF1;PTPRJ;PTK2;ACVRL1;DUSP3
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.5339964842343046,1.1411387967915747,0.3234750462107209,0.7398677228388515,1.0,6/13,23.53%,ARID1A;SMARCD1;SPI1;SERTAD2;PADI2;ZMIZ2
prerank,COPII vesicle coating (GO:0048208),-0.33609037015395044,-1.1411156392295707,0.2328767123287671,0.7352147698510064,1.0,15/61,15.06%,SEC24D;SEC24A;USO1;GOLGA2;TRAPPC3;STX5;SEC31A;CUL3;SEC16B;SEC23A;SCFD1;SEC16A;LMAN1;CTSZ;TRAPPC10
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.33609037015395044,-1.1411156392295707,0.2328767123287671,0.7352147698510064,1.0,15/61,15.06%,SEC24D;SEC24A;USO1;GOLGA2;TRAPPC3;STX5;SEC31A;CUL3;SEC16B;SEC23A;SCFD1;SEC16A;LMAN1;CTSZ;TRAPPC10
prerank,vesicle coating (GO:0006901),-0.33609037015395044,-1.1411156392295707,0.2328767123287671,0.7352147698510064,1.0,15/61,15.06%,SEC24D;SEC24A;USO1;GOLGA2;TRAPPC3;STX5;SEC31A;CUL3;SEC16B;SEC23A;SCFD1;SEC16A;LMAN1;CTSZ;TRAPPC10
prerank,regulation of postsynapse organization (GO:0099175),0.4560346432230098,1.1407756752194214,0.2902711323763955,0.7400362374736066,1.0,5/28,6.95%,SHANK3;EPHA4;HOMER1;ABHD17A;KIF1A
prerank,regulation of cellular amide metabolic process (GO:0034248),0.4345600848215029,1.1404879069921086,0.30551181102362207,0.7400162567719841,1.0,6/32,13.66%,NANOS3;APP;CYFIP1;EIF4E;PUM3;PGAM1
prerank,neural tube closure (GO:0001843),-0.37900345022731136,-1.1399389472004229,0.28254847645429365,0.7372037289842719,1.0,17/34,20.98%,LMO4;COBL;PLXNB2;KDM2B;MTHFD1;IFT122;MTHFR;FUZ;SKI;CELSR1;DVL2;LRP6;STIL;PAX2;MTHFD1L;DVL3;BBS4
prerank,positive regulation of leukocyte migration (GO:0002687),0.46160101934439585,1.1398688698966368,0.31343283582089554,0.7409196874958788,1.0,5/27,15.04%,IL6R;PTN;ADAM17;PLVAP;NCKAP1L
prerank,negative regulation of macroautophagy (GO:0016242),-0.40959325731971197,-1.1397069521482595,0.2827763496143959,0.7364680221421277,1.0,11/26,20.01%,NUPR1;NRBP2;TMEM39A;LRRK2;CLEC16A;SCFD1;FEZ1;PHF23;SMG1;SMCR8;TSC1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.5568752320508705,1.1394514340566217,0.34345351043643263,0.7412872898753061,1.0,3/10,10.02%,FBXW7;TGFA;ADAM17
prerank,negative regulation of nervous system development (GO:0051961),0.4845277178879863,1.1392124610851955,0.3222416812609457,0.7411944929592366,1.0,3/17,4.29%,B2M;NOTCH1;WNT7A
prerank,response to interferon-beta (GO:0035456),0.4805110356859173,1.1390795578856765,0.3305227655986509,0.740743474743823,1.0,6/22,8.01%,IFNAR2;XAF1;STAT1;AIM2;BST2;IRGM
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.5534372302683161,1.1386220031699963,0.3333333333333333,0.7411901338669027,1.0,2/11,8.34%,ITM2A;ABCA7
prerank,negative regulation of protein modification process (GO:0031400),0.38094301816616866,1.1384850989184536,0.26657263751763044,0.7407703358142098,1.0,13/79,7.94%,OCLN;MFHAS1;PPP1R16B;DAB2IP;PRR5L;XDH;NIBAN1;MEN1;LYN;WWTR1;PPIA;INSM1;TGFB1
prerank,positive regulation of chemotaxis (GO:0050921),0.42116892249216326,1.1383558454829046,0.3028919330289193,0.7403190494854078,1.0,11/43,11.20%,PDGFB;KDR;IL6R;STX3;PRKD2;PRKD1;TMSB4X;PTN;TGFB1;ADAM17;HSPB1
prerank,cellular response to glucose starvation (GO:0042149),-0.36658370486971836,-1.1379916811855293,0.24468085106382978,0.7399770500744914,1.0,7/41,10.19%,PRKAG2;PRKAA2;IMPACT;FOXO3;MTMR3;NUAK1;PRKAG3
prerank,positive regulation of nuclear division (GO:0051785),0.4704255568071437,1.1378646918885997,0.31699346405228757,0.7408531509265823,1.0,6/25,8.67%,PDGFB;INSR;RGCC;NPM2;LRP5;TGFA
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.47520460281869054,1.1375452005378928,0.3153310104529617,0.7409466654975909,1.0,4/21,3.74%,LIMCH1;MACF1;PTK2;DUSP3
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.4283908947083999,1.1374269930357717,0.2955271565495208,0.7404578937377445,1.0,11/39,12.08%,DAB2IP;ITGA1;PTPRJ;PTPN12;DUSP3;GRB2;TGFA;ARHGEF7;ACP4;EPS15;HGS
prerank,positive regulation of T cell differentiation (GO:0045582),0.43332427282105435,1.136851414572333,0.3215434083601286,0.7411728681804339,1.0,2/36,3.68%,LEF1;ZAP70
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.5119076262662774,-1.1367479307809034,0.3051224944320713,0.7422420184755643,1.0,4/11,9.10%,DAB2;RAB21;PRKN;EZR
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.5220234249808582,1.1367458368988406,0.33639705882352944,0.7406795231347628,1.0,5/13,12.41%,NOTCH1;FOXF1;NPY5R;GSK3A;TGFBR2
prerank,epithelium development (GO:0060429),-0.30813851680208676,-1.1363745356330937,0.2084942084942085,0.7419414448655895,1.0,22/107,8.79%,ALDH1A2;ERRFI1;WNT4;FGFR2;KANK2;OSR1;MEOX2;PKD1;SMO;SALL1;VCL;LOXL3;DAG1;PKD2;ANXA4;SIX1;RCN3;DACT1;CNN3;BDH2;MTHFD1;IFT122
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.5433289904793127,1.1360452301049446,0.32656826568265684,0.7417745745888072,1.0,6/11,18.38%,KCNQ1;ATP1A1;KCNH2;KCNJ5;KCNJ3;KCNIP2
prerank,regulation of phagocytosis (GO:0050764),0.40887761654227417,1.135998345380192,0.28858024691358025,0.7411155685183219,1.0,14/53,17.04%,DYSF;SCARB1;MERTK;TGM2;SNX3;GATA2;SYT7;HCK;ABCA7;SYK;IL15;DOCK2;GAS6;LYAR
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.4934410901260019,1.1359569973555261,0.30685920577617326,0.7404526013889755,1.0,5/16,10.33%,PDGFB;PDGFD;PTPRJ;PLAT;PIK3C2A
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.5010120270576013,1.1359443636373507,0.3249581239530988,0.7397054998014597,1.0,5/18,10.02%,MTUS1;IL6R;LYN;PTN;ADAM17
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.3753811469275993,1.1357615049013066,0.2471264367816092,0.7393967913204463,1.0,24/76,18.62%,TEK;FES;NES;EVL;VIL1;CCR7;BAIAP2;CDC42EP3;NCKAP1;HCK;P2RX7;PFDN2;HRAS;NCKAP1L;SPAG5;NCK1;FCHSD1;EDN1;BIN1;NRP1;PROX1;WDR1;PRKCE;TENM1
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.3617969102512585,1.1351576582377632,0.2601626016260163,0.7402388471947611,1.0,24/107,13.96%,SLC39A10;SLC39A8;CXCL12;CAV1;CD40;SLC30A1;ATP2C1;SLC24A4;SLC24A2;ATP2B1;SLC10A7;HTR2A;CALCB;CCL1;CSRP3;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;CDH5
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.4598313933787318,-1.135082299762336,0.29954954954954954,0.7444440192628154,1.0,5/16,11.46%,DDX5;PPARGC1B;AR;DDX17;ESR1
prerank,negative regulation of cilium assembly (GO:1902018),0.5357134344350766,1.1349774697564183,0.35315315315315315,0.7399685949746159,1.0,5/12,11.94%,MAP4;LIMK2;CCP110;ODF2L;TBC1D30
prerank,circulatory system development (GO:0072359),0.36167764011890774,1.1349471739463175,0.253315649867374,0.7392687880350364,1.0,17/118,4.39%,TEK;RBM20;PDGFB;TGFB2;NOTCH4;HEG1;TBX1;SOX17;FLT4;MEF2C;ACVRL1;ZFPM1;APLNR;NOTCH1;HDAC9;RAMP2;FOXF1
prerank,regulation of ruffle assembly (GO:1900027),0.47368550839195184,1.1346393223689029,0.29809358752166376,0.7393734225011415,1.0,9/23,16.00%,CAV1;EVL;EPS8;EPS8L2;ABI3;PLEKHM1;HRAS;FAM98A;NLGN1
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.5167729533266984,1.1342242579475528,0.33393501805054154,0.739676511961251,1.0,3/15,11.57%,NLRC5;SAMHD1;USP18
prerank,aerobic respiration (GO:0009060),-0.4243068039166779,-1.1338406868316424,0.2989010989010989,0.7466953932414825,1.0,9/20,19.81%,SIRT3;SDHC;MDH2;SDHB;MTFR1;SLC25A14;SURF1;MTFR2;UQCRC2
prerank,negative regulation of cellular process (GO:0048523),0.3171024731050196,1.1337471489830133,0.15778251599147122,0.7401774336486474,1.0,78/521,11.25%,ETS1;SRGAP2;PODXL;AQP11;DAB2IP;CD34;APBB2;BMPR2;TGFB2;PPP1R13B;NOS3;NOTCH4;RAPGEF2;SH3BP4;JAM2;APP;DDAH1;TBX1;ITGA1;PDE8A;SOX17;CD200;DYSF;CTTNBP2NL;DCUN1D3;ADGRG1;PTPRJ;RGCC;PLXND1;SMARCA2;SP100;SIPA1;ADAM15;ACVRL1;CCDC85B;NOTCH1;PRKD1;MEN1;LYN;PPP1R9B;TNFRSF21;SNX3;CTNNB1;IGFBP7;SOX7;PIWIL1;DLL4;HYAL2;BTG4;ST18;RHOB;CDKN2B;WFDC1;ADAM10;KLF4;NR1H2;ACTN1;INSM1;BST2;TGFB1;TMEM115;FOXP3;ADAMTS8;NPR1;BNIP3L;HMGA1;ARHGDIA;LPCAT3;AXIN2;BTG1;CBLL1;AGTR2;CDC6;PDE12;CTCF;FERMT2;DUSP1;PLXNB3
prerank,positive regulation of endopeptidase activity (GO:0010950),0.4493367542242761,1.1334819437407526,0.31841652323580033,0.7401355421191361,1.0,10/26,12.21%,LYN;EPHA4;FYN;AIM2;EFNA1;PSME2;AGER;GRIN2B;APH1A;VSIR
prerank,determination of bilateral symmetry (GO:0009855),0.47693653022082283,1.1333675354273771,0.3310924369747899,0.7396531518430054,1.0,6/24,15.53%,ZIC3;TBX1;NOTCH1;KIF3B;FOXJ1;DNAH5
prerank,transcription preinitiation complex assembly (GO:0070897),0.5440015198487856,1.1332728282198166,0.34386617100371747,0.7391326217030441,1.0,9/12,34.55%,TAF1B;TAF7L;GTF2B;BDP1;TAF7;GTF2A2;DR1;TAF11;TAF12
prerank,positive regulation of binding (GO:0051099),0.3788965132138596,1.1332169563310117,0.26390870185449355,0.7385096002920717,1.0,12/84,4.05%,CLDN5;RAPGEF2;APP;CAV1;HIP1R;PLAUR;B2M;EPB41;TIAM1;MEN1;HMBOX1;STMN1
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.37843896963760154,1.13316241368803,0.2684659090909091,0.7378741501541215,1.0,28/80,16.24%,OCLN;WASF2;FNBP1L;PALM;AGRN;EPS8;CCR7;CDC42EP3;EPS8L2;CCDC88A;CCP110;NCKAP1;MARK4;GPM6A;P2RX7;TWF2;CYFIP1;CLRN1;RAC1;PLEKHM1;HRAS;FSCN1;FAM98A;ANLN;NLGN1;ACTR2;APC;RALA
prerank,peptidyl-lysine modification (GO:0018205),-0.31309421417404387,-1.1330757668953444,0.2126865671641791,0.7474768296286265,1.0,20/99,14.07%,EYA1;LOXL1;PLOD2;HDAC4;LOXL3;PIAS1;SEH1L;P3H3;NNAT;LOX;ATP7A;SIRT3;NUP205;SENP3;TRPM4;SENP6;SENP7;PIAS2;EP300;SIRT2
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.47401799349504337,-1.1330384251917058,0.31221719457013575,0.7462135939330911,1.0,7/14,20.67%,SRSF6;SRSF4;PCBP4;SAP18;C1QBP;U2AF2;SRSF10
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.40596362894460086,-1.132821782935007,0.26535626535626533,0.7455062610361142,1.0,5/26,5.92%,SULF1;CCBE1;SULF2;RORA;CYP1B1
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.4083025148810143,1.1325265296215838,0.29475308641975306,0.7388051925064713,1.0,7/46,8.18%,SEMA6A;DAB2IP;CNKSR3;DUSP3;LYN;PTPRR;PIN1
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.48484119581668733,1.1324319581175868,0.324468085106383,0.7382855978198015,1.0,5/20,8.39%,ENTPD1;APP;HSP90AB1;ENTPD5;P2RX7
prerank,organic cation transport (GO:0015695),-0.43440571939469536,-1.1322813819929065,0.2847058823529412,0.7457658004736559,1.0,6/20,17.69%,SLC47A1;SLC22A4;SLC22A18;SLC5A7;SLC22A2;SLC25A29
prerank,response to cholesterol (GO:0070723),-0.44800346636657395,-1.1320705094768226,0.3076923076923077,0.7450010508703753,1.0,11/17,30.40%,SMO;TGFBR1;GRAMD1B;GRAMD1C;LRP6;GRAMD1A;PTCH1;MLC1;PMVK;SMAD2;GPLD1
prerank,translesion synthesis (GO:0019985),0.4222955718247424,1.131883319853335,0.30672926447574334,0.7389900972058941,1.0,2/42,2.24%,POLK;TRIM25
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.4429776280821945,-1.1314136427136152,0.28776978417266186,0.7455641479601416,1.0,10/19,30.83%,GFPT1;RENBP;GFPT2;SLC35D1;PGM3;NAGK;UAP1;UAP1L1;GNPDA1;PMM1
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.4465339369383239,-1.1303888722758195,0.3087885985748218,0.7471127080605274,1.0,7/17,16.23%,ARRB1;ANXA4;ANXA1;SSC5D;PTPN22;MAP2K5;MAPKBP1
prerank,regulation of myoblast fusion (GO:1901739),-0.5187753659063319,-1.1303552976707083,0.3333333333333333,0.7458586036342795,1.0,4/11,16.69%,RIPOR2;EHD1;MAPK14;EHD2
prerank,glucose homeostasis (GO:0042593),0.38008762789494377,1.1299169762235097,0.25396825396825395,0.7433257886092931,1.0,6/83,5.05%,IGF1R;INSR;ADIPOR2;KLF7;FOXO1;CYP11B1
prerank,cardiac myofibril assembly (GO:0055003),-0.447743033471627,-1.129782436214963,0.29550827423167847,0.7460956065401332,1.0,3/15,3.87%,PDGFRB;PDGFRA;OBSL1
prerank,positive regulation of wound healing (GO:0090303),-0.37034772340540556,-1.129580363341604,0.24776119402985075,0.7453354252108678,1.0,9/36,5.42%,PLPP3;VTN;MYLK;ST3GAL4;KANK1;SMOC2;THBS1;FOXC2;ANXA1
prerank,mRNA metabolic process (GO:0016071),-0.31489485694153796,-1.129084581931138,0.23552123552123552,0.7454628015743777,1.0,26/90,21.75%,DDX5;PPARGC1A;SON;SRSF5;SRSF11;PCF11;AKAP8L;SRRM4;CPSF3;PRKACA;SRSF4;RNASE4;HNRNPR;PRMT9;NONO;HNRNPA2B1;PCBP2;LSM10;PRPF3;PRPF18;U2AF2;LSM3;U2AF1;TCERG1;CSTF3;AURKAIP1
prerank,embryonic digit morphogenesis (GO:0042733),-0.4397259402408422,-1.1289606105065038,0.3,0.7444415528355249,1.0,4/18,4.42%,GLI3;OSR1;SALL1;WDPCP
prerank,postreplication repair (GO:0006301),0.42117637793451707,1.1288451133609603,0.2981651376146789,0.7453470281482414,1.0,5/45,10.07%,POLK;TRIM25;UBE2V2;USP43;UBE2V1
prerank,positive regulation of telomerase activity (GO:0051973),0.4427984559200126,1.1288132091959644,0.3105691056910569,0.7446790712219769,1.0,14/33,25.53%,HMBOX1;CTNNB1;HSP90AB1;MAPK3;KLF4;GREM1;ACD;MAPK1;NAF1;MAP2K7;NVL;PTGES3;MYC;PNKP
prerank,regulation of small molecule metabolic process (GO:0062012),-0.397644788010021,-1.1285602586126378,0.27692307692307694,0.7442403610126171,1.0,5/28,8.31%,PDK1;PPARA;RORA;PRKN;APOE
prerank,negative regulation of potassium ion transport (GO:0043267),0.5230933355534851,1.1283954340639524,0.33025830258302585,0.7450543657285562,1.0,3/13,8.04%,CAV1;NEDD4L;KCNH2
prerank,regulation of protein processing (GO:0070613),-0.43057956703381417,-1.1281951467549365,0.3025,0.7439712525913544,1.0,7/21,14.65%,CCBE1;GAS1;SNX12;CLN3;LRRK2;NKD2;SERPINE2
prerank,postsynaptic membrane organization (GO:0001941),0.49564541336125867,1.1281011967983101,0.3400735294117647,0.7450665964289903,1.0,4/17,9.31%,SHANK3;CHRNB1;GPHN;NRXN1
prerank,positive regulation of cellular respiration (GO:1901857),0.5385822996969949,1.1277751674389775,0.3233644859813084,0.74519595381776,1.0,2/11,3.49%,IFNAR1;IL10RB
prerank,mesenchyme development (GO:0060485),-0.4602634730592926,-1.1277323418063918,0.31627906976744186,0.7439648866862806,1.0,5/15,4.80%,BMP7;FGFR2;BMP4;TGFBR1;PKD2
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.5003766106960938,1.1274051019624898,0.35,0.7454744686000881,1.0,4/15,11.75%,NOD2;GBP5;CD6;HIF1A
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.3659477537555071,1.1274015474748258,0.2729766803840878,0.744714826486629,1.0,13/113,4.45%,TEK;EGFL7;PDGFB;KDR;PPP1R16B;BMPR2;TBX1;FLT4;NOD2;PRKD2;PRKD1;WNT7A;RREB1
prerank,negative regulation of cholesterol transport (GO:0032375),-0.4939116244037158,-1.1272627461583151,0.3347547974413646,0.7439357452573874,1.0,8/10,50.63%,APOC1;SHH;NFKB1;SREBF2;ABCA2;ABCG5;APOA2;PLA2G10
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.4486506995892533,1.1271836646409699,0.2992,0.7444927316979364,1.0,7/30,5.22%,ARHGEF3;NET1;F11R;ADGRG1;LPAR6;PRAG1;P2RY10
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.4633447128078084,-1.1266490942949652,0.3076923076923077,0.7443531058707382,1.0,7/15,19.87%,PRKCD;SMPD3;SIRT3;NSMAF;SPHK1;PLA2G6;ORMDL2
prerank,protein dephosphorylation (GO:0006470),0.35273268284059905,1.1264017131413597,0.25647668393782386,0.7457763544827832,1.0,21/135,11.19%,PTPRG;PTPRM;PTPRB;CTTNBP2NL;PTPRJ;PPM1L;DUSP7;PTPN12;SSH2;DUSP3;PPP3CC;PPP4R1;PPP2R5A;PTPRR;MTMR6;PTPN5;PPP1CB;SSU72;PPP3CA;DUSP12;DUSP1
prerank,negative regulation of receptor binding (GO:1900121),0.5483611406642042,1.12634466030293,0.3161904761904762,0.7451425756758491,1.0,2/10,3.09%,B2M;ADAM15
prerank,oligodendrocyte development (GO:0014003),0.49878942274165,1.1261622214798672,0.3454861111111111,0.7448593907263663,1.0,9/15,28.85%,B4GALT5;EIF2B1;EIF2B2;SOX10;TPPP;EIF2B4;MYRF;PLP1;HES5
prerank,myeloid leukocyte differentiation (GO:0002573),0.3925376716954257,1.126020694787898,0.2972582972582973,0.7444687809808948,1.0,12/65,13.73%,LEF1;TNFRSF11A;CCR7;CD4;PIR;LGALS9;TNFSF11;CASP8;PPARG;TGFBR2;IL15;MT1G
prerank,regulation of lamellipodium organization (GO:1902743),-0.4607146422464411,-1.1259135807968308,0.3161290322580645,0.7451813707758687,1.0,3/14,2.66%,PDPN;CARMIL1;CAPZB
prerank,macrophage chemotaxis (GO:0048246),-0.49629055086077956,-1.1254628553108599,0.3235294117647059,0.745251384118962,1.0,7/10,47.94%,CKLF;CCL2;CCL5;TAFA4;CXCL17;CCL3;LGALS3
prerank,prostaglandin metabolic process (GO:0006693),-0.40103107979822783,-1.1254422317973372,0.3139240506329114,0.7440065287149003,1.0,5/26,9.48%,PTGDS;PTGIS;PTGS1;PTGES;PTGR2
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.3319540673469953,1.124900731170749,0.2322053675612602,0.7467732093248179,1.0,47/259,13.77%,DNM3;ABCC4;FGD5;PARVB;ABLIM1;SRGAP2;RAPGEF2;FNBP1L;NTN1;EXOC6;S1PR1;SPATA13;MTSS1;NOTCH1;CD2AP;CNGA2;PPP1R9B;CEP83;POC1B;CDC14A;CFAP52;CCDC88A;DYNLL1;OCRL;RAB11A;RAP1B;TTLL3;OPHN1;P2RX7;ARHGEF7;DISC1;FGD6;CYFIP1;KIF3B;EXOC4;RAC1;CFAP54;MAP4K4;EHD4;EXOC2;SNAP29;RAB1A;SDCBP;FGD2;BBIP1;FSCN1;MINK1
prerank,negative regulation of cell development (GO:0010721),-0.4060801129346637,-1.1248179919748615,0.2914691943127962,0.7444885794880765,1.0,3/25,1.30%,IGF1;FBN1;APPL2
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.4458274737233186,1.1244043525405227,0.3248407643312102,0.7473100420651302,1.0,3/30,5.18%,BCL2L1;CXCL12;SNAI2
prerank,homeostasis of number of cells (GO:0048872),0.5293492164962392,1.1241393598240967,0.3513011152416357,0.7472691028122314,1.0,3/12,9.84%,NOS3;NOTCH1;LPCAT3
prerank,chromosome condensation (GO:0030261),0.43177205701551097,1.1240916246491248,0.30359937402190923,0.7466335415871107,1.0,10/36,18.92%,TENT4A;NCAPH;MCPH1;DFFB;NCAPG;BANF1;CSNK2B;TTN;SET;NCAPH2
prerank,positive regulation of autophagy (GO:0010508),0.3774568218869361,1.1240824449889304,0.2869318181818182,0.7458969862915334,1.0,21/81,15.14%,KDR;SH3BP4;TRIM14;FOXO1;PRKD1;CAMKK2;SESN3;IRGM;BNIP3L;EIF2AK4;PIK3C2A;GSK3A;SH3GLB1;ORMDL3;PIK3CB;SVIP;TFEB;EPM2A;PIM2;TMEM59;PLK2
prerank,ethanol metabolic process (GO:0006067),-0.4824615904510683,-1.1240540777445243,0.33636363636363636,0.7454130859950632,1.0,1/12,0.30%,ALDH1A1
prerank,RNA destabilization (GO:0050779),-0.4484326274235349,-1.123391346105772,0.3160270880361174,0.7459099849842252,1.0,5/18,24.35%,ROCK2;YTHDF1;RBM24;ZC3H18;MEX3D
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.4325347243209553,-1.1232141498982167,0.3333333333333333,0.745143035187089,1.0,6/20,10.79%,GRK3;MGRN1;MET;BICD1;GPRASP1;RPGRIP1L
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.41234295643656105,-1.1231671305101203,0.28743961352657005,0.7439645949083141,1.0,9/24,10.46%,PHLDB2;ARHGAP6;ARHGAP28;ARAP1;CGNL1;ARHGEF18;MET;MYOC;TMEFF2
prerank,negative regulation of lipid storage (GO:0010888),0.494389041759082,1.122890575792634,0.3333333333333333,0.7482770066020495,1.0,4/19,6.99%,PPARD;NFKBIA;ABCG1;NR1H2
prerank,regulation of protein modification process (GO:0031399),0.41388607348875445,1.1228813916563765,0.3055555555555556,0.7475402781820578,1.0,12/50,13.96%,PPP1R16B;PTK2;LYN;FNIP2;CCDC88A;PIN1;ASPSCR1;HPF1;PARG;HSPB1;PUM3;CDH5
prerank,positive regulation of neurogenesis (GO:0050769),-0.3291924091753034,-1.122618456564283,0.2613240418118467,0.7442960314446342,1.0,19/68,13.27%,ROBO1;PLXNA2;TIAM2;SLIT2;CUX1;OBSL1;NGF;FBXW8;PLXNB2;SERPINF1;FZD3;SMARCD3;CUL7;NUMBL;CAPRIN2;MAP6;KDM1A;ROBO2;CDKL3
prerank,vitamin transport (GO:0051180),0.446052338780466,1.1223722502228899,0.3256578947368421,0.7481503173932545,1.0,5/29,11.10%,ABCG2;SLC52A2;SLC25A32;SLC52A3;AMN
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.38665263590061427,-1.121673996112172,0.29198966408268734,0.7458060554503858,1.0,6/30,6.64%,FSTL1;TGFBR3;SMAD3;DKK3;TWSG1;SFRP4
prerank,long-chain fatty acid metabolic process (GO:0001676),0.38844544410053133,1.1216280017827744,0.3034379671150972,0.7493199381249225,1.0,15/64,13.67%,CYP2E1;PLA2G4B;ACSL5;CPT1A;ACOX1;ACSL6;ELOVL5;AIG1;ACSL3;ABCD1;ELOVL6;SLC27A2;PNPLA8;HACL1;LTA4H
prerank,negative regulation of establishment of protein localization (GO:1904950),0.5627959765374266,1.1215535528489153,0.3435114503816794,0.7487642893520274,1.0,6/10,17.23%,CORO2B;SNX3;NDFIP2;TERF1;DNAJA1;PPM1F
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.5242720105043324,1.1203611360653636,0.3563636363636364,0.7511242281842497,1.0,3/13,9.84%,AQP11;NR1H2;LPCAT3
prerank,phosphatidylcholine catabolic process (GO:0034638),0.5339545841776164,1.1202115091425886,0.3494809688581315,0.7507227902353336,1.0,3/10,12.90%,LIPC;ENPP2;PNPLA8
prerank,mitochondrial fusion (GO:0008053),-0.4325557488651045,-1.1201798655547421,0.30786516853932583,0.7486515428825197,1.0,5/18,14.18%,MIGA2;MIEF1;AFG3L2;MFN2;MIEF2
prerank,lymphocyte proliferation (GO:0046651),0.4648654635326181,1.1200565754881715,0.3310344827586207,0.7503846802120562,1.0,6/22,13.14%,MEF2C;CD40;CD79A;MSN;TNFRSF4;HELLS
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.5483436962995369,1.1196211176230964,0.3563636363636364,0.7508151278186971,1.0,3/10,6.62%,SIGIRR;PALM3;KLF4
prerank,positive regulation of apoptotic process (GO:0043065),0.3275412814947125,1.1194103374472986,0.22235023041474655,0.7506709158892162,1.0,36/293,8.71%,MCF2L;ITGA6;ARHGEF3;DAB2IP;TGFB2;RASGRF2;FAS;NET1;UNC13B;HIP1R;PLEKHG5;TPD52L1;DCUN1D3;TNFSF10;ARHGEF2;RYBP;KALRN;FOXO1;FOXL2;TIAM1;ABR;TGM2;CTNNB1;RHOB;SOS1;CRADD;ARHGEF12;RNPS1;DNM2;IRF5;JMY;JUN;PREX1;ARHGEF5;PIDD1;ARHGEF7
prerank,renal filtration (GO:0097205),0.5341642768801229,1.1191732889544506,0.3511450381679389,0.7505494733917605,1.0,2/10,1.06%,MYO1E;CD34
prerank,negative regulation of leukocyte migration (GO:0002686),-0.49620086723741974,-1.1191215678635942,0.32548179871520344,0.7505136506297269,1.0,5/10,11.76%,BMP5;SLIT2;HOXA7;EMILIN1;CD300A
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.3608895706557272,1.1190552366300726,0.2914364640883978,0.7493385888251186,1.0,25/104,18.25%,MUC3A;MUC3B;LYN;ICAM2;IKBKB;PRKACB;FYN;RPS6KA5;PSMB3;PSMD11;PSMC6;PAK1;MALT1;PSME2;PSMD8;HRAS;SYK;PSMB10;BCL10;CARD11;PSMA8;RELB;SKP1;PAK2;PSMD9
prerank,cellular response to lectin (GO:1990858),0.3608895706557272,1.1190552366300726,0.2914364640883978,0.7493385888251186,1.0,25/104,18.25%,MUC3A;MUC3B;LYN;ICAM2;IKBKB;PRKACB;FYN;RPS6KA5;PSMB3;PSMD11;PSMC6;PAK1;MALT1;PSME2;PSMD8;HRAS;SYK;PSMB10;BCL10;CARD11;PSMA8;RELB;SKP1;PAK2;PSMD9
prerank,regulation of protein secretion (GO:0050708),0.3546591430746426,1.118929280637702,0.2949061662198391,0.7489539893654201,1.0,15/119,6.03%,SLC2A1;CACNA1A;TGFB2;UNC13B;STX1A;RHBDF2;CD2AP;ABCG1;RAPGEF3;NOS2;KCNC2;RAPGEF4;SYT7;KCNG2;PPIA
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.5312671717877365,1.1187104503642162,0.34657039711191334,0.7487808195655926,1.0,4/12,4.02%,DOCK4;PDGFB;MEF2C;PRKG1
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.3649709750195515,1.1182277448554168,0.2916666666666667,0.74929728718986,1.0,14/90,12.14%,IGF1R;EPAS1;ADIPOR2;GATM;CAV1;UCP2;OXTR;YBX2;IL4R;FABP5;PRKAB1;ELOVL6;ADIPOR1;SYK
prerank,rRNA processing (GO:0006364),0.3364672051351335,1.1180799285514023,0.27581863979848864,0.7489352123577571,1.0,79/172,30.05%,RPL38;RPL13;MAK16;RPL36A;RPL3;RPL27;SNU13;WDR74;DHX37;RPS7;RPL9;RPLP2;RPL18;PDCD11;RPL13A;WDR36;MPHOSPH10;UTP3;PWP2;RPL8;RPS27;RPL19;RPS9;MRM2;NOL9;RPL11;RIOK1;RPS15;RPL37;RRP15;RPS28;ESF1;UTP11;RPS25;NHP2;NOC4L;RPL37A;LYAR;NOL8;RPL15;EXOSC10;RRP12;RPL17;RPL23;RPL34;WDR75;EXOSC9;THUMPD1;XRN2;RPL21;NVL;DDX54;EXOSC8;RPL18A;RPL10A;MRPL1;RIOK3;RPL24;RPL7A;RPL4;BYSL;RPS2;RPL32;TBL3;RPL6;RPL14;HEATR1;DDX10;UTP4;RPL26;RPS19;LSM6;SBDS;DCAF13;RPS6;TFB1M;POP5;DDX27;RPS14
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.5320840158408477,1.117311506167848,0.3567467652495379,0.7502855242459299,1.0,4/12,19.13%,UNC13B;SYT7;RIMS2;UNC13A
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.48266287759512394,-1.1169414085669391,0.3220338983050847,0.75541090202095,1.0,6/12,23.89%,IRS1;IGF2;SNX5;ZBTB7B;PRKCZ;C1QTNF12
prerank,macrophage activation (GO:0042116),0.43112996999805636,1.1167205208594344,0.31869918699186994,0.7510918728270972,1.0,11/34,22.23%,APP;DYSF;CD93;AGER;SYK;SBNO2;IFNGR1;FOXP1;NMI;PLCG2;SNCA
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.3594094526790049,1.1162595403737796,0.2988980716253444,0.751571569255972,1.0,25/105,18.25%,MUC3A;MUC3B;LYN;ICAM2;IKBKB;PRKACB;FYN;RPS6KA5;PSMB3;PSMD11;PSMC6;PAK1;MALT1;PSME2;PSMD8;HRAS;SYK;PSMB10;BCL10;CARD11;PSMA8;RELB;SKP1;PAK2;PSMD9
prerank,response to iron ion (GO:0010039),-0.4838399290865836,-1.1155922477561402,0.34285714285714286,0.7579650985441186,1.0,4/12,11.79%,BMP6;BCL2;FXN;ACO1
prerank,negative regulation of mitotic cell cycle (GO:0045930),-0.3564057573772953,-1.1147791261198376,0.2978142076502732,0.759110778401721,1.0,10/45,8.02%,SMAD3;BMP7;BMP4;PTPN3;GAS1;FOXC1;BCL6;FZD3;PRCC;ZWINT
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.5301526464514171,1.1145207638546082,0.35135135135135137,0.7554563139540864,1.0,3/10,15.04%,SH3RF1;CBFB;NCKAP1L
prerank,SNARE complex assembly (GO:0035493),0.5425480081990057,1.1140975489414962,0.3685152057245081,0.7558104491106616,1.0,5/10,22.23%,STXBP6;STXBP1;UVRAG;VAMP8;SNCA
prerank,cellular component disassembly (GO:0022411),-0.3412162959167921,-1.1139595148231685,0.26038781163434904,0.7602099217891092,1.0,12/53,8.83%,GSN;TIMP2;MMP14;MMP16;SH3PXD2B;ADAMTS5;SCUBE1;TLL1;CTSL;ADAMTS15;MMP2;KLK2
prerank,histone H2B ubiquitination (GO:0033523),-0.49240600187837724,-1.1136598827773134,0.33402922755741127,0.759789892352513,1.0,4/10,13.71%,CTR9;UBE2E1;RNF20;PAF1
prerank,B cell mediated immunity (GO:0019724),0.5480366693093488,1.1134060621296344,0.3575525812619503,0.7569281250186869,1.0,3/10,16.03%,CD19;TLR8;MSH2
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.47420412002281453,-1.1129352786897486,0.3284823284823285,0.7606534014963136,1.0,6/12,27.83%,PLK5;SDE2;WAC;RPS27L;CCND1;PLK3
prerank,sodium ion import across plasma membrane (GO:0098719),-0.44194280029867833,-1.112835320549236,0.33029612756264237,0.7595975161557021,1.0,7/17,11.35%,SLC12A2;SLC9A2;SLC6A1;SLC8A1;SLC9A9;TRPM4;SLC9A1
prerank,muscle cell development (GO:0055001),-0.3834845577999631,-1.112672709261369,0.3189873417721519,0.7587142849109938,1.0,8/30,8.97%,ANK2;IGF1;CXADR;MYOF;DMD;SLC8A1;MYH11;EFEMP2
prerank,regulation of macrophage differentiation (GO:0045649),-0.45066797176658996,-1.1126551972782537,0.3415730337078652,0.757444387616191,1.0,9/15,36.09%,IL34;PRKCA;INHA;ID2;INHBA;FADD;LIF;HSF1;PF4
prerank,rRNA methylation (GO:0031167),-0.4054234560729818,-1.1125953897113032,0.3082706766917293,0.7562799199293884,1.0,14/22,38.96%,NOP2;MTERF4;NSUN3;EMG1;NSUN4;FDXACB1;TRMT112;DIMT1;MRM3;MRM1;FTSJ3;NSUN5;BUD23;FBLL1
prerank,amyloid-beta metabolic process (GO:0050435),-0.452461331405545,-1.1125205808921288,0.3325301204819277,0.7552018433971147,1.0,5/16,12.73%,MGAT3;BACE2;ACE;IDE;PSEN1
prerank,lipoprotein localization (GO:0044872),-0.49432271795609234,-1.1125031860186898,0.3399122807017544,0.7539478838674893,1.0,1/11,0.53%,LRP1
prerank,regulation of fibroblast migration (GO:0010762),0.47577237622788227,1.1120541543006444,0.33613445378151263,0.7598277353126298,1.0,8/20,10.81%,PRR5L;PTK2;GNA12;HYAL2;RFFL;TGFB1;ARHGEF7;RAC1
prerank,negative regulation of lyase activity (GO:0051350),0.48504749312786744,1.1115483011573264,0.34341637010676157,0.7604051919477642,1.0,2/16,2.60%,PALM;GNAI2
prerank,substrate-dependent cell migration (GO:0006929),0.5154334084322614,1.1110920119773022,0.35789473684210527,0.7608083733709415,1.0,4/14,8.15%,NTN1;ANKS1A;CD2AP;OPHN1
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.5029927725323888,1.110144045326582,0.36312849162011174,0.7626376581294099,1.0,2/13,2.60%,PALM;GNAI2
prerank,ketone body metabolic process (GO:1902224),-0.5089150017989461,-1.110090857680757,0.3468950749464668,0.7595343113472777,1.0,6/10,15.86%,OXCT1;ACSS3;BDH2;AACS;BDH1;HMGCLL1
prerank,negative regulation of secretion by cell (GO:1903531),0.42848830596654786,1.1100825180706242,0.33707865168539325,0.7620513396794099,1.0,9/38,17.18%,RHBDF2;SLC30A1;NOTCH1;STXBP6;PNKD;SYT4;HMGCR;GRM7;TRH
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.43558729639832705,1.1100059187332862,0.33952702702702703,0.7615203744174083,1.0,9/29,20.57%,HSP90AB1;MRE11;PPIA;TERF2;ACD;TERF1;NHP2;RPA1;PINX1
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.5288660607976803,1.109677825108898,0.3629489603024575,0.7616271019568648,1.0,6/11,21.58%,UQCRB;CYC1;UQCRC1;CYCS;UQCRQ;UQCR11
prerank,negative regulation of cyclase activity (GO:0031280),0.4975142704465626,1.109546712145757,0.379182156133829,0.7611977636317574,1.0,2/14,2.60%,PALM;GNAI2
prerank,negative regulation of MAP kinase activity (GO:0043407),0.41528998771044634,1.1094957805015573,0.3187311178247734,0.7605701506105793,1.0,7/44,5.12%,DAB2IP;STK38;PTPRJ;DUSP7;LYN;NPPA;HYAL2
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.4489943865403884,1.109311544968751,0.37018425460636517,0.7602816474531229,1.0,6/29,7.96%,MFSD2A;SCARB1;CREB1;NR1H2;SORBS1;ELOVL5
prerank,regulation of transcription by RNA polymerase II (GO:0006357),-0.236190376521111,-1.1092509921673288,0.0,0.7606707783889052,1.0,332/1668,15.83%,BMP6;AUTS2;PID1;FOXP2;PBX1;PRDM6;IGF1;SOX5;MAF;FHL2;NFIA;ZIC1;EGFR;AEBP1;ZIC4;NR2F2;BMPR1A;ZEB2;GLI3;ZBTB7C;PRRX1;DCN;RARB;ZBTB20;CREB5;ZFHX3;GLI2;ZKSCAN2;ZFHX4;GLIS3;FOXD1;HLF;SMAD3;FOXP4;PKNOX2;SSBP2;BMP5;HOXC4;FGFR2;ZNF462;HOXC6;BMP4;KANK2;ARNT2;ZFPM2;OSR1;HOXB3;TEAD1;FGF1;DDX5;PPARGC1B;SMAD6;NR6A1;FNIP1;RGMA;HOXA3;HOXA5;MEOX2;PKD1;NFAT5;THRB;TNRC6A;HDAC4;CUX1;FRK;GABPB2;PER3;IKZF2;MXI1;TRAK1;HOXB4;WWOX;PRRX2;TEF;IL18;CREB3L2;RHOQ;SALL1;IMPACT;KIT;HOXB6;CCNT2;NR1D2;ZHX2;FOXC2;DNMT3A;BCOR;FOXC1;ARRB1;TBX15;CAMK2D;KCNIP3;HIVEP2;PLAGL1;OGT;MLXIP;PPARGC1A;SUFU;HOXA7;CDK8;VGLL3;RBPJ;BAZ1B;DAB2;MKX;FGF2;PIAS1;PKD2;TBL1XR1;EHMT2;ZNF367;MIER3;KDM7A;MDM4;AR;DLG1;PER2;GLIS2;HDGFL3;ANXA4;PBX4;PPARA;PHF21A;PURG;HIF3A;CTR9;KAT6B;KLF3;MED23;SIX1;NR3C2;EBF4;RUNX2;IKZF4;RORA;ZMYM5;TBX18;IGF2;CBX7;ZNF25;SSBP3;CRTC3;TSHZ1;HOXC8;PAXBP1;TEAD3;HEYL;BCL6;DACT1;CHD2;CCN1;SMARCC2;GLI1;PBX3;SMAD9;MEIS1;KDM2A;ZNF568;FOXJ2;CCNL1;KDM3B;EBF2;LCOR;NFATC4;ATF5;AGO2;PRKN;ZSCAN29;SOD2;KLF15;ATN1;CHD3;ZEB1;ELF4;FHOD1;RFX7;CBX5;FOXL1;KDM5B;MET;CHD8;FBXL19;KDM6B;SMARCD3;JAG1;AKAP8L;TNIP2;MED25;MITF;ATM;SMARCB1;APOE;KDM2B;RBBP8;CHD4;RBAK;POU6F1;ATOH8;HSF2;TNRC6B;YAP1;USP2;EZR;ZNF23;SOX6;SMURF2;PCGF2;STAT5A;BRD9;MGA;FOXO3;CXXC5;CDH13;PPM1D;TWIST2;ZKSCAN7;TGFB3;ZNF483;ELP3;SLC30A9;CEBPB;CREB3L1;ITGB1BP1;ELK1;ZNF507;URI1;DDX17;ZNF697;CCNC;ARNT;EZH1;RNF10;NOP2;SP140;SMARCA1;CREBRF;ARID3A;CRY2;ZNF148;WWP2;PPP3CB;PARP1;CCNH;ZNF182;NR2F1;ETV1;CHUK;GATA6;PHF8;SLC9A1;CAPRIN2;ZBTB38;ESR1;RXRA;KDM1A;NUCKS1;RFXAP;TFCP2L1;NFX1;MED14;PGR;ABL1;ZNF219;BMP2;CDK7;BCAS3;SKI;PIAS2;PSEN1;HOXB5;HOXC5;ZBTB4;E4F1;FOXE1;TWIST1;ZNF3;SMARCA5;MED15;NKX6-1;SP3;PTEN;DVL2;AKNA;PAF1;PEX2;SNAI1;HOXA9;GZF1;MAPK14;MTF1;NR4A1;CAMTA2;PSIP1;ZBTB1;EP300;SIRT2;BRD8;NFIB;TLR4;AHI1;CD81;MAFB;DDX3X;IFI27;ATF2;MRGBP;DDRGK1;ZFP64;PIK3R1;USP9X;CBX6;ZBTB7B;MAP2K5;LAGE3;RFX5;IKBKG;ZSCAN20;ELP4;MYBL2;ZSCAN2;PHF12;LDB1;LDB2;TSHZ3;CAMK1;GTF2F1;SREBF1;E2F3;PROX2;NFATC2;LRP6;SAP18
prerank,regulation of cell cycle process (GO:0010564),0.3611639775933157,1.1089908139694036,0.2979002624671916,0.7603981617932694,1.0,26/104,17.12%,BCL2L1;DCUN1D3;CALM1;CTNNB1;CDKN2B;CCP110;RAB11A;INSM1;MARK4;PIN1;CETN2;RAB11FIP4;CAV2;PIK3C3;SH3GLB1;SOX9;GIT1;TTL;PLK2;SPAG5;SND1;RPRD1B;PRPF40A;APC;HMGA2;CEP85
prerank,cardiac muscle cell differentiation (GO:0055007),-0.4100503975546948,-1.108498299043635,0.3220338983050847,0.7615629113426622,1.0,6/21,12.31%,CXADR;AKAP13;SLC8A1;MYH11;KDM6B;BMP2
prerank,regulation of cell-matrix adhesion (GO:0001952),0.3854153694846498,1.1084064420586723,0.31432748538011696,0.7612517169902998,1.0,8/64,5.21%,LIMCH1;UTRN;MACF1;ACER2;PTK2;ADAM15;DUSP3;CCR7
prerank,microtubule anchoring at centrosome (GO:0034454),-0.5037338018852984,-1.1080251761256192,0.35610766045548653,0.7615901949105681,1.0,4/10,21.52%,NINL;PCM1;BBS4;CEP19
prerank,modulation by symbiont of host process (GO:0044003),0.5440525952215578,1.1078856949887737,0.34896810506566606,0.7618474487671147,1.0,2/10,12.08%,B2M;HGS
prerank,focal adhesion assembly (GO:0048041),0.4629960111898231,1.107813542392752,0.33865248226950356,0.7612949638918781,1.0,5/21,10.94%,THSD1;ACTN1;SORBS1;ARHGEF7;FERMT2
prerank,regulation of protein autophosphorylation (GO:0031952),0.41770131059561577,1.1070835361363207,0.339171974522293,0.7624902988836536,1.0,6/36,6.45%,PDGFB;ENG;PDGFD;CALM1;MRE11;PPP2R5A
prerank,potassium ion export across plasma membrane (GO:0097623),-0.46550580053367996,-1.1069912991399369,0.34675615212527966,0.7633297378761386,1.0,2/13,2.97%,KCNT2;KCNK5
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.34400340496932413,-1.1068209658466335,0.27514792899408286,0.762518308270022,1.0,9/49,16.37%,LDLRAD4;SMAD6;IMPACT;DACT1;ANKRD27;EP300;DDX3X;CRYAB;NLRP2B
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),-0.48087809802529047,-1.1067333454309516,0.34913793103448276,0.7614757934700069,1.0,5/12,21.52%,NINL;BICD1;PCM1;BBS4;CEP19
prerank,negative regulation of multicellular organismal process (GO:0051241),0.3305023145770085,1.1066201290560196,0.2634730538922156,0.7629290358011095,1.0,25/199,7.94%,PTPRG;RAB11FIP1;DAB2IP;BMPR2;NOS3;NOVA2;MCC;ID1;KLF7;RGCC;MEF2C;SRGN;NOTCH1;HDAC9;EVL;SMAD7;IL17RD;ATP2B1;RPS6KA5;NR1H2;N4BP1;PTPRR;EFNA1;BRCA2;TGFB1
prerank,exit from mitosis (GO:0010458),0.5223550993038767,1.1062976280150687,0.3678373382624769,0.7630492251509711,1.0,5/12,25.70%,EPS8;SIRT7;SPAST;CLASP1;CLASP2
prerank,activation of protein kinase activity (GO:0032147),-0.2981002617734886,-1.106165499898154,0.2765957446808511,0.7619037027018752,1.0,25/106,13.31%,IGF1;NTRK3;ADCY5;ANGPT1;ADCY1;ADCY9;FGF1;NRK;IL18;PRKCD;OSBPL8;ADCY2;ADCY7;CARD14;PDPK1;AXIN1;PRKACA;ITGB1BP1;STK11;PTK2B;ADCY6;ABL1;PRLR;PIBF1;STRADA
prerank,peptidyl-glutamic acid modification (GO:0018200),0.4551491971282345,1.1058527994323561,0.3338870431893688,0.763503418692179,1.0,5/24,8.89%,TTLL7;TTLL10;TTLL5;TTLL3;AGBL5
prerank,nerve growth factor signaling pathway (GO:0038180),0.5249798316188636,1.1056354828807746,0.3530534351145038,0.7633146614315496,1.0,2/10,3.02%,RAPGEF2;RAPGEF1
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.38162033739639506,1.105535267514825,0.3146551724137931,0.7628421791050547,1.0,7/73,2.75%,HIP1;ACER2;XDH;FAS;HIP1R;TNFSF10;NOD1
prerank,cristae formation (GO:0042407),0.4388815662604945,1.1054566278793938,0.3487972508591065,0.7623063388033311,1.0,9/27,19.47%,ATP5F1E;ATP5MC2;ATP5PO;LETM1;SAMM50;ATP5F1A;ATP5MF;ATP5PF;CHCHD3
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.5380597856359672,1.1053428563949454,0.3591682419659735,0.7618634208629635,1.0,4/10,26.18%,LGALS9;FOXP3;SCRIB;PRKAR1A
prerank,outflow tract septum morphogenesis (GO:0003148),0.4602839799068415,1.1053000618897513,0.337228714524207,0.7612417336070469,1.0,5/24,1.89%,SEMA3C;ENG;BMPR2;TGFB2;TBX1
prerank,ribosome biogenesis (GO:0042254),0.3298290264815803,1.1052820154117469,0.2701363073110285,0.7605482888725879,1.0,94/187,32.42%,RPL38;RPL13;RPL36A;RPL3;RPL27;NOP16;SNU13;WDR74;DHX37;RPS7;RPL9;RPLP2;RPL18;PDCD11;RPL13A;WDR36;MPHOSPH10;UTP3;PWP2;RPL8;RPS27;RPL19;GTF3A;RPS9;MRM2;NOL9;RPL11;RIOK1;RPS15;RPL37;RPS28;ESF1;UTP11;RPS25;NOC4L;RPL37A;LYAR;NOL8;RPL15;NAF1;EXOSC10;RRP12;NOC2L;RPL17;RPL23;RPL34;WDR75;EXOSC9;PAK1IP1;XRN2;RPL21;NVL;DDX54;ABCE1;EXOSC8;RPL18A;RPL10A;SURF6;RPL24;RPL7A;MRPL22;RPL4;BYSL;RPS2;RPL32;TBL3;RPL6;RPL14;HEATR1;DDX10;DHX29;UTP4;RPL26;RPS19;RAN;SBDS;DCAF13;RPS6;POP5;DDX27;RPS14;RPS24;URB2;MALSU1;RPL12;MTREX;DDX31;RPL41;WDR3;RPS16;RPL27A;NOL11;RPL10;EXOSC3
prerank,extracellular matrix disassembly (GO:0022617),-0.34197078793374763,-1.1052232870962815,0.27808988764044945,0.7632904585084607,1.0,12/53,8.83%,GSN;TIMP2;MMP14;MMP16;SH3PXD2B;ADAMTS5;SCUBE1;TLL1;CTSL;ADAMTS15;MMP2;KLK2
prerank,membrane depolarization (GO:0051899),0.42934217276028347,1.1050740253927096,0.33825944170771755,0.7603231124727976,1.0,6/32,8.39%,CACNA1A;CAV1;SCN1A;KCNH2;YWHAH;P2RX7
prerank,Golgi ribbon formation (GO:0090161),-0.46267979409649684,-1.104995951346802,0.35550935550935553,0.7626182310276147,1.0,5/13,22.19%,GOLGA2;PRMT5;STX16;OPTN;MYO18A
prerank,regulation of dendrite development (GO:0050773),0.41550423358884364,1.104630860049769,0.3446244477172312,0.7608197267789254,1.0,7/37,7.81%,MFSD2A;DAB2IP;LRP8;NEDD4L;LZTS1;CSMD3;PTN
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.5402312518136996,1.1045221572933002,0.38721804511278196,0.7603577826373912,1.0,3/10,4.57%,PDE2A;APLNR;PDE4D
prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.2843193714874339,-1.10448422067744,0.20707070707070707,0.7628196693221024,1.0,26/166,8.76%,SAMD4A;IGF1;EGFR;ZEB2;PLD1;PDGFRB;GLI2;SMAD3;IRS1;SMOC2;SLC6A9;THBS1;PPARGC1A;FGF2;PKD2;IRS2;IGF2;GLI1;PLXNB2;ATP7A;P2RX4;LPGAT1;PTH1R;LDLR;FXR2;NNMT
prerank,hyaluronan metabolic process (GO:0030212),-0.4029665191085636,-1.1039749501116503,0.3097560975609756,0.7630286517887259,1.0,12/23,27.09%,CEMIP;CEMIP2;FGF2;SLC9A1;HEXA;ABCC5;CD44;LYVE1;HAS1;HMMR;GUSB;HYAL3
prerank,acute inflammatory response (GO:0002526),0.4597416354363364,1.103612143069037,0.3561643835616438,0.7620212452649867,1.0,4/23,5.00%,IL6R;CTNNBIP1;SIGIRR;CD6
prerank,positive regulation of fibroblast proliferation (GO:0048146),-0.3916635818362906,-1.103581868883782,0.3161764705882353,0.7628987376230136,1.0,4/27,6.93%,IGF1;PDGFRA;S100A6;PDGFC
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.43392532712342247,-1.103503859350113,0.34965034965034963,0.7618612729612151,1.0,3/17,11.01%,IGF1;APOE;RTN1
prerank,arachidonic acid metabolic process (GO:0019369),-0.3701120239420306,-1.10333840836282,0.32180851063829785,0.7610710805799561,1.0,6/35,6.06%,PTGDS;PTGIS;PTGS1;DAGLA;CYP1B1;PTGES
prerank,aorta morphogenesis (GO:0035909),-0.4323830578013928,-1.1031951394311936,0.3073394495412844,0.7602067572710878,1.0,7/17,8.97%,LRP1;BMPR1A;PDGFRB;MYLK;RBPJ;JAG1;EFEMP2
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.5314237671414828,1.1028862193636884,0.3793103448275862,0.7631800683079969,1.0,5/11,23.53%,ARID1A;SMARCD1;SERTAD2;PADI2;ZMIZ2
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.5232105551371838,1.1025227249064238,0.3634686346863469,0.763430847122942,1.0,4/11,17.38%,STMN1;PAK1;RAC1;NRP1
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.42544915583863846,1.1023714451187197,0.32334384858044163,0.7630768753618326,1.0,4/34,5.34%,MFHAS1;DAB2IP;LYN;TLR3
prerank,RNA catabolic process (GO:0006401),0.3996929570158149,1.1013926309613071,0.33384615384615385,0.7648526232701519,1.0,19/46,28.51%,NANOS2;DNA2;ZPR1;DCP2;DXO;PPP1R8;SND1;RNASEH2C;NUDT16;ZFP36L2;XRN2;NCBP1;METTL3;RNASE6;NUDT12;RIDA;NUDT16L1;RNASE3;LSM6
prerank,excitatory postsynaptic potential (GO:0060079),0.4659834550696067,1.100965528342789,0.3543441226575809,0.7651880612530633,1.0,4/19,11.69%,MEF2C;GRID2;GRIN2B;GSK3A
prerank,long-term memory (GO:0007616),-0.424621579453425,-1.1007175700951182,0.33774834437086093,0.766124373398855,1.0,5/19,14.60%,NFATC4;APOE;LDLR;PJA2;RASGRF1
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.40960672575624335,-1.1005136507820696,0.31873479318734793,0.7654221969557403,1.0,3/20,3.97%,ACTN2;OSR1;CAMK2D
prerank,oligosaccharide biosynthetic process (GO:0009312),0.47674114145327917,1.1000234467583632,0.3445378151260504,0.7669163680576255,1.0,3/20,6.08%,ST3GAL6;FUT8;FUT9
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.4285257262300422,1.1000181219682232,0.340625,0.7661916312128082,1.0,11/35,16.00%,ATP2C1;PCDHGB4;CDH20;CDH8;DCHS1;CDH19;CDH23;CDH10;PCDHB14;CDH5;NLGN1
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.5113346314560354,1.099938988187904,0.36429872495446264,0.7656719903180753,1.0,3/13,8.34%,STX3;HSP90AB1;ABCA7
prerank,negative regulation of cell death (GO:0060548),0.3632131549044718,1.0994991046045193,0.3149171270718232,0.766044303203627,1.0,13/88,12.39%,MECOM;SRGAP2;CD34;PDE8A;CD200;PRKD1;FYN;CD200R1;BNIP3L;PDE12;FERMT2;KIR3DL2;SOX11
prerank,cellular protein modification process (GO:0006464),0.30241639133808795,1.0994561732286738,0.17604912998976457,0.7654139292342513,1.0,220/982,18.30%,PTPRG;ST8SIA4;PRKCH;PTPRM;ST3GAL6;PTPRB;ERG;EPAS1;PDGFB;INSR;ST8SIA6;LMO7;BMPR2;TGFB2;MAP4K2;KLHL5;KLHL2;APP;CDK17;ST3GAL1;MAP4K3;B4GALT5;CTTNBP2NL;DCUN1D3;ST6GALNAC2;STK38;SPARCL1;PTPRJ;PKN3;VWA1;PPM1L;LIPE;SNRK;DUSP7;JAK3;PTPN12;ACVRL1;PRAG1;MAP3K1;CDH2;STK10;PRKD2;PRKD1;MEN1;SSH2;CDK19;ZAP70;MERTK;LYN;FNIP2;PRKG1;TGM2;ZBTB16;SOCS2;B3GNT2;PPP3CC;IKBKB;PPP4R1;IGFBP7;OGA;NOTUM;CREB1;PIGU;CAMKK2;PKN1;STT3B;LIMK2;PRKACB;KLHL25;AATK;FUT9;FYN;PAK5;MAPK3;RPS6KA5;PPP2R5A;FBXW7;YES1;ADAM10;RET;PSMB3;PKN2;HCK;GOLM1;LCMT1;COG3;RAB11A;PXK;PTPRR;PSMD11;PDIA6;MTMR6;MARK4;FBXO41;TGFB1;MAP3K6;RHBDD1;ABCA7;PIGK;MARK3;PSMC6;PLAT;QSOX1;FEM1C;PTPN5;PPP1CB;NPC1;PAK1;PSME2;SOCS5;PGGT1B;PIK3C3;KLHL3;EIF2AK4;SCG3;TRIB2;PTK6;PRKAB1;KLHL20;JMJD7;FBXL2;PPP3CA;MAP4K4;DUSP12;DUSP1;CHRM3;PSMD8;GSK3A;UBA3;HIF1A;PRKCB;WSB1;SYK;B3GALT4;FBXO6;TGFBR2;DUSP16;DCUN1D1;RAB1A;EVA1A;HIPK2;SSH1;MANBA;ASB13;STK24;STK3;ASB5;B3GALT2;PSMB10;MINK1;FBXW2;METAP2;CAMK2B;FBXO21;PIM2;MAN2B1;RBX1;SERP2;SGK1;TBCK;HIPK3;VRK1;DUSP8;DAD1;NUS1;STK26;FBXL8;MTMR2;SERPINC1;GCNT2;CTBP1;UBE2D3;NEK3;PLK2;FBXL15;GRK6;MMP15;LORICRIN;LOXL2;ASB15;SGK3;SGK2;ELOB;PSMA8;DCAF5;ACVR1;MAPK1;ZC3HAV1;MCRS1;PTPRZ1;SIRT7;ASB7;PROC;ATE1;B3GNT3;YWHAZ;COPS5;GAS6;FBXO2;SEPHS1;TMEM132A;WDR45;GPS1;PPM1F;SKP1;SIK2;FN3K;MAP3K11;PRKG2;CDK11B;KBTBD8;RCE1;PAK2;PRKCG;TBK1;SCG2;WNK2;PRKCE;PSMD9;CCNT1
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.3550440658497979,-1.0994510242392141,0.3064066852367688,0.7672546204065727,1.0,12/43,12.28%,PID1;ENPP1;IRS1;KANK1;PRKCD;OGT;IGF2;TNS2;GRB10;PIP4K2C;NUCKS1;SNX5
prerank,regulation of cellular senescence (GO:2000772),0.43368456866323457,1.099302931999335,0.32784184514003295,0.7650860386904528,1.0,10/28,18.81%,B2M;YBX1;VASH1;TERF2;MAP3K3;HMGA1;ABI3;RBL1;HMGA2;CDK6
prerank,regulation of transforming growth factor beta production (GO:0071634),0.48736051377653866,1.0992729257873648,0.3553299492385787,0.7644296312818352,1.0,4/18,6.29%,CD34;TGFB2;CD200;LGALS9
prerank,inorganic cation import across plasma membrane (GO:0098659),0.3737490796366308,1.0992403835309792,0.3123209169054441,0.7637861189449925,1.0,13/75,9.58%,SLC39A10;SLC39A8;SLC24A2;SLC9A5;SLC12A6;ATP1A4;ATP1A3;ATP1A1;SLC12A9;SLC9A3;KCNH2;SLC9A6;SLC9A7
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.4860288520986528,-1.0989924735999148,0.3638344226579521,0.7673025541243662,1.0,2/10,2.42%,ACTN2;CARMIL1
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.3901413023675391,-1.0989441946532168,0.3115942028985507,0.7661920727688543,1.0,4/27,5.04%,CACNA1C;ANK2;CAMK2D;DLG1
prerank,embryonic organ development (GO:0048568),0.3810082143897243,1.0985452269665856,0.3347953216374269,0.7648678163126443,1.0,8/61,3.22%,KITLG;MFSD2A;KDR;TGFB2;TEAD4;SOX17;NES;ZFPM1
prerank,tube closure (GO:0060606),-0.36912020876990936,-1.0982694758384637,0.31398416886543534,0.7668367573678476,1.0,14/31,18.44%,LMO4;COBL;PLXNB2;MTHFD1;IFT122;MTHFR;FUZ;SKI;CELSR1;DVL2;LRP6;STIL;PAX2;MTHFD1L
prerank,regulation of amyloid-beta formation (GO:1902003),-0.36294938110255814,-1.098212383635137,0.33163265306122447,0.7657291023536581,1.0,3/34,2.08%,IGF1;ROCK2;SLC2A13
prerank,cellular response to light stimulus (GO:0071482),0.37769406147732143,1.0977382249784384,0.3284457478005865,0.7662069130578928,1.0,19/66,22.10%,POLK;N4BP1;OPN5;RHBDD1;GPR52;COPS9;EIF2AK4;GNB1;OPN3;RRH;TRIAP1;PTPRK;NOC2L;NSMCE3;BAK1;POLD1;INO80;METTL3;ERCC4
prerank,glycogen metabolic process (GO:0005977),-0.3896742308291159,-1.0974977538445585,0.3276283618581907,0.7666528971796538,1.0,9/27,11.39%,PRKAG2;PYGB;PHKB;PER2;PYGM;GAA;PPP1R3C;PHKA2;AGL
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.4796178179059249,-1.0970879078968374,0.35607675906183367,0.7665437195363638,1.0,8/11,36.15%,BCL2;KDM1A;CD44;TAF9B;TAF9;SIRT1;MUC1;CD74
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.47359599253161316,1.0970317872629505,0.35800344234079173,0.767355815030963,1.0,7/20,12.53%,PDGFB;CCNY;RGCC;HSP90AB1;CCND3;ADAM17;MAPRE3
prerank,actomyosin structure organization (GO:0031032),0.37194821891924,1.096875287359539,0.32734806629834257,0.766983498748884,1.0,6/75,3.06%,FLII;FRMD5;TJP1;PGM5;F11R;EPB41
prerank,positive regulation of endocytosis (GO:0045807),-0.3543972102904191,-1.0966841062383492,0.27299703264094954,0.7663963422287092,1.0,11/45,9.03%,LRP1;APPL2;VTN;AXL;GPC3;ANO6;DAB2;RAB21;APOE;BICD1;CLIP3
prerank,primary neural tube formation (GO:0014020),-0.3732748215437163,-1.0964933886515893,0.3238341968911917,0.7656527688795155,1.0,14/30,18.44%,LMO4;COBL;PLXNB2;MTHFD1;IFT122;MTHFR;FUZ;SKI;CELSR1;DVL2;LRP6;STIL;PAX2;MTHFD1L
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.47642014149265716,1.0964610882318442,0.36363636363636365,0.7673359293971256,1.0,6/16,18.30%,ATP5F1E;ATP5MC2;ATP5PO;ATP5F1A;ATP5MF;ATP5PF
prerank,inflammatory response (GO:0006954),0.3299611654661825,1.096427703640674,0.28553770086526575,0.7666778931713981,1.0,26/195,11.46%,MFHAS1;LY75;ADGRE5;AFAP1L2;F11R;NOD1;CD40;PLA2G4B;IL10RB;HDAC9;IKBKB;NOS2;CCR7;NRROS;LGALS9;PXK;TGFB1;CXCR2;SIGLEC1;AGTR2;CYBB;RAC1;TAC4;CCL1;S100A8;TNFRSF4
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.3520989993843142,-1.0962409607216452,0.3287671232876712,0.7651358223535175,1.0,14/44,10.02%,LPAR1;ROCK2;PPM1E;CCN2;ARHGEF10L;TPM1;CARMIL1;TGFBR1;S100A10;FHOD1;PFN2;MYOC;TGFB3;ITGB1BP1
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.312451232355279,1.095999731974867,0.24837310195227766,0.767055960536035,1.0,85/476,14.43%,LEF1;MECOM;PLCB1;ETS1;FLI1;PDGFB;NOTCH4;TRIM16;ZIC3;PPARD;TBX1;SOX17;AFAP1L2;FZD4;MEF2C;RYBP;NCOA1;SMARCA2;SP100;FOXO1;FOXL2;ACVRL1;RPS6KA1;NOTCH1;KLF2;ZBTB16;IKBKB;WNT7A;FOXF1;HHEX;RREB1;CTNNB1;CREB1;MRPL12;KLF1;CD4;TAL1;CAMKK2;CD38;STAT1;RET;KLF4;NR1H2;DNM2;SOX18;HINFP;BRCA2;KAT6A;TGFB1;JUN;KCNH2;KLF6;YWHAH;LRP5;FOXP3;CDK5RAP2;ARID1A;HMGA1;UBE2V1;SMAD5;ELF2;BRD4;CTCF;NR5A2;HIF1A;RAI1;SOX10;PPARG;SOX11;BRPF1;RNF187;MAPRE3;TFEB;NAA16;HMGB2;HIPK2;EDF1;SOX9;NAT14;BCL10;BICRA;YAF2;PIM2;SP1;SEC14L2
prerank,defense response to tumor cell (GO:0002357),-0.4941415669441317,-1.0959221501130945,0.38293216630196936,0.7647516636775811,1.0,1/10,0.11%,RBMS3
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.4556638848836697,-1.0955715910188042,0.3610503282275711,0.7645491215256319,1.0,4/13,14.45%,SAR1A;SEC16B;SEC16A;CD81
prerank,cellular amino acid catabolic process (GO:0009063),-0.3020547428346498,-1.095224237674032,0.2775800711743772,0.7642866867334519,1.0,29/87,20.83%,DDO;ACADSB;ASPA;ALDH7A1;HNMT;IVD;MCCC2;AUH;HIBADH;ABAT;ALDH4A1;PRODH;BCKDHB;GOT1;HIBCH;GLUL;GLS;GLS2;HMGCLL1;PHYKPL;KYAT1;SARDH;HYKK;PIPOX;BCKDK;FAH;KYNU;KMO;GOT2
prerank,mesenchymal cell differentiation (GO:0048762),0.39489135917710966,1.0950554253827065,0.34142640364188165,0.7688618635179995,1.0,8/51,5.18%,LEF1;ENG;TGFB2;NOTCH4;MEF2C;NOTCH1;CTNNB1;SNAI2
prerank,neutrophil activation involved in immune response (GO:0002283),0.3099021713566291,1.0948594214052028,0.25848849945235486,0.7686389515080582,1.0,96/428,17.53%,PTPRB;PECAM1;ATP8A1;ADGRE5;PGLYRP1;IMPDH1;PLAUR;RAB31;B2M;PTPRJ;ATP11B;TSPAN14;CD93;STK10;ATP6V0A1;CTSC;OSTF1;PRCP;DNAJC13;ATP11A;CFD;HSP90AB1;CMTM6;CAT;DYNLL1;PPIA;DBNL;UNC13D;ADAM10;RAP1B;LRRC7;ENPP4;BST2;PSMD11;SRP14;SCAMP1;PKM;NFASC;CXCR2;IQGAP1;PDAP1;SPTAN1;TUBB;PDXK;QSOX1;GLB1;FABP5;VAT1;CYFIP1;DNAJC5;CYBB;TOLLIP;HSPA8;RAC1;NBEAL2;KCNAB2;MGAM;PNP;S100A8;ORMDL3;SYK;SLC27A2;CEACAM1;SNAP29;SVIP;SLPI;SDCBP;CSNK2B;MANBA;PGAM1;LTA4H;DEGS1;MAN2B1;PTGES2;PRDX6;PFKL;DYNC1LI1;TMEM30A;NCKAP1L;TUBB4B;MAPK1;CTSS;TMEM179B;ACTR2;CPNE3;RAB24;ARMC8;SLCO4C1;CSTB;DOCK2;PRG2;STOM;TTR;DGAT1;NEU1;ADGRG3
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.3151755198906716,-1.0947080232167181,0.292358803986711,0.7645342001809897,1.0,28/84,23.86%,CELF2;DDX5;SON;RBM39;FXR2;SRRM4;NOVA1;SRSF6;DDX17;SRSF4;RBM5;FMR1;NSRP1;PCBP4;RBFOX1;SAP18;C1QBP;U2AF2;CIRBP;TRA2B;ZC3H10;SRSF10;MBNL2;RBM24;SF1;KHDRBS3;CELF6;NCL
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.48493149497799387,1.0946628236652642,0.36741767764298094,0.7684404820205853,1.0,3/17,4.28%,CLDN5;F11R;IKBKB
prerank,rRNA transcription (GO:0009303),0.49422677961744854,1.0944872728658281,0.3763440860215054,0.7681319990348381,1.0,6/17,22.85%,TAF1B;GTF3A;GTF3C5;SIRT7;SPIN1;GTF3C1
prerank,sphingoid biosynthetic process (GO:0046520),0.5151946048665066,1.094302539831511,0.33807829181494664,0.7671651611613789,1.0,3/11,7.18%,ACER2;ACER1;SPTLC2
prerank,sphingosine biosynthetic process (GO:0046512),0.5151946048665066,1.094302539831511,0.33807829181494664,0.7671651611613789,1.0,3/11,7.18%,ACER2;ACER1;SPTLC2
prerank,protein-containing complex subunit organization (GO:0043933),0.3498777212631716,1.0935176115871148,0.3074829931972789,0.768468744444015,1.0,20/109,16.52%,OCLN;SLC2A1;FAS;MAGI1;CD40;PARD3;CD2AP;VIL1;CARD10;CLDN14;CAPG;PEX14;NUP54;RANBP9;SOX9;SH3BGR;NCKAP1L;ELOB;APC;IL1RAP
prerank,tryptophan catabolic process (GO:0006569),-0.4835999604020129,-1.0934131368468352,0.3596673596673597,0.7670268073669989,1.0,6/11,29.97%,AFMID;KYAT1;KYNU;KMO;IL4I1;HAAO
prerank,glial cell development (GO:0021782),0.44285544950467687,1.0933917735531482,0.3396825396825397,0.7680514249482475,1.0,8/25,18.81%,APP;NRROS;EIF2B1;EIF2B2;SOX10;SOX11;TPPP;CDK6
prerank,negative regulation of cellular component organization (GO:0051129),-0.31966957526311823,-1.0932207569907688,0.28135593220338984,0.7663398185312771,1.0,18/74,17.53%,BMP6;EPHA3;CARMIL1;IMPACT;AR;FAP;LRSAM1;RTEL1;TMEFF2;IRAK3;XRCC5;SCAMP5;EP300;DDX3X;SNX33;CRYAB;DNAJB2;PACSIN3
prerank,lymphocyte chemotaxis (GO:0048247),-0.3747821844116901,-1.0931583424276596,0.32345013477088946,0.7652750930107415,1.0,14/34,34.12%,CYP7B1;SLC12A2;CXCL16;CCL13;CKLF;ADAM8;PIK3CD;CCL19;CXCL10;CCL2;CCL15;CX3CL1;GPR183;CCL5
prerank,snRNA processing (GO:0016180),-0.44028143842617307,-1.0930361361634984,0.337468982630273,0.764371875172717,1.0,9/16,29.43%,INTS8;INTS2;TUT1;INTS4;INTS10;INTS3;TOE1;INTS6L;INTS5
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.4152299719314927,1.0930079339511058,0.36012861736334406,0.7682874195245891,1.0,13/36,18.99%,AQP11;RYBP;HSP90AB1;N4BP1;OPHN1;UBXN1;F8A1;SDCBP;RPL11;TRIM39;BAG6;PRKCG;USP25
prerank,phagosome maturation (GO:0090382),0.41499436698870495,1.0923764999327357,0.33228346456692914,0.769213063850664,1.0,6/35,7.88%,RAB31;ATP6V0A1;MCOLN1;PIKFYVE;RAB39A;RAB34
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.39824080574972903,-1.0916527821699227,0.33980582524271846,0.7671547821195671,1.0,6/24,11.66%,ITPR1;FGF2;PKD2;ANXA6;ITPR2;IBTK
prerank,monocyte differentiation (GO:0030224),-0.4940353584527085,-1.0913109948392028,0.3717948717948718,0.7668170581394493,1.0,2/10,1.84%,IL31RA;BMP4
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.40239296194353014,-1.0912093516991788,0.3381294964028777,0.7658716770893396,1.0,8/21,23.00%,SLC30A10;PPARA;PRKN;TRAP1;SIRT2;PAX2;BRCA1;AATF
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.42149868771217036,-1.0907559937024474,0.3181818181818182,0.7659799701989766,1.0,7/19,18.08%,IL34;CAMK1D;THBS1;CMKLR1;MPP1;RARRES2;MDK
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.4560214142263878,1.0905599087685218,0.3389261744966443,0.7733591470381224,1.0,10/22,18.00%,SLC16A2;NES;GATA2;DLL4;INSM1;DISP3;TOX;PTPRZ1;PROX1;TRIM71
prerank,myoblast differentiation (GO:0045445),-0.44493713635183463,-1.0901530694352781,0.3630831643002028,0.7664218856294155,1.0,5/14,10.49%,IGF1;DDX5;PLEKHM3;JAG1;DDX17
prerank,ATP synthesis coupled proton transport (GO:0015986),0.46454846587136,1.0900033117824606,0.36313868613138683,0.774108711334453,1.0,6/17,18.30%,ATP5F1E;ATP5MC2;ATP5PO;ATP5F1A;ATP5MF;ATP5PF
prerank,neutrophil degranulation (GO:0043312),0.30852655815699204,1.089856987459706,0.26914660831509846,0.7737775277057453,1.0,95/425,17.53%,PTPRB;PECAM1;ATP8A1;ADGRE5;PGLYRP1;IMPDH1;PLAUR;RAB31;B2M;PTPRJ;ATP11B;TSPAN14;CD93;STK10;ATP6V0A1;CTSC;OSTF1;PRCP;DNAJC13;ATP11A;CFD;HSP90AB1;CMTM6;CAT;DYNLL1;PPIA;DBNL;UNC13D;ADAM10;RAP1B;LRRC7;ENPP4;BST2;PSMD11;SRP14;SCAMP1;PKM;NFASC;CXCR2;IQGAP1;PDAP1;SPTAN1;TUBB;PDXK;QSOX1;GLB1;FABP5;VAT1;CYFIP1;DNAJC5;CYBB;TOLLIP;HSPA8;RAC1;NBEAL2;KCNAB2;MGAM;PNP;S100A8;ORMDL3;SLC27A2;CEACAM1;SNAP29;SVIP;SLPI;SDCBP;CSNK2B;MANBA;PGAM1;LTA4H;DEGS1;MAN2B1;PTGES2;PRDX6;PFKL;DYNC1LI1;TMEM30A;NCKAP1L;TUBB4B;MAPK1;CTSS;TMEM179B;ACTR2;CPNE3;RAB24;ARMC8;SLCO4C1;CSTB;DOCK2;PRG2;STOM;TTR;DGAT1;NEU1;ADGRG3
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.3404269711334407,-1.0897370780168425,0.31085043988269795,0.7663348376449336,1.0,15/51,10.02%,LPAR1;ROCK2;PPM1E;CCN2;ARHGEF10L;TPM1;CARMIL1;TGFBR1;S100A10;SYNPO;FHOD1;PFN2;MYOC;TGFB3;ITGB1BP1
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.2980382496704934,-1.0896586743889898,0.23049645390070922,0.7653400135834073,1.0,22/101,15.58%,SAMD4A;PLD1;CYFIP2;THBS1;ASPH;OGT;ATG10;DACT1;PLXNB2;AGTR1;FXR2;PERP;EZR;VGLL4;BTRC;TBC1D10A;EIF3C;FMR1;FBXW11;DDX3X;LARP6;YTHDF1
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.4009713817660524,-1.0894512948424402,0.3247663551401869,0.7646994623905906,1.0,5/23,10.14%,UACA;BMP7;C1QTNF3;CCN3;PPM1B
prerank,neural crest cell differentiation (GO:0014033),0.4805423859865477,1.089018511566016,0.3820840950639854,0.7752869724711893,1.0,6/18,17.90%,MEF2C;CDH2;SNAI2;SOX11;PDCD6;KBTBD8
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.4363903702823905,1.0887280767668401,0.37099494097807756,0.775293512191868,1.0,5/27,4.05%,SHANK3;TJP1;WASF2;F11R;STMN1
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.34950116099212986,-1.088717476612738,0.3384223918575064,0.7653976595367001,1.0,15/40,28.25%,FBH1;RTEL1;TIPIN;NUCKS1;ZRANB3;TRAIP;PRIMPOL;DONSON;WRN;BOD1L1;THOC1;ATR;CDK9;MCM9;SETMAR
prerank,positive regulation of DNA replication (GO:0045740),-0.4404977259578723,-1.088411432255467,0.3617511520737327,0.7649954850118664,1.0,3/16,6.56%,EGFR;GLI2;GLI1
prerank,cell-cell junction maintenance (GO:0045217),0.5215765536294719,1.0882674432995192,0.3838951310861423,0.7757603673726681,1.0,5/11,20.14%,TJP1;FERMT2;INAVA;CSF1R;F2R
prerank,hexose biosynthetic process (GO:0019319),-0.3528479230759501,-1.0881124994787366,0.29315068493150687,0.7646613673020606,1.0,14/42,22.12%,RBP4;SLC39A14;CHST15;PPARGC1A;AKR1B1;PER2;MDH2;GOT1;SLC25A12;ALDOA;ENO2;GOT2;PGK1;ENO3
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.4379726096474074,1.0880728776029842,0.3706896551724138,0.7755673215757024,1.0,8/26,16.57%,SHANK3;APP;WNT7A;NRXN1;TMEM25;MTMR2;NLGN1;RIMS2
prerank,regulation of platelet activation (GO:0010543),0.46525896872595374,1.0879375164439875,0.3673469387755102,0.775180428120472,1.0,3/21,3.86%,PDGFB;NOS3;LYN
prerank,artery morphogenesis (GO:0048844),0.4342363305680251,1.0878693136425484,0.357495881383855,0.7746579643516222,1.0,7/30,4.39%,ENG;BMPR2;TGFB2;TBX1;NOTCH1;SMAD7;FOXF1
prerank,calcium ion import (GO:0070509),-0.38638667385943404,-1.0875962357943993,0.32981530343007914,0.7649795255950684,1.0,8/28,11.80%,CACNA1C;MCU;CACNA1G;SLC8A1;CACNA1D;CACNB2;AFG3L2;TRPC4
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.45433095174221927,1.087404599889768,0.36551724137931035,0.7751198891040568,1.0,7/24,10.81%,OCLN;WASF2;NCKAP1;TWF2;CYFIP1;CLRN1;RAC1
prerank,negative regulation of protein phosphorylation (GO:0001933),-0.28219178114631926,-1.087150740857641,0.24782608695652175,0.7650629190946062,1.0,35/150,14.07%,PID1;PTPN13;PRKAG2;NTRK3;LDLRAD4;PLPP3;PPM1E;ERRFI1;FBLN1;ENPP1;SLIT2;SMAD6;DEPTOR;DMD;IMPACT;RASSF2;PRKCD;DTNBP1;EMILIN1;PRKN;EPHB2;IGFBP3;PDPK1;QARS1;ITGB1BP1;SPRED1;PPEF2;IBTK;GPD1L;LRRK2;DMTN;TWIST1;PTEN;NF1;SIRT2
prerank,positive regulation of hemostasis (GO:1900048),-0.49637973534707036,-1.087043457314463,0.3986784140969163,0.7629650936855774,1.0,5/10,22.90%,ST3GAL4;THBS1;DMTN;SERPINE1;HPSE
prerank,positive regulation of coagulation (GO:0050820),-0.49637973534707036,-1.087043457314463,0.3986784140969163,0.7629650936855774,1.0,5/10,22.90%,ST3GAL4;THBS1;DMTN;SERPINE1;HPSE
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.37309980445798446,-1.0868932949386392,0.34554973821989526,0.7621684314927325,1.0,12/30,22.66%,DDX5;DAB2;AR;HEYL;KLK2;KDM1A;PIAS2;EP300;SFRP1;NCOR1;RNF14;SAFB2
prerank,regulation of cell aging (GO:0090342),-0.47105967323967657,-1.0868597776229167,0.3572938689217759,0.7610712326066382,1.0,3/11,10.17%,LMNA;NEK6;NUAK1
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.42556859344274617,-1.0867754768084583,0.35920177383592017,0.7601356802039174,1.0,2/17,2.18%,ANK2;SNTA1
prerank,second-messenger-mediated signaling (GO:0019932),0.36351862028774956,1.086676328340111,0.3403954802259887,0.7763008231413674,1.0,13/82,11.27%,NDNF;NOS3;DDAH1;PLA2G4B;PPP1R9B;PLCG1;NOS2;CCR7;CAMKK2;CXCR2;TNFSF11;AGTR2;CHRM3
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.3789670717450068,1.086018620559711,0.33284457478005863,0.7772492651321549,1.0,14/63,14.16%,ITGA6;CAV1;FAS;SH3RF1;TNFSF10;SP100;HYAL2;DEDD2;ZMYND11;CASP8;AGTR2;TNFSF12;CYLD;BCL10
prerank,regulation of biosynthetic process (GO:0009889),0.5194335702210717,1.085973705792524,0.3821892393320965,0.7766513845259462,1.0,2/11,6.20%,PIKFYVE;SLC25A33
prerank,"regulation of transcription, DNA-templated (GO:0006355)",-0.2299577270941975,-1.08584365953557,0.0,0.7615354791958334,1.0,330/1646,16.22%,FOXP2;BNC2;PBX1;IGF1;SOX5;MAF;NFIA;ZIC1;EGFR;ZIC4;NR2F2;ZEB2;DENND4A;GLI3;ZBTB7C;COL1A1;PRRX1;ZBTB20;CREB5;ZFHX3;GLI2;ZKSCAN2;EFEMP1;ZFHX4;GLIS3;FOXD1;HLF;WNT4;SMAD3;FOXP4;PKNOX2;IL31RA;SSBP2;HOXC4;DKK3;BMP7;HOXC6;BMP4;ARNT2;ZFPM2;OSR1;HOXB3;TEAD1;DDX5;PPARGC1B;SMAD6;NR6A1;TULP3;HOXA3;HOXA5;MEOX2;NFAT5;MDFIC;RGMB;LBH;HDAC4;CUX1;IKZF2;MXI1;TRAK1;HOXB4;PRRX2;TEF;CREB3L2;MAP3K5;SALL1;FZD2;KIT;SHC1;HOXB6;SNX6;CCNT2;CDH1;NR1D2;ZHX2;FOXC2;LOXL3;BCOR;FOXC1;ARRB1;TBX15;TGFBR1;CAMK2D;HIVEP2;PLAGL1;OGT;MLXIP;PPARGC1A;SUFU;HOXA7;VGLL3;ZNF423;RBPJ;BAZ1B;MKX;FGF2;PIAS1;TBL1XR1;ZNF367;KDM7A;MDM4;AR;PER2;GLIS2;HDGFL3;MAP3K12;ANXA4;PBX4;PPARA;PURG;HIF3A;CTR9;KAT6B;KLF3;MED23;SPP1;SIX1;NR3C2;EBF4;RUNX2;IKZF4;RORA;TBX18;IGF2;ZNF25;TSHZ1;POLR2A;CRABP2;NFXL1;HOXC8;FZD7;TEAD3;HEYL;BCL6;CHD2;SMARCC2;GLI1;PBX3;SMAD9;MEIS1;ILF2;ZFAT;KDM2A;ZNF568;FOXJ2;CCNL1;KDM3B;EBF2;LCOR;NFATC4;ATF5;GPBP1L1;ZSCAN29;SOD2;KLF15;PFDN5;CHD3;ZEB1;TGFB1I1;ELF4;VSX1;RFX7;CBX5;FOXL1;KDM5B;PHC2;CHD8;FBXL19;RUNX1T1;SMARCD3;MITF;SMARCB1;APOE;KDM2B;TP53INP2;MLLT3;RBBP8;ZMYND15;CHD4;ACTR8;RBAK;POU6F1;ATOH8;HSF2;YAP1;AXIN1;PML;ZNF23;SOX6;REXO4;SMURF2;STAT5A;CDK16;BRD9;MGA;VGLL4;FOXO3;SFMBT1;GCFC2;ACTA2;TWIST2;ZKSCAN7;TGFB3;ZNF483;QARS1;ELP3;CEBPB;CREB3L1;BTRC;ELK1;ARHGEF11;MBTD1;NIBAN2;URI1;DDX17;ZNF697;CCNC;ARNT;CDK14;NSD2;RNF10;TSC22D4;NOP2;SP140;SMARCA1;PBXIP1;CREBRF;ARID3A;PRDM11;CRY2;ZNF148;CBFA2T2;WWP2;PPP3CB;SETD5;CCNH;ZNF182;NR2F1;ETV1;CHUK;GATA6;PHF8;ZBTB38;ESR1;RNF20;MTERF3;RXRA;PRMT5;KDM1A;NUCKS1;RFXAP;TFCP2L1;NFX1;MED14;BCL7A;PGR;TGFBRAP1;SBNO1;ABL1;XRCC5;SNX5;ZNF219;BMP2;PIAS2;PSEN1;HOXB5;HOXC5;ZBTB4;E4F1;ATP8B1;FOXE1;GCLC;TWIST1;PCBD2;ZNF3;SMARCA5;NKX6-1;SP3;DVL2;SNAI1;HOXA9;GZF1;MAPK14;MTF1;NR4A1;CAMTA2;PSIP1;ZBTB1;EP300;SIRT2;WNT11;FBXW11;NFIB;TCIM;ACVR1B;MAFB;ATF2;MRGBP;SPTY2D1;ZBTB7B;RFX5;NONO;ZSCAN20;ELP4;MYBL2;ZSCAN2;PHF12;TLE2;LDB1;TSHZ3;LIMD1;CRYAB;SREBF1;E2F3;PROX2;NFATC2;LRP6;PSPC1;SAP18;CDKN1C;MED30;SPINDOC;JDP2;HIVEP3;POLR3G;NFIL3;APBB3;MTA3;MAP3K2;ZFP37
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.4008846152658351,-1.0858027362721676,0.36054421768707484,0.7604474937813541,1.0,1/23,0.34%,IGF1
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.3764276515947586,1.0857743943127147,0.31771595900439237,0.7764719552304302,1.0,7/62,6.78%,BCL2L1;CXCL12;PLAUR;ARHGEF2;SNAI2;PPIA;MCL1
prerank,protein K48-linked deubiquitination (GO:0071108),0.45177294281587466,1.0857354095697234,0.3653516295025729,0.775870257700274,1.0,8/23,19.50%,MINDY1;ATXN3;OTUD7A;MINDY2;TNFAIP3;USP25;OTUD7B;OTUD4
prerank,calcium ion import across plasma membrane (GO:0098703),-0.4432944833936523,-1.0857211122069652,0.3550561797752809,0.7594867362717215,1.0,3/14,7.19%,SLC8A3;CACNA2D1;SLC8A1
prerank,regulation of keratinocyte differentiation (GO:0045616),0.43785389392908913,1.0851726932665449,0.3410981697171381,0.7765889625020946,1.0,5/24,10.93%,PRKCH;TRIM16;CTSK;CBFB;ZFP36L1
prerank,lipid homeostasis (GO:0055088),-0.3211491752748978,-1.08515316028937,0.31671554252199413,0.7599362167168713,1.0,10/57,10.11%,ZBTB20;PRKAA2;RBP1;NR1D2;ABCA1;THADA;IRS2;RCN3;APOE;TLCD2
prerank,neutrophil mediated immunity (GO:0002446),0.30676822092610273,1.0840352088096739,0.283205268935236,0.7788545700934201,1.0,96/432,17.53%,PTPRB;PECAM1;ATP8A1;ADGRE5;PGLYRP1;IMPDH1;PLAUR;RAB31;B2M;PTPRJ;ATP11B;TSPAN14;CD93;STK10;ATP6V0A1;CTSC;OSTF1;PRCP;DNAJC13;ATP11A;CFD;HSP90AB1;CMTM6;CAT;DYNLL1;PPIA;DBNL;UNC13D;ADAM10;RAP1B;LRRC7;ENPP4;BST2;PSMD11;SRP14;SCAMP1;PKM;NFASC;CXCR2;IQGAP1;PDAP1;SPTAN1;TUBB;PDXK;QSOX1;GLB1;FABP5;VAT1;ADAM17;CYFIP1;DNAJC5;CYBB;TOLLIP;HSPA8;RAC1;NBEAL2;KCNAB2;MGAM;PNP;S100A8;ORMDL3;SLC27A2;CEACAM1;SNAP29;SVIP;SLPI;SDCBP;CSNK2B;MANBA;PGAM1;LTA4H;DEGS1;MAN2B1;PTGES2;PRDX6;PFKL;DYNC1LI1;TMEM30A;NCKAP1L;TUBB4B;MAPK1;CTSS;TMEM179B;ACTR2;CPNE3;RAB24;ARMC8;SLCO4C1;CSTB;DOCK2;PRG2;STOM;TTR;DGAT1;NEU1;ADGRG3
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.45718370014912074,-1.0837937706590106,0.36607142857142855,0.762459853044789,1.0,4/14,23.03%,IL18;IL17D;CD84;CD80
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.43210693077270845,1.0837443866243148,0.3667763157894737,0.7789074763293508,1.0,6/28,9.55%,DAB2IP;PTK2;CTSC;FBXW7;PSMC6;SMURF1
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.4457637964785221,-1.0836787602352804,0.37583892617449666,0.7615810916886506,1.0,5/15,8.65%,PDGFRA;FGFR2;TGFBR1;SIX1;MTHFD1
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.5040921665231693,1.0836196158954274,0.38128249566724437,0.7785129896214028,1.0,2/13,1.87%,PDGFB;PPARD
prerank,response to glucose (GO:0009749),0.39558857325939023,1.083183565257667,0.3404255319148936,0.7789090042515227,1.0,2/46,2.01%,IGF1R;UNC13B
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.4322402275372882,-1.0831529259068402,0.36342042755344417,0.7618049389657741,1.0,6/18,12.31%,HDAC4;FRS2;FZD7;CCN3;SOX6;BMP2
prerank,regulation of protein-containing complex assembly (GO:0043254),0.35065406936253857,1.0830603486368378,0.33557951482479786,0.7785143079737458,1.0,25/110,16.82%,TFRC;DAB2IP;TIRAP;FNIP2;TAL1;BIK;STXBP1;HCK;RALB;LCMT1;INSM1;TGFB1;IRGM;MMP1;HSPA8;SH3GLB1;SYK;SVIP;BBS10;CDH5;GFAP;OPRD1;MPP7;HCFC1;SUMO1
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.4319068178620159,-1.0827755657320086,0.35412026726057905,0.7616215870971736,1.0,6/16,22.00%,KLHL22;SEH1L;CLEC16A;RRAGA;FLCN;LARS1
prerank,regulation of blood coagulation (GO:0030193),-0.38651745020074135,-1.0825884006725568,0.36684782608695654,0.7609087447868831,1.0,8/27,8.31%,TFPI;VTN;ST3GAL4;THBS1;FAP;THBD;EPHB2;APOE
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.44032151646815043,1.0825626861900952,0.37564322469982847,0.7791256071060573,1.0,5/25,11.69%,MEF2C;GRID2;INSYN2A;GRIN2B;GSK3A
prerank,negative regulation of protein polymerization (GO:0032272),0.43614182777721483,1.082547381710126,0.3698630136986301,0.7784427482689117,1.0,8/27,13.96%,KANK3;HIP1R;SSH2;STMN1;TWF2;CYRIB;SSH1;CDH5
prerank,response to interleukin-1 (GO:0070555),0.365476861386051,1.0817874534037017,0.3300699300699301,0.7797101107590725,1.0,12/73,14.75%,DAB2IP;APP;IL1R1;TNFRSF11A;CD40;HYAL2;LGALS9;IRAK2;CCL1;HIF1A;SOX9;YTHDC2
prerank,negative regulation of phagocytosis (GO:0050765),0.4855272424435083,1.081199737165435,0.37906137184115524,0.7804650362814354,1.0,2/17,4.38%,DYSF;SNX3
prerank,cellular protein catabolic process (GO:0044257),0.37750781096789576,1.0807905578660066,0.32814710042432815,0.7807694968820438,1.0,23/59,23.98%,DAB2IP;DENND3;CTSC;CTSW;CTSO;CTSK;UBE2G1;AP2M1;BNIP3L;MALT1;CASP8;AP2B1;AFG1L;CTSS;CAPN2;UBE2G2;PISD;RSPRY1;AP2S1;BNIP3;LGMN;RIPK1;LONP1
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.31125316530865055,-1.0805714951829992,0.27137546468401486,0.7652137778138083,1.0,30/80,24.33%,PLPP3;ATP9A;GBF1;COPA;KDELR3;COPZ2;COPB1;ARFGAP1;ARFGAP3;ERGIC3;COG4;STX18;RAB6A;ERGIC1;SCFD1;SURF4;COPB2;RACGAP1;ATP9B;KIF18A;CENPE;KIF15;ERGIC2;SCYL1;COPZ1;TMED9;RER1;KIF3C;HTT;COPG1
prerank,regulation of cellular component movement (GO:0051270),0.38978866273141566,1.0798614068727543,0.34332833583208394,0.7825553013601976,1.0,10/49,7.01%,ETS1;FES;SP100;PRAG1;LYN;PKN1;INPP5F;ACTN4;PKN2;ACTN1
prerank,negative regulation of Wnt signaling pathway (GO:0030178),-0.26941220406113986,-1.0795745368494998,0.2631578947368421,0.7666897769914994,1.0,32/186,10.21%,BICC1;RBMS3;TRABD2B;LRP1;GLI3;IGFBP2;DKK3;RNF43;IGFBP6;WWOX;INVS;AMFR;DAB2;IGFBP4;DACT1;GLI1;SFRP4;PRKN;PFDN5;TMEM64;TLE3;CHD8;PSME4;APOE;MLLT3;GRB10;NXN;AXIN1;VGLL4;CUL3;FUZ;STK11
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.5202388419570941,1.0795445531108632,0.4040590405904059,0.7826378102516292,1.0,4/11,10.14%,ARHGEF2;PELI1;BIRC3;CASP8
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.4784610971552712,1.079309599850422,0.3828264758497317,0.7825166867071506,1.0,4/18,11.69%,HIP1R;SLC25A5;ZNF205;GSK3A
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.5078680649989122,1.0792873928300253,0.3945945945945946,0.7818685170036159,1.0,6/12,26.08%,PCGF3;RBM15;RLIM;METTL3;CDYL;PCGF5
prerank,negative regulation of ion transport (GO:0043271),-0.39713030998660126,-1.0786710853634143,0.3583138173302108,0.767998416788255,1.0,10/24,24.92%,ACTN2;WNK4;PTK2B;WNK1;HTR1B;PACSIN3;WNK3;ADRA2A;NEDD4;STC1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.3894408159724024,1.0783758267016317,0.34782608695652173,0.7835447690606144,1.0,15/51,18.50%,CXCL12;IL6R;PTK2;CCR7;MAPK3;LGALS9;PTN;PGF;ADAM17;CCL1;MAPK1;GAS6;CCR2;CSF1R;MOSPD2
prerank,glycosphingolipid metabolic process (GO:0006687),0.4071128016183085,1.0782485665200785,0.3603053435114504,0.7831359053001182,1.0,9/42,14.06%,ST6GALNAC3;ESYT2;NEU4;ESYT1;GLB1;GLTP;B4GALNT1;CERK;NEU2
prerank,regulation of telomerase activity (GO:0051972),0.40513332882481834,1.0777337111129792,0.368,0.7838322043307965,1.0,19/45,25.53%,MEN1;HMBOX1;CTNNB1;HSP90AB1;MAPK3;KLF4;GREM1;ACD;TERF1;MAPK1;NAF1;MAP2K7;PINX1;NVL;ERCC4;PTGES3;MYC;NABP2;PNKP
prerank,negative regulation of blood coagulation (GO:0030195),0.41300164567141817,1.0774632504520387,0.3746130030959752,0.7837789869336061,1.0,4/38,2.27%,PDGFB;CD34;NOS3;PLAUR
prerank,negative regulation of viral transcription (GO:0032897),0.5008788569754783,1.0773325712083708,0.3789279112754159,0.7833802675859436,1.0,1/13,2.37%,TRIM14
prerank,positive regulation of cell cycle (GO:0045787),0.3759245806935996,1.0768974830319595,0.3554913294797688,0.7838288669228478,1.0,14/62,12.76%,PDGFB;TGFB2;APP;TBX3;CCNY;RGCC;DUSP3;TAL1;PKN2;CCND3;ADAM17;PTK6;MAPRE3;EIF4E
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.506915660448642,1.0768719906819224,0.3974358974358974,0.7831854738066636,1.0,4/12,7.48%,PTK2;LYN;MAPK3;BST2
prerank,organonitrogen compound catabolic process (GO:1901565),-0.32172061109282984,-1.0759547660225988,0.30194805194805197,0.774343671128289,1.0,10/57,10.32%,CPQ;ANPEP;PDXDC1;ACE;ENPEP;NPEPPS;LRSAM1;IDE;RENBP;GGACT
prerank,transition metal ion homeostasis (GO:0055076),0.43227384417631226,1.0758739440547318,0.38682432432432434,0.7850249655771673,1.0,3/28,5.11%,SLC40A1;B2M;XIAP
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.4116498225034082,-1.0755532466735023,0.3935643564356436,0.7743245607337155,1.0,8/19,21.23%,PLCE1;NFAT5;NFATC4;PPP3CB;INPP5A;NFATC2;NFATC3;HRH1
prerank,lytic vacuole organization (GO:0080171),-0.3678505954965359,-1.0752693069321095,0.32791327913279134,0.7738928726198252,1.0,12/32,18.66%,ABCA1;HOOK2;ARSB;GAA;AKTIP;CLN3;LRRK2;ACP2;GNPTAB;GRN;MBTPS1;CLN6
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.39259473950963686,1.0748696808686604,0.353968253968254,0.7869743658563971,1.0,6/47,6.50%,CD34;RAPGEF2;CAV1;SNAI2;FYN;FBXW7
prerank,regulation of response to external stimulus (GO:0032101),0.3430175766884221,1.0747980943172133,0.3342391304347826,0.7864669318875087,1.0,23/121,14.36%,SEMA7A;IL1R1;CAV1;TIRAP;LRP8;BCL6B;NOD2;TMSB4X;SAMHD1;CALM1;XIAP;HCK;N4BP1;BIRC3;NLRP6;CASP8;BRD4;USP18;CYRIB;CYLD;STK24;METAP2;AREL1
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.4629713140155434,-1.0746504346142836,0.38235294117647056,0.7744558118122,1.0,4/11,14.04%,CAMK2D;CACNA2D1;CACNB2;CACNB1
prerank,negative regulation of protein kinase activity (GO:0006469),0.3585956158185205,1.0746106994282578,0.3418803418803419,0.7862444002710779,1.0,17/88,12.57%,PTPRB;DAB2IP;CAV1;GNAQ;DUSP3;ADAR;WWTR1;HYAL2;PPIA;LRP5;TRIB2;PTK6;ACP4;HSPB1;CEACAM1;PTPRQ;DBNDD1
prerank,positive regulation of DNA binding (GO:0043388),-0.373708369866255,-1.0740611707069294,0.35064935064935066,0.7748105925851251,1.0,8/31,14.07%,IGF1;FOXC1;NGF;PRKN;NIBAN2;SKI;TWIST1;SIRT2
prerank,regulation of fatty acid metabolic process (GO:0019217),0.4751089495324404,1.0739262628180684,0.38198198198198197,0.7872636878453927,1.0,3/17,1.87%,ADIPOR2;CAV1;PPARD
prerank,sterol metabolic process (GO:0016125),-0.3230545094094245,-1.0735236798366528,0.33222591362126247,0.775146365044356,1.0,15/60,18.66%,PRKAG2;CYP7B1;CYP26B1;INSIG2;CYP27A1;ABCA1;CYP1B1;APOE;OSBPL5;RXRA;TSKU;FDX1;SQLE;ANGPTL3;CLN6
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.37525820205088745,1.073164063412418,0.358187134502924,0.7885123112789256,1.0,13/60,12.43%,PDGFB;RGCC;PRKD2;HMBOX1;CTNNB1;HSP90AB1;MAPK3;KLF4;GREM1;CCT3;ACD;CCT5;POLG2
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.41498457680796386,-1.0731248740989479,0.37327188940092165,0.7750695043983192,1.0,7/19,17.48%,WNT4;BMP4;EMILIN1;TGFB3;CREB3L1;LARP6;SUCO
prerank,regulation of feeding behavior (GO:0060259),-0.4728272593983509,-1.073098646938728,0.37130801687763715,0.7739624489775524,1.0,1/11,1.09%,LEPR
prerank,aortic valve morphogenesis (GO:0003180),-0.37283554346570147,-1.072808104934055,0.3541666666666667,0.7736794732963679,1.0,9/30,8.12%,ROBO1;ROCK2;BMP4;ELN;SLIT2;SMAD6;HEYL;EMILIN1;JAG1
prerank,Notch signaling pathway (GO:0007219),0.3817366219200559,1.0726700316882918,0.3482810164424514,0.7890474372084256,1.0,11/59,6.58%,SORBS2;NOTCH4;JAG2;PLXND1;NOTCH1;YBX1;DLL4;SNAI2;MAML2;STAT1;ADAM10
prerank,regulation of secretion (GO:0051046),0.5013930495905552,1.072551836879508,0.3761814744801512,0.78862008985314,1.0,4/13,14.58%,MYO6;KCNQ1;ACSL3;SGK1
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.5165517161856812,1.0719479890277333,0.3962962962962963,0.7894057498190161,1.0,2/10,7.56%,ST3GAL1;ST6GAL1
prerank,glucan catabolic process (GO:0009251),-0.4433161874489471,-1.0710865466063466,0.4170403587443946,0.7772140930571635,1.0,10/15,23.20%,PYGB;PHKB;PYGM;GAA;PHKA2;AGL;PHKG2;PHKA1;PHKG1;PYGL
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.46437814961378054,1.0708378695956955,0.38419117647058826,0.7914998584126931,1.0,2/18,5.14%,BCL2L1;SLC25A5
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.39064502700070947,-1.0707293528738426,0.35678391959798994,0.7770189433718335,1.0,8/25,10.64%,SLIT2;CAPZB;ARHGAP24;KANK1;PRKCD;YAP1;PFN2;ARHGAP44
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.45181896909486285,1.0697329160498232,0.39649122807017545,0.7936541246355254,1.0,6/20,9.43%,IMPDH1;HPRT1;NT5C2;AK4;ADSS2;GART
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.4022598177201239,-1.0694553947810843,0.3654320987654321,0.7793004832683367,1.0,6/23,8.56%,CAMK1D;MCU;SLIT2;RIPOR2;DAPK2;DPP4
prerank,supramolecular fiber organization (GO:0097435),0.304544374731466,1.0693221197438367,0.32233223322332233,0.7940179835714168,1.0,59/333,11.67%,ITGA6;FLII;HIP1;COLGALT2;MYO1D;MYO1E;RHOBTB1;SHROOM4;TGFB2;SHROOM1;PGM5;APP;TSPAN5;ELMO1;HIP1R;B2M;COL4A2;ARHGEF2;FGF13;TSPAN14;CD2AP;EVL;PXDN;PPP1R9B;ELMO2;MYO6;STMN1;CCDC13;NPPA;CLIP1;HSP90AB1;COL4A1;RHOB;TPM3;CCDC88A;NCKAP5;CCDC88B;KIF2A;ADAM10;ARHGAP25;STMN3;ACTN1;STMN4;KLHL24;PIN1;PLOD3;TMOD1;GREM1;COL9A3;MYO1F;ARHGAP17;CLRN1;RAC1;TPM4;HOOK1;CRIPT;APH1A;SLK;MAP10
prerank,regulation of establishment of protein localization (GO:0070201),0.49533895657737476,1.069206640122192,0.38956521739130434,0.7935981177987768,1.0,4/13,16.49%,CORO2B;CEP135;DNAJA1;PTP4A3
prerank,cellular response to interleukin-6 (GO:0071354),0.43055202099123796,1.069012036004841,0.37375415282392027,0.7934039707613681,1.0,4/26,6.27%,ST3GAL6;IL6R;ST18;STAT1
prerank,cholesterol efflux (GO:0033344),0.453278009673304,1.0690117324425366,0.37225042301184436,0.7926933076657869,1.0,4/20,9.00%,SCARB1;ABCG1;ABCA7;NPC1
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.4954031323760232,1.0688827632679299,0.39114391143911437,0.7923075780444128,1.0,2/13,5.21%,PLCB1;CCR7
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.48909141892247754,1.0684597234605486,0.38003502626970226,0.7927700231427331,1.0,4/13,14.64%,LCMT1;CDK5RAP2;DUSP1;DYNC1LI1
prerank,aorta development (GO:0035904),-0.44578803852653215,-1.0684213653006933,0.40380549682875266,0.7809204563654472,1.0,6/14,8.97%,ROBO1;LRP1;PDGFRB;PKD2;JAG1;EFEMP2
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.3701094212777909,-1.068406763102663,0.34153005464480873,0.7797806584255035,1.0,10/29,24.33%,COPA;COPZ2;COPB1;TRAPPC3;RAB6A;TRAPPC10;COPB2;GOLGA5;COPZ1;COPG1
prerank,protein-containing complex assembly (GO:0065003),0.31321467455743135,1.067432416013418,0.33178654292343385,0.7947063781612164,1.0,42/259,15.04%,LEF1;OCLN;SLC2A1;CXCL12;FAS;MAGI1;CD40;TIAM1;PARD3;CD2AP;MEN1;CTSC;VIL1;CTNNB1;CARD10;TCF7;DBNL;ADAM10;AIM2;CLDN14;TLE4;AP2M1;P2RX7;TGFA;CAPG;AXIN2;CASP8;RSPH4A;SAMM50;FERMT2;PEX14;TLE1;RANBP9;RAB1A;CNIH3;CSNK2B;SOX9;PDCD6;RBX1;TSPAN33;SH3BGR;NCKAP1L
prerank,nuclear body organization (GO:0030575),0.5052636758095905,1.0672913901572547,0.3996316758747698,0.7943597793375659,1.0,4/12,14.46%,ETS1;ZPR1;HIPK2;SERBP1
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.3948164953618569,-1.0662847594470948,0.3564356435643564,0.7845921635258402,1.0,12/22,31.83%,ANK2;PKD2;SLC9A1;GSTM2;STAC3;JPH2;HTT;HAP1;GSTO1;ATP1B1;TRDN;ATP2A1
prerank,negative regulation of platelet activation (GO:0010544),0.4863564631374779,1.0657431963296695,0.41354723707664887,0.7975740256992262,1.0,3/16,4.02%,PDGFB;NOS3;PRKG1
prerank,regulation of interferon-alpha production (GO:0032647),0.4351420412912298,1.0656075031152628,0.3837011884550085,0.7972073850971135,1.0,6/23,11.18%,IFIH1;TLR3;STAT1;IRF5;TLR7;TLR8
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.4640919225876941,1.0655622476142033,0.38476190476190475,0.7966153242491333,1.0,3/18,9.31%,SHANK3;NPS;NRXN1
prerank,regulation of type I interferon production (GO:0032479),0.3545474237035138,1.0654930455204659,0.3680456490727532,0.7960649748750339,1.0,15/84,14.82%,TIRAP;TRIM25;LRRFIP1;IFIH1;NLRC5;RNF125;CTNNB1;MRE11;IRF5;PIN1;NLRP4;TNFAIP3;CYLD;G3BP1;CRCP
prerank,calcium ion import into cytosol (GO:1902656),-0.42647316417986914,-1.0654837637682941,0.3761467889908257,0.7856128138554068,1.0,3/15,7.19%,SLC8A3;CACNA2D1;SLC8A1
prerank,cAMP-mediated signaling (GO:0019933),0.43411136165951864,1.06500668784292,0.38879736408566723,0.7965943146724033,1.0,5/24,4.60%,PDE2A;RAPGEF2;RAPGEF3;PDE4D;PDE7B
prerank,response to glucocorticoid (GO:0051384),-0.38387892322866185,-1.0649013877287998,0.3725,0.7860325495256735,1.0,4/26,11.57%,SLIT2;ADAM9;ANXA1;GOT1
prerank,cellular response to tumor necrosis factor (GO:0071356),0.32562025140114764,1.064761339260788,0.3409378960709759,0.7965653492804875,1.0,28/175,12.36%,DAB2IP;NFKBIA;TNFRSF25;TNFRSF11A;ARHGEF2;CD40;TNFRSF21;TMSB4X;IKBKB;HYAL2;ST18;ACTN4;STAT1;AIM2;PSMB3;BIRC3;PSMD11;PSMC6;TNFSF11;PSME2;ADAM17;EIF5A;ZFP36L1;CCL1;PLVAP;TNFRSF4;PSMD8;TNFSF12
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.45246728626810356,1.0642921587308016,0.39078498293515357,0.7970545579241306,1.0,2/19,1.96%,CSGALNACT1;EXTL3
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.500109455703879,1.0641924400739733,0.41729323308270677,0.7965876979111262,1.0,3/12,9.79%,LAMA5;ACTB;ACTG1
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.33706775158350655,1.0638643597618667,0.35496688741721855,0.7967135268572596,1.0,16/122,8.52%,NAMPT;PDGFB;KDR;INSR;TGFB2;BCAR3;RGCC;NIBAN1;NOD2;PRKD2;NLRC5;KLF4;NPM2;SORBS1;EIF3E;DNA2
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.3397376250077929,-1.063766897939419,0.37175792507204614,0.7879675937200568,1.0,8/41,11.66%,ITPR1;SLC8A3;CACNA2D1;FGF2;PKD2;SLC8A1;ITPR2;IBTK
prerank,histone methylation (GO:0016571),-0.3787834291508533,-1.0637552354076985,0.35391923990498814,0.7868228455648357,1.0,14/26,34.68%,SMYD3;EHMT2;PRMT5;PRMT8;TRMT112;EZH2;SETD6;NSD1;SMYD2;PRMT2;CREBBP;PRMT1;CARM1;NTMT1
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.5241812722474303,1.0636765517376277,0.40636704119850187,0.7965120103273766,1.0,5/10,13.65%,TBX1;STAT1;LRP5;TGFBR2;SOX9
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.41644592417040116,-1.0633188683058317,0.39545454545454545,0.7868484480449157,1.0,7/18,19.39%,IRS1;PRKN;CCN3;KCNB1;INHBB;SFRP1;ADRA2A
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.43441784142831824,1.0632330840194892,0.40939597315436244,0.7969402735178804,1.0,3/25,6.07%,PLAUR;TNFSF10;BIK
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.48105445827533844,1.0631539974679367,0.3724770642201835,0.7964033977572161,1.0,7/15,25.75%,SMAD7;RPS7;RPL11;BAG2;RPL23;DTX3L;BAG5
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.4305448729606938,-1.0627028549673054,0.38530066815144765,0.787383557267447,1.0,9/15,32.07%,PRKN;BCL2;KDM1A;CD44;TAF9B;TAF9;ARMC10;SIRT1;MUC1
prerank,inositol lipid-mediated signaling (GO:0048017),0.37960074935612215,1.0617716895336786,0.37576687116564417,0.7992815027736203,1.0,3/50,0.56%,IGF1R;PLCB1;PLCB4
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.47548212501121623,-1.0614917071952295,0.39503386004514673,0.7897103411639911,1.0,4/12,5.98%,IGF1;IRS1;IRS2;IGF2
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.40913027822554837,-1.0610654308636362,0.4134831460674157,0.7897460836241541,1.0,4/17,4.75%,ROBO1;EFNB2;SLIT2;FGF2
prerank,hyaluronan catabolic process (GO:0030214),-0.416148767823128,-1.0610408880573443,0.3847926267281106,0.7886508145461611,1.0,10/18,27.09%,CEMIP;CEMIP2;FGF2;SLC9A1;HEXA;CD44;LYVE1;HMMR;GUSB;HYAL3
prerank,glutathione biosynthetic process (GO:0006750),0.5122852172893051,1.060868618817259,0.4265232974910394,0.8008166269627446,1.0,2/11,5.15%,GCLM;MGST2
prerank,positive regulation of glucose import (GO:0046326),0.4497763988026924,1.06050904500256,0.39378238341968913,0.8010418491391347,1.0,2/21,0.95%,OCLN;INSR
prerank,actin filament bundle assembly (GO:0051017),-0.36439107000268,-1.0604539711394618,0.3791348600508906,0.78916555076265,1.0,3/33,0.50%,CALD1;DPYSL3;PAWR
prerank,ephrin receptor signaling pathway (GO:0048013),0.353519754739265,1.0602606422319494,0.37357954545454547,0.800915356967205,1.0,26/82,14.08%,ANKS1A;PTK2;KALRN;ARPC4;TIAM1;LYN;ACTB;EPHA4;FYN;YES1;EPHB4;EFNA1;ANKS1B;AP2M1;ARPC3;ARHGEF7;PAK1;ACTG1;RAC1;GRIN2B;APH1A;HRAS;AP2B1;EPHB1;SDCBP;GIT1
prerank,regulation of cellular localization (GO:0060341),-0.3392595829403983,-1.0600794487762746,0.3633720930232558,0.7890062879741593,1.0,13/46,14.62%,ADCY5;GSN;PARD6G;EFNA5;CAMK2D;STXBP4;PRKN;CDK16;PARP1;KDM1A;LRRK2;BRSK1;MAP2
prerank,regulation of JUN kinase activity (GO:0043506),0.40545771596468944,1.0596739743484918,0.3807266982622433,0.8017295751734373,1.0,9/33,17.65%,DAB2IP;TNFRSF11A;NPPA;ARHGEF5;PAK1;HIPK3;DNAJA1;EDN1;MAP3K11
prerank,bicarbonate transport (GO:0015701),0.4374084610076101,1.059600954653453,0.3898858075040783,0.8012055981462125,1.0,2/25,1.25%,CA4;SLC39A8
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.3942452868403705,-1.059364829741902,0.3721461187214612,0.7886082557263947,1.0,11/23,19.16%,ZEB2;THBS1;DAB2;TGFB1I1;STK11;GIPC1;EP300;SLC2A10;CDKN1C;CITED2;FLCN
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.3942452868403705,-1.059364829741902,0.3721461187214612,0.7886082557263947,1.0,11/23,19.16%,ZEB2;THBS1;DAB2;TGFB1I1;STK11;GIPC1;EP300;SLC2A10;CDKN1C;CITED2;FLCN
prerank,axonal fasciculation (GO:0007413),-0.4478344143484697,-1.059154975599121,0.38085106382978723,0.78802198948451,1.0,2/12,7.27%,EPHA3;EPHB2
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.44777445931757937,-1.0591287680934562,0.38461538461538464,0.7869375152230953,1.0,3/12,3.56%,APOD;F3;CBLB
prerank,peptidyl-proline modification (GO:0018208),-0.38188897723856896,-1.0586845485715208,0.37017994858611825,0.7870776236537812,1.0,8/25,18.91%,FKBP5;PPIC;FKBP10;PPIL2;P3H2;OGFOD1;PPIH;NKTR
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.3440105674997328,-1.0586197346991155,0.33707865168539325,0.7860982831013064,1.0,5/41,6.12%,ANK2;ACTN2;KCNMB2;KCNJ2;FLNA
prerank,proteolysis (GO:0006508),-0.2610868003499193,-1.0582806362934174,0.25333333333333335,0.7858920888258597,1.0,46/252,16.26%,TRABD2B;CPQ;AEBP1;ADAMTS12;PCSK5;HTRA3;MMP14;ADGRV1;MMP16;F3;ANPEP;OGT;SUFU;BACE2;GGT5;FAP;CTSL;NAALAD2;MMP2;ACE;ENPEP;NPEPPS;DPP4;ADAM19;CPXM1;CPXM2;ADAM33;CUL7;IDE;ATG4A;CLN3;MMP19;AFG3L2;SENP6;PSEN1;HTRA1;CTSH;HTRA2;HTRA4;CASP3;CAPN1;CTSZ;SDE2;ZMPSTE24;ADAMTS9;HM13
prerank,negative regulation of B cell proliferation (GO:0030889),0.5164021971399878,1.0581237841565252,0.4197080291970803,0.8041695153187929,1.0,2/11,4.08%,LYN;TNFRSF21
prerank,regulation of response to biotic stimulus (GO:0002831),0.41857047843143946,1.0578999898588028,0.391025641025641,0.8040175606390607,1.0,7/28,10.14%,TIRAP;LRP8;SAMHD1;XIAP;N4BP1;BIRC3;CASP8
prerank,apical protein localization (GO:0045176),0.5101552604676728,1.0575714392102715,0.4072727272727273,0.8041720383366308,1.0,2/10,3.92%,MAL;ACTB
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.3788405596344232,-1.0572162870082085,0.3746556473829201,0.787721785789971,1.0,3/26,5.25%,LGR4;APPL2;FLOT2
prerank,positive regulation of signal transduction (GO:0009967),0.3108927665892078,1.0564333108942656,0.34554334554334554,0.8063296957675723,1.0,33/238,9.31%,TEK;SHANK3;JCAD;DAB2IP;MACF1;LIMS2;TGFB2;EPN2;NOS3;NOTCH4;TRIM16;JAG2;TSPAN5;FAS;TPD52L1;NOD2;TSPAN14;PRKD2;NOTCH1;VWF;KLF2;WNT7A;HHEX;DLL4;MAML2;HOMER1;CRADD;SORBS1;RAB34;CAV2;TNFSF11;DISC1;NRXN1
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.3644018068111018,1.0563446665673355,0.3847305389221557,0.8058421884335503,1.0,13/69,11.27%,IGF1R;PLCB1;PLCB4;INPP5F;PLEKHA1;PIRT;CD160;HTR2A;PLCH2;PIK3C3;PIK3C2A;ZFP36L1;PLCH1
prerank,clathrin-dependent endocytosis (GO:0072583),0.4207971278911176,1.0559229759408386,0.3976311336717428,0.8062361135137293,1.0,9/26,14.94%,FNBP1L;ITSN2;PIP5K1C;INPP5F;FCHO2;AP2M1;SIGLEC1;AP2B1;LMBRD1
prerank,cell differentiation in spinal cord (GO:0021515),0.5116325916772063,1.0550680993710422,0.41044776119402987,0.8077184691122957,1.0,6/10,26.63%,SOX13;MDGA2;LHX1;DRAXIN;ISL1;ZC4H2
prerank,metal ion export (GO:0070839),-0.35680881889306426,-1.0540473596637865,0.38071065989847713,0.7954642705221876,1.0,6/31,7.12%,ATP1A2;KCNT2;KCNK5;ATP1B3;ATP7A;ATP1B2
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.49004945684629014,1.0538538648876594,0.42213883677298314,0.8100108169243525,1.0,1/12,1.64%,IL1R1
prerank,positive regulation of protein metabolic process (GO:0051247),0.3393143714698723,1.053284802166799,0.35918367346938773,0.8107577574917303,1.0,23/110,15.14%,DAB2IP;APP;NFKBIA;NKD1;NEDD4L;FOXO1;KLF2;WNT7A;KLF4;NR1H2;EGLN2;OAZ1;TGFB1;SMURF1;GSK3A;TNFAIP3;RANBP9;TNFSF12;RAB1A;ASB5;BCL10;AREL1;PLK2
prerank,amyloid fibril formation (GO:1990000),0.37324337913346134,1.0531466714924678,0.38288288288288286,0.8103923566627682,1.0,6/51,6.58%,APP;TSPAN5;B2M;TSPAN14;NPPA;ADAM10
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.44223803595537947,1.0530651007574068,0.38408304498269896,0.8098967878562746,1.0,9/21,25.70%,ARHGEF2;FGF13;ATXN7;APC;CAMSAP2;CLASP1;NAV3;CAMSAP1;CLASP2
prerank,sarcomere organization (GO:0045214),-0.37166404663255836,-1.0530616819828342,0.36790123456790125,0.7970718323444705,1.0,7/27,20.84%,ACTN2;TPM1;TNNT3;SIX4;MYOM2;CSRP2;KRT19
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.43616009807841194,1.0528901075413368,0.4190800681431005,0.8096025329691461,1.0,4/21,4.57%,CAV1;CNKSR3;SMAD7;PDE4D
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.41076232575239474,1.0525610572455377,0.40131578947368424,0.8097287539458355,1.0,6/32,8.39%,CAV1;APLNR;PLCG1;CD19;RAMP3;P2RX7
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",-0.23484126826865948,-1.0520267391076388,0.05714285714285714,0.7988386927326202,1.0,176/807,16.22%,BMP6;FOXP2;PRDM6;FHL2;AEBP1;NR2F2;ZEB2;GLI3;RARB;ZFHX3;GLI2;GLIS3;FOXD1;WNT4;SMAD3;FOXP4;DKK3;BMP7;FGFR2;BMP4;KANK2;ZFPM2;OSR1;DDX5;NR6A1;FNIP1;THRB;MDFIC;LBH;HDAC4;CUX1;FRK;PER3;MXI1;WWOX;SALL1;IMPACT;SHC1;SNX6;NR1D2;ZHX2;FOXC2;DNMT3A;LOXL3;BCOR;FOXC1;KCNIP3;SUFU;HOXA7;ZNF423;RBPJ;DAB2;TBL1XR1;EHMT2;MIER3;MDM4;AR;DLG1;PER2;GLIS2;PPARA;PHF21A;CTR9;KAT6B;RUNX2;IKZF4;ZMYM5;IGF2;CBX7;ZNF25;FLNA;HEYL;BCL6;DACT1;SMARCC2;KDM2A;ZNF568;LCOR;ATF5;PRKN;PFDN5;ATN1;CHD3;ZEB1;CBX5;PHC2;CHD8;RUNX1T1;MED25;MITF;KDM2B;ZMYND15;RBAK;POU6F1;ATOH8;YAP1;USP2;EZR;PML;SMURF2;PCGF2;VGLL4;FOXO3;SFMBT1;CXXC5;GCFC2;TWIST2;QARS1;CEBPB;CREB3L1;BTRC;MBTD1;NIBAN2;URI1;EZH1;TSC22D4;PBXIP1;PRDM11;CRY2;ZNF148;CBFA2T2;WWP2;PARP1;NR2F1;GATA6;ZBTB38;ESR1;MTERF3;RXRA;KDM1A;NFX1;BCL7A;XRCC5;ZNF219;BMP2;SKI;PSEN1;ZBTB4;E4F1;ATP8B1;FOXE1;GCLC;TWIST1;ZNF3;NKX6-1;SP3;PAF1;PEX2;SNAI1;GZF1;ZBTB1;EP300;SIRT2;WNT11;FBXW11;IFI27;USP9X;CBX6;ZBTB7B;MAP2K5;NONO;PHF12;TLE2;LDB1;LDB2;TSHZ3;LIMD1;CRYAB;PSPC1;SAP18;CDKN1C;SPINDOC;JDP2;NFIL3;MTA3;ZFP37
prerank,regulation of extracellular matrix organization (GO:1903053),-0.44081988661994886,-1.0516247861572838,0.40311804008908686,0.798831868213452,1.0,5/15,8.97%,LRP1;AEBP1;DDR1;FAP;EFEMP2
prerank,spermatid development (GO:0007286),0.41215887473859725,1.0514488060962475,0.4029363784665579,0.8119448182356742,1.0,5/32,14.75%,JAM2;PIWIL1;RSPH1;RNF8;YTHDC2
prerank,peptidyl-methionine modification (GO:0018206),0.5097575453647233,1.0514068275791781,0.4254545454545455,0.8113492175074709,1.0,3/12,14.01%,NAA60;NAA16;METAP2
prerank,ventricular septum development (GO:0003281),-0.35047988099914257,-1.051103219969267,0.3815789473684211,0.7992047021824391,1.0,9/37,6.39%,ROBO1;TGFBR3;BMPR1A;ZFPM2;SLIT2;SALL1;TGFBR1;MDM4;HEYL
prerank,regulation of tau-protein kinase activity (GO:1902947),0.5019273383827588,1.050761091318601,0.42883211678832117,0.8122708588112239,1.0,1/10,5.11%,HSP90AB1
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.5172019833506145,1.0501889100286539,0.42883211678832117,0.8130256095690476,1.0,4/10,8.49%,CALM1;NPPA;SRI;PDE4B
prerank,endothelial cell migration (GO:0043542),0.39894139447664706,1.0494088164344946,0.3851132686084142,0.8142868022223729,1.0,8/37,7.35%,NOS3;PLEKHG5;ID1;PLXND1;STARD13;PXN;STAT1;SOX18
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.3721425474171358,1.0493312077278913,0.3812849162011173,0.8137658408107172,1.0,13/61,5.61%,ARHGEF3;RASGRP4;NET1;F11R;ADGRG1;LPAR6;RAPGEF1;PRAG1;NOTCH1;LYN;GRB2;P2RY10;MAPRE2
prerank,histone ubiquitination (GO:0016574),-0.3979577754263695,-1.0492922209929605,0.3864168618266979,0.803097558377414,1.0,7/21,15.72%,CTR9;UBE2E1;HUWE1;RNF20;PAF1;UBE2B;UBR2
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.44770383223279586,1.0492176062243683,0.3989455184534271,0.8133361047224974,1.0,7/18,18.74%,CCT3;DCP2;CCT5;NHP2;CCT7;NAF1;EXOSC10
prerank,positive regulation of cell projection organization (GO:0031346),0.3379400834499197,1.04872023539457,0.36904761904761907,0.8138621496251157,1.0,23/115,10.25%,ITGA6;NDNF;DAB2IP;RAPGEF2;FES;SCARF1;FZD4;PLXND1;RAPGEF1;TIAM1;PRKD1;LYN;SNX3;FUT9;RET;LRRC7;PTN;SLITRK1;TWF2;ARHGDIA;SERPINI1;METRN;PTK6
prerank,ERBB signaling pathway (GO:0038127),0.3628956568790679,1.048575280017178,0.4101796407185629,0.813517112937617,1.0,17/64,10.47%,PTK2;PTPN12;VIL1;PLCG1;GRB2;GAB1;SOS1;RPS6KA5;PTPRR;TGFB1;IQGAP1;TGFA;SHC3;ADAM17;PTK6;PIK3C2A;GRB7
prerank,activation of GTPase activity (GO:0090630),0.3466300435572934,1.0483127011793598,0.3810810810810811,0.8135225398265692,1.0,15/89,6.66%,TBC1D4;ARHGEF15;TBC1D14;TBC1D22A;SIPA1L2;SIPA1;TIAM1;ABR;TBC1D12;RALGAPA1;TBC1D2;CCR7;USP6NL;TBC1D5;ARHGAP25
prerank,zymogen activation (GO:0031638),-0.3458907017956035,-1.0481102629604233,0.3687002652519894,0.8052551425246697,1.0,9/39,16.24%,CYFIP2;MMP14;ASPH;CTSL;KLK2;PERP;TBC1D10A;CTSH;PRSS12
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.35457298766525697,1.0477472959831777,0.39970717423133234,0.8142637966059135,1.0,13/74,10.14%,ITGA6;BCL2L1;NOS3;FAS;SH3RF1;TNFSF10;ARHGEF2;SNAI2;RFFL;MCL1;FAIM;ZMYND11;CASP8
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.3406623442175838,1.0476982868813844,0.3657219973009447,0.8136756916822311,1.0,39/109,23.32%,MAP3K1;LYN;PLCG1;IKBKB;GRB2;CALM1;SOS1;MAPK3;PSMB3;PSMD11;JUN;PSMC6;PAK1;MALT1;PSME2;RAC1;PPP3CA;PSMD8;PPP3R1;SYK;PIK3CB;LCP2;PSMB10;BCL10;CARD11;PSMA8;LAT2;MAPK1;SKP1;PAK2;PSMD9;MAP2K7;PLCG2;VAV1;CUL1;PSMD1;PSMC3;TRAF6;PSMD10
prerank,protein monoubiquitination (GO:0006513),-0.35234578870060784,-1.0474286875007444,0.39185750636132316,0.8059964500865172,1.0,11/36,15.01%,KLHL22;CTR9;UBE2R2;MGRN1;PRKN;UBE2E1;CUL3;HUWE1;RNF20;PAF1;UBE2B
prerank,negative regulation of protein secretion (GO:0050709),0.4018332598203007,1.0470303665437095,0.41497659906396256,0.814724377117838,1.0,3/38,2.98%,RAB11FIP1;CD200;RHBDF2
prerank,positive regulation of T cell cytokine production (GO:0002726),0.4354351220587346,1.0466799632160242,0.398989898989899,0.8149632263348903,1.0,4/20,10.90%,IL1R1;B2M;MALT1;DENND1B
prerank,signal transduction by p53 class mediator (GO:0072331),0.41042138917684073,1.0466306326287658,0.4180064308681672,0.8143969375018177,1.0,6/30,8.93%,PPP1R13B;ACER2;MYO6;HINT1;JMY;GREM1
prerank,protein insertion into membrane (GO:0051205),0.40175877619167333,1.0465418505564237,0.40268456375838924,0.8139395211876229,1.0,5/32,8.33%,APP;REEP1;STX1A;GRIN3B;RTP4
prerank,positive regulation of bone resorption (GO:0045780),0.49558566629357803,1.0465375291790295,0.42230347349177333,0.8132490134175445,1.0,4/11,12.14%,TNFRSF11A;TNFSF11;PLEKHM1;SYK
prerank,regulation of vesicle-mediated transport (GO:0060627),0.33915394865877035,1.046401125028986,0.3796423658872077,0.8128732817968717,1.0,23/91,18.85%,HIP1;FES;HIP1R;SCARB1;DNAJC13;SYT7;INPP5F;MAPK3;HCK;RAB11A;OPHN1;RAB3B;RAB4A;SYK;LGI3;CPLX1;RNF139;MAPK1;RALA;RIMS2;NRP1;RAB8A;RAB5C
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.4190439795852496,1.0462058087699704,0.4044368600682594,0.8126752522956585,1.0,6/29,7.94%,ENG;S1PR1;ZFPM1;NOTCH1;SMAD7;TGFB1
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.4216201187742137,-1.0461392458321395,0.3991228070175439,0.8084234942736612,1.0,6/15,16.69%,RIPOR2;ADAM9;EHD1;MAPK14;CAMK1;EHD2
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.292544924172547,1.0456761339490213,0.36219640971488914,0.8132944598323537,1.0,74/497,13.15%,LEF1;MECOM;PLCB1;DACH1;PDGFB;ELK3;DAB2IP;BMPR2;NANOS3;ZHX3;PPARD;TBX3;ID1;SMARCA2;FOXO1;FOXL2;ACVRL1;SOX13;CCDC85B;NOTCH1;YBX1;MEN1;HDAC9;HMBOX1;ZBTB16;HHEX;CTNNB1;NANOS2;SOX7;GATAD2A;ENC1;MRPL13;CD38;NANOS1;RPS6KA5;KLF4;PHC1;NR1H2;SOX18;YEATS2;HINFP;KAT6A;L3MBTL4;TGFB1;JUN;CIART;FOXP3;ZBTB14;HMGA1;DEDD2;ZMYND11;KDM4A;CNOT9;YWHAQ;RPL13A;GRB7;CDC6;HSPA8;CTCF;PEX14;EID2;TLE1;TNFRSF4;ZBTB7A;GSK3A;LHX9;RCOR2;PPARG;TERF1;BTG2;POU2F1;PAIP2;HMGB2;ZBTB33
prerank,Rho protein signal transduction (GO:0007266),0.3698490693910614,1.0455776988929113,0.3930131004366812,0.8128719969504447,1.0,13/53,9.48%,ARHGEF3;NTN1;PLEKHG5;ADGRG1;RIPOR1;EPS8;GNA12;RHOB;CDC42EP3;EPS8L2;ARHGAP4;ARHGDIA;PHACTR4
prerank,regulation of T cell cytokine production (GO:0002724),0.4712785164891593,1.0453468059151871,0.4146341463414634,0.8127575841859412,1.0,4/15,9.25%,B2M;SMAD7;FOXP3;MALT1
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.45638217454807906,-1.0446322976565028,0.3982494529540481,0.8115535556057207,1.0,4/12,18.81%,SEH1L;CENPC;RMDN1;CENPE
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.375719872865029,-1.0445002134096593,0.40786240786240785,0.8107856159420864,1.0,9/26,21.60%,KANK2;DAB2;HEYL;CRY2;PIAS2;SFRP1;NCOR1;BRCA1;PER1
prerank,response to UV-A (GO:0070141),-0.4355324938515587,-1.0442161687307387,0.4041095890410959,0.8104351094985409,1.0,2/14,6.98%,EGFR;MMP2
prerank,response to steroid hormone (GO:0048545),0.4142198680365502,1.0441471558707307,0.4117647058823529,0.8151941866062096,1.0,6/31,7.94%,ABHD2;TGFB2;CAV1;ATP1A3;ATP1A1;TGFB1
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.38736281770112957,-1.0436637487985094,0.4,0.8108586370766013,1.0,7/24,10.75%,SEC24D;SEC24A;ACE;SEC31A;CANX;IDE;SEC23A
prerank,mononuclear cell differentiation (GO:1903131),-0.39243235391779935,-1.0435873443405392,0.4207920792079208,0.8099322021159685,1.0,3/24,1.84%,IL31RA;AXL;BMP4
prerank,protein stabilization (GO:0050821),-0.26134551768384506,-1.0431508621220615,0.3888888888888889,0.8100062704878843,1.0,45/168,18.76%,ANK2;IGF1;PARVA;PLPP3;PER3;LAMP2;RASSF2;PRKCD;PPARGC1A;MDM4;ATP1B3;FLOT2;STXBP4;RAB21;AAK1;FLNA;ATP1B2;PRKN;TNIP2;USP2;PFN2;BAG1;CCNH;CDK7;SYVN1;P3H1;NCLN;SEC16A;PTEN;OTUD3;EP300;BAG3;MORC3;PIK3R1;USP9X;UBE2B;CRYAB;CCT2;GRN;GET1;TAF9B;ATF7IP;MUL1;CCT6A;USP19
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.44927570980006415,1.043024552520746,0.42439862542955326,0.8173613160318959,1.0,3/20,5.15%,GATM;GCLM;MGST2
prerank,cellular response to cadmium ion (GO:0071276),0.4304504651682502,1.0422266432929672,0.4114671163575042,0.8186491619548101,1.0,12/24,16.82%,MAPK3;JUN;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;MAPK1;SUMO1
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.4624231769544764,-1.0420582708917137,0.40670859538784065,0.8120463677030716,1.0,3/11,13.50%,GRK3;ARRB1;ADM
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.40628575730939287,-1.041853693438522,0.3783132530120482,0.8114799588567982,1.0,6/17,32.96%,LPGAT1;LCLAT1;PLA2G12A;PLA2G4F;PLA2G5;PLBD1
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.4064313476866608,-1.0417490163822412,0.4009216589861751,0.8105928167422369,1.0,10/17,33.72%,CPEB1;CTR9;RNF20;NELFE;ZC3H3;CDK9;RNF40;ZC3H14;VIRMA;HSF1
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.41630386174011996,1.0417286424042855,0.42589437819420783,0.8191505584440651,1.0,6/26,11.83%,PLCB1;RGCC;CCND3;ADAM17;CDC6;RPTOR
prerank,regulation of cholesterol transport (GO:0032374),-0.3955222805466626,-1.0410848436210878,0.38967136150234744,0.8113302056097118,1.0,1/20,0.53%,LRP1
prerank,regulation of mitochondrial fusion (GO:0010635),0.4963813631074573,1.0410031961390178,0.43263757115749524,0.8202631502015387,1.0,1/11,0.14%,TFRC
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.4575635922661274,-1.0409798311298137,0.4216589861751152,0.8104611106320718,1.0,4/13,5.98%,IGF1;IRS1;IRS2;IGF2
prerank,positive regulation of lyase activity (GO:0051349),-0.42909997362575997,-1.0407414298921107,0.3982102908277405,0.8099863289784607,1.0,5/14,13.80%,CACNA1C;STIM1;CACNA1D;FXN;NF1
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.45166364291631544,-1.040608654296556,0.43537414965986393,0.8092034763611466,1.0,4/12,13.59%,CDC14B;GOLGA2;BTRC;PTEN
prerank,calcium ion homeostasis (GO:0055074),0.33633616283939427,1.0405668705221682,0.39290586630286495,0.8206899755591808,1.0,11/95,7.54%,TMTC2;CXCL12;CAV1;CD40;SLC30A1;ATP2C1;SLC24A4;SLC24A2;ATP2B1;SLC10A7;HTR2A
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.5194655226093751,1.0404938308428948,0.4336448598130841,0.8201625585832196,1.0,4/10,7.38%,NOTCH4;RGCC;NOTCH1;NEXMIF
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.5010861309542922,1.0402701824775074,0.45269016697588127,0.8200117885727041,1.0,2/10,3.86%,JAK3;LYN
prerank,amyloid precursor protein catabolic process (GO:0042987),0.47623452678777534,1.0400941939745911,0.44483985765124556,0.8197332652014508,1.0,5/14,11.59%,ABCG1;ADAM10;ABCA7;ADAM17;APH1A
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.4871344069977634,1.0400489575952307,0.4216417910447761,0.8191685102209425,1.0,4/12,10.34%,LYN;CD19;ELF2;CBFB
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.39910862152758103,-1.0396929540552198,0.40326340326340326,0.808292681890969,1.0,13/20,32.95%,KLHL22;ZWINT;ATM;MAD2L1;TTK;CENPF;TEX14;KNTC1;TPR;PLK1;CDC20;BUB1;TRIP13
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.39910862152758103,-1.0396929540552198,0.40326340326340326,0.808292681890969,1.0,13/20,32.95%,KLHL22;ZWINT;ATM;MAD2L1;TTK;CENPF;TEX14;KNTC1;TPR;PLK1;CDC20;BUB1;TRIP13
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.39910862152758103,-1.0396929540552198,0.40326340326340326,0.808292681890969,1.0,13/20,32.95%,KLHL22;ZWINT;ATM;MAD2L1;TTK;CENPF;TEX14;KNTC1;TPR;PLK1;CDC20;BUB1;TRIP13
prerank,generation of neurons (GO:0048699),0.31822068023501704,1.039546219677799,0.39060568603213847,0.8197754244728511,1.0,35/190,13.03%,NDNF;TGFB2;RAPGEF2;ADGRL3;SH3RF1;NAV1;FZD4;MEF2C;FGF13;WNT7A;CTNNB1;BTG4;FUT9;INSM1;OPHN1;PIN1;GPM6A;ACSL3;DISC1;SPOCK1;DNER;DCX;ATOH7;DDIT4;CEP85L;RAC1;LHX5;VXN;IER2;LHX9;LHX6;SOX11;HMGB2;EML1;OLIG1
prerank,basement membrane organization (GO:0071711),0.46703753725054775,1.0393345142604098,0.42830540037243947,0.8196237769080923,1.0,4/14,5.24%,NTNG2;RAMP2;PXDN;COL4A1
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.3193474752660147,-1.0392350308278528,0.378698224852071,0.8083844715111108,1.0,11/51,8.63%,GAS7;DCLK1;NBL1;BMP7;NRK;NGF;DTNBP1;MAP1S;ATP7A;EPB41L3;ANKRD27
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.4948444159439055,1.0389427804278397,0.43357933579335795,0.8199313185248036,1.0,4/12,12.29%,NFKBIA;ABCG1;NR1H2;PPARG
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.5055047524980889,1.0387617314598407,0.43575418994413406,0.8196728581460008,1.0,6/10,29.06%,PDE8A;STK26;TXN;RIPK1;NFE2L2;PARK7
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.3671053227435192,1.0387491837266476,0.4130105900151286,0.8190182171584366,1.0,7/52,8.39%,PRKCH;SPTBN1;STX3;ATP2C1;RAMP3;SORBS1;ACSL3
prerank,purine-containing compound biosynthetic process (GO:0072522),-0.36450751593197844,-1.0385707945095892,0.3995381062355658,0.8091331877550334,1.0,10/25,17.16%,AMPD3;PAICS;MTHFD1;PRPS2;GMPR2;PRPSAP1;DGUOK;GMPS;PRPSAP2;ADSL
prerank,regulation of cytokinesis (GO:0032465),0.35067563119407785,1.0384275260807951,0.4017094017094017,0.8191512643479532,1.0,20/78,16.56%,BCL2L1;CALM1;CDC14A;CCP110;PKN2;RAB11A;PKP4;PIN1;CETN2;RAB11FIP4;PIK3C3;CDC6;MAP10;SH3GLB1;KIF23;GIT1;PLK2;RXFP3;PRPF40A;SPAST
prerank,nucleocytoplasmic transport (GO:0006913),0.38749893964639476,1.0382824329269844,0.4156050955414013,0.8188147516990107,1.0,20/40,30.03%,BACH2;NXT1;SNRPF;SNRPE;MALT1;RITA1;NCBP2;SNRPB;RSRC1;SNRPD2;NCBP1;NXT2;DDX20;SMN1;SNRPD1;ANP32A;GEMIN5;HNRNPA1;NUTF2;HTATIP2
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.43810188657235416,-1.0377187893091948,0.4118895966029724,0.8103255564059763,1.0,3/13,4.48%,MDFIC;APOD;SUFU
prerank,skeletal muscle tissue development (GO:0007519),0.40520895315783223,1.037097001281546,0.43037974683544306,0.821124488097547,1.0,6/32,12.26%,CAV1;MEF2C;FOXL2;MYH14;CAV2;CSRP3
prerank,actin crosslink formation (GO:0051764),-0.4516618190795317,-1.0370764449436425,0.41721854304635764,0.810921058306898,1.0,2/12,6.12%,DPYSL3;FLNA
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.4359396877813696,1.036550309640479,0.43265993265993263,0.8217955396135584,1.0,7/23,11.75%,PDGFB;INSR;APP;ENTPD5;P2RX7;PFKFB3;HIF1A
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.3798322893765699,1.0362113962596295,0.43137254901960786,0.821987947280869,1.0,15/46,17.38%,SHANK3;MEF2C;CDH2;TPRG1L;DGKI;HOMER1;OPHN1;NPS;NRXN1;DGKZ;GRIK1;GRM7;NLGN1;GRM8;CCR2
prerank,vitamin D metabolic process (GO:0042359),0.4736592101332387,1.036052688961615,0.43005181347150256,0.8216876061423597,1.0,5/13,27.27%,CYP11A1;LRP2;CYP24A1;LGMN;CYP2R1
prerank,positive regulation of catabolic process (GO:0009896),0.36355859377145905,1.0357516106945839,0.3942446043165468,0.8217353218968819,1.0,15/65,16.21%,DAB2IP;NKD1;NEDD4L;FOXO1;EGLN2;OAZ1;SMURF1;GSK3A;VSIR;TNFAIP3;TNFSF12;ASB5;AREL1;PLK2;APC
prerank,pulmonary valve development (GO:0003177),-0.40717055704313504,-1.0353748661916131,0.4223194748358862,0.8145605995112803,1.0,7/18,8.12%,ROBO1;NOTCH2;BMP4;SLIT2;SMAD6;HEYL;JAG1
prerank,positive regulation of organelle assembly (GO:1902117),0.3809733775121889,1.0352305831157473,0.413312693498452,0.822351823780803,1.0,16/44,18.22%,CNOT6L;CCDC88A;CCP110;RALB;MARK4;CAPG;PIP4K2A;SH3GLB1;CNOT6;SDCBP;FSCN1;G3BP1;SPAG5;PDCD6IP;IL5;KCTD17
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.36988671700154063,-1.0351599520008408,0.40369393139841686,0.8139743856617664,1.0,8/27,9.81%,PID1;ENPP1;IRS1;KANK1;PRKCD;TNS2;GRB10;PIP4K2C
prerank,catecholamine metabolic process (GO:0006584),0.4883873033226252,1.0351337033687846,0.4444444444444444,0.8219195901285359,1.0,1/14,0.62%,DDC
prerank,visual perception (GO:0007601),-0.2903150498769267,-1.0348046511650675,0.39338235294117646,0.8138002436861336,1.0,9/84,4.98%,COL1A1;SLC4A10;EFEMP1;EYA4;ADGRV1;COL18A1;COL11A1;DHRS3;EML2
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.2838926733666625,1.0346456977994354,0.37731958762886597,0.8224298012427452,1.0,95/834,8.68%,LEF1;ETS1;ITGA6;ERG;LMO2;NAMPT;EPAS1;PDGFB;ELK3;DAB2IP;ENG;LMO7;BMPR2;TGFB2;NOTCH4;MRTFB;APP;ZIC3;PPARD;TBX1;NFKBIA;MRTFA;TBX3;SOX17;KLF7;ARHGEF2;RGCC;AGRN;MEF2C;MOSPD1;NCOA1;PLXND1;SMARCA2;CD40;FOXO1;ACVRL1;RPS6KA1;NOD2;ZFPM1;PRKD2;NOTCH1;PRKD1;YBX1;MEN1;NLRC5;MYO6;KLF2;PRDM2;IRF2;ASXL3;IKBKB;WNT7A;SMAD7;FOXF1;HHEX;RREB1;CTNNB1;GATA2;POU2AF1;CREB1;WWTR1;SPAG8;HYAL2;TAL1;TLR3;ST18;CRTC1;MAML2;CDKN2B;MAPK3;STAT1;RPS6KA5;NKX2-8;KLF4;MAX;TOX3;NR1H2;IRF5;NCOA2;SOX18;NFIC;HINFP;PHOX2A;SOX12;KAT6A;TGFB1;JUN;TCF12;PIN1;KLF6;ATF6B;ELK4;LRP5;FOXP3;NFATC2IP
prerank,motor neuron axon guidance (GO:0008045),0.4611775963801551,1.034497123377393,0.43257443082311736,0.8221100185276186,1.0,4/15,10.81%,NTN1;TMEFF1;EPHA4;RAC1
prerank,acute-phase response (GO:0006953),0.4881953515735944,1.0343250509607609,0.43233743409490333,0.8218618518068578,1.0,2/12,3.46%,IL6R;SIGIRR
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.4617664623345458,1.0343004694225653,0.4260869565217391,0.8212344620176873,1.0,6/17,12.53%,PDGFB;CCNY;RGCC;CCND3;ADAM17;MAPRE3
prerank,endodermal cell fate commitment (GO:0001711),0.5042040719316397,1.0339308806217635,0.4577205882352941,0.8214588426716196,1.0,1/10,2.13%,SOX17
prerank,regulation of tumor necrosis factor production (GO:0032680),0.3252585325547259,1.033735936448528,0.40331491712707185,0.8212591071909267,1.0,16/112,12.30%,CD34;APP;TIRAP;PTPRJ;ARHGEF2;NOD2;IFIH1;TLR3;LGALS9;AGER;HSPB1;SYK;DDT;VSIR;TNFAIP3;C1QTNF4
prerank,histone monoubiquitination (GO:0010390),-0.37384160785700593,-1.0334537156437409,0.4036281179138322,0.8164149743827152,1.0,13/24,29.85%,BCOR;CTR9;KDM2B;UBE2E1;DDB2;RNF20;PAF1;TRIM37;CUL4B;WAC;RNF40;RNF168;UHRF1
prerank,negative regulation of endopeptidase activity (GO:0010951),0.3699771115108728,1.0333701087598421,0.39705882352941174,0.8214982756577497,1.0,6/47,9.78%,SPOCK2;SERPINB5;SERPINA9;SERPINA11;SPOCK1;SERPINI1
prerank,response to cadmium ion (GO:0046686),0.41836114396472374,1.0331359814249732,0.43097643097643096,0.821392379685257,1.0,12/26,16.82%,MAPK3;JUN;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;MAPK1;SUMO1
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.39971231538707735,1.0329323556084888,0.4340567612687813,0.8212024587112027,1.0,9/34,12.55%,PTPRB;PTPRJ;DUSP7;PTPN12;DUSP3;ACP4;DUSP1;PTPRQ;DUSP16
prerank,lysine metabolic process (GO:0006553),-0.4430215350747257,-1.0329106653086673,0.4337078651685393,0.8156362788673628,1.0,5/12,21.84%,ALDH7A1;PHYKPL;HYKK;PIPOX;AASS
prerank,lysine catabolic process (GO:0006554),-0.4430215350747257,-1.0329106653086673,0.4337078651685393,0.8156362788673628,1.0,5/12,21.84%,ALDH7A1;PHYKPL;HYKK;PIPOX;AASS
prerank,muscle tissue development (GO:0060537),0.46809760758649216,1.0327682139165482,0.4267399267399267,0.8209354522285472,1.0,4/13,12.26%,ENG;PGM5;STRA6;CSRP3
prerank,protein modification by small protein conjugation (GO:0032446),-0.2392302449460978,-1.0324647491267314,0.2717391304347826,0.8158158770995522,1.0,78/361,17.71%,RNF220;PDZRN3;EYA1;RNF152;FBXL7;RNF43;SPSB1;AMFR;ASB2;ARRB1;FBXL17;PIAS1;DTX3;SEH1L;DTX4;TRIM23;FBXO10;HIF3A;CTR9;FBH1;ATG10;FBXW8;ZSWIM8;DTX1;UBE2R2;MGRN1;PRKN;SELENOS;PJA2;UBE2E1;KLHL18;RNF135;NUP205;UBE2M;SMURF2;FBXO45;CUL3;CUL7;BTRC;TRIM63;HUWE1;TRPM4;WWP2;UBE2E3;RNF20;KLHL13;NFX1;DCUN1D5;RNF181;ARRDC4;PIAS2;TRPC4AP;MYLIP;UBA1;SYVN1;PAF1;PEX2;FBXW11;UFC1;DDRGK1;USP9X;LZTR1;RRAGA;UBE2B;SDE2;SPSB4;UBR2;UBR3;RCHY1;MKRN1;RNF144A;ATG3;DTX2;FBXO4;NUB1;TRAIP;FBXO9;CAND1
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.3679107357375639,-1.0323746920493515,0.42065491183879095,0.8149230518020789,1.0,6/26,11.66%,ITPR1;FGF2;PKD2;SLC8B1;ITPR2;IBTK
prerank,regulation of TORC1 signaling (GO:1903432),-0.34755836513616,-1.031697321908746,0.4143646408839779,0.8157299364809198,1.0,9/33,19.16%,RNF152;KLHL22;SEH1L;ATM;STK11;CLEC16A;RRAGA;SMCR8;FLCN
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.31925850095855784,1.031666624754643,0.41259640102827766,0.8229755286502647,1.0,33/136,19.79%,DAB2IP;FZD6;NFKBIA;CD200;CTNNBIP1;ID1;SP100;SIGIRR;MEN1;NLRC5;TMSB4X;SMAD7;KLF4;AIM2;FOXP3;IRAK2;EIF2AK4;PEX14;TNFRSF4;TNFAIP3;EGLN1;CYLD;FOXJ1;ID3;LRRC14;SUMO1;GAS6;ADGRG3;PROX1;RBCK1;NWD1;TRAF3;COMMD7
prerank,RNA metabolic process (GO:0016070),-0.27333869160358665,-1.0313192157403754,0.35968379446640314,0.8157271120640716,1.0,26/127,17.56%,CELF2;RBMS1;HNRNPH1;HNRNPUL1;POLR2A;PABPN1;AGO2;RBM39;NOVA1;BICD1;DDX17;HNRNPH2;RBM5;RNASE4;HNRNPR;ALKBH1;TENT2;DDX3X;SIDT2;LAGE3;HNRNPA2B1;DDX39B;GTF2F1;PABPC4;PCBP2;FASTKD1
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),-0.27071689103171337,-1.0309305985644146,0.38288288288288286,0.8157229425306947,1.0,26/138,12.44%,NOTCH2;RARB;CCN2;TEAD1;NR6A1;THRB;NOTCH3;NR1D2;PPARGC1A;RBPJ;TBL1XR1;AR;PPARA;MED23;NR3C2;RORA;POLR2A;TEAD3;YAP1;CCNH;NR2F1;ESR1;RXRA;TAF8;PGR;CDK7
prerank,regulation of Ras protein signal transduction (GO:0046578),0.3488196263310536,1.0306179203089791,0.40607734806629836,0.8248467639023359,1.0,17/85,10.36%,DAB2IP;TGFB2;DENND3;RASGRP4;ARHGEF2;RAPGEF1;NOTCH1;STARD13;LYN;GRB2;EPS8;DENND4C;EPS8L2;OPHN1;ARHGDIA;PDCD10;ARHGAP17
prerank,negative regulation of protein ubiquitination (GO:0031397),0.3741330384227946,1.030617242590994,0.40425531914893614,0.8241661869581459,1.0,12/50,20.57%,IVNS1ABP;CAV1;SMAD7;N4BP1;UBXN1;TNFAIP3;DNAJA1;BAG2;SIRT7;PRKCG;PRR7;PINX1
prerank,positive regulation of peptide hormone secretion (GO:0090277),-0.3345067692811838,-1.0305473286761544,0.39669421487603307,0.8157039227710716,1.0,5/39,6.17%,MCU;NLGN2;RBP4;IRS2;NNAT
prerank,cardiac muscle cell development (GO:0055013),-0.3923733984733817,-1.030484469237153,0.4430992736077482,0.8147728943284163,1.0,6/20,7.82%,PDGFRB;PDGFRA;CXADR;OBSL1;SLC8A1;MYH11
prerank,cellular response to nutrient levels (GO:0031669),0.3639921286886686,1.0304734159000162,0.4148471615720524,0.8238271774059607,1.0,16/62,17.48%,MFSD2A;BMPR2;FOXO1;RIPOR1;CDKN2B;FAM107A;RALB;MAP1LC3B;HSPA8;RPTOR;TFEB;STK24;STK26;ATG14;WDR45;MAP1LC3A
prerank,response to prostaglandin E (GO:0034695),-0.4627532090436805,-1.029984775715672,0.44565217391304346,0.8150058430649006,1.0,1/10,0.41%,TGFBR3
prerank,icosanoid metabolic process (GO:0006690),-0.32603976617656577,-1.0299163559806002,0.4088397790055249,0.8140783409811867,1.0,6/40,6.71%,PTGIS;PTGS1;DAGLA;GGT5;CYP1B1;PON3
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.45324158077347393,1.029381582963012,0.45276292335115864,0.8258732085052378,1.0,3/18,4.05%,RASIP1;HEG1;STMN1
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.3927652958781094,-1.0291877230193316,0.4066193853427896,0.8149941710427987,1.0,13/21,32.95%,KLHL22;ZWINT;ATM;MAD2L1;TTK;CENPF;TEX14;KNTC1;TPR;PLK1;CDC20;BUB1;TRIP13
prerank,protein depolymerization (GO:0051261),-0.36135095392142447,-1.0289974442898016,0.4260204081632653,0.8144301745283826,1.0,3/27,1.64%,MICAL3;GSN;MICAL2
prerank,regulation of immunoglobulin production (GO:0002637),-0.37487750605454356,-1.0289711924561906,0.42819148936170215,0.8133880235155597,1.0,5/23,21.01%,RBP4;EPHB2;STX4;PTPRC;VAMP3
prerank,cellular response to estradiol stimulus (GO:0071392),-0.4052638125784632,-1.0289518451512465,0.42650602409638555,0.8123259797788709,1.0,3/18,11.46%,EGFR;LCOR;ESR1
prerank,response to reactive oxygen species (GO:0000302),-0.31976269516781797,-1.028398156919579,0.3993993993993994,0.8127661514416573,1.0,10/54,11.62%,EGFR;PDGFRA;TPM1;APOD;ADAM9;PKD2;SOD2;APOE;CHUK;MPV17
prerank,regulation of cation transmembrane transport (GO:1904062),-0.36052991158725184,-1.0283594064336907,0.42650602409638555,0.811781254184149,1.0,6/29,8.29%,SNTA1;KCNIP3;CD63;DLG1;CACNA1D;SLMAP
prerank,axon development (GO:0061564),0.35066876924857554,1.028031966919431,0.42349726775956287,0.8286098561431924,1.0,20/78,18.79%,APP;KLF7;NTNG2;PARD3;DSCAML1;ACTB;WNT7A;BAIAP2;SLITRK3;SLITRK1;ZPR1;GRM7;DCC;PLPPR4;NRCAM;ANK3;CAMSAP2;SLITRK6;CTNNA2;RAB8A
prerank,cochlea morphogenesis (GO:0090103),0.5017473410903415,1.0278863766298414,0.4400749063670412,0.828287260111866,1.0,3/10,13.65%,TBX1;POU3F4;SOX9
prerank,atrioventricular valve morphogenesis (GO:0003181),0.45009679617976023,1.0276948431072568,0.4369287020109689,0.8280788596338078,1.0,5/19,7.56%,BMPR2;TGFB2;ZFPM1;NOTCH1;EFNA1
prerank,sensory perception of sound (GO:0007605),0.34300327420976096,1.0271980670113086,0.41620111731843573,0.8286733116996866,1.0,20/88,12.00%,CLIC5;USP53;TBX1;GRAP;HOMER2;PCDH15;CDC14A;SNAI2;KCNQ1;EPS8L2;LHFPL3;MARVELD2;POU3F4;MYH14;TIMM13;SLC52A3;TIMM10;CLRN1;LRP2;CDH23
prerank,regulation of macroautophagy (GO:0016241),-0.27742004370643913,-1.0271111953024379,0.3759124087591241,0.8141786118244757,1.0,35/105,23.17%,PRKAG2;DCN;PRKAA2;SNX6;NRBP2;PRKACA;PRKAG3;CLN3;ATP6V1C1;LRRK2;RHEB;SNX5;ATP6V1G2;CLEC16A;LAMTOR3;CASP3;CAPN1;GNAI3;RRAGA;IKBKG;SNX32;SMG1;ATP6V1E1;SCOC;SMCR8;TSC1;GPSM1;ATP6V0D2;PRKAB2;CDK5;NEDD4;ATP13A2;WAC;VPS26A;SLC38A9
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.4387445386580583,-1.0267482537725003,0.4401805869074492,0.8140688235911969,1.0,6/13,19.18%,ABCA1;LDLR;CD9;CDH13;CD81;FCER1G
prerank,negative regulation of cell population proliferation (GO:0008285),0.29408998240896067,1.0266298728856522,0.41855203619909503,0.8293677473327108,1.0,33/351,5.39%,ETS1;AQP11;DAB2IP;BMPR2;TGFB2;NOS3;RAPGEF2;SH3BP4;APP;SLC16A2;DDAH1;MCC;ITGA1;TBX3;CD200;CTNNBIP1;B2M;ADGRG1;PTPRJ;RGCC;MTSS1;SMARCA2;ACVRL1;NOTCH1;MEN1;LYN;CTNNB1;IGFBP7;GATA2;SOX7;DLL4;BTG4;ST18
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.44099674153809804,-1.0263596590722126,0.4391304347826087,0.8140217976108967,1.0,5/12,18.76%,DAB2;HEYL;PIAS2;SFRP1;NCOR1
prerank,regulation of myoblast differentiation (GO:0045661),0.40676632472227536,1.0261550045771592,0.4176,0.8299101411051409,1.0,7/32,10.93%,PLCB1;TBX3;MEF2C;NOTCH1;TGFB1;BTG1;ZFP36L1
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.47121789889780574,1.0259357560038285,0.424408014571949,0.8297452427107422,1.0,1/13,0.77%,NAMPT
prerank,plasma membrane organization (GO:0007009),-0.30984717492322855,-1.0256706338847525,0.4163934426229508,0.8148256378997987,1.0,13/61,11.12%,ANK2;COL5A1;MYOF;ANO6;AHNAK2;A4GALT;ANXA6;STX2;PLSCR2;EPB41L3;SNX9;TLCD2;CLN3
prerank,response to acidic pH (GO:0010447),-0.4285505750156496,-1.0248056103836174,0.4400921658986175,0.8161216726070212,1.0,3/13,15.44%,IMPACT;SLC9A1;RAB11B
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.4266115406160028,-1.02426416177742,0.4282560706401766,0.816504876083767,1.0,5/14,18.74%,DMD;WNK4;SLC9A1;WNK1;WNK3
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.43273356979848676,-1.0240274520611932,0.43356643356643354,0.8161005611943151,1.0,6/13,26.73%,SLC4A10;CLN3;SYP;SHISA7;PPFIA3;SLC8A2
prerank,male meiosis I (GO:0007141),-0.4051636948638968,-1.023790824182794,0.441588785046729,0.8156234173097258,1.0,7/16,28.41%,FOXJ2;ZSCAN21;FOXJ3;HSF2BP;MYBL1;TDRD9;DDX4
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.43878248271733256,1.0237382535540793,0.4355716878402904,0.8346237466613118,1.0,3/18,9.31%,SHANK3;WNT7A;NRXN1
prerank,regulation of necroptotic process (GO:0060544),0.4168036858526268,1.023553291115698,0.43559322033898307,0.8344344636042292,1.0,7/23,16.25%,ARHGEF2;PELI1;BIRC3;CASP8;SDCBP;CYLD;PDCD6IP
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.4963465368746798,1.0235468677349457,0.40540540540540543,0.833766018626166,1.0,3/11,6.29%,CD34;CD200;LGALS9
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.330763971694692,-1.0235245017424686,0.4084507042253521,0.8152503847331457,1.0,5/41,9.15%,PRKAG2;OGT;SEH1L;LACC1;NUP205
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.37206909874002714,1.0234506814010198,0.4332298136645963,0.8333153743830408,1.0,17/51,20.57%,HMBOX1;CTNNB1;MAPK3;TERF2;CCT3;HNRNPC;DCP2;ACD;CCT5;TERF1;MAPK1;CCT7;XRN1;NAF1;EXOSC10;MAP2K7;PINX1
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.3395803634539719,1.023439910834769,0.4283746556473829,0.8326572337149202,1.0,19/88,16.82%,TFRC;DAB2IP;TIRAP;RGCC;FNIP2;VIL1;TAL1;BIK;TGFB1;MMP1;SH3GLB1;HGS;SYK;SDCBP;CDH5;HAS3;PDCD6IP;MPP7;SUMO1
prerank,homotypic cell-cell adhesion (GO:0034109),-0.33096247662719547,-1.023163729547538,0.4088397790055249,0.8151666652226535,1.0,7/39,8.70%,PLPP3;PDGFRA;MEGF11;VCL;FLNA;GNAS;MYL9
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.38235913688032497,-1.0230408974042522,0.4258373205741627,0.8144087293685408,1.0,4/22,7.60%,CACNA1C;STIM1;ADGRV1;CACNA1D
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.3737828623695206,-1.0227895960270326,0.3945578231292517,0.8139994455777748,1.0,4/22,6.12%,NTRK3;MAGI2;NGF;ACAP2
prerank,post-transcriptional gene silencing by RNA (GO:0035194),-0.3904598501899425,-1.0226782533301297,0.423444976076555,0.8132070872072801,1.0,9/20,30.89%,TNRC6A;AGO2;TNRC6B;LIMD1;HELZ;AJUBA;MOV10;CNOT1;AGO4
prerank,positive regulation of synapse assembly (GO:0051965),0.40251473334640137,1.0224952202046298,0.4332191780821918,0.8343029561075432,1.0,9/27,16.52%,AGRN;WNT7A;CLSTN1;GRID2;NRXN1;LRRC4B;EPHB1;NLGN1;IL1RAP
prerank,in utero embryonic development (GO:0001701),-0.3735390976713886,-1.0224855449988917,0.41262135922330095,0.8126669512275825,1.0,8/25,12.31%,FGFR2;ARNT2;PKD1;TGFBR1;IGF2;ZNF568;TGFB3;BMP2
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.4725558428887646,1.0224291254467905,0.4635879218472469,0.83379417066677,1.0,6/14,17.23%,PPP3CA;DUSP1;PPP2R2C;PPP1R15B;NCK1;PPM1F
prerank,necroptotic process (GO:0070266),0.4494978625317385,1.022425680203359,0.44265232974910396,0.833118215467157,1.0,5/16,23.18%,TLR3;IPMK;CYLD;TICAM2;RIPK1
prerank,cellular calcium ion homeostasis (GO:0006874),-0.2674981215272911,-1.022237223318152,0.38095238095238093,0.8122511815543174,1.0,23/133,11.87%,SLC24A3;ANK2;ATP13A5;MCU;STIM1;SLC8A3;DMPK;ATP13A3;CAMK2D;TRPC3;SLC35G1;ANXA6;SLC8B1;SLC8A1;BCL2;PTH1R;TRPC6;PML;PRKACA;CLN3;AFG3L2;TRPC4;SLC24A5
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.42054393572277277,-1.021953243213767,0.4367816091954023,0.8119031251306373,1.0,10/16,23.20%,PYGB;PHKB;PYGM;GAA;PHKA2;AGL;PHKG2;PHKA1;PHKG1;PYGL
prerank,positive regulation of lymphocyte activation (GO:0051251),0.4053828478748006,1.0219518668772998,0.44190140845070425,0.8336084789689879,1.0,7/28,17.38%,NOD2;CCDC88B;TNFSF11;CYRIB;SH3KBP1;NCKAP1L;CCR2
prerank,positive regulation of protein transport (GO:0051222),0.34915828285274725,1.0216726412167179,0.45095168374816985,0.8335939393504213,1.0,12/67,8.39%,TGFB2;PRR5L;UNC13B;CD2AP;ATP2C1;ABCG1;RIPOR1;PPIA;OAZ1;TGFB1;ARHGEF5;ACSL3
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.41575254703497194,1.021488756439822,0.44333333333333336,0.8333928457389238,1.0,2/26,0.95%,OCLN;INSR
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.4116600070050527,1.0214478611422702,0.4519867549668874,0.8328175773922624,1.0,6/29,14.41%,DCUN1D3;SMAD7;FBXW7;PIN1;DCUN1D1;BMI1
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.43038110488133907,1.0209268992222782,0.4369602763385147,0.8334606218626344,1.0,2/21,2.85%,CSGALNACT1;CHST11
prerank,barbed-end actin filament capping (GO:0051016),0.43802677000183027,1.0208967684466355,0.4364937388193202,0.8321720609816705,1.0,5/18,9.11%,FLII;VIL1;EPS8;TWF2;CAPG
prerank,actin filament capping (GO:0051693),0.43802677000183027,1.0208967684466355,0.4364937388193202,0.8321720609816705,1.0,5/18,9.11%,FLII;VIL1;EPS8;TWF2;CAPG
prerank,regulation of cell development (GO:0060284),-0.33896290455111416,-1.020798899991797,0.415041782729805,0.8139713200402954,1.0,6/36,11.96%,NOTCH2;DOCK7;PER2;HEYL;YAP1;RHEB
prerank,stem cell differentiation (GO:0048863),-0.3351380813949112,-1.020633609910083,0.3989071038251366,0.813344480526325,1.0,17/39,21.05%,FGFR2;OSR1;HOXB4;KIT;FBXL17;ACE;MLLT3;LMBR1L;LRP6;PAX2;PTPRC;SFRP1;BATF;SP7;EEF1AKMT4-ECE2;SETD2;SETD6
prerank,positive regulation of phospholipase activity (GO:0010518),-0.38311284070454477,-1.020588605247755,0.4230769230769231,0.8123811293045997,1.0,10/22,11.46%,NTRK3;PDGFRB;PDGFRA;FGFR2;KIT;FGF2;AGTR1;PDPK1;ARL1;ESR1
prerank,brain development (GO:0007420),0.32047459058665617,1.0205259340235404,0.4375821287779238,0.8323971998236361,1.0,25/136,14.59%,MFSD2A;SHANK3;ADGRL2;SHROOM4;RAPGEF2;ADGRL3;ADGRG1;NES;CDH2;DSCAML1;COL4A1;AATK;DHX37;CDK5RAP2;TBC1D23;AGTR2;DDIT4;GRIN2B;UTP3;UFM1;TGFBR2;EML1;CNTNAP2;FOXJ1;CIC
prerank,regulation of protein sumoylation (GO:0033233),-0.4029569188326227,-1.0204060602317642,0.4474885844748858,0.8117827518998663,1.0,8/17,26.11%,HDAC4;PIAS1;MUL1;UBA2;ZMIZ1;RWDD3;GNL3L;EGR1
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.31402106838971444,-1.0199742783735912,0.4032697547683924,0.8118877715472324,1.0,18/48,18.23%,DOCK5;CARMIL1;CUX1;OBSL1;S100A10;FBXW8;FLNA;MYOC;CUL7;CAPRIN2;DMTN;ABL1;CDKL3;P4HB;TESK1;MYADM;MDK;C1QBP
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.3981416753517181,-1.0194145655514297,0.4222737819025522,0.8123708048115973,1.0,2/16,8.31%,LRP1;APOE
prerank,epithelial cell development (GO:0002064),-0.39027587969160304,-1.0190321719066844,0.4206896551724138,0.8123376240261658,1.0,7/20,19.46%,WNT5B;SLC4A7;ACTA2;DACT2;RILPL2;PDZD7;BFSP1
prerank,regulation of microtubule nucleation (GO:0010968),0.4900898320544123,1.018820948624909,0.45579567779960706,0.8359328366826416,1.0,6/10,20.10%,ARHGEF7;PAK1;GIT1;CKAP5;MECP2;DCTN1
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.28825377439417804,1.0186837986451966,0.4329004329004329,0.8355955429027653,1.0,70/417,15.59%,LEF1;MECOM;PLCB1;DACH1;PDGFB;ELK3;DAB2IP;ZHX3;PPARD;TBX3;ID1;SMARCA2;FOXO1;FOXL2;SOX13;CCDC85B;NOTCH1;MEN1;HDAC9;HMBOX1;ZBTB16;HHEX;CTNNB1;SOX7;GATAD2A;CD38;RPS6KA5;KLF4;PHC1;NR1H2;SOX18;YEATS2;HINFP;KAT6A;L3MBTL4;TGFB1;JUN;CIART;FOXP3;ZBTB14;HMGA1;DEDD2;ZMYND11;KDM4A;YWHAQ;HSPA8;CTCF;PEX14;EID2;TLE1;TNFRSF4;ZBTB7A;LHX9;RCOR2;PPARG;POU2F1;HMGB2;ZBTB33;SOX9;YAF2;HDAC5;CIC;NR3C1;ID3;CTBP1;RIOX1;ARID4A;LOXL2;IKZF1;RCOR1
prerank,negative regulation of myoblast differentiation (GO:0045662),0.47682611202959324,1.018579139971574,0.4593128390596745,0.8351800527974935,1.0,4/13,13.65%,TBX3;NOTCH1;TGFB1;SOX9
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.46077336739278585,1.0185068408436428,0.44101633393829404,0.8346890145465847,1.0,4/14,7.43%,RGCC;CD40;PLCG1;CD160
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.4025599014078133,1.0179405857058832,0.4368,0.8353992788029444,1.0,9/29,14.16%,CAV1;TNFSF10;HYAL2;RET;DEDD2;AGTR2;TNFSF12;CYLD;BCL10
prerank,modulation of chemical synaptic transmission (GO:0050804),0.32858730133866165,1.017695734602791,0.41553133514986373,0.8353310682549742,1.0,29/107,17.36%,CACNA1A;APP;LRP8;MEF2C;CDH2;ABR;CLSTN1;TPRG1L;DGKI;BTBD9;GRID2;HOMER1;PXK;OPHN1;AKAP9;AGER;DGKZ;GRIK5;GRIK2;CPLX1;GRIK1;GRM7;DLGAP3;NLGN1;LRRC4C;RIMS2;GRM8;LGI1;CNTNAP4
prerank,negative regulation of cellular component movement (GO:0051271),0.45703340085495125,1.017452265830052,0.46,0.8352114599731078,1.0,4/15,8.18%,FRMD5;SP100;ACTN1;PIN1
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.3620739936298618,1.0172619529666143,0.44036697247706424,0.834980125755469,1.0,13/52,18.24%,PPP1R13B;PPP3CC;FBXW7;YWHAH;YWHAQ;CASP8;GSK3A;SH3GLB1;PPP3R1;UBE2D3;YWHAZ;YWHAB;TOMM7
prerank,regulation of endopeptidase activity (GO:0052548),0.354367737348536,1.0172476280179397,0.44478063540090773,0.8343377654698875,1.0,10/59,12.21%,SPOCK2;SERPINB5;SERPINA9;SERPINA11;BIRC3;SPOCK1;PSME2;SERPINI1;APH1A;VSIR
prerank,regulation of lymphocyte activation (GO:0051249),0.47602479663219577,1.0168721801635803,0.4434782608695652,0.8345772970202407,1.0,2/12,5.23%,CD19;CD4
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.349563575819408,-1.0167638446832714,0.412987012987013,0.8173889204083413,1.0,10/31,13.27%,RANBP3L;CRIM1;SMAD6;SUFU;TMEM64;TWIST2;TRPM4;CHRD;SKI;TWIST1
prerank,cellular response to metal ion (GO:0071248),-0.27252644643864987,-1.0164762450363158,0.39748953974895396,0.8171078959651162,1.0,16/123,8.33%,BMP6;EGFR;PRKAA2;SLC41A1;ADCY1;ADGRV1;SLC12A2;CDH1;CAMK2D;PKD2;ADCY7;DLG4;P2RX4;PRKN;SYT9;SLC25A24
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.34833472574898017,-1.0164040058737511,0.4409448818897638,0.8162399728090984,1.0,5/32,8.31%,PRKAG2;ZBTB20;PRKAA2;PPARA;APOE
prerank,mRNA methylation (GO:0080009),0.4533506832314581,1.016390344923538,0.4584103512014787,0.835100863135739,1.0,7/15,23.86%,CBLL1;TRMT10C;TRMT61B;ZC3H13;CMTR1;METTL3;PCIF1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.4390684449386342,-1.016224942348696,0.44666666666666666,0.8156420299212671,1.0,8/12,36.15%,BCL2;KDM1A;CD44;TAF9B;TAF9;SIRT1;MUC1;CD74
prerank,regulation of protein localization to cell periphery (GO:1904375),0.4534962515931988,1.0160674583210427,0.4587628865979381,0.8352473817414364,1.0,2/18,3.92%,SPTBN1;ACTB
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.42769478568579605,1.0158309437434005,0.4463373083475298,0.8351796759014831,1.0,4/21,9.84%,MBOAT1;PLA2G4B;OSBPL10;LPCAT3
prerank,cellular response to hormone stimulus (GO:0032870),0.34664729230986063,1.0151549552246415,0.4199134199134199,0.8362299482630934,1.0,14/69,9.38%,LMO2;CAV1;MEF2C;NCOA1;RAMP2;SOCS2;RAMP3;CYP11B1;CYP11A1;ATP1A3;ATP1A1;NCOA2;TRIM24;NCOA4
prerank,axonemal dynein complex assembly (GO:0070286),0.3996893201284829,1.0147694862543162,0.4269293924466338,0.8364865022473725,1.0,9/27,16.83%,ZMYND10;LRRC49;CFAP100;DRC1;DNAAF2;DNAH8;DNAAF3;DNAH5;TTC12
prerank,positive regulation of vasoconstriction (GO:0045907),0.47030026542355313,1.0144781754230314,0.4829443447037702,0.8365226763052599,1.0,2/13,5.83%,CAV1;OXTR
prerank,Fc receptor signaling pathway (GO:0038093),0.32929257880110097,1.014416259522131,0.44549125168236875,0.8359991704366708,1.0,35/110,20.88%,MAP3K1;LYN;PLCG1;IKBKB;GRB2;CALM1;SOS1;MAPK3;PSMB3;PSMD11;JUN;PSMC6;PAK1;MALT1;PSME2;RAC1;PPP3CA;PSMD8;PPP3R1;SYK;PIK3CB;LCP2;PSMB10;BCL10;CARD11;PSMA8;LAT2;MAPK1;SKP1;PAK2;PSMD9;MAP2K7;PLCG2;VAV1;CUL1
prerank,respiratory electron transport chain (GO:0022904),0.4627712807066058,1.0142618052160455,0.45504587155963305,0.8357026020802738,1.0,3/14,10.09%,GPD2;ETFRF1;ETFB
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.4427858217764594,1.0136496671327975,0.4747826086956522,0.8365353013097995,1.0,3/18,6.27%,IL6R;ST18;STAT1
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.42433214470838043,-1.0133791872735696,0.45454545454545453,0.8223705475302757,1.0,7/15,24.73%,SELENOS;HSP90B1;SYVN1;AUP1;SEC61B;DERL1;UFD1
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.44411495096594705,-1.0128531288574905,0.4331896551724138,0.8226646432604594,1.0,9/12,42.10%,TIPIN;WDR18;NBN;METTL4;GMNN;TICRR;NUGGC;CDT1;KAT7
prerank,cellular protein-containing complex assembly (GO:0034622),0.3103423704124179,1.0127112152087363,0.44106463878326996,0.8381709240438557,1.0,39/159,19.34%,HIP1;HIP1R;TIAM1;STXBP6;PXN;POMP;HSP90AB1;RPL38;EIF4H;STXBP1;FCHO2;PSMD11;TGFB1;DRC1;AP2M1;SMAD1;PIK3C2A;SAMM50;DNAAF2;EID2;EPS15;GTF2B;HIGD1A;BBS10;CSNK2B;ANLN;OMA1;DNAAF3;NCK1;IMMP2L;TESPA1;TBCEL;TTC12;BIN1;NUP153;POGZ;GPX4;CHCHD4;FKBP1A
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.3467625750304837,1.0126811230097277,0.4363376251788269,0.8375782456856607,1.0,11/70,13.63%,LMO2;GATA2;TAL1;PSMB3;PSMD11;TCF12;PSMC6;PSME2;CBFB;PSMD8;PSMB10
prerank,regulation of signal transduction (GO:0009966),0.30177736050979137,1.0126021731377428,0.4475609756097561,0.837114146299172,1.0,30/190,10.42%,PLCB1;RGS12;TMEM204;APP;RGS3;RASGRP4;GIT2;SP100;PRAG1;PRKD1;PXN;MFNG;SOCS2;SNX3;KIF26A;IGFBP7;TSPAN12;WWTR1;GNG7;PPIA;FYN;HOMER1;TGFB1;FOXP3;IRAK2;LIFR;SOCS5;PTK6;CBFB;SHARPIN
prerank,epiboly involved in wound healing (GO:0090505),-0.40627257554018964,-1.0123968575749194,0.4341801385681293,0.822820801656019,1.0,5/16,10.46%,PDPN;DDR1;FLNA;CCN1;TMEFF2
prerank,snRNA 3'-end processing (GO:0034472),-0.37444891079925047,-1.0121157788028532,0.44471153846153844,0.8225374284727501,1.0,7/19,29.43%,INTS8;INTS2;TUT1;EXOSC2;TOE1;INTS6L;INTS5
prerank,reticulophagy (GO:0061709),-0.44535194299014513,-1.0116162725834479,0.4688888888888889,0.8227981868438754,1.0,5/12,14.70%,ULK2;ATG2B;TEX264;UFC1;DDRGK1
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.478830657344247,1.011183635391195,0.4467680608365019,0.8399150017226568,1.0,3/12,12.04%,SEC62;SGTB;GET3
prerank,regulation of organelle organization (GO:0033043),0.3420359591014375,1.0111369045744405,0.42565597667638483,0.8393723554368532,1.0,13/80,11.24%,TJP1;PDE2A;F11R;PTK2;USP6NL;MAPK3;STMN3;ARHGEF5;MSN;CLIC4;AKAP9;PDCD10;S100A8
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.44631655894768024,1.011108640353089,0.4571917808219178,0.8387685174235475,1.0,2/19,2.58%,KDR;PTPRJ
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.3440315096292714,1.0110335672792237,0.4452247191011236,0.83827193132205,1.0,17/74,13.14%,LEF1;DAB2IP;TGFB2;RGCC;TIAM1;SMAD7;CTNNB1;WWTR1;IL17RD;EFNA1;TGFB1;GREM1;AXIN2;FERMT2;ADIPOR1;TGFBR2;SDCBP
prerank,monocarboxylic acid biosynthetic process (GO:0072330),-0.30668516922460337,-1.009855145241236,0.42679127725856697,0.826512258431163,1.0,6/59,5.75%,ALDH1A2;CYP7B1;ABCD3;CYP27A1;PER2;ACOT8
prerank,regulation of cellular pH (GO:0030641),-0.3534186232729093,-1.009601871140465,0.45685279187817257,0.8261537632852234,1.0,8/29,11.35%,SLC4A10;SLC9A2;LACC1;SLC4A7;SLC4A2;SLC9A9;CLN3;SLC9A1
prerank,regulation of viral life cycle (GO:1903900),0.4265280466900744,1.0095449170922834,0.46853146853146854,0.841213447000483,1.0,3/21,6.03%,TRIM25;TRIM14;PPIA
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.3785149372552844,-1.0095254454729892,0.4296482412060301,0.8252956926035103,1.0,3/23,1.67%,PRKAG2;CEMIP;BMP7
prerank,secondary alcohol metabolic process (GO:1902652),0.3766845567567363,1.008931337366191,0.444104134762634,0.8420575484329385,1.0,6/42,6.57%,PPARD;OSBPL1A;ABCG1;CYP11B1;CYP11A1;IDH3A
prerank,nucleoside phosphate catabolic process (GO:1901292),0.46107802034949463,1.0083255765473957,0.4712041884816754,0.842890673117077,1.0,2/13,6.18%,ENTPD1;ENTPD5
prerank,glycerol metabolic process (GO:0006071),-0.44914531020891857,-1.0081094560814192,0.45434298440979953,0.8281258368973164,1.0,4/10,17.67%,GK;GOT1;COQ2;ANGPTL3
prerank,regulation of lamellipodium assembly (GO:0010591),0.38887253698532237,1.0080229600299035,0.4514003294892916,0.8429518827141054,1.0,9/34,11.35%,OCLN;WASF2;NCKAP1;TWF2;CYFIP1;CLRN1;RAC1;PLXNB3;ABI3
prerank,neuronal action potential (GO:0019228),-0.3757668181233939,-1.007912974894691,0.42670157068062825,0.8275799151333643,1.0,3/22,4.82%,SCN7A;KCNMB2;CACNA1G
prerank,positive regulation of extracellular matrix organization (GO:1903055),-0.3902910236326539,-1.0078885622377423,0.4573304157549234,0.8265685660856265,1.0,5/18,12.31%,SMAD3;PDPN;EMILIN1;EFEMP2;BMP2
prerank,negative regulation of catalytic activity (GO:0043086),0.4142895301102389,1.0078252239522485,0.4506065857885615,0.8428349358850546,1.0,2/24,3.41%,NES;NOTCH1
prerank,macrophage differentiation (GO:0030225),-0.4271869931564679,-1.0077610278920694,0.43982494529540483,0.8258284351535916,1.0,2/13,1.84%,IL31RA;BMP4
prerank,sterol homeostasis (GO:0055092),0.34879489360012383,1.0069265433872951,0.42981186685962375,0.8444516819453294,1.0,11/65,11.50%,CAV1;SCARB1;HDAC9;ABCG1;ABCB11;NR1H2;LIPC;LRP5;NPC1;ABCD1;MTTP
prerank,cellular response to gamma radiation (GO:0071480),-0.39655433450007704,-1.0067569344041964,0.44772727272727275,0.8275841569816872,1.0,7/17,25.08%,ATM;YAP1;KDM1A;XRCC5;CRYAB;WRN;ATR
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.3519028568063078,1.0064598764344155,0.46075581395348836,0.8448838886101764,1.0,12/66,11.79%,TFRC;WWTR1;HYAL2;CARD10;LIMK2;TGFB1;CCT3;ZPR1;LAMTOR5;FERMT2;CCT5;ORMDL3
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.3421510344692361,1.005998586982412,0.45170454545454547,0.8453474204754973,1.0,15/74,15.58%,EPAS1;NOTCH1;PSMB3;EGLN2;PSMD11;PSMC6;PSME2;PSMD8;HIF1A;HIGD1A;EGLN1;PSMB10;RBX1;ELOB;PSMA8
prerank,myeloid cell development (GO:0061515),0.4361624240871473,1.0057276459630662,0.44673539518900346,0.8453241000711581,1.0,3/18,5.38%,APP;ALAS1;NRROS
prerank,organophosphate biosynthetic process (GO:0090407),0.3865504254119526,1.0057264566241144,0.4741100323624595,0.844663284020023,1.0,6/37,14.40%,ITPKB;MBOAT1;TPK1;GPHN;IPMK;TPI1
prerank,pore complex assembly (GO:0046931),-0.38815403049647457,-1.0055928599970498,0.46875,0.8297902602129473,1.0,6/19,14.48%,ANO6;PLEKHA7;AFDN;NUP205;TMEM170A;GSDMD
prerank,cholesterol metabolic process (GO:0008203),0.3493768685401622,1.0053369212255499,0.45244956772334294,0.8449622471012361,1.0,7/68,5.46%,SCARF1;PPARD;OSBPL1A;PLPP6;ABCG1;CYP11B1;CYP11A1
prerank,digestive tract morphogenesis (GO:0048546),-0.42776202646319117,-1.0042978990668867,0.46296296296296297,0.8320941506236301,1.0,4/14,6.56%,PDGFRA;FGFR2;RBPMS2;GLI1
prerank,acetyl-CoA metabolic process (GO:0006084),0.45426880360539784,1.0040604729629394,0.47079037800687284,0.8474048410408668,1.0,3/15,6.87%,HMGCS2;DIP2A;ACACB
prerank,positive regulation of cell death (GO:0010942),0.35723059214020136,1.00396620454987,0.46656760772659733,0.8469679132058257,1.0,8/59,11.56%,SLC6A6;ACER2;RAMP3;FYN;MARK4;AXIN2;DDIT4;GRIN2B
prerank,protein transport (GO:0015031),0.29239454194895664,1.003878545321958,0.47038724373576307,0.8465045935366157,1.0,47/332,12.29%,TFRC;TBC1D4;SPTBN1;MACF1;RAB31;STX3;ARHGEF2;TBC1D14;STX1A;TBC1D22A;TBC1D12;RAMP2;ATP6V0A1;CALCRL;SNX13;ABCG1;MYO6;MCOLN1;TBC1D2;ARF5;RAMP3;USP6NL;CMTM6;TBC1D5;REP15;SLC10A7;LRP1B;STXBP1;DNM2;ARL4A;SCAMP1;RAB34;CHMP1B;YWHAH;RAB3B;KIF3B;TBC1D10B;LRP2;AMN;ACD;ARL6IP5;PPY;STX19;MTTP;PRKCB;TBC1D30;PPARG
prerank,positive regulation of nervous system process (GO:0031646),0.4322795398856107,1.0029770920458112,0.47697974217311234,0.8480608938830757,1.0,6/18,18.52%,UNC13B;PARD3;CST7;RIMS2;TPPP;DICER1
prerank,pyruvate metabolic process (GO:0006090),0.3563738384734862,1.002903903571593,0.44542772861356933,0.8475958535401076,1.0,9/52,14.55%,BSG;PDHB;PKM;HK1;PDHX;PGAM4;PGAM1;TPI1;PFKL
prerank,cellular response to organonitrogen compound (GO:0071417),0.33009498539346144,1.0028147310526412,0.4583333333333333,0.8471426649977046,1.0,21/99,14.09%,PDE2A;RAPGEF2;SH3BP4;MEF2C;RAPGEF1;RAPGEF3;ACTB;CTNNB1;KCNQ1;RAP1B;GABRB1;P2RX7;AKAP9;LAMTOR5;ZFP36L1;RPTOR;HCN2;NSMF;SSH1;SOX9;AKAP6
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.42266288561107085,1.0026986058761078,0.46735395189003437,0.8467751342254345,1.0,3/21,5.75%,CAV1;CTNNB1;FRAT2
prerank,response to purine-containing compound (GO:0014074),-0.3897691164623487,-1.0025702259268503,0.47072072072072074,0.8357810747496307,1.0,3/17,7.21%,TRPC3;ABCC9;P2RX4
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.4002339280930159,-1.0024555554934926,0.4781659388646288,0.8349923007609832,1.0,8/16,23.86%,WNT4;BMP4;TGFB3;CREB3L1;LARP6;SUCO;RUNX1;AMELX
prerank,negative regulation of response to external stimulus (GO:0032102),0.3245286130049821,1.0023634618366215,0.46132971506105835,0.8469198508636245,1.0,9/105,6.62%,TEK;MFHAS1;PPARD;SIGIRR;DUSP3;EPHA4;INPP5F;GRID2;KLF4
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.31927039542824875,1.0021666058040382,0.46258503401360546,0.846752028913178,1.0,26/117,15.14%,RHBDF2;RAMP2;CALCRL;LYN;PLCG1;CREB1;RAMP3;PRKACB;FYN;INSL3;YES1;ADCY4;HCK;PRKAR2B;NPS;CALCB;ADAM17;PRKAR2A;ADCYAP1R1;CYSLTR1;CD163;SYK;GNB1;RXFP2;HTR4;PLK2
prerank,regulation of mononuclear cell migration (GO:0071675),-0.36569942846499154,-1.0021452947400644,0.452970297029703,0.8348027139763808,1.0,4/23,3.26%,IL34;BMP5;SLIT2;THBS1
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.4626224857994505,1.0016334108343363,0.4446529080675422,0.8474082035276821,1.0,2/12,6.62%,TIRAP;KLF4
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.31996359760423626,1.0016109911191018,0.4598639455782313,0.8468089305894274,1.0,26/116,15.14%,RHBDF2;RAMP2;CALCRL;LYN;PLCG1;CREB1;RAMP3;PRKACB;FYN;INSL3;YES1;ADCY4;HCK;PRKAR2B;NPS;CALCB;ADAM17;PRKAR2A;ADCYAP1R1;CYSLTR1;CD163;SYK;GNB1;RXFP2;HTR4;PLK2
prerank,sensory perception of mechanical stimulus (GO:0050954),0.3389137311580471,1.0013187541857704,0.46494992846924177,0.8468400827639858,1.0,19/85,11.00%,CLIC5;USP53;TBX1;GRAP;HOMER2;PCDH15;CDC14A;SNAI2;KCNQ1;EPS8L2;LHFPL3;MARVELD2;POU3F4;MYH14;TIMM13;SLC52A3;TIMM10;CLRN1;LRP2
prerank,transcription by RNA polymerase II (GO:0006366),-0.23842543174758568,-1.0007163546979512,0.43846153846153846,0.8376056057330876,1.0,62/305,18.00%,NOTCH2;SOX5;MAF;PRRX1;RARB;GLIS3;CCN2;TEAD1;DDX5;NR6A1;THRB;NOTCH3;CCNT2;NR1D2;PHAX;PPARGC1A;RBPJ;TBL1XR1;AR;PPARA;CTR9;MED23;NR3C2;RORA;POLR2A;DTX1;TEAD3;PABPN1;PCF11;RPRD2;MLLT3;YAP1;INTS8;CPSF3;PARP1;CCNH;NR2F1;ESR1;RXRA;TAF8;NFX1;PGR;TSC22D1;CDK7;INTS2;AFF4;PAF1;NR4A1;ZBTB1;ZBTB7B;NELFE;ELP4;GTF2F1;E2F3;INTS4;ERCC6;RARA;INTS10;RPAP1;LSM10;TAF9B;NRBP1
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.33632577143703396,1.000586730001043,0.45,0.8480651814254031,1.0,22/72,22.11%,POLK;MRE11;EDC3;GTF2H2;DNA2;PDE12;RNASE1;GTF2H4;DXO;DCP1B;FAN1;PNRC2;RBX1;RPA1;DICER1;POLD1;XRN2;DDB1;GTF2H3;RFC2;ERCC4;RNASE6
prerank,negative regulation of response to wounding (GO:1903035),-0.38220994913223616,-1.0000106471642898,0.4474327628361858,0.8383949897471441,1.0,8/19,21.36%,CASK;PTPRS;FGF2;CD109;MDK;SERPINE1;CERS2;RTN4R
prerank,copper ion transport (GO:0006825),0.4746942742545639,0.9997214023857464,0.46511627906976744,0.8495513057618174,1.0,2/11,4.06%,ATOX1;SLC31A1
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.31537533329068823,0.9995957402723983,0.47182175622542594,0.8492023347459581,1.0,26/128,15.91%,PLCB1;CCNY;TPD52L1;NES;DYNLL1;CDKN2B;CCP110;LCMT1;DNM2;PRKAR2B;CETN2;TUBB;CDK5RAP2;PPP1CB;AKAP9;HAUS6;CEP78;CEP72;CEP135;TUBA1A;FBXL8;FBXL15;TUBB4B;CKAP5;PPME1;CEP70
prerank,actin filament bundle organization (GO:0061572),-0.3495852344864531,-0.9995625280784813,0.48,0.8385586858049867,1.0,3/33,0.50%,CALD1;DPYSL3;PAWR
prerank,central nervous system neuron axonogenesis (GO:0021955),0.46324959039228125,0.9992794452888315,0.4772313296903461,0.8493040595331552,1.0,3/12,12.82%,B4GALT5;HSP90AB1;EPHB1
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.3502132275964678,0.9983405840993536,0.4597875569044006,0.8509149511799416,1.0,5/52,5.01%,PRKCH;SPTBN1;STX3;EPB41;RAMP3
prerank,protein lipidation (GO:0006497),0.35164568583639927,0.9983133808357343,0.4505988023952096,0.8503169992518528,1.0,19/59,22.44%,ZDHHC14;ZDHHC9;PIGU;ZDHHC20;PIGM;PGAP4;ZDHHC18;PIGF;PIK3C3;ZDHHC22;ATG12;DPM3;ZDHHC21;WDR45;ATG7;ZDHHC17;PIGO;PIGV;PIGQ
prerank,regulation of cilium assembly (GO:1902017),0.3522301993989841,0.998263779603209,0.4630681818181818,0.8497868291337322,1.0,19/62,18.22%,TBC1D14;TBC1D22A;TBC1D2;USP6NL;TBC1D24;CCDC88A;LIMK2;TBC1D5;CCP110;MARK4;ODF2L;TBC1D10B;TBC1D30;CYLD;TBC1D1;TBC1D22B;IFT140;TBC1D15;KCTD17
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.4092523737636643,0.9980832011751366,0.4803921568627451,0.8496079994479931,1.0,2/25,1.56%,ITGA6;APP
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.4746677798369924,0.9978664712027049,0.4715909090909091,0.8494985537776869,1.0,3/11,12.26%,SMAD7;FOXP3;CEACAM1
prerank,regulation of vacuole organization (GO:0044088),0.4277849341304125,0.9978517063911869,0.4756944444444444,0.8488792213471065,1.0,3/20,4.87%,TBC1D14;TBC1D12;PIKFYVE
prerank,stress granule assembly (GO:0034063),-0.3789413238612712,-0.9975774287924499,0.4549763033175355,0.8429269291415018,1.0,8/20,24.09%,UBAP2L;BICD1;OGFOD1;DDX3X;YTHDF1;ATXN2L;CIRBP;CSDE1
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.41969608369460326,-0.9975654994867907,0.4886128364389234,0.8418715018835397,1.0,9/14,30.20%,MRPS27;RMND1;RPUSD4;C1QBP;RCC1L;FASTKD3;FASTKD2;MPV17L2;RPUSD3
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.47444115090243455,0.997013233159745,0.4766355140186916,0.8502634252934211,1.0,4/11,22.85%,SP100;HIPK2;TFAP4;ING4
prerank,T cell migration (GO:0072678),0.4583524763843805,0.9967995323654996,0.47377938517179025,0.8501161195382723,1.0,3/13,8.46%,S1PR1;ZAP70;MSN
prerank,telomere maintenance via telomerase (GO:0007004),0.39507117886251997,0.9967608322727,0.48464163822525597,0.8495556777338206,1.0,8/28,20.57%,HSP90AB1;MRE11;TERF2;ACD;TERF1;NHP2;RPA1;PINX1
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.4153134371902834,-0.9964980364231867,0.4732334047109208,0.8436818722819566,1.0,3/13,5.33%,PID1;PPARGC1A;PPARA
prerank,peptidyl-amino acid modification (GO:0018193),-0.44570505571962604,-0.9964118977220424,0.48625792811839325,0.8428100828615345,1.0,2/10,10.84%,ATP7A;FKBP10
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.27275303563339337,0.9963844228063338,0.508646998982706,0.8498057615604161,1.0,117/1082,9.15%,LEF1;MECOM;PLCB1;ETS1;ITGA6;FLI1;ERG;LMO2;NAMPT;EPAS1;PDGFB;ELK3;DAB2IP;ENG;LMO7;BMPR2;NOTCH4;MRTFB;APP;TRIM16;ZIC3;PPARD;TBX1;NFKBIA;MRTFA;TBX3;SOX17;AFAP1L2;KLF7;FZD4;ARHGEF2;RGCC;AGRN;MEF2C;MOSPD1;RYBP;NCOA1;SMARCA2;SP100;CD40;FOXO1;FOXL2;ACVRL1;RPS6KA1;NOD2;ZFPM1;PRKD2;NOTCH1;PRKD1;YBX1;MEN1;NLRC5;MYO6;KLF2;PRDM2;ZBTB16;IRF2;ASXL3;IKBKB;WNT7A;SMAD7;FOXF1;HHEX;RREB1;CTNNB1;GATA2;POU2AF1;CREB1;WWTR1;MRPL12;SPAG8;KLF1;HYAL2;CD4;TAL1;TLR3;CAMKK2;ST18;CD38;CRTC1;MAML2;CDKN2B;MAPK3;STAT1;RPS6KA5;NKX2-8;RET;KLF4;MAX;TOX3;NR1H2;DNM2;IRF5;NCOA2;SOX18;NFIC;HINFP;PHOX2A;SOX12;BRCA2;KAT6A;TGFB1;JUN;KCNH2;TCF12;PIN1;KLF6;ATF6B;ELK4;YWHAH;LRP5;FOXP3;NFATC2IP;CDK5RAP2;GREM1;TNFSF11;ARID1A
prerank,ganglion development (GO:0061548),0.4758957182169873,0.9961160933237249,0.5099099099099099,0.8498014144133286,1.0,4/11,17.38%,CTNNB1;INSM1;NRP2;NRP1
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.4060986231240318,-0.9956085704352543,0.4872389791183295,0.8439439349143956,1.0,3/16,3.80%,SOX5;HOXB4;FOXC1
prerank,negative regulation of lymphocyte activation (GO:0051250),0.4184000573480878,0.9954195154817871,0.46815834767641995,0.8508312200757585,1.0,6/21,17.87%,JAK3;DUSP3;TNFAIP3;SOX11;FOXJ1;SAMSN1
prerank,T cell differentiation in thymus (GO:0033077),-0.4147289554917244,-0.9951067040090881,0.4794520547945205,0.8442322988297561,1.0,1/14,0.68%,GLI3
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.431920554649324,-0.9946729758915931,0.45727482678983833,0.8443349913982433,1.0,6/12,22.22%,CLN3;LRRK2;GRN;CLN6;ATP6AP2;TMEM9
prerank,positive regulation of RNA splicing (GO:0033120),0.40000511502643754,0.9938754952091675,0.4799357945425361,0.8538285831233273,1.0,1/29,0.46%,RBM20
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.4922356231162462,0.9936637970693069,0.49466192170818507,0.8536737572624006,1.0,1/10,0.34%,CSGALNACT1
prerank,female gamete generation (GO:0007292),0.3965065391257912,0.9935394644415254,0.48105436573311366,0.8533516245859928,1.0,5/29,8.71%,NANOS3;NANOS2;NANOS1;PTN;PRDM9
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.3032460665582989,0.9934193441718844,0.4968152866242038,0.8529965031453927,1.0,46/172,20.61%,MFSD2A;PIK3R6;DGKH;INPP5D;PIK3R3;PLA2G4B;SLC44A5;PIKFYVE;PIP5K1C;OCRL;INPP5F;PLEKHA1;DGKE;CDS2;CHKA;MTMR6;SELENOI;PIK3C3;LPCAT3;PIK3C2A;PIP4K2A;RAB4A;CEPT1;DGKZ;PIK3CB;CPNE6;CSNK2B;LPIN3;MTMR12;CDIPT;PIK3R5;MTMR2;PLEKHA3;SYNJ1;CPNE3;INPP5E;ETNPPL;INPPL1;PIP5K1B;CPNE1;MTMR1;PGS1;ETNK1;MBOAT7;PLCG2;PISD
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.2819163302602469,-0.993280752547896,0.4726027397260274,0.8470914562869027,1.0,19/76,21.23%,LPAR1;PLCE1;ACTN2;ADRA1B;ANO1;AGTR1;PTH1R;ESR1;LPAR4;CHRM2;GNA14;CMKLR1;GPR157;OPRK1;HTR2C;ADRA2A;CCKBR;C3AR1;HRH1
prerank,apoptotic nuclear changes (GO:0030262),0.41519457809984,0.9932486917280592,0.4811643835616438,0.8527594167817173,1.0,9/24,18.52%,FOXL2;CECR2;DFFB;DEDD2;HMGB2;DNASE2;EXOG;ENDOG;DICER1
prerank,diacylglycerol metabolic process (GO:0046339),0.4148610183970364,0.9931909198203542,0.4660033167495854,0.8522443537922386,1.0,8/23,19.24%,DGKH;LIPE;DGKI;DGKE;DGKZ;MOGAT2;DGAT1;PGS1
prerank,nucleotide biosynthetic process (GO:0009165),-0.38727192717860287,-0.9931766873420005,0.47494033412887826,0.8462691541400293,1.0,8/18,18.29%,NMNAT2;ME1;MTHFD1;PRPS2;PRPSAP1;PRPSAP2;ADSL;NMNAT1
prerank,epithelial cell migration (GO:0010631),0.38094646165962015,0.9930959228111256,0.4842271293375394,0.8517992228347162,1.0,10/37,6.91%,NOS3;PLEKHG5;PKN3;PLXND1;STARD13;PXN;PKN1;NANOS1;STAT1;PKN2
prerank,regulation of macrophage activation (GO:0043030),0.39447520632087457,0.9927735783701442,0.44805194805194803,0.8519346663190859,1.0,2/30,2.15%,MFHAS1;CD200
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.34817993067344194,-0.9926989564501987,0.4792746113989637,0.846511074187311,1.0,2/28,1.32%,PRKAG2;PRKAA2
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.3237762623704144,0.992594694117591,0.4797687861271676,0.8516859298453802,1.0,19/88,12.08%,EXOC6B;APP;EXOC6;STXBP6;AP1S2;SORT1;SORCS1;DNM2;SCAMP1;CLINT1;AP1S3;KLHL20;EXOC4;HSPA8;CLVS2;AP4S1;EXOC2;EPS15;HGS
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.2832338373737906,0.9925763887632172,0.4866369710467706,0.8510817978526001,1.0,51/348,12.39%,LEF1;TFRC;ETS1;OCLN;CLDN5;PDGFB;INSR;CD34;NOS3;PDE2A;APP;RGCC;MEF2C;PIK3R3;NOTCH1;RAMP2;KLF2;GATA2;TCF23;FGF16;DLL4;RAMP3;TLR3;INPP5F;TBC1D5;MAPK3;LGALS9;KLF4;HINFP;TGFB1;TERF2;P2RX7;MSN;RPS7;GREM1;ACTG1;ZPR1;PDCD10;SMAD1;PRKAB1;LAMTOR5;CNTF;CTCF;TASOR;TLE1;GSK3A;HIF1A;HGS;VSIR;PIK3CB;SOX11
prerank,T cell mediated immunity (GO:0002456),0.45939188941640535,0.9923063566085832,0.4796116504854369,0.8510788400085947,1.0,1/13,0.96%,CADM1
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.41118095101969376,-0.9919343112629628,0.4326241134751773,0.8475279133034926,1.0,2/14,5.16%,ENPP1;ENPP3
prerank,gonad development (GO:0008406),0.3677550398327924,0.9918344358869925,0.45,0.8515077383222875,1.0,6/41,11.00%,KITLG;TGFB2;BIK;COL9A3;NCOA4;LRP2
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.3601427916159675,-0.9911437711238048,0.461734693877551,0.8485878190504385,1.0,9/22,19.58%,DMD;CACNB4;CACNB2;GNB5;FMR1;CACNB1;STAC3;AHNAK;CACNB3
prerank,regulation of chemotaxis (GO:0050920),-0.3394447093537729,-0.9909701356854693,0.4645669291338583,0.8479784167437516,1.0,6/30,7.21%,PDGFRB;PDGFRA;EFNB2;THBS1;ZSWIM8;P2RX4
prerank,cytoskeleton organization (GO:0007010),0.316072559567766,0.9908801992219279,0.48043184885290147,0.8532375103381382,1.0,26/114,14.65%,FGD5;SEMA6A;ARAP3;RHOBTB1;FMNL3;NEDD9;SIPA1;MAST4;RHOB;PAK5;CECR2;DPYSL2;ARHGAP4;FGD6;RANBP10;STRIP1;KLHL20;PDZD8;RAC1;RND1;TNFAIP3;RANBP9;FGD2;CFL1;LRCH3;SH3KBP1
prerank,sprouting angiogenesis (GO:0002040),0.35743869874180295,0.9905530790912608,0.47128129602356406,0.8533882399411159,1.0,7/51,3.59%,TEK;KDR;ENG;FLT4;ACVRL1;PIK3R3;RAMP2
prerank,regulation of cell death (GO:0010941),-0.2800391579238144,-0.9905375895383558,0.47719298245614034,0.8481246961545648,1.0,22/94,15.68%,LRP1;CCN2;BMP7;BMP4;ACER3;IMPACT;FGF2;CCN5;CCN1;PRKN;CCN3;PRODH;SLC25A24;SRSF6;CCN4;LRRK2;RAB29;WNT11;DUS2;CTSZ;SARM1;CRYAB
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.3563617032967901,-0.9903709724456947,0.5126903553299492,0.8475161807718297,1.0,4/25,13.27%,IGF1;PER2;NIBAN2;TWIST1
prerank,positive regulation of receptor internalization (GO:0002092),-0.3752959438478954,-0.9899082769906709,0.48370927318295737,0.8477289402296224,1.0,5/22,6.64%,ANGPT1;MAGI2;ARRB1;CD63;SFRP4
prerank,cellular response to oxygen-containing compound (GO:1901701),0.28727720015257563,0.9897046813906276,0.5011337868480725,0.8547803745635243,1.0,51/291,14.44%,PDGFB;DAB2IP;PDE2A;RAPGEF2;SH3BP4;FES;TBX1;TIRAP;FZD4;MEF2C;FOXO1;RAPGEF1;DEFA6;NOD2;PRKD1;PXN;LYN;RAPGEF3;ACTB;TGM2;CREB1;RAMP3;KCNQ1;KCNC2;CAMKK2;MAPK3;RET;RAP1B;JUN;IRGM;P2RX7;TWF2;PDE4B;AKAP9;BRINP3;PTK6;LAMTOR5;ZFP36L1;BRINP2;RPTOR;TNFAIP3;GNB1;HCN2;HMGB2;NSMF;SSH1;SOX9;GIT1;AKAP6;BCL10;PRDX5
prerank,response to organophosphorus (GO:0046683),0.441746237935608,0.989534288984593,0.4690265486725664,0.8545539453314305,1.0,3/16,8.39%,TRIM16;STAT1;P2RX7
prerank,regulation of G0 to G1 transition (GO:0070316),0.37878574187524044,0.9892020905566141,0.4784688995215311,0.8546802013785947,1.0,5/38,6.74%,DAB2IP;RYBP;CDKN2B;MAX;PHC1
prerank,negative regulation of developmental growth (GO:0048640),0.396086715270983,0.9889383161672022,0.46229508196721314,0.8546560373393453,1.0,9/30,17.40%,NKD1;FGF13;DIP2B;GDF15;WWC1;MAG;SEMA3G;DCC;WWC2
prerank,protein acylation (GO:0043543),0.3750992902998008,0.9884619946051696,0.4666666666666667,0.8551992653105915,1.0,16/38,25.80%,ZDHHC14;FOXO1;ZDHHC9;ZDHHC20;KAT6A;ZDHHC18;ZDHHC22;GTF2B;ZDHHC21;ZDHHC17;KAT2B;ING4;ING5;ZDHHC6;ZDHHC7;CLOCK
prerank,translational elongation (GO:0006414),0.32366457842424573,0.9882409041064467,0.4869684499314129,0.8550593593349552,1.0,42/101,27.31%,MRPL12;MRPL13;MRPL10;MRPL50;MRPL14;GTPBP1;GFM1;MRPL57;MRPL54;MRPL30;MRPL28;MRPL20;EEFSEC;MRPL19;MRPS2;MRPL40;EEF1D;MRPL44;MRPL9;MRPS9;MRPL58;MRPL16;MRPL23;MRPL39;MRPS18A;MRPL21;RACK1;GTPBP2;EEF1B2;MRPL1;ERAL1;MRPL27;MRPL41;PTCD3;MRPL49;MRPL51;MRPL22;MRPS33;MRPL37;MRPL2;MRPL15;MRPS18C
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.4867968781248513,0.9868131865025042,0.4790528233151184,0.8577936510539347,1.0,3/10,17.38%,ADAM10;ADAM17;CCR2
prerank,positive regulation of myoblast differentiation (GO:0045663),0.45083466673781425,0.9861642792532314,0.46788990825688076,0.8586858138546946,1.0,2/16,2.77%,PLCB1;MEF2C
prerank,histone H3-K9 demethylation (GO:0033169),-0.45009453349797024,-0.9861325909390025,0.4784688995215311,0.8569764718298825,1.0,6/11,23.33%,KDM7A;KDM3B;PHF8;KDM1A;KDM4D;HR
prerank,cellular response to organic cyclic compound (GO:0071407),0.31052435406122003,0.9860904766827464,0.49097938144329895,0.8582365928216263,1.0,26/141,11.15%,SLC1A1;PDGFB;PDE2A;RAPGEF2;FES;MEF2C;RAPGEF1;RAPGEF3;ACTB;TGM2;CTNNB1;RAMP3;KCNQ1;ATP1A3;ATP1A1;CASP7;RAP1B;GABRB1;TGFB1;P2RX7;MSN;NCOA4;AKAP9;PDE12;ZFP36L1;ARL6IP5
prerank,membrane repolarization during action potential (GO:0086011),0.45076785151827226,0.9859500034997455,0.47653429602888087,0.8579092223356578,1.0,3/13,8.04%,KCNQ1;ATP1A1;KCNH2
prerank,regulation of coagulation (GO:0050818),0.4716359055007307,0.9858057879344378,0.4963768115942029,0.8576214291303339,1.0,1/11,1.79%,CAV1
prerank,cell cycle G2/M phase transition (GO:0044839),0.31001476199432754,0.9856878189748418,0.49477806788511747,0.8572506035437943,1.0,26/129,15.91%,PLCB1;CCNY;TPD52L1;NES;DYNLL1;CDKN2B;CCP110;LCMT1;DNM2;PRKAR2B;CETN2;TUBB;CDK5RAP2;PPP1CB;AKAP9;HAUS6;CEP78;CEP72;CEP135;TUBA1A;FBXL8;FBXL15;TUBB4B;CKAP5;PPME1;CEP70
prerank,regulation of tube diameter (GO:0035296),-0.4227101869489049,-0.985615779877454,0.4911894273127753,0.8563350942408635,1.0,8/13,15.15%,ROCK2;SCPEP1;ACE;AGTR1;ITGB1BP1;ADCY6;GCLC;ACE2
prerank,vascular process in circulatory system (GO:0003018),-0.4227101869489049,-0.985615779877454,0.4911894273127753,0.8563350942408635,1.0,8/13,15.15%,ROCK2;SCPEP1;ACE;AGTR1;ITGB1BP1;ADCY6;GCLC;ACE2
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.3268302262263706,0.9851589062869895,0.47233468286099867,0.8578758271390892,1.0,21/87,12.20%,ESAM;RHOBTB1;HIP1R;F11R;CORO2B;RAPGEF3;EPS8;RHOB;BAIAP2;CCDC88A;FAM107A;BST2;ARHGEF5;IQGAP1;TWF2;PAK1;ARHGDIA;ARHGAP17;RAC1;ABI3;RND1
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.45937506790229193,0.9848910938159491,0.4918032786885246,0.8578700811350433,1.0,8/12,29.48%,STK33;CDC6;ORC1;HUS1;RAD17;TOPBP1;CHEK2;HUS1B
prerank,positive regulation of immune response (GO:0050778),0.3452909501053082,0.9847199894049063,0.4813218390804598,0.8576359016631626,1.0,8/64,13.26%,TGFB2;NOD2;GBP5;CCR7;LGALS9;EIF2AK4;TLR8;IL15
prerank,histone H3-K4 trimethylation (GO:0080182),-0.4316044702448083,-0.9846085331935496,0.5087336244541485,0.8580266423136889,1.0,2/11,5.39%,OGT;CTR9
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.3352263955870154,0.984192624297173,0.503586800573888,0.8582472088732673,1.0,18/72,21.31%,ACER2;CNOT6L;RGCC;SP100;MYO6;CRADD;PIDD1;CNOT9;CNOT6;BTG2;HIPK2;PLK2;TRIAP1;NDRG1;CNOT11;TFAP4;E2F4;CNOT4
prerank,negative regulation of defense response (GO:0031348),0.33372868744206863,0.9840828319651568,0.48783977110157367,0.8578719667558045,1.0,3/77,1.87%,TEK;MFHAS1;PPARD
prerank,negative regulation of histone acetylation (GO:0035067),0.47097058843244866,0.9837262403675912,0.4875,0.8580530040316426,1.0,7/11,27.89%,CTBP1;SIN3A;SET;NOC2L;SPI1;SNCA;TAF7
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.3599680290491783,0.9834046026625947,0.48049921996879874,0.8581583585941246,1.0,14/45,10.47%,PTK2;VIL1;PLCG1;GRB2;GAB1;SOS1;RPS6KA5;TGFB1;IQGAP1;TGFA;SHC3;ADAM17;PIK3C2A;GRB7
prerank,negative regulation of transport (GO:0051051),0.35533273057637493,0.9829399287692588,0.4676923076923077,0.8586182531660655,1.0,10/51,11.15%,DYSF;CTTNBP2NL;PRKD1;SNX3;NR1H2;PXK;BST2;ABCA7;NDFIP2;ARL6IP5
prerank,metal ion transport (GO:0030001),0.32804510133530995,0.9829398682181041,0.4783216783216783,0.8579746112971255,1.0,13/86,9.41%,CACNA1A;SLC39A8;CAV1;SLC30A1;NIPAL3;ATP2C1;RAMP2;CALCRL;RAMP3;FYN;SLC3A2;NIPAL4;NDFIP2
prerank,regulation of cytoskeleton organization (GO:0051493),0.31811204628476525,0.9828869752841961,0.4980289093298292,0.8574626561578635,1.0,25/108,11.24%,TJP1;RHOBTB1;HIP1R;F11R;PTK2;CORO2B;RHOB;BAIAP2;CCDC88A;MAPK3;FAM107A;STMN3;BST2;MAP6D1;ARHGEF5;IQGAP1;P2RX7;TWF2;TRIM36;PAK1;CLIC4;PFDN2;ARHGAP17;RAC1;S100A8
prerank,positive regulation of protein acetylation (GO:1901985),0.4612352616672236,0.982715480581962,0.48628884826325414,0.8572332216990857,1.0,3/12,5.88%,DIP2B;RAPGEF3;DIP2A
prerank,primary alcohol metabolic process (GO:0034308),-0.35700588497896074,-0.9826904609910014,0.46551724137931033,0.8622017556269244,1.0,6/25,10.10%,IGF1;RBP4;DHRS3;CYP1B1;NAAA;PECR
prerank,regulation of B cell apoptotic process (GO:0002902),-0.42449550639791495,-0.982666616039741,0.4855769230769231,0.8612070780212243,1.0,3/12,6.40%,FNIP1;IRS2;BCL6
prerank,regulation of protein kinase C signaling (GO:0090036),0.44885844361747396,0.9825805125994149,0.4911660777385159,0.8569145829057541,1.0,2/14,2.92%,FLT4;CD40
prerank,muscle tissue morphogenesis (GO:0060415),-0.3916095028383769,-0.9824378563409072,0.484304932735426,0.8607744526200878,1.0,3/16,2.10%,TGFBR3;BMP4;MYLK
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.4790415645088718,0.9819727301922386,0.4932562620423892,0.8577498103777029,1.0,4/10,22.85%,SP100;HIPK2;TFAP4;ING4
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.31996960107200223,0.9819536677832965,0.5146666666666667,0.8571516541896262,1.0,19/108,12.29%,HIP1;ACER2;XDH;FAS;HIP1R;TNFSF10;NOD1;FOXL2;SOX7;ST18;LGALS9;CRADD;PIDD1;MALT1;CASP8;ARL6IP5;S100A8;SYK;PPARG
prerank,toxin transport (GO:1901998),-0.4438238377057521,-0.9817946512794239,0.4860813704496788,0.8614339320393788,1.0,3/10,13.73%,ANTXR2;RAB29;SLC22A2
prerank,positive regulation of positive chemotaxis (GO:0050927),0.44359582613888204,0.9816907975152792,0.5058236272878536,0.8571328751449933,1.0,2/15,1.28%,KDR;CXCL12
prerank,ceramide catabolic process (GO:0046514),0.4546639424339005,0.9813853264911598,0.5,0.8572087008405713,1.0,3/14,5.45%,ACER2;ACER1;NEU4
prerank,regulation of store-operated calcium entry (GO:2001256),-0.44607568485584254,-0.9811672413177098,0.5086580086580087,0.8620213932090376,1.0,4/10,8.86%,STIM1;EFHB;SLC8B1;SARAF
prerank,regulation of cellular protein catabolic process (GO:1903362),0.4218935275219466,0.9808008768257649,0.5089928057553957,0.857905886686199,1.0,5/18,17.80%,DAB2IP;MSN;RGP1;NELL1;PTTG1IP
prerank,plasma membrane repair (GO:0001778),-0.4038909898137698,-0.9803552452283912,0.47045454545454546,0.8632085184848305,1.0,3/13,5.43%,MYOF;AHNAK2;ANXA6
prerank,establishment of vesicle localization (GO:0051650),0.4303395372573089,0.9802926046240802,0.48353552859618715,0.8584260057838311,1.0,6/18,18.35%,LIMK2;RAB11A;DNM2;F8A1;SYNJ1;CCDC186
prerank,regulation of wound healing (GO:0061041),0.3653653673456371,0.9799773487621969,0.4847161572052402,0.858488621274991,1.0,8/42,12.24%,OCLN;CAV1;PTK2;VIL1;INSL3;ACTG1;HRAS;TNFAIP3
prerank,mRNA stabilization (GO:0048255),0.36699205729974915,0.9798444350760982,0.4845679012345679,0.858157365801646,1.0,7/40,14.82%,TIRAP;YBX1;NOCT;HNRNPC;AXIN2;PAIP1;ELAVL1
prerank,protein processing (GO:0016485),-0.2736755543599544,-0.9793839075875899,0.5,0.864823617398642,1.0,22/102,17.15%,AEBP1;PCSK5;MMP14;MMP16;F3;OGT;CTSL;ADAM19;KLK2;CPXM1;CPXM2;FXN;CLN3;AFG3L2;PSEN1;CTSH;HTRA2;SDE2;ZMPSTE24;PRSS12;HM13;PARL
prerank,regulation of phospholipase C activity (GO:1900274),0.43274816749786343,0.9793338274576917,0.5121042830540037,0.858725889824997,1.0,2/15,4.13%,FLT1;PLCG1
prerank,central nervous system development (GO:0007417),0.28849596876019684,0.9787706957316932,0.5191387559808612,0.8594299068142203,1.0,52/250,16.40%,SLC2A1;MFSD2A;ADGRL2;SHROOM4;ZIC3;ADGRL3;MAL;TBX3;SEMA6B;ADGRG1;NES;CDH2;DSCAML1;LSR;ZBTB16;MOG;COL4A1;AATK;NCKAP1;SOX12;DHX37;CDK5RAP2;CAPG;SPOCK1;DNER;SERPINI1;ZPR1;TBC1D23;DCX;AGTR2;DDIT4;THOC6;EIF2B2;GRIN2B;UTP3;UFM1;SOX10;SOX11;TGFBR2;EML1;CNTNAP2;GRIK1;SOX9;HAPLN2;FOXJ1;CIC;TAGLN3;PTPRZ1;SYNJ1;NRCAM;UGP2;BAG6
prerank,regulation of fibroblast proliferation (GO:0048145),-0.31199983978260376,-0.9784110995464553,0.5027322404371585,0.8663392123368832,1.0,12/45,14.49%,IGF1;PDGFRA;S100A6;PDGFC;MED25;SPHK1;CD300A;SKI;EMD;PEX2;NF1;MORC3
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),-0.28641460272130254,-0.9778043271730049,0.4882154882154882,0.8669032161510583,1.0,10/72,10.30%,FGFR2;FGF1;KL;FRS2;FGF2;HNRNPH1;POLR2A;FLRT1;SPRED1;FGFBP1
prerank,iron-sulfur cluster assembly (GO:0016226),0.39631499887864746,0.9777925785821223,0.48709122203098104,0.8611497565106945,1.0,15/24,30.31%,CIAO2B;CIAPIN1;HSCB;HSPA9;CIAO3;BOLA2;NUBPL;LYRM4;GLRX3;NFU1;NUBP1;NUBP2;ISCA2;ISCA1;ISCU
prerank,phosphatidylserine metabolic process (GO:0006658),0.3834198197194635,0.9776785824575481,0.49755301794453505,0.8607844170064923,1.0,5/32,9.84%,MBOAT1;PLA2G4B;SERINC5;OSBPL10;LPCAT3
prerank,ncRNA processing (GO:0034470),0.2922536517735987,0.9776135711828694,0.522867737948084,0.860309137989944,1.0,59/200,22.56%,ADAR;SARS1;RPL38;RPL13;RPL36A;RPL3;RPL27;SNU13;WDR74;DHX37;RPS7;RPL9;RPLP2;RPL18;PDCD11;INTS11;RPL13A;SMAD1;WDR36;MPHOSPH10;UTP3;PWP2;RPL8;RPS27;RPL19;RPS9;MRM2;NOL9;RPL11;RPS15;RPL37;RPS28;ESF1;UTP11;RPS25;NOC4L;MRPL44;RPL37A;RPP21;LYAR;NOL8;RPL15;DICER1;EXOSC10;RRP12;RPL17;RPL23;RPL34;WDR75;EXOSC9;XRN2;RPL21;NVL;RPP30;DDX54;METTL3;EXOSC8;RPL18A;RPL10A
prerank,water-soluble vitamin metabolic process (GO:0006767),0.3391202390707656,0.9774183447315901,0.49189985272459497,0.8601101845101302,1.0,11/68,11.87%,SLC2A1;SLC19A3;ABCD4;TPK1;SLC52A2;SLC25A32;SHMT2;PDXK;SLC52A3;AMN;MMAA
prerank,aortic valve development (GO:0003176),0.38422934640510414,0.9769492791235408,0.5048231511254019,0.8605794329419434,1.0,9/34,7.94%,TIE1;BMPR2;NOS3;NOTCH1;NPPA;DLL4;SNAI2;EFNA1;TGFB1
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.4315277148274443,0.97660194976103,0.49829351535836175,0.8607652741817082,1.0,4/17,7.28%,HDAC9;SORT1;NR1H2;LIPC
prerank,cellular response to topologically incorrect protein (GO:0035967),0.37882652504040626,0.9763738033626749,0.4975845410628019,0.8606563465710524,1.0,4/31,10.78%,DAB2IP;ATXN3;RHBDD1;HSPA8
prerank,detection of mechanical stimulus (GO:0050982),0.41915359692807264,0.9758735584236555,0.5041322314049587,0.8612110133928901,1.0,4/19,4.47%,PTK2;CDH2;PIEZO1;CTNNB1
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.4677512553679284,0.9757080535295649,0.5018518518518519,0.860968730251628,1.0,2/10,1.79%,ENG;CAV1
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.36405793887655824,0.9755683215259074,0.49053627760252366,0.8606595118409028,1.0,5/38,6.30%,XDH;PHLPP1;PTPRJ;HYAL2;PLEKHA1
prerank,regulation of cellular component size (GO:0032535),0.3839120991936872,0.9754057174801732,0.5056726094003241,0.8604015545064837,1.0,8/30,11.83%,RIN3;EPS8;AP2M1;MSN;LAMTOR5;RAB3B;RAC1;RPTOR
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.44072747420435104,-0.9754017285549975,0.5142231947483589,0.8724524483146326,1.0,6/11,30.82%,FBH1;TIPIN;ZRANB3;DONSON;LIG3;GMNN
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.42363641475103125,0.9752687145582677,0.4753521126760563,0.8601081403609034,1.0,4/17,10.53%,PARD3;SMAD7;CALM1;DDIT4
prerank,negative regulation of organelle assembly (GO:1902116),-0.3246963116479632,-0.9752006464938114,0.49076517150395776,0.8719343429948312,1.0,14/35,19.96%,NUPR1;TMEM39A;YAP1;LRRK2;SCFD1;MDM1;TESK1;FEZ1;PHF23;TRIM37;TCHP;SMCR8;BRCA1;TBC1D7
prerank,microglial cell activation (GO:0001774),0.41165552165623787,0.9751544230881172,0.4872665534804754,0.8597502519204052,1.0,8/21,29.39%,APP;AGER;IFNGR1;SNCA;ITGB2;CX3CR1;CLU;AIF1
prerank,androgen receptor signaling pathway (GO:0030521),-0.4279571760944447,-0.9747601621048584,0.485838779956427,0.8720334415789749,1.0,3/11,10.49%,DDX5;AR;DDX17
prerank,inner mitochondrial membrane organization (GO:0007007),0.3517439239298856,0.9739621293372358,0.5165354330708661,0.8618731524705426,1.0,13/47,19.47%,ATP5F1E;TIMM13;ATP5MC2;ATP5PO;LETM1;GHITM;TIMM10;SAMM50;ATP5F1A;ATP5MF;HSPA9;ATP5PF;CHCHD3
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.47101344643270626,0.9737909722840264,0.5150976909413855,0.8616478393600531,1.0,4/12,12.36%,STX3;STX1A;STX19;SNAP29
prerank,cardiac ventricle morphogenesis (GO:0003208),0.3600753923350613,0.9735768653724087,0.510236220472441,0.8614935750016592,1.0,12/41,12.41%,ENG;TGFB2;MEF2C;NOTCH1;SMAD7;FOXF1;DLL4;TGFB1;NPY5R;GSK3A;SOX11;TGFBR2
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.4296979274043294,-0.973502645626176,0.5032822757111597,0.8744896477462433,1.0,6/11,34.22%,UGGT2;AUP1;DERL1;UFD1;UGGT1;POMT2
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.4006139675650151,0.9733939479558633,0.4991304347826087,0.8612852353705186,1.0,4/23,10.81%,TOMM22;TIMM13;TIMM10;SAMM50
prerank,cellular protein localization (GO:0034613),0.2849744385639214,0.9729588645277865,0.5194954128440367,0.8616532668384045,1.0,43/285,12.26%,OCLN;ESAM;TBC1D4;REEP1;RAB31;STX3;ID1;ARHGEF2;TBC1D14;STX1A;TBC1D22A;AMOT;TBC1D12;SNX13;MYO6;TBC1D2;HHEX;CTNNB1;ARF5;CEP68;USP6NL;PIGU;MESD;TBC1D5;GRID2;ABHD17A;STXBP1;CNTN2;COG3;GRIN3B;ARL4A;YWHAH;RTP4;PIGK;SMURF1;AXIN2;TBC1D10B;FERMT2;ACD;STX19;TBC1D30;HGS;CSRP3
prerank,nuclear envelope organization (GO:0006998),-0.37438995568134237,-0.9726910664560664,0.49330357142857145,0.8755933873510088,1.0,9/20,26.30%,DMPK;TMEM170A;TOR1AIP1;EMD;SUN2;VPS4A;TMEM43;LEMD2;NUP155
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.3366878537042905,0.97247526700514,0.4823008849557522,0.8621841681148436,1.0,1/60,0.03%,LEF1
prerank,Notch signaling involved in heart development (GO:0061314),-0.43366331638586175,-0.9722145554328234,0.49892008639308855,0.8758817975678241,1.0,4/11,8.12%,NOTCH2;RBPJ;HEYL;JAG1
prerank,morphogenesis of an epithelium (GO:0002009),-0.34340513842255094,-0.9721436107340083,0.5076923076923077,0.8750059323620286,1.0,8/25,15.81%,FGFR2;VCL;DAG1;TBX18;KDM2B;ARHGAP12;AHI1;LRP6
prerank,negative regulation of peptidase activity (GO:0010466),0.35259142441367713,0.9720186305398679,0.47976011994003,0.8626422969963924,1.0,8/47,10.05%,SPOCK2;SERPINB5;SERPINA9;SERPINA11;CST7;SPOCK1;SERPINI1;UBXN1
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.3468087849284047,0.9719668146876429,0.49767441860465117,0.8621496631309112,1.0,9/50,12.30%,APP;NOD1;NOD2;TLR3;ACTN4;LGALS9;TLR7;AGER;C1QTNF4
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.32602110552300073,0.9718253713329121,0.4897959183673469,0.8618467393901487,1.0,26/72,23.87%,IFNAR2;SIGIRR;IKBKB;PALM3;HSP90AB1;STAT1;BIRC3;IRAK2;LIFR;CASP8;CBFB;SHARPIN;USP18;SYK;TNFAIP3;CYLD;SUMO1;GAS6;RBCK1;SPPL2A;IFNGR1;ABCE1;RACK1;SOCS1;RIPK1;IFNGR2
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.30261851143423424,-0.9717280452218537,0.5181818181818182,0.8750062107543471,1.0,9/48,12.06%,ANK2;CEMIP;DMD;CAMK2D;DIAPH1;PDPK1;PRKACA;PTK2B;JPH1
prerank,glycine metabolic process (GO:0006544),0.465659219448581,0.9717086121385744,0.5166666666666667,0.8614931566154379,1.0,5/12,24.37%,GLYAT;SHMT2;SDSL;GCSH;RIDA
prerank,sensory perception of light stimulus (GO:0050953),-0.2702853769686512,-0.971635605969862,0.5474452554744526,0.8741849063123999,1.0,9/87,4.98%,COL1A1;SLC4A10;EFEMP1;EYA4;ADGRV1;COL18A1;COL11A1;DHRS3;EML2
prerank,protein localization to lysosome (GO:0061462),0.39482280174206696,0.9716335382567821,0.511437908496732,0.8610594233476769,1.0,8/28,17.75%,SH3BP4;NCOA4;LAMTOR5;HGS;M6PR;LMBRD1;LAMTOR4;AP3M1
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.4488017552707399,0.9715198812184271,0.4929078014184397,0.8607002741800343,1.0,3/14,11.09%,MFSD2A;ABCB11;ABCD1
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.3667477811312751,0.9714632883169406,0.5016025641025641,0.86021010977774,1.0,11/38,19.42%,DAB2IP;STAT1;ZMYND11;OTUD7A;CASP8;TLE1;TNFAIP3;TRIM39;TRIM59;TNIP1;OTUD7B
prerank,dendritic cell migration (GO:0036336),0.42889108068798654,0.9713681109799476,0.473967684021544,0.8597981952615976,1.0,3/16,8.27%,EPS8;CCR7;CXCR2
prerank,actin filament network formation (GO:0051639),-0.41974908497127406,-0.9712102907975312,0.5110619469026548,0.874274446449359,1.0,3/11,7.79%,COBL;CARMIL1;FHOD1
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.4467201131877385,0.9709882401379343,0.5081967213114754,0.8600856758002364,1.0,2/14,5.83%,NOS3;OXTR
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.3926064141443307,-0.9709796840540694,0.5205479452054794,0.8738181768309617,1.0,2/15,5.33%,OSBPL8;PPARA
prerank,cellular lipid catabolic process (GO:0044242),0.39886688446904145,0.9706075843219971,0.5056179775280899,0.8603343953222566,1.0,9/27,21.01%,PPARD;MGST2;ACOX1;ENPP2;LPIN3;SMPDL3B;ACBD5;AOAH;FAAH
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.30273226479306253,-0.9704748729104095,0.5386740331491713,0.874067378267377,1.0,17/47,18.23%,DOCK5;FBLN1;PDPN;CARMIL1;EFNA5;KANK1;S100A10;FLNA;MYOC;ITGB1BP1;DMTN;ABL1;P4HB;TESK1;MYADM;MDK;C1QBP
prerank,actin nucleation (GO:0045010),0.4031114230258778,0.970430137580706,0.5076923076923077,0.8601023384101474,1.0,8/21,26.28%,ARPC4;JMY;ARPC3;ACTR2;ARPC1B;ARPC2;WHAMM;ARPC5
prerank,positive regulation of macroautophagy (GO:0016239),0.350181161917647,0.9702103314471462,0.5068702290076336,0.8600031520116179,1.0,13/48,14.25%,KDR;SLC25A5;SESN3;RALB;SPTLC2;IRGM;FYCO1;BNIP3L;VPS13D;PIP4K2A;SH3GLB1;SPTLC1;EPM2A
prerank,mRNA destabilization (GO:0061157),-0.31921393072236853,-0.9697570633344041,0.5026737967914439,0.8748733091063321,1.0,2/38,2.75%,ROCK2;TUT4
prerank,purine-containing compound catabolic process (GO:0072523),0.4474324780064761,0.9692775469881146,0.5,0.8615433926792686,1.0,3/13,11.16%,XDH;NT5C2;PNP
prerank,mitotic cell cycle phase transition (GO:0044772),0.2906663396668028,0.9692144616990137,0.5460048426150121,0.8610617207443737,1.0,55/203,22.63%,PLCB1;CCNY;TPD52L1;NES;EPS8;DYNLL1;CDKN2B;CCP110;MAX;LCMT1;DNM2;CCNI;HINFP;PRKAR2B;CETN2;TUBB;CDK5RAP2;PPP1CB;CCND3;AKAP9;HAUS6;CEP78;EIF4E;CEP72;CEP135;PIM2;TUBA1A;FBXL8;PLK2;FBXL15;TUBB4B;CKAP5;ACVR1;PPME1;CEP70;ANAPC7;SPAST;SKP1;TRIM71;CDK6;USP29;DCTN1;BRSK2;TAF2;SFI1;CUL1;CLASP1;NASP;HAUS2;NDE1;CDK4;CDC23;CCNJL;CDC27;ENSA
prerank,cholesterol homeostasis (GO:0042632),0.3369927741470897,0.9689649769742479,0.5108538350217077,0.8610017288520194,1.0,9/64,9.00%,CAV1;SCARB1;HDAC9;ABCG1;ABCB11;NR1H2;LIPC;LRP5;NPC1
prerank,cellular response to misfolded protein (GO:0071218),-0.3662261988153455,-0.9687297059654039,0.4963680387409201,0.8767348139457379,1.0,8/20,24.73%,UGGT2;CUL3;KLHL15;AUP1;DNAJC18;DNAJB14;DERL1;UFD1
prerank,inorganic anion transmembrane transport (GO:0098661),-0.2941530613396006,-0.9686943502828583,0.4890282131661442,0.8757798781436323,1.0,11/63,7.09%,SLC1A3;SLC26A2;SLC12A2;GABRA3;ANO6;SLC5A5;SLC6A1;SLC12A7;SLC5A6;ANO1;SLC20A2
prerank,negative regulation of cellular protein localization (GO:1903828),0.37205710205876774,0.9686938694747143,0.5016077170418006,0.8610284555182763,1.0,3/34,3.14%,MFHAS1;NEDD4L;ANKRD13A
prerank,regulation of Golgi organization (GO:1903358),0.4247689352579039,0.9682802457821473,0.4981751824817518,0.861381611747402,1.0,6/17,16.98%,USP6NL;MAPK3;AKAP9;PDCD10;MAPK1;CAMSAP2
prerank,regulation of presynapse assembly (GO:1905606),-0.38251376234356377,-0.9681462928419341,0.5105386416861827,0.875187257705051,1.0,2/18,4.60%,GPC6;GPC4
prerank,regulation of presynapse organization (GO:0099174),-0.38251376234356377,-0.9681462928419341,0.5105386416861827,0.875187257705051,1.0,2/18,4.60%,GPC6;GPC4
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.37453798155578016,0.9677605037739881,0.493006993006993,0.8619820475814242,1.0,12/29,24.72%,CD40;IKBKB;TLR3;BIRC3;CASP8;UBE2D3;TBK1;UBE2D1;TRAF3;TICAM2;RIPK1;IRF7
prerank,regulation of centriole replication (GO:0046599),-0.3896157452415373,-0.9676666198043602,0.5034324942791762,0.8754294521784733,1.0,8/17,23.02%,ALMS1;MDM1;SPICE1;STIL;TRIM37;CEP295NL;BRCA1;CEP76
prerank,regulation of cartilage development (GO:0061035),-0.37621337893707907,-0.9675491048155694,0.4745762711864407,0.8746765426053312,1.0,6/18,14.08%,SOX5;BMP4;SOX6;PTHLH;BMP2;WNT11
prerank,"phagocytosis, engulfment (GO:0006911)",0.37117253133432576,0.9674924880541887,0.5,0.8619889615418159,1.0,3/36,2.03%,RHOBTB1;DOCK1;ELMO1
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.38151178002541536,0.9672052570449984,0.4950166112956811,0.8620463768702235,1.0,5/28,10.14%,DAB2IP;SORT1;CRADD;DEDD2;CASP8
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.42814182138879897,-0.9670019714329796,0.4942263279445728,0.8750719497590054,1.0,6/11,16.97%,EFNB2;FRS2;FZD7;SOX6;BMP2;MYOCD
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.474154598504405,0.9669010656544447,0.5099818511796733,0.8621088300527484,1.0,2/11,7.28%,ABCG1;LIPC
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.3547316494261014,0.9665642223098783,0.5101088646967341,0.8622706083816997,1.0,4/40,6.07%,BCL2L1;PLAUR;TNFSF10;BIK
prerank,inner dynein arm assembly (GO:0036159),0.46290790320768194,0.9664719822888264,0.5279850746268657,0.861877729028466,1.0,2/10,7.51%,ZMYND10;CFAP100
prerank,proteoglycan metabolic process (GO:0006029),0.3962162596400364,0.9663021546205922,0.49331103678929766,0.8616284835742306,1.0,3/26,2.85%,CSGALNACT1;BMPR2;CHST11
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.42943322563794245,-0.9662703516812869,0.5116279069767442,0.8760277831068886,1.0,2/10,8.02%,OGT;SELENOS
prerank,pentose-phosphate shunt (GO:0006098),-0.4275570655048828,-0.9661664389808868,0.5178197064989518,0.8752709942111875,1.0,4/11,14.14%,PGLS;PGD;H6PD;DERA
prerank,skeletal muscle organ development (GO:0060538),0.39487282069812013,0.9659576550488874,0.5222405271828665,0.8617975524879226,1.0,6/26,12.26%,CAV1;MEF2C;FOXL2;MYH14;STRA6;CSRP3
prerank,negative regulation of telomere maintenance (GO:0032205),-0.3918830305991319,-0.965951781391489,0.48267898383371827,0.8747978003755741,1.0,8/15,25.03%,TNKS2;ATM;RTEL1;PARP1;ERCC1;RAD50;NBN;TNKS
prerank,mitochondrial membrane organization (GO:0007006),0.3735325325839661,0.9654847402880061,0.5041597337770383,0.8622550201521373,1.0,11/32,24.95%,BCL2L1;SLC25A5;GHITM;SAMM50;HSPA9;CHCHD3;BAK1;MTX1;BNIP3;TMEM11;PMAIP1
prerank,protein palmitoylation (GO:0018345),0.38024894582059054,0.9654697670589619,0.5075125208681135,0.8616600649569188,1.0,6/30,9.99%,ZDHHC14;ZDHHC9;ZDHHC20;ZDHHC19;ZDHHC18;ZDHHC22
prerank,phospholipid dephosphorylation (GO:0046839),0.3658728770814452,0.9654620875135852,0.504601226993865,0.8610652355086175,1.0,11/37,18.87%,SGPP2;PLPP6;OCRL;INPP5F;MTMR6;MTMR12;MTMR2;PLPPR4;SYNJ1;PLPP2;MTMR1
prerank,regulation of response to interferon-gamma (GO:0060330),0.4363746713973249,0.9651424637568101,0.5105263157894737,0.8611956751430496,1.0,7/14,23.87%,HSP90AB1;STAT1;SUMO1;IFNGR1;PARP9;SOCS1;IFNGR2
prerank,inositol phosphate biosynthetic process (GO:0032958),0.4566365167492122,0.9649910207198653,0.48854961832061067,0.8609378142575641,1.0,1/11,1.17%,ITPKB
prerank,cellular response to acid chemical (GO:0071229),0.38882400754533714,0.9648739750586547,0.5023771790808241,0.8605706536042492,1.0,7/27,16.35%,SH3BP4;KLF2;LAMTOR5;RPTOR;NSMF;LAMTOR4;CAPN2
prerank,sulfur compound biosynthetic process (GO:0044272),0.31268675125450657,0.964844395575218,0.521497919556172,0.8600182224281226,1.0,16/104,9.86%,CSGALNACT1;ST3GAL6;ST3GAL1;B4GALT5;B4GALT4;CHST11;GCLM;B3GNT2;TPK1;MGST2;GSTA4;SLC10A7;MAT2A;HPGDS;GSTK1;CBS
prerank,DNA modification (GO:0006304),0.4115013372707291,0.9645640515167943,0.5093062605752962,0.860013416505969,1.0,6/22,12.39%,NTHL1;TERF2;MPG;SMUG1;ACD;TERF1
prerank,regulation of filopodium assembly (GO:0051489),0.3657001415614734,0.9636778593211344,0.5247524752475248,0.8614798152724097,1.0,6/38,5.21%,MYO10;PPP1R16B;FNBP1L;PALM;AGRN;CCR7
prerank,telomere capping (GO:0016233),0.4401948338184074,0.9636085842350124,0.5413533834586466,0.8610242381176253,1.0,4/16,12.39%,MRE11;TERF2;ACD;TERF1
prerank,pharyngeal system development (GO:0060037),0.4320814814440044,0.9633694878957267,0.49740932642487046,0.8609832639086326,1.0,3/15,1.89%,BMPR2;TGFB2;TBX1
prerank,nucleotide-excision repair (GO:0006289),0.31258845691401227,0.9632716440561193,0.5323741007194245,0.8605684649156645,1.0,28/101,22.10%,POLK;ATXN3;GTF2H2;BRCA2;CETN2;GTF2H4;POLB;FAN1;RBX1;RAD23A;AQR;COPS5;GPS1;ISY1;TCEA1;HUS1;RPA1;POLR2J;POLL;POLD1;COPS6;DDB1;GTF2H3;POLA1;ERCC8;RFC2;RAD23B;ERCC4
prerank,T cell differentiation (GO:0030217),0.3643401213834762,0.9631177909585688,0.525,0.8603197466863,1.0,10/40,12.18%,JAG2;SOX13;ZAP70;DLL4;CD4;TCF7;ADAM17;ZFP36L1;GPR89A;GPR89B
prerank,serine family amino acid metabolic process (GO:0009069),0.43631230711035174,0.9630443027796904,0.5216606498194946,0.859864847922141,1.0,4/16,9.86%,SARS1;GLYAT;SHMT2;CBS
prerank,indolalkylamine catabolic process (GO:0046218),-0.43917131322794645,-0.9629613961182535,0.5269978401727862,0.8816935442260572,1.0,5/10,29.97%,KYAT1;KYNU;KMO;IL4I1;HAAO
prerank,establishment of melanosome localization (GO:0032401),-0.37340852142157693,-0.9626153707435305,0.5412621359223301,0.8815803856740003,1.0,14/19,42.32%,MYO5A;MKKS;RAB11B;MREG;BBS4;BLOC1S5;BLOC1S6;BBS2;ARL6;GPR143;RAB17;MLPH;BLOC1S3;RAB27B
prerank,cellular response to chemokine (GO:1990869),0.35010829339407123,0.9622992866512717,0.5197568389057751,0.8609931423851542,1.0,2/46,1.28%,LRCH1;CXCL12
prerank,regulation of cell cycle (GO:0051726),0.28214886565479796,0.9622420217829782,0.5677867902665121,0.8605153357232019,1.0,28/271,8.29%,MECOM;DAB2IP;APBB2;TGFB2;PPP1R13B;NANOS3;TBX3;AFAP1L2;DCUN1D3;RGCC;SIPA1;NOTCH1;MEN1;PPP1R9B;CDC14A;XIAP;HSP90AB1;BTG4;RHOB;CDKN2B;TTC28;ADAM10;INSM1;BIRC3;JMY;TGFB1;JUN;IQGAP1
prerank,intracellular lipid transport (GO:0032365),0.4054264978809099,0.9620391529691508,0.5181975736568457,0.8603970716529273,1.0,4/21,6.87%,CERT1;ABCD4;CPT1A;ACACB
prerank,phosphatidylinositol metabolic process (GO:0046488),0.30826026106821924,0.9612815221769886,0.527369826435247,0.861529066943176,1.0,26/109,18.11%,PLCB1;PIK3R6;INPP5D;PIK3R3;PLCG1;PIKFYVE;PIP5K1C;OCRL;INPP5F;PLEKHA1;MTMR6;PIK3C3;PIK3C2A;PIP4K2A;RAB4A;PIK3CB;MTMR12;CDIPT;PIK3R5;MTMR2;PLEKHA3;SYNJ1;INPP5E;INPPL1;CSF1R;PIP5K1B
prerank,peptide cross-linking (GO:0018149),0.39135357113687885,0.9612591199814842,0.5016722408026756,0.8609720225262804,1.0,3/25,8.34%,NDNF;TGM2;ABCA7
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.4204047842461761,-0.9610165356514394,0.532293986636971,0.8847711485319364,1.0,4/12,17.54%,SMO;SIX1;SIX4;PAX2
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.43276106744529597,-0.9609132033510218,0.505175983436853,0.8839733738587573,1.0,4/10,10.51%,VTN;ITGA5;GRB10;ARNT
prerank,regulation of receptor binding (GO:1900120),0.46137751283190326,0.9608649136146875,0.5350701402805611,0.8612930429559638,1.0,2/10,3.09%,B2M;ADAM15
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.3235528514005326,0.9608620455605263,0.5158045977011494,0.8606902477356569,1.0,10/78,8.24%,PRKCH;SPTBN1;BCL2L1;STX3;ACTB;RAMP3;PPP2R5A;SORBS1;TGFB1;AP2M1
prerank,negative regulation of lipid biosynthetic process (GO:0051055),-0.36450304162572167,-0.9607178194926167,0.48081264108352145,0.8834529298542493,1.0,2/20,1.60%,WNT4;BMP5
prerank,response to thyroid hormone (GO:0097066),0.4437602300073642,0.9605889479519999,0.5083179297597042,0.8606684984421462,1.0,1/13,0.77%,LMO2
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.4650439790377085,0.9601406680026963,0.5111940298507462,0.8611017081754743,1.0,2/10,12.26%,LGALS9;CEACAM1
prerank,microtubule-based transport (GO:0099111),-0.40757519498447314,-0.959910655508071,0.5138004246284501,0.8845598234722732,1.0,9/12,35.14%,DYNC1I1;ROPN1L;HTT;ADCY10;SPAG17;SPA17;DYNC1I2;CCDC40;DNAAF4
prerank,protein heterotetramerization (GO:0051290),-0.4077437217276715,-0.9598619885674091,0.5300429184549357,0.8836277693460703,1.0,2/13,4.80%,PKD1;PKD2
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.33353345960039404,-0.959799860433098,0.5092348284960422,0.8827444497757637,1.0,4/29,7.25%,SMAD3;TUT4;ZC3H7B;AGO2
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.3834955036927858,-0.9596274247022921,0.5177777777777778,0.8821675443037061,1.0,3/16,10.49%,DDX5;SRSF6;DDX17
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.4157363012411386,-0.959533110819744,0.5158371040723982,0.8813773865299328,1.0,2/12,4.67%,BMP4;PTPN14
prerank,cellular protein metabolic process (GO:0044267),0.2723669081905351,0.958863246762351,0.573170731707317,0.8634559871703548,1.0,95/396,19.40%,ST8SIA4;ST3GAL6;DAB2IP;DENND3;APP;ST3GAL1;STK38;SPARCL1;VWA1;CDH2;MEN1;SARS1;IGFBP7;NOTUM;ZAR1L;RPL38;MRPL13;RPL13;RPS29;ABCA3;MRPL10;RPL36A;YES1;ADAM10;RPL3;GOLM1;LCMT1;UBE2G1;YARS2;MSRB2;MSRB3;RPSA;PDIA6;RPL27;RPS7;PLAT;QSOX1;RPL9;RPLP2;RPL18;SCG3;ADAM17;RPL13A;MMP1;FBXL2;DUSP12;RPS11;CHRM3;APH1A;UBA3;RPL8;RPS27;RPL19;RPS9;MRPL28;EVA1A;RPL11;MANBA;SPCS2;LTA4H;RPS15;RPL37;FBXW2;SRBD1;RPS28;MAN2B1;OMA1;SERPINC1;UBE2D3;RPS10;MMP15;RPS25;LOXL2;MCRS1;PROC;RPL37A;MRPL9;COPS5;GAS6;FBXO2;SEPHS1;TMEM132A;UBE2G2;SPPL3;SCG2;SFTPC;RPL15;TNIP1;FARSB;ERO1A;USP25;MRPL23;RPL17;RPL23;CPE
prerank,NIK/NF-kappaB signaling (GO:0038061),0.328906481715427,0.9588117942298794,0.531700288184438,0.8629751788841389,1.0,21/72,23.32%,TIRAP;TLR3;CARD10;PSMB3;BIRC3;PSMD11;PSMC6;MALT1;PSME2;PSMD8;PSMB10;PSMA8;RELB;SKP1;PSMD9;DICER1;CUL1;PSMD1;PSMC3;TRAF6;PSMD10
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.4616783514372223,0.958598995358235,0.5223613595706619,0.8628502017439739,1.0,4/11,18.03%,CCT3;CCT5;TERF1;CCT7
prerank,secretion (GO:0046903),-0.3995561337861348,-0.9578565009680629,0.5227272727272727,0.8847432081797187,1.0,4/14,4.42%,FBLN5;SLC22A4;SLC22A6;PRKCI
prerank,regulation of intracellular transport (GO:0032386),-0.31091041115166423,-0.957645367253088,0.5163043478260869,0.8842724634553186,1.0,9/38,15.68%,ATP9A;GAS1;GRIPAP1;LRRK2;SCFD1;NEFH;MAP2;RAB11B;CRYAB
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.35349787865163096,-0.9574768902773998,0.5121951219512195,0.8836710485192653,1.0,7/23,15.04%,KIT;CYP1B1;OCIAD1;PTK2B;PRLR;PIBF1;GHR
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.3965468103483545,0.9574721212543129,0.5141430948419301,0.864834778427011,1.0,8/23,18.52%,FOXL2;CECR2;DFFB;HMGB2;DNASE2;EXOG;ENDOG;DICER1
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.3460974497610861,-0.9571797010026518,0.5106382978723404,0.8834497763293282,1.0,6/24,12.21%,PID1;RHOQ;DAB2;ITGB1BP1;LZTFL1;DMTN
prerank,negative regulation of ossification (GO:0030279),-0.35392902005055427,-0.9566615808472996,0.5285714285714286,0.8837549195084148,1.0,10/23,18.36%,ENPP1;SMAD6;BCOR;RBPJ;ECM1;TRPM4;PTK2B;CHSY1;MDK;SFRP1
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.42231626390968124,-0.9565910715102335,0.5178571428571429,0.8829062772195384,1.0,3/11,7.90%,NBL1;SLIT2;CCN3
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.45096025330113126,0.9565203702157513,0.5045703839122486,0.8663610876144213,1.0,1/12,0.77%,LMO2
prerank,amyloid precursor protein metabolic process (GO:0042982),0.41643406462013843,0.9564148606704465,0.5061511423550088,0.86599391116118,1.0,5/18,11.59%,ABCG1;ADAM10;TMCC2;ADAM17;APH1A
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.42887373686970076,-0.9560621612925084,0.5458333333333333,0.8832895796148114,1.0,3/10,11.76%,APPL2;ANO6;CD300A
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.354259524950729,0.9560386859465203,0.5069124423963134,0.8662491609330545,1.0,7/44,12.43%,NANOS3;PRR5L;NANOS2;NANOS1;GTPBP1;ZFP36L1;BTG2
prerank,regulation of lipase activity (GO:0060191),-0.39147203286363413,-0.9557457865423938,0.5191873589164786,0.8830709466962058,1.0,4/13,18.58%,PCSK5;LMF1;ANGPTL3;PCSK6
prerank,negative regulation of kinase activity (GO:0033673),-0.28392671078020765,-0.9554206128591465,0.5335365853658537,0.8829205509349681,1.0,9/62,10.22%,PRKAG2;PPM1E;DEPTOR;DTNBP1;IRS2;PDPK1;QARS1;ITGB1BP1;SPRED1
prerank,regulation of actin nucleation (GO:0051125),-0.41401181619935795,-0.955418270583723,0.49184149184149184,0.8818876987260099,1.0,5/12,20.73%,GSN;ARFIP2;WASHC5;CORO1B;ARF1
prerank,blood vessel endothelial cell migration (GO:0043534),0.4009104422914909,0.955369534047083,0.5067567567567568,0.8670934155923885,1.0,6/22,8.93%,KDR;ID1;PIK3R3;EPHB4;SOX18;GREM1
prerank,lysosome organization (GO:0007040),-0.317797107424571,-0.9552029620166242,0.5508021390374331,0.8814413006997555,1.0,12/36,18.66%,ABCA1;HOOK2;ARSB;GAA;AKTIP;CLN3;LRRK2;ACP2;GNPTAB;GRN;MBTPS1;CLN6
prerank,actin-myosin filament sliding (GO:0033275),-0.32509897604076676,-0.955165140949108,0.5308310991957105,0.879476560759216,1.0,5/38,10.46%,ACTN2;TPM1;DMD;TPM2;DES
prerank,muscle filament sliding (GO:0030049),-0.32509897604076676,-0.955165140949108,0.5308310991957105,0.879476560759216,1.0,5/38,10.46%,ACTN2;TPM1;DMD;TPM2;DES
prerank,regulation of protein localization to cell surface (GO:2000008),0.36745937814946317,0.9551467294140015,0.5155993431855501,0.8669710624581622,1.0,9/33,17.48%,STX3;NEDD4L;CTNNB1;HSP90AB1;ABCA7;KCNAB2;GOPC;GPM6B;LEPROTL1
prerank,regulation of membrane depolarization (GO:0003254),-0.3853842425326557,-0.9547857883747731,0.5220264317180616,0.8794533453978223,1.0,5/18,11.89%,FHL1;PTPN3;CAMK2D;GPD1L;LRRK2
prerank,response to interleukin-6 (GO:0070741),0.4701125091422653,0.9546745865316583,0.515686274509804,0.8674580801892726,1.0,1/10,0.37%,ST3GAL6
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.3431214304133407,-0.954388002250794,0.5311720698254364,0.8795111112049417,1.0,8/26,11.35%,ROCK2;ASAP3;ALMS1;SYNPO;PRKN;FHOD1;PFN2;SLC9A1
prerank,double-strand break repair via break-induced replication (GO:0000727),-0.41200899513474387,-0.9543676136002086,0.5316742081447964,0.8785361334652741,1.0,11/12,53.28%,CDC45;MCM3;MCM4;MCM5;CDC7;MUS81;MCMDC2;MCM2;MCM7;GINS4;GINS2
prerank,positive regulation of cell aging (GO:0090343),0.4505512597662351,0.9538576480611836,0.5195530726256983,0.8687774701413046,1.0,4/11,16.37%,B2M;HMGA1;ABI3;HMGA2
prerank,positive regulation of myelination (GO:0031643),0.4551645363854858,0.9538466408533007,0.5067698259187621,0.8681938437883145,1.0,4/11,18.52%,PARD3;CST7;TPPP;DICER1
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.3722898807760526,0.9538391244634786,0.5058430717863105,0.8676053472876022,1.0,3/28,6.17%,ESAM;CXCL12;DBNL
prerank,negative regulation of interferon-beta production (GO:0032688),-0.43073944459834673,-0.9532595931633822,0.5098901098901099,0.8804324878589009,1.0,3/10,20.51%,PTPRS;PPM1B;PYCARD
prerank,melanosome transport (GO:0032402),-0.3749024626754015,-0.9532442869550913,0.5552884615384616,0.878422518679197,1.0,14/18,42.32%,MYO5A;MKKS;RAB11B;MREG;BBS4;BLOC1S5;BLOC1S6;BBS2;ARL6;GPR143;RAB17;MLPH;BLOC1S3;RAB27B
prerank,pigment granule transport (GO:0051904),-0.3749024626754015,-0.9532442869550913,0.5552884615384616,0.878422518679197,1.0,14/18,42.32%,MYO5A;MKKS;RAB11B;MREG;BBS4;BLOC1S5;BLOC1S6;BBS2;ARL6;GPR143;RAB17;MLPH;BLOC1S3;RAB27B
prerank,ribosomal small subunit biogenesis (GO:0042274),0.3542017873938073,0.9531967584757458,0.5328,0.8684756572065894,1.0,22/39,32.70%,RPSA;SNU13;RPS7;PWP2;RPS27;RIOK1;RPS15;RPS28;RPS25;SURF6;RIOK3;ERAL1;UTP4;RPS19;LSM6;RPS6;RPS14;RPS24;WDR3;RPS16;NOL11;DDX52
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.41988706555378685,0.9531304936678586,0.5304659498207885,0.8680120407181445,1.0,1/18,0.20%,TEK
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.3671150264306652,0.9530984408835905,0.5112262521588946,0.8674837964448436,1.0,12/30,24.72%,CD40;IKBKB;TLR3;BIRC3;CASP8;UBE2D3;TBK1;UBE2D1;TRAF3;TICAM2;RIPK1;IRF7
prerank,intrinsic apoptotic signaling pathway (GO:0097193),-0.2684485791004573,-0.9529969058123898,0.5513307984790875,0.8780618593119609,1.0,17/94,10.21%,FHIT;ITPR1;PDK1;DDX5;MAP3K5;PRKCD;IKBKE;TMEM117;CYP1B1;BCL2;PRODH;ATM;PML;CUL3;CEBPB;CRIP1;STK11
prerank,regulation of leukocyte migration (GO:0002685),-0.37759684477081623,-0.9529724944573582,0.5224215246636771,0.8771191112894157,1.0,4/16,19.55%,HOXA7;ANXA1;CD81;RHOH
prerank,peptidyl-threonine modification (GO:0018210),-0.2860634010616545,-0.9528510954441455,0.5331230283911672,0.8764385794457731,1.0,24/66,26.60%,ROCK2;PRKCD;TGFBR1;CAMK2D;MAP3K12;PDPK1;PRKCA;LRRK2;GALNTL6;GALNT16;WNK1;DYRK2;ACVR1B;CDC42BPG;SBK1;WNK3;CSNK2A1;CDK5;GALNT1;MAP2K1;CIT;TNKS;GALNT3;CDK10
prerank,negative regulation of cellular catabolic process (GO:0031330),0.32643456729783116,0.9528483481711197,0.5401459854014599,0.8674448108083455,1.0,4/63,2.62%,MFSD2A;DAB2IP;RASIP1;TBC1D14
prerank,endochondral bone morphogenesis (GO:0060350),0.44804779499868863,0.9527366731499795,0.5193661971830986,0.8670919995230132,1.0,2/11,2.77%,BMPR2;MEF2C
prerank,positive regulation of filopodium assembly (GO:0051491),-0.35234721167700955,-0.9525966150412353,0.49882903981264637,0.8760837230418549,1.0,5/24,4.21%,DPYSL3;DOCK11;ARAP1;RHOQ;RIPOR2
prerank,limb morphogenesis (GO:0035108),-0.36596037036224804,-0.9522127661091746,0.53,0.8760003992303264,1.0,3/20,2.42%,GLI3;CYP26B1;PCSK5
prerank,regulation of fat cell differentiation (GO:0045598),0.3221435208826451,0.9516187752276477,0.5372714486638537,0.868984162731321,1.0,16/74,12.45%,PPARD;FOXO1;ZFPM1;CCDC85B;ZBTB16;GATA2;NOCT;CREB1;WWTR1;TGFB1;LRP5;TRIB2;ZFP36L1;FERMT2;PPARG;PTPRQ
prerank,carbohydrate catabolic process (GO:0016052),0.3629240925264854,0.9516162186363103,0.5362776025236593,0.8683859595572203,1.0,12/38,18.64%,NEU4;PKM;HK1;MANBA;PGAM4;PGAM1;NEU2;MAN2B1;TPI1;PFKL;NEU1;LDHA
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.34209056023159956,-0.9515970020253938,0.5147058823529411,0.8766180564261943,1.0,3/23,2.88%,IGF1;EFNB2;MMP14
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.29947124219678634,0.9514619022174973,0.5425824175824175,0.8681194903109654,1.0,18/121,10.71%,PECAM1;PDGFB;IL6R;LRP8;NEDD9;ARL2BP;PTPRJ;ARHGEF2;CD40;LYN;EPHA4;STAP2;EFNA1;TGFB1;ENPP2;GREM1;PTK6;CNTF
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.41336208460717294,-0.9509416014689368,0.5360169491525424,0.8773186933549784,1.0,4/12,16.47%,GLI2;EPHB2;NFIB;TSKU
prerank,positive regulation of sodium ion transport (GO:0010765),0.4395336808399632,0.9508305766938924,0.5074074074074074,0.8689082852614929,1.0,1/12,2.03%,CNKSR3
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.36637730077861186,0.9505773193690537,0.5122749590834698,0.8688416405406857,1.0,13/32,25.70%,ARHGEF2;FGF13;STMN1;ATXN7;CDH5;APC;CAMSAP2;DYRK1A;CLASP1;SNCA;NAV3;CAMSAP1;CLASP2
prerank,synaptic vesicle membrane organization (GO:0048499),0.4239127752168514,0.9505512023619366,0.5492957746478874,0.8683051744777741,1.0,4/17,12.36%,STX3;STX1A;STX19;SNAP29
prerank,regulation of astrocyte differentiation (GO:0048710),0.45007891712236325,0.9505072841710204,0.5371024734982333,0.8678018879942831,1.0,2/12,5.69%,NOTCH1;EPHA4
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.3177468002575211,0.9499604429793927,0.5284327323162274,0.8684442700898936,1.0,21/88,18.00%,DAB2IP;NANOS3;YBX1;NANOS2;ENC1;MRPL13;NANOS1;PLAT;CNOT9;RPL13A;GRB7;BTG2;PAIP2;CLN8;RNF139;BAG6;EDN1;CSTB;RGP1;NELL1;TRIM71
prerank,regulation of protein kinase A signaling (GO:0010738),-0.36491608163791445,-0.9498487100315959,0.5530474040632054,0.8791361744481029,1.0,6/20,14.27%,ADGRV1;AKAP12;AKAP7;PJA2;LRRK2;TCIM
prerank,regulation of hemopoiesis (GO:1903706),0.45668299055215616,0.9497929624945188,0.510934393638171,0.8682218204657267,1.0,4/10,11.78%,PTN;MYSM1;CBFB;PRKCB
prerank,regulation of inclusion body assembly (GO:0090083),-0.40395465251374135,-0.9496228688079422,0.5340909090909091,0.8787286086539686,1.0,1/11,0.87%,SNCAIP
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.4305794722270429,0.9495881094066547,0.5174953959484346,0.868093260752301,1.0,4/14,19.93%,TIRAP;HNRNPC;ELAVL1;DAZL
prerank,triglyceride metabolic process (GO:0006641),-0.29056608545536633,-0.94939510637385,0.5591715976331361,0.8783085207656648,1.0,8/48,15.27%,AGMO;MOGAT3;GK;LPGAT1;APOE;LMF1;GPAT3;PNPLA3
prerank,negative regulation of cell cycle (GO:0045786),-0.27254825085498563,-0.949367433706393,0.5828025477707006,0.8773662583933594,1.0,8/73,3.80%,NR2F2;SMAD3;BMP7;BMP4;NUPR1;PTPN3;GAS1;FOXC1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.41834579238438785,0.9488978808979877,0.5229681978798587,0.8690477021957447,1.0,4/15,10.53%,GRB2;SORT1;SOS1;DDIT4
prerank,melanosome localization (GO:0032400),-0.35537341109461207,-0.9488486300926607,0.5160493827160494,0.877681590401681,1.0,14/21,40.12%,MYO5A;MKKS;RAB11B;MREG;BBS4;BLOC1S5;BLOC1S6;BBS2;ARL6;GPR143;RAB17;VPS33A;MLPH;BLOC1S3
prerank,Golgi inheritance (GO:0048313),-0.42188703459433696,-0.9483886869350545,0.5462555066079295,0.8778319068033209,1.0,4/11,14.46%,GBF1;GOLGA2;STX5;PLK5
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.3138869277496559,0.9482349780303115,0.53360768175583,0.8699481233330892,1.0,37/87,29.24%,NDUFAF3;NDUFA2;NDUFA8;SLC25A33;SCO2;NDUFAF7;DMAC2;SAMM50;TMEM126B;SCO1;OMA1;NDUFA12;IMMP2L;NDUFB3;NDUFAF8;SDHAF4;CHCHD4;SDHAF1;COA3;SMIM20;NDUFC1;NUBPL;NDUFA10;SDHAF2;DMAC1;COX20;COX17;ECSIT;NDUFA7;PET100;TIMMDC1;TIMM21;NDUFS5;NDUFAB1;COA5;AIFM1;BCS1L
prerank,peptide hormone secretion (GO:0030072),0.38659860313191274,0.9480524952830311,0.5315161839863713,0.8697708890670477,1.0,6/26,19.85%,LTBP4;RAB1A;EDN1;RIMS2;CAMK2G;CYB5R4
prerank,genitalia development (GO:0048806),0.45145778092373157,0.9478772231040685,0.5196998123827392,0.8695272410013151,1.0,4/12,16.80%,TBX3;STRA6;DNAJC19;FOXF2
prerank,carboxylic acid transmembrane transport (GO:1905039),0.35574639680453496,0.9476530891443653,0.5150078988941548,0.8694459041509397,1.0,2/40,1.99%,SLC7A5;SLC38A5
prerank,positive regulation of nervous system development (GO:0051962),0.3544613525329704,0.9476049637062008,0.5401574803149606,0.8689554685904477,1.0,12/42,16.52%,TGM2;WNT7A;CLSTN1;GRID2;FAIM;NRXN1;LRRC4B;LRP2;SOX11;EPHB1;NLGN1;IL1RAP
prerank,positive regulation of mitochondrion organization (GO:0010822),0.3394576078426472,0.9475429362762191,0.5592705167173252,0.8685049222954241,1.0,6/57,6.07%,KDR;HIP1R;PLAUR;TNFSF10;CAMKK2;BIK
prerank,mesenchymal cell development (GO:0014031),0.41390347637687536,0.947499997733182,0.5348432055749129,0.8680074153023233,1.0,6/18,17.90%,CDH2;NOTCH1;SNAI2;SOX11;PDCD6;KBTBD8
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.3665852827634001,-0.9472950271284696,0.5406032482598608,0.8796162439953915,1.0,2/18,3.71%,UGGT2;AMFR
prerank,regulation of nucleic acid-templated transcription (GO:1903506),-0.22240246181090653,-0.947198567658822,0.6491228070175439,0.8788630121731241,1.0,70/327,16.22%,BNC2;NFIA;DENND4A;ZFHX3;EFEMP1;SSBP2;ARNT2;PPARGC1B;TULP3;PRRX2;NR1D2;FOXC1;TGFBR1;PPARGC1A;SUFU;ZNF423;CTR9;KAT6B;MED23;SIX1;RORA;IGF2;POLR2A;CRABP2;NFXL1;FZD7;ZFAT;ATF5;GPBP1L1;PFDN5;CHD3;VSX1;MITF;ACTR8;RBAK;PML;SOX6;REXO4;GCFC2;CEBPB;NSD2;ZBTB38;ESR1;RNF20;PRMT5;NFX1;TGFBRAP1;SBNO1;ABL1;ZNF219;BMP2;ZBTB4;SP3;DVL2;GZF1;EP300;ACVR1B;MAFB;ATF2;SPTY2D1;NONO;MYBL2;PHF12;LDB1;LIMD1;NFATC2;PSPC1;NFIL3;APBB3;ZFP37
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.38490837229973784,0.9471208174065134,0.5373134328358209,0.8682357216188172,1.0,3/27,8.61%,TIRAP;MAP3K1;IRAK2
prerank,cellular response to unfolded protein (GO:0034620),0.37875371036461897,0.9468341663325684,0.5354200988467874,0.8682946102657559,1.0,3/26,10.78%,DAB2IP;RHBDD1;HSPA8
prerank,positive regulation of cell development (GO:0010720),-0.33372402403686563,-0.946552747788169,0.5626666666666666,0.879573947990516,1.0,7/31,15.46%,PDE3A;BMP4;SERPINF1;NIBAN2;NUMBL;NKX6-1;NAP1L1
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.316339521168057,0.9463554603787058,0.5393759286775631,0.8687905490397169,1.0,6/77,6.78%,ITGA6;BCL2L1;SH3RF1;PLAUR;SLC25A5;MCL1
prerank,determination of left/right symmetry (GO:0007368),0.36072737157032525,0.9461666102259596,0.5383386581469649,0.8686228838890528,1.0,7/36,15.53%,ZIC3;TBX1;NOTCH1;KIF3B;FOXJ1;DAND5;DNAH5
prerank,positive regulation of gene expression (GO:0010628),0.267322811210764,0.9456098767828528,0.6245883644346871,0.869258079230485,1.0,54/442,12.39%,LEF1;TFRC;ETS1;TENT4A;OCLN;RBM20;CLDN5;PDGFB;CADM1;CD34;NOS3;PDE2A;APP;RGCC;NIBAN1;MEF2C;PIK3R3;NOTCH1;RAMP2;ACTB;GATA2;TCF23;FGF16;DLL4;RAMP3;TLR3;TAF1B;CCDC88B;MAPK3;LGALS9;KLF4;HINFP;TGFB1;TERF2;EIF3E;P2RX7;MSN;RPS7;ACTG1;ZPR1;PDCD10;EIF3D;SMAD1;PRKAB1;LAMTOR5;CNTF;CTCF;TLE1;GSK3A;HIF1A;HGS;VSIR;PIK3CB;SOX11
prerank,primary miRNA processing (GO:0031053),-0.42748188864116565,-0.9456059077320215,0.5408805031446541,0.8809797235642003,1.0,3/10,15.29%,SMAD3;PUS10;HNRNPA2B1
prerank,embryonic heart tube development (GO:0035050),0.42411440989539123,0.9454546467165791,0.5353901996370236,0.8690122756533267,1.0,2/14,7.35%,SOX17;SOX18
prerank,endomembrane system organization (GO:0010256),-0.23951763413414107,-0.9454417215988723,0.6551724137931034,0.880421986890069,1.0,50/178,19.65%,RAB30;MYOF;DMPK;GBF1;OBSL1;TANGO2;ARHGAP21;GOLGB1;A4GALT;FAM174B;FBXW8;GOLGA2;DYNC2H1;HOOK2;PI4K2B;SEC31A;TMEM170A;CUL7;SEC16B;COG4;PLEKHF1;TLCD2;ARL1;HUWE1;AKTIP;ARFGEF2;ATP8B2;LRRK2;GORASP2;RAB29;SPTSSB;BCAS3;PLEKHM2;ATP8B1;SEC16A;LMAN1;SNX33;WASHC5;SURF4;OPTN;SYP;USP50;SUN2;SNX10;BLZF1;RAB22A;GOLGA5;GOLGA8B;VPS4A;ATL3
prerank,positive regulation of protein ubiquitination (GO:0031398),0.31964782533110686,0.9453266221497056,0.5652777777777778,0.8687180631976341,1.0,18/80,15.16%,CAV1;DCUN1D3;SMAD7;XIAP;FAM107A;FBXW7;BIRC3;PIN1;MALT1;NDFIP2;UBQLN1;GSK3A;DCUN1D1;BCL10;PDCD6;BMI1;RBX1;INAVA
prerank,Wnt signaling pathway (GO:0016055),0.3126075994471423,0.9453172792300814,0.5658073270013568,0.8681417197642143,1.0,7/92,5.64%,LEF1;FZD6;FZD4;WNT7A;SNX3;CTNNB1;TCF7
prerank,cilium organization (GO:0044782),-0.23132516382719986,-0.9452791501454221,0.6521739130434783,0.8798499774338958,1.0,41/209,14.45%,PARVA;GSN;CYS1;CC2D2A;DCDC2;PKD1;IFT80;WDR35;GBF1;DYNC2I1;IFT81;ARL3;WDPCP;PKD2;CDC14B;DZIP1;DZIP1L;IFT74;CCDC57;TTC39C;FLNA;PTPDC1;CFAP44;DYNC2H1;TTC8;IFT122;CEP164;BBS9;FUZ;ARMC9;LZTFL1;EHD1;MKKS;TRAPPC14;CLUAP1;PIBF1;RILPL2;PCM1;AHI1;DYNC2I2;WDR19
prerank,chromatin organization (GO:0006325),0.29642697909950794,0.9451919718653083,0.558408215661104,0.8678040003535876,1.0,24/132,16.38%,MECOM;SMARCA2;NPM3;BAZ2B;NPM2;PWWP3A;FOXP3;HCFC2;CHD1;PAK1;ARID1A;KDM4A;MYSM1;ZBTB7A;TADA2B;SMARCD1;SETDB1;HMGB2;SOX9;HDAC5;LOXL2;SMARCAD1;HMGA2;HCFC1
prerank,regulation of sensory perception of pain (GO:0051930),-0.42354637922221905,-0.9450593936045552,0.5548387096774193,0.8794112096940062,1.0,2/11,7.90%,TMEM100;CCN3
prerank,cellular response to interferon-beta (GO:0035458),0.43599967001256057,0.9447157693801583,0.5372340425531915,0.8682742692550096,1.0,3/14,8.01%,STAT1;AIM2;IRGM
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.3702236957744038,0.9442806305448475,0.5395799676898223,0.8686536134252352,1.0,11/32,24.97%,CDK17;HINFP;ZPR1;BRD4;CDC6;ORC1;CDK18;POLA1;DHFR;TYMS;KLF11
prerank,release of cytochrome c from mitochondria (GO:0001836),0.42204635157997045,0.9438255115166766,0.5413005272407733,0.8690726903072111,1.0,1/17,0.99%,BCL2L1
prerank,protein localization to centrosome (GO:0071539),-0.3743699901011533,-0.9434468938483431,0.5369928400954654,0.8825894538865318,1.0,11/17,29.11%,GOLGB1;CCDC14;PIBF1;PCM1;STIL;SNX10;BBS4;CEP131;C2CD3;CEP192;NEDD1
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.44781606111106975,0.9432021869717602,0.534,0.8699281116422602,1.0,3/10,11.79%,ATP5MC2;ATP5PO;ATP5F1A
prerank,central nervous system neuron differentiation (GO:0021953),0.36944207468573176,0.9429292175585874,0.5478119935170178,0.8698814047072132,1.0,10/33,18.62%,CTNNB1;MDGA2;GRID2;OPHN1;SPOCK1;TOX;LHX1;PROX1;SIN3A;DRAXIN
prerank,substantia nigra development (GO:0021762),0.35849150068125246,0.9428768911000405,0.5243506493506493,0.8693984406563026,1.0,15/37,22.46%,ACTB;CALM1;INA;DYNLL1;YWHAH;YWHAQ;GNB4;MAOB;SYPL2;MBP;ATP5PF;BASP1;SUDS3;RAD1;PADI2
prerank,response to tumor necrosis factor (GO:0034612),0.3103389773901017,0.9426139429723482,0.5710306406685237,0.8693846874638916,1.0,10/91,6.58%,DAB2IP;MAP4K3;GCH1;TNFRSF11A;ARHGEF2;CD40;TNFRSF21;IKBKB;HYAL2;ADAM10
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.3950704018413539,-0.942417093351845,0.5248380129589633,0.8842228051988539,1.0,3/12,10.46%,AR;SELENOS;TMEFF2
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.33185619517426773,0.942371920978663,0.539039039039039,0.8693356799618578,1.0,14/56,16.70%,SPTBN1;EFHC2;STMN1;RHOB;CECR2;TRIM36;KIF23;MITD1;ANLN;APC;PDCD6IP;SPAST;ANK3;MYH10
prerank,extracellular matrix assembly (GO:0085029),-0.3504096270779641,-0.9423426029000417,0.5509708737864077,0.8834059837140205,1.0,8/23,11.48%,TNXB;FBLN5;ATP7A;EMILIN1;MYH11;EFEMP2;LAMB1;MFAP4
prerank,detection of calcium ion (GO:0005513),-0.3989729528832348,-0.942224588601754,0.5452538631346578,0.8826771010251588,1.0,2/13,4.40%,STIM1;KCNMB2
prerank,protein methylation (GO:0006479),-0.30320883047821456,-0.9412331053878028,0.5457227138643068,0.8842155196496214,1.0,13/40,23.18%,PCMT1;EHMT2;EEF2KMT;PRMT5;RAB6A;PRMT8;METTL22;FAM98B;TRMT112;EZH2;GSPT1;NSD1;EEF1AKMT2
prerank,response to muscle stretch (GO:0035994),0.42822544602025914,0.9411438912440591,0.5367132867132867,0.8714818554005253,1.0,4/15,4.91%,PTK2;CDH2;CTNNB1;NPPA
prerank,regulation of exit from mitosis (GO:0007096),0.35669918377404364,0.9406682192666527,0.5532915360501567,0.8719716042308907,1.0,15/38,23.33%,RGCC;PPP1R9B;CDC14A;NPM2;BUB3;ANLN;ANAPC16;ANAPC7;ANAPC10;UBE2D1;ANAPC2;ZW10;CDC23;CDC27;CDC26
prerank,positive regulation of phospholipid transport (GO:2001140),0.45664837282798787,0.9405128592895164,0.5662431941923775,0.8717062794078957,1.0,4/10,17.32%,ABCA3;ABCA7;TMEM30A;TRIAP1
prerank,sympathetic nervous system development (GO:0048485),0.42563697875540685,0.9404628712790505,0.5277777777777778,0.8712433576730124,1.0,5/15,17.38%,CTNNB1;INSM1;SOX11;NRP2;NRP1
prerank,nuclear export (GO:0051168),-0.2630035008695366,-0.9401475426096301,0.5635179153094463,0.886055520150916,1.0,25/80,26.97%,RANBP3L;PKD1;PHAX;RANBP17;SRSF5;SRSF11;XPO5;SRSF6;XPO6;SRSF4;STRADA;DDX39B;XPO1;THOC2;U2AF2;THOC7;U2AF1;DDX39A;RAE1;EIF4A3;POLDIP3;THOC1;NUP155;TPR;WASHC4
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.3741068589626984,0.9392148866426113,0.5141065830721003,0.8733975692819762,1.0,6/29,4.33%,RASGRP4;RAPGEF1;NOTCH1;LYN;TGM2;GRB2
prerank,mitochondrial translational elongation (GO:0070125),0.3106488391451783,0.9384369391303815,0.543448275862069,0.8744598451408565,1.0,36/88,27.31%,MRPL12;MRPL13;MRPL10;MRPL50;MRPL14;GFM1;MRPL57;MRPL54;MRPL30;MRPL28;MRPL20;MRPL19;MRPS2;MRPL40;MRPL44;MRPL9;MRPS9;MRPL58;MRPL16;MRPL23;MRPL39;MRPS18A;MRPL21;MRPL1;ERAL1;MRPL27;MRPL41;PTCD3;MRPL49;MRPL51;MRPL22;MRPS33;MRPL37;MRPL2;MRPL15;MRPS18C
prerank,toll-like receptor signaling pathway (GO:0002224),0.31097727716702894,0.9382167080538135,0.5573294629898403,0.8743546247604919,1.0,28/84,23.18%,TIRAP;MAP3K1;IKBKB;TLR3;TRIL;LGALS9;CTSK;BIRC3;TLR7;IRAK2;PIK3C3;CASP8;TLR8;S100A8;RFTN1;BCL10;UBE2D3;CTSS;TNIP1;UBE2D1;TRAF3;RPS6KA3;NMI;PLCG2;LGMN;TICAM2;TRAF6;RIPK1
prerank,positive regulation of monooxygenase activity (GO:0032770),0.3840610790586387,0.9381346757649497,0.5473856209150327,0.8739420658469774,1.0,7/26,14.80%,GCH1;SCARB1;TERF2;AGTR2;HIF1A;PIK3CB;NUS1
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.45024844243981416,0.9377873227858758,0.5405405405405406,0.8740834321125852,1.0,1/11,1.49%,NOVA2
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.4322807258626984,0.9373559944784604,0.5446096654275093,0.8744677858258005,1.0,1/14,0.99%,BCL2L1
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.3862558304336361,-0.9372978117994986,0.5489749430523918,0.8923772819815932,1.0,6/15,7.94%,FGF1;SMOC2;THBS1;FGF2;P2RX4;MET
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.3627248887358064,0.9372363601868429,0.5499231950844854,0.8741486627080179,1.0,5/34,8.67%,PDGFB;INSR;RGCC;LRP5;TGFA
prerank,steroid biosynthetic process (GO:0006694),-0.29358187895557003,-0.9370497140726438,0.5857988165680473,0.8919942985110193,1.0,5/56,5.75%,PRKAG2;CYP7B1;INSIG2;CYP27A1;ACOT8
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.3038580347360528,-0.935930712483756,0.5925925925925926,0.8937403326819482,1.0,9/38,21.15%,BMP6;PRKCA;CYBA;POLR3G;GRN;SLC15A4;PLSCR1;ADAM8;USP15
prerank,protein K11-linked ubiquitination (GO:0070979),-0.33851093763514106,-0.934901125494075,0.5182291666666666,0.8952390640839337,1.0,9/27,25.44%,UBE2E2;ANAPC5;PRKN;UBE2E3;UBE2B;CDC16;UBE2S;ANAPC4;ANAPC13
prerank,regulation of neuron death (GO:1901214),0.3137589557724364,0.9348468897405073,0.5775623268698061,0.8789263916496628,1.0,16/82,15.67%,CD34;CD200;MEF2C;FYN;GRID2;EGLN2;CD200R1;DDIT4;KIR3DL2;GRIN2B;EPHB1;NSMF;GPR75;TRIM2;BTBD10;DCC
prerank,fatty acid transmembrane transport (GO:1902001),0.3983147191210303,0.9347482524716592,0.5545927209705372,0.8785457296063536,1.0,4/19,6.87%,SLC2A1;ABCD4;CPT1A;ACACB
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.3138886607012084,0.9344472366867846,0.5591240875912409,0.8786389792329844,1.0,9/76,8.61%,DAB2IP;NFKBIA;CD200;NLRC5;TMSB4X;KLF4;AIM2;FOXP3;IRAK2
prerank,negative regulation of immune system process (GO:0002683),-0.36620171596499485,-0.934378147244057,0.5497737556561086,0.895557210112742,1.0,3/16,7.17%,COL3A1;HOXA7;IL17D
prerank,signal peptide processing (GO:0006465),-0.4092750084654298,-0.9336440257908851,0.540084388185654,0.8964543929620669,1.0,3/11,17.15%,PCSK5;HM13;PARL
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.323301217710786,0.9334570981767105,0.5645161290322581,0.8802403392324258,1.0,1/59,0.03%,LEF1
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.3112356289552174,0.9332542322350605,0.5644937586685159,0.880111334572684,1.0,20/87,12.51%,CLDN5;ENG;TGFB2;ID1;F11R;PTK2;ACVRL1;PARD3;PXN;SMAD7;NRROS;TGFB1;JUN;SMURF1;SMAD5;SMAD1;FERMT2;EID2;TGFBR2;GDF15
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.4074908762976129,-0.9332506322140097,0.5496828752642706,0.8964426748844012,1.0,3/12,10.80%,CACNA1C;DLG1;TRPM4
prerank,neuron differentiation (GO:0030182),-0.24202347652688325,-0.9331387993908761,0.6616161616161617,0.8957313812916331,1.0,19/165,8.69%,PBX1;GLI2;WNT4;WNT5B;WNT6;FZD2;TGFBR1;WNT9A;PBX4;NRBP2;RUNX2;FZD7;TDP2;PBX3;HS6ST1;FZD3;VSX1;MET;ATOH8
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.3933398598321025,-0.9328485848529282,0.5575620767494357,0.8954741101527721,1.0,7/13,19.26%,PKD1;SUFU;PKD2;FLNA;MDFI;LATS1;DBN1
prerank,response to ATP (GO:0033198),-0.36279982049143084,-0.9326922042507737,0.5454545454545454,0.8948602243081536,1.0,4/18,12.78%,TRPC3;ABCC9;P2RX4;HSP90B1
prerank,negative regulation of viral life cycle (GO:1903901),0.42526385093659724,0.9324558294227256,0.5163511187607573,0.8812514614646595,1.0,4/15,7.48%,LY6E;SNX3;PPIA;BST2
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.45028943648824876,0.9321271531161144,0.5711645101663586,0.8813692844367298,1.0,1/12,0.22%,PLCB1
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.40073510092394204,-0.9315796960956984,0.5677570093457944,0.8947969722077863,1.0,7/12,31.99%,ANAPC5;CUL3;NSMCE2;CDC16;ANAPC4;DLGAP5;ESPL1
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.40073510092394204,-0.9315796960956984,0.5677570093457944,0.8947969722077863,1.0,7/12,31.99%,ANAPC5;CUL3;NSMCE2;CDC16;ANAPC4;DLGAP5;ESPL1
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.40073510092394204,-0.9315796960956984,0.5677570093457944,0.8947969722077863,1.0,7/12,31.99%,ANAPC5;CUL3;NSMCE2;CDC16;ANAPC4;DLGAP5;ESPL1
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.4135132393097069,0.9307019786791076,0.5504424778761062,0.8839197134127447,1.0,5/17,6.27%,NOTCH4;PLXND1;NOTCH1;MAML2;STAT1
prerank,response to insulin (GO:0032868),0.3112131499672197,0.9305444484290958,0.5938864628820961,0.8836862324693567,1.0,17/80,14.37%,TBC1D4;INSR;RAB31;FOXO1;HDAC9;SORT1;DENND4C;SLC25A33;PKM;SORBS1;ZFP36L1;GSK3A;CEACAM1;PPARG;LPIN3;PDE3B;HDAC5
prerank,negative regulation of hemostasis (GO:1900047),-0.4035188887826334,-0.9300634611221045,0.5566265060240964,0.8975192533814146,1.0,4/12,8.31%,TFPI;VTN;THBD;APOE
prerank,negative regulation of autophagy (GO:0010507),-0.28702888952406824,-0.9299705319887581,0.5658682634730539,0.8967678852154585,1.0,19/54,21.09%,LEPR;NUPR1;KLHL22;NRBP2;SNRNP70;DAPL1;GOLGA2;BCL2;MET;PTPN22;LRRK2;SIRT2;RRAGA;SMG1;CTSA;SMCR8;TSC1;EIF4G1;TAB3
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.27154340000032823,-0.9296151991963856,0.6336336336336337,0.896654251978878,1.0,10/66,6.41%,EGFR;APPL2;KANK2;FHL1;UBE2E2;PKD1;PKD2;DLG1;ANXA1;DACT1
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.34710993265072,0.9295849241907925,0.5483359746434231,0.8851938736694768,1.0,12/43,15.10%,DAB2IP;ITGA1;PTPRJ;DUSP3;GRB2;TGFA;ARHGEF7;SOCS5;EPS15;HGS;SH3KBP1;VPS25
prerank,meiosis I (GO:0007127),-0.34005326387939533,-0.9293135513629319,0.5252525252525253,0.8964360561744047,1.0,10/23,29.86%,FOXJ2;ZSCAN21;FOXJ3;HSF2BP;ZCWPW1;MYBL1;SGO1;TDRD9;DDX4;MEIOB
prerank,DNA conformation change (GO:0071103),-0.36481001562270665,-0.929211449473218,0.5532786885245902,0.8957121216073327,1.0,4/17,12.26%,TOP2B;TOP1;HAT1;ABL1
prerank,negative regulation of chemokine production (GO:0032682),0.41970686272941715,0.9283257320643368,0.5437262357414449,0.8874047489713156,1.0,3/14,6.62%,SIGIRR;LGALS9;KLF4
prerank,immunoglobulin mediated immune response (GO:0016064),0.45724722405912954,0.9282802927273998,0.5598526703499079,0.8869113181855902,1.0,2/10,11.18%,CD19;TLR8
prerank,regulation of spindle organization (GO:0090224),-0.36066391338064285,-0.9282390874900516,0.5711252653927813,0.8971245638005235,1.0,9/18,37.41%,PARP3;GPSM2;SENP6;RAE1;TPX2;NUMA1;PSRC1;TACC3;NUP62
prerank,negative regulation of RNA splicing (GO:0033119),-0.3505576671882853,-0.9281524498108191,0.5666666666666667,0.8963788498279283,1.0,8/19,20.67%,SRSF6;SRSF4;PCBP4;SAP18;C1QBP;U2AF2;PTBP2;SRSF10
prerank,regulation of mitotic nuclear division (GO:0007088),0.33686230362309466,0.9280410254380661,0.5771513353115727,0.8868472616119248,1.0,9/55,8.89%,PDGFB;INSR;RGCC;LCMT1;PIN1;LRP5;TGFA;CDK5RAP2;CAV2
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.3577422210739651,0.9280359104977413,0.5768595041322314,0.8862678208348003,1.0,8/33,20.57%,HSP90AB1;MRE11;TERF2;ACD;TERF1;NHP2;RPA1;PINX1
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.3704418293331555,0.9276790046547871,0.564935064935065,0.8864115542563931,1.0,10/29,25.89%,PLA2G4B;NR1H2;LPCAT3;PNPLA8;MBOAT7;LPCAT2;MBOAT2;LPCAT4;TMEM86B;LPCAT1
prerank,cellular respiration (GO:0045333),-0.29733824768647665,-0.9270487416980857,0.5676392572944297,0.8981661269021273,1.0,16/41,23.74%,PPARGC1A;SIRT3;SDHC;MDH2;SDHB;COQ10A;UQCRFS1;MTFR1;NDUFS1;SLC25A14;SURF1;MTFR2;UQCRC2;COQ10B;NR4A3;LYRM7
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.3439223720725888,-0.9269349065542117,0.5421686746987951,0.8974929068829608,1.0,6/21,16.26%,DAG1;ADAM9;BACE2;ADAM19;PSEN1;HM13
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.37059570359327004,0.926872093760864,0.5417348608837971,0.8876688673312119,1.0,15/28,30.76%,STMN1;MAPRE2;STMN3;STMN4;MAPRE3;CAMSAP2;CLASP1;CAMSAP1;GAS2L1;CLASP2;ARL2;PRUNE1;STMN2;SKA3;FKBP4
prerank,anterior/posterior axis specification (GO:0009948),-0.38378907648295746,-0.9262387702341198,0.540084388185654,0.8982413167825303,1.0,1/15,0.24%,WLS
prerank,positive regulation of organelle organization (GO:0010638),-0.31605680772027583,-0.9261522030941898,0.5684210526315789,0.8974536888266644,1.0,11/32,19.65%,ANXA2;PPARGC1A;ANXA1;STX18;HTRA2;LMAN1;SURF4;RAB3GAP2;C2CD5;SMCR8;ATL3
prerank,respiratory chain complex IV assembly (GO:0008535),0.39346718827651095,0.9257575626700666,0.5476575121163166,0.8895237684442198,1.0,14/21,30.55%,SCO2;SCO1;COA6;COA3;SMIM20;COX10;COX20;COX17;COX15;PET100;TIMM21;COA5;BCS1L;COA8
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.4109053462102434,0.9256666330029842,0.5520446096654275,0.8891326334094849,1.0,7/15,23.47%,HOMER2;HOMER1;GRM7;GRM8;GRM2;GRM3;GRIK3
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.3893504432683287,-0.9256307489025797,0.5480984340044742,0.8976938806720965,1.0,5/13,20.81%,SAR1A;SEC16B;SEC16A;CD81;EDEM2
prerank,negative regulation of cellular senescence (GO:2000773),0.4318846631959528,0.9253885348672979,0.5709090909090909,0.8891310599539997,1.0,7/13,21.83%,YBX1;TERF2;MAP3K3;RBL1;HMGA2;CDK6;AKT3
prerank,regulation of mast cell activation (GO:0033003),0.4594132651247248,0.9253336145559734,0.5559772296015181,0.8886621406420421,1.0,3/10,16.79%,LYN;MILR1;CRLF2
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.3668212450602621,-0.9248446377142215,0.5698447893569845,0.8986503824896409,1.0,6/17,17.48%,WNT4;BMP4;TGFB3;CREB3L1;LARP6;SUCO
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.30772958711163245,0.9247716994606745,0.573049645390071,0.8893194718629178,1.0,28/85,24.93%,RNF144B;DAB2IP;SMAD7;ATXN3;FBXW7;PSMC6;SOCS5;HECTD1;TRIB2;GSK3A;RBX1;BAG2;ELOB;RAD23A;BAG6;SUMO1;RNF19A;CBFA2T3;GABARAP;CSNK1A1;RACK1;PSMC3;PABIR1;ZYG11B;PSMD10;ANKIB1;KEAP1;OSBPL7
prerank,protein K63-linked deubiquitination (GO:0070536),0.36060074983188084,0.9246699975510531,0.5805369127516778,0.8889383094189612,1.0,10/31,19.50%,ATXN3;SHMT2;OTUD7A;BABAM1;TNFAIP3;CYLD;USP25;BRCC3;OTUD7B;OTUD4
prerank,striated muscle tissue development (GO:0014706),0.3653101548877895,0.9246522174061695,0.5467741935483871,0.8883846085424206,1.0,4/29,2.77%,BMPR2;PGM5;CAV1;MEF2C
prerank,regulation of water loss via skin (GO:0033561),0.4197765125991232,0.9245482916780431,0.5444839857651246,0.8874205052694509,1.0,6/15,24.43%,STMN1;LSR;FA2H;HRNR;TMEM79;SFN
prerank,establishment of skin barrier (GO:0061436),0.4197765125991232,0.9245482916780431,0.5444839857651246,0.8874205052694509,1.0,6/15,24.43%,STMN1;LSR;FA2H;HRNR;TMEM79;SFN
prerank,regulation of muscle cell differentiation (GO:0051147),0.3648182148408459,0.9244042780778319,0.5784313725490197,0.8871556289020816,1.0,6/31,7.33%,MEF2C;CDH2;HDAC9;CTNNB1;TCF23;SPAG9
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.34869162459702363,-0.924284299593944,0.5696821515892421,0.8990736304576386,1.0,2/21,2.75%,SAMD4A;TUT4
prerank,regulation of nervous system process (GO:0031644),0.3915213868973363,0.9239509046466288,0.5441941074523396,0.8875457193018519,1.0,2/18,1.56%,NOS3;APP
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.2956134333518059,-0.9233778070611703,0.569060773480663,0.9003841682759417,1.0,9/44,11.02%,GSN;FCHSD2;CARMIL1;CDC42EP4;CDC42EP5;SNX9;PFN2;LMOD1;PTK2B
prerank,pinocytosis (GO:0006907),-0.42991775167462226,-0.9233750328836643,0.5735294117647058,0.8994044153290274,1.0,7/10,29.77%,CARMIL1;MAPKAPK3;SNX5;SNX33;PYCARD;AHSG;MAPKAPK2
prerank,negative regulation of coagulation (GO:0050819),-0.38442724261133077,-0.9231772530560527,0.5518867924528302,0.8988635467033474,1.0,4/14,8.31%,TFPI;VTN;THBD;APOE
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.4102293895049911,0.9230484152985532,0.5622775800711743,0.8888865813570256,1.0,5/15,18.44%,CCT3;CCT5;NHP2;CCT7;NAF1
prerank,"DNA-templated transcription, initiation (GO:0006352)",-0.23257056224094463,-0.922718420921947,0.6859903381642513,0.8990378523134502,1.0,18/166,6.34%,NOTCH2;RARB;CCN2;TEAD1;NR6A1;THRB;NOTCH3;NR1D2;PPARGC1A;RBPJ;TBL1XR1;AR;PPARA;MED23;NR3C2;RORA;POLR2A;TEAD3
prerank,regulation of T cell activation (GO:0050863),0.3358916170433529,0.9225787744052154,0.5728,0.8893005897368221,1.0,6/42,12.59%,JAK3;DUSP3;CD4;CCDC88B;TNFSF11;CYRIB
prerank,regulation of lipid kinase activity (GO:0043550),0.4430512664447046,0.9225048609076384,0.5561904761904762,0.8888669631200726,1.0,2/11,6.45%,PIK3R3;PPP2R5A
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.2969480088283066,-0.9223236775709701,0.5614525139664804,0.8990661586223901,1.0,4/41,9.15%,PRKAG2;OGT;SEH1L;NUP205
prerank,mitochondrial transport (GO:0006839),0.32041742610504537,0.9223191000704537,0.5811023622047244,0.8886988283611176,1.0,18/53,29.26%,BCL2L1;TOMM22;SLC25A5;TIMM13;TIMM10;DNAJC19;MFF;TOMM7;BAK1;TOMM5;BNIP3;PMAIP1;TOMM70;STARD3;BCAP31;TIMM9;BCS1L;FIS1
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.385156951471155,0.9222606503885511,0.5606326889279437,0.888237281472523,1.0,8/22,14.35%,LYN;ABCG1;EPHA4;EFNA1;AGER;GSK3A;RANBP9;SP1
prerank,sphingolipid catabolic process (GO:0030149),0.4195166576842395,0.9221246729205356,0.5741710296684118,0.8879690627115329,1.0,3/15,8.73%,ACER2;ACER1;ENPP2
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.3891198938641084,-0.9213977003018794,0.5788288288288288,0.900354717376779,1.0,3/13,10.21%,RNF152;ATM;STK11
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.43173815516287584,0.9210774963924053,0.5473098330241187,0.8896458855147812,1.0,2/12,4.04%,TRIM16;KLF2
prerank,negative regulation of phosphate metabolic process (GO:0045936),-0.3435005642197836,-0.9208672784495447,0.5714285714285714,0.900651988266645,1.0,2/22,1.84%,BMP7;BMP4
prerank,protein kinase B signaling (GO:0043491),0.380688114515802,0.920829318232301,0.5707236842105263,0.8895950356035381,1.0,4/23,10.93%,KDR;PIK3R3;TGFB1;ZFP36L1
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.3558997774962324,0.9207898220394247,0.5711864406779661,0.8890952470157308,1.0,7/34,10.94%,LIMS2;DOCK1;NEDD9;RREB1;ARHGEF7;RAC1;FERMT2
prerank,neuron projection morphogenesis (GO:0048812),0.2903917610372478,0.9207602463864596,0.6193548387096774,0.8885599535705039,1.0,41/137,18.79%,SHANK3;SRGAP2;DAB2IP;APP;KLF7;NTNG2;PARD3;DSCAML1;ACTB;WNT7A;CTNNB1;BAIAP2;DIP2A;DBNL;NCKAP1;SLITRK3;DNM2;SLITRK1;GPM6A;IQGAP1;PAK1;SLC9A6;EIF2AK4;LRP2;MAP4K4;EPHB1;CNTNAP2;MINK1;SGK1;NCKAP1L;DCC;PLPPR4;NLGN1;NRCAM;ANK3;SLITRK6;CPNE1;DICER1;CTNNA2;TRIO;RAB8A
prerank,"phototransduction, visible light (GO:0007603)",0.416896207672935,0.9207598400012678,0.5431654676258992,0.8879745015029693,1.0,3/14,12.29%,GNAQ;RP1;GNB1
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.41629731986627316,0.9207037940123932,0.5267175572519084,0.887506867010967,1.0,7/14,24.46%,PRKD2;BCL10;CARD11;TESPA1;KCNN4;TRAT1;NECTIN2
prerank,positive regulation of cyclase activity (GO:0031281),-0.3871572299090309,-0.9205053947781622,0.5563063063063063,0.9005767435346297,1.0,5/14,13.88%,CACNA1C;STIM1;CACNA1D;NF1;MAPK14
prerank,glutamine family amino acid metabolic process (GO:0009064),0.36101983516812813,0.920485221272473,0.5770392749244713,0.8874148165990726,1.0,3/33,3.74%,SLC39A8;DDAH1;GCLM
prerank,female gonad development (GO:0008585),-0.35390769936268185,-0.9204054715369778,0.6041189931350115,0.8998455077404363,1.0,5/19,18.13%,NR2F2;KIT;CEBPB;INHA;INHBB
prerank,regulation of monocyte differentiation (GO:0045655),0.41983449427488684,0.9202148172927194,0.570902394106814,0.8874304276685047,1.0,3/14,5.23%,FES;CTNNBIP1;CD4
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.3605488329750823,-0.9200677070242083,0.5568181818181818,0.8997142116336859,1.0,2/18,2.08%,ROCK2;SLC2A13
prerank,oxoacid metabolic process (GO:0043436),-0.3207534890011231,-0.9199164224066119,0.6076555023923444,0.8991090442618576,1.0,2/27,1.74%,DDO;ENPP1
prerank,regulation of protein targeting to mitochondrion (GO:1903214),-0.305385088263094,-0.9197473425077933,0.5606469002695418,0.8985505439767965,1.0,11/38,17.65%,PRKN;NPEPPS;RNF31;HUWE1;LRRK2;HTRA2;ATP5IF1;LMAN1;SREBF1;PARL;ABLIM3
prerank,regulation of protein ubiquitination (GO:0031396),0.2956022881951795,0.9194884184778821,0.6010709504685409,0.8884459521076008,1.0,29/108,20.57%,IVNS1ABP;CAV1;SMAD7;XIAP;HSP90AB1;FAM107A;FBXW7;N4BP1;BIRC3;MALT1;NDFIP2;UBXN1;UBQLN1;GSK3A;TNFAIP3;DCUN1D1;BCL10;DNAJA1;INAVA;BAG2;SIRT7;FOXF2;PTTG1IP;PRKCG;UBE2D1;FKBP1A;NSMCE3;PRR7;PINX1
prerank,GTP metabolic process (GO:0046039),0.4099597374987045,0.9194362388917607,0.5783582089552238,0.8879692313562556,1.0,3/15,9.16%,IMPDH1;AK4;GTPBP1
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.3293232153519769,-0.9194212353796164,0.577023498694517,0.8983810273515118,1.0,2/25,1.56%,ANK2;CEMIP
prerank,mitotic cytokinesis (GO:0000281),0.3363172934506532,0.9192797428801679,0.5790273556231003,0.887733125814687,1.0,13/47,16.70%,SPTBN1;EFHC2;STMN1;RHOB;TRIM36;KIF23;MITD1;ANLN;APC;PDCD6IP;SPAST;ANK3;MYH10
prerank,long-chain fatty acid transport (GO:0015909),0.3569131768535064,0.918912094238613,0.5785123966942148,0.8879356884523466,1.0,9/30,12.29%,MFSD2A;ABCD4;CPT1A;ACACB;ACSL3;FABP5;ABCD1;SLC27A2;PPARG
prerank,negative regulation of bone mineralization (GO:0030502),-0.3849247364700504,-0.918135837307092,0.5736607142857143,0.9006434073729856,1.0,5/13,11.02%,ENPP1;BCOR;ECM1;TRPM4;PTK2B
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.3426217008251796,-0.9181105338312887,0.5861182519280206,0.899727556526882,1.0,9/21,28.89%,MITF;MED14;TWIST1;MED30;BCLAF1;MED4;MED24;MED16;DHX36
prerank,central nervous system myelination (GO:0022010),0.44034593800184013,0.917857672280779,0.5404411764705882,0.8896379439416446,1.0,2/11,12.28%,B4GALT5;SOX10
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.40519723788162976,0.9174792626813965,0.5699115044247788,0.8898935484350653,1.0,7/16,28.37%,SNRPC;NCBP2;DCPS;WBP11;SRSF12;SRSF1;SFSWAP
prerank,cell projection assembly (GO:0030031),0.3793203370300687,0.9172297804948254,0.5668276972624798,0.8898722244938159,1.0,8/22,15.04%,PARVB;PARVG;NCKAP1;CAPG;CYFIP1;RAC1;RHOV;NCKAP1L
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.2997111753771916,-0.9172201054692588,0.6113861386138614,0.9009710885592211,1.0,8/39,12.95%,ANK2;FHL1;PTPN3;CACNA1D;TRPC6;WWP2;GPD1L;FXYD1
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.38762276421017366,0.9171436545260107,0.5803722504230119,0.8894808283587325,1.0,6/23,12.39%,ENG;LTBP4;SMAD7;TGFB1;EID2;SOX11
prerank,activation of protein kinase B activity (GO:0032148),0.36437599333740056,0.9167734967383724,0.5960912052117264,0.8897274016038911,1.0,5/29,6.42%,PDGFB;INSR;CCDC88A;PPIA;ADRA2B
prerank,negative regulation of interleukin-17 production (GO:0032700),0.4472564838274969,0.9166820622537839,0.5872727272727273,0.8893472294859253,1.0,3/10,15.04%,FOXP3;VSIR;NCKAP1L
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.34245402938900377,0.9166506793553074,0.5709923664122137,0.8888282928677627,1.0,14/40,21.92%,PTK2;GNA12;FBXW7;RPS7;SMURF1;HIPK2;RPL11;TRIM39;RNF139;RAD23A;FOXF2;RPL23;DESI1;RAD23B
prerank,chemical homeostasis (GO:0048878),-0.27251653448168733,-0.9163678884886391,0.6194690265486725,0.9020335819572524,1.0,14/61,15.27%,ZBTB20;SLC4A10;RBP1;NR1D2;WNK4;THADA;IRS2;SLC4A7;SLC4A2;TLCD2;WNK1;DDX3X;SLC4A3;PNPLA3
prerank,AMP metabolic process (GO:0046033),0.4171510076173166,0.916229142542525,0.5804701627486437,0.8891477079982675,1.0,3/13,7.32%,XDH;AK4;ADSS2
prerank,positive regulation of cilium assembly (GO:0045724),0.4070914385541281,0.9161353923536596,0.5747747747747748,0.8887693210168212,1.0,6/18,18.22%,ZMYND10;CCDC88A;CCP110;MARK4;CEP135;KCTD17
prerank,response to growth factor (GO:0070848),0.344185496495779,0.9159028081482338,0.5909090909090909,0.8887011744489905,1.0,8/41,12.41%,PDGFB;BMPR2;ACVRL1;CTNNB1;KLF4;TWF2;LRP2;TGFBR2
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.26443334126490187,0.9158683430187965,0.6799091940976163,0.8881959177179849,1.0,108/306,27.39%,B4GALT5;ALAS1;SARS1;PTMA;ZAR1L;RPL38;TAF1B;MRPL13;RPL13;MRE11;RPS29;FUT9;MRPL10;NKX2-8;RPL36A;RPL3;RNPS1;YARS2;RPSA;RPL27;DNA2;RPS7;RPL9;RPLP2;PWP1;RPL18;GTPBP1;MCM10;RPL13A;CDC6;RPS11;RECQL4;RPL8;RPS27;RPL19;RPS9;MRPL28;POLE3;EEFSEC;RPL11;ORC1;RPS15;RPL37;SRBD1;RPS28;RPS10;RPS25;EEF1D;RPL37A;MRPL9;COPS5;HUS1;RPA1;POLR2J;RPL15;TNIP1;SET;FARSB;MRPL23;RPL17;RPL23;RPL34;GRWD1;RPS18;RAD9B;POLL;POLD1;MRPS18A;POLA1;RPL21;RFC2;RPS4X;RAD1;DHPS;RPS21;RPL18A;GTPBP2;RPL10A;ING4;EEF1B2;RAD17;RSL24D1;RPL24;ING5;RMI1;MRPL27;MRPL41;TYMS;RPL7A;TOPBP1;MRPL51;HARS1;RFC4;RPL4;MRPS33;RPS2;RPL32;BLM;RPL6;UPF1;MRPL37;MEF2A;RPS20;RPL14;EXT2;RPS13;MRPS18C;ST3GAL2
prerank,cellular response to calcium ion (GO:0071277),0.3223774218409574,0.9156736592960709,0.5977175463623395,0.8880297460279278,1.0,29/67,27.57%,ITPKB;MEF2C;MCOLN1;ACER1;CPNE8;SYT7;RASGRP2;IQGAP1;CLIC4;CPNE5;SYT4;CPNE6;NLGN1;CPNE3;CRHBP;NEUROD2;CPNE1;PLCG2;PRKAA1;LGMN;HPCA;SYT17;SMPD1;CPNE4;CPNE7;MEF2A;SYT15;TRPM2;ADD1
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.3404974711774954,-0.9154664626642621,0.5802752293577982,0.9032468169501976,1.0,4/22,10.91%,ROCK2;PPP4R4;PTPA;CRY2
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.43584082305744587,0.9152208215226098,0.5652173913043478,0.8884028071510274,1.0,2/12,5.15%,GCLM;MGST2
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.42506945258991163,0.9152017435300916,0.5418994413407822,0.8878657242509114,1.0,3/11,11.69%,FOXO1;NOTCH1;GSK3A
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.3795192695298656,-0.9151360271064396,0.5911330049261084,0.9030869675546621,1.0,7/14,26.21%,IL18;ANXA1;RARA;PRKCZ;CD80;CCL19;CD86
prerank,cation transport (GO:0006812),0.28151681257385364,0.9142238360346927,0.6505576208178439,0.8893730915530453,1.0,17/167,9.69%,SLC6A6;SLC7A1;SLC1A1;SLC38A5;NEDD4L;FGF13;PIEZO1;MCOLN1;KCNG2;ATP1A4;KCNK6;CHRNB1;SCN1A;KCNN2;SLC3A2;NDFIP2;KCNV1
prerank,T cell activation (GO:0042110),0.31110592352734984,0.9134288924102961,0.5962910128388017,0.8905284266761179,1.0,14/69,12.18%,JAG2;ZAP70;DLL4;CCR7;CD4;MSN;FOXP3;CD8B;EIF2AK4;CASP8;PPP3CA;TNFRSF4;GPR89A;GPR89B
prerank,mitotic DNA replication (GO:1902969),-0.4079354141172491,-0.9132849611662888,0.5582417582417583,0.9065419145986289,1.0,6/10,33.64%,CDC45;MCM3;LIG1;MCM4;GINS1;GINS3
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.3074573514568536,0.9132552785451618,0.6065340909090909,0.8903336084559212,1.0,13/78,12.53%,PDGFB;CCNY;RGCC;MEN1;ACTB;HHEX;CDKN2B;CCNI;CCND3;ADAM17;CDC6;CCNK;MAPRE3
prerank,cellular response to superoxide (GO:0071451),0.4554180137038821,0.9129619198481176,0.5491329479768786,0.8904063600130625,1.0,1/10,1.37%,NOS3
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.284083726243219,0.9128392477402822,0.6420525657071339,0.8900611941333261,1.0,34/161,15.07%,DAB2IP;FZD6;CAV1;ANKRD6;MCC;SOX17;NKD1;FZD4;SOX13;ZNRF3;CTNND1;NOTUM;WWTR1;SNAI2;PSMB3;PSMD11;TLE4;TMEM88;PSMC6;GREM1;PSME2;AXIN2;AMER2;TLE1;PSMD8;GSK3A;SHISA6;CYLD;STK3;PSMB10;SOX9;RBX1;TPBG;TMEM131L
prerank,antibacterial humoral response (GO:0019731),0.4003369029267215,0.9128230436847811,0.5849731663685152,0.8895067131600712,1.0,4/16,22.11%,DEFA6;SLPI;JCHAIN;RNASE6
prerank,negative regulation of bone remodeling (GO:0046851),0.43851382419960877,0.9125589244121644,0.568738229755179,0.8894996882273521,1.0,3/11,12.24%,P2RX7;GREM1;TNFAIP3
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.32622993833028274,-0.912353795969845,0.595,0.9078634449228475,1.0,6/27,10.91%,PER3;FBXL17;PER2;USP2;PML;CRY2
prerank,renal absorption (GO:0070293),-0.41902609758447024,-0.9123229730282746,0.5769230769230769,0.9069644711160821,1.0,2/10,3.62%,GSN;WNK4
prerank,regulation of neuron apoptotic process (GO:0043523),-0.2538362542937757,-0.9107084586539979,0.6872586872586872,0.9098589904581286,1.0,20/96,11.12%,EPHA7;NUPR1;SLC30A10;SNX6;PPARGC1A;PRKCI;NGF;SIX1;NRBP2;EGLN3;NFATC4;PRKN;SOD2;BCL2;APOE;KDM2B;FOXO3;TGFB3;PTK2B;CLN3
prerank,embryonic appendage morphogenesis (GO:0035113),0.4305828238954689,0.9102681414714532,0.5862708719851577,0.8938532364078874,1.0,1/12,1.29%,TGFB2
prerank,photoperiodism (GO:0009648),-0.31820987226696984,-0.9098581643404128,0.6077481840193705,0.9109353210985266,1.0,6/28,10.91%,PER3;FBXL17;PER2;USP2;PML;CRY2
prerank,peptidyl-serine modification (GO:0018209),0.2805267967233752,0.9096261510359518,0.6361323155216285,0.8946591734270682,1.0,33/166,18.21%,PRKCH;NDNF;PDGFB;STK38;PKN3;RPS6KA1;PRKD2;PRKD1;IKBKB;MAST4;PKN1;RPS6KA5;PKN2;MARK3;HPF1;STK32C;PRKCB;TGFBR2;HIPK2;NAA11;SGK1;HIPK3;VRK1;PLK2;SGK3;SGK2;MAPK1;GAS6;POGLUT1;PAK2;PRKCG;TBK1;PRKCE
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.3280515569084256,-0.9093576416153566,0.5897435897435898,0.911211464436093,1.0,5/25,13.49%,UGGT2;FBXL17;CUL3;KLHL15;AUP1
prerank,miRNA mediated inhibition of translation (GO:0035278),0.43758828095746233,0.9092586764204751,0.577490774907749,0.8942452396895149,1.0,1/11,1.39%,NOTCH4
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.43758828095746233,0.9092586764204751,0.577490774907749,0.8942452396895149,1.0,1/11,1.39%,NOTCH4
prerank,response to endoplasmic reticulum stress (GO:0034976),-0.2532804189356259,-0.9089239066504137,0.6923076923076923,0.9112729505204877,1.0,24/107,14.94%,ITPR1;THBS1;CREB3L2;MAP3K5;ATG10;TMEM117;RCN3;PRKN;TMEM259;BCL2;SELENOS;CEBPB;CREB3L1;GORASP2;HSP90B1;SCAMP5;SYVN1;SEC16A;P4HB;RASGRF1;UFC1;DDRGK1;PIK3R1;ATP2A3
prerank,regulation of execution phase of apoptosis (GO:1900117),0.42362764590316154,0.9086406595117023,0.5540540540540541,0.8949877912871098,1.0,1/11,0.99%,BCL2L1
prerank,melanosome organization (GO:0032438),-0.33189906073761744,-0.9085701782380393,0.553475935828877,0.911134996666593,1.0,15/26,36.30%,DTNBP1;AP3B1;RAB29;BLOC1S2;LYST;BLOC1S5;BLOC1S6;HPS4;KIF13A;HPS1;BLOC1S4;RAB38;AP1M1;PMEL;GPR143
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.36463211388269806,0.9084775963765442,0.5811258278145696,0.8947736789375631,1.0,8/28,13.47%,EGFL7;GATA2;DLL4;FBXW7;RITA1;DLK2;ZBTB7A;ARRDC1
prerank,cellular response to chemical stress (GO:0062197),-0.25070747060420806,-0.9074678097722533,0.657258064516129,0.9128306934647794,1.0,22/96,14.53%,PRKAA2;MGAT3;CPEB2;PPARGC1A;PKD2;STX2;SOD3;SOD2;GPX8;NOX4;SELENOS;ATM;SLC25A24;FOXO3;CYBA;PARP1;TMEM161A;LRRK2;ABL1;HTRA2;SIRT2;DDX3X
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.31272516894765573,-0.9073454037372904,0.6174142480211082,0.9112030220786062,1.0,8/29,18.57%,CENPC;CENPP;CENPK;SMARCA5;MIS18BP1;CENPL;RBBP4;CENPQ
prerank,CENP-A containing chromatin organization (GO:0061641),-0.31272516894765573,-0.9073454037372904,0.6174142480211082,0.9112030220786062,1.0,8/29,18.57%,CENPC;CENPP;CENPK;SMARCA5;MIS18BP1;CENPL;RBBP4;CENPQ
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.3091538671725874,-0.9071663369300934,0.6019900497512438,0.9106512224404653,1.0,12/33,23.05%,DDX5;AR;KLK2;AXIN1;ESR1;KDM1A;EP300;DDRGK1;LATS1;RNF14;SAFB2;RUNX1
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.3049057952468303,0.9071303318877829,0.6085753803596127,0.8971497055893446,1.0,25/76,24.69%,RNF144B;PTK2;SMAD7;FBXW7;SOCS5;SMURF1;HECTD1;TRIB2;GSK3A;RBX1;BAG2;RNF139;ELOB;RAD23A;SUMO1;RNF19A;CBFA2T3;GABARAP;CSNK1A1;RACK1;PABIR1;ZYG11B;PSMD10;ANKIB1;KEAP1
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.36533673368451625,0.9067179850006248,0.5859247135842881,0.897430018275304,1.0,2/26,1.98%,ST8SIA6;B4GALT5
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.327813387070948,0.9060930556546509,0.5766871165644172,0.8982254461667839,1.0,6/50,6.62%,SH3RF1;PLAUR;RPS6KA1;XIAP;RFFL;KLF4
prerank,positive regulation of cell communication (GO:0010647),-0.3187576930332061,-0.9058091985548131,0.6028708133971292,0.9129381258826473,1.0,3/28,7.18%,WLS;CLSTN2;DLG4
prerank,intracellular sterol transport (GO:0032366),0.4149637324466368,0.9057936255995647,0.5780141843971631,0.8983049159714306,1.0,4/13,14.94%,OSBP;ABCG1;NPC1;STARD4
prerank,presynaptic endocytosis (GO:0140238),0.38049154728699386,0.9057481998147769,0.5782537067545305,0.8978303210619613,1.0,7/24,16.18%,STX1A;PIP5K1C;FCHO2;OPHN1;AMPH;NLGN1;SYNJ1
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.29686003096608243,0.9056561232160889,0.5912921348314607,0.8974437134025223,1.0,7/86,2.61%,PECAM1;PDGFB;APP;IL6R;LRP8;PTPRJ;ARHGEF2
prerank,icosanoid biosynthetic process (GO:0046456),0.43919843395817226,0.9055024651162501,0.5813084112149532,0.8972009653684772,1.0,2/10,13.67%,MGST2;LTA4H
prerank,regulation of intracellular pH (GO:0051453),-0.30989103414717845,-0.9054488110120097,0.5837696335078534,0.9128735551347946,1.0,8/34,11.89%,SLC4A10;SLC9A2;SLC4A7;SLC4A2;SLC9A9;CLN3;SLC9A1;LRRK2
prerank,proteasome assembly (GO:0043248),0.4405489055515006,0.9052817548555299,0.5765765765765766,0.8970816117648884,1.0,5/11,27.74%,POMP;PSMD11;PSMD9;PSMD10;ADRM1
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.4231304283189823,-0.9052739682177215,0.6247334754797441,0.9123011314528857,1.0,5/10,30.33%,GALNT16;POGLUT2;GALNT1;GALNT3;MGAT5B
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.3249310903102022,-0.9046390116094675,0.6059850374064838,0.9128570175673771,1.0,5/26,6.43%,ERRFI1;SHC1;SNX6;CBLB;TSG101
prerank,regulation of microtubule depolymerization (GO:0031114),0.36710725085389784,0.9044449849707407,0.5784148397976391,0.8983030883313082,1.0,10/25,25.70%,ARHGEF2;FGF13;ATXN7;APC;CAMSAP2;TRPV4;CLASP1;NAV3;CAMSAP1;CLASP2
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.2919849696013173,0.9042386685557382,0.6463576158940397,0.8981331006935833,1.0,32/100,23.32%,RNF144B;RYBP;SMAD7;GNA12;HSP90AB1;N4BP1;SOCS5;HECTD1;UBXN1;TRIB2;GSK3A;SDCBP;RPL11;TRIM39;RBX1;BAG2;ELOB;RAD23A;BAG6;FOXF2;SUMO1;RNF19A;CBFA2T3;DESI1;EIF3H;GABARAP;RAD23B;CSNK1A1;RACK1;PABIR1;ZYG11B;PSMD10
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.4133456573180648,0.9042063324361327,0.580110497237569,0.8976324908959904,1.0,7/14,20.61%,CHKA;SELENOI;CEPT1;LPIN3;ETNPPL;ETNK1;PISD
prerank,positive regulation of neuron death (GO:1901216),-0.2841883272683898,-0.9037290418913302,0.638728323699422,0.9141171024013224,1.0,10/46,17.50%,EPHA7;EFNB2;NUPR1;MAP3K5;FOXO3;NF1;TLR4;SARM1;GRN;DDIT3
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.37831601779996893,-0.9037029157235685,0.5934065934065934,0.9132134062749071,1.0,4/14,14.45%,CD55;IL18;PTPN22;CD81
prerank,neurotransmitter transport (GO:0006836),0.3094264598735186,0.903686344687326,0.6244604316546762,0.8981737734021055,1.0,9/73,10.78%,SLC1A1;SLC6A2;UNC13B;STX1A;SLC1A2;STXBP1;NRXN1;DNAJC5;HSPA8
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.3467904832514021,0.9036688072922585,0.6054313099041534,0.897643917324427,1.0,4/36,6.74%,DAB2IP;RYBP;MAX;PHC1
prerank,sterol biosynthetic process (GO:0016126),-0.30699672998733896,-0.9036072637585583,0.607940446650124,0.9124839891934436,1.0,2/33,3.02%,PRKAG2;INSIG2
prerank,programmed necrotic cell death (GO:0097300),0.38948176938398466,0.9035620482926556,0.59245960502693,0.8973100075944624,1.0,5/18,23.18%,TLR3;IPMK;CYLD;TICAM2;RIPK1
prerank,regulation of protein targeting to membrane (GO:0090313),-0.31194423061791543,-0.9035124841645006,0.615979381443299,0.9117632778779143,1.0,7/28,17.35%,CEMIP;MIEF1;ITGB1BP1;DMTN;MIEF2;KCNB1;C2CD5
prerank,positive regulation of heart contraction (GO:0045823),-0.3493595387726755,-0.9033503483674101,0.6107226107226107,0.9112068813154928,1.0,1/19,0.02%,ATP1A2
prerank,negative regulation of fatty acid metabolic process (GO:0045922),-0.3620196310283783,-0.9027614536967571,0.576837416481069,0.9116785926614502,1.0,1/16,1.30%,APPL2
prerank,cell differentiation in hindbrain (GO:0021533),0.4378842398270277,0.9027139550750185,0.5923217550274223,0.8985499947267287,1.0,4/11,17.86%,GRID2;OPHN1;LHX1;PROX1
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.30307158930067135,-0.9022912337356936,0.6186666666666667,0.9118642401678403,1.0,7/33,12.26%,MAP3K5;IMPACT;PRKCD;ANXA1;CYP1B1;FXN;ABL1
prerank,defense response to Gram-negative bacterium (GO:0050829),0.3347903986858456,0.902125005074658,0.5925324675324676,0.8992849760585159,1.0,4/42,8.01%,IL6R;DEFA6;NOS2;IRGM
prerank,regulation of vasoconstriction (GO:0019229),0.3659367730396187,0.9020121261855756,0.5882352941176471,0.8989707305693247,1.0,4/27,6.22%,BMPR2;CAV1;OXTR;ATP2B1
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.3703902178389264,0.9019053379024583,0.5918367346938775,0.8985986488327066,1.0,4/24,6.78%,TGFB2;CTNNB1;FBXW7;MCL1
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.40952606277152903,-0.9018999904608781,0.5838926174496645,0.9118759783748689,1.0,2/10,3.01%,LRP1;APOD
prerank,mammary gland epithelium development (GO:0061180),-0.3749233829846213,-0.9017841823566147,0.6083150984682714,0.9111749579903509,1.0,1/14,1.34%,WNT4
prerank,cellular response to purine-containing compound (GO:0071415),-0.4126901561879241,-0.9017535303856506,0.5915789473684211,0.9102879799569779,1.0,5/10,33.09%,SLC8A1;GSTM2;RYR3;P2RY1;CASQ2
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.30238450780803666,-0.9016301145210894,0.5989010989010989,0.9096531606799311,1.0,10/37,14.07%,PRKAG2;CEMIP;BMP7;AXIN1;SPRED1;PPEF2;SPHK1;DMTN;S1PR2;SIRT2
prerank,atrial septum development (GO:0003283),0.4104599699869853,0.9016292237685786,0.5788497217068646,0.8985736544436893,1.0,3/13,3.22%,BMPR2;TGFB2;ZFPM1
prerank,B cell activation involved in immune response (GO:0002312),0.4213111470184089,0.9015708927366008,0.5721830985915493,0.8981389666937899,1.0,3/13,16.03%,CD19;RNF8;MSH2
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.4081625843655709,0.9015141764759736,0.5863309352517986,0.8977003114335034,1.0,1/15,1.84%,REEP1
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.2920383587179604,-0.9014867894832218,0.6038781163434903,0.909017629636619,1.0,11/38,22.85%,CENPC;HAT1;CENPP;CENPK;SMARCA5;MIS18BP1;CENPL;RBBP4;CENPQ;UBN1;RBBP7
prerank,positive regulation of viral transcription (GO:0050434),-0.31917124158018184,-0.9011997448407947,0.5861244019138756,0.9087672442729375,1.0,8/25,29.90%,MDFIC;POLR2A;NELFE;GTF2F1;POLR2L;POLR2I;CDK9;POLR2K
prerank,fatty acid catabolic process (GO:0009062),0.30871143228021153,0.9010235361831704,0.6137404580152672,0.8981361292593734,1.0,12/67,15.75%,ABHD2;PPARD;ABCD4;ACOX1;AIG1;ABCD1;MMAA;SLC27A2;LPIN3;HACL1;ECI2;ACAT1
prerank,negative regulation of type I interferon production (GO:0032480),0.3338197709403447,0.9007194724177187,0.6012759170653907,0.8981953452909563,1.0,7/40,13.42%,TRIM25;IFIH1;NLRC5;RNF125;PIN1;TNFAIP3;CYLD
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.3426941339615476,0.9002620928282531,0.5977382875605816,0.898582593555555,1.0,6/33,11.83%,PLCB1;RGCC;CRNN;CCND3;ADAM17;RPTOR
prerank,monocarboxylic acid metabolic process (GO:0032787),-0.2417475398607475,-0.9002595322800689,0.6986899563318777,0.9100186229410707,1.0,19/117,9.82%,IGF1;ALDH1A2;CYP26B1;ACADSB;ME1;PER2;PPARA;CPT1C;GGT5;ME2;SLC5A6;MCCC2;SCPEP1;ABAT;CKB;ACOT11;ALDH4A1;NAAA;AMACR
prerank,mitochondrial translational termination (GO:0070126),0.2973364449621293,0.9002223383430996,0.6184573002754821,0.8980919460544693,1.0,35/88,27.31%,MRPL12;MRPL13;MRPL10;MRPL50;MRPL14;MRPL57;MRPL54;MRPL30;MRPL28;MRPL20;MRPL19;MRPS2;MRPL40;MRPL44;MRPL9;MRPS9;MRPL58;MRPL16;MRPL23;MRPL39;MRPS18A;MRPL21;MRPL1;ERAL1;MRPL27;MRPL41;PTCD3;MRPL49;MRPL51;MRPL22;MRPS33;MRPL37;MRPL2;MRPL15;MRPS18C
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.33113121926189837,-0.8991835480491941,0.5612745098039216,0.9116625931029712,1.0,10/23,20.36%,ERRFI1;SNX6;CBLB;TSG101;ZFYVE28;SRCIN1;GPRC5A;MVP;PTPRC;THY1
prerank,positive regulation of small molecule metabolic process (GO:0062013),-0.3662269192342542,-0.8988342033628633,0.5986078886310905,0.9115641075151296,1.0,5/15,13.50%,IRS1;PPARA;IRS2;SLC45A3;ADM
prerank,negative regulation of translation (GO:0017148),-0.2486258242473371,-0.8983417463927038,0.6824817518248175,0.9117145819906239,1.0,5/87,2.13%,SAMD4A;ROCK2;IGFBP5;CPEB1;CPEB2
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.41108426425596745,0.8981095427281447,0.5660714285714286,0.9020344422121658,1.0,4/15,10.29%,TJP1;KLF4;PKM;SMAD1
prerank,response to retinoic acid (GO:0032526),0.31306570472752027,0.897854577325037,0.6182336182336182,0.901987450972734,1.0,11/59,11.42%,ACER2;TRIM16;TBX1;FZD4;LYN;CREB1;RET;TWF2;BRINP3;PTK6;BRINP2
prerank,regulation of actin filament-based process (GO:0032970),0.3062131551205075,0.8976977737196986,0.6376021798365122,0.9017405531521406,1.0,15/70,10.81%,RHOBTB1;HIP1R;F11R;CORO2B;RHOB;BAIAP2;CCDC88A;FAM107A;BST2;ARHGEF5;IQGAP1;TWF2;PAK1;ARHGAP17;RAC1
prerank,regulation of gene expression (GO:0010468),0.24737782037651507,0.8975080347893334,0.8135245901639344,0.901564008268319,1.0,102/903,10.98%,LEF1;SLC7A5;TFRC;ETS1;OCLN;RBM20;CLDN5;PDGFB;KDR;INSR;CD34;APBB2;ENG;SLC39A8;TGFB2;NOS3;PDE2A;NOVA2;APP;XDH;SOX17;TRIM14;BCL6B;RGCC;MEF2C;RYBP;SMARCA2;ACVRL1;PIK3R3;SOX13;APLNR;NOTCH1;YBX1;RAMP2;LYN;PRDM2;IRF2;RREB1;NOS2;GATA2;HINT1;MOG;SOX7;NOCT;TCF23;WWTR1;FGF16;DLL4;RAMP3;KLF1;SNAI2;SORT1;TLR3;TCF7;DIP2A;CAVIN4;NANOS1;MAPK3;LGALS9;RPS6KA5;PTBP3;FBXW7;ADAM10;KLF4;DNM2;INSM1;YBX2;NCOA2;SOX18;HINFP;SOX12;BRCA2;TGFB1;TDRD7;CRNN;PIN1;TERF2;P2RX7;MSN;RPS7;FOXP3;PRDM9;HCFC2;HMGA1;NDFIP2;KDM4A;ACTG1;ZPR1;BTG1;UBE2V1;CASP8;PDCD10;SMAD1;PRKAB1;LAMTOR5;ZNF205;PTRH2;CNTF;CTCF;ADNP;ZFP36L1;NR5A2
prerank,superoxide metabolic process (GO:0006801),0.36140202712856306,0.8974509033303131,0.5935919055649241,0.9011102719923675,1.0,7/29,12.71%,NOS3;NOS2;NRROS;PREX1;CYBB;NCF4;NOX3
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.29542993072062024,0.8974432467183701,0.6374829001367989,0.9005537866862078,1.0,15/86,15.58%,EPAS1;KLF2;PSMB3;EGLN2;PSMD11;PSMC6;PSME2;PSMD8;HIF1A;HIGD1A;EGLN1;PSMB10;RBX1;ELOB;PSMA8
prerank,cortical cytoskeleton organization (GO:0030865),0.32894067720502485,0.8973001055208824,0.5987558320373251,0.9002975163810178,1.0,11/41,17.04%,RHOBTB1;FMNL3;IKBKB;RHOB;NCKAP1;STRIP1;RAC1;RND1;NCKAP1L;NLGN1;TRPV4
prerank,nuclear pore organization (GO:0006999),-0.37218503921995105,-0.8967832969520578,0.5995475113122172,0.9143861000834363,1.0,7/14,30.60%,SEH1L;NUP205;TMEM170A;TPR;NDC1;NUP35;RTN4
prerank,mitochondrial translation (GO:0032543),0.2898394094060286,0.8964411524538428,0.6318681318681318,0.9014644723162383,1.0,45/104,29.16%,MRPL12;MRPL13;MRPL10;MRPL50;MRPL14;MTIF3;GFM1;MRPL57;MRPL54;MRPL30;MRPL28;MRPL20;GATC;MRPL19;MRPS2;MRPL40;MRPL44;MRPL9;MRPS9;MRPL58;MRPL16;MRPL23;MRPL39;MRPS18A;MRPL21;MRPL1;IARS2;ERAL1;MRPL27;MRPL41;PTCD3;MRPL49;MRPL51;HARS1;NDUFA7;MRPL22;MRPS33;MRPL37;MRPL2;MRPL15;MRPS18C;QRSL1;LARS2;MRPS34;MRPS12
prerank,response to peptide hormone (GO:0043434),0.32793648545949217,0.8964346201631704,0.6123778501628665,0.9009049740937053,1.0,10/43,11.22%,TRIM16;CAV1;CREB1;CYP11B1;SORT1;CYP11A1;STAT1;EIF2B1;ZFP36L1;EIF2B2
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.3463811575445924,0.8956935722953294,0.6277602523659306,0.9019113199795415,1.0,12/39,16.02%,ACER2;FZD4;CORO2B;ADAM15;NOTCH1;ACTN4;NEXMIF;SPOCK1;MAP4K4;GCNT2;RCC2;AP1AR
prerank,regulation of hormone secretion (GO:0046883),-0.3657965354269884,-0.8956862010362054,0.5969162995594713,0.9160672026261738,1.0,7/15,33.27%,SNX6;ANXA1;VAMP2;VAMP3;SCG5;IL11;LIF
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.3929528424224218,0.8956651613314698,0.5759717314487632,0.9014015051279283,1.0,5/17,16.82%,NPPA;AKAP6;KCNRG;ANK3;SUMO1
prerank,mitochondrion distribution (GO:0048311),-0.3814968889108782,-0.8956544769862483,0.6035242290748899,0.915198442402133,1.0,2/12,11.89%,TRAK1;LRRK2
prerank,positive regulation of dendrite development (GO:1900006),0.43498852609094746,0.895651901172211,0.5837837837837838,0.9008558908660893,1.0,3/10,7.81%,DAB2IP;LRP8;PTN
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.37007073722344713,0.895506641455482,0.5934256055363322,0.9006144550318019,1.0,4/24,7.33%,MEF2C;CDH2;CTNNB1;SPAG9
prerank,purine nucleotide metabolic process (GO:0006163),0.36162379826692326,0.8954710303759171,0.5852842809364549,0.9001166352818343,1.0,5/24,11.16%,XDH;HPRT1;NT5C2;GART;PNP
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.35794462947793204,-0.8953071922002602,0.6183908045977011,0.9150726504508069,1.0,4/17,6.82%,CAMK1D;MCU;RIPOR2;DAPK2
prerank,UV protection (GO:0009650),-0.40971880457916854,-0.894899222652195,0.6037344398340249,0.9151010351193893,1.0,2/10,11.48%,SCARA3;MFAP4
prerank,positive regulation of cell cycle process (GO:0090068),0.2954797169812146,0.8946380808389534,0.6353591160220995,0.9012536805511492,1.0,21/91,18.21%,PDGFB;INSR;RGCC;CDC14A;PKN2;NPM2;PKP4;LRP5;TGFA;CDC6;MAP10;KIF23;DYNC1LI1;SPAG5;RXFP3;RCC2;EDN1;SPAST;RAD21;DDX11;PRKCE
prerank,motile cilium assembly (GO:0044458),0.4212340244398428,0.8945423619938725,0.5855018587360595,0.9008880937276129,1.0,3/12,20.31%,ZMYND10;DNAAF3;E2F4
prerank,positive regulation of transmembrane transport (GO:0034764),-0.38431819282077484,-0.8945115857283853,0.5929978118161926,0.9150539892407491,1.0,4/13,10.59%,ACSL1;ANO6;CLIP3;AZIN1
prerank,leukocyte tethering or rolling (GO:0050901),0.39417076793445655,0.8942136798969137,0.6042780748663101,0.9009952229795509,1.0,1/17,1.52%,JAM2
prerank,nuclear pore complex assembly (GO:0051292),-0.40257007960569463,-0.8936696979125092,0.6096491228070176,0.9160822480794342,1.0,8/10,43.56%,NUP205;TMEM170A;TPR;NDC1;RTN4;NUP98;NUP107;AHCTF1
prerank,snRNA metabolic process (GO:0016073),-0.3517423969661372,-0.8936357815803642,0.5782828282828283,0.9152349814345664,1.0,5/17,17.39%,INTS8;INTS2;TUT1;INTS4;INTS10
prerank,keratinocyte differentiation (GO:0030216),-0.31160926887853424,-0.8934395650349265,0.6370558375634517,0.9147391053014419,1.0,9/29,19.63%,ADAM9;ANXA1;TXNIP;JAG1;BCR;SCEL;CASP3;DSP;WNT16
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.3508646683292825,0.8934260965053843,0.601957585644372,0.902104098449094,1.0,5/29,6.27%,IFNAR1;IFNAR2;JAK3;SOCS2;STAT1
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.42297834762235725,0.8932802708533302,0.5895652173913043,0.9018277795232558,1.0,1/13,0.28%,ABHD2
prerank,ERBB2 signaling pathway (GO:0038128),0.34866282177586394,0.8931091055693806,0.6070287539936102,0.9016294143145465,1.0,7/31,10.47%,PTPN12;GRB2;GAB1;SOS1;PTPRR;PTK6;GRB7
prerank,regulation of translation (GO:0006417),0.2725073395604307,0.8925874322672105,0.6742138364779874,0.9021617472121902,1.0,33/173,15.60%,NANOS3;APP;NIBAN1;RPS6KA1;YBX1;MTG1;NANOS2;EIF4H;ENC1;MRPL13;KLHL25;NANOS1;YBX2;SHMT2;EIF3E;EIF2AK4;CNOT9;CYFIP1;RPL13A;EIF3D;GRB7;NCBP2;HSPB1;EIF2B2;BTG2;EIF4E;PUM3;PAIP2;PAIP1;EIF3B;ELAVL1;RNF139;EIF1B
prerank,apoptotic cell clearance (GO:0043277),-0.30938925086162133,-0.892407513102083,0.6265984654731458,0.9163370084483619,1.0,7/30,10.48%,LRP1;THBS1;XKR4;ANXA1;RHOBTB2;TXNDC5;ITGAV
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.3846349078806084,0.8923445379250432,0.5913978494623656,0.9020726977599686,1.0,1/18,0.68%,MFHAS1
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.3615590324258806,-0.8923376345325433,0.604494382022472,0.915567069093288,1.0,8/17,24.73%,SELENOS;HSP90B1;SYVN1;AUP1;HM13;SEC61B;DERL1;UFD1
prerank,negative regulation of protein depolymerization (GO:1901880),0.36144858322710555,0.8920343566159032,0.5870307167235495,0.9021316986017215,1.0,9/24,25.70%,ARHGEF2;FGF13;ATXN7;APC;CAMSAP2;CLASP1;NAV3;CAMSAP1;CLASP2
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.28585831327865296,0.8917335036798562,0.6554959785522788,0.9021779349747757,1.0,23/102,14.37%,TBC1D4;INSR;CAV1;RAB31;FOXO1;HDAC9;CYP11B1;CYP11A1;DENND4C;PRKACB;SLC25A33;ADCY4;PRKAR2B;PKM;SORBS1;PRKAR2A;ZFP36L1;GSK3A;CEACAM1;PPARG;LPIN3;PDE3B;HDAC5
prerank,positive regulation of phosphatase activity (GO:0010922),0.38752776674460565,0.8915691665640443,0.6121739130434782,0.901959678426421,1.0,4/21,5.11%,ITGA1;MEF2C;CALM1;HSP90AB1
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.35162406770534477,-0.8914886406920205,0.6177884615384616,0.9166215078511084,1.0,4/19,6.82%,CAMK1D;MCU;RIPOR2;DAPK2
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.36355704365376273,0.8913883960686599,0.6081771720613288,0.9017721140917662,1.0,2/27,2.85%,CSGALNACT1;CHST11
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.3424346689269925,-0.8912816880565622,0.6333333333333333,0.9161501881320147,1.0,7/22,20.36%,BMP7;FLOT2;WNK1;MAP2K5;CD44;MYADM;THY1
prerank,negative regulation of neuron apoptotic process (GO:0043524),-0.2614313897419441,-0.8911423838358987,0.6895424836601307,0.9155502517329843,1.0,16/69,11.12%,SLC30A10;SNX6;PPARGC1A;PRKCI;NGF;SIX1;NRBP2;NFATC4;PRKN;SOD2;BCL2;APOE;KDM2B;TGFB3;PTK2B;CLN3
prerank,regulation of T cell chemotaxis (GO:0010819),0.43062997457037816,0.8908516093997951,0.5899280575539568,0.90227576365416,1.0,3/11,17.38%,ADAM10;ADAM17;CCR2
prerank,protein destabilization (GO:0031648),-0.3045089513981391,-0.8904092964111322,0.6353591160220995,0.9163057476566938,1.0,8/32,14.20%,GSN;PRKN;CUL3;BTRC;CTSH;PEX2;EP300;FBXW11
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.3742850236859274,0.890229358614066,0.6112084063047285,0.9029680369459161,1.0,9/24,22.10%,TERF2;HNRNPC;DCP2;ACD;TERF1;XRN1;EXOSC10;PINX1;ERCC4
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.37734091907976497,0.8899339116773431,0.5924657534246576,0.9030471332296743,1.0,6/20,11.65%,DIP2B;DIP2A;MAPK3;RPS6KA5;FOXP3;TADA2B
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.36585628037633044,-0.8894570329702438,0.6227678571428571,0.9176346577182561,1.0,2/13,6.77%,PLXNA2;PLXNB2
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.32944002878210543,-0.8893502207026123,0.5829268292682926,0.9169505762402563,1.0,5/20,12.73%,CAMK2D;THADA;BCL2;PML;PSEN1
prerank,maturation of 5.8S rRNA (GO:0000460),-0.34533433874304736,-0.8892093667531609,0.6261061946902655,0.9163443235543843,1.0,3/17,12.14%,NSA2;WDR12;LAS1L
prerank,negative regulation of cell communication (GO:0010648),0.3719379201986622,0.8890470279666336,0.6042402826855123,0.9043108015796322,1.0,5/21,15.71%,KIF26A;SOCS5;PTK6;SRMS;ACVR1
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.38947824937663655,-0.8888932144036922,0.6180698151950719,0.9161330061207685,1.0,4/10,27.70%,DDIT3;QRICH1;CCL2;EIF2AK3
prerank,regulation of oxidative phosphorylation (GO:0002082),0.39779598396740756,0.8888810267662371,0.5977653631284916,0.9040775017133166,1.0,5/16,11.09%,AK4;SLC25A33;SHMT2;PDE12;ABCD1
prerank,protein K63-linked ubiquitination (GO:0070534),-0.2907462533816138,-0.8886309849026737,0.659942363112392,0.9157546902625667,1.0,10/41,15.01%,RNF152;UBE2E2;TRAF3IP2;PRKN;RNF135;WWP2;UBE2E3;PRPF19;PELI3;UBE2B
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.3148138222674742,-0.8885984738399626,0.6252983293556086,0.914897141873945,1.0,4/26,10.02%,PRKAG2;PRKAA2;LPGAT1;SLC45A3
prerank,signal release from synapse (GO:0099643),0.33023483657614283,0.8884995239367185,0.6310679611650486,0.9043047643784146,1.0,7/43,13.36%,STX1A;PIP5K1C;STXBP1;NRXN1;DNAJC5;HSPA8;CPLX1
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.2974108928211538,0.888470954845561,0.648876404494382,0.9038073769480747,1.0,23/78,24.69%,RNF144B;CAV1;SMAD7;SOCS5;HECTD1;TRIB2;UBQLN1;GSK3A;RBX1;BAG2;ELOB;RAD23A;SUMO1;RNF19A;CBFA2T3;GABARAP;CSNK1A1;RACK1;PABIR1;ZYG11B;PSMD10;ANKIB1;KEAP1
prerank,dendrite morphogenesis (GO:0048813),0.34123226994137845,0.8881289202205795,0.6247987117552335,0.9039670518855717,1.0,5/35,7.81%,SHANK3;KLF7;WNT7A;DIP2A;PTN
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.34663727535357913,-0.8880977150602237,0.5944055944055944,0.9151951273920623,1.0,6/18,14.18%,DCN;MCU;PRKN;MIEF1;DDHD1;MIEF2
prerank,nuclear membrane organization (GO:0071763),-0.3446924016885172,-0.8879060911093714,0.6410256410256411,0.9147211263493511,1.0,7/19,24.65%,AKAP8L;TOR1AIP1;EMD;VPS4A;GPER1;UBXN2A;TMEM43
prerank,regulation of macromolecule metabolic process (GO:0060255),-0.22561459531092684,-0.8875905723580854,0.7198067632850241,0.9145243560470313,1.0,24/170,13.12%,PRDM6;IGF1;ROCK2;AFF3;AFF2;ZNF462;CDH1;SLC8A1;YBX3;KDM6B;APOE;AFF1;LDLR;NOVA1;FUBP1;MTMR3;CRIP1;ZNF507;PRDM11;STX1B;PTHLH;IGF2BP2;PSEN1;AFF4
prerank,positive regulation of transporter activity (GO:0032411),-0.3795937141788994,-0.8875612447848267,0.6172043010752688,0.9136803817597996,1.0,7/13,31.06%,TRPC6;RXRA;KCTD7;WNK3;SYNGR3;KMT2A;PDZK1
prerank,regulation of aerobic respiration (GO:1903715),0.4038373643467142,0.8874423983305311,0.6095764272559853,0.904820376746305,1.0,4/15,11.09%,AK4;SLC25A33;SHMT2;ABCD1
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.40142589944376433,-0.8871468522890239,0.6222707423580786,0.9137568346673851,1.0,4/10,17.89%,IMPACT;SIRT2;BAG3;CITED2
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.3578823244776448,0.8863590018371209,0.5973813420621932,0.9064724972118683,1.0,3/25,6.08%,CSGALNACT1;B3GNT2;FUT9
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),-0.3976911745922127,-0.8862304457969814,0.6191489361702127,0.9148542234606275,1.0,2/10,13.71%,CPEB1;PAF1
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.3926535737356429,-0.8853509134032718,0.6088888888888889,0.9159454733509961,1.0,2/10,5.98%,DNMT3A;IGF2
prerank,response to organic cyclic compound (GO:0014070),0.315170783296854,0.8852178823256197,0.6267281105990783,0.9082660748325152,1.0,7/52,11.92%,SLC1A1;SOCS2;CTNNB1;TLR3;TGFB1;ARL6IP5;PAQR7
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.3824149013874118,-0.8851800115635898,0.643652561247216,0.9154146725919502,1.0,2/11,9.99%,IL34;PRKCA
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.3404798375086521,0.8846590857056322,0.6168384879725086,0.9088931011371489,1.0,13/34,26.19%,MEF2C;GRID2;INSYN2A;GRIN2B;GSK3A;GABRG1;GABRG3;GABRA1;RAB3GAP1;GRIN1;GABRA2;GLRA1;GABRG2
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.33098756390852757,0.8846408739910147,0.6386292834890965,0.9083645453467013,1.0,3/40,2.45%,HIP1;INSR;B2M
prerank,negative regulation of cation channel activity (GO:2001258),-0.3145379015215342,-0.8845520531746756,0.6227848101265823,0.9158941252817826,1.0,7/26,16.22%,SLC6A9;PKD2;EPHB2;GNB5;FMR1;GSTM2;KCNAB1
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.40712203148019,0.8843291475934992,0.6014234875444839,0.9084309659424361,1.0,5/13,18.92%,STAT1;OASL;EBI3;IL27RA;IL27
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.32908641513491194,-0.8843278113575745,0.6108247422680413,0.9155163039706313,1.0,6/22,17.80%,DDX5;PLA2R1;ATM;SPRED1;HIC1;CHD5
prerank,cellular response to lipopolysaccharide (GO:0071222),0.28237434107696835,0.8842523125258143,0.6584022038567493,0.9080157369350801,1.0,10/101,8.49%,DAB2IP;MEF2C;DEFA6;NOD2;LYN;CD6;HCK;TGFB1;IRGM;PDE4B
prerank,positive regulation of keratinocyte migration (GO:0051549),0.4323911892207064,0.8842189824030267,0.6086142322097379,0.9075163130406482,1.0,3/10,11.13%,MAPRE2;IQSEC1;MAP4K4
prerank,regulation of glycogen metabolic process (GO:0070873),-0.38315225474030157,-0.8841941652585986,0.6160337552742616,0.9149229293196035,1.0,3/12,19.27%,PPP1R3B;PPP1R3C;PPP1R3F
prerank,negative regulation by host of viral transcription (GO:0043922),0.41848061306931683,0.8838060015607692,0.6190476190476191,0.9078120197762083,1.0,5/12,22.50%,JUN;HMGA2;TFAP4;INPP5K;PSMC3
prerank,ERK1 and ERK2 cascade (GO:0070371),0.37854448461075385,0.8836117481720581,0.6031468531468531,0.9076761950633428,1.0,6/21,15.81%,KDR;MAPK3;LGALS9;ZFP36L1;SOX9;MAPK1
prerank,regulation of response to stress (GO:0080134),0.4265118344057908,0.8836012945819027,0.5814393939393939,0.9071371955925637,1.0,1/10,2.63%,CORO2B
prerank,regulation of posttranscriptional gene silencing (GO:0060147),-0.2756109362206471,-0.8834017355306364,0.6347826086956522,0.9149597921518702,1.0,17/50,29.90%,TNRC6A;SEH1L;POLR2A;AGO2;NUP205;FMR1;EIF4G1;RAE1;POLR2L;IPO8;POLR2I;NUP155;TPR;NDC1;NUP35;NUP43;POLR2K
prerank,regulation of gene silencing by RNA (GO:0060966),-0.2756109362206471,-0.8834017355306364,0.6347826086956522,0.9149597921518702,1.0,17/50,29.90%,TNRC6A;SEH1L;POLR2A;AGO2;NUP205;FMR1;EIF4G1;RAE1;POLR2L;IPO8;POLR2I;NUP155;TPR;NDC1;NUP35;NUP43;POLR2K
prerank,positive regulation of interferon-beta production (GO:0032728),0.34285073965664686,0.8832659378089287,0.6152597402597403,0.9072779862625707,1.0,14/33,28.13%,IFIH1;TLR3;IRF5;TLR7;TLR8;TBK1;POLR3F;FLOT1;RIOK3;IRF7;POLR3B;ISG15;POLR3C;TOMM70
prerank,cellular glucan metabolic process (GO:0006073),-0.3893799712948118,-0.8824757756691763,0.6339285714285714,0.9161565037268611,1.0,4/11,10.47%,PRKAG2;PHKB;PYGM;PPP1R3C
prerank,positive regulation of macrophage migration (GO:1905523),-0.3438424352819273,-0.8819315521723741,0.625,0.9164588176587194,1.0,6/19,18.08%,IL34;THBS1;P2RX4;CMKLR1;RARRES2;MDK
prerank,metallo-sulfur cluster assembly (GO:0031163),0.3652139343347186,0.881842004155898,0.6102292768959435,0.9097024348086774,1.0,13/22,30.31%,CIAO2B;CIAPIN1;HSCB;HSPA9;CIAO3;NUBPL;LYRM4;NFU1;NUBP1;NUBP2;ISCA2;ISCA1;ISCU
prerank,negative regulation of inclusion body assembly (GO:0090084),0.4276905332814094,0.8815606724656702,0.6029143897996357,0.9097501994638704,1.0,3/10,16.87%,SACS;DNAJA4;DNAJB6
prerank,positive regulation of protein localization to membrane (GO:1905477),0.2866038793207983,0.8814686743453138,0.6657496561210454,0.9093730647487837,1.0,13/98,12.02%,PRKCH;SPTBN1;PPP1R13B;STX3;PPP3CC;RAMP3;FYN;SORBS1;YWHAH;YWHAQ;CASP8;HRAS;PPP3R1
prerank,positive regulation of cell division (GO:0051781),-0.28662592298981987,-0.8812884079716276,0.6694444444444444,0.9169942650744638,1.0,9/38,15.82%,FGFR2;FGF1;SVIL;CDC14B;CUL3;CDC25B;GIPC1;SIRT2;RACGAP1
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.38554701089886545,0.8811846634289573,0.6194852941176471,0.9093835104436401,1.0,4/18,8.04%,CAV1;NEDD4L;SLC43A2;KCNH2
prerank,proteasomal protein catabolic process (GO:0010498),0.2637904536416921,0.8808490841584431,0.7240948813982522,0.9094800548817878,1.0,53/201,20.96%,ZNRF1;NEDD4L;PELI1;CTNNB1;ENC1;ATXN3;FBXW7;RFFL;ZFAND2A;PSMB3;UBE2G1;PSMD11;RHBDD1;PSMC6;FEM1C;PSME2;SMURF1;KCTD10;UBXN1;KLHL20;SHARPIN;UBE3D;PSMD8;GSK3A;RNF187;MAEA;PSMB10;NHLRC1;AREL1;RBX1;UBE2D3;TRIM2;RNF139;PSMA8;RAD23A;ATE1;BAG6;ARMC8;GID8;BFAR;TRIM71;TRIM3;KCTD17;PSMD9;SIAH1;RNF4;RBCK1;BRSK2;NSFL1C;PLAA;ANKRD9;DDB1;ERCC8
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.30325740072319934,-0.8804859170052312,0.6475,0.9178536048968976,1.0,5/31,6.41%,KANK2;FHL1;PKD2;DLG1;DACT1
prerank,homocysteine metabolic process (GO:0050667),-0.38883659157741135,-0.8802912535962375,0.6321585903083701,0.9173951964828642,1.0,2/11,8.91%,NOX4;MTHFR
prerank,nucleosome organization (GO:0034728),0.31117736493642373,0.8802133935383779,0.642965204236006,0.9102674444162642,1.0,24/55,25.52%,PRDM9;ARID1A;HMGA1;CTCF;CHAF1A;NAA60;SMARCD1;POLE3;HMGB2;SOX9;VPS72;RNF8;CHAF1B;SET;SRCAP;GRWD1;INO80;NASP;DAXX;LIN54;NAP1L4;ARID2;SMARCA4;SART3
prerank,protein localization to synapse (GO:0035418),-0.38039076068714894,-0.8801156502397209,0.6303901437371663,0.9168639036466613,1.0,6/12,30.65%,NLGN2;DLG4;ZDHHC12;NRXN2;ZDHHC15;BSN
prerank,smooth muscle tissue development (GO:0048745),-0.39866467640269393,-0.8799826047005161,0.6328293736501079,0.9162696438490056,1.0,5/10,13.80%,BMP4;MYLK;SMO;EFEMP2;NF1
prerank,polyol biosynthetic process (GO:0046173),-0.35951433489462237,-0.879811393243304,0.6206896551724138,0.9157511815593787,1.0,5/16,10.75%,CYP27A1;ACER3;FGF2;ISYNA1;PPIP5K2
prerank,electron transport chain (GO:0022900),0.39909399806928175,0.879612622876242,0.6179577464788732,0.9109142630187741,1.0,4/15,10.09%,ETFRF1;ENOX2;CYB561;ETFB
prerank,chloride transport (GO:0006821),0.2961912224196416,0.8795655509460953,0.6643356643356644,0.9104553553614951,1.0,18/74,19.80%,CLIC5;SLC1A1;SLC12A6;SLC12A9;GABRB1;CLCN3;CLIC4;TTYH3;GABRQ;GABRG1;CLIC1;PACC1;GABRG3;GABRA1;ANO3;GABRB2;GLRA2;ANO5
prerank,autophagosome maturation (GO:0097352),0.3441168886475802,0.8792237492596404,0.6296296296296297,0.9105734140745552,1.0,15/32,23.92%,CALM1;TECPR1;MAP1LC3B;UBQLN1;SNAP29;ATG14;VPS16;MAP1LC3A;VAMP7;VMP1;UVRAG;RUBCNL;GABARAP;VAMP8;GABARAPL2
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.39432159479244383,0.8791492842219047,0.60580204778157,0.910162556523081,1.0,5/17,18.54%,STX1A;UNC13D;SYT4;NLGN1;CACNA1I
prerank,negative regulation of stem cell differentiation (GO:2000737),0.4212327111544672,0.8786080260720245,0.6044362292051756,0.9106654840835376,1.0,1/12,3.41%,NOTCH1
prerank,negative regulation of endocytosis (GO:0045806),0.3651341955519961,0.8785659295067966,0.6264462809917355,0.910210959466985,1.0,5/24,10.81%,CAV1;PRKD1;NR1H2;ABCA7;RAC1
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.27568697167417944,-0.8785345821801828,0.674863387978142,0.9176046482806581,1.0,5/41,5.92%,ACSL1;PTGS1;DAGLA;ACOT8;CYP1B1
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.28400045087593284,0.8784177899729639,0.6773743016759777,0.9099476203706476,1.0,12/95,14.16%,DAB2IP;TIRAP;MEF2C;DEFA6;NOD2;IRGM;PDE4B;TNFAIP3;CYRIB;HMGB2;GIT1;BCL10
prerank,positive regulation of exosomal secretion (GO:1903543),-0.35085515283253366,-0.8784107501650157,0.6312217194570136,0.9169698326881074,1.0,3/15,8.00%,SMPD3;TSG101;SDC4
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.3946924377644617,-0.8783438797694588,0.6153846153846154,0.916235788651011,1.0,3/10,9.98%,ABCA1;APOE;PRKACA
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.3691990273206793,0.8783044376517206,0.6147110332749562,0.9096281322419311,1.0,3/19,6.29%,TIRAP;TRIL;LGALS9
prerank,cardiocyte differentiation (GO:0035051),0.4200126892540965,0.8782884076355307,0.6022304832713755,0.9091080954330544,1.0,1/10,1.29%,TGFB2
prerank,regulation of establishment of planar polarity (GO:0090175),0.29320086449331495,0.8780019059907217,0.7012622720897616,0.909122965046845,1.0,14/88,13.63%,FZD6;FZD4;TIAM1;WNT7A;PSMB3;PSMD11;AP2M1;PSMC6;PSME2;SMURF1;RAC1;PSMD8;AP2B1;PSMB10
prerank,response to estrogen (GO:0043627),0.33934455264928876,0.8779706230955597,0.6134868421052632,0.9086336040388534,1.0,4/31,9.38%,CAV1;TRIM25;TRIM24;NCOA4
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.34543660287041583,-0.8779620973655687,0.6241610738255033,0.9161778981142722,1.0,6/18,14.45%,DACT1;APOE;EZR;VGLL4;ATP5IF1;CD81
prerank,GPI anchor biosynthetic process (GO:0006506),0.35131868032262514,0.8778449355661567,0.626057529610829,0.9083367449651997,1.0,10/30,22.44%,PIGU;PIGM;PGAP4;PIGK;PIGF;DPM3;PIGS;PIGO;PIGV;PIGQ
prerank,B cell homeostasis (GO:0001782),0.428053236563382,0.8777525988803184,0.5961538461538461,0.9079616767947393,1.0,4/10,15.04%,MEF2C;LYN;TNFAIP3;NCKAP1L
prerank,protein-containing complex disassembly (GO:0032984),0.31121480401453905,0.8775400046634697,0.6529411764705882,0.9078510769544018,1.0,18/54,22.04%,CAV1;CTNNB1;FRAT2;TECPR1;MAP1LC3B;UBQLN1;HSPA8;SNAP29;APC;VPS16;MAP1LC3A;VAMP7;RPL23;UVRAG;RUBCNL;GABARAP;CSNK1A1;VAMP8
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.39834108873894664,0.8775341744452079,0.6234234234234234,0.9073080701517575,1.0,1/13,2.06%,PDE8A
prerank,establishment of mitotic spindle localization (GO:0040001),-0.3047658916389981,-0.8774312248237495,0.6609336609336609,0.9163949437343082,1.0,14/28,32.27%,GJA1;GPSM2;FBXW11;NUSAP1;MAD2L1;MISP;HTT;SPDL1;KPNB1;NUMA1;ITGB1;PLK1;ESPL1;PKHD1
prerank,positive regulation of signaling (GO:0023056),-0.2896143344762279,-0.8773238313803432,0.6743589743589744,0.9157272185699147,1.0,4/37,7.18%,WLS;ANXA2;CLSTN2;DLG4
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.33192615203080145,-0.87729916007549,0.6296296296296297,0.9148692940752696,1.0,11/23,28.65%,AXL;TLR4;RARA;DDIT3;LAPTM5;INHA;C1QBP;NR1H4;HMGB1;INHBA;LILRB1
prerank,negative regulation of cell aging (GO:0090344),0.3954860901151981,0.8771590194129162,0.627906976744186,0.9075277694306289,1.0,7/16,21.83%,YBX1;TERF2;MAP3K3;RBL1;HMGA2;CDK6;AKT3
prerank,response to sterol (GO:0036314),-0.38449271374623,-0.8771350464085689,0.6316916488222698,0.9142995675071075,1.0,2/11,5.82%,TGFBR1;RORA
prerank,regulation of neuron differentiation (GO:0045664),-0.25688095075317496,-0.8767991065722295,0.7446808510638298,0.9141852752720496,1.0,11/76,8.88%,ZFHX3;NBL1;BMP7;IMPACT;NGF;SIX1;DTX1;HEYL;CDK5RAP1;ZEB1;BEND6
prerank,positive regulation of type I interferon production (GO:0032481),0.2964185445891363,0.8767056682040141,0.6940836940836941,0.9078780404061886,1.0,8/73,7.31%,LRRFIP1;IFIH1;CTNNB1;TLR3;MRE11;STAT1;IRF5;TLR7
prerank,regulation of cardiac muscle contraction (GO:0055117),0.3388217224376248,0.8766980961044333,0.6190476190476191,0.9073378578676907,1.0,7/34,8.49%,SMAD7;CALM1;PDE4D;NPPA;KCNQ1;SRI;PDE4B
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.3843236831221126,-0.8766403850162909,0.6263736263736264,0.9136096635253014,1.0,3/11,12.09%,SLC30A10;PPARA;TRAP1
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.4246519690882998,0.8761987943254396,0.6238185255198487,0.9077827465374212,1.0,2/11,10.64%,TIMM13;TIMM10
prerank,oligodendrocyte differentiation (GO:0048709),0.3771760760256009,0.8759142648914928,0.6302083333333334,0.9078198920008458,1.0,7/19,17.88%,SOX13;EIF2B1;EIF2B2;SOX10;SOX9;PTPRZ1;TPPP
prerank,regulation of interferon-beta production (GO:0032648),0.3169962860159241,0.8756839067618305,0.6546310832025117,0.9076975346361826,1.0,17/46,26.63%,TIRAP;IFIH1;TLR3;IRF5;TLR7;TLR8;RELB;TBK1;TRAF3;POLR3F;FLOT1;RIOK3;IRF7;RNF216;POLR3B;ISG15;POLR3C
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.40321142394942566,0.8756438731094104,0.6039783001808319,0.9072301459495726,1.0,3/14,9.48%,LIMS2;PRKD1;PHACTR4
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.38970626856849283,0.875631939618432,0.6135181975736569,0.9067055212470088,1.0,4/16,18.09%,HMGA1;RECQL4;TWNK;RPA1
prerank,regulation of neuroblast proliferation (GO:1902692),0.3990308430670397,0.8754490493037619,0.612565445026178,0.9065189190664104,1.0,4/15,9.18%,CTNNB1;DCT;PTN;DISC1
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.2945984741073388,0.8748962050451354,0.6510948905109489,0.9070744677234583,1.0,18/72,22.10%,POLK;GTF2H2;GTF2H4;RBX1;AQR;COPS5;GPS1;ISY1;TCEA1;RPA1;POLR2J;POLD1;COPS6;DDB1;GTF2H3;ERCC8;RFC2;ERCC4
prerank,regulation of phosphatase activity (GO:0010921),-0.322785295098293,-0.8745721438113148,0.6666666666666666,0.9173048277557562,1.0,10/24,29.16%,SH3RF2;URI1;PTPA;BMP2;HSP90B1;SH2D4A;TSC1;HTT;ZCCHC9;MTMR9
prerank,gene expression (GO:0010467),0.24869552496087258,0.8744446286389522,0.7694877505567929,0.9074587065004982,1.0,116/348,27.60%,TSPAN5;AGFG1;TSPAN14;ADAR;SARS1;PTMA;HHEX;ZAR1L;RPL38;TAF1B;MRPL13;RPL13;RPS29;MRPL10;NKX2-8;RPL36A;RPL3;RNPS1;YARS2;RPSA;RPL27;RPS7;NXT1;RPL9;RPLP2;PWP1;RPL18;DEDD2;CPSF1;MAGOHB;RPL13A;THOC6;NCBP2;RPS11;MPHOSPH10;NUP54;RBPMS;RPL8;RPS27;RPL19;RPS9;MRPL28;EIF4E;ADAD1;NOL9;RPL11;ZC3H11A;RPS15;RPL37;SRBD1;RPS28;TSPAN33;RPS10;RPS25;NUP160;MRPL44;RPL37A;MRPL9;COPS5;PRPF4;NUP153;POLR2J;RPL15;TNIP1;FARSB;RBMS2;NUP50;MRPL23;RPL17;RPL23;RPL34;RBM8A;RPS18;UPF2;MRPS18A;XRN2;RPL21;DDX54;RPS4X;NCBP1;NUP42;DUSP11;DHPS;RPS21;RPL18A;RPL10A;RSL24D1;RPL24;ADARB2;MRPL27;MRPL41;NUP85;RPL7A;NUP210;MRPL51;HARS1;NUP188;RPL4;DHX38;MRPS33;UPF3B;RPS2;RPL32;RPL6;UPF1;MRPL37;MEF2A;CHTOP;RPS20;RPL14;DNAJB11;RPS13;HNRNPF;MRPS18C;DDX20;HNRNPL
prerank,polyamine metabolic process (GO:0006595),0.4036818310477653,0.8741572673316543,0.633147113594041,0.9074590846546705,1.0,8/13,29.68%,SMOX;AMD1;SMS;OAZ2;DHPS;AOC1;SRM;HDAC6
prerank,neutrophil activation (GO:0042119),0.412338280702498,0.8740195215643909,0.6289424860853432,0.9071731619525103,1.0,4/12,13.26%,PREX1;CXCR2;SYK;IL15
prerank,positive regulation of vacuole organization (GO:0044090),-0.39983571642952787,-0.8739295177970277,0.6344827586206897,0.9178295639566653,1.0,5/10,16.64%,ANXA2;LRSAM1;PIP4K2C;GRN;RAB3GAP2
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.2801985215460251,-0.8732428205027291,0.6745562130177515,0.9184872146953308,1.0,10/47,15.15%,PID1;PDGFRB;THBS1;PRKCD;AGTR1;SLC5A3;CYBA;MAPK14;TLR4;ACE2
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.394440016895973,-0.8731932464266949,0.6033402922755741,0.917701283086202,1.0,7/10,32.16%,GAR1;RPUSD4;RPUSD1;TSR3;RPUSD2;RPUSD3;NOP10
prerank,cellular amide metabolic process (GO:0043603),-0.2370060142654792,-0.8731017308444455,0.789272030651341,0.9169999609212488,1.0,22/102,18.44%,AEBP1;PLPP3;ACOT8;SMPD3;SLC5A6;MCCC2;ACOT11;MTHFD1;NNMT;CPXM1;MTHFR;NAAA;CPXM2;ACSF2;NSMAF;PCCB;NIT1;DBI;BTD;MTHFD2;OXSM;MTHFD1L
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.35410410071617093,-0.8730757018149963,0.6351351351351351,0.916157873152947,1.0,3/17,8.12%,CD55;IL18;JAG1
prerank,mesoderm formation (GO:0001707),0.37372390694777186,0.8726629226737098,0.6190476190476191,0.9093340667045567,1.0,1/17,1.27%,BMPR2
prerank,positive regulation of neutrophil migration (GO:1902624),-0.34512151989777307,-0.8724997482403132,0.6431924882629108,0.916545842926746,1.0,4/18,6.82%,CAMK1D;MCU;RIPOR2;DAPK2
prerank,positive regulation of fat cell differentiation (GO:0045600),0.32055022674385963,0.8724133669370754,0.6488888888888888,0.909284326554729,1.0,9/47,12.29%,PPARD;SOX13;ZBTB16;RREB1;NOCT;CREB1;LRP5;ZFP36L1;PPARG
prerank,C-terminal protein amino acid modification (GO:0018410),0.428461339962493,0.8721816831907121,0.6351118760757315,0.909178958620925,1.0,7/11,30.54%,LCMT1;ATG12;TTL;ATG7;AGBL4;FOLH1;AGTPBP1
prerank,cell cycle checkpoint signaling (GO:0000075),-0.38290679099731034,-0.8719355614313434,0.6320346320346321,0.91691496710997,1.0,3/12,13.79%,PRCC;ZWINT;ZWILCH
prerank,protein autoprocessing (GO:0016540),-0.3370358676248083,-0.8714696076987887,0.6179775280898876,0.9170503426316496,1.0,4/17,13.82%,CTSL;FXN;AFG3L2;HTRA2
prerank,protein import into peroxisome matrix (GO:0016558),0.4086152455160855,0.8714282035354729,0.6003787878787878,0.910120139310989,1.0,8/12,29.90%,PEX5L;PEX14;PEX16;PEX6;PEX1;PEX12;PEX10;PEX5
prerank,regulation of ion transmembrane transport (GO:0034765),0.3371679681552584,0.8711241655068077,0.6434231378763867,0.9101647540539474,1.0,10/33,18.27%,NEDD4L;KCNQ1;KCNH2;P2RX7;AKAP9;CHRM3;AKAP6;KCNJ5;KCNJ3;KCNJ6
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.4254203682648079,0.8710496511055926,0.6060070671378092,0.9097450702944548,1.0,6/10,29.58%,INPP5F;SH2B3;SOCS1;PARP14;PPP2R1A;NF2
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.4145615845607166,0.8704832176283562,0.6313932980599647,0.9102935037316691,1.0,4/11,8.73%,VIL1;RREB1;ARHGEF7;ENPP2
prerank,mitotic recombination (GO:0006312),-0.354254693687127,-0.8703811926693401,0.6277056277056277,0.9185290614655978,1.0,7/15,19.35%,SMC6;TEP1;ERCC1;RAD50;DMC1;NSMCE2;TPRKB
prerank,methylguanosine-cap decapping (GO:0110156),0.4145556633728875,0.870218828985954,0.6171875,0.9102738717978878,1.0,4/10,13.97%,EDC3;DCP2;DCP1B;PNRC2
prerank,adrenergic receptor signaling pathway (GO:0071875),0.371147473812129,0.8693659363688435,0.6219512195121951,0.9114420508272182,1.0,3/20,6.42%,RAPGEF2;PDE4D;ADRA2B
prerank,positive regulation of viral life cycle (GO:1903902),-0.3258714963080589,-0.8691394764055126,0.7016317016317016,0.9202422295747728,1.0,5/22,14.50%,AXL;LGALS1;TSG101;FMR1;P4HB
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.334127385036574,0.8689890005426106,0.6391096979332274,0.9116380828745827,1.0,6/35,4.91%,PDE2A;RAPGEF2;RAPGEF3;PDE4D;PDE7B;NPPA
prerank,regulation of amyloid fibril formation (GO:1905906),0.3933606295646901,0.8688413440780168,0.618421052631579,0.9113716371140294,1.0,3/15,9.39%,APP;PFDN4;PFDN2
prerank,protein tetramerization (GO:0051262),-0.2550781965714565,-0.8688259655218171,0.7138461538461538,0.9199860963753456,1.0,8/67,7.40%,ALDH1A2;APPL2;PKD1;KCNJ2;PKD2;UPB1;SOD2;GOLGA2
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.3712116942043655,0.867745658550106,0.6178010471204188,0.912991108052205,1.0,7/20,15.05%,BCL2L1;PPP2R5A;TGFB1;AP2M1;ABI3;MRAP;TMEM59
prerank,response to UV (GO:0009411),0.28234503978649494,0.8675705325621413,0.6868131868131868,0.9128239293259557,1.0,10/95,9.75%,POLK;MAP4K3;DCUN1D3;MEN1;CAT;GTF2H2;N4BP1;RHBDD1;COPS9;EIF2AK4
prerank,protein deubiquitination (GO:0016579),0.2533894460692253,0.8669737899269546,0.7735849056603774,0.9134958811193382,1.0,88/242,27.74%,MINDY1;NFKBIA;IFIH1;ACTB;SMAD7;SNX3;CCP110;ATXN3;EIF3F;PSMB3;BIRC3;PSMD11;SHMT2;PSMC6;PSME2;MYSM1;OTUD7A;SMAD1;BABAM1;MINDY2;USP18;TADA2B;PSMD8;HIF1A;HGS;TNFAIP3;POLB;ATXN7;WDR48;CYLD;PSMB10;WDR20;PSMA8;TRRAP;RAD23A;MCRS1;APC;HCFC1;COPS5;ASXL1;RCE1;JOSD2;USP49;PSMD9;TNIP1;UBE2D1;USP32;USP25;USP21;BRCC3;USP29;OTUD7B;OTUD4;TRAF3;JOSD1;DESI2;SUDS3;INO80;MBD5;KAT2B;RAD23B;PSMD1;PSMC3;STAMBP;TRAF6;RIPK1;PSMD10;VCPIP1;USP30;ENY2;USP38;FOXO4;KEAP1;MYC;ZC3H12A;KDM1B;TAB1;PSME1;ACTR5;NFRKB;USP45;PSMB8;PSMD2;ADRB2;UBB;PSMA1;BECN1;ADRM1
prerank,fatty acid metabolic process (GO:0006631),0.2770002260929825,0.8667488941971399,0.7046979865771812,0.9133863182058264,1.0,18/115,13.49%,ADIPOR2;FASN;PPARD;ACSL5;CPT1A;ACOX1;CRAT;ABCB11;LIPC;ACSL6;ACSL3;ADIPOR1;SLC27A2;PPARG;PNPLA8;LPIN3;HACL1;HSD17B8
prerank,monocarboxylic acid catabolic process (GO:0072329),0.3673677224475086,0.8664325231281534,0.622673434856176,0.9134317205938319,1.0,7/21,21.01%,PPARD;ACOX1;LDHD;LPIN3;AGXT;ACBD5;FAAH
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.4048420027086955,0.8659432031673682,0.6194029850746269,0.9138205342592208,1.0,3/12,9.43%,IMPDH1;ADSS2;GART
prerank,positive regulation of calcium ion transport (GO:0051928),0.33656255302859317,0.8658657854736955,0.6547433903576982,0.9134295730983947,1.0,5/36,8.39%,PDGFB;CXCL12;CAV1;ATP2B1;P2RX7
prerank,neurotransmitter secretion (GO:0007269),0.31884337396829526,0.8657450948032724,0.6629213483146067,0.9131372679894332,1.0,12/44,24.30%,STX1A;PIP5K1C;STXBP1;NRXN1;DNAJC5;HSPA8;CPLX1;RIMS2;UNC13A;SNCA;PTPRN2;SYN1
prerank,intestinal lipid absorption (GO:0098856),-0.38769911246607675,-0.8648817181761369,0.6277056277056277,0.927638841523329,1.0,7/11,52.23%,LDLR;CD36;SOAT2;AKR1C1;ABCG5;NPC1L1;UGCG
prerank,regulation of macrophage chemotaxis (GO:0010758),0.36607189176262506,0.8647872040431317,0.6327212020033389,0.9145207964834404,1.0,3/21,6.24%,MTUS1;PTK2;MAPK3
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.2633844539691054,-0.8646497554541425,0.7090395480225988,0.9272387900333607,1.0,15/59,19.98%,ROCK2;PRKCD;TGFBR1;CAMK2D;MAP3K12;PDPK1;PRKCA;LRRK2;WNK1;DYRK2;ACVR1B;CDC42BPG;SBK1;WNK3;CSNK2A1
prerank,alcohol catabolic process (GO:0046164),0.42821445648715006,0.8641739598969221,0.6,0.9152016423539365,1.0,1/10,1.75%,SCARF1
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.2899279470097158,0.8640310561513681,0.7134831460674157,0.9149469197464255,1.0,14/85,13.63%,FZD6;FZD4;TIAM1;WNT7A;PSMB3;PSMD11;AP2M1;PSMC6;PSME2;SMURF1;RAC1;PSMD8;AP2B1;PSMB10
prerank,neuromuscular junction development (GO:0007528),-0.31150565653030715,-0.8633472920403182,0.6442786069651741,0.9291487112342274,1.0,7/24,14.04%,PDZRN3;UNC13C;PPFIBP2;CACNB4;CACNB2;LRRK2;CACNB1
prerank,long-term synaptic potentiation (GO:0060291),-0.32474269464215766,-0.8633028524804871,0.6417910447761194,0.9283398615927176,1.0,9/21,26.73%,SLC8A3;NFATC4;PTK2B;TSHZ3;STX4;VAMP2;PRKCZ;GRIN2D;SLC8A2
prerank,epidermal cell differentiation (GO:0009913),-0.2809663874446333,-0.8632318608071277,0.6723646723646723,0.927599584057465,1.0,9/41,14.36%,ADAM9;ANXA1;GLI1;TXNIP;JAG1;GATA6;BCR;SCEL;CASP3
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.33423467293372977,0.8628844395088928,0.6912,0.916619551607467,1.0,5/37,11.24%,BCL2L1;CAV1;RPS7;EIF5A;S100A8
prerank,zinc ion transport (GO:0006829),0.3627630162076145,0.8626320456046445,0.634974533106961,0.9165957347087522,1.0,2/21,3.00%,SLC39A8;SLC30A1
prerank,response to estradiol (GO:0032355),-0.2956903545807937,-0.8624175152996942,0.6725888324873096,0.9284381727188432,1.0,4/31,7.09%,EGFR;ANXA1;GGT5;LCOR
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.3527369663455512,0.8620619246815705,0.6695059625212947,0.9171535403767644,1.0,10/23,29.98%,CYP2E1;ELOVL6;LTA4H;GPX4;HPGD;GSTM1;LTC4S;ACSBG1;ASAH2;FADS1
prerank,translational termination (GO:0006415),0.2822721649443598,0.8619433800104206,0.7150610583446404,0.9168475619575892,1.0,37/95,27.31%,MRPL12;MRPL13;MRPL10;MRPL50;MRPL14;MRPL57;MRPL54;MRPL30;MRPL28;MRPL20;MRPL19;MRPS2;MRPL40;MRPL44;MRPL9;MRPS9;MRPL58;MRPL16;MRPL23;MRPL39;APEH;MRPS18A;MRPL21;ABCE1;MRPL1;ERAL1;MRPL27;MRPL41;PTCD3;MRPL49;MRPL51;MRPL22;MRPS33;MRPL37;MRPL2;MRPL15;MRPS18C
prerank,regulation of urine volume (GO:0035809),-0.382402640401375,-0.8614348106591833,0.6447368421052632,0.929698088607886,1.0,3/10,13.50%,NPR3;ADCY6;ADM
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.34014314373136567,-0.8609696716596514,0.6152073732718893,0.9298037163042441,1.0,7/17,24.17%,EMC8;EMC7;GET1;EMC2;EMC1;EMC3;EMC4
prerank,regulation of hippo signaling (GO:0035330),0.37931124859856374,0.8609163809008132,0.6471663619744058,0.918328690549409,1.0,6/17,17.40%,MOB3B;MARK3;SCHIP1;SOX11;WWC1;WWC2
prerank,histone H2A acetylation (GO:0043968),-0.3467339509428389,-0.8607012478952575,0.684931506849315,0.9294729078963517,1.0,6/16,30.71%,MORF4L2;BRD8;NAA40;EPC1;MSL3;SPHK2
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.4302536783186121,0.8606227700762064,0.6254752851711026,0.9183569667090548,1.0,3/10,9.18%,CTNNB1;DCT;DISC1
prerank,rRNA 3'-end processing (GO:0031125),-0.3892753642467569,-0.8603351318727823,0.6349892008639308,0.9293672170904308,1.0,2/10,7.20%,ERI3;ERI2
prerank,negative regulation of T cell activation (GO:0050868),0.3318488389629638,0.8602295956636258,0.6616915422885572,0.9185756010107278,1.0,6/35,15.04%,JAK3;DUSP3;TNFRSF21;FOXP3;CEACAM1;NCKAP1L
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.3166603302667603,-0.8593025068646505,0.6855036855036855,0.9306927139954223,1.0,4/25,10.48%,PARVA;CXADR;ITGA5;ITGAV
prerank,macrophage migration (GO:1905517),-0.36159490844093795,-0.8591882256528517,0.6470588235294118,0.9300413969240419,1.0,8/13,44.57%,P2RX4;CKLF;CCL2;P2RY12;CCL5;TAFA4;CXCL17;CCL3
prerank,proton transmembrane transport (GO:1902600),-0.28934569459008,-0.8590121641470218,0.7162921348314607,0.9295252556134437,1.0,2/36,5.02%,ATP1A2;ATP6V0A4
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.39132564009474535,0.8589243800614639,0.6297029702970297,0.9206299247108766,1.0,6/14,25.20%,CSTF2;CPSF1;NCBP2;NCBP1;CPSF4L;CSTF2T
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.3872712513971993,-0.8587979744287269,0.6555772994129159,0.9291055398060133,1.0,3/11,23.89%,C1QTNF3;EP300;C1QTNF12
prerank,response to laminar fluid shear stress (GO:0034616),0.41214572388383675,0.8583669293670675,0.6134615384615385,0.9212134420843473,1.0,3/10,6.62%,KLF2;SMAD7;KLF4
prerank,cellular response to amino acid stimulus (GO:0071230),0.33569378983483183,0.8581925083716747,0.6343402225755167,0.9209933532627457,1.0,8/33,16.35%,SH3BP4;SESN3;FYN;LAMTOR5;RPTOR;NSMF;LAMTOR4;CAPN2
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.38047243021596755,-0.8576261954795804,0.6277533039647577,0.9307365533759587,1.0,3/10,12.17%,SOX5;SOX6;PKDCC
prerank,glycoprotein catabolic process (GO:0006516),0.3756421758246282,0.8572874528480304,0.6559865092748736,0.9222551817851776,1.0,8/17,17.02%,OGA;NEU4;STT3B;FBXO6;EDEM1;MANBA;NEU2;FBXO2
prerank,cellular response to nitrogen compound (GO:1901699),-0.3218471064187759,-0.8572551639396081,0.6472019464720195,0.9306171866406024,1.0,1/20,0.65%,ROCK2
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.33150179789254314,-0.8567571214610806,0.6411483253588517,0.9307051679780804,1.0,15/19,45.97%,APOE;SLC5A7;NQO1;CHRNA4;CHRNB2;ACHE;COLQ;CHRNA5;CHRFAM7A;CHRNA7;CHRNA3;CHRNE;CHRNB4;CHRNB3;RAPSN
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.39255586264875997,0.8566645719277214,0.6495412844036698,0.9229123914076285,1.0,4/15,12.29%,PPARD;NR1H2;ELOVL5;PPARG
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.28497293303819987,0.856402950136894,0.6867305061559508,0.9229096209780289,1.0,8/87,7.72%,NDNF;TBX1;GRB2;FGF16;DLL4;HYAL2;MAPK3;TIAL1
prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.3005838740290451,-0.8562323528861309,0.6951219512195121,0.9309430467727087,1.0,6/24,17.35%,CEMIP;MIEF1;ITGB1BP1;MIEF2;KCNB1;C2CD5
prerank,regulation of receptor internalization (GO:0002090),0.3247701245271515,0.8550871456440778,0.6443719412724307,0.9249666927803571,1.0,6/35,8.93%,INSR;ANKRD13A;RIN3;TBC1D5;MKLN1;GREM1
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.36670692348077444,0.8544830221020477,0.6426056338028169,0.9255917514098483,1.0,7/20,15.05%,BCL2L1;PPP2R5A;TGFB1;AP2M1;ABI3;MRAP;TMEM59
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.3518938750465177,0.8542009596081815,0.6655629139072847,0.9255802116483098,1.0,4/26,11.20%,PDE8A;PPIA;FYN;HSPB1
prerank,regulation of autophagy (GO:0010506),-0.21370811555144126,-0.8539427461445418,0.9047619047619048,0.9348838323206127,1.0,62/216,23.22%,PRKAG2;DCN;ITPR1;LEPR;PRKAA2;RNF152;NUPR1;SNX6;KLHL22;DAPK2;DAPL1;PRKN;GOLGA2;BCL2;MET;ATM;FOXO3;PTPN22;PIP4K2C;PRKACA;MTMR3;PLEKHF1;PRKAG3;STK11;ATP6V1C1;LRRK2;RHEB;ABL1;SNX5;ATP6V1G2;TPCN1;HTRA2;EP300;SIRT2;LAMTOR3;CASP3;CAPN1;WDR41;RRAGA;SREBF1;OPTN;SNX32;CISD2;ATP6V1E1;DDIT3;PSAP;CTSA;SMCR8;FLCN;USP13;RAB39B;EIF4G1;TAB3;ATP6V0D2;PRKAB2;CDK5;TRIM8;NEDD4;ATP13A2;VPS26A;SLC38A9;PIP4K2B
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.336663963135025,-0.8531618012107316,0.6740576496674058,0.9356494142728432,1.0,3/16,11.60%,SLC39A14;PRKCA;PRMT5
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.30281095451808315,-0.8531393965158445,0.6803874092009685,0.93482050932668,1.0,6/25,16.31%,CCNT2;WDR43;SETD5;LDB1;DDX39B;ERCC6
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.33490454293191707,-0.8528256018850876,0.6674057649667405,0.9345605175392995,1.0,1/18,0.46%,FBN1
prerank,manganese ion transport (GO:0006828),0.3953196750311231,0.8526653073191693,0.6329588014981273,0.9280351564775734,1.0,2/14,3.51%,SLC39A8;ATP2C1
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.3836361778652929,-0.8524099963096123,0.644880174291939,0.9345236572768728,1.0,2/10,3.97%,OSR1;CAMK2D
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.26552371336109193,-0.8521899767716982,0.7195467422096318,0.934112449046374,1.0,10/46,15.36%,PLD1;AGPAT4;LCLAT1;GPD1L;ACP6;PLA2G12A;DDHD1;GPAT3;PNPLA3;SLC27A1
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.30119321322363923,0.8520051630696968,0.6926605504587156,0.9287470878142355,1.0,8/57,10.71%,IL6R;ARL2BP;CD40;LYN;INPP5F;STAP2;PTK6;CNTF
prerank,regulation of tissue remodeling (GO:0034103),0.36365542200198786,0.8519997638312947,0.6377816291161178,0.9282084511397131,1.0,5/18,13.26%,FLT4;SYT7;TGFB1;CEACAM1;IL15
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.32429826302487264,-0.8519276951020457,0.6872146118721462,0.9337640555602201,1.0,2/19,2.88%,AXL;MMP14
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.3843354967613165,0.8515770707241962,0.6415094339622641,0.9285188550671375,1.0,3/14,9.43%,IMPDH1;ADSS2;GART
prerank,positive regulation of immune effector process (GO:0002699),-0.2982104788837554,-0.8514921868621621,0.6926829268292682,0.933759504979291,1.0,2/27,2.77%,APPL2;LBP
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.2633659832362391,-0.8513430559535113,0.778125,0.9331930818694291,1.0,13/52,17.10%,LMNA;SHC1;KDELR3;GFPT1;ARFGAP1;TSPYL2;SEC31A;CUL7;FKBP14;TLN1;SYVN1;DNAJC3;TATDN2
prerank,positive regulation of cartilage development (GO:0061036),0.3800072252722215,0.8508113403608033,0.658578856152513,0.9294102976649578,1.0,3/17,4.12%,BMPR2;ACVRL1;ZBTB16
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.3250799103223318,-0.8507890636043035,0.6594202898550725,0.9334762175056525,1.0,6/19,13.27%,CUX1;OBSL1;FBXW8;CUL7;CAPRIN2;CDKL3
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.32316134921297357,-0.8506127781059546,0.6537530266343826,0.932960941302248,1.0,5/20,18.91%,FKBP5;PPIC;PPIL2;PPIH;NKTR
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.3927789673816037,0.8502998202794297,0.6485943775100401,0.9298420519627266,1.0,6/13,25.20%,CSTF2;CPSF1;NCBP2;NCBP1;CPSF4L;CSTF2T
prerank,negative regulation of signaling (GO:0023057),0.3461584069578055,0.8500440373673392,0.6625222024866785,0.9298232848625245,1.0,9/25,25.22%,KIF26A;SOCS5;PTK6;SRMS;ACVR1;AP1AR;TRAT1;OPRM1;GLRA1
prerank,regulation of phosphorylation (GO:0042325),0.272803857925087,0.8497836875175628,0.7602649006622516,0.929784855858141,1.0,26/120,17.61%,ITGA6;APP;PTK2;NLRC5;LYN;FNIP2;IKBKB;CCDC88A;DYNLL1;CDKN2B;PIN1;HSPB1;NUP54;ZBTB7A;HIF1A;KCTD20;SDCBP;PGAM1;CDH5;BCL10;NCKAP1L;BTBD10;NUP160;ATG14;NRP1;NUP153
prerank,protein modification by small protein conjugation or removal (GO:0070647),-0.3597237392597552,-0.8495642659910091,0.6889400921658986,0.9342316430615492,1.0,5/13,20.76%,ATG10;SENP6;UBA1;UBA6;UBA2
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.2733962736883159,0.849288366385102,0.7291381668946648,0.930182841720868,1.0,16/104,12.38%,DAB2IP;ACTB;CALM1;FGF16;CDKN2B;RALB;CCNI;IRGM;LRP5;CCND3;PDCD10;TRIB2;CDC6;RPTOR;HGS;CCNK
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.37030723875765753,-0.8491972303935497,0.6455981941309256,0.9340839705253325,1.0,1/13,0.68%,GLI3
prerank,"transcription, DNA-templated (GO:0006351)",0.25415808123449407,0.848255000966223,0.7723378212974297,0.9316509830208208,1.0,52/207,20.86%,IVNS1ABP;PTMA;RREB1;NOCT;MRPL12;PIR;TAF1B;IRF9;SLC25A33;NKX2-8;GTF2H2;ABT1;RNPS1;YBX2;NFIC;PWP1;TRIM24;KLF13;CEBPD;CBFB;PKNOX1;NCBP2;GTF2H4;NELFCD;GTF3A;CCNK;GTF2B;MLLT1;GTF3C5;RO60;NAT14;HIPK3;CRCP;TWNK;ELOB;UBTF;TAF4B;TAF4;LHX1;MNT;TCEA1;TAF5;POLR2J;CCNT1;DEK;TBPL1;EAF1;THRA;BRF2;TAF2;GTF2E2;GTF2H3
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.3122089695536448,0.8480000811335809,0.7092651757188498,0.9315930906326454,1.0,21/46,31.88%,TOMM22;TIMM13;TIMM10;HK1;DNAJC19;MFF;RALA;TOMM20L;TOMM7;CHCHD4;TOMM5;TIMM50;TIMM21;TOMM70;BCAP31;TIMM9;AIFM1;FIS1;AKT1;GRPEL2;GRPEL1
prerank,cytoplasmic microtubule organization (GO:0031122),0.3001463893326195,0.8478657710586439,0.6837881219903692,0.9313180602861458,1.0,16/54,17.88%,CCDC13;CLIP1;CCDC88A;LIMK2;CCDC88B;STMN3;RAB11A;HOOK1;CRIPT;SLK;MAP10;SPAST;CAMSAP2;TRPV4;CLIP2;TPPP
prerank,ether lipid biosynthetic process (GO:0008611),-0.3718724479129777,-0.8469003916355786,0.6486486486486487,0.9379340079343682,1.0,4/10,30.27%,PEX7;AGPS;GNPAT;FAR1
prerank,regulation of myotube differentiation (GO:0010830),0.35496660862929075,0.8468964127177766,0.6610169491525424,0.932650923097083,1.0,4/24,4.75%,NOTCH1;HDAC9;PIEZO1;ATP11A
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.3690469280192123,0.8467294591446985,0.6444833625218914,0.932423740660647,1.0,4/16,17.48%,VPS36;TMEM50A;VPS25;LEPROTL1
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.3748050931724338,0.8463013180091654,0.6618181818181819,0.9326548285749306,1.0,1/18,1.02%,DAB2IP
prerank,regulation of cation channel activity (GO:2001257),-0.23607173000248122,-0.8462673761014285,0.8154362416107382,0.938318866696605,1.0,22/89,18.28%,ANK2;ACTN2;NLGN2;DMD;CAMK2D;DLG1;DLG4;SLMAP;CACNB4;PRKACA;PRRT1;PTK2B;CACNB2;GRIA3;JPH1;CACNB1;CAPN1;FGF11;KCNAB1;VAMP2;AHNAK;JPH2
prerank,regulation of microglial cell activation (GO:1903978),-0.35133679017747066,-0.8460481343668065,0.6636771300448431,0.9379244814795467,1.0,4/15,18.20%,LDLR;SPHK1;GRN;PTPRC
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.34611072042608615,-0.8459047553649469,0.6752941176470588,0.9373336378891733,1.0,2/14,4.08%,NMNAT2;ME1
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.35940111177013856,0.8458686680083206,0.6690140845070423,0.9329307666252471,1.0,1/21,0.99%,BCL2L1
prerank,positive regulation of synaptic transmission (GO:0050806),0.2872532850235714,0.845818058467968,0.7052785923753666,0.9324694480042583,1.0,15/72,17.38%,SHANK3;APP;SLC24A2;CLSTN1;NPS;NRXN1;EIF2AK4;AGER;GRIN2B;GRIK2;PLK2;NLGN1;RIMS2;LGI1;CCR2
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.3731244357033933,0.8452372525287007,0.68,0.9330470077210267,1.0,2/18,3.74%,JAK3;DUSP3
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.3016350742824745,0.8451539240935158,0.6807228915662651,0.932118742924627,1.0,19/56,27.71%,NDUFAF3;NDUFA2;NDUFA8;NDUFAF7;DMAC2;TMEM126B;NDUFA12;NDUFB3;NDUFAF8;NDUFC1;NUBPL;NDUFA10;DMAC1;ECSIT;NDUFA7;TIMMDC1;TIMM21;NDUFS5;NDUFAB1
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.3016350742824745,0.8451539240935158,0.6807228915662651,0.932118742924627,1.0,19/56,27.71%,NDUFAF3;NDUFA2;NDUFA8;NDUFAF7;DMAC2;TMEM126B;NDUFA12;NDUFB3;NDUFAF8;NDUFC1;NUBPL;NDUFA10;DMAC1;ECSIT;NDUFA7;TIMMDC1;TIMM21;NDUFS5;NDUFAB1
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.349696944456649,0.8447211751455148,0.6672297297297297,0.9324214189434726,1.0,8/24,25.89%,PLA2G4B;ABCA3;CDS2;PNPLA8;PGS1;LPCAT4;GPAM;LPCAT1
prerank,response to hexose (GO:0009746),-0.30943901025134246,-0.8443281001656555,0.6911392405063291,0.9396001478418589,1.0,3/25,8.02%,THBS1;IRS2;SELENOS
prerank,negative regulation of response to biotic stimulus (GO:0002832),-0.29911946038285164,-0.8442888732440605,0.7022900763358778,0.9387827163862975,1.0,8/26,18.63%,TRAFD1;PPM1B;IRAK3;SIRT2;MAPKBP1;PCBP2;C1QBP;MUL1
prerank,neuromuscular synaptic transmission (GO:0007274),-0.3344383196820987,-0.844203280321772,0.6633906633906634,0.9380774857191064,1.0,4/18,15.76%,FCHSD2;DTNA;SLC5A7;STAC3
prerank,cellular response to UV (GO:0034644),0.28332832694324156,0.8434402383959458,0.724679029957204,0.9343317507067382,1.0,20/76,22.10%,POLK;HYAL2;N4BP1;OPN5;RHBDD1;COPS9;EIF2AK4;MMP1;OPN3;TRIAP1;PTPRK;NOC2L;NSMCE3;BAK1;POLD1;DDB1;INO80;METTL3;HYAL1;ERCC4
prerank,resolution of meiotic recombination intermediates (GO:0000712),-0.33917369833228034,-0.8432113136243496,0.6399026763990268,0.9392915832746768,1.0,8/16,39.96%,TOP2B;TOP2A;HFM1;MEIOB;EME1;SHOC1;CENPS;MUS81
prerank,cortical actin cytoskeleton organization (GO:0030866),-0.3280478705790081,-0.8431522998889894,0.6926605504587156,0.9385269425874769,1.0,4/20,7.79%,ROCK2;RHOQ;DLG1;FHOD1
prerank,positive regulation of translational initiation (GO:0045948),-0.3309338528279057,-0.8430305717866914,0.687192118226601,0.937894155276307,1.0,6/18,28.48%,HABP4;DDX3X;YTHDF1;RPS6KB1;CDC123;BOLL
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.24213589382415548,0.8428305744719262,0.8284090909090909,0.9349627129419211,1.0,95/341,23.33%,RNF144B;ZNRF1;TRIM25;NEDD4L;PELI1;RNF125;ZNRF3;CTNNB1;KLHL25;ATXN3;FBXW7;RFFL;ZFAND2A;PSMB3;RNF215;UBE2G1;PSMD11;PSMC6;FEM1C;PSME2;NDFIP2;PPP1R11;SMURF1;KCTD10;KLHL3;OTUD7A;UBXN1;KLHL20;SHARPIN;UBQLN1;TOLLIP;RNF130;UBE3D;PSMD8;GSK3A;TNFAIP3;RNF187;MAEA;ARRDC1;PSMB10;BUB3;FBXO21;NHLRC1;AREL1;RBX1;RNF8;PTTG1;ANAPC16;UBE2D3;TRIM2;PSMA8;RAD23A;ATE1;BAG6;ANAPC7;ARMC8;UBE2G2;CBL;GID8;BFAR;RNF19A;TRIM71;TRIM3;ANAPC10;KCTD17;PSMD9;SIAH1;VPS37A;UBE2D1;RNF4;RBCK1;ANAPC2;OTUD7B;RNF166;NSFL1C;FBXO8;PLAA;ANKRD9;MIB1;DDB1;ERCC8;VPS37B;CNOT4;RLIM;VPS37C;CDC23;RAD23B;PSMD1;PSMC3;CDC27;UBL7;RNF126;FBXL14;PSMD10;CDC26
prerank,chromatin assembly or disassembly (GO:0006333),0.3982423010767677,0.842744908292401,0.6672727272727272,0.9345877758388876,1.0,4/11,19.18%,CHAF1A;CHAF1B;HIRIP3;NOC2L
prerank,peptidyl-serine phosphorylation (GO:0018105),0.26112908583063477,0.8424214291376213,0.7583547557840618,0.9346603454877321,1.0,13/153,6.91%,PRKCH;PDGFB;STK38;PKN3;RPS6KA1;PRKD2;PRKD1;IKBKB;MAST4;PIKFYVE;PKN1;RPS6KA5;PKN2
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.3954967910921269,0.8424083293112586,0.6472795497185742,0.934138460999354,1.0,5/11,15.71%,TGFB2;SMAD7;TGFB1;TGFBR2;ACVR1
prerank,response to calcium ion (GO:0051592),0.2782477718082003,0.8422796779890384,0.7634691195795007,0.9338301354039658,1.0,24/102,18.50%,ITPKB;CAV1;MEF2C;MCOLN1;CALM1;ACER1;CPNE8;SYT7;HOMER1;RASGRP2;IQGAP1;CLIC4;CPNE5;PPP3CA;SYT4;CPNE6;PDCD6;NLGN1;CPNE3;CRHBP;TTN;NEUROD2;KCNIP2;CPNE1
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.41306172026364374,0.8420867532719256,0.653211009174312,0.9336453845102273,1.0,1/10,2.08%,TIRAP
prerank,nucleoside salvage (GO:0043174),0.4209369518693881,0.8417888946658851,0.6525096525096525,0.9336906399958225,1.0,1/10,3.05%,HPRT1
prerank,regulation of mitochondrial fission (GO:0090140),-0.30812987058964714,-0.840901601595316,0.6843373493975904,0.9413311255440001,1.0,7/24,14.18%,DCN;MCU;PRKN;MIEF1;LRRK2;DDHD1;MIEF2
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.23865646037153765,-0.8404414692108613,0.7960526315789473,0.9413769478771857,1.0,17/80,16.14%,DENND2A;SGSM2;SNX6;GBF1;SNX12;STX5;ARL1;TBC1D10A;RAB29;SNX5;SNX8;RAB6A;STX16;LMAN1;TRAPPC10;SURF4;SNX32
prerank,cellular senescence (GO:0090398),0.33892446761819933,0.8403517327311024,0.6809917355371901,0.9358687220565439,1.0,6/27,11.71%,TBX3;CDKN2B;KAT6A;TERF2;HMGA1;HRAS
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.35815674374861695,0.8395402420195619,0.6419965576592083,0.9368684019697685,1.0,4/18,16.40%,LYN;CD19;SH2B2;BAG6
prerank,positive regulation of TOR signaling (GO:0032008),-0.2748594950429033,-0.8395123903815732,0.7011494252873564,0.9424067839963827,1.0,11/40,23.17%,FNIP1;KLHL22;SEH1L;RHEB;CLEC16A;LAMTOR3;RRAGA;SMCR8;FLCN;LARS1;SLC38A9
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.2842567510357193,-0.8394863263714166,0.749379652605459,0.9415782861668771,1.0,5/33,6.41%,KANK2;FHL1;PKD2;DLG1;DACT1
prerank,protein localization to nucleus (GO:0034504),-0.23019645283850004,-0.8394540958293608,0.8070866141732284,0.9407549596083093,1.0,28/102,26.53%,COL1A1;APPL2;BMP7;BMP4;LMNA;RANBP17;SIX1;PML;TOR1AIP1;TAF8;PAF1;MORC3;E2F3;SIX4;FAM53B;IPO7;CNEP1R1;BBS4;WRN;GBP2;HIKESHI;MSX1;KPNB1;IPO8;STAT3;NOP53;NUP155;TPR
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.3217366433436519,-0.8389713837208016,0.6909090909090909,0.9407966118038584,1.0,3/20,5.68%,MCU;SLC8A3;SLC8B1
prerank,negative regulation of biosynthetic process (GO:0009890),-0.3316450854149967,-0.8388994748196108,0.6605080831408776,0.9400643399561401,1.0,4/16,12.09%,SLC30A10;PPARA;EMILIN1;TRAP1
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.3341743310232891,0.8388109729944849,0.6683587140439933,0.9377139947242817,1.0,9/30,16.40%,RYBP;HSP90AB1;N4BP1;UBXN1;SVIP;SDCBP;RPL11;TRIM39;BAG6
prerank,macrophage activation involved in immune response (GO:0002281),0.38387880423149184,0.8386785896980975,0.6386404293381037,0.9374317102079827,1.0,5/13,20.26%,DYSF;SYK;SBNO2;NMI;PLCG2
prerank,negative regulation by host of viral process (GO:0044793),0.39495856062107737,0.8385324550153788,0.626641651031895,0.9371491650951833,1.0,5/10,25.45%,EIF2AK4;CCNK;PSMC3;PTX3;ZC3H12A
prerank,plasma membrane tubulation (GO:0097320),0.3898433373591289,0.8382967729160357,0.657608695652174,0.9370372245279998,1.0,2/13,9.40%,FNBP1L;CAVIN2
prerank,mitotic nuclear division (GO:0140014),-0.23869478161680643,-0.8379170275062718,0.8055555555555556,0.9411558022857037,1.0,31/71,31.99%,KLHL22;FLNA;GOLGA2;ZWINT;SMC4;PIBF1;CENPK;KLHDC8B;SPICE1;TUBG1;STAG2;KIF18A;NUSAP1;MISP;CCDC61;KNSTRN;TPX2;KIFC1;NSL1;UBE2S;KPNB1;KIF11;SGO1;CDCA8;CEP192;ABRAXAS2;BCCIP;ABRAXAS1;TOGARAM2;PLK1;ESPL1
prerank,DNA methylation (GO:0006306),-0.31399323259200096,-0.8378645786055876,0.6932989690721649,0.9404001333389955,1.0,10/23,30.81%,DNMT3A;EHMT2;PPM1D;ATF7IP;TEX15;ZFP57;METTL4;PICK1;FOS;BAZ2A
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.317827292839924,-0.8377870206121776,0.7086419753086419,0.9396639350650383,1.0,9/23,28.25%,PRCC;ZWINT;ZWILCH;PLK5;CHMP4C;VPS4A;INTS3;PLK3;SETMAR
prerank,protein complex oligomerization (GO:0051259),0.27903552914981855,0.8377295743840166,0.7290780141843972,0.9376149319812623,1.0,17/85,16.77%,AQP11;LRRC8C;KCNC2;HOMER1;SHMT2;MAT2A;LETM1;EHD4;LRRC8D;BCL10;TRMT61B;ELAVL1;TWNK;CARD11;PDCD6IP;SPAST;NLRC4
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.3096803412390773,-0.836704641606019,0.7279596977329975,0.9409206608787596,1.0,9/24,17.14%,PKD1;APOE;PRKACA;PSME3;PTK2B;ATP5IF1;RHBDF1;NUB1;LATS1
prerank,positive regulation of cellular catabolic process (GO:0031331),0.2626540709426178,0.8364934093692491,0.7676240208877284,0.9393801903365645,1.0,23/132,12.65%,INSR;SH3BP4;APP;PRR5L;TRIM14;FOXO1;PRKD1;ENTPD5;IRGM;P2RX7;MSN;GTPBP1;PFKFB3;PIK3C2A;ABCD1;GSK3A;SH3GLB1;HIF1A;ORMDL3;DXO;PIK3CB;SVIP;TFEB
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.3204389400584342,-0.8363484986383709,0.6923076923076923,0.9407725176563768,1.0,7/20,20.49%,NR2F2;CDK5RAP1;PTEN;CDKN1C;MYOCD;LATS1;IPO7
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.304030451920349,-0.8353048018759164,0.7004716981132075,0.9419655265207978,1.0,11/23,32.27%,GJA1;GPSM2;FBXW11;MAD2L1;MISP;HTT;SPDL1;NUMA1;ITGB1;PLK1;PKHD1
prerank,myofibril assembly (GO:0030239),0.31165177742001476,0.8352718438482206,0.7018633540372671,0.9411234801366317,1.0,2/42,1.55%,FLII;PGM5
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.33044981268117973,0.835050157638128,0.6868852459016394,0.9410300067281183,1.0,10/32,19.82%,HMBOX1;CTNNB1;MAPK3;CCT3;ACD;CCT5;MAPK1;CCT7;NAF1;MAP2K7
prerank,positive regulation of glycolytic process (GO:0045821),0.36214775525049164,0.8349909263600086,0.6731107205623902,0.9400575508399289,1.0,6/20,11.75%,INSR;APP;ENTPD5;P2RX7;PFKFB3;HIF1A
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.36214775525049164,0.8349909263600086,0.6731107205623902,0.9400575508399289,1.0,6/20,11.75%,INSR;APP;ENTPD5;P2RX7;PFKFB3;HIF1A
prerank,lipoprotein catabolic process (GO:0042159),0.39796972463613767,0.8347620836364812,0.666077738515901,0.9399367832691592,1.0,3/11,8.87%,NOTUM;ABHD17A;LYPLA1
prerank,positive regulation of actin nucleation (GO:0051127),-0.37082252423548634,-0.8343364344722345,0.6869369369369369,0.9430176904499883,1.0,3/11,7.43%,GSN;FCHSD2;ABI2
prerank,regulation of axon guidance (GO:1902667),-0.38272052759370523,-0.8335961661862142,0.6845493562231759,0.9435498227427678,1.0,3/10,16.74%,ZSWIM8;YTHDF1;TUBB2B
prerank,NAD biosynthetic process (GO:0009435),0.3533695359378736,0.8332492550648521,0.6569965870307167,0.9422287976939655,1.0,1/20,0.77%,NAMPT
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.3225965615815399,0.8331535056548892,0.7037617554858934,0.9418662610861895,1.0,9/32,23.12%,TAF1B;MAPK3;GTF2H2;RRN3;GTF2H4;UBTF;POLR1A;GTF2H3;TAF1C
prerank,regulation of platelet aggregation (GO:0090330),0.3647146794350634,0.8330444654974194,0.6360544217687075,0.9415257417299565,1.0,5/17,12.26%,F11R;LYN;PRKG1;SYK;CEACAM1
prerank,myotube differentiation (GO:0014902),0.3700398199825461,0.8323302149357161,0.6740994854202401,0.9423046707013911,1.0,3/17,5.20%,JAM2;MEF2C;SORT1
prerank,cellular response to heat (GO:0034605),-0.28141219475657053,-0.8319716966290832,0.7546666666666667,0.9458566909317829,1.0,14/35,26.53%,FGF1;THBS1;ANO1;PRKACA;HTRA2;BAG3;TCIM;HSBP1;CLPB;RBBP7;HIKESHI;HSPA1A;HMOX1;TPR
prerank,cellular response to inorganic substance (GO:0071241),0.3530459909837232,0.8315600048976322,0.680628272251309,0.9432086570789888,1.0,2/21,5.32%,FOXO1;KCNC2
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.335195610116518,0.8313661849603458,0.6798623063683304,0.9429944166003723,1.0,2/27,2.60%,UTRN;NEDD4L
prerank,peroxisome organization (GO:0007031),-0.30607823008976215,-0.830961237541501,0.7128463476070529,0.9469050706814737,1.0,6/25,14.11%,ABCD3;ACOT8;SEC16B;PEX7;PEX2;TMEM135
prerank,mRNA polyadenylation (GO:0006378),0.33267967997261955,0.8309561288567314,0.6793103448275862,0.9426801847450237,1.0,4/26,10.76%,APP;MTPAP;CPSF1;SSU72
prerank,RNA polyadenylation (GO:0043631),0.33267967997261955,0.8309561288567314,0.6793103448275862,0.9426801847450237,1.0,4/26,10.76%,APP;MTPAP;CPSF1;SSU72
prerank,placenta development (GO:0001890),0.3877890891923098,0.8301533771319006,0.6684981684981685,0.9436796209873434,1.0,2/12,12.29%,PTK2;PPARG
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.3115488257623996,-0.8295285399776262,0.7083333333333334,0.9488251940591278,1.0,7/22,20.49%,NR2F2;CDK5RAP1;PTEN;CDKN1C;MYOCD;LATS1;IPO7
prerank,macromolecule catabolic process (GO:0009057),0.33330767758716284,0.8289921607076443,0.6971608832807571,0.9452599368485591,1.0,13/26,27.58%,TGFB1;TRIM24;SMURF1;SH3GLB1;CLN8;USE1;SIAH1;UVRAG;LGMN;SNX25;MTOR;PPT1;BECN1
prerank,alpha-linolenic acid metabolic process (GO:0036109),-0.3538748074498082,-0.8288691052456298,0.6854838709677419,0.949186943037351,1.0,2/12,5.75%,ACSL1;ACOT8
prerank,regulation of response to oxidative stress (GO:1902882),-0.3534645258398412,-0.8288126373761155,0.6991341991341992,0.9484207876947234,1.0,9/11,42.27%,PRKN;AIFM2;ACOX2;HEBP2;MCTP1;STOX1;SELENON;ALOX5;PINK1
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.2798322617540968,0.8287610423343014,0.7402402402402403,0.9451421805206096,1.0,10/76,7.31%,APP;NFKBIA;NOD1;NOD2;HDAC7;TMSB4X;TLR3;ACTN4;LGALS9;TLR7
prerank,triglyceride catabolic process (GO:0019433),0.36289375156952725,0.8285578061736001,0.6606822262118492,0.9449624157550592,1.0,2/19,9.49%,LIPC;FABP5
prerank,protein maturation (GO:0051604),-0.22948046628481705,-0.8282564403251148,0.8526315789473684,0.9486069172652328,1.0,15/95,12.73%,AEBP1;PCSK5;MMP14;MMP16;F3;OGT;NAA35;NNAT;ADAM19;CPXM1;CPXM2;CLN3;LMF1;AFG3L2;PSEN1
prerank,acyl-CoA metabolic process (GO:0006637),0.3229618622430235,0.8279898310564401,0.6942675159235668,0.9455223445681055,1.0,5/35,7.76%,HMGCS2;ACBD6;GLYAT;ACACB;ACSL6
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.2695457148962996,-0.827951210222289,0.7744360902255639,0.9483261906159984,1.0,7/40,13.95%,PID1;SLC25A36;BCL2;PPA2;LRRK2;ABL1;ATP5IF1
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.28708568065966816,-0.8273739285281845,0.725,0.948599569719189,1.0,5/28,9.91%,ITPR1;MAP3K5;TMEM117;BCL2;CEBPB
prerank,cell projection organization (GO:0030030),0.32687597651185535,0.8268162801413498,0.7086614173228346,0.9471647057235609,1.0,8/30,15.04%,PARVB;PARVG;NCKAP1;CAPG;CYFIP1;RAC1;RHOV;NCKAP1L
prerank,negative regulation of neuron death (GO:1901215),0.2669604180627067,0.8267802740826236,0.760752688172043,0.9466797076410116,1.0,15/93,16.05%,NDNF;CD34;CD200;MEF2C;RETREG1;TOX3;CD200R1;FOXQ1;CNTF;KIR3DL2;MAG;UNC5B;BTBD10;MSH2;PTPRZ1
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.28332479075403044,0.826587451016853,0.7688953488372093,0.9465000548978084,1.0,20/76,19.56%,CAV1;DCUN1D3;SMAD7;XIAP;FAM107A;FBXW7;BIRC3;MALT1;NDFIP2;UBQLN1;GSK3A;DCUN1D1;WDR48;BCL10;INAVA;PTTG1IP;TNIP1;UBE2D1;FKBP1A;NSMCE3
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.39965873072632196,0.825964175662269,0.6724137931034483,0.9471400628035141,1.0,3/11,12.21%,LGALS9;CBFB;VSIR
prerank,cellular response to decreased oxygen levels (GO:0036294),0.288959725226337,0.8252644014657717,0.7443267776096822,0.9479431381447412,1.0,11/65,13.07%,NDNF;EPAS1;RGCC;AK4;EGLN2;BNIP3L;UBQLN1;ZFP36L1;HIF1A;EGLN1;HIPK2
prerank,positive regulation of intracellular protein transport (GO:0090316),-0.2157987064540829,-0.825241078287117,0.9121338912133892,0.9517458255530954,1.0,33/144,17.65%,ZIC1;SMAD3;CEMIP;CDH1;PRKCD;FLNA;BCL2;SAR1A;NPEPPS;UBR5;MIEF1;BID;RNF31;SEC16B;ITGB1BP1;HUWE1;RAB29;BCAS3;EMD;PSEN1;SEC16A;HTRA2;PCM1;BAG3;MIEF2;CD81;PIK3R1;KCNB1;CAMK1;VAMP2;C2CD5;TFDP2;ABLIM3
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.3282475923434299,-0.8248568504405819,0.6960556844547564,0.951629669311328,1.0,5/16,15.29%,TNKS2;ATM;RTEL1;PARP1;HNRNPA2B1
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.3628423707040469,0.8247842347262783,0.6622390891840607,0.9483010403461314,1.0,5/14,16.44%,ACOX1;CRAT;ABCD1;ECI2;DECR2
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.3713596091411405,0.8242288343942713,0.6861702127659575,0.9488007548073004,1.0,5/15,23.64%,FAM107A;ZFP36L1;NR3C1;ZFP36L2;ISL1
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.29649696632803507,0.8241129957023271,0.7071651090342679,0.9484984896311955,1.0,7/49,10.71%,IL6R;ARL2BP;CD40;LYN;STAP2;PTK6;CNTF
prerank,negative regulation of fat cell differentiation (GO:0045599),0.31451331399774335,0.8235061281259117,0.7055016181229773,0.9490720168397062,1.0,8/34,10.94%,FOXO1;ZFPM1;CCDC85B;GATA2;WWTR1;TGFB1;TRIB2;FERMT2
prerank,regulation of mitotic cell cycle (GO:0007346),0.2537845355741447,0.8233988429837906,0.8252788104089219,0.948730118298601,1.0,53/171,23.33%,APP;AFAP1L2;DUSP3;TAL1;BTG4;TTC28;PSMB3;PKN2;PSMD11;HECA;TGFB1;PIN1;IQGAP1;PSMC6;CAV2;PSME2;BTG1;BRINP3;BRINP2;PSMD8;BTG2;EIF4E;SDCBP;MAEA;CYLD;PSMB10;BUB3;PIM2;TTL;ANAPC16;PSMA8;ANAPC7;SKP1;CDK11B;ANAPC10;PSMD9;UBE2D1;ANAPC2;PIM3;ASNS;BTG3;TFAP4;DDB1;CUL1;CDC23;SCRIB;PSMD1;PSMC3;CDC27;LGMN;CDKN1B;PSMD10;CDC26
prerank,DNA alkylation (GO:0006305),-0.32161220270846025,-0.8233612448095088,0.691566265060241,0.9527368973592583,1.0,5/19,19.40%,DNMT3A;EHMT2;PPM1D;ATF7IP;TEX15
prerank,DNA methylation or demethylation (GO:0044728),-0.32161220270846025,-0.8233612448095088,0.691566265060241,0.9527368973592583,1.0,5/19,19.40%,DNMT3A;EHMT2;PPM1D;ATF7IP;TEX15
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.2887852655214248,0.8232473133872213,0.74079754601227,0.9484722468066039,1.0,14/56,20.26%,NOD1;NOD2;TLR3;CTSK;TLR7;IRAK2;TLR8;S100A8;BCL10;INAVA;CTSS;TRAF3;RPS6KA3;PLCG2
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.3772205477136379,0.8231724706848544,0.6660550458715596,0.9480797701174073,1.0,7/12,33.20%,TASOR;SETDB1;SETDB2;DNMT1;MPHOSPH8;PPHLN1;TRIM28
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.34580267923864333,0.8229333954449738,0.7009966777408638,0.9479746672550913,1.0,9/22,27.42%,GTF2H2;CETN2;GTF2H4;RBX1;DDB1;GTF2H3;RAD23B;XPC;UBB
prerank,positive regulation of viral genome replication (GO:0045070),0.324828142976647,0.8229007804836769,0.7159090909090909,0.9475040292175049,1.0,6/29,10.98%,FKBP6;ADAR;PPIA;PKN2;PDE12;NR5A2
prerank,membrane raft organization (GO:0031579),-0.3397016163715581,-0.8216877426292097,0.6975169300225733,0.9551088773376353,1.0,4/15,11.12%,ANXA2;S100A10;FLOT2;CLN3
prerank,regulation of lipid storage (GO:0010883),0.347821292430546,0.8213375308236368,0.6778169014084507,0.9498740531028833,1.0,2/22,6.50%,NFKBIA;FBXW7
prerank,glial cell differentiation (GO:0010001),0.32518822159543315,0.8213108361948415,0.7052980132450332,0.9493838909479579,1.0,8/28,17.88%,CDH2;MMP24;METRN;SOX10;SOX11;SOX9;PTPRZ1;TPPP
prerank,cell junction maintenance (GO:0034331),-0.3396263712591475,-0.820906317824176,0.7081545064377682,0.9557218153671482,1.0,6/14,31.00%,NLGN2;CLDN1;MYADM;CBLN2;PRTN3;PARD6A
prerank,myoblast fusion (GO:0007520),0.3772468767638647,0.8207931007073328,0.6880570409982175,0.9498266991316637,1.0,3/12,13.84%,JAM2;PTGFRN;ADAM12
prerank,GPI anchor metabolic process (GO:0006505),0.34031846964467827,0.820742431817261,0.7015437392795884,0.949389401090223,1.0,8/26,22.44%,PIGU;PIGM;PGAP4;PIGF;DPM3;PIGO;PIGV;PIGQ
prerank,regulation of mitochondrion organization (GO:0010821),-0.26380635407758607,-0.8206945363459115,0.7894736842105263,0.9552494640757231,1.0,12/47,19.16%,PID1;PPARGC1A;PRKN;LRRK2;HTRA2;EP300;MIEF2;SREBF1;PARL;RHOT1;MUL1;FLCN
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.36132578174399455,-0.8205761760065476,0.6898876404494382,0.9537378865514782,1.0,5/10,19.26%,NFAT5;NFATC4;PPP3CB;NFATC2;NFATC3
prerank,calcineurin-mediated signaling (GO:0097720),-0.36132578174399455,-0.8205761760065476,0.6898876404494382,0.9537378865514782,1.0,5/10,19.26%,NFAT5;NFATC4;PPP3CB;NFATC2;NFATC3
prerank,DNA packaging (GO:0006323),0.3686602335330835,0.820243168551914,0.7223230490018149,0.9497961042845782,1.0,5/16,19.18%,KAT6A;BANF1;CHAF1A;CHAF1B;NOC2L
prerank,transport along microtubule (GO:0010970),-0.3442330802059392,-0.8200699861705378,0.6810933940774487,0.9537888802669229,1.0,7/13,19.34%,ARHGAP21;CLIP3;DYNC1I1;SPG11;BAG3;APBA1;BORCS5
prerank,regulation of proteolysis (GO:0030162),0.2991557279394376,0.8198090761341269,0.7538699690402477,0.9500244447217204,1.0,3/48,2.27%,LTBP4;CAV1;PLAUR
prerank,negative regulation of cell division (GO:0051782),-0.3590872878085602,-0.8195578805101921,0.723175965665236,0.9539025458767223,1.0,4/11,22.91%,TXNIP;CHMP4C;VPS4A;E2F7
prerank,ubiquinone metabolic process (GO:0006743),-0.33706714740395405,-0.8193071165344946,0.7110091743119266,0.9534763686615972,1.0,5/15,20.41%,COQ10A;AIFM2;COQ2;COQ8B;COQ10B
prerank,positive regulation of secretion by cell (GO:1903532),0.2808283864606117,0.8192078522429652,0.7570789865871833,0.9505662617078222,1.0,9/70,7.94%,TGFB2;UNC13B;RGCC;STX1A;CD2AP;ABCG1;PPIA;UNC13D;TGFB1
prerank,mitochondrion organization (GO:0007005),0.2473574270165132,0.8191015613199114,0.8331257783312578,0.9502361550780243,1.0,26/165,16.71%,DNM3;BCL2L1;NOS3;ALAS1;TOMM22;BIK;SLC25A33;DNM2;MYH14;TIMM13;CAV2;FANCG;BNIP3L;TIMM10;SAMM50;VPS13D;DNAJC19;POLG2;HIGD1A;AFG1L;OMA1;MFF;TWNK;IMMP2L;HCFC1;GABPB1
prerank,fatty acid oxidation (GO:0019395),0.28796308342245114,0.819019159767428,0.7456828885400314,0.9498365265240539,1.0,14/57,18.78%,ADIPOR2;PPARD;ABCD4;ACOX1;ABCD1;ADIPOR1;SLC27A2;ADH5;HACL1;ECI2;ACAT1;CYP24A1;ACAD11;ABCD2
prerank,nuclear membrane disassembly (GO:0051081),-0.335656685003306,-0.8181492642723673,0.7188208616780045,0.9547998892567967,1.0,3/14,9.99%,NEK6;AKAP8L;PRKCA
prerank,tRNA wobble base modification (GO:0002097),-0.3432643535537595,-0.8181248565583435,0.6935123042505593,0.9539716576534649,1.0,4/14,15.31%,TRMT9B;ELP3;ALKBH1;ELP4
prerank,protein homotetramerization (GO:0051289),0.29976770002142794,0.8180064100611414,0.740340030911901,0.951204916418897,1.0,7/49,8.10%,B2M;HPRT1;GBP5;MCOLN1;SAMHD1;ACACB;SHMT2
prerank,regulation of cellular amine metabolic process (GO:0033238),0.29866056652017403,0.8178725701849481,0.7431192660550459,0.9509036211960882,1.0,23/50,32.37%,PSMB3;PSMD11;OAZ1;PSMC6;PSME2;PSMD8;PSMB10;PSMA8;PSMD9;OAZ2;PSMD1;PSMC3;PSMD10;PSME1;PSMB8;PSMD2;PSMA1;PSMA7;PSMB9;PSMF1;PSMB1;PSMA4;OAZ3
prerank,bone morphogenesis (GO:0060349),-0.3402064303786662,-0.8177597442581549,0.7139689578713969,0.9538002454829846,1.0,5/14,15.81%,FGFR2;CYP26B1;SFRP4;SKI;LRP6
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.2963567403007688,-0.8171617768322793,0.722488038277512,0.9540691525089854,1.0,8/22,26.18%,ERI3;ERI2;WDR12;NOP14;EXOSC2;NOP9;UTP20;ERI1
prerank,heart process (GO:0003015),-0.34567273332976023,-0.817129647037078,0.7354260089686099,0.953281621912999,1.0,3/14,7.80%,SGCD;ACE;NOX4
prerank,regulation of protein polymerization (GO:0032271),-0.2683013760648532,-0.8169442177986127,0.7543424317617866,0.9527537684875513,1.0,9/35,17.14%,ARHGAP28;FCHSD2;PLEKHG2;ARHGAP18;PFN2;ABL1;MAP2;CTTN;LATS1
prerank,protein targeting to mitochondrion (GO:0006626),0.29189059641869886,0.8168288430868865,0.7583081570996979,0.9522201081913589,1.0,19/52,29.26%,TOMM22;TIMM13;PMPCA;TIMM10;SAMM50;DNAJC19;MFF;IMMP2L;TOMM20L;TOMM7;CHCHD4;TOMM5;TIMM50;TIMM21;TOMM70;BCAP31;TIMM9;AIFM1;FIS1
prerank,ether lipid metabolic process (GO:0046485),-0.3414462889778337,-0.816693246812306,0.6882793017456359,0.9523593885346502,1.0,5/14,23.18%,AGMO;PEX7;PLA2G6;AGPS;GNPAT
prerank,RNA 3'-end processing (GO:0031123),0.2780357801811003,0.8165461616662929,0.7693430656934307,0.9522055319720345,1.0,8/69,11.11%,TENT4A;MTPAP;RNPS1;CSTF2;CPSF1;MAGOHB;THOC6;NCBP2
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.3415275398435907,-0.8163336717668702,0.7011494252873564,0.9521866855545658,1.0,2/14,3.26%,IL34;THBS1
prerank,negative regulation of transferase activity (GO:0051348),0.32239555103235346,0.8160505530177689,0.7138211382113822,0.952562884944153,1.0,14/28,31.04%,MEN1;SMAD7;GSK3A;TERF1;PINX1;INPP5K;ERCC4;CDKN1B;DTX3L;BAG5;PARK7;GSK3B;TP53;SRC
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.29211422173637647,-0.8159631882072333,0.7398568019093079,0.9520423267367416,1.0,6/26,17.78%,FBN1;HOXA7;TLR4;MAFB;RARA;INHA
prerank,nucleus organization (GO:0006997),0.297486820430107,0.8158121520564614,0.733652312599681,0.9524733347586058,1.0,10/47,17.06%,SYNE1;CHMP1B;LEMD3;NUP54;ATXN7;SUN1;PITPNB;PDCD6IP;REEP3;BIN1
prerank,spliceosomal snRNP assembly (GO:0000387),0.30400303410293184,0.8154775644448876,0.7091757387247278,0.9525550808929981,1.0,19/38,30.26%,SNRPF;SNRPE;SNRPC;SNRPB;AAR2;PRMT7;SNRPD2;LSM4;WDR77;PRPF8;SART3;SRSF12;DDX20;SMN1;COIL;SNRPD1;PRPF31;GEMIN5;PRPF6
prerank,regulation of TOR signaling (GO:0032006),0.2808295989113462,0.8154197781652925,0.7652173913043478,0.952123437054534,1.0,16/67,17.01%,SH3BP4;TNFAIP8L1;GNA12;WDR59;RFFL;LAMTOR5;DEPDC5;DDIT4;GSK3A;RPTOR;TMEM127;EPM2A;PDCD6;TBCK;LAMTOR4;GAS6
prerank,regulation of stem cell differentiation (GO:2000736),0.2706846928755718,0.8153709636043536,0.7626404494382022,0.951673467853409,1.0,12/89,11.68%,LMO2;NOTCH1;GATA2;TAL1;PSMB3;PSMD11;PTN;TCF12;PSMC6;PSME2;CBFB;PSMD8
prerank,negative regulation of transposition (GO:0010529),-0.32751819785911285,-0.8151754397245078,0.7268518518518519,0.9526203403793378,1.0,8/16,29.11%,TUT4;UBR2;TEX15;PIWIL2;MYBL1;TDRD9;DDX4;MOV10
prerank,glycolipid biosynthetic process (GO:0009247),-0.2785471422979663,-0.8147783313679934,0.787012987012987,0.9525160790720923,1.0,10/38,15.90%,LARGE1;ST3GAL4;A4GALT;ST3GAL5;GBGT1;PIGN;B4GALT6;ST6GALNAC5;PIGA;PIGP
prerank,phosphatidic acid metabolic process (GO:0046473),-0.25259807196334766,-0.8147343983593918,0.7906976744186046,0.9517418582894768,1.0,10/48,15.36%,PLD1;AGPAT4;LCLAT1;GPD1L;ACP6;PLA2G12A;DDHD1;GPAT3;PNPLA3;SLC27A1
prerank,kinetochore organization (GO:0051383),-0.3516321422285158,-0.8146735854660734,0.7053763440860215,0.9509908448489106,1.0,8/13,40.77%,CENPC;CENPE;CENPF;DLGAP5;NUF2;CENPW;CENPH;CDT1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.27299431260363066,0.8146029798534034,0.7673130193905817,0.9524995414939117,1.0,18/80,17.32%,SH3RF1;TNFSF10;NOD1;FOXL2;RPS6KA1;SOX7;XIAP;KLF4;MALT1;LAMTOR5;ARL6IP5;SYK;BCL10;PDCD6;DNAJB6;GAS6;PPM1F;TRIAP1
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.38110671835778787,0.8144673171025884,0.6910420475319927,0.9522223856755078,1.0,3/11,12.46%,STAT1;EBI3;IL27RA
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.3320523642262335,0.8141638414813763,0.7263843648208469,0.9522790050427251,1.0,4/26,6.91%,APP;DUSP3;TAL1;PKN2
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.28749766107440183,0.8139792046396157,0.7526395173453997,0.9520705314836713,1.0,20/57,23.57%,APP;MEF2C;LRRC7;GRIA4;AKAP9;GRIN2B;SHISA6;CNIH3;MINK1;CAMK2B;DLGAP3;NLGN1;CRHBP;NPTXR;NPTX1;GRIA2;CACNG2;OPRM1;GSG1L;GRIN1
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.350304902333134,-0.813844918413647,0.7079439252336449,0.9516662874402976,1.0,6/13,27.46%,CBLB;KPNA3;KPNA6;KPNB1;KPNA1;NUP35
prerank,cellular response to retinoic acid (GO:0071300),0.29941305962346204,0.8138064964120048,0.7136563876651982,0.9518207972783284,1.0,9/42,11.42%,TBX1;FZD4;LYN;CREB1;RET;TWF2;BRINP3;PTK6;BRINP2
prerank,lipid catabolic process (GO:0016042),0.36070169785370704,0.8135663580142073,0.6955782312925171,0.951712798597224,1.0,2/18,7.28%,LIPE;LIPC
prerank,positive regulation of neuron differentiation (GO:0045666),0.3063568684587697,0.8135135290495269,0.7449139280125195,0.9512665251322099,1.0,12/40,18.50%,ARHGEF2;MEF2C;MMD;ADRA2B;BRINP3;BRINP2;SOX11;NRCAM;PROX1;SIN3A;NEUROD2;CPNE1
prerank,protein N-linked glycosylation (GO:0006487),0.28042277305298546,0.813173128328233,0.7786032689450223,0.9513167112407294,1.0,7/66,7.56%,SLC39A8;ST3GAL1;FUT8;STT3B;ENTPD5;GAL3ST1;ST6GAL1
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.36164081047638386,0.8130864318712431,0.6981818181818182,0.95094261812899,1.0,4/17,18.50%,CXCL12;CCL1;CCR2;MOSPD2
prerank,plasma membrane invagination (GO:0099024),0.32591000469829234,0.8130285083844112,0.6857610474631751,0.9505026243140081,1.0,3/29,6.66%,DOCK1;ELMO1;ARHGAP25
prerank,leukotriene metabolic process (GO:0006691),-0.3067187719826452,-0.8123937438894527,0.7384259259259259,0.9533591744240423,1.0,10/19,33.08%,GGT5;ABCC10;MGST3;PTGR1;ABCC1;MAPKAPK2;PLA2G5;ALOX12;DPEP1;GGT1
prerank,tRNA modification (GO:0006400),-0.24981774823395297,-0.8123398505201123,0.84375,0.952598280278108,1.0,19/62,21.56%,THADA;TRMT9B;THUMPD3;NSUN2;OSGEP;METTL6;ALKBH1;PUS7;ELP5;DUS2;PUS10;TRIT1;TPRKB;TYW5;TRMT112;DTWD1;BCDIN3D;ANKRD16;LCMT2
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.3274138844237947,-0.8120539125162805,0.7400468384074942,0.9522597406331224,1.0,6/15,33.72%,CPEB2;DDX3X;GSTO1;DHX36;ZFAND1;HSF1
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.33213865990714164,-0.8115367089499448,0.7268623024830699,0.9523589403404017,1.0,7/16,17.16%,AMPD3;PAICS;LHPP;IMPDH2;GMPS;ATIC;ADSL
prerank,protein import into peroxisome membrane (GO:0045046),-0.3047795522319822,-0.8113025528087247,0.7426636568848759,0.9519274402854042,1.0,6/22,23.62%,ABCD3;PXMP2;PEX2;ALDH3A2;ATAD1;PEX13
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.2810560418178836,0.810669193838463,0.7568345323741007,0.9541884467562077,1.0,20/70,23.32%,B2M;IKBKB;PSMB3;PSMD11;MFSD6;PSMC6;TAP2;PSME2;CYBB;PSMD8;NCF4;PSMB10;PSMA8;PSMD9;TAP1;VAMP8;PSMD1;PSMC3;CALR;PSMD10
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.34426328339133827,0.8098849672254443,0.688695652173913,0.9551643156573209,1.0,10/20,25.88%,ADAM10;TGFB1;RHBDD1;ADAM17;APH1A;SPPL2A;APH1B;TRAF6;MBTPS2;NCSTN
prerank,response to unfolded protein (GO:0006986),0.28748358046187267,0.809868152463132,0.746177370030581,0.9546610227862292,1.0,10/48,19.73%,DAB2IP;HSP90AB1;STT3B;RHBDD1;HSPA8;HSPB1;DNAJA1;HSPE1;HSPA9;BAK1
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.3746689809605577,-0.8093717760420568,0.7094017094017094,0.9545295424457841,1.0,4/10,17.29%,ALDH7A1;HNMT;COMT;SARDH
prerank,negative regulation of immune response (GO:0050777),0.24944276894058243,0.8093078426178193,0.8174807197943444,0.9551299274353103,1.0,25/154,12.29%,RHBDF2;RAMP2;CALCRL;LYN;PLCG1;CREB1;RAMP3;PRKACB;FYN;INSL3;YES1;ADCY4;HCK;PRKAR2B;NPS;FOXP3;CALCB;ADAM17;PRKAR2A;ADCYAP1R1;CYSLTR1;CD163;SYK;TNFAIP3;GNB1
prerank,transcription by RNA polymerase I (GO:0006360),0.31060495749709044,0.8088071575787069,0.7352941176470589,0.9555039133023641,1.0,9/34,23.12%,TAF1B;MAPK3;GTF2H2;RRN3;GTF2H4;UBTF;POLR1A;GTF2H3;TAF1C
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.3100975895175663,0.8086352928399311,0.7375201288244766,0.9552594462943056,1.0,10/37,16.40%,RYBP;HSP90AB1;N4BP1;RPS7;UBXN1;HIPK2;SDCBP;RPL11;TRIM39;BAG6
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.31854432930612486,0.807169318975168,0.7266881028938906,0.9573330097269062,1.0,2/31,7.49%,GCH1;GPHN
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.3626502297050993,-0.8069562135398755,0.6917808219178082,0.9579305005835891,1.0,5/10,19.16%,PRKAA2;KLF15;SETD5;MYOCD;FLCN
prerank,pseudouridine synthesis (GO:0001522),-0.3511912113217689,-0.8068621375133235,0.7235955056179775,0.957219827865697,1.0,3/13,14.74%,PUS7;PUS10;GAR1
prerank,regulation of lipid metabolic process (GO:0019216),0.2674366091070066,0.80636219888836,0.7950138504155124,0.9582011698023006,1.0,18/88,14.35%,CAV1;FASN;PPARD;NCOA1;ACACB;NCOA2;ZFP69;ABCA7;OPA3;LACTB;HELZ2;ELOVL6;ADIPOR1;HMGCR;PPARG;EDF1;DISP3;SP1
prerank,regulation of protein catabolic process (GO:0042176),0.2636105509281654,0.8060844841663088,0.7994542974079127,0.9581558278394674,1.0,19/99,16.21%,DAB2IP;NKD1;NEDD4L;FOXO1;SNX3;EGLN2;OAZ1;PIN1;SMURF1;GSK3A;HGS;HMGCR;TNFAIP3;TNFSF12;ASB5;AREL1;PLK2;GFAP;APC
prerank,global genome nucleotide-excision repair (GO:0070911),0.3302170633164151,0.806064680071809,0.7292006525285482,0.9576601580724664,1.0,11/26,27.42%,GTF2H2;CETN2;GTF2H4;RBX1;DDB1;GTF2H3;RAD23B;ERCC4;XPC;USP45;UBB
prerank,cellular response to hypoxia (GO:0071456),0.25423287838233,0.805870618235897,0.8052631578947368,0.9574636218475624,1.0,22/126,16.30%,NDNF;EPAS1;RGCC;AK4;PSMB3;EGLN2;PSMD11;PSMC6;BNIP3L;PSME2;UBQLN1;ZFP36L1;PSMD8;HIF1A;HIGD1A;EGLN1;HIPK2;PSMB10;RBX1;ELOB;PSMA8;OPRD1
prerank,regulation of cellular catabolic process (GO:0031329),-0.23874094629653775,-0.8056107487694769,0.8388157894736842,0.9585825939012282,1.0,18/62,19.71%,ITPR1;NUPR1;DAPK2;PRKN;ATM;PIP4K2C;MTMR3;LRRK2;ABL1;EP300;WDR41;RRAGA;CISD2;DDIT3;PSAP;SMCR8;USP13;RAB39B
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.28818292908395815,0.8054572272101167,0.7466666666666667,0.9576529941778278,1.0,18/57,20.14%,TNFSF10;NOD1;FOXL2;SOX7;FYN;AIM2;MALT1;CASP8;ARL6IP5;GRIN2B;SYK;BCL10;PDCD6;NLRC4;PPM1F;CYCS;BAK1;F2R
prerank,protein K48-linked ubiquitination (GO:0070936),0.28685692398436136,0.8054408302639067,0.7443946188340808,0.9571528006454799,1.0,16/54,18.60%,ZNRF1;NEDD4L;PELI1;RFFL;UBE2G1;KLHL3;TNFAIP3;RNF187;RBX1;RNF8;UBE2D3;UBE2Q2;UBE2G2;BFAR;UBE2D1;RNF4
prerank,regulation of cell killing (GO:0031341),-0.3242013505566601,-0.805382037685773,0.7527352297592997,0.958164784382571,1.0,5/16,13.64%,CD55;CFH;FZD7;CYBA;DVL2
prerank,organelle organization (GO:0006996),0.2277875490514028,0.805171571850973,0.9147286821705426,0.9570963545119247,1.0,53/388,13.94%,FGD5;SEMA6A;ARAP3;SYNE1;NOS3;CAV1;FNBP1L;FMNL3;RAB31;NEDD9;ALAS1;SIPA1;PRKD1;MCOLN1;ABCD4;MAST4;PIKFYVE;SORT1;USP6NL;PPIA;ABCA3;SLC25A33;PAK5;COG3;CECR2;MARK4;RAB34;CHMP1B;DPYSL2;ARHGEF7;CAV2;FANCG;ARHGAP4;FGD6;RANBP10;STRIP1;KLHL20;PDZD8;REEP5;ABCD1;VPS13D;PEX14;CEP78;EPS15;TNFAIP3;RANBP9;POLG2;ATXN7;RAB1A;FGD2;AFG1L;TSGA10IP;CFL1
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.3752053486880883,0.8050841267595209,0.684981684981685,0.9567257481379394,1.0,4/13,26.65%,PVR;CYRIB;NECTIN2;IL12A
prerank,ncRNA metabolic process (GO:0034660),-0.26462376940737725,-0.8050243954180861,0.7711864406779662,0.9579929990388115,1.0,14/37,28.41%,TUT4;AGO2;XPO5;DDX17;EXD1;DTD1;BCDIN3D;PIWIL2;TARBP2;PARN;DROSHA;DTD2;TDRD9;DDX4
prerank,regulation of organelle assembly (GO:1902115),0.2728615153527269,0.8048237518225461,0.780281690140845,0.9566589266888789,1.0,19/72,18.60%,TBC1D14;TBC1D22A;TBC1D12;TBC1D2;PIKFYVE;USP6NL;TBC1D24;TBC1D5;HCK;MSN;TBC1D10B;CYLD;PLK2;TBC1D1;PDCD6IP;TBC1D22B;IFT140;TBC1D15;RNF4
prerank,chromatin remodeling at centromere (GO:0031055),-0.2707807886747655,-0.8045344035424632,0.7780678851174935,0.9579966895193376,1.0,8/31,18.57%,CENPC;CENPP;CENPK;SMARCA5;MIS18BP1;CENPL;RBBP4;CENPQ
prerank,microtubule anchoring (GO:0034453),-0.3454995157379799,-0.8032509909025638,0.7204301075268817,0.9594091367059058,1.0,3/12,13.98%,DAG1;BICD1;PCM1
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.2653701536353028,-0.8032229224322229,0.7727272727272727,0.9586139192617936,1.0,9/41,19.69%,IGF1;LBP;SELENOS;PTPN22;IRAK3;TLR4;RARA;PTPN6;NR1H4
prerank,positive regulation of stem cell proliferation (GO:2000648),-0.3173881477342326,-0.8030802389643877,0.7428571428571429,0.9580206314972566,1.0,5/17,21.85%,GJA1;KDM1A;PTPRC;PDCD2;LTBP3
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.27527658515604414,0.8029764259454736,0.7541729893778453,0.9592794882381348,1.0,25/69,28.15%,NDUFA2;UQCRB;NDUFA8;CYC1;NDUFA4;UQCRC1;AFG1L;COA6;COX6C;NDUFA12;NDUFB3;CYCS;UQCRQ;NDUFC1;COX10;UQCR11;NDUFA10;SDHAF2;COX15;NDUFA7;COX7A2L;UQCR10;NDUFS5;NDUFAB1;COX5B
prerank,neurogenesis (GO:0022008),-0.2625946944347973,-0.8026872590344418,0.8147138964577657,0.9578832644416456,1.0,5/43,5.58%,LPAR1;TRAK1;DAGLA;ANXA1;SIX1
prerank,purine ribonucleotide metabolic process (GO:0009150),0.2743511428221673,0.8025164469877426,0.7718023255813954,0.9595368144837614,1.0,10/68,9.16%,HPRT1;HINT1;NT5C2;ACBD6;GLYAT;AK4;TPST2;ADSS2;ACSL6;GTPBP1
prerank,regulation of mitochondrial depolarization (GO:0051900),0.3922264992618465,0.8023092906169844,0.7022132796780685,0.9593614231801081,1.0,1/10,0.90%,KDR
prerank,cellular response to UV-A (GO:0071492),0.38383207615025655,0.802287031482111,0.688212927756654,0.9588784765439946,1.0,3/11,15.46%,OPN5;MMP1;OPN3
prerank,protein localization to microtubule organizing center (GO:1905508),-0.3298511636562777,-0.8019816204727841,0.7494145199063232,0.9582770770940652,1.0,10/15,29.11%,CCDC14;PIBF1;PCM1;STIL;SNX10;BBS4;CEP131;C2CD3;CEP192;NEDD1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.28535514834091197,-0.8018942916363053,0.7562814070351759,0.957578353331745,1.0,6/26,14.30%,SLC30A10;PPARA;SLC5A3;CYBA;TRAP1;TLR4
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),-0.20859333950842748,-0.801831467526,0.9411764705882353,0.9568414062077208,1.0,47/148,26.46%,PRKAG2;PRKAA2;EHMT2;MDM4;CHD3;ATM;RBBP8;CHD4;USP2;PDPK1;PML;NUAK1;PRKAG3;STK11;NOP2;PRMT5;DYRK2;MAPK14;EP300;RAD50;ATRIP;CHD5;TAF9B;RBBP4;BOP1;RFC3;TP53RK;BRCA1;CSNK2A1;RNF34;WRN;PRKAB2;TBP;KMT5A;CDK5;TPX2;NBN;RBBP7;PIP4K2B;TAF9;PPP1R13L;MAPK11;ATR;SMYD2;EXO1;NOP53;RFC5
prerank,RNA splicing (GO:0008380),0.26591160769320293,0.80156324920111,0.8067567567567567,0.9596146147382286,1.0,20/95,21.60%,IVNS1ABP;PPP1R9B;RNPS1;SNRPF;HNRNPC;MAGOHB;SNRPN;ZCRB1;NCBP2;MPHOSPH10;SNRPB;RSRC1;PRPF4;SMU1;SCNM1;SNRPD2;LSM4;RBM8A;SF3B3;NCBP1
prerank,lipoprotein biosynthetic process (GO:0042158),-0.3411148838205335,-0.8011067665725083,0.7368421052631579,0.9573482022390769,1.0,2/11,8.31%,ATG10;APOE
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.379003484004587,0.8011064636239362,0.704119850187266,0.9598947056496525,1.0,4/11,17.48%,NEDD4L;GOPC;GPM6B;LEPROTL1
prerank,mitotic metaphase plate congression (GO:0007080),-0.24649274032510923,-0.8006703030547379,0.8609467455621301,0.957271954265203,1.0,15/51,26.83%,EML4;SEH1L;CENPC;CUL3;PIBF1;RMDN1;CHMP4C;KIF18A;CENPE;VPS4A;EML3;KIFC1;SPDL1;KPNB1;CDCA8
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.35840446581497587,-0.8005441760661273,0.7360178970917226,0.956680912131529,1.0,5/10,36.39%,KDM1A;BRCA1;SIRT1;JARID2;MYB
prerank,regulation of cellular response to heat (GO:1900034),0.2673426220825631,0.8003633156292889,0.8008658008658008,0.9607083798615655,1.0,25/77,25.75%,CD34;HSP90AB1;MAPK3;HSPA8;NUP54;RPTOR;CAMK2B;DNAJC7;BAG2;NUP160;MAPK1;DNAJB6;NUP153;RPA1;CAMK2G;NUP50;IER5;NUP42;PTGES3;NUP85;MTOR;NUP210;NUP188;BAG4;BAG5
prerank,multivesicular body assembly (GO:0036258),0.31755994818788646,0.7991951794237717,0.75,0.9622264683226431,1.0,9/30,21.73%,RAB11A;CHMP1B;VPS36;HGS;VPS25;PDCD6IP;VPS37A;VPS37B;VPS37C
prerank,protein alkylation (GO:0008213),-0.2863522410897652,-0.7991761927169346,0.7914572864321608,0.9581616321453064,1.0,9/22,28.47%,PCMT1;EEF2KMT;PRMT8;METTL22;FAM98B;GSPT1;EEF1AKMT2;PRMT2;METTL21C
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.3527052389608535,0.798990238833335,0.7162393162393162,0.9620524109973567,1.0,6/18,15.81%,DNAJC13;SNX3;MAPK3;MSN;MTMR2;MAPK1
prerank,positive regulation of protein catabolic process (GO:0045732),0.2661121031097375,0.7986139655117157,0.8285714285714286,0.9621573421575316,1.0,15/84,16.21%,DAB2IP;NKD1;NEDD4L;FOXO1;EGLN2;OAZ1;MSN;SMURF1;GSK3A;TNFAIP3;TNFSF12;ASB5;AREL1;PLK2;APC
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.3940922073946646,0.797886211512717,0.6867030965391621,0.9628903617736685,1.0,3/10,18.03%,CCT3;CCT5;CCT7
prerank,chromatin remodeling (GO:0006338),0.2566350020201501,0.7978363816807313,0.7964721845318861,0.9624511307212626,1.0,22/100,16.38%,SMARCA2;NPM3;ACTB;BAZ2B;CECR2;NPM2;FOXP3;HCFC2;PAK1;ARID1A;HNRNPC;KDM4A;MYSM1;ZBTB7A;TADA2B;SMARCD1;POLE3;SOX9;HDAC5;SMARCAD1;HMGA2;HCFC1
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.26073604067792405,-0.7972045565452163,0.7938931297709924,0.9607241736002607,1.0,9/43,19.69%,IGF1;LBP;SELENOS;PTPN22;IRAK3;TLR4;RARA;PTPN6;NR1H4
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.3001268431871688,-0.796854230240944,0.7654320987654321,0.9604993599434964,1.0,7/20,19.33%,RBPJ;RUNX2;SMAD9;BMP2;EP300;CHD6;CREB3
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.3617799338959382,0.7964473945914219,0.7147826086956521,0.9643439429173851,1.0,3/15,12.37%,HIP1R;TNK2;PIK3CB
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.34106148706768813,-0.7963408052900031,0.7088888888888889,0.9605357657067762,1.0,1/12,1.67%,BMP7
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.3880653503522146,0.7958065435567627,0.6942800788954635,0.9648811062049848,1.0,4/10,18.78%,NR1H2;ELOVL5;ABCD1;ABCD2
prerank,positive regulation of cation channel activity (GO:2001259),0.30249846595428864,0.7957027483126425,0.7515822784810127,0.9645284251482384,1.0,4/40,7.08%,SHANK3;TMSB4X;CALM1;PIRT
prerank,positive regulation of lipid metabolic process (GO:0045834),0.3431133924885829,0.7955566009129563,0.7197986577181208,0.9642462969893161,1.0,5/22,14.22%,PPARD;CREB1;SORBS1;PPARG;DISP3
prerank,cGMP biosynthetic process (GO:0006182),0.39136951213432425,0.7954673826219912,0.7052023121387283,0.9638704187555175,1.0,3/10,13.22%,NPPA;NPR1;NPR2
prerank,prostanoid metabolic process (GO:0006692),-0.3347444718248818,-0.795056844098311,0.7093275488069414,0.9618844743309123,1.0,5/13,20.49%,PTGS1;PTGES;PTGR2;CYP2S1;PTGR1
prerank,mitochondrial genome maintenance (GO:0000002),-0.35168677665314546,-0.7948346341618222,0.7257019438444925,0.9614014174520964,1.0,3/11,11.62%,SLC25A36;PARP1;MPV17
prerank,protein polyubiquitination (GO:0000209),0.23348176954028946,0.793937988347357,0.8965116279069767,0.9659875560585088,1.0,84/297,23.33%,RNF144B;LMO7;ZNRF1;TRIM14;NEDD4L;PELI1;RNF125;CTNNB1;UBE2V2;FBXW7;RFFL;PSMB3;UBE2G1;PSMD11;FBXO41;TRIM36;PSMC6;PSME2;SMURF1;KLHL3;HECTD1;UBE2V1;CBFB;KLHL20;SHARPIN;UBOX5;HERC6;UBE3D;ZNRF2;PSMD8;WSB1;TNFAIP3;FBXO6;RNF187;TRIM69;PSMB10;FBXW2;FBXO21;NHLRC1;AREL1;RBX1;RNF8;FBXL8;UBE2D3;TRIM2;FBXL15;PSMA8;UBE2Q2;ANAPC7;FBXO2;SKP1;UBE2G2;BFAR;RNF19A;TRIM71;TRIM68;TRIM3;ANAPC10;PSMD9;SIAH1;UBE2D1;RNF4;FBXW9;RBCK1;FBXO28;ANAPC2;TMEM129;TRAF3;RNF166;CUL1;ERCC8;UBE2J1;RLIM;CDC23;PSMD1;PSMC3;CDC27;FBXO32;UNKL;RNF126;FBXL14;TRAF6;PSMD10;CDC26
prerank,glutathione derivative biosynthetic process (GO:1901687),0.3368928714818434,0.7936083397423356,0.7333333333333333,0.9655007287931334,1.0,4/20,9.75%,MGST2;GSTA4;HPGDS;GSTK1
prerank,glutathione derivative metabolic process (GO:1901685),0.3368928714818434,0.7936083397423356,0.7333333333333333,0.9655007287931334,1.0,4/20,9.75%,MGST2;GSTA4;HPGDS;GSTK1
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.2888370172046473,-0.793582402474726,0.7783018867924528,0.9626883646717489,1.0,4/22,11.56%,PPM1E;PPM1D;PPM1B;DUSP10
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.34247431108272197,-0.7931517887189847,0.755741127348643,0.9625596533589046,1.0,4/12,15.68%,PFDN5;APOE;LDLR;CRYAB
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.3115959663238732,0.7927664157867572,0.7515923566878981,0.9664006192274177,1.0,4/32,4.84%,APLNR;PLCG1;CALM1;CD19
prerank,chloride transmembrane transport (GO:1902476),0.2864015272617881,0.7926522996679737,0.7861538461538462,0.966072324319178,1.0,13/48,19.80%,SLC1A1;SLC12A6;SLC12A9;GABRB1;CLCN3;GABRQ;GABRG1;GABRG3;GABRA1;ANO3;GABRB2;GLRA2;ANO5
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.3333120056387302,0.7925606749202743,0.705574912891986,0.9657111040082705,1.0,4/20,7.94%,LYN;CD6;HCK;TGFB1
prerank,centromere complex assembly (GO:0034508),-0.2608479965829628,-0.7922897822163102,0.8346883468834688,0.9631491433085595,1.0,11/36,23.62%,CENPC;CENPP;CENPK;SMARCA5;MIS18BP1;CENPL;RBBP4;CENPQ;CENPE;RBBP7;CENPF
prerank,regulation of primary metabolic process (GO:0080090),0.25072161860136827,0.7919426393442487,0.8402061855670103,0.9662063287614672,1.0,24/126,14.35%,FASN;PPARD;NCOA1;ACACB;PSMB3;NCOA2;PSMD11;OAZ1;ZFP69;ABCA7;PSMC6;OPA3;PSME2;PRKAB1;LACTB;HELZ2;PSMD8;ELOVL6;ADIPOR1;HMGCR;PPARG;EDF1;PSMB10;SP1
prerank,detection of visible light (GO:0009584),0.3558629409181644,0.7915370938144458,0.7019748653500898,0.9663613284945021,1.0,2/16,5.63%,GNAQ;RP1
prerank,protein targeting to peroxisome (GO:0006625),-0.275503327743818,-0.7914674164704304,0.8009367681498829,0.9637231949158995,1.0,5/29,13.72%,ABCD3;ZFAND6;PXMP2;PEX7;PEX2
prerank,engulfment of apoptotic cell (GO:0043652),0.35591999728292567,0.791272789840368,0.712280701754386,0.9662757961712188,1.0,1/15,1.07%,RHOBTB1
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.27652297483481947,0.7910853371051194,0.7889374090247453,0.9660735624927372,1.0,19/67,23.32%,B2M;IKBKB;PSMB3;PSMD11;PSMC6;TAP2;PSME2;CYBB;PSMD8;NCF4;PSMB10;PSMA8;PSMD9;TAP1;VAMP8;PSMD1;PSMC3;CALR;PSMD10
prerank,axonal transport of mitochondrion (GO:0019896),-0.3546991946823276,-0.7909051785205903,0.7474332648870636,0.9638455397392599,1.0,1/11,3.07%,TRAK1
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.3672873302332458,-0.7907568429323446,0.7257383966244726,0.963265951347967,1.0,6/10,27.47%,MTHFD1;MTHFR;MTHFD2;MTHFD1L;MTHFS;SHMT1
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.36346159526092403,-0.7907291344783758,0.75,0.9624759330301855,1.0,2/10,1.67%,BMP5;BMP7
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.31510301425942,0.7900485770067844,0.7260726072607261,0.9672844923225427,1.0,4/29,7.56%,DAB2IP;SMAD7;IL17RD;EFNA1
prerank,negative regulation of T cell proliferation (GO:0042130),0.31807659730357407,0.7895004057749213,0.7353951890034365,0.9677106062125999,1.0,3/28,8.56%,TNFRSF21;LGALS9;FOXP3
prerank,receptor signaling pathway via STAT (GO:0097696),0.317756366084512,0.789467970238798,0.7549019607843137,0.9672382405772111,1.0,4/25,6.27%,IFNAR1;IFNAR2;SOCS2;STAT1
prerank,piRNA metabolic process (GO:0034587),0.34191748464233584,0.7890137178717004,0.7155635062611807,0.9674810964774194,1.0,2/19,4.94%,FKBP6;PIWIL1
prerank,regulation of DNA replication (GO:0006275),-0.24985832351591178,-0.7889380181076944,0.8121212121212121,0.9645619802591987,1.0,7/49,11.65%,EGFR;GLI2;EHMT2;GLI1;TSPYL2;ZBTB38;NUCKS1
prerank,regulation of cell cycle phase transition (GO:1901987),0.26218875159798627,0.788706499774744,0.8108484005563282,0.9674890781301767,1.0,28/91,23.33%,FBXW7;PSMB3;PSMD11;PSMC6;PSME2;PSMD8;PSMB10;TRIM39;BUB3;ANAPC16;PSMA8;ANAPC7;SKP1;ANAPC10;PSMD9;UBE2D1;ANAPC2;TFAP4;ATP2B4;DDB1;CUL1;CDC23;PSMD1;PSMC3;CDC27;CDKN1B;PSMD10;CDC26
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.3630256735071104,-0.7886490823507403,0.7511415525114156,0.96419856488551,1.0,2/10,6.82%,ZEB2;ATP7A
prerank,DNA metabolic process (GO:0006259),0.2300013908539512,0.788432395719183,0.9047619047619048,0.9674253270707097,1.0,62/270,22.12%,POLK;SP100;MEN1;SAMHD1;NTHL1;MRE11;UBE2V2;HINFP;PWWP3A;TERF2;DNA2;DFFB;FANCG;CBS;MCM10;AXIN2;MGMT;MPG;CDC6;PARG;SMUG1;ACD;RECQL4;GTF2H4;FBXO6;TERF1;BTG2;POLB;POLE3;HMGB2;HELLS;ORC1;FAN1;NSMCE4A;MSH3;TSN;TRRAP;SMARCAD1;MSH2;SIRT7;DNASE2;SUMO1;UHRF2;RAD21;NUDT1;HUS1;RPA1;ENDOG;ADPRS;NSMCE3;RAD9B;POLL;UVRAG;POLD1;DDB1;GTF2H3;POLA1;PARP2;INO80;RFC2;ERCC4;RAD1
prerank,establishment of spindle localization (GO:0051293),0.3591148090415177,0.788187761990989,0.7459165154264973,0.967286100290224,1.0,5/14,28.06%,MAP4;CFL1;CLASP1;CLASP2;DYNC1H1
prerank,regulation of synapse assembly (GO:0051963),0.28385280963981263,0.7881062690188553,0.7918622848200313,0.9668874453814853,1.0,9/46,10.18%,APP;MEF2C;WNT7A;CLSTN1;GRID2;SLITRK3;SLITRK1;NRXN1;LRRC4B
prerank,mRNA catabolic process (GO:0006402),0.2908740096732847,0.7880432486862047,0.7468553459119497,0.966468842807085,1.0,18/44,26.97%,NANOS2;PDE12;DCP2;DXO;XRN1;EXOSC10;NBAS;NUDT16;EXOSC9;ZFP36L2;XRN2;METTL3;NUDT12;RIDA;UPF1;NUDT16L1;AGO1;NBDY
prerank,negative regulation of interleukin-12 production (GO:0032695),0.3592176734858425,0.7880077593835563,0.725925925925926,0.9660094050541869,1.0,3/14,11.18%,JAK3;CCR7;TLR8
prerank,regulation of protein transport (GO:0051223),0.3152048811045597,0.7874309257342289,0.7405582922824302,0.966456690012019,1.0,6/27,17.23%,RHBDF2;SNX3;NDFIP2;HSPA8;DNAJA1;PPM1F
prerank,regulation of nervous system development (GO:0051960),-0.2611368442951341,-0.7874248651814425,0.8338192419825073,0.965354154841925,1.0,6/37,14.07%,DOCK7;PER2;HEYL;YAP1;LGI4;SIRT2
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.265501368635768,0.7873208218529429,0.815592203898051,0.9661060929140747,1.0,17/79,16.54%,OSBPL1A;AP1S2;KIF26A;PIKFYVE;DYNLL1;KIF2A;DNM2;AP2M1;MFSD6;AP1S3;KIF3B;DCTN4;KIF23;AP2B1;DYNC1LI1;CTSS;AP1G1
prerank,mitochondrial gene expression (GO:0140053),0.2899093821340698,0.7869891383930753,0.7725806451612903,0.9661620531153329,1.0,19/42,29.16%,MRPL12;SLC25A33;MRPL57;GATC;TWNK;MRPS2;MRPL16;MRPL23;MRPS18A;IARS2;PTCD3;MRPL51;HARS1;NDUFA7;MRPL2;QRSL1;LARS2;MRPS34;MRPS12
prerank,cGMP-mediated signaling (GO:0019934),0.37301167670656743,0.7862520373157192,0.7129629629629629,0.9668205716972784,1.0,3/13,5.32%,PDE2A;NPPA;KCNC2
prerank,maturation of SSU-rRNA (GO:0030490),0.3010565722549243,0.785914230264154,0.7687188019966722,0.9668541232585384,1.0,7/34,14.11%,SNU13;DHX37;UTP3;PWP2;NOL10;RIOK1;RPS28
prerank,positive regulation of catalytic activity (GO:0043085),0.30064183344438283,0.7856721856304101,0.7727272727272727,0.966743320060665,1.0,9/37,17.60%,CAV1;NOD2;MAPK3;PHACTR4;APH1A;B3GAT3;MSH3;MSH2;YWHAB
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.2893801028392146,0.7856091106307442,0.7774343122102009,0.9663364775356187,1.0,6/44,10.32%,SH3RF1;RPS6KA1;XIAP;KLF4;CST7;LAMTOR5
prerank,multivesicular body organization (GO:0036257),0.31015968783592673,0.7855974212322765,0.768595041322314,0.9658346971101355,1.0,13/31,29.17%,RAB11A;CHMP1B;VPS36;HGS;VPS25;PDCD6IP;VPS37A;VPS37B;VPS37C;CHMP2B;VPS4B;VPS28;RAB27A
prerank,regulation of interleukin-1 production (GO:0032652),0.34438047395039656,0.7851604214951952,0.7195571955719557,0.9660270373397281,1.0,5/15,20.15%,CCR7;CEACAM1;GAS6;F2R;FOXP1
prerank,positive regulation of cell killing (GO:0031343),0.3564405076240951,0.7851395385210519,0.7388059701492538,0.965540749477186,1.0,3/13,12.14%,NOS2;RAC1;SYK
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.2922006239941678,0.7843969607696125,0.7611464968152867,0.9662452756978221,1.0,3/39,3.25%,UTRN;NEDD4L;FGF13
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.29137989894590305,0.7842150310728664,0.7325949367088608,0.966031235853575,1.0,5/37,5.00%,NOD2;GBP5;NOS2;PLD4;CD6
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.336893016968155,0.784188649333322,0.7078260869565217,0.9655473717640062,1.0,5/18,23.64%,FAM107A;ZFP36L1;NR3C1;ZFP36L2;ISL1
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.36756260217742964,0.7840641737621852,0.7235494880546075,0.9652465181952029,1.0,2/12,5.46%,CYP11B1;CYP11A1
prerank,mitochondrial protein processing (GO:0034982),0.3693760837829332,0.7840370725218563,0.7025089605734767,0.9647805258175147,1.0,3/11,16.06%,PMPCA;OMA1;IMMP2L
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.36558118100882875,0.7838545552648823,0.7335834896810507,0.9645628223565721,1.0,3/13,9.68%,TLR7;IRAK2;PIK3C3
prerank,negative regulation of biomineral tissue development (GO:0070168),0.3348587481743029,0.7837644393662264,0.7316666666666667,0.9641909781303828,1.0,5/21,8.93%,NOS3;SRGN;NOTCH1;TGFB1;GREM1
prerank,cilium assembly (GO:0060271),0.22678660991708002,0.7834001179433663,0.9285714285714286,0.9642867708374552,1.0,50/296,16.13%,ABCC4;ABLIM1;FNBP1L;EXOC6;NOTCH1;CNGA2;CEP83;POC1B;CCDC13;ZMYND10;CDC14A;CFAP52;RP1;DYNLL1;OCRL;CCP110;RAB11A;PRKAR2B;MARK4;TTLL3;CETN2;TUBB;CDK5RAP2;DISC1;AKAP9;DCX;RSPH4A;HAUS6;KIF3B;EXOC4;CFAP54;TBC1D32;EHD4;CEP78;EXOC2;SNAP29;RAB1A;BBS10;BBIP1;RSPH1;CEP72;CEP135;FOXJ1;TUBA1A;DNAAF3;TUBB4B;CKAP5;DNAH5;CEP70;ACTR2
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.3525305232382232,-0.7832813507365456,0.7306122448979592,0.9712477440988982,1.0,6/10,40.77%,DBF4;E2F7;E2F8;WIZ;CDC7;CDT1
prerank,DNA replication checkpoint signaling (GO:0000076),0.34498530832403174,0.7830190050992963,0.7266313932980599,0.9643862750101042,1.0,9/16,29.48%,DNA2;CDC6;ORC1;HUS1;RAD9B;RAD17;TOPBP1;TIMELESS;HUS1B
prerank,DNA catabolic process (GO:0006308),-0.3411896041086424,-0.7826630201158582,0.7286995515695067,0.9713603376879061,1.0,2/11,9.33%,FBH1;REXO4
prerank,lipid biosynthetic process (GO:0008610),-0.21886339956080814,-0.7825088326645592,0.8951048951048951,0.9707718815619171,1.0,4/77,3.96%,ABCD3;PRKAA2;ACSL1;PAM
prerank,organelle assembly (GO:0070925),0.22311601774801623,0.7823200452095355,0.9322974472807991,0.9650798481715117,1.0,45/384,12.80%,ABCC4;FLII;ABLIM1;CD34;PGM5;FNBP1L;EXOC6;STARD9;NOTCH1;CNGA2;CEP83;POC1B;CDC14A;CFAP52;MAPRE2;DYNLL1;OCRL;ABCA3;DBNL;EDC3;CDS2;RAB11A;SAC3D1;TTLL3;CHMP1B;IRGM;MAP1LC3B;DHX37;TMOD1;DISC1;PIK3C3;GRB7;HAUS6;KIF3B;EXOC4;UBQLN1;VPS36;ATG12;CFAP54;EHD4;EXOC2;HGS;SNAP29;MAPRE3;RAB1A
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.3115058163675389,-0.7820823160085629,0.7418546365914787,0.9706165269140266,1.0,3/15,9.56%,EGFR;RBPJ;CDH13
prerank,negative regulation of insulin secretion (GO:0046676),-0.3077098431572455,-0.781686564008252,0.766743648960739,0.97039004651984,1.0,7/17,19.39%,IRS1;PRKN;CCN3;KCNB1;INHBB;SFRP1;ADRA2A
prerank,regulation of NMDA receptor activity (GO:2000310),0.3036393722903965,0.7815162568013243,0.7821138211382114,0.9658918840238572,1.0,9/32,17.38%,APP;MEF2C;LRRC7;GRIA4;GRIN2B;CAMK2B;NLGN1;CRHBP;CCR2
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.34059409846281885,-0.7813973105849419,0.7415254237288136,0.9700464679687268,1.0,2/11,9.56%,P2RX4;CDH13
prerank,positive regulation of protein maturation (GO:1903319),-0.35154868271975437,-0.780696511134363,0.7494824016563147,0.9703197581199483,1.0,1/11,1.66%,CCBE1
prerank,platelet aggregation (GO:0070527),0.30072289190003887,0.7801895600372549,0.780952380952381,0.9675691475845248,1.0,8/33,12.68%,ACTB;PPIA;STXBP1;ACTN1;ACTG1;HSPB1;PIK3CB;MYL12A
prerank,mitochondrial transcription (GO:0006390),0.381907198077201,0.7790338768739251,0.7311411992263056,0.9689499062538938,1.0,3/10,15.32%,MRPL12;SLC25A33;TWNK
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.3845630167495884,0.7784194442123495,0.7319391634980988,0.9694536895458435,1.0,1/10,4.47%,CTNNB1
prerank,regulation of cellular response to stress (GO:0080135),-0.21187969697535367,-0.7783212603223257,0.9320754716981132,0.9732047013006593,1.0,23/115,18.76%,ROCK2;NUPR1;AMFR;CAMK2D;NEK6;SEH1L;PRKN;ATM;NUP205;BAG1;CEBPB;NUAK1;CLN3;ABL1;ARMT1;AIFM2;EP300;BAG3;CRYAB;SMG1;SLC38A2;HSBP1;USP19
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.3609620376157145,0.7780851181449397,0.7164179104477612,0.9694974217672042,1.0,3/12,15.16%,NOD2;SOX9;INAVA
prerank,ncRNA catabolic process (GO:0034661),0.3105052351081295,0.7772885341647281,0.7574257425742574,0.97025769217159,1.0,9/28,22.32%,DEDD2;TRIR;SND1;DIS3L;XRN1;EXOSC10;NUDT16;EXOSC9;EXOSC8
prerank,ribosome assembly (GO:0042255),0.2779407099909724,0.7771226421626398,0.8058103975535168,0.9700155521148232,1.0,10/47,15.50%,RPL3;RPSA;DHX37;PWP2;RPS27;MRPL20;RPL11;RPS15;RPS28;MRPS2
prerank,positive regulation of telomere maintenance (GO:0032206),-0.2644628141927767,-0.7769870180620365,0.8113695090439277,0.9744206693778864,1.0,14/31,28.89%,TNKS2;ATM;PML;RTEL1;ERCC1;HNRNPA2B1;RAD50;NBN;SIRT6;TNKS;MAP3K4;HNRNPD;PKIB;DHX36
prerank,neuron projection regeneration (GO:0031102),0.3773066583389545,0.7766986086308191,0.7179023508137432,0.9702199731868963,1.0,1/10,7.81%,PTN
prerank,negative regulation of axonogenesis (GO:0050771),0.31706811271713264,0.7766453747465899,0.7556270096463023,0.9697862448857122,1.0,6/27,15.67%,FGF13;DIP2B;ARHGDIA;MAG;SEMA3G;DCC
prerank,thymus development (GO:0048538),0.3605436033713251,0.775958927892812,0.737037037037037,0.9703930591889491,1.0,1/13,1.89%,TBX1
prerank,response to zinc ion (GO:0010043),0.3099614178449507,0.7757192379274076,0.7473867595818815,0.970236907939523,1.0,10/25,20.49%,MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;GLRA2;SLC30A4
prerank,post-translational protein modification (GO:0043687),0.2234358912449351,0.775484575287187,0.9443826473859844,0.970103109591013,1.0,66/332,18.25%,EPAS1;LMO7;KLHL5;KLHL2;APP;DCUN1D3;SPARCL1;VWA1;CDH2;MEN1;ZBTB16;SOCS2;IGFBP7;NOTUM;STT3B;KLHL25;FBXW7;ADAM10;PSMB3;GOLM1;RAB11A;PSMD11;PDIA6;FBXO41;RHBDD1;PSMC6;QSOX1;FEM1C;PSME2;SOCS5;KLHL3;SCG3;KLHL20;PSMD8;UBA3;HIF1A;WSB1;FBXO6;DCUN1D1;RAB1A;EVA1A;ASB13;ASB5;PSMB10;FBXW2;FBXO21;RBX1;FBXL8;SERPINC1;FBXL15;ASB15;ELOB;PSMA8;DCAF5;ASB7;PROC;COPS5;GAS6;FBXO2;TMEM132A;GPS1;SKP1;FN3K;KBTBD8;SCG2;PSMD9
prerank,striated muscle cell differentiation (GO:0051146),0.33847713356071385,0.7744437910091888,0.7258883248730964,0.971269096693521,1.0,2/16,5.20%,MEF2C;SORT1
prerank,protein insertion into ER membrane (GO:0045048),0.2890937020742776,0.7741890240958808,0.7951219512195122,0.9711559725891696,1.0,2/37,2.65%,APP;STX1A
prerank,monoacylglycerol metabolic process (GO:0046462),-0.31934497383599647,-0.7738603366738122,0.7477064220183486,0.9784638293754236,1.0,1/13,1.72%,MOGAT3
prerank,nucleic acid-templated transcription (GO:0097659),0.28338221652273793,0.7734871197692545,0.7866449511400652,0.9717582808881612,1.0,5/42,8.82%,PTMA;TAF1B;NKX2-8;RNPS1;PWP1
prerank,regulation of defense response to virus (GO:0050688),-0.3177093571886386,-0.7733165590783129,0.758695652173913,0.9784649325465391,1.0,4/14,18.23%,PPM1B;ZMPSTE24;PCBP2;C1QBP
prerank,aerobic electron transport chain (GO:0019646),0.26440137660119606,0.773111670034714,0.8102409638554217,0.9718534484659207,1.0,24/68,28.15%,NDUFA2;UQCRB;NDUFA8;CYC1;NDUFA4;UQCRC1;AFG1L;COX6C;NDUFA12;NDUFB3;CYCS;UQCRQ;NDUFC1;COX10;UQCR11;NDUFA10;SDHAF2;COX15;NDUFA7;COX7A2L;UQCR10;NDUFS5;NDUFAB1;COX5B
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.25780324547013805,0.7729581611899131,0.8515950069348127,0.971571810443378,1.0,25/87,22.50%,DCUN1D3;RGCC;CDKN2B;FAM107A;KLF4;PSMB3;PSMD11;PSMC6;PSME2;ZFP36L1;PSMD8;PSMB10;RBX1;PSMA8;RBL1;APC;SKP1;PSMD9;CDK6;ZFP36L2;PINX1;CUL1;CDK4;PSMD1;PSMC3
prerank,regulation of keratinocyte migration (GO:0051547),0.36716909679647053,0.7728327744450498,0.7504690431519699,0.9712699745191293,1.0,3/12,11.13%,MAPRE2;IQSEC1;MAP4K4
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),-0.2431555917237473,-0.7724712032703841,0.8541666666666666,0.9788834795445019,1.0,3/48,5.11%,PRKAG2;OGT;SEH1L
prerank,histone H2A ubiquitination (GO:0033522),-0.30157847722006337,-0.7723936645355299,0.763855421686747,0.9781751707780495,1.0,7/17,21.76%,BCOR;KDM2B;DDB2;UBE2B;UBR2;TRIM37;CUL4B
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.3086561388415819,0.7723752197871253,0.7814569536423841,0.9714628301291484,1.0,8/29,23.87%,YBX1;NOCT;AXIN2;PAIP1;ELAVL1;NBAS;TENT5C;PABPC1
prerank,regulation of autophagosome assembly (GO:2000785),0.30031845721524025,0.7723006274626841,0.7944983818770227,0.971062766557905,1.0,7/33,12.56%,TBC1D14;TBC1D12;PIKFYVE;RALB;PIP4K2A;SH3GLB1;FEZ2
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.3009325528574911,-0.7719481477242368,0.7846153846153846,0.9780281603492229,1.0,8/18,29.90%,FLNA;WDR43;PHF8;POLR2L;RASL11A;ERBB2;EIF2AK3;POLR2K
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.3268219304879386,-0.7719111752351869,0.7632743362831859,0.9772526696820246,1.0,1/13,1.59%,AXL
prerank,regulation of cell division (GO:0051302),0.26275875821466405,0.7716730938177356,0.8390313390313391,0.9715759618249101,1.0,13/72,16.08%,BCL2L1;CALM1;TAL1;CCP110;RAB11A;PIN1;CETN2;RAB11FIP4;PIK3C3;SH3GLB1;GIT1;PLK2;PRPF40A
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.2787787880401421,0.7714241198874133,0.8083832335329342,0.9714464689846793,1.0,23/53,32.37%,PSMB3;PSMD11;OAZ1;PSMC6;PSME2;PSMD8;PSMB10;PSMA8;PSMD9;OAZ2;PSMD1;PSMC3;PSMD10;PSME1;PSMB8;PSMD2;PSMA1;PSMA7;PSMB9;PSMF1;PSMB1;PSMA4;OAZ3
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.3372594188469164,-0.7712766550922024,0.7635574837310195,0.9773979118601666,1.0,5/11,37.97%,SIRT1;CIITA;PF4;IL4;TMEM106A
prerank,regulation of osteoclast differentiation (GO:0045670),-0.26481087323809654,-0.7711953591007578,0.8158567774936062,0.9766849652835652,1.0,4/33,14.51%,FBN1;CEBPB;TLR4;MAFB
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.3484256505014548,-0.7711571230639667,0.7746781115879828,0.9759067806591344,1.0,3/10,15.00%,CD55;CD81;ZBTB7B
prerank,positive regulation of leukocyte degranulation (GO:0043302),-0.3270447985029763,-0.7708995230675029,0.7585470085470085,0.9754585690715613,1.0,1/13,2.01%,GAB2
prerank,regulation of protein acetylation (GO:1901983),0.35873343262962687,0.7705063510840674,0.7206703910614525,0.9724253401494942,1.0,1/12,3.90%,RAPGEF3
prerank,regulation of myeloid cell differentiation (GO:0045637),0.2676622757484735,0.7704466519149067,0.8122270742358079,0.9720078708077431,1.0,5/62,4.12%,FES;MEF2C;ZFPM1;LYN;ZBTB16
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.32239356816006365,0.7700538818516667,0.7372881355932204,0.9721207242723043,1.0,5/23,9.58%,SLC12A6;SLC12A9;KCNH2;CLCN3;SLC9A7
prerank,glutathione metabolic process (GO:0006749),0.2904276856282596,0.7697080862520931,0.804416403785489,0.9721743750806248,1.0,5/38,9.75%,GCLM;MGST2;GSTA4;HPGDS;GSTK1
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.22299089467115019,0.7696681240745226,0.9418604651162791,0.9717265647125108,1.0,86/314,23.33%,ZNRF1;TRIM25;NEDD4L;PELI1;CTNNB1;STT3B;ATXN3;FBXW7;RFFL;ZFAND2A;PSMB3;UBE2G1;PSMD11;SGTB;PSMC6;FEM1C;PSME2;DMAC2;SMURF1;KCTD10;UBXN1;KLHL20;SHARPIN;UBQLN1;FBXL2;UBE3D;PSMD8;GSK3A;FBXO6;RNF187;DERL2;EDEM1;MAN1B1;MAEA;PSMB10;BUB3;NHLRC1;AREL1;RBX1;PTTG1;ANAPC16;FBXL8;UBE2D3;TRIM2;FBXL15;TMUB2;PSMA8;DNAJB9;RAD23A;BAG6;ANAPC7;ARMC8;FBXO2;SKP1;UBE2G2;GID8;BFAR;TRIM71;TRIM3;ANAPC10;KCTD17;PSMD9;SIAH1;UBE2D1;RNF4;RBCK1;ANAPC2;TMEM129;NSFL1C;PLAA;ANKRD9;DDB1;CUL1;ERCC8;UBE2J1;ANKZF1;CDC23;RAD23B;TMUB1;PSMD1;PSMC3;CDC27;RNF126;FBXL14;PSMD10;CDC26
prerank,negative regulation of cell cycle process (GO:0010948),0.2685767687736233,0.7694102632408696,0.834319526627219,0.971629059649256,1.0,7/61,8.25%,DAB2IP;RYBP;NANOS2;CCP110;MAX;PHC1;TERF2
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.2733244642468663,0.7691068906479995,0.8218125960061444,0.9716265771052666,1.0,7/56,11.83%,PLCB1;RGCC;RAB11A;CCND3;ADAM17;BRD4;RPTOR
prerank,histone H4-K8 acetylation (GO:0043982),0.3439632411413998,0.7690968409358608,0.7287822878228782,0.9706193218346113,1.0,4/15,16.38%,PHF20;JADE2;MCRS1;HCFC1
prerank,histone H4-K5 acetylation (GO:0043981),0.3439632411413998,0.7690968409358608,0.7287822878228782,0.9706193218346113,1.0,4/15,16.38%,PHF20;JADE2;MCRS1;HCFC1
prerank,regulation of smooth muscle contraction (GO:0006940),-0.292934191457064,-0.7689476081506181,0.7903614457831325,0.9775734129956795,1.0,6/20,16.97%,PLCE1;KCNB2;SPHK1;CHRM2;CTTN;MYOCD
prerank,aggrephagy (GO:0035973),0.31242064727907287,0.7687719087914598,0.7563025210084033,0.9706055968438171,1.0,12/27,29.68%,DYNLL1;WDFY3;UBE2V1;UBQLN1;DYNC1LI1;ACBD5;ARL13B;UBB;DYNC1H1;PCNT;PARK7;HDAC6
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.35513905734093915,0.7683739744840605,0.7540394973070018,0.9707411894709072,1.0,2/14,4.15%,NFKBIA;TMSB4X
prerank,osteoclast differentiation (GO:0030316),-0.28091875267539484,-0.7677802569844137,0.7750611246943765,0.978510659097231,1.0,2/22,2.22%,GAB2;ANXA2
prerank,regulation of neurotransmitter transport (GO:0051588),-0.3068615483979181,-0.7675376977860361,0.7549019607843137,0.978056413457556,1.0,1/16,0.87%,SNCAIP
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.21995222354771796,0.7667755087530433,0.9585666293393057,0.9727074464607772,1.0,46/366,12.95%,INSR;APBB2;ENG;SLC39A8;NANOS3;APP;SOX17;MEF2C;RYBP;SMARCA2;ACVRL1;SOX13;NOTCH1;YBX1;PRDM2;IRF2;RREB1;HINT1;SOX7;WWTR1;KLF1;SNAI2;TCF7;CCDC88A;RPS6KA5;DNM2;NCOA2;SOX18;HINFP;SOX12;BRCA2;FOXP3;HCFC2;HMGA1;BTG1;UBE2V1;CYFIP1;ZNF205;NR5A2;HIF1A;ONECUT1;SOX11;TFEB;EIF4E;WWC1;PUM3
prerank,regulation of stem cell population maintenance (GO:2000036),0.33389288236422193,0.7662579891439235,0.7395833333333334,0.9729994877842154,1.0,5/18,16.37%,PTN;ELAVL1;LOXL2;ZC3H13;HMGA2
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.27099868015760675,0.7661926744983458,0.8227474150664698,0.9725886284677263,1.0,15/54,19.54%,CAV1;NEDD4L;KCNQ1;KCNH2;KCNN2;KCNN3;KCNAB2;GNB1;AKAP6;BIN1;KCNJ5;KCNJ3;KCNJ6;KCNIP2;KCNN4
prerank,sensory perception of smell (GO:0007608),0.3631776953503721,0.7661218934293866,0.7383177570093458,0.9721856777761154,1.0,1/11,4.10%,SLC24A4
prerank,positive regulation of transport (GO:0051050),-0.21779464783730615,-0.765347456370573,0.9391891891891891,0.9803985862103054,1.0,12/85,11.50%,LRP1;GPC3;CAMK1D;ANXA2;DAB2;ANXA1;IL15RA;APOE;CLIP3;BID;CYBA;RXRA
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.3035523495729718,0.7650110303270027,0.7688442211055276,0.9734334416723605,1.0,11/29,30.21%,RNF212B;PRDM9;SIRT7;BAG6;RAD21;SYCP2;REC8;TEX12;IHO1;TERB1;P3H4
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.33016597952160226,0.764701740273795,0.7590579710144928,0.9734044179729451,1.0,9/17,30.49%,NDUFA4;AFG1L;COX6C;CYCS;COX10;COX15;COX7A2L;COX5B;COX4I1
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.2780381884452842,0.7644354218987706,0.828101644245142,0.9733061129035473,1.0,8/48,12.29%,SIGIRR;NLRC5;SAMHD1;PALM3;RFFL;NR1H2;USP18;PPARG
prerank,body fluid secretion (GO:0007589),-0.3126588588422514,-0.7641497676544404,0.7690631808278867,0.9813525501508044,1.0,4/15,15.00%,SLC22A4;PRLR;SLC22A2;ZBTB7B
prerank,regulation of adaptive immune response (GO:0002819),-0.2875061998923282,-0.7640075161352489,0.7718120805369127,0.9807509022969424,1.0,8/18,30.00%,ADCY7;PYCARD;IL6ST;AHR;FADD;IL4I1;IRF1;SIRT1
prerank,regulation of endocytosis (GO:0030100),0.26713853276102717,0.7634047716027744,0.8301329394387001,0.9744090411642438,1.0,4/61,3.42%,HIP1;HIP1R;NEDD4L;PRKD1
prerank,regulation of protein export from nucleus (GO:0046825),0.3110777213337549,0.7632913911456382,0.7538200339558574,0.9740562576875721,1.0,5/23,18.04%,SP100;RAPGEF3;SIRT7;GAS6;RANGAP1
prerank,bile acid biosynthetic process (GO:0006699),-0.285365772792902,-0.7629250144548029,0.8160377358490566,0.9815165028636035,1.0,4/24,9.82%,CYP7B1;CYP27A1;ACOT8;AMACR
prerank,termination of RNA polymerase II transcription (GO:0006369),0.29671715413979804,0.7620608609209459,0.7993527508090615,0.9754701122138557,1.0,7/33,12.89%,CSTF2;SNRPF;SNRPE;CPSF1;SSU72;NCBP2;SNRPB
prerank,rRNA modification (GO:0000154),-0.28601408773248094,-0.7620549624317589,0.8121951219512196,0.9819667441460843,1.0,7/21,21.61%,MTERF4;GAR1;NSUN3;NSUN4;TRMT112;TSR3;DIMT1
prerank,dendritic cell differentiation (GO:0097028),0.3167413771777855,0.7611395684412621,0.7721943048576214,0.9763903377636306,1.0,4/22,12.41%,LYN;CCR7;LGALS9;TGFBR2
prerank,extracellular transport (GO:0006858),-0.3270401427874186,-0.7610791991212222,0.7625,0.9825274159665488,1.0,8/12,35.14%,TSG101;WWP2;ROPN1L;ADCY10;SPAG17;SPA17;CCDC40;DNAAF4
prerank,modification-dependent protein catabolic process (GO:0019941),0.22924221618412394,0.7603043309932531,0.9206161137440758,0.9771633616740585,1.0,51/193,23.33%,RNF144B;TRIM25;NEDD4L;RNF125;ZNRF3;KLHL25;ATXN3;RFFL;RNF215;UBE2G1;PSMD11;FEM1C;NDFIP2;PPP1R11;SMURF1;KCTD10;KLHL3;UBQLN1;TOLLIP;RNF130;ARRDC1;BUB3;FBXO21;AREL1;RBX1;RNF8;PTTG1;ANAPC16;BAG6;ANAPC7;UBE2G2;CBL;BFAR;RNF19A;ANAPC10;PSMD9;SIAH1;UBE2D1;ANAPC2;RNF166;FBXO8;MIB1;DDB1;CNOT4;RLIM;CDC23;CDC27;UBL7;RNF126;FBXL14;CDC26
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.338928817663417,0.7599991953894552,0.7468354430379747,0.9770984750190879,1.0,2/17,6.42%,RAPGEF2;ADRA2B
prerank,cellular response to pH (GO:0071467),-0.2977373633028666,-0.7592354764213594,0.8037383177570093,0.9842746372381268,1.0,3/17,15.44%,IMPACT;SLC9A1;RAB11B
prerank,outer dynein arm assembly (GO:0036158),0.3394645890511197,0.758976774533968,0.7617328519855595,0.9781917033398965,1.0,4/14,15.53%,ZMYND10;LRRC49;DNAH8;DNAH5
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.30829814182930887,-0.7587047285623016,0.7659090909090909,0.9833887952247355,1.0,6/15,21.26%,DTNBP1;AP3B1;AP3S2;BLOC1S2;BLOC1S5;BLOC1S6
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.30829814182930887,-0.7587047285623016,0.7659090909090909,0.9833887952247355,1.0,6/15,21.26%,DTNBP1;AP3B1;AP3S2;BLOC1S2;BLOC1S5;BLOC1S6
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.32180635629334087,-0.7586329126182697,0.7572383073496659,0.9826658464000978,1.0,1/12,1.07%,B3GALT1
prerank,toll-like receptor 3 signaling pathway (GO:0034138),-0.33086449593534994,-0.7585937300673694,0.7663157894736842,0.9818924408590003,1.0,2/11,8.17%,SCARA3;TNIP2
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.3155624850048166,-0.7585552332188812,0.8185745140388769,0.9811170550487855,1.0,4/13,23.40%,ENPP1;TPST1;ABHD14B;SULT1A1
prerank,negative regulation of protein transport (GO:0051224),0.3090572162472063,0.7585521986270686,0.795,0.9783498706409205,1.0,4/25,12.14%,RHBDF2;SNX3;NDFIP2;HMGCR
prerank,pre-miRNA processing (GO:0031054),-0.3109947742036139,-0.7584344776160945,0.8100436681222707,0.9804567816980039,1.0,2/14,7.25%,TUT4;AGO2
prerank,vacuolar acidification (GO:0007035),-0.2800139229837166,-0.7576150966112648,0.805,0.9807408948030324,1.0,8/21,22.22%,ATP6V0A4;CLN3;GRN;CLN6;TCIRG1;ATP6AP2;ATP6V0D2;TMEM9
prerank,protein localization to Golgi apparatus (GO:0034067),-0.27242593831038286,-0.7575116285324012,0.8438287153652393,0.9800656927891522,1.0,6/27,15.88%,GBF1;OBSL1;VPS13A;ARL1;RAB6A;OPTN
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.33610922073014776,0.7573693820424472,0.7687074829931972,0.9796705454246314,1.0,11/18,30.55%,SCO2;SCO1;COA3;SMIM20;COX20;COX17;PET100;TIMM21;COA5;BCS1L;COA8
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.3301627690579978,0.7571790672870786,0.743006993006993,0.9794458998703279,1.0,6/19,14.66%,PARD3;LRRC7;CLIC4;FSCN1;FOXJ1;SYNJ2BP
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.3489372676905964,-0.7571436493991611,0.7416666666666667,0.9798024409062787,1.0,4/10,32.69%,TLR4;TLR6;CD36;CD68
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.3616778539160263,0.7569269230498326,0.7241379310344828,0.9787959782561251,1.0,3/11,18.03%,CCT3;CCT5;CCT7
prerank,regulation of protein localization to Cajal body (GO:1904869),0.3616778539160263,0.7569269230498326,0.7241379310344828,0.9787959782561251,1.0,3/11,18.03%,CCT3;CCT5;CCT7
prerank,protein import (GO:0017038),-0.21435524483282953,-0.7568447766673656,0.9233333333333333,0.9794057951529744,1.0,21/84,26.53%,ABCD3;APPL2;LAMP2;RANBP17;HSPA4;APOE;PXMP2;PEX2;SNX33;E2F3;FAM53B;ALDH3A2;IPO7;ATAD1;PEX13;HIKESHI;KPNB1;IPO8;STAT3;NUP155;TPR
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.36601594375745405,0.7562192549141035,0.7567567567567568,0.9793331052891784,1.0,11/11,63.42%,MALT1;NFKBID;PRKCQ;NFKBIZ;NLRP10;CLEC6A;IL23R;IL12B;IL23A;CARD9;IL12RB1
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.2377829325299235,-0.756053942946882,0.8695652173913043,0.9797632209468181,1.0,13/42,18.79%,SMARCC2;CHD3;CHD8;SMARCB1;CHD4;ACTR8;SMARCA1;SMARCA5;SPTY2D1;ERCC6;MBD2;RBBP4;SMARCC1
prerank,protein modification by small protein removal (GO:0070646),0.22039164893069757,0.7559607502169341,0.9528857479387515,0.9792064910092592,1.0,88/252,27.74%,NFKBIA;IFIH1;ACTB;SMAD7;SNX3;CCP110;ATXN3;EIF3F;PSMB3;BIRC3;PSMD11;PSMC6;PSME2;MYSM1;OTUD7A;SMAD1;BABAM1;USP18;TADA2B;PSMD8;HIF1A;HGS;TNFAIP3;POLB;ATXN7;WDR48;CYLD;PSMB10;WDR20;PSMA8;TRRAP;RAD23A;MCRS1;APC;HCFC1;COPS5;GPS1;ASXL1;RCE1;JOSD2;USP49;PSMD9;TNIP1;UBE2D1;USP32;USP25;USP21;BRCC3;USP29;OTUD7B;OTUD4;TRAF3;JOSD1;DESI2;DESI1;COPS6;SUDS3;INO80;MBD5;KAT2B;RAD23B;PSMD1;PSMC3;STAMBP;TRAF6;RIPK1;PSMD10;VCPIP1;USP30;USP38;FOXO4;KEAP1;MYC;COPS2;ZC3H12A;KDM1B;TAB1;PSME1;ACTR5;NFRKB;USP45;PSMB8;PSMD2;ADRB2;UBB;PSMA1;BECN1;ADRM1
prerank,neuron cell-cell adhesion (GO:0007158),0.3399962676940057,0.7555645758994249,0.769090909090909,0.9792974271542297,1.0,4/14,16.00%,RET;NCAM2;NRXN1;NLGN1
prerank,hexose metabolic process (GO:0019318),0.28354044341294143,0.7555631348846746,0.7980295566502463,0.9787913404040224,1.0,6/39,14.84%,SORD;PPARD;HK1;BRAT1;HECTD4;OMA1
prerank,regulation of histone acetylation (GO:0035065),0.29429249443217903,0.7555136354278716,0.7845911949685535,0.9783624057141271,1.0,11/33,22.23%,RAPGEF3;MAPK3;RPS6KA5;FOXP3;TADA2B;HDAC5;CTBP1;SET;NOC2L;SPI1;SNCA
prerank,regulation of monocyte chemotaxis (GO:0090025),0.313373816122449,0.7548775316039501,0.7926421404682275,0.9787990639965204,1.0,5/24,11.19%,CXCL12;LYN;GREM1;CCL1;DUSP1
prerank,fatty acid beta-oxidation (GO:0006635),-0.23719929078313878,-0.7545745492509953,0.9067357512953368,0.9810422887320132,1.0,17/51,21.97%,ABCD3;IVD;ACOT8;AUH;ECHDC2;BDH2;AMACR;ECHDC1;DECR1;CROT;PEX2;EHHADH;ECI1;ACAT2;ACADS;HADH;HADHA
prerank,histone mRNA catabolic process (GO:0071044),-0.3058356563480997,-0.7538399586562142,0.7695749440715883,0.9812325091862146,1.0,4/15,15.75%,TUT4;ATM;TENT2;TUT1
prerank,membrane assembly (GO:0071709),-0.2572726204411329,-0.7533076295536553,0.8289473684210527,0.9811328633478756,1.0,5/34,5.88%,ANXA2;NLGN2;S100A10;FLOT2;STX2
prerank,ribosomal large subunit biogenesis (GO:0042273),0.26490596122914045,0.7532721024371158,0.848575712143928,0.980710213795803,1.0,23/54,27.85%,MAK16;RPL3;NOP16;SNU13;WDR74;GTF3A;MRPL20;RPL11;RRP15;NHP2;NOC2L;PAK1IP1;NVL;RPL10A;SURF6;MRPL1;RSL24D1;RPL24;RPL7A;RPL6;RPL14;TRAF7;RPL26
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.3236500970703583,0.7528143192779837,0.774247491638796,0.9808856064696287,1.0,5/21,10.59%,MCUB;TGM2;RAP1GDS1;LETM1;PDZD8
prerank,histone exchange (GO:0043486),-0.24404923558872307,-0.752523237278065,0.8434065934065934,0.9813844544593203,1.0,9/37,18.57%,CENPC;CENPP;CENPK;SMARCA5;SPTY2D1;MIS18BP1;CENPL;RBBP4;CENPQ
prerank,regulation of autophagosome maturation (GO:1901096),-0.31391720166681936,-0.7524450807544136,0.7686915887850467,0.9806855999729209,1.0,5/13,18.62%,TMEM39A;CLN3;CLEC16A;PHF23;SMCR8
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.28387634582538507,0.7523860211265883,0.8181818181818182,0.9809991170070849,1.0,12/36,24.49%,NLRC5;IRGM;ADAM17;HIF1A;C1QTNF4;EDN1;GAS6;CPNE1;PARP9;TICAM2;RIPK1;PARP14
prerank,insulin secretion (GO:0030073),-0.29112609551116475,-0.7518129037421497,0.7928571428571428,0.9807570327640712,1.0,2/19,5.42%,RAB11FIP2;ANXA1
prerank,regulation of intracellular protein transport (GO:0033157),0.2943129837011472,0.7516915805545987,0.8054226475279107,0.9815273175601739,1.0,9/32,20.07%,PRR5L;RIPOR1;OAZ1;TGFB1;PDCD10;B3GAT3;SIRT7;TENM1;OAZ2
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.311313104578572,-0.7513389231324268,0.7866666666666666,0.9806337930425376,1.0,1/13,1.07%,B3GALT1
prerank,protein-DNA complex assembly (GO:0065004),0.23953927647039738,0.7511996565573449,0.8950863213811421,0.9817573269177912,1.0,36/116,27.54%,GTF2H2;PSMB3;PSMD11;CETN2;PSMC6;PSME2;CDC6;PSMD8;GTF2H4;CHAF1A;NAA60;HMGB2;ORC1;PSMB10;SOX9;RBX1;PSMA8;CHAF1B;RPA1;PSMD9;GRWD1;DDB1;GTF2H3;DAXX;RAD23B;PSMD1;PSMC3;PSMD10;NAP1L4;XPC;SART3;PSME1;PSMB8;PSMD2;UBB;PSMA1
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.2673536475154675,0.7511070422676284,0.8323442136498517,0.9813915945418077,1.0,12/53,18.03%,DAB2IP;GNA12;HSP90AB1;FBXW7;OPHN1;PSMC6;PSME2;F8A1;BAG2;RAD23A;FOXF2;PRKCG
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.22895392653870247,0.7509098029092295,0.9402985074626866,0.9811978006098742,1.0,54/184,23.33%,RGCC;PPP1R9B;CDC14A;DYNLL1;CCP110;PSMB3;PSMD11;NPM2;PRKAR2B;CETN2;PSMC6;TUBB;CDK5RAP2;PSME2;AKAP9;HAUS6;CDC6;ZFP36L1;CEP78;PSMD8;CEP72;CEP135;PSMB10;BUB3;ANLN;TUBA1A;ANAPC16;TUBB4B;CKAP5;PSMA8;CEP70;ANAPC7;SKP1;ANAPC10;PSMD9;UBE2D1;ANAPC2;ZW10;DCTN1;ZFP36L2;TFAP4;SFI1;DDB1;CUL1;CLASP1;INO80;HAUS2;NDE1;CDC23;PSMD1;PSMC3;CDC27;PSMD10;CDC26
prerank,intracellular cholesterol transport (GO:0032367),0.3359455951897851,0.75019049166475,0.7531083481349912,0.9817253288630011,1.0,4/15,14.94%,OSBP;ABCG1;NPC1;STARD4
prerank,positive regulation of heart rate (GO:0010460),0.3257802538826132,0.750140618335327,0.7570422535211268,0.981298673559637,1.0,3/17,5.26%,PDE4D;NPPA;KCNQ1
prerank,regulation of chromatin organization (GO:1902275),-0.316209028016827,-0.7498730666712131,0.7732181425485961,0.981869886172513,1.0,3/14,11.01%,IGF2;MLLT3;SETD5
prerank,regulation of gene silencing by miRNA (GO:0060964),-0.2245319238994724,-0.7493868539028339,0.9146341463414634,0.9817370263792247,1.0,20/62,29.90%,TNRC6A;SEH1L;POLR2A;AGO2;NUP205;FMR1;LIMD1;EIF4G1;RAE1;AJUBA;POLR2L;IPO8;STAT3;POLR2I;NUP155;TPR;NDC1;NUP35;NUP43;POLR2K
prerank,cellular response to starvation (GO:0009267),0.23472381225561595,0.7493041624710425,0.9208173690932312,0.9820278965087907,1.0,28/147,17.48%,MFSD2A;BMPR2;FAS;FOXO1;PRKD1;RIPOR1;WDR59;XPR1;SESN3;MAPK3;RALB;MAP1LC3B;PIK3C3;EIF2AK4;LAMTOR5;DEPDC5;HSPA8;SH3GLB1;RPTOR;TFEB;STK24;STK26;LAMTOR4;MAPK1;ATG14;WDR45;SIK2;MAP1LC3A
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.31647149368095406,0.7492505418190728,0.8076923076923077,0.9816088785820295,1.0,11/22,32.33%,ENC1;PSMB3;PSMB10;PSMA8;NFE2L2;PSMB8;PSMA1;PSMA7;PSMB9;PSMB1;PSMA4
prerank,regulation of T cell differentiation (GO:0045580),0.28518056960961186,0.7489686849736986,0.8194888178913738,0.9814894835073982,1.0,4/33,10.34%,ZAP70;TCF7;FOXP3;CBFB
prerank,"base-excision repair, gap-filling (GO:0006287)",0.28990611079914475,0.7485750554933706,0.8378812199036918,0.9815706175537949,1.0,13/35,26.31%,NTHL1;MPG;PARG;SMUG1;POLB;RPA1;ADPRS;POLL;POLD1;RFC2;RFC4;PNKP;POLD4
prerank,glycolytic process (GO:0006096),0.3028834895504933,0.7484053439432735,0.8258706467661692,0.9813265701196646,1.0,7/28,18.64%,PKM;HK1;PGAM4;PGAM1;TPI1;PFKL;LDHA
prerank,"DNA-templated transcription, elongation (GO:0006354)",-0.22043449760011308,-0.748249544362557,0.9141104294478528,0.9825124761158177,1.0,20/64,27.25%,CCNT2;CTR9;POLR2A;MLLT3;CCNH;CDK7;AFF4;PAF1;NELFE;ELP4;GTF2F1;SETD2;GTF2H1;POLR2L;EAF2;CDK12;POLR2I;CDK9;ELOA;TCEA2
prerank,regulation of exocytosis (GO:0017157),0.271083060451889,0.7481843032945796,0.8230647709320695,0.9811320383356198,1.0,13/46,22.29%,STXBP6;UNC13D;RAB3B;LGI3;CPLX1;CADPS;RALA;RIMS2;CADPS2;RAB8A;CLASP1;SNCA;ATP6AP1
prerank,negative regulation of neuron differentiation (GO:0045665),0.3163384843145779,0.748109620008253,0.781786941580756,0.9807318502390184,1.0,5/22,16.48%,B2M;EIF2AK4;SOX9;DISP3;HEY1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.33901395520459604,0.7479043516347784,0.7837338262476895,0.9805231669824127,1.0,7/13,29.59%,CIAO2B;BOLA2;GLRX3;YAE1;NFU1;ISCA2;ISCA1
prerank,cellular response to catecholamine stimulus (GO:0071870),0.31039962949931116,0.7478462850554064,0.7832764505119454,0.9800865535558368,1.0,9/23,23.23%,TGM2;KCNQ1;MAPK3;PDE4B;GNB1;MAPK1;ATP2B4;SNCA;RYR2
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.25835070343428623,0.7475928725420563,0.8328358208955224,0.9799804029821739,1.0,15/57,21.33%,RPL38;NOP16;WDR74;DHX37;RPS7;GTF3A;RPL11;RIOK1;RPS15;RPS28;RPS25;NAF1;NOC2L;PAK1IP1;NVL
prerank,positive regulation of cytokinesis (GO:0032467),0.29526253500885064,0.7472801265130827,0.8268608414239482,0.9799292484496837,1.0,9/32,18.21%,CDC14A;PKN2;PKP4;CDC6;MAP10;KIF23;RXFP3;SPAST;PRKCE
prerank,regulation of RNA metabolic process (GO:0051252),0.2629669714916148,0.7467670306267441,0.8520710059171598,0.9801503487607326,1.0,2/59,1.49%,RBM20;NOVA2
prerank,ruffle organization (GO:0031529),-0.3061618092468445,-0.7464077506299189,0.816933638443936,0.9841511596619722,1.0,2/16,2.42%,TPM1;CARMIL1
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.27178333541025324,-0.7462949540109066,0.84375,0.9835000772295812,1.0,8/26,19.73%,ANAPC5;NEK6;RIOK2;CUL3;CENPE;NSMCE2;HECW2;CDC16
prerank,triglyceride homeostasis (GO:0070328),-0.2712686667374987,-0.7459647351466155,0.8025316455696202,0.9831509412313314,1.0,4/26,8.31%,IL18;RORA;C1QTNF3;APOE
prerank,import into nucleus (GO:0051170),0.25298770257502007,0.74543369907881,0.8832853025936599,0.9816469367075621,1.0,29/73,31.35%,BACH2;IPO11;NXT1;SNRPF;SNRPE;RANBP6;SYK;SNRPB;NUP153;PTTG1IP;SNRPD2;NUP50;IPO4;NXT2;CSE1L;NUP85;NUP188;FAM53A;DDX20;SMN1;SNRPD1;RAN;GEMIN5;HNRNPA1;NUTF2;HTATIP2;AKT1;MMP12;RPAIN
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.25177744406282687,0.7452536331602894,0.881559220389805,0.980894707086175,1.0,16/78,16.54%,OSBPL1A;AP1S2;KIF26A;PIKFYVE;DYNLL1;KIF2A;DNM2;AP2M1;AP1S3;KIF3B;DCTN4;KIF23;AP2B1;DYNC1LI1;CTSS;AP1G1
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.25177744406282687,0.7452536331602894,0.881559220389805,0.980894707086175,1.0,16/78,16.54%,OSBPL1A;AP1S2;KIF26A;PIKFYVE;DYNLL1;KIF2A;DNM2;AP2M1;AP1S3;KIF3B;DCTN4;KIF23;AP2B1;DYNC1LI1;CTSS;AP1G1
prerank,internal peptidyl-lysine acetylation (GO:0018393),-0.26619764847104666,-0.7451480003509676,0.8372641509433962,0.9834302238499829,1.0,13/27,32.79%,KAT6B;SGF29;MORF4L2;EP300;BRD8;MRGBP;TAF6L;KAT8;NAA50;CREBBP;MSL3;KAT5;TAF6
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.23921970997462005,-0.7446010431429327,0.8732394366197183,0.9833281413994934,1.0,6/45,9.01%,EGFR;BMP4;DDX5;POLR2A;RIOK2;WDR43
prerank,receptor catabolic process (GO:0032801),0.30612212638928976,0.7445106232166445,0.7785714285714286,0.9814188254480364,1.0,10/24,23.40%,ZNRF3;TGFB1;AP2M1;SMURF1;SH3GLB1;AP2B1;UVRAG;AP2S1;LGMN;SNX25
prerank,serine family amino acid catabolic process (GO:0009071),0.3684285006295852,0.744365857310499,0.7626459143968871,0.9811393606533246,1.0,2/10,9.86%,SHMT2;CBS
prerank,early endosome to late endosome transport (GO:0045022),-0.28444891424497737,-0.7441263757514373,0.8154613466334164,0.9831715121640867,1.0,12/20,35.85%,EEA1;ANKRD27;HOOK2;AKTIP;WDR81;WDR91;EMP2;SNF8;PTPN23;SNX16;RILP;RAB5A
prerank,positive regulation of ATPase activity (GO:0032781),-0.24227570179126295,-0.7440957728636605,0.8770491803278688,0.9823952802542132,1.0,8/41,17.75%,TPM1;ATP1B3;ATP1B2;PFN2;TOR1AIP1;TNNT3;DNAJB2;PLSCR1
prerank,regulation of dopamine secretion (GO:0014059),-0.27177968908948025,-0.7439547549311923,0.8681592039800995,0.9817568874630042,1.0,5/25,16.96%,DTNBP1;PRKN;SYT9;SYT13;SYT3
prerank,mRNA modification (GO:0016556),0.31065304387229503,0.7436387046668395,0.7898423817863398,0.9817024000459958,1.0,7/22,23.86%,CBLL1;TRMT10C;TRMT61B;ZC3H13;CMTR1;METTL3;PCIF1
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.31893660467142493,-0.7435394043787613,0.7935779816513762,0.9815040123275209,1.0,4/12,18.30%,CLCN2;H6PD;SREBF1;MBTPS1
prerank,negative regulation of transmembrane transport (GO:0034763),0.36186915932282326,0.7434899000911164,0.7575757575757576,0.9814111030879498,1.0,2/10,11.78%,CTTNBP2NL;PRKCB
prerank,DNA repair (GO:0006281),0.21686750802256147,0.7434854909542652,0.9563719862227325,0.9809135388356334,1.0,63/284,22.12%,TENT4A;POLK;MEN1;MRE11;UBE2V2;ATXN3;GTF2H2;ALKBH2;HINFP;BRCA2;PWWP3A;CETN2;DNA2;FANCG;KDM4A;HPF1;MGMT;UBXN1;UBE2V1;MPG;BABAM1;SMUG1;RECQL4;GTF2H4;ASCC3;FBXO6;BTG2;POLB;WDR48;FAN1;NSMCE4A;FANCF;RNF8;MSH3;TRRAP;RAD23A;MSH2;HERC2;HMGA2;SUMO1;RAD21;FANCB;NUDT1;HUS1;RPA1;ADPRS;BRCC3;NSMCE3;RAD9B;POLL;UVRAG;POLD1;DDB1;GTF2H3;POLA1;ERCC8;PARP2;DCLRE1C;INO80;RFC2;RAD23B;ERCC4;RAD1
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.3631793801980634,0.7429110310972511,0.7707509881422925,0.9812496060892694,1.0,2/10,7.94%,NOTCH1;TGFB1
prerank,response to light stimulus (GO:0009416),0.26500976792875625,0.7428114315815685,0.839258114374034,0.9808862189665066,1.0,6/55,8.81%,MAP4K3;MEN1;DCT;GTF2H2;OPN5;GPR52
prerank,synaptic vesicle localization (GO:0097479),0.34398098195341686,0.7424753473604983,0.7728085867620751,0.9808619298903376,1.0,3/13,16.18%,DNM2;NLGN1;SYNJ1
prerank,response to gamma radiation (GO:0010332),0.30922004592911057,0.7420632175996442,0.8023648648648649,0.9809332081165196,1.0,2/24,3.49%,DCUN1D3;MEN1
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.30727907780536556,0.7417531112490958,0.79073756432247,0.980867400909374,1.0,2/22,3.49%,NOTCH1;IL10RB
prerank,regulation of neurogenesis (GO:0050767),0.2675954379938066,0.7412941333628784,0.8561046511627907,0.9810049998045882,1.0,9/55,12.97%,B2M;NOTCH1;TGM2;WNT7A;CTNNB1;FAIM;LRP2;SOX11;HMGB2
prerank,C21-steroid hormone metabolic process (GO:0008207),0.32014903924052596,0.7408067961584497,0.7710843373493976,0.9812103758668302,1.0,2/20,5.46%,CYP11B1;CYP11A1
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.2485361926991045,0.7400115480884447,0.8736111111111111,0.9818145496935476,1.0,15/84,12.97%,NANOS3;YBX1;NANOS2;ENC1;MRPL13;NANOS1;PIN1;ABCA7;CNOT9;RPL13A;GRB7;ORMDL1;ORMDL3;BTG2;PAIP2
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.29385805890453975,0.7398846072847561,0.8319039451114922,0.9815024115894257,1.0,8/27,20.88%,MAP3K8;IKBKB;MAPK3;CCM2;MAPK1;SKP1;MAP2K7;CUL1
prerank,response to metal ion (GO:0010038),0.2555011749616959,0.7396139071187167,0.8526466380543634,0.9813883392027156,1.0,13/67,18.34%,CAV1;NEDD4L;CALM1;HOMER1;GPHN;PPP3CA;HIF1A;MT1A;MT1X;PDCD6;LOXL2;TTN;NDRG1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.24189777543085417,0.7392634159368102,0.8956043956043956,0.9814223592344751,1.0,24/94,21.67%,CEP83;DYNLL1;CCP110;RAB11A;PRKAR2B;MARK4;CETN2;TUBB;CDK5RAP2;AKAP9;HAUS6;CEP78;CEP72;CEP135;TUBA1A;TUBB4B;CKAP5;CEP70;CEP97;DCTN1;SFI1;CLASP1;HAUS2;NDE1
prerank,regulation of lipid catabolic process (GO:0050994),0.31667519782323905,0.7392397453951254,0.7972508591065293,0.980960929101899,1.0,6/19,22.36%,ABCB11;ABCD1;PDE3B;ALK;LONP2;PRKAA1
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.29121232647693257,0.7389864370762982,0.7965811965811965,0.9808142271031657,1.0,5/29,11.96%,ABT1;DHX37;UTP3;PWP2;NOL10
prerank,regulation of RNA export from nucleus (GO:0046831),-0.32669571935633324,-0.7388987113278662,0.7632135306553911,0.9867548029993484,1.0,4/11,26.53%,AKAP8L;NSUN2;SETD2;TPR
prerank,autophagosome assembly (GO:0000045),0.26816687559334773,0.7385821200669955,0.8588235294117647,0.9808665687864494,1.0,23/52,27.73%,IRGM;MAP1LC3B;SMURF1;PIK3C3;UBQLN1;ATG12;RAB1A;ATG14;WDR45;MAP1LC3A;ATG9B;VMP1;ATG7;NSFL1C;ATG2A;GABARAP;GABARAPL2;ULK1;UBXN2B;RAB1B;RAB7A;BECN1;UBQLN2
prerank,embryonic axis specification (GO:0000578),0.3331546477509848,0.7385320266924514,0.7604562737642585,0.9804360740196573,1.0,3/15,10.95%,TBX3;WNT7A;TASOR
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.353867919028018,0.7379596248042053,0.7681159420289855,0.9807378228940149,1.0,4/11,22.60%,ZFP36L1;NCBP2;NCBP1;PAPOLA
prerank,response to hydrogen peroxide (GO:0042542),0.27127277397377975,0.7377649585347946,0.8524844720496895,0.9805265392463139,1.0,9/45,14.83%,NET1;RHOB;CAT;FYN;PLEKHA1;PDCD10;TNFAIP3;STK24;STK26
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.2794385549320239,-0.7377015275585548,0.8240740740740741,0.9874590390802519,1.0,9/19,30.00%,CDIP1;PML;DYRK2;EP300;PHLDA3;PYCARD;RPS27L;BCL3;SIRT1
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.2654354839927573,0.7376927008611062,0.8400597907324364,0.9801278070126197,1.0,5/55,6.20%,PDGFB;XDH;GRB2;PIKFYVE;SLC25A33
prerank,tyrosine metabolic process (GO:0006570),0.36054225280115304,0.7376519054619041,0.7972972972972973,0.9796928937236185,1.0,3/11,24.45%,DCT;HGD;THAP4
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.28875108114568215,0.737184622537919,0.8072100313479624,0.9798744039756062,1.0,7/31,17.26%,DCUN1D3;FBXW7;PIN1;DCUN1D1;RAB1A;BMI1;SKP1
prerank,midbody abscission (GO:0061952),0.32149562466232756,0.7369953926987525,0.7845117845117845,0.9796387632570195,1.0,10/17,34.76%,CHMP1B;MITD1;PDCD6IP;CHMP2B;VPS4B;CEP55;CHMP3;CHMP4A;CHMP4B;CHMP7
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.3254522973702021,0.7366547490285988,0.7741347905282332,0.979626145555653,1.0,1/15,0.99%,BCL2L1
prerank,regulation of chromatin binding (GO:0035561),0.3587529359700656,0.7366431824205366,0.7678571428571429,0.9791394003042699,1.0,5/10,25.67%,HMBOX1;DDX11;WAPL;PARP9;DTX3L
prerank,chromatin assembly (GO:0031497),0.2763917061571019,0.7366262736876419,0.8341384863123994,0.9786654840047722,1.0,14/38,23.71%,PRDM9;CTCF;CHAF1A;NAA60;POLE3;HMGB2;SOX9;CHAF1B;HMGA2;NOC2L;GRWD1;DAXX;LIN54;NAP1L4
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.2522433583986122,0.7360893275583222,0.8762169680111266,0.97888558478718,1.0,17/71,16.40%,CTSC;CTSW;ATXN3;CTSO;CTSK;RHBDD1;MALT1;OTUD7A;CASP8;TNFAIP3;OMA1;PSMA8;CTSS;PDCD6IP;CAPN2;ATE1;BAG6
prerank,negative regulation of ATPase activity (GO:0032780),-0.29471556916741626,-0.7359244830079023,0.841991341991342,0.988900342623352,1.0,3/16,20.01%,THADA;ATP5IF1;TSC1
prerank,folic acid-containing compound metabolic process (GO:0006760),-0.28319760281178674,-0.7358479612447845,0.8153153153153153,0.9881784345019782,1.0,7/19,22.32%,MTHFD1;MTHFR;MTHFD2;MTHFD1L;MTHFS;GGH;FPGS
prerank,protein ubiquitination (GO:0016567),0.20827645303524178,0.7355892877154844,0.9838709677419355,0.9790767084055655,1.0,96/471,18.84%,RNF144B;EPAS1;LMO7;ZNRF1;KLHL2;SH3RF1;TRIM25;TRIM14;NEDD4L;KLHL7;PELI1;RNF125;ZNRF3;CTNNB1;ENC1;KLHL25;UBE2V2;ABCB11;FBXW7;PHC1;PSMB3;UBE2G1;PSMD11;FBXO41;KLHL24;TRIM36;PSMC6;TRIM24;PSME2;SMURF1;KCTD10;KLHL3;UBE2V1;CBFB;KLHL20;CBLL1;UBOX5;FBXL2;HERC6;UBE3D;PEX14;ZNRF2;PSMD8;HIF1A;WSB1;FBXO6;RNF187;TRIM69;ARRDC1;ASB5;RNF38;PSMB10;TRIM39;RNF208;FBXW2;BCL10;FBXO21;NHLRC1;AREL1;RBX1;RNF8;ANAPC16;FBXL8;UBE2D3;TRIM2;FBXL15;RNF139;ELOB;PSMA8;UBE2Q2;MSL2;HERC2;ANAPC7;TRIM26;FBXO2;SKP1;UBE2G2;CBL;TRIM11;UHRF2;TRIM47;UBE2Z;BFAR;KBTBD8;RNF19A;HLTF;TRIM71;TRIM68;TRIM3;NEUROD2;PSMD9;SIAH1;UBE2D1;RNF4;FBXW9;RBCK1
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.2662034923030619,0.73545133989119,0.8614916286149162,0.978757506419309,1.0,7/50,12.38%,ACTB;HSP90AB1;CDKN2B;CCNI;CCND3;CDC6;CCNK
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.32556035160461927,-0.7354202419460975,0.8035714285714286,0.9879549123888136,1.0,5/11,30.47%,STX4;TYROBP;MAVS;CAMK4;ITGAM
prerank,positive regulation of phagocytosis (GO:0050766),0.2682214792541125,0.7349953240760069,0.8495440729483282,0.9788977192851629,1.0,10/47,17.04%,RAB31;PTPRJ;MERTK;GATA2;ABCA7;IL15;NCKAP1L;DOCK2;GAS6;LYAR
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.285025052154516,-0.7349264127923473,0.8274231678486997,0.9878132242796659,1.0,4/18,13.80%,IL34;DAAM2;SLC45A3;NF1
prerank,regulation of nuclear division (GO:0051783),-0.2766400460210686,-0.7348106381087874,0.8520408163265306,0.9871586164059029,1.0,3/20,11.60%,OBSL1;CUL7;PRMT5
prerank,Golgi to endosome transport (GO:0006895),-0.29836090141985355,-0.7344622491748811,0.8148936170212766,0.9867809799301032,1.0,6/16,19.76%,GBF1;VPS13A;AP4M1;MON2;AP2A1;RAB14
prerank,negative regulation of lipid metabolic process (GO:0045833),0.30091111179895474,0.733950819535293,0.7887323943661971,0.9798124693757485,1.0,5/22,17.24%,ASXL3;PPP2R5A;CEACAM1;PDE3B;ALK
prerank,positive regulation of rRNA processing (GO:2000234),-0.3366197026274354,-0.7338708660652116,0.7938775510204081,0.986698759254409,1.0,4/10,21.61%,RIOK2;WDR43;TRMT112;DIMT1
prerank,bile acid metabolic process (GO:0008206),0.2911325665359348,0.7336635979398713,0.8203799654576857,0.9797157757595415,1.0,5/27,12.21%,OSBPL1A;OSBP;ABCB11;NPC1;SLC27A2
prerank,DNA replication (GO:0006260),-0.19875023494866806,-0.7335599623351547,0.9680851063829787,0.9862998221160281,1.0,33/105,26.80%,TOP1;RBMS1;REV1;ATM;RBBP8;TIPIN;IGHMBP2;HELB;NAP1L1;RAD50;CLSPN;DUT;ATRIP;POLD2;BAZ1A;RFC3;BRCA1;PCLAF;DONSON;CDC45;WRN;DBF4;MCM3;NBN;MCM4;POLE2;ATR;MCM5;EXO1;ORC5;RFC5;MCM9;ORC2
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.2851249668929744,0.7335361183289452,0.8137931034482758,0.9793805060936113,1.0,6/30,16.51%,FUT8;STT3B;ST6GAL1;DAD1;DPM3;MGAT2
prerank,endoplasmic reticulum organization (GO:0007029),0.24674631460268007,0.7333955280382527,0.8961988304093568,0.9790691229170819,1.0,6/72,10.62%,APP;REEP1;STX1A;CAV2;LPCAT3;REEP5
prerank,protein deacylation (GO:0035601),0.3064385804085525,0.7333253932890876,0.8202054794520548,0.9786680018632039,1.0,7/23,18.10%,HDAC7;NOTUM;ABHD17A;LYPLA1;HDAC5;SIRT7;SIN3A
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.33556692925767917,0.7329897584203297,0.7677304964539007,0.9786288455312081,1.0,3/14,17.38%,ADAM10;ADAM17;CCR2
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.3493504274692868,0.7329408135220807,0.7855822550831792,0.9782073935618513,1.0,1/11,4.47%,CTNNB1
prerank,response to ionizing radiation (GO:0010212),0.24837376986639947,0.732553456315061,0.8797736916548797,0.9782109121108181,1.0,25/70,27.32%,NET1;DCUN1D3;MEN1;GRB2;RHOB;BABAM1;BRAT1;RNF8;EEF1D;MSH2;HUS1;BRCC3;RAD9B;INO80;RAD1;PRKAA1;SMPD1;TOPBP1;MYC;NABP2;MTA1;CLOCK;BLM;XRRA1;GADD45A
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.28932669616594325,0.7318646813797912,0.8481421647819063,0.9786540784121769,1.0,4/31,12.39%,LYN;TNFRSF21;FOXP3;SOX11
prerank,regulation of cytoplasmic transport (GO:1903649),0.3488181083506222,0.7317488594939634,0.7710622710622711,0.9783184818389308,1.0,2/11,6.24%,DNAJC13;MAPK3
prerank,covalent chromatin modification (GO:0016569),0.34418688426256533,0.7314725611045851,0.7742537313432836,0.9781699248916541,1.0,5/14,20.97%,CHD1;HELLS;SIRT7;HLCS;PARP2
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.3552190592681873,0.731119197967959,0.7740112994350282,0.9781408242277693,1.0,4/10,19.84%,AKAP9;DLGAP3;NPTXR;NPTX1
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.2829007891660475,0.7309404313216392,0.8282504012841091,0.9778814123274353,1.0,10/35,19.82%,HMBOX1;CTNNB1;MAPK3;CCT3;ACD;CCT5;MAPK1;CCT7;NAF1;MAP2K7
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.2617526557793931,-0.7298366292536126,0.844059405940594,0.9901468964205316,1.0,7/24,18.28%,DMD;CAMK2D;PKD2;PRKACA;JPH1;GSTM2;JPH2
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.30693648548448604,-0.729386820891702,0.819838056680162,0.9898666141464074,1.0,3/12,14.30%,SLC5A3;CYBA;TLR4
prerank,leukotriene biosynthetic process (GO:0019370),-0.29741423591667593,-0.7293766339477465,0.8136363636363636,0.9890785220067093,1.0,3/14,15.35%,GGT5;GGTA1;MGST3
prerank,DNA duplex unwinding (GO:0032508),0.2690436138814731,0.7290354003358469,0.8775193798449612,0.980001929981016,1.0,14/50,21.92%,MRE11;GTF2H2;CETN2;HMGA1;RECQL4;GTF2H4;ASCC3;RBX1;TWNK;DDX11;RPA1;DDB1;GTF2H3;RAD23B
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),-0.21623432678849946,-0.7285125007131118,0.9341317365269461,0.9893566139504181,1.0,19/62,27.07%,CCNT2;CTR9;POLR2A;MLLT3;CCNH;CDK7;AFF4;PAF1;NELFE;ELP4;GTF2F1;SETD2;GTF2H1;POLR2L;EAF2;CDK12;POLR2I;CDK9;ELOA
prerank,regulation of peptidase activity (GO:0052547),0.30902164497197687,0.7284762420353167,0.7900355871886121,0.9802636632818983,1.0,2/19,8.37%,CAV1;CST7
prerank,nuclear transport (GO:0051169),0.3180885055652617,0.7275985162308467,0.7902350813743219,0.9809199908774124,1.0,4/16,16.76%,NXT1;HMGA1;BANF1;RSRC1
prerank,regulation of transferase activity (GO:0051338),0.31666385276873754,0.7271408361403333,0.7859649122807018,0.9810085926332714,1.0,2/17,3.79%,NLRC5;HMBOX1
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.33090088662324724,0.7266951301740506,0.7884615384615384,0.9811032055247754,1.0,3/16,12.59%,AGER;CEACAM1;CYRIB
prerank,DNA-dependent DNA replication (GO:0006261),0.22873961956127073,0.726501203295443,0.9439124487004104,0.9808542671909146,1.0,37/128,27.54%,PSMB3;PSMD11;DNA2;PSMC6;HMGA1;PSME2;MCM10;CDC6;RECQL4;PSMD8;POLG2;POLB;POLE3;ORC1;PSMB10;TWNK;PSMA8;SIRT7;RPA1;PSMD9;REV3L;POLD1;POLA1;RFC2;PSMD1;PSMC3;PSMD10;TOPBP1;RFC4;PNKP;BLM;POLD4;PSME1;PSMB8;PSMD2;UBB;PSMA1
prerank,DNA double-strand break processing (GO:0000729),0.3089063066038468,0.7260232923713562,0.8078291814946619,0.9809701909460656,1.0,3/18,8.52%,MRE11;UBE2V2;DNA2
prerank,telomere organization (GO:0032200),0.27046008390814386,0.7258649834512588,0.8426966292134831,0.9806900992863288,1.0,7/43,12.39%,SP100;MRE11;TERF2;DNA2;ACD;RECQL4;TERF1
prerank,peptidyl-asparagine modification (GO:0018196),0.2809649274524285,0.725834136602307,0.8242320819112628,0.9802423682425929,1.0,6/31,16.51%,FUT8;STT3B;ST6GAL1;DAD1;DPM3;MGAT2
prerank,positive regulation of acute inflammatory response (GO:0002675),0.33641703409873586,0.7240943511346724,0.8082706766917294,0.9820241031727313,1.0,1/14,4.22%,OSMR
prerank,snRNA transcription (GO:0009301),-0.20953744686613351,-0.7240086626511131,0.9419354838709677,0.9939903140106822,1.0,23/70,30.60%,CCNT2;PHAX;POLR2A;RPRD2;INTS8;TAF8;CDK7;INTS2;GTF2F1;INTS4;INTS10;USPL1;TBP;TAF9;POLR2L;SNAPC2;POLR2I;INTS3;CDK9;ZC3H8;INTS5;POLR2K;SNAPC4
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.2991626221354187,0.7227602195564637,0.8205574912891986,0.9832947213425941,1.0,4/24,11.75%,NOTCH1;KLF2;ATF6B;HIF1A
prerank,carnitine metabolic process (GO:0009437),0.3383632757789852,0.7227286685396518,0.7800751879699248,0.9828402819318166,1.0,2/12,5.79%,CPT1A;CRAT
prerank,membrane protein proteolysis (GO:0033619),-0.2418100760114699,-0.7224348925270428,0.8784530386740331,0.9949809418908893,1.0,10/37,18.30%,DAG1;ADAM9;BACE2;ADAM19;AFG3L2;PSEN1;CTSH;HM13;PARL;MBTPS1
prerank,negative regulation of microtubule polymerization (GO:0031115),0.3369680227304298,0.7215964287913453,0.770949720670391,0.9837917765257592,1.0,5/12,22.23%,STMN1;ARHGEF7;CDH5;DYRK1A;SNCA
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.3339038934637397,0.7212085849266859,0.7982300884955752,0.9837929825479401,1.0,4/13,18.10%,TMSB4X;SOX11;HEY1;SIN3A
prerank,regulation of protein localization to centrosome (GO:1904779),0.3515825919762867,0.7211046666089327,0.7885714285714286,0.9834269822178138,1.0,5/10,25.21%,MARK4;CEP72;APC;NSFL1C;UBXN2B
prerank,response to nutrient levels (GO:0031667),-0.28166943402218547,-0.7205399509128233,0.8298368298368298,0.9963428034517572,1.0,1/17,1.32%,PRKAA2
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.2251729781823936,0.7203859536273118,0.9343832020997376,0.9838924547059116,1.0,39/145,22.50%,DYNLL1;CCP110;PSMB3;RAB11A;PSMD11;PRKAR2B;CETN2;PSMC6;TUBB;CDK5RAP2;PSME2;AKAP9;BRD4;HAUS6;CEP78;PSMD8;CEP72;CEP135;PSMB10;RBX1;TUBA1A;TUBB4B;CKAP5;PSMA8;RCC2;CEP70;SKP1;PSMD9;MECP2;DCTN1;PINX1;SFI1;CUL1;CLASP1;HAUS2;NDE1;CDK4;PSMD1;PSMC3
prerank,protein deacetylation (GO:0006476),-0.23496333035768796,-0.7202533681833222,0.9224806201550387,0.9958666651497056,1.0,6/41,9.24%,HDAC4;TBL1XR1;MIER3;FLNA;SIRT3;MORF4L2
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.22885899585248168,-0.7200180209355435,0.9046153846153846,0.9953351852990383,1.0,11/42,27.05%,FBH1;RTEL1;PARP1;KDM1A;KLHL15;HELB;ERCC6;SETD2;SIRT6;SPIDR;RAD51AP1
prerank,mitotic nuclear membrane disassembly (GO:0007077),-0.3052295324085043,-0.7189846803694067,0.8031674208144797,0.9957569079208972,1.0,4/12,23.01%,NEK6;PRKCA;CNEP1R1;CCNB2
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.2935079031060447,-0.7182861288864624,0.84,0.9957518713766029,1.0,5/15,19.73%,NEK6;RIOK2;CENPE;HECW2;CDC16
prerank,response to amino acid (GO:0043200),0.2819249592594673,0.7182281524957096,0.8492063492063492,0.9861861024417051,1.0,10/31,25.22%,SH3BP4;LAMTOR5;RPTOR;NSMF;LAMTOR4;CAPN2;GLRA2;GRIN1;MTOR;GLRA1
prerank,negative regulation of viral entry into host cell (GO:0046597),0.34853660817825727,0.7181091641473498,0.8036697247706422,0.985847234484128,1.0,2/12,4.38%,LY6E;SNX3
prerank,regulation of ATP metabolic process (GO:1903578),-0.2193656124435465,-0.7174716170311154,0.9378698224852071,0.9959053106108053,1.0,5/54,9.15%,PRKAG2;OGT;SEH1L;ATP7A;NUP205
prerank,negative regulation of macrophage activation (GO:0043031),0.3221648334872345,0.7174255590108084,0.809009009009009,0.9862487194946697,1.0,2/16,8.37%,CD200;CST7
prerank,regulation of centrosome duplication (GO:0010824),-0.25157575634228563,-0.7173570744450962,0.8961038961038961,0.9952486846118905,1.0,8/29,23.02%,ALMS1;SPICE1;STIL;CHMP4C;CEP295NL;FBXW5;CEP131;CEP76
prerank,heterochromatin assembly (GO:0031507),0.3027578888172703,0.7172455646548239,0.8006700167504187,0.9860115688795612,1.0,5/20,16.37%,ZNFX1;HMGA1;POLE3;HELLS;HMGA2
prerank,protein homooligomerization (GO:0051260),0.2292017114283439,0.7171337565319229,0.9260752688172043,0.9856758143580557,1.0,19/114,16.77%,AQP11;B2M;HPRT1;GBP5;MCOLN1;SAMHD1;SLC1A2;KCNC2;ACACB;SHMT2;LETM1;EHD4;BCL10;TRMT61B;ELAVL1;CARD11;PDCD6IP;SPAST;NLRC4
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.32565608585630706,0.7169889254420357,0.7869158878504673,0.985377691892673,1.0,3/14,8.37%,CD200;CD200R1;CST7
prerank,regulation of synapse organization (GO:0050807),0.29295889773987993,0.7166847021615854,0.8354632587859425,0.9853080792272987,1.0,6/26,18.59%,MEF2C;EPHA4;ABHD17A;CAMK2B;YWHAZ;CTNNA2
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.2761194565220585,-0.7165634861826213,0.8491879350348028,0.995410940414134,1.0,8/18,33.64%,POLD2;RFC3;MCM3;LIG1;MCM4;LIG3;GINS1;GINS3
prerank,regulation of oxidoreductase activity (GO:0051341),0.33701953257945944,0.7165535063418871,0.7996575342465754,0.9849907973731908,1.0,1/13,3.22%,NOD2
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.3250276484031055,0.7160238528477852,0.8402903811252269,0.9851444001940537,1.0,4/17,10.52%,ITGA1;CALM1;HSP90AB1;AGTR2
prerank,non-motile cilium assembly (GO:1905515),-0.24020372939419143,-0.7158371897859418,0.9004854368932039,0.995413277074664,1.0,11/30,24.85%,TTC8;IFT122;FUZ;RPGRIP1L;IFT57;PIBF1;PCM1;BBS4;CEP250;TMEM17;C2CD3
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.25479388326831104,0.7156424274659846,0.8803030303030303,0.9851373829223533,1.0,12/54,21.31%,CNOT6L;RGCC;CRADD;PIDD1;CNOT9;CNOT6;BTG2;PLK2;TRIAP1;CNOT11;E2F4;CNOT4
prerank,positive chemotaxis (GO:0050918),-0.28321944339919825,-0.7152159329403632,0.8132118451025057,0.9953048038303349,1.0,2/17,7.94%,ANGPT1;MET
prerank,regulation of programmed necrotic cell death (GO:0062098),0.2984572499751327,0.7148977903630503,0.8067226890756303,0.9855863981770672,1.0,6/20,16.25%,PELI1;BIRC3;CASP8;SDCBP;CYLD;PDCD6IP
prerank,mRNA 3'-end processing (GO:0031124),-0.20782212883983536,-0.7144221960164697,0.9634551495016611,0.9954108720784643,1.0,27/78,25.22%,SRSF5;PABPN1;SRSF11;PCF11;RPRD2;SRSF6;CPSF3;SRSF4;TENT2;PAF1;DDX39B;TUT1;PAPOLB;THOC2;U2AF2;THOC7;CPSF2;U2AF1;CSTF3;FIP1L1;PAPOLG;DDX39A;EIF4A3;POLDIP3;THOC1;GRSF1;SYMPK
prerank,cellular response to estrogen stimulus (GO:0071391),-0.29515330785226546,-0.714403952767862,0.840958605664488,0.9946333139828913,1.0,6/14,21.51%,AR;BCAS3;RARA;SFRP1;PELP1;SRA1
prerank,histone H4 deacetylation (GO:0070933),0.35130164105194617,0.7143905845226179,0.7950664136622391,0.9857409853705393,1.0,3/10,15.88%,HDAC9;RCOR1;SMARCAD1
prerank,sensory perception of chemical stimulus (GO:0007606),-0.2948993502130429,-0.7138864614918486,0.8496583143507973,0.9944355716707947,1.0,5/15,22.72%,GNAS;MKKS;UBR3;BBS4;GNAL
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.2771962116077615,0.7131420859069924,0.8604651162790697,0.9868166133644571,1.0,9/35,15.77%,ITGA1;CALM1;HSP90AB1;PPP1R2;PPP1R11;AGTR2;CSNK2B;PPP1R15B;BOD1
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.3029357854532341,0.7101097531193611,0.8168067226890756,0.9895567896659401,1.0,7/21,22.10%,GTF2H2;GTF2H4;RBX1;RPA1;DDB1;GTF2H3;ERCC4
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.3029357854532341,0.7101097531193611,0.8168067226890756,0.9895567896659401,1.0,7/21,22.10%,GTF2H2;GTF2H4;RBX1;RPA1;DDB1;GTF2H3;ERCC4
prerank,microtubule nucleation (GO:0007020),-0.27299840353095534,-0.7099221657242883,0.8421052631578947,0.9981015714279593,1.0,7/19,25.61%,CCDC57;GOLGA2;TUBGCP2;TUBGCP4;TUBG1;TPX2;TUBGCP5
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.35809997029761226,0.7092175742053674,0.8029739776951673,0.9901725332557041,1.0,4/10,16.34%,TBX1;ACTN4;PPARG;RXRB
prerank,Golgi localization (GO:0051645),0.3455604949121722,0.709008339840801,0.8109640831758034,0.9899304555514361,1.0,6/11,27.33%,RIPOR1;PDCD10;YWHAZ;UVRAG;CDC42;HOOK3
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.3272834571044823,-0.7089313454364007,0.827433628318584,0.998416390606086,1.0,6/10,36.64%,IL18;RARA;PRKCZ;SPHK2;GATA3;IL4
prerank,lysosome localization (GO:0032418),0.27026874812473006,0.708564827656383,0.8522550544323484,0.9899767186810758,1.0,7/37,13.86%,SPAG9;RAB34;MILR1;PLEKHM1;TFEB;KXD1;FAM98A
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.3116030569886529,0.7084932382097134,0.8377483443708609,0.9895737192548733,1.0,3/17,10.09%,WASF2;NCKAP1;CYFIP1
prerank,negative regulation of hippo signaling (GO:0035331),-0.30624176527051883,-0.7082702144194112,0.8326359832635983,0.9983560874144832,1.0,6/12,24.70%,VGLL4;MAPK14;LIMD1;MAP2K3;AJUBA;CIT
prerank,negative regulation of TOR signaling (GO:0032007),0.27560620812397946,0.7079556197535624,0.8543371522094927,0.9897172198450763,1.0,9/36,14.31%,SH3BP4;TNFAIP8L1;SESN3;DEPDC5;DDIT4;GSK3A;TMEM127;EPM2A;PDCD6
prerank,regulation of pH (GO:0006885),0.34727113462282855,0.7078794370384947,0.7734806629834254,0.9893177476441289,1.0,3/11,9.58%,ATP1A4;CLCN3;SLC9A7
prerank,autophagosome organization (GO:1905037),0.2583653933778574,0.7072424160556877,0.8852459016393442,0.9896272524437633,1.0,22/50,27.73%,IRGM;MAP1LC3B;PIK3C3;UBQLN1;ATG12;RAB1A;ATG14;WDR45;MAP1LC3A;ATG9B;VMP1;ATG7;NSFL1C;ATG2A;GABARAP;GABARAPL2;ULK1;UBXN2B;RAB1B;RAB7A;BECN1;UBQLN2
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.241078787516384,-0.7069933240439857,0.920844327176781,0.9989272990741835,1.0,5/31,9.10%,PRKCI;PARD3B;DLG1;MYO9A;EZR
prerank,negative regulation of phosphatase activity (GO:0010923),0.2790810841367907,0.7067321674272193,0.853781512605042,0.9897930061514604,1.0,6/25,20.41%,TGFB2;PPP1R11;PPP1R35;BOD1;FKBP1A;SEMA4D
prerank,dopaminergic neuron differentiation (GO:0071542),0.3040565087541267,0.7066270962528456,0.7895652173913044,0.9894210632791506,1.0,2/19,7.58%,CTNNB1;PHOX2A
prerank,ncRNA transcription (GO:0098781),0.32874929447903734,0.7064724917236685,0.8166666666666667,0.9891104035892787,1.0,5/13,26.45%,GTF3A;SIRT7;SPIN1;GTF3C1;SNAPC3
prerank,regulation of mitochondrial translation (GO:0070129),-0.2662343331728451,-0.7063128848815349,0.875,0.9988682455579205,1.0,9/21,21.36%,MRPS27;RMND1;ALKBH1;NSUN3;RPUSD4;C1QBP;RCC1L;FASTKD3;FASTKD2
prerank,nucleic acid metabolic process (GO:0090304),-0.205695036485807,-0.706301773471082,0.9840255591054313,0.9980797899908695,1.0,11/69,16.99%,ENPP1;NT5E;HNRNPH1;POLR2A;DDX1;HNRNPH2;HNRNPR;HNRNPA2B1;GTF2F1;RAD50;PCBP2
prerank,mRNA processing (GO:0006397),-0.16725144399209138,-0.7059425613265765,1.0,0.9976558806440838,1.0,73/287,25.52%,DDX5;SRRM2;PPARGC1A;HNRNPH1;HNRNPUL1;SON;SRSF5;POLR2A;RNPC3;PABPN1;SNRNP70;SRSF11;PRCC;RAVER2;PCF11;RPRD2;AKAP8L;SRRM4;NOVA1;SRSF6;CPSF3;GCFC2;PRKACA;SUGP1;CCNH;SRSF4;HNRNPH2;RBM5;PNN;PRPF19;CDK7;HNRNPR;RBM41;PRMT9;NONO;HNRNPA2B1;PPIH;DDX39B;GTF2F1;PSPC1;PCBP2;RAMAC;THOC2;CCAR1;PRPF3;PRPF18;U2AF2;THOC7;LSM3;TRA2B;CPSF2;U2AF1;SRSF10;TCERG1;CSTF3;FIP1L1;DDX39A;RBMX2;AURKAIP1;SF1;EIF4A3;TBRG4;DBR1;PPIL1;RBM10;GTF2H1;POLR2L;CWF19L1;POLDIP3;THOC1;SYMPK;RNMT;LSM8
prerank,histone H3-K4 methylation (GO:0051568),-0.25398781455616076,-0.7055937643833353,0.8977556109725686,0.9972201839378193,1.0,3/26,6.27%,OGT;CTR9;SETD4
prerank,N-terminal protein amino acid modification (GO:0031365),0.3253496032970419,0.7053980081791571,0.8120567375886525,0.9899613967132207,1.0,4/14,14.01%,NAA60;NAA16;NAA11;METAP2
prerank,negative regulation of interleukin-6 production (GO:0032715),0.28102041727009375,0.7053138173061584,0.8502673796791443,0.989561985189737,1.0,6/27,17.01%,CD200;CD200R1;TNFAIP3;FOXJ1;NCKAP1L;GAS6
prerank,regulation of pseudopodium assembly (GO:0031272),0.3422641907817098,0.7052471344304483,0.8042328042328042,0.9886681596701784,1.0,2/10,5.77%,CCR7;CDC42EP3
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.3422641907817098,0.7052471344304483,0.8042328042328042,0.9886681596701784,1.0,2/10,5.77%,CCR7;CDC42EP3
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.3353287258173623,0.7043229917243935,0.7925233644859813,0.9887668108369475,1.0,2/11,7.23%,CALM1;SRI
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.3353287258173623,0.7043229917243935,0.7925233644859813,0.9887668108369475,1.0,2/11,7.23%,CALM1;SRI
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.23577767337763592,0.7043127496420437,0.9328671328671329,0.9882933284585725,1.0,24/83,25.08%,CDK17;MAX;HINFP;BRD4;CDC6;EIF4E;ORC1;PIM2;PLK2;ACVR1;TRIM71;CDK6;CDK18;USP29;CUL1;POLA1;NASP;CDK4;CDKN1B;DHFR;TYMS;MYC;KLF11;CDKN2C
prerank,protein-DNA complex disassembly (GO:0032986),0.31055494666528566,0.7036559886940355,0.8259325044404974,0.9885658564370471,1.0,9/16,24.90%,ARID1A;HMGA1;SMARCD1;SET;RPL23;GRWD1;ARID2;SMARCA4;MYC
prerank,dendritic cell chemotaxis (GO:0002407),0.31985528995197193,0.7035564510414472,0.8318098720292505,0.9882023025939861,1.0,2/14,8.27%,CCR7;CXCR2
prerank,myeloid cell activation involved in immune response (GO:0002275),0.3071223753394731,0.7027030256734917,0.8278260869565217,0.9887657771024481,1.0,6/18,20.26%,DYSF;SYK;DOCK2;SBNO2;NMI;PLCG2
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.3026895526707713,-0.7017421798791733,0.8586497890295358,1.0,1.0,6/12,30.97%,ESR1;NCOR1;ZC3H10;BCDIN3D;STAT3;TERT
prerank,positive regulation of peptidase activity (GO:0010952),-0.26750937583205564,-0.7016895000854991,0.8794642857142857,0.9997643081882089,1.0,5/20,16.41%,RCN3;PSME3;CTSH;DDRGK1;GRN
prerank,maturation of LSU-rRNA (GO:0000470),-0.2499051582111026,-0.7016380291676004,0.8807106598984772,0.9990303421629463,1.0,4/26,12.14%,NSA2;WDR12;NOP2;LAS1L
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.322054506864719,-0.7014539209499736,0.8471615720524017,0.9984365345186329,1.0,6/10,41.13%,DDX39B;THOC1;FEM1B;ETAA1;CCAR2;THOC5
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.34643373444193243,0.701167848589631,0.8003565062388592,0.9901029492934825,1.0,1/10,4.40%,CALM1
prerank,glucose metabolic process (GO:0006006),0.24789019658745126,0.7011218075657342,0.8989598811292719,0.9896781211884429,1.0,10/58,14.84%,SORD;PPARD;LRP5;BRAT1;SLC25A1;G6PC3;PGAM1;HECTD4;TPI1;OMA1
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.2617994732931502,-0.701073945226104,0.8619153674832962,0.9980415175589924,1.0,2/21,5.21%,EPHA7;NGF
prerank,regulation of steroid metabolic process (GO:0019218),0.2908722664654879,0.7009456910626871,0.8336134453781513,0.98938717191854,1.0,2/23,6.23%,ABCG1;ABCB11
prerank,regulation of ion transport (GO:0043269),0.23936638230595847,0.7007526818424947,0.9233038348082596,0.9891401465915048,1.0,16/76,18.70%,B2M;NEDD4L;NKAIN2;SYT7;ATP1A1;PXK;YWHAH;P2RX7;NKAIN1;SYT4;ANK3;KCNJ5;KCNJ3;CA2;KCNJ6;KCNA5
prerank,negative regulation of double-strand break repair (GO:2000780),-0.2434894871306163,-0.700365614187903,0.9342465753424658,0.9979401745006509,1.0,7/30,16.31%,FBH1;UBR5;KLHL15;TWIST1;HELB;TRIP12;ERCC6
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.279062857569193,0.699229202061203,0.8644859813084113,0.9904442876009382,1.0,4/31,11.74%,STX1A;SYT7;STXBP1;SYT4
prerank,signal transduction in response to DNA damage (GO:0042770),0.25456062716204486,0.6985390612311281,0.8937784522003035,0.9907518572083924,1.0,10/49,19.46%,ACER2;MYO6;GRB2;HINFP;STK33;FBXO6;TRIAP1;HUS1;NDRG1;CDC5L
prerank,spindle assembly (GO:0051225),0.2347274158312276,0.6973769041293025,0.9155937052932761,0.9916043172926988,1.0,9/67,12.53%,STARD9;MAPRE2;KIF2A;RAB11A;SAC3D1;MZT1;HAUS6;KIF3B;MAPRE3
prerank,protein sumoylation (GO:0016925),-0.21675880761043623,-0.696585535334884,0.9433962264150944,1.0,1.0,6/49,12.63%,EYA1;PIAS1;SEH1L;NUP205;TRPM4;PIAS2
prerank,steroid hormone biosynthetic process (GO:0120178),0.2768559422644085,0.6960841482935306,0.8450479233226837,0.9926177898425642,1.0,6/29,20.00%,CYP11B1;CYP11A1;HSD17B7;HSD17B8;DHCR7;STARD3NL
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.27979424904346495,-0.6947608709132527,0.8288508557457213,1.0,1.0,3/16,14.20%,FBH1;KLHL15;HELB
prerank,DNA geometric change (GO:0032392),-0.25291222018336174,-0.6944942758656028,0.9009661835748792,1.0,1.0,14/24,31.87%,ANXA1;DDX1;RTEL1;ZRANB3;HNRNPA2B1;RAD50;WRN;NBN;RECQL;HMGB1;MCM9;DHX36;PIF1;SUPV3L1
prerank,regulation of RNA splicing (GO:0043484),0.23872864718327366,0.6944119110164266,0.9239598278335724,0.9939909066845549,1.0,2/69,1.60%,RBM20;QKI
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.3302323499434099,0.6935905487119924,0.8243727598566308,0.9944558569451757,1.0,3/12,18.03%,CCT3;CCT5;CCT7
prerank,histone H2A monoubiquitination (GO:0035518),-0.26929488043160527,-0.69297681654534,0.8791469194312796,1.0,1.0,4/17,9.65%,BCOR;KDM2B;PCGF2;DDB2
prerank,cellular response to virus (GO:0098586),0.2767696130364486,0.6926814630780939,0.8564437194127243,0.994977188747993,1.0,6/30,11.75%,IFIH1;POU2AF1;LGALS9;IRGM;EIF5A;HIF1A
prerank,histone mRNA metabolic process (GO:0008334),0.2760969288519201,0.6916462204524069,0.8707037643207856,0.9956778188570056,1.0,8/27,18.74%,MTPAP;SNRPF;SNRPE;DCP2;NCBP2;SNRPB;XRN1;EXOSC10
prerank,pre-replicative complex assembly (GO:0036388),0.24205343458128936,0.690980223639325,0.9172821270310192,0.9959531575975847,1.0,18/64,27.54%,PSMB3;PSMD11;PSMC6;PSME2;CDC6;PSMD8;ORC1;PSMB10;PSMA8;PSMD9;PSMD1;PSMC3;PSMD10;PSME1;PSMB8;PSMD2;UBB;PSMA1
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.30235633052192157,0.690897567984256,0.8409506398537477,0.9955437553402986,1.0,5/17,19.53%,CTCF;BUB3;BOD1;ZW10;IK
prerank,action potential (GO:0001508),0.2582283178134743,0.6904226006339196,0.904320987654321,0.9955850901386298,1.0,7/44,8.32%,GNAQ;KCNQ1;SRI;SCN1A;MYH14;KCNH2;YWHAH
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.28333319870198964,0.6901851397278479,0.856198347107438,0.995365581292553,1.0,10/23,27.42%,CETN2;RBX1;COPS5;GPS1;COPS6;DDB1;RAD23B;XPC;COPS2;UBB
prerank,purine nucleotide biosynthetic process (GO:0006164),0.31954102329435713,0.6901810748903301,0.833976833976834,0.9948861016287422,1.0,2/12,9.43%,HPRT1;GART
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.27675913513079126,0.6900229427689799,0.8693548387096774,0.9945804593016297,1.0,4/30,10.25%,CAV1;HYAL2;INPP5F;PTK6
prerank,tRNA methylation (GO:0030488),-0.23450898671418358,-0.6899188286388895,0.9093198992443325,1.0,1.0,7/34,12.37%,THADA;PRORP;DALRD3;THUMPD3;TRMT1L;NSUN2;METTL6
prerank,regulation of protein localization (GO:0032880),0.24658524702653933,0.6897800934868548,0.8962536023054755,0.9943809569115054,1.0,6/58,8.92%,TRIM25;TRIM14;MMD;HSP90AB1;FBXW7;TRIM67
prerank,acylglycerol homeostasis (GO:0055090),0.29434625746727133,0.688000197695602,0.8684654300168634,0.9958698916890505,1.0,4/20,14.43%,SCARB1;LIPC;PNPLA8;ANGPTL4
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.2840964314356068,0.6878789862859368,0.8494271685761048,0.9955332324584286,1.0,7/23,18.87%,OCRL;INPP5F;MTMR6;MTMR12;MTMR2;SYNJ1;MTMR1
prerank,glycerolipid metabolic process (GO:0046486),0.32348484908961284,0.6878377928757136,0.8237547892720306,0.9950926846864057,1.0,3/11,19.43%,GAL3ST1;DGKZ;PGP
prerank,regulation of mRNA stability (GO:0043488),-0.1773513550552538,-0.6876965442316908,1.0,1.0,1.0,31/145,24.94%,SAMD4A;ROCK2;PRKCD;TENT5A;DCP1A;CSDC2;PSME4;FXR2;PRKCA;PSME3;IGF2BP2;FMR1;PCBP4;YTHDF1;XPO1;FASTKD1;EXOSC2;FASTKD3;CIRBP;PSMD7;PSMA3;EIF4G1;EXOSC1;SAMD4B;RBM24;PSMD14;TBRG4;PARN;MEX3D;HSPA1A;TNFSF13
prerank,phospholipid homeostasis (GO:0055091),0.3278679580138891,0.6874488252414567,0.8303886925795053,0.9950441623810147,1.0,2/11,6.23%,ABCG1;ABCB11
prerank,snRNA transcription by RNA polymerase II (GO:0042795),-0.20020197777889334,-0.686496422177679,0.9644012944983819,1.0,1.0,22/69,30.60%,CCNT2;PHAX;POLR2A;RPRD2;INTS8;TAF8;CDK7;INTS2;GTF2F1;INTS4;INTS10;TBP;TAF9;POLR2L;SNAPC2;POLR2I;INTS3;CDK9;ZC3H8;INTS5;POLR2K;SNAPC4
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.28276334017978455,0.6864043101612094,0.8771331058020477,0.9957338151407644,1.0,3/25,10.77%,SORT1;CHMP1B;TMEM50A
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.26716936581746553,0.6863133718659062,0.8795379537953796,0.9953556587951351,1.0,16/31,31.88%,PEX14;DNAJC19;TOMM20L;PEX16;CHCHD4;PEX6;PEX1;TIMM50;TIMM21;TOMM70;AIFM1;PEX12;PEX10;PEX5;GRPEL2;GRPEL1
prerank,regulation of dendrite morphogenesis (GO:0048814),0.2722996863468729,0.6847412330592166,0.8782894736842105,0.996570447419436,1.0,3/32,4.17%,RAPGEF2;NEDD4L;LZTS1
prerank,mitotic sister chromatid segregation (GO:0000070),0.2253313747913985,0.6844188644247992,0.9537815126050421,0.9964281303729706,1.0,21/98,21.74%,TENT4A;RAB11A;NCAPH;MCPH1;CHMP1B;NCAPG;KIF23;CSNK2B;SPAG5;BOD1;PDCD6IP;TTN;RAD21;POGZ;SET;NCAPH2;ZW10;PINX1;TUBG2;INO80;CDC23
prerank,cardiolipin metabolic process (GO:0032048),0.32531159883026795,0.684025527310004,0.8333333333333334,0.9963624148856662,1.0,3/13,19.24%,PTPMT1;PNPLA8;PGS1
prerank,regulation of cholesterol esterification (GO:0010872),0.33324969721073827,0.6838057379993071,0.8202676864244742,0.9961120639550963,1.0,3/10,19.18%,ABCG1;STARD4;AGT
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.2841737729822623,0.6837213820433902,0.833616298811545,0.9957179884398302,1.0,3/22,12.59%,B2M;MALT1;CYRIB
prerank,sensory perception (GO:0007600),-0.22175325920494304,-0.6837132083421423,0.9438502673796791,1.0,1.0,6/45,8.61%,ADGRV1;PTGES;GNAS;P2RX4;ADORA2A;TTC8
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.32339225991353293,0.68366851287989,0.8237410071942446,0.995293947541717,1.0,2/13,4.45%,SOX13;RREB1
prerank,regulation of histone deacetylation (GO:0031063),0.3228358236861496,0.6834461915035297,0.8213592233009709,0.9950542580884376,1.0,3/13,15.00%,APLNR;FOXP3;CTBP1
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.3227414229969517,0.6833963819012254,0.8480565371024735,0.9946343685862115,1.0,2/13,11.74%,STX1A;SYT4
prerank,synaptonemal complex organization (GO:0070193),0.302459230712136,0.682876851290337,0.843103448275862,0.994210052465084,1.0,6/15,30.21%,BAG6;RAD21;SYCP2;REC8;TEX12;P3H4
prerank,synaptonemal complex assembly (GO:0007130),0.302459230712136,0.682876851290337,0.843103448275862,0.994210052465084,1.0,6/15,30.21%,BAG6;RAD21;SYCP2;REC8;TEX12;P3H4
prerank,tRNA transport (GO:0051031),0.25642309047160067,0.6816967607045832,0.8906497622820919,0.9949532512892353,1.0,11/35,25.19%,YBX1;NUP54;NUP160;TOMM20L;NUP153;NUP50;XPOT;NUP42;NUP85;NUP210;NUP188
prerank,regulation of protein kinase activity (GO:0045859),0.21988209144351997,0.6815061460865826,0.964769647696477,0.9946757476116393,1.0,23/106,17.99%,RAPGEF2;PTK2;MMD;GNAQ;WWTR1;CCR7;CD4;CAMKK2;PPIA;IQGAP1;TRIB2;HSPB1;CEACAM1;MAPRE3;DBNDD1;LCP2;RTRAF;GAS6;CEP85;PPM1F;TTN;EPHA1;PAK2
prerank,negative regulation of myotube differentiation (GO:0010832),-0.297338378427958,-0.6812868998761222,0.8679653679653679,1.0,1.0,2/12,7.90%,HDAC4;CCN3
prerank,regulation of telomere maintenance (GO:0032204),-0.24183533543667018,-0.6806123490004546,0.8886075949367088,1.0,1.0,11/26,31.04%,PML;RTEL1;XRCC5;ERCC1;RAD50;SMG1;NBN;SIRT6;HNRNPD;DHX36;PIF1
prerank,histone H4-K16 acetylation (GO:0043984),0.29073561944252896,0.6805505673471388,0.8677536231884058,0.9951809382539184,1.0,5/19,16.38%,PHF20;JADE2;MCRS1;MSL2;HCFC1
prerank,positive regulation of glial cell differentiation (GO:0045687),0.3034870614819105,0.6805454524259303,0.8375451263537906,0.9947066163006518,1.0,6/17,18.52%,NOTCH1;PTN;TGFB1;PTPRZ1;BIN1;DICER1
prerank,linoleic acid metabolic process (GO:0043651),-0.27046888926631263,-0.6804981850701679,0.8979591836734694,1.0,1.0,1/17,1.85%,ACSL1
prerank,myelination in peripheral nervous system (GO:0022011),-0.2964683435258109,-0.6803573063171964,0.8614718614718615,1.0,1.0,8/13,27.95%,MYOC;SKI;NF1;LGI4;SIRT2;NCMAP;PRX;CNTNAP1
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.29141259599635444,0.67907091335571,0.8404074702886248,0.9957537041122734,1.0,2/17,4.02%,MEF2C;PRKG1
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.2658143425356954,-0.6783988630339015,0.9022727272727272,1.0,1.0,4/18,17.63%,PABPN1;DDX19B;MCM3AP;THOC2
prerank,selective autophagy (GO:0061912),-0.20792973574203377,-0.6777662652472398,0.9814814814814815,1.0,1.0,11/56,15.08%,LGALS8;ULK2;ATG2B;PRKN;TEX264;ATM;DYNC1I1;AUP1;UFC1;DDRGK1;AMBRA1
prerank,regulation of sodium ion transport (GO:0002028),0.2558330910148828,0.6767597312417162,0.8827361563517915,0.997610312881004,1.0,6/34,11.65%,CNKSR3;NKAIN2;ATP1A1;YWHAH;P2RX7;NKAIN1
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.3116944465761334,0.6764940904824956,0.8354898336414048,0.9973979263085964,1.0,3/12,14.82%,TGFB1;PPARG;ELAVL1
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.3143290690679145,0.6762319070908518,0.8442776735459663,0.9971735777666146,1.0,3/14,11.12%,BRCA2;TERF2;ACD
prerank,cellular response to amino acid starvation (GO:0034198),0.23108569557767425,0.6759809854951483,0.9441340782122905,0.9969577130325354,1.0,11/71,12.65%,FAS;PRKD1;WDR59;SESN3;MAPK3;EIF2AK4;LAMTOR5;DEPDC5;SH3GLB1;RPTOR;TFEB
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.3247482536542048,0.6752933791059326,0.8160291438979964,0.997179114412363,1.0,3/11,14.83%,FYN;UBQLN1;STK26
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.31537036022861115,0.675212105586586,0.8234200743494424,0.996789005379545,1.0,7/11,33.20%,TASOR;SETDB1;SETDB2;DNMT1;MPHOSPH8;PPHLN1;TRIM28
prerank,regulation of double-strand break repair (GO:2000779),-0.21634660172743986,-0.6742747942370511,0.9391304347826087,1.0,1.0,13/39,27.05%,UBR5;PML;RTEL1;KDM1A;TWIST1;TRIP12;OTUB1;SETD2;SLF2;SIRT6;ZCWPW1;SPIDR;RAD51AP1
prerank,response to amino acid starvation (GO:1990928),0.23031343090646278,0.6738864365500171,0.9497206703910615,0.9976334236686321,1.0,11/72,12.65%,FAS;PRKD1;WDR59;SESN3;MAPK3;EIF2AK4;LAMTOR5;DEPDC5;SH3GLB1;RPTOR;TFEB
prerank,magnesium ion transport (GO:0015693),-0.29136434243503634,-0.6735263193577585,0.8461538461538461,1.0,1.0,4/12,20.21%,SLC41A1;NIPAL2;MAGT1;TUSC3
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.2441255550209292,0.6729760726901545,0.9307086614173228,0.9980910902394164,1.0,13/48,23.53%,ACTB;TAF1B;ARID1A;HMGA1;SMARCD1;POLR1A;DEK;MYO1C;KAT2B;SERTAD2;PADI2;TAF1C;ZMIZ2
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.2305539566417006,0.6726196111524568,0.9468390804597702,0.9979878766114474,1.0,18/69,21.94%,TRIM25;STT3B;SGTB;PSMC6;UBQLN1;FBXO6;DERL2;EDEM1;MAN1B1;TMUB2;DNAJB9;BAG6;FBXO2;UBE2G2;TMEM129;UBE2J1;ANKZF1;TMUB1
prerank,cellular response to DNA damage stimulus (GO:0006974),0.19379280641502883,0.6721697585409163,0.9988962472406181,0.9979890365746513,1.0,72/336,22.12%,POLK;BCL2L1;ACER2;FOXO1;MEN1;LYN;FNIP2;GRB2;SAMHD1;CCDC13;RNF169;XIAP;MRE11;MAPK3;MCL1;HINFP;PWWP3A;PIDD1;FANCG;PAK1;HPF1;STK33;MCM10;MGMT;RECQL4;GTF2H4;BRAT1;FBXO6;CCNK;BTG2;POLB;POLE3;WDR48;FAN1;NSMCE4A;FANCF;RNF8;MSH3;GNL1;TRRAP;CDKN2AIP;MSH2;SIRT7;APC;HERC2;SUMO1;ALKBH8;NUDT1;CBX1;DDX11;HUS1;RPA1;SLF1;ADPRS;NSMCE3;BAK1;RAD9B;FOXP1;RBBP5;UVRAG;POLD1;DDB1;GTF2H3;POLA1;ERCC8;PARP2;TIGAR;INO80;RFC2;METTL3;ERCC4;RAD1
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.266356677838283,0.6721272948922994,0.899513776337115,0.9975461480446008,1.0,8/29,21.92%,GTF2H2;CETN2;GTF2H4;RBX1;RPA1;DDB1;GTF2H3;RAD23B
prerank,secretory granule organization (GO:0033363),-0.30622413999981996,-0.6715798064867794,0.8543478260869565,1.0,1.0,2/10,5.23%,ABCA1;DTNBP1
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.2381050706491163,-0.6715697487269436,0.9221698113207547,1.0,1.0,15/29,35.14%,KANK2;YAP1;AXIN1;ESR1;DDRGK1;LATS1;BRCA1;RUNX1;CNOT1;KCTD6;UFSP2;VPS11;CARM1;VPS18;DNAAF4
prerank,chemokine-mediated signaling pathway (GO:0070098),0.25169283633706874,0.6714374515702595,0.9166666666666666,0.997754414885566,1.0,7/42,21.19%,CXCL12;CCL1;GPR75;CCR2;SH2B3;CCL25;RBM15
prerank,"regulation of gene expression, epigenetic (GO:0040029)",-0.19275865454130167,-0.6711517721120791,0.9821428571428571,1.0,1.0,15/73,19.82%,HDAC4;DNMT3A;BAZ1B;IGF2;TDG;PPM1D;SMARCA5;EP300;TAF1D;ERCC6;POLR1C;EED;RBBP4;EZH2;PHF2
prerank,ERAD pathway (GO:0036503),0.22404543088958684,0.67086994921164,0.9579710144927536,0.9978249402548601,1.0,23/83,21.94%,TRIM25;STT3B;ATXN3;RHBDD1;SGTB;PSMC6;UBQLN1;FBXO6;DERL2;EDEM1;MAN1B1;RNF139;TMUB2;DNAJB9;BAG6;FBXO2;UBE2G2;GET4;TMEM129;BRSK2;UBE2J1;ANKZF1;TMUB1
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.2656350334003948,-0.6707549883884487,0.8912037037037037,1.0,1.0,5/18,15.20%,PRKN;SOD2;TRAP1;HTRA2;NONO
prerank,integrated stress response signaling (GO:0140467),-0.2750888167806952,-0.6699184433339797,0.8755868544600939,1.0,1.0,6/14,31.85%,IMPACT;DDIT3;QRICH1;CCL2;EIF2AK3;EIF2AK1
prerank,regulation of DNA recombination at telomere (GO:0072695),0.2822891868026485,0.6697653414743658,0.8603448275862069,0.9979430485737706,1.0,5/19,21.79%,TERF2;ACD;TERF1;POLR2J;DAXX
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.2822891868026485,0.6697653414743658,0.8603448275862069,0.9979430485737706,1.0,5/19,21.79%,TERF2;ACD;TERF1;POLR2J;DAXX
prerank,regulation of lymphocyte differentiation (GO:0045619),0.28618806678142245,0.6695853227941613,0.8664122137404581,0.9976419687255301,1.0,5/18,21.67%,ZFP36L1;NCKAP1L;CCR2;ZFP36L2;METTL3
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.2723967722617018,-0.6690740465473863,0.8728070175438597,1.0,1.0,7/16,25.42%,PIGN;PIGA;PIGP;PIGX;PIGB;PIGH;PIGL
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.29871544797731553,-0.6688414361085216,0.8937007874015748,1.0,1.0,5/10,28.65%,GATA6;TSKU;CDH3;TYROBP;LILRB1
prerank,ubiquinone biosynthetic process (GO:0006744),-0.2754979219365943,-0.6684474350178231,0.875,1.0,1.0,6/15,29.60%,COQ10A;COQ2;COQ8B;COQ10B;NDUFA9;COQ6
prerank,RNA modification (GO:0009451),-0.20392841786032462,-0.6678983806893437,0.9683908045977011,1.0,1.0,15/54,21.59%,TRMT9B;NOP2;NSUN2;ALKBH1;PUS7;ELP5;NSUN3;TRIT1;NSUN4;TYW5;DTWD1;BCDIN3D;ANKRD16;LCMT2;TSR3
prerank,regulation of cellular metabolic process (GO:0031323),0.2493105965075632,0.6678164735069343,0.9231974921630094,0.9989058838616282,1.0,5/45,8.03%,FASN;ABCG1;ABCB11;ACACB;MKLN1
prerank,negative regulation of DNA recombination (GO:0045910),-0.21608701603418232,-0.6669545989621615,0.9728997289972899,1.0,1.0,7/43,14.20%,FBH1;POLR2A;PARP3;RTEL1;KLHL15;ZRANB3;HELB
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.2420947827164474,-0.666589939939942,0.9223300970873787,1.0,1.0,7/22,28.89%,ESR1;MED14;MED30;MED4;MED24;MED16;DHX36
prerank,gastrulation (GO:0007369),-0.27802538418678746,-0.6662892707903819,0.8883826879271071,1.0,1.0,1/15,1.76%,GPC3
prerank,cellular response to interleukin-7 (GO:0098761),0.291551815340623,0.6659169533621436,0.87215411558669,0.9997505018408116,1.0,8/17,25.03%,JAK3;SOCS2;IL7R;CRLF2;CISH;SOCS1;SMARCA4;IL2RG
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.291551815340623,0.6659169533621436,0.87215411558669,0.9997505018408116,1.0,8/17,25.03%,JAK3;SOCS2;IL7R;CRLF2;CISH;SOCS1;SMARCA4;IL2RG
prerank,peptidyl-arginine modification (GO:0018195),-0.26939403313654936,-0.6658467582613017,0.9004629629629629,1.0,1.0,10/15,44.53%,PRMT5;PRMT8;ART3;KRTCAP2;PRMT1;ART1;PADI1;PADI4;ART4;ART5
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.2778356090825512,-0.6653121670861181,0.8850325379609545,1.0,1.0,5/14,23.47%,PELI3;NLRP2B;TRAIP;GPS2;CCDC3
prerank,negative regulation of leukocyte activation (GO:0002695),0.3040823929388993,0.6652853558368036,0.8539898132427843,0.9999004523480224,1.0,2/15,10.20%,CD200;MILR1
prerank,endocytic recycling (GO:0032456),-0.20665172062804585,-0.6644614870763167,0.9656160458452722,1.0,1.0,17/50,26.19%,SNX12;ENTR1;ACAP2;ANKRD27;VPS35L;EHD1;RAB11B;EHD2;VPS26C;RAB13;RAB14;ANKRD50;SNX17;CCDC22;VPS26A;ARF6;VPS39
prerank,protein acetylation (GO:0006473),0.2581692990995009,0.6639708975560051,0.8944,1.0,1.0,6/30,13.59%,FOXO1;KAT6A;NAA60;GTF2B;NAA16;NAA11
prerank,response to UV-B (GO:0010224),-0.28564674522705424,-0.6632331633030032,0.8814655172413793,1.0,1.0,3/12,11.48%,CRIP1;STK11;MFAP4
prerank,steroid metabolic process (GO:0008202),-0.1921885828598408,-0.6619886760325465,0.9773462783171522,1.0,1.0,4/72,5.92%,CYP7B1;CYP26B1;CYP27A1;CYP1B1
prerank,mitochondrial RNA metabolic process (GO:0000959),0.30593369167229023,0.6616314807698597,0.8635514018691589,1.0,1.0,2/14,6.20%,MRPL12;SLC25A33
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.27925423937601596,-0.6615784013114734,0.8760683760683761,1.0,1.0,3/13,14.95%,RHOQ;LRRK2;GNAI3
prerank,aromatic amino acid family catabolic process (GO:0009074),-0.27130593468267,-0.6611304129304449,0.884090909090909,1.0,1.0,6/15,29.97%,KYAT1;FAH;KYNU;KMO;IL4I1;HAAO
prerank,membrane lipid catabolic process (GO:0046466),-0.2949608520286898,-0.6609629623671962,0.8673684210526316,1.0,1.0,3/10,13.75%,PDXDC1;CYP1B1;NAGA
prerank,mismatch repair (GO:0006298),-0.2331779011576093,-0.6607899186563433,0.9317647058823529,1.0,1.0,9/27,26.63%,TDG;ABL1;ERCC1;MLH3;POLD2;SETD2;LIG1;EXO1;MCM9
prerank,cytoplasmic translational initiation (GO:0002183),0.2887505843078428,0.6607807414267015,0.8553571428571428,1.0,1.0,6/17,24.04%,EIF4H;EIF3D;EIF3M;EIF4A1;EIF4B;EIF2S2
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.268969033277543,0.6596024535471826,0.9075907590759076,1.0,1.0,8/27,20.61%,CHKA;SELENOI;CEPT1;PNPLA8;LPIN3;ETNPPL;ETNK1;PISD
prerank,intracellular protein transport (GO:0006886),0.19212729809156776,0.659522212410573,1.0,1.0,1.0,44/304,16.38%,TBC1D4;RASSF9;RAB31;STX3;ARHGEF2;TBC1D14;STX1A;TBC1D22A;TBC1D12;SNX13;MYO6;TBC1D2;ARF5;IPO11;USP6NL;TBC1D5;STXBP1;ARL4A;TGFB1;YWHAH;NXT1;AP1S3;SMURF1;RANBP6;TBC1D10B;VPS36;ACD;AP4S1;STX19;TBC1D30;SYK;RANBP3;RAB1A;RPL11;AKAP6;PDCD6;TBCK;VPS25;ARL4D;SCFD2;NLGN1;TBC1D1;HERC2;RAB24
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.3235428633957671,0.6592649954902132,0.8477443609022557,1.0,1.0,2/10,11.12%,TERF2;ACD
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.2278303125176624,-0.6589994256011049,0.9507389162561576,1.0,1.0,14/32,32.39%,CDC14B;ATM;BRSK1;CLSPN;BRCA1;DONSON;NBN;DTL;NOP53;TAOK3;ABRAXAS1;PLK1;TICRR;TAOK2
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.288839411384085,0.6587045025960016,0.8730434782608696,1.0,1.0,1/17,3.48%,PLA2G4B
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.2598505681645902,-0.6586553302655566,0.9043280182232346,1.0,1.0,4/16,22.71%,PARP3;KMT5C;KMT5B;KDM4D
prerank,negative regulation of B cell activation (GO:0050869),0.27860310383096704,0.6583203084550432,0.8898163606010017,1.0,1.0,5/21,17.87%,LYN;TNFRSF21;TNFAIP3;FOXJ1;SAMSN1
prerank,sulfur amino acid catabolic process (GO:0000098),0.32271429421897324,0.6581658226072798,0.8587786259541985,1.0,1.0,2/10,19.51%,CBS;TXN2
prerank,cellular response to osmotic stress (GO:0071470),0.2740130735599662,0.6564950223107123,0.8729372937293729,1.0,1.0,5/21,17.04%,ARHGEF2;RCSD1;ZFP36L1;LRRC8D;TRPV4
prerank,positive regulation of hormone secretion (GO:0046887),-0.2631377882256056,-0.6563142803059284,0.9149425287356322,1.0,1.0,2/17,7.31%,SPP1;C1QTNF3
prerank,presynapse organization (GO:0099172),-0.2932247083618442,-0.6561583919969715,0.8812095032397408,1.0,1.0,1/10,2.75%,NLGN2
prerank,regulation of catabolic process (GO:0009894),0.28301908934958475,0.6545751091841723,0.8691910499139415,1.0,1.0,2/18,12.08%,NEDD4L;HGS
prerank,receptor clustering (GO:0043113),0.2591352309028429,0.6543587370778886,0.8894557823129252,1.0,1.0,7/27,16.99%,AGRN;LRRC7;PTN;NRXN1;SYNJ2BP;NLGN1;ITGA4
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.21552731032340838,-0.6538861822043908,0.9430051813471503,1.0,1.0,11/37,19.70%,DLG4;PRKN;APOE;ITGAV;TRAP1;SIRT2;OPTN;PAX2;ITGB3;NCOR1;BRCA1
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.2752083626195997,-0.6525846653585723,0.8967889908256881,1.0,1.0,4/15,14.50%,MAGI2;DACT1;SKI;ACVR1B
prerank,regulation of regulated secretory pathway (GO:1903305),0.25295078351351763,0.6521471663564317,0.9142857142857143,1.0,1.0,15/34,31.43%,SYT7;UNC13D;SYT4;RIMS4;RIMS2;PREPL;DOC2A;SYN1;SYT17;RIMS1;SYT15;RAB27A;GSK3B;SYT2;RAB3D
prerank,vesicle transport along microtubule (GO:0047496),0.26984136241821577,0.6520169262392077,0.8787878787878788,1.0,1.0,5/23,12.80%,KIF1A;FYCO1;BICDL1;KIF3B;RAB1A
prerank,apoptotic mitochondrial changes (GO:0008637),0.2563926715524929,0.6519809104041921,0.9069020866773676,1.0,1.0,2/32,6.07%,BCL2L1;BIK
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.2895384795395498,0.6514823887593333,0.8548672566371681,1.0,1.0,6/15,23.46%,CSTF2;CPSF1;RTRAF;TSEN15;RTCB;TSEN34
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.2184228280487511,0.6513639783285562,0.967741935483871,1.0,1.0,20/82,21.67%,DYNLL1;CCP110;PRKAR2B;CETN2;TUBB;CDK5RAP2;AKAP9;HAUS6;CEP78;CEP72;CEP135;TUBA1A;TUBB4B;CKAP5;CEP70;DCTN1;SFI1;CLASP1;HAUS2;NDE1
prerank,quinone biosynthetic process (GO:1901663),-0.27389761091969134,-0.6511836476951959,0.8977272727272727,1.0,1.0,4/14,20.41%,COQ10A;COQ2;COQ8B;COQ10B
prerank,regulation of viral release from host cell (GO:1902186),0.2791054654892913,0.6511225570073355,0.8769230769230769,1.0,1.0,6/21,23.80%,TRIM25;TRIM26;TRIM11;DDB1;VPS37B;MID2
prerank,regulation of brown fat cell differentiation (GO:0090335),0.2952592355968151,0.6505128059884662,0.856637168141593,1.0,1.0,2/16,4.45%,SOX13;RREB1
prerank,sensory perception of taste (GO:0050909),0.3179763996987194,0.6500522413697076,0.8682170542635659,1.0,1.0,10/10,68.22%,TAS1R1;PKD2L1;ASIC1;ASIC2;PKD1L3;TAS1R3;GNAT3;TAS1R2;ASIC3;CD36
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.281838540760331,-0.6499048895930281,0.8938053097345132,1.0,1.0,3/11,11.02%,SHC1;STAT5A;PTK2B
prerank,cellular response to interleukin-2 (GO:0071352),-0.281838540760331,-0.6499048895930281,0.8938053097345132,1.0,1.0,3/11,11.02%,SHC1;STAT5A;PTK2B
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.2733151160065111,0.648861230759979,0.8890784982935154,1.0,1.0,4/21,12.93%,PGM2L1;TALDO1;HK1;G6PC3
prerank,folic acid metabolic process (GO:0046655),-0.2529755835734869,-0.6487479123949446,0.9287305122494433,1.0,1.0,9/18,32.45%,MTHFD1;MTHFR;MTHFD2;MTHFD1L;MTHFS;FPGS;SHMT1;ALDH1L1;PM20D2
prerank,regulation of mitotic spindle organization (GO:0060236),-0.21496773625025134,-0.6485539193787623,0.949468085106383,1.0,1.0,12/35,32.71%,PARP3;GPSM2;CHMP4C;EML3;RAE1;TPX2;HSPA1A;CCSAP;TPR;NUMA1;PLK1;PSRC1
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.23066404204706836,0.6485440741596844,0.9363636363636364,1.0,1.0,9/52,12.99%,CNOT6L;EDC3;PAN3;CNOT9;PAN2;PDE12;DCP2;CNOT6;DCP1B
prerank,negative regulation of JUN kinase activity (GO:0043508),0.3187600466074443,0.6483837346861693,0.8521256931608133,1.0,1.0,3/10,14.99%,NPPA;HIPK3;DNAJA1
prerank,secondary alcohol biosynthetic process (GO:1902653),0.25535295435747224,0.6471096102913769,0.9176470588235294,1.0,1.0,7/30,19.06%,PLPP6;HMGCR;HSD17B7;LBR;IDI1;DHCR7;HMGCS1
prerank,histone deacetylation (GO:0016575),-0.20801791352901022,-0.646884111842713,0.9645776566757494,1.0,1.0,4/43,5.12%,HDAC4;TBL1XR1;MIER3;PER2
prerank,DNA strand elongation (GO:0022616),-0.251528657548924,-0.6466732195984913,0.929384965831435,1.0,1.0,9/18,33.64%,RAD50;POLD2;RFC3;MCM3;NBN;MCM4;GINS1;TERT;GINS3
prerank,anterograde axonal transport (GO:0008089),-0.2124702206968574,-0.6459121922573703,0.9442896935933147,1.0,1.0,4/37,8.27%,TRAK1;DTNBP1;RAB21;AP3B1
prerank,TOR signaling (GO:0031929),0.2665951459488141,0.6456541215873908,0.9131832797427653,1.0,1.0,4/26,15.51%,PRR5L;CCDC88A;RPTOR;CARD11
prerank,tRNA metabolic process (GO:0006399),0.28442326693949016,0.6455840194693021,0.8819320214669052,1.0,1.0,2/17,7.07%,SARS1;YARS2
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.29048308541629364,0.644090746533749,0.8553345388788427,1.0,1.0,6/14,23.46%,CSTF2;CPSF1;RTRAF;TSEN15;RTCB;TSEN34
prerank,intracellular pH reduction (GO:0051452),0.25033165502606947,0.6436172623788892,0.9238249594813615,1.0,1.0,5/33,12.18%,ATP6V0A1;RAB39A;CLCN3;GPR89A;GPR89B
prerank,mitotic nuclear membrane organization (GO:0101024),-0.20423261869052045,-0.6434327686503409,0.9757575757575757,1.0,1.0,15/51,28.54%,LMNA;SEH1L;NUP205;EMD;SIRT2;CHMP4C;VPS4A;CCNB2;LEMD2;KPNB1;NUP155;NDC1;NUP35;IST1;NUP43
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.20423261869052045,-0.6434327686503409,0.9757575757575757,1.0,1.0,15/51,28.54%,LMNA;SEH1L;NUP205;EMD;SIRT2;CHMP4C;VPS4A;CCNB2;LEMD2;KPNB1;NUP155;NDC1;NUP35;IST1;NUP43
prerank,positive regulation of defense response to virus by host (GO:0002230),0.26275560252689795,0.6433997656173776,0.8993055555555556,1.0,1.0,8/24,25.67%,STAT1;AIM2;EIF2AK4;SIN3A;PARP9;ZC3H12A;CGAS;DTX3L
prerank,mitotic spindle organization (GO:0007052),-0.16612860787502193,-0.6429641934553609,1.0,1.0,1.0,67/153,33.55%,EML4;NEK6;SEH1L;FLNA;CENPC;GOLGA2;ZWINT;GPSM2;DYNC1I1;CENPP;TBCE;PTPA;SKA2;PIBF1;CENPK;ZWILCH;RMDN1;DCTN6;XPO1;SUN2;EFHC1;SPICE1;STIL;TUBG1;STAG2;KIF18A;CENPL;CENPQ;CENPE;PRC1;MAD2L1;TTK;MISP;CCDC61;TPX2;CENPF;KIFC1;NSL1;TNKS;KNTC1;SPDL1;KPNB1;KIF11;SPC25;SGO1;CDCA8;KNL1;NUP43;CEP192;ABRAXAS2;BCCIP;DLGAP5;DYNC1I2;NUF2;DYNLL2;ABRAXAS1;AURKA;TOGARAM2;PLK1;SPC24;CDC20;BUB1;KIF4A;DCTN2;AAAS;INCENP;CENPO
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.25076123780221327,0.6426682878293,0.9358552631578947,1.0,1.0,7/32,16.40%,PPP1R13B;HINT1;JMY;DDIT4;HIPK2;MSH2;BAG6
prerank,skeletal muscle contraction (GO:0003009),0.2744831653082664,0.6419810350576783,0.8934010152284264,1.0,1.0,4/19,22.08%,MYH14;RCSD1;STAC2;CCDC78
prerank,purine-containing compound salvage (GO:0043101),-0.2716597813920491,-0.6416809314508173,0.880085653104925,1.0,1.0,3/12,15.80%,AMPD3;GMPR2;DGUOK
prerank,microtubule polymerization (GO:0046785),0.2570155635493287,0.64105392811182,0.9196581196581196,1.0,1.0,10/28,21.67%,FGF13;PIN1;AKAP9;RANBP9;CKAP5;TRPV4;TPPP;TUBG2;CLASP1;NDE1
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.25832513566443793,0.6409299047907372,0.9239302694136292,1.0,1.0,6/29,14.12%,APP;ACP4;SHISA6;GRIK2;NSMF;CAMK2B
prerank,peroxisomal membrane transport (GO:0015919),-0.2273120797441568,-0.6405998252319176,0.9534883720930233,1.0,1.0,7/27,23.62%,ABCD3;PXMP2;PEX7;PEX2;ALDH3A2;ATAD1;PEX13
prerank,cholesterol biosynthetic process (GO:0006695),0.2521298875881714,0.640594902834578,0.9327731092436975,1.0,1.0,7/31,19.06%,PLPP6;HMGCR;HSD17B7;LBR;IDI1;DHCR7;HMGCS1
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.23962255401344276,-0.6404414778382758,0.9361179361179361,1.0,1.0,4/21,13.59%,CDC14B;GOLGA2;BTRC;PTEN
prerank,regulation of defense response to virus by host (GO:0050691),0.24920655979051207,0.6393481544089716,0.9239864864864865,1.0,1.0,10/30,25.67%,STAT1;AIM2;EIF2AK4;TNFAIP3;SIN3A;PARP9;RNF216;ZC3H12A;CGAS;DTX3L
prerank,regulation of neutrophil migration (GO:1902622),0.3139255324921555,0.6391552591930141,0.8675373134328358,1.0,1.0,2/10,15.04%,RAC1;NCKAP1L
prerank,inositol phosphate dephosphorylation (GO:0046855),-0.2762305690802613,-0.6388932859446984,0.8816067653276956,1.0,1.0,4/11,15.38%,SYNJ2;PTEN;INPP5A;INPP5B
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.2762305690802613,-0.6388932859446984,0.8816067653276956,1.0,1.0,4/11,15.38%,SYNJ2;PTEN;INPP5A;INPP5B
prerank,macroautophagy (GO:0016236),0.2037129347776642,0.6378354581588138,0.9896103896103896,1.0,1.0,36/118,22.36%,TOMM22;TECPR1;DYNLL1;TBC1D5;TOMM6;MAP1LC3B;PIK3C3;KLHL3;PRKAB1;UBQLN1;VPS36;ATG12;PIP4K2A;PLEKHM1;HGS;SNAP29;CSNK2B;TMEM74;VPS25;ATG14;VPS16;MAP1LC3A;VAMP7;TOMM7;VPS37A;ATG7;ACBD5;UVRAG;PLAA;VPS37B;RUBCNL;TOMM5;GABARAP;VPS37C;VAMP8;PRKAA1
prerank,protein kinase A signaling (GO:0010737),-0.2761621767111989,-0.6375571404547516,0.9020501138952164,1.0,1.0,4/12,18.92%,EZR;PRKACA;MYOM1;RAB13
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.2632855113349887,0.6367924369010923,0.896551724137931,1.0,1.0,4/22,12.21%,SOX12;FOXP3;CBFB;VSIR
prerank,inositol phosphate catabolic process (GO:0071545),0.3060295427358726,0.6361549976763843,0.886654478976234,1.0,1.0,6/12,24.80%,OCRL;NUDT3;INPP1;SYNJ1;INPP5K;IMPA1
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.2230811314086148,0.635285875957191,0.9606299212598425,1.0,1.0,13/54,19.04%,IKBKB;RFFL;BIRC3;ADAM17;CASP8;SHARPIN;SYK;TNFAIP3;CYLD;GAS6;CPNE1;RBCK1;SPPL2A
prerank,production of siRNA involved in RNA interference (GO:0030422),0.3131967134334956,0.6330252430694967,0.8484848484848485,1.0,1.0,4/10,18.52%,TSNAX;TSN;MRPL44;DICER1
prerank,modulation by host of viral genome replication (GO:0044827),0.2929457905351596,0.6330234110600671,0.8770642201834863,1.0,1.0,4/13,14.75%,EIF2AK4;FBXL2;CCNK;YTHDC2
prerank,cellular response to ionizing radiation (GO:0071479),0.23090590560559215,0.6327341194655828,0.9454277286135693,1.0,1.0,3/47,5.40%,NET1;GRB2;RHOB
prerank,RNA transport (GO:0050658),-0.183349698500627,-0.6326816669452584,0.9936708860759493,1.0,1.0,22/71,26.53%,SIDT1;SRSF5;SRSF11;XPO5;SRSF6;SRSF4;FMR1;SIDT2;RBFOX1;HNRNPA2B1;DDX39B;THOC2;U2AF2;THOC7;U2AF1;DDX39A;RAE1;EIF4A3;POLDIP3;THOC1;NUP155;TPR
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.27602135537705547,0.6321229802597569,0.9018003273322422,1.0,1.0,10/19,26.63%,RPTOR;PRDX5;TENM1;POLR3F;BRF2;ZNF76;MAF1;ICE1;MTOR;POLR3C
prerank,calcium import into the mitochondrion (GO:0036444),0.30800939552223255,0.632056865059345,0.8697247706422019,1.0,1.0,1/10,2.85%,MCUB
prerank,establishment of apical/basal cell polarity (GO:0035089),0.28232793512239174,0.631608444192867,0.8820422535211268,1.0,1.0,4/14,14.17%,OPHN1;MSN;FSCN1;FOXJ1
prerank,DNA biosynthetic process (GO:0071897),0.27652131202649666,0.6304259930131995,0.8894830659536542,1.0,1.0,7/16,28.95%,PPIA;POLL;POLD1;POLA1;TYMS;POLD4;WRNIP1
prerank,cranial nerve development (GO:0021545),-0.2751548890963653,-0.6302924954319834,0.8905908096280087,1.0,1.0,5/11,32.15%,SALL1;PAX2;TMEM126A;CHRNB2;POU4F1
prerank,intracellular protein transmembrane transport (GO:0065002),0.23434242167850974,0.6296112122530018,0.9384116693679092,1.0,1.0,20/42,31.88%,SEC62;PEX14;DNAJC19;TOMM20L;PEX16;CHCHD4;PEX6;PEX1;ZFAND2B;SEC63;TIMM50;TIMM21;TOMM70;AKT2;AIFM1;PEX12;PEX10;PEX5;GRPEL2;GRPEL1
prerank,regulation of neurotransmitter secretion (GO:0046928),0.25221945884759944,0.62950742474355,0.937007874015748,1.0,1.0,7/32,18.82%,MEF2C;SLC30A1;PNKD;CPLX1;RIMS4;RIMS2;PREPL
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.2705763286924005,-0.6287927795020901,0.9056603773584906,1.0,1.0,3/12,18.08%,PPARA;WNK1;MDK
prerank,positive regulation of viral process (GO:0048524),-0.18626661890112756,-0.6284043018450154,0.9852941176470589,1.0,1.0,9/60,15.69%,AXL;MDFIC;PPARA;POLR2A;TMEM39A;DDX3X;NELFE;PPIH;GTF2F1
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.16498524929205904,-0.628211680133988,1.0,1.0,1.0,14/132,12.28%,CELF2;SRSF5;MCTS1;LUC7L3;DDX1;SRSF6;TGS1;GCFC2;NOP2;RBM5;PRMT5;PRPF19;LUC7L2;XRCC5
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.2001992394578635,-0.6281362727236934,0.967391304347826,1.0,1.0,19/42,30.12%,QARS1;PPA2;EPRS1;HARS2;YARS1;VARS2;WARS2;DARS2;RARS2;DARS1;FARS2;FARSA;LARS1;EARS2;AIMP1;TARS1;RARS1;KARS1;PPA1
prerank,lipoxygenase pathway (GO:0019372),-0.2576945610251001,-0.6278204637613943,0.9265658747300216,1.0,1.0,7/14,41.88%,PON3;PTGS2;ALOXE3;ALOX12;GPX1;PON1;ALOX5
prerank,nuclear membrane reassembly (GO:0031468),-0.19587897445547792,-0.6276565692187219,0.9849397590361446,1.0,1.0,16/54,28.54%,LMNA;SEH1L;NUP205;EMD;SIRT2;CHMP4C;VPS4A;CCNB2;UBXN2A;LEMD2;KPNB1;NUP155;NDC1;NUP35;IST1;NUP43
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.27171166186795714,0.6276049830885574,0.9078498293515358,1.0,1.0,3/19,11.69%,CAMKK2;FBXW7;GSK3A
prerank,positive regulation of innate immune response (GO:0045089),0.2505814612249529,0.6273768794141363,0.9232,1.0,1.0,11/30,27.94%,GBP5;NLRC5;TLR8;POLR3F;NMI;SPI1;RIOK3;POLR3B;IFI35;POLR3C;RPS19
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.2844787956687454,-0.6272409984905928,0.8900634249471459,1.0,1.0,3/10,14.65%,PRKCD;CD9;SERPINE2
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.27520869962887845,0.6261589463026642,0.8868940754039497,1.0,1.0,1/15,3.54%,GBP5
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.22985642786865318,-0.6260284104320778,0.9370277078085643,1.0,1.0,6/22,25.05%,CCNT2;DDX39B;ERCC6;TCERG1;CDK12;THOC1
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.21781167273721888,0.6256994213548892,0.9613670133729569,1.0,1.0,7/63,12.43%,CNOT6L;RGCC;CRADD;PIDD1;CNOT9;CNOT6;BTG2
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.30064733079073197,0.6253787826465907,0.87279843444227,1.0,1.0,3/10,21.41%,AP2M1;AP2B1;AP2S1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.30064733079073197,0.6253787826465907,0.87279843444227,1.0,1.0,3/10,21.41%,AP2M1;AP2B1;AP2S1
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.29917321256447393,0.6253607625004814,0.8874773139745916,1.0,1.0,2/10,8.46%,OPHN1;MSN
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.27187138571373665,-0.6251517287658247,0.9106753812636166,1.0,1.0,3/11,21.13%,HAT1;RBBP4;UBN1
prerank,homologous chromosome segregation (GO:0045143),0.26696725856326575,0.6251210353770918,0.8964346349745331,1.0,1.0,4/20,16.12%,RNF212B;PRDM9;PTTG1;SIRT7
prerank,RNA processing (GO:0006396),0.1904731606207132,0.6250553997445556,0.9974937343358395,1.0,1.0,18/176,13.10%,TENT4A;IVNS1ABP;PPP1R9B;ADAR;MTPAP;RNPS1;SNRPF;HNRNPC;DEDD2;MAGOHB;SNRPN;ZCRB1;NCBP2;MPHOSPH10;RBPMS;SNRPB;ADAD1;NOL9
prerank,Golgi to lysosome transport (GO:0090160),0.3019499853325416,0.6248916403052057,0.8773946360153256,1.0,1.0,3/11,20.29%,SORT1;AP1G1;ANKFY1
prerank,superoxide anion generation (GO:0042554),0.29146708991021764,0.6247333213448353,0.8576576576576577,1.0,1.0,3/13,12.71%,CYBB;NCF4;NOX3
prerank,regulation of B cell differentiation (GO:0045577),-0.24974257208306844,-0.6242087513340513,0.9349240780911063,1.0,1.0,4/17,18.54%,MMP14;INHA;SFRP1;ID2
prerank,gene silencing by miRNA (GO:0035195),0.24625175327340812,0.624138508720847,0.9317460317460318,1.0,1.0,2/32,4.32%,NOTCH4;ADAR
prerank,positive regulation of histone modification (GO:0031058),0.24265623966973038,0.6241382072689639,0.9283387622149837,1.0,1.0,6/33,15.00%,APLNR;MAPK3;RPS6KA5;FOXP3;TADA2B;CTBP1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.2709504384368002,-0.6239767455985216,0.8845315904139434,1.0,1.0,3/11,17.50%,CEBPB;CREB3L1;DDIT3
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.300343681407025,0.622264705678051,0.8803921568627451,1.0,1.0,5/11,24.73%,PWP1;SIRT7;DDX11;SMARCA4;MTOR
prerank,regulation of receptor recycling (GO:0001919),0.2739424046804662,0.6221624622873356,0.8873239436619719,1.0,1.0,8/16,27.15%,RAMP3;INPP5F;AP1AR;SCRIB;SNCA;TRAT1;NSF;ECE1
prerank,base-excision repair (GO:0006284),0.2248146712452456,0.6220043404189479,0.9660493827160493,1.0,1.0,12/48,21.53%,NTHL1;DNA2;MPG;PARG;SMUG1;POLB;HMGA2;RPA1;ADPRS;POLL;POLD1;RFC2
prerank,positive regulation of protein deacetylation (GO:0090312),0.2844193302556117,0.6219948970599048,0.8874538745387454,1.0,1.0,3/14,19.29%,APLNR;CTBP1;DYRK1A
prerank,error-free translesion synthesis (GO:0070987),-0.2317949458476966,-0.6214359969244053,0.9385342789598109,1.0,1.0,6/22,28.79%,REV1;RCHY1;RFC3;UFD1;RFC5;SPRTN
prerank,endosome organization (GO:0007032),0.24011884167516515,0.6208749996463566,0.959375,1.0,1.0,5/41,11.06%,ALS2CL;DNAJC13;SNX3;CLCN3;HOOK1
prerank,replication fork processing (GO:0031297),0.23801153022224342,0.6200616299188233,0.93929173693086,1.0,1.0,4/38,8.52%,SAMHD1;MRE11;BRCA2;DNA2
prerank,protein targeting to lysosome (GO:0006622),-0.23695759948746226,-0.6199072537580432,0.9492753623188406,1.0,1.0,6/20,22.26%,LAMP2;AP4M1;GNPTAB;LAPTM5;VPS4A;NEDD4
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.2145165795135075,0.6198783790902999,0.9719887955182073,1.0,1.0,9/61,15.58%,CAV1;PSMB3;PSMD11;OAZ1;PSMC6;PSME2;PSMD8;PSMB10;PSMA8
prerank,sulfur amino acid metabolic process (GO:0000096),-0.2233862985573012,-0.6197691337866973,0.9464720194647201,1.0,1.0,4/24,13.22%,NOX4;MTHFD1;MTHFR;GCLC
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.22232841636748535,0.6187098830469188,0.9679878048780488,1.0,1.0,7/48,16.40%,BCL2L1;FNIP2;MCL1;DDIT4;HIPK2;MSH2;BAG6
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.23690260180048825,-0.6184462934119539,0.941031941031941,1.0,1.0,8/20,28.00%,HSPA4;MKKS;CCT2;PSMG1;PTGES3L;HSPA1A;HOPX;TMEM35A
prerank,regulation of DNA recombination (GO:0000018),-0.21432278732219873,-0.6183063956488223,0.9626666666666667,1.0,1.0,11/32,27.05%,RTEL1;KDM1A;ZRANB3;RAD50;SETD2;SIRT6;ZCWPW1;THOC1;SPIDR;KPNA1;RAD51AP1
prerank,regulation of translational initiation (GO:0006446),0.2119820249573255,0.6170676355429779,0.9749262536873157,1.0,1.0,13/63,15.60%,EIF4H;KLHL25;EIF3E;EIF2AK4;NCBP2;HSPB1;EIF2B2;PAIP2;PAIP1;EIF3B;PPP1R15B;NCK1;EIF1B
prerank,regulation of cell size (GO:0008361),0.2546471463646488,0.6168676785560109,0.9222972972972973,1.0,1.0,10/23,24.73%,MSN;LAMTOR5;RAC1;RPTOR;LAMTOR4;EDN1;VAV1;RDX;RAP1GAP2;MTOR
prerank,protein deneddylation (GO:0000338),0.2935544025306805,0.6166333639803332,0.8735632183908046,1.0,1.0,4/10,25.31%,COPS5;GPS1;COPS6;COPS2
prerank,regulation of actin filament depolymerization (GO:0030834),0.28122422212162745,0.6163946207919435,0.8802177858439202,1.0,1.0,1/12,3.95%,VIL1
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),-0.2668187216266008,-0.6153585986873603,0.9308755760368663,1.0,1.0,3/13,9.08%,FGF2;IGF2;PDPK1
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.26974753830001597,0.6152507432788615,0.8822495606326889,1.0,1.0,8/18,26.29%,RAP1B;RIMS4;NLGN1;RIMS2;PREPL;RAB3GAP1;SYN1;RIMS1
prerank,lipid droplet organization (GO:0034389),0.26248584237898376,0.6146888082106253,0.9311531841652324,1.0,1.0,2/22,6.86%,PPIA;CDS2
prerank,termination of RNA polymerase I transcription (GO:0006363),0.24057441709056626,0.6145076999793897,0.9481132075471698,1.0,1.0,7/30,23.12%,TAF1B;GTF2H2;GTF2H4;UBTF;POLR1A;GTF2H3;TAF1C
prerank,negative regulation of histone modification (GO:0031057),0.29032360286731435,0.6140831169223541,0.9048507462686567,1.0,1.0,5/14,22.23%,FOXP3;CTBP1;SET;NOC2L;SNCA
prerank,tRNA wobble uridine modification (GO:0002098),-0.25410452931176986,-0.6128227050601014,0.915929203539823,1.0,1.0,3/14,15.31%,TRMT9B;ELP3;ELP4
prerank,aminoglycan metabolic process (GO:0006022),0.30648317324494184,0.6126914924533808,0.887189292543021,1.0,1.0,6/10,29.52%,XYLT2;B3GAT3;CHST9;B3GAT2;GAL3ST3;XYLT1
prerank,histone H3 deacetylation (GO:0070932),0.27687784959991,0.612657168470455,0.8957952468007313,1.0,1.0,4/15,16.12%,HDAC9;ELK4;SMARCAD1;SIRT7
prerank,regulation of acute inflammatory response (GO:0002673),0.2682617340377389,0.6118912221205116,0.9122807017543859,1.0,1.0,1/18,4.22%,OSMR
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.2673153682228719,-0.6112224787161759,0.9342403628117913,1.0,1.0,2/13,12.52%,ALG1;MPDU1
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.2761599652277363,0.6109820435198428,0.9080675422138836,1.0,1.0,3/17,11.20%,PPIA;UBQLN1;HSPB1
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.20640993912950467,0.6105387578066792,0.9902777777777778,1.0,1.0,26/84,27.54%,PSMB3;PSMD11;PSMC6;PSME2;PSMD8;PSMB10;BUB3;PTTG1;ANAPC16;PSMA8;ANAPC7;ANAPC10;PSMD9;UBE2D1;ANAPC2;CDC23;PSMD1;PSMC3;CDC27;PSMD10;CDC26;PSME1;PSMB8;PSMD2;UBB;PSMA1
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.2999145752963211,0.6104146940345359,0.90715667311412,1.0,1.0,2/10,12.39%,DNA2;TERF1
prerank,telomere maintenance via telomere trimming (GO:0090737),0.2999145752963211,0.6104146940345359,0.90715667311412,1.0,1.0,2/10,12.39%,DNA2;TERF1
prerank,t-circle formation (GO:0090656),0.2999145752963211,0.6104146940345359,0.90715667311412,1.0,1.0,2/10,12.39%,DNA2;TERF1
prerank,negative regulation of translational initiation (GO:0045947),0.281168515946175,0.6091671147297419,0.9087591240875912,1.0,1.0,3/13,12.97%,EIF3E;EIF2AK4;PAIP2
prerank,presynapse assembly (GO:0099054),-0.24113909802165837,-0.6089147452387617,0.9198218262806236,1.0,1.0,6/16,31.25%,NLGN2;PTEN;LRRTM3;DVL1;BSN;NLGN3
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.24465968093013307,0.6085047658062449,0.9279869067103109,1.0,1.0,3/27,7.95%,LPAR6;P2RY10;GPR17
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.18567849834263844,-0.6081102444321235,0.9942196531791907,1.0,1.0,21/57,32.39%,CDC14B;ATM;TIPIN;BRSK1;ATF2;SDE2;CLSPN;FANCD2;BRCA1;DONSON;WAC;NBN;DTL;RPS27L;CCND1;NOP53;TAOK3;ABRAXAS1;PLK1;TICRR;TAOK2
prerank,myelin assembly (GO:0032288),-0.274563386692247,-0.6067594761234637,0.9132231404958677,1.0,1.0,2/10,9.52%,EPB41L3;CD9
prerank,double-strand break repair via homologous recombination (GO:0000724),-0.16871467602809256,-0.606644206301301,0.9962546816479401,1.0,1.0,30/95,27.36%,FBH1;RAD51B;RBBP8;SMC6;PARP1;NUCKS1;XRCC1;NSMCE1;RAD50;SWI5;NSMCE2;BRCA1;CDC45;WRN;PSMD14;MCM3;NBN;KDM4D;SEM1;MCM4;AP5Z1;ZSWIM7;SPIDR;MCM5;RAD54L;RECQL;LIG3;MCM9;RAD51AP1;ZFYVE26
prerank,DNA recombination (GO:0006310),0.23228377399388736,0.6063288728787154,0.9605911330049262,1.0,1.0,9/37,18.25%,RAD54B;MRE11;RECQL4;MSH3;TSN;MSH2;RAD21;RPA1;ENDOG
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.28377553394374044,0.6050529545759326,0.9141856392294221,1.0,1.0,2/13,10.75%,NTHL1;SMUG1
prerank,pyroptosis (GO:0070269),0.27006956371519536,0.603292061676729,0.9089285714285714,1.0,1.0,3/15,16.77%,AIM2;CASP8;NLRC4
prerank,glucose catabolic process to pyruvate (GO:0061718),0.24706904403527408,0.6029766295923963,0.9443507588532883,1.0,1.0,5/24,14.55%,PKM;HK1;PGAM1;TPI1;PFKL
prerank,canonical glycolysis (GO:0061621),0.24706904403527408,0.6029766295923963,0.9443507588532883,1.0,1.0,5/24,14.55%,PKM;HK1;PGAM1;TPI1;PFKL
prerank,positive regulation of type 2 immune response (GO:0002830),0.2793582115176406,0.6029345161845115,0.874766355140187,1.0,1.0,2/14,10.90%,NOD2;DENND1B
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.26555355710792355,-0.6025468325217622,0.9410480349344978,1.0,1.0,3/11,22.97%,PRKN;NONO;NR4A3
prerank,'de novo' posttranslational protein folding (GO:0051084),0.23748023880133215,0.6018742919061228,0.9391025641025641,1.0,1.0,7/30,19.08%,ENTPD5;HSPA8;DNAJC7;HSPE1;HSPA9;ERO1A;CHCHD4
prerank,negative regulation of DNA replication (GO:0008156),-0.25829525796507585,-0.6012328200744296,0.928416485900217,1.0,1.0,7/13,30.94%,TSPYL2;CDAN1;S100A11;ATR;GMNC;GMNN;PDS5A
prerank,synaptic vesicle transport (GO:0048489),0.28543205548169953,0.6010890851157641,0.9102333931777379,1.0,1.0,2/11,16.18%,DNM2;SYNJ1
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.25447716313768187,0.5997007123521018,0.9308600337268128,1.0,1.0,4/18,19.73%,ATXN3;NCK1;BAG6;BAK1
prerank,cilium movement (GO:0003341),0.21715332054364478,0.5993661919101881,0.9699248120300752,1.0,1.0,6/47,11.28%,DNHD1;CFAP100;CFAP91;RSPH4A;CFAP54;DNAAF2
prerank,maintenance of protein localization in organelle (GO:0072595),0.2629039315203523,0.5990461235147461,0.9211908931698775,1.0,1.0,2/19,11.04%,ARL2BP;HK1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.21353325553312982,0.5968878661788625,0.9835575485799701,1.0,1.0,8/53,16.59%,CALCRL;HTR2A;AGTR2;CHRM3;MTNR1A;HTR4;OPRD1;SSTR1
prerank,histone deubiquitination (GO:0016578),0.25930434154694915,0.5959121294081767,0.9175627240143369,1.0,1.0,6/18,23.54%,ATXN7;TRRAP;USP49;USP21;BRCC3;ENY2
prerank,telomere maintenance (GO:0000723),0.2155395162542348,0.5957536505489128,0.9702194357366771,1.0,1.0,7/50,12.39%,SP100;MRE11;TERF2;DNA2;ACD;RECQL4;TERF1
prerank,negative regulation of centrosome duplication (GO:0010826),-0.26287480075612485,-0.5955174396416468,0.9267241379310345,1.0,1.0,3/11,19.70%,MDM1;TRIM37;BRCA1
prerank,double-strand break repair (GO:0006302),0.18231169242244438,0.5946784520232526,1.0,1.0,1.0,30/158,21.45%,TENT4A;SAMHD1;RAD54B;MRE11;UBE2V2;PALB2;BRCA2;DNA2;KDM4A;HPF1;UBXN1;BABAM1;RECQL4;POLB;HMGB2;FAN1;RNF8;SMARCAD1;HERC2;SUMO1;RAD21;HUS1;RPA1;REV3L;BRCC3;POLL;POLA1;PARP2;DCLRE1C;INO80
prerank,cellular response to alkaloid (GO:0071312),0.2605419288984853,0.5946355815568638,0.9222614840989399,1.0,1.0,2/17,6.48%,TGM2;CASP7
prerank,regulation of mRNA processing (GO:0050684),0.2357270526326615,0.5943773218847735,0.9442622950819672,1.0,1.0,1/32,1.60%,QKI
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.2334634131598574,-0.593800498267652,0.9662921348314607,1.0,1.0,8/17,26.29%,PRKN;KDM1A;TWIST1;SNAI1;CD44;RNF34;YJU2;ARMC10
prerank,chromatin disassembly (GO:0031498),0.2715415922160097,0.5935824486386158,0.9175824175824175,1.0,1.0,7/14,24.56%,ARID1A;HMGA1;SMARCD1;SET;GRWD1;ARID2;SMARCA4
prerank,nucleosome disassembly (GO:0006337),0.2715415922160097,0.5935824486386158,0.9175824175824175,1.0,1.0,7/14,24.56%,ARID1A;HMGA1;SMARCD1;SET;GRWD1;ARID2;SMARCA4
prerank,autophagy of nucleus (GO:0044804),-0.23712777104257332,-0.5932942816154239,0.9368932038834952,1.0,1.0,2/16,6.24%,ULK2;ATG2B
prerank,protein localization to chromosome (GO:0034502),0.23025312861550087,0.5930449558471608,0.9579967689822294,1.0,1.0,10/34,21.87%,TERF2;CTCF;ACD;BOD1;MSH2;RAD21;RPA1;SLF1;PINX1;WAPL
prerank,positive regulation of histone acetylation (GO:0035066),0.2425246921970765,0.5926633494574323,0.937394247038917,1.0,1.0,4/23,11.65%,MAPK3;RPS6KA5;FOXP3;TADA2B
prerank,calcium-ion regulated exocytosis (GO:0017156),0.23978229394067582,0.5918858837275742,0.9392446633825944,1.0,1.0,8/27,26.58%,SYT7;ARHGAP17;SYT4;RIMS2;VAMP7;SYT17;RIMS1;SYT15
prerank,phosphate ion transport (GO:0006817),0.26394513319036006,0.5917997945771465,0.9137614678899083,1.0,1.0,5/16,23.37%,XPR1;SLC37A3;SLC37A2;SLC34A3;SLC37A1
prerank,regulation of mRNA metabolic process (GO:1903311),-0.26375978283173823,-0.5916324922138954,0.9333333333333333,1.0,1.0,5/11,34.32%,SAFB2;SLTM;SRPK1;PTCD2;SRPK2
prerank,regulation of catecholamine secretion (GO:0050433),0.23847302352458613,0.5912116585702075,0.9446308724832215,1.0,1.0,3/29,11.74%,STX1A;SYT7;SYT4
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.2170833629543851,-0.5911890902426249,0.9591836734693877,1.0,1.0,7/24,26.31%,DNMT3A;PPM1D;EED;RBBP4;EZH2;RBBP7;EPC1
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.22992344944959764,0.5907282305553434,0.9573770491803278,1.0,1.0,8/29,22.90%,EDC3;DCP2;CNOT6;DCP1B;LSM4;EXOSC9;EXOSC8;DCPS
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.1739956991690071,0.5900620700311738,1.0,1.0,1.0,84/241,30.35%,NOVA2;YBX1;EFTUD2;GPATCH1;RNPS1;BUD31;SNU13;CSTF2;SNRPF;SNRPE;SNRPC;HNRNPC;RBM19;CPSF1;MAGOHB;SNRPN;ZCRB1;HSPA8;NCBP2;PPWD1;GPKOW;CTNNBL1;SNRPB;SNRNP27;ELAVL1;PRPF40A;FRG1;AQR;RSRC1;SNRPB2;PRPF4;ISY1;SMU1;SF3A2;USP49;POLR2J;SNRPD2;LSM4;PUF60;CDC5L;IK;RBM8A;HNRNPM;SF3B3;RBM15;ELAVL2;NCBP1;METTL3;PAPOLA;WBP11;PRPF8;PABPC1;PPIE;CSTF2T;SMNDC1;SNRPA;DHX38;SART3;SNW1;UPF3B;PHF5A;CSTF1;SNRNP48;CWC27;SRSF12;HNRNPF;CWF19L2;HNRNPL;HNRNPA3;SRSF1;LSM6;SNRPD1;PRPF31;GEMIN5;SRSF7;DDX41;XAB2;BCAS2;HNRNPA1;ZRSR2;CPSF7;DDX42;PRPF6;METTL14
prerank,regulation of DNA metabolic process (GO:0051052),0.21694468964367147,0.5887106505668293,0.9678972712680578,1.0,1.0,14/44,26.23%,UBE2V2;TERF2;UBE2V1;PARG;IL7R;YLPM1;SMARCAD1;SIRT7;SUB1;RADX;WDR70;MYC;KDM1B;UPF1
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.23426457063665507,-0.588567587394122,0.9455337690631809,1.0,1.0,5/16,22.39%,PLEKHM2;VAMP2;RAET1E;LYST;ULBP1
prerank,RNA export from nucleus (GO:0006405),-0.16039788213868889,-0.5878935869431474,1.0,1.0,1.0,30/100,27.46%,SEH1L;SRSF5;SRSF11;DDX19B;XPO5;SRSF6;NUP205;CPSF3;SRSF4;MCM3AP;HNRNPA2B1;DDX39B;SMG1;FYTTD1;THOC2;U2AF2;THOC7;CPSF2;U2AF1;FIP1L1;DDX39A;RAE1;EIF4A3;POLDIP3;THOC1;SYMPK;NUP155;TPR;NDC1;NUP35
prerank,recombinational repair (GO:0000725),-0.17066375347999652,-0.5872227408024385,0.9965156794425087,1.0,1.0,25/77,27.36%,FBH1;RAD51B;RBBP8;SMC6;PARP1;NUCKS1;XRCC1;NSMCE1;RAD50;SWI5;NSMCE2;BRCA1;WRN;PSMD14;NBN;KDM4D;SEM1;AP5Z1;ZSWIM7;SPIDR;RECQL;LIG3;MCM9;RAD51AP1;ZFYVE26
prerank,negative regulation of RNA metabolic process (GO:0051253),0.25001697896295916,0.5871446766063733,0.9354275741710296,1.0,1.0,6/18,27.05%,PTBP3;TGFB1;NUDT16;KAT2B;ZC3H12A;RPS13
prerank,axonal transport (GO:0098930),0.22601577728859965,0.5868887949441416,0.9670846394984326,1.0,1.0,8/36,20.10%,AP3M2;KIF1A;AP3S1;KIF3B;HIF1A;SPAST;AP3M1;DCTN1
prerank,"DNA-templated transcription, termination (GO:0006353)",0.19930272124714157,0.5849099527681874,0.9842406876790831,1.0,1.0,10/68,12.89%,TAF1B;GTF2H2;CSTF2;SNRPF;SNRPE;CPSF1;SSU72;NCBP2;GTF2H4;SNRPB
prerank,cellular response to leucine starvation (GO:1990253),0.28885868619028987,0.5844669766344859,0.8974358974358975,1.0,1.0,2/10,9.75%,SESN3;EIF2AK4
prerank,retrograde axonal transport (GO:0008090),0.25946837798920824,0.5844449359320503,0.9274047186932849,1.0,1.0,1/16,6.95%,KIF1A
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.2240074367880756,0.5832983609095067,0.9612903225806452,1.0,1.0,8/31,22.90%,EDC3;DCP2;CNOT6;DCP1B;LSM4;EXOSC9;EXOSC8;DCPS
prerank,positive regulation of intracellular transport (GO:0032388),0.22253176508023959,0.5829708265661963,0.9641744548286605,1.0,1.0,6/38,15.42%,PRR5L;RIPOR1;OAZ1;PDCD10;B3GAT3;SPAG5
prerank,ESCRT III complex disassembly (GO:1904903),0.28801000914037034,0.5827314034731572,0.9223300970873787,1.0,1.0,1/10,7.90%,CHMP1B
prerank,ESCRT complex disassembly (GO:1904896),0.28801000914037034,0.5827314034731572,0.9223300970873787,1.0,1.0,1/10,7.90%,CHMP1B
prerank,autophagy of peroxisome (GO:0030242),0.27866145950058324,0.5826808069685404,0.9029304029304029,1.0,1.0,4/12,23.45%,MAP1LC3B;PIK3C3;ACBD5;USP30
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.28926593140374235,0.5824930701835499,0.9188640973630832,1.0,1.0,2/10,14.37%,RAPGEF3;HDAC5
prerank,protein heterooligomerization (GO:0051291),0.25352000423012955,0.5787682083202792,0.9429097605893186,1.0,1.0,4/17,13.49%,KCNC2;MAT2A;GRIN2B;HSD17B8
prerank,tRNA 5'-end processing (GO:0099116),0.2635485957549401,0.5776025615906966,0.922509225092251,1.0,1.0,5/15,21.39%,TRMT10C;RPP38;RPP21;HSD17B10;RPP30
prerank,receptor recycling (GO:0001881),-0.2600514308343336,-0.5773649825050693,0.9398663697104677,1.0,1.0,6/10,35.71%,ARFGEF2;RAB11B;NSG1;PHETA2;PLEKHJ1;PHETA1
prerank,autophagy of mitochondrion (GO:0000422),0.22160547346085566,0.5767446204401462,0.9667673716012085,1.0,1.0,14/38,24.85%,CTSK;MAP1LC3B;ATG12;ATG14;WDR45;MAP1LC3A;ATG9B;ATG7;ATG2A;GABARAP;BNIP3;USP30;GABARAPL2;ULK1
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.262299666727568,-0.5763918028454518,0.9362637362637363,1.0,1.0,2/10,21.55%,PRKN;AOC3
prerank,positive regulation of protein export from nucleus (GO:0046827),0.261668365119478,0.5761841735321664,0.9379562043795621,1.0,1.0,1/15,3.90%,RAPGEF3
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.2580714529216711,-0.5752653385166312,0.928,1.0,1.0,3/10,17.30%,WNK1;MAP2K5;MYADM
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.2580714529216711,-0.5752653385166312,0.928,1.0,1.0,3/10,17.30%,WNK1;MAP2K5;MYADM
prerank,regulation of cilium movement (GO:0003352),0.2864594254794285,0.5744605285264165,0.8989169675090253,1.0,1.0,1/10,8.02%,DRC1
prerank,ovarian follicle development (GO:0001541),0.265351068459251,0.5743164465203869,0.9259259259259259,1.0,1.0,2/13,11.22%,FOXL2;EIF2B2
prerank,neuron projection fasciculation (GO:0106030),0.2801954618125117,0.5720850801954733,0.92578125,1.0,1.0,2/10,16.30%,EPHA4;NRCAM
prerank,protein localization to mitochondrion (GO:0070585),-0.25236968567119344,-0.5718973420710052,0.9459459459459459,1.0,1.0,4/11,22.68%,HK2;LRRK2;COX18;MTCH2
prerank,regulation of phosphate metabolic process (GO:0019220),0.24771927362506338,0.5702651817274135,0.9409660107334525,1.0,1.0,4/16,23.60%,IKBKB;PGAM1;TIGAR;RAD17
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.2452322482517667,-0.5693144833849091,0.95,1.0,1.0,1/13,3.61%,PRKCD
prerank,nucleosome assembly (GO:0006334),0.22224297945241633,0.5679243080449572,0.9707792207792207,1.0,1.0,12/31,25.52%,CHAF1A;NAA60;HMGB2;SOX9;CHAF1B;IPO4;GRWD1;NASP;DAXX;HIRA;NAP1L4;SART3
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.2742960470567732,0.5648869403197129,0.9142857142857143,1.0,1.0,6/10,26.19%,GABRG1;GABRG3;GABRA1;GABRB2;GABRA2;GABRG2
prerank,regulation of secretion by cell (GO:1903530),-0.17023824753020833,-0.5648785459399492,0.9910714285714286,1.0,1.0,9/54,18.92%,SNCAIP;ANXA1;RAB21;FMR1;P3H1;STX4;RHBDF1;VAMP2;RAB13
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.2544291658271798,0.5647321152370233,0.9443478260869566,1.0,1.0,8/15,31.04%,MRE11;HUS1;RAD9B;RAD17;CHEK2;HUS1B;MDC1;EME2
prerank,cytosolic transport (GO:0016482),0.18147754807971378,0.5643796539050725,0.9986338797814208,1.0,1.0,12/108,12.02%,MYO1D;PIKFYVE;SORT1;TBC1D5;SPAG9;HEATR5A;PIK3C3;TBC1D23;KLHL20;TBC1D10B;HOOK1;EPS15
prerank,regulation of telomere capping (GO:1904353),-0.20584589475334314,-0.5641567775299253,0.9566265060240964,1.0,1.0,9/23,27.38%,TNKS2;ATM;RTEL1;RAD50;NBN;TNKS;MAP3K4;HNRNPD;PKIB
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.21242558893739982,0.5639603692068427,0.9836601307189542,1.0,1.0,8/40,16.37%,UBE2V2;MCL1;UBE2V1;PARG;IER3;NSMCE4A;SIRT7;HMGA2
prerank,chromosome organization (GO:0051276),-0.15281697407730266,-0.5627677346356543,1.0,1.0,1.0,35/99,33.79%,TOP2B;SETD7;HMGN3;MTHFR;DDB2;EZH1;PARP1;NUCKS1;ABL1;LDB1;COPS4;CDAN1;LATS1;TOP2A;EZH2;CUL4B;COPS8;RAE1;NUP155;FAM50A;CDCA8;BAHD1;BRWD1;COPS7B;HMGN2;SIRT1;NUF2;GEM;LIG4;MTF2;HDAC1;SOX2;CENPW;LRWD1;DOT1L
prerank,eye photoreceptor cell development (GO:0042462),-0.22682793883791785,-0.5606023892430996,0.9591836734693877,1.0,1.0,7/15,34.84%,RPGRIP1L;TULP1;THY1;BBS4;MYO7A;CRB2;NRL
prerank,regulation of rRNA processing (GO:2000232),-0.22620406436688972,-0.560432893735858,0.9497816593886463,1.0,1.0,5/16,25.79%,RIOK2;WDR43;TRMT112;DIMT1;USP36
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.2213138994756425,0.5594578574559772,0.958664546899841,1.0,1.0,3/29,7.76%,ACBD6;GLYAT;ACSL6
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.2213138994756425,0.5594578574559772,0.958664546899841,1.0,1.0,3/29,7.76%,ACBD6;GLYAT;ACSL6
prerank,phagosome acidification (GO:0090383),-0.20165995305225204,-0.5592575510432137,0.972568578553616,1.0,1.0,7/26,21.13%,ATP6V0A4;ATP6V1C1;ATP6V1G2;ATP6V1E1;ATP6V1F;TCIRG1;ATP6V0D2
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.19511780363348608,0.558881296651271,0.9941520467836257,1.0,1.0,22/65,27.54%,PSMB3;PSMD11;PSMC6;PSME2;PSMD8;PSMB10;RBX1;PSMA8;SKP1;PSMD9;PINX1;ZFYVE19;CUL1;PSMD1;PSMC3;PABIR1;PSMD10;NABP2;PSME1;PSMB8;PSMD2;PSMA1
prerank,RNA stabilization (GO:0043489),0.2186899154900548,0.557467137245249,0.9532554257095158,1.0,1.0,5/33,14.82%,YBX1;NOCT;AXIN2;PAIP1;ELAVL1
prerank,protein import into nucleus (GO:0006606),-0.16542731747300835,-0.5570805936559913,0.9938650306748467,1.0,1.0,3/66,4.82%,APPL2;CBLB;RANBP17
prerank,peripheral nervous system development (GO:0007422),0.22470560546300786,0.5547615892216499,0.9513422818791947,1.0,1.0,4/23,16.27%,NFASC;SERPINI1;SOX10;PMP22
prerank,RNA biosynthetic process (GO:0032774),-0.19052922677606385,-0.5546775277009872,0.9891304347826086,1.0,1.0,7/31,21.80%,POLR2A;PRMT5;SMARCA5;HELB;PRIM2;BRF1;TBP
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.22609592948371857,-0.553729127664898,0.965,1.0,1.0,7/16,31.69%,NAA35;NAA80;EP300;NAA40;NAA50;CREBBP;AANAT
prerank,protein localization to chromatin (GO:0071168),-0.21664355052676418,-0.5535198475779058,0.9776286353467561,1.0,1.0,8/18,33.66%,SGF29;ESR1;LEMD2;MCM9;PIH1D1;PLK1;MCM8;LRWD1
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.2199602169112771,-0.5533956782036791,0.9432098765432099,1.0,1.0,4/17,18.30%,FGF1;APOE;SREBF1;MBTPS1
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.23255073360912726,-0.5533814605647117,0.9539473684210527,1.0,1.0,3/13,24.98%,SDAD1;XPO1;NOP9
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.17323785163255173,0.5531585599870082,0.9986504723346828,1.0,1.0,17/125,15.90%,EFHC2;MAP4;STMN1;CLIP1;DYNLL1;KIF2A;KIF3B;RPS27;EML1;CENPU;BUB3;CENPN;DYNC1LI1;PLK2;CKAP5;NUP160;RCC2
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.16183783220643289,0.5530039071221335,1.0,1.0,1.0,92/264,30.35%,NOVA2;YBX1;EFTUD2;GPATCH1;RNPS1;BUD31;SNU13;CSTF2;SNRPF;SNRPE;SNRPC;HNRNPC;RBM19;CPSF1;MAGOHB;SNRPN;ZCRB1;HSPA8;NCBP2;PPWD1;GPKOW;CTNNBL1;SNRPB;SNRNP27;ELAVL1;PRPF40A;FRG1;AQR;PRMT7;RSRC1;SNRPB2;PRPF4;ISY1;SMU1;SCNM1;SF3A2;USP49;POLR2J;SNRPD2;LSM4;PUF60;CDC5L;IK;WDR77;RBM8A;HNRNPM;SF3B3;RBM15;ELAVL2;NCBP1;METTL3;PAPOLA;DCPS;WBP11;PRPF8;PABPC1;PPIE;CSTF2T;SMNDC1;SNRPA;DHX38;SART3;SNW1;UPF3B;PHF5A;SCAF11;CSTF1;SNRNP48;CWC27;SRSF12;HNRNPF;CWF19L2;DDX20;HNRNPL;SMN1;HNRNPA3;SRSF1;COIL;LSM6;SNRPD1;PRPF31;GEMIN5;SRSF7;DDX41;XAB2;BCAS2;HNRNPA1;ZRSR2;CPSF7;DDX42;PRPF6;METTL14
prerank,establishment of protein localization to organelle (GO:0072594),-0.16195331220284068,-0.5523095704911326,1.0,1.0,1.0,5/72,9.38%,APPL2;LAMP2;RANBP17;HK2;LRSAM1
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.18255562564787103,0.5521087857281134,0.9959349593495935,1.0,1.0,17/88,18.25%,FBXW7;PSMB3;PSMD11;PSMC6;PSME2;DMAC2;FBXL2;PSMD8;FBXO6;PSMB10;RBX1;FBXL8;FBXL15;PSMA8;FBXO2;SKP1;PSMD9
prerank,protein localization to kinetochore (GO:0034501),0.2516365722034345,0.551826499163143,0.9434306569343066,1.0,1.0,6/14,28.26%,BUB3;RCC2;ZW10;IK;CHAMP1;CENPT
prerank,positive regulation of chromosome organization (GO:2001252),0.25079028721441826,0.5517849140932511,0.9555160142348754,1.0,1.0,4/15,18.00%,MRE11;SHCBP1L;RAD21;DDX11
prerank,steroid catabolic process (GO:0006706),-0.2460372493508589,-0.5517319833370923,0.9528907922912205,1.0,1.0,1/10,5.50%,SPP1
prerank,mRNA transport (GO:0051028),0.17688922020031167,0.5513433954050808,1.0,1.0,1.0,12/101,13.42%,AGFG1;HHEX;RNPS1;NXT1;CPSF1;MAGOHB;THOC6;ZFP36L1;NCBP2;NUP54;EIF4E;ZC3H11A
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.22325396159634653,0.5510430252497903,0.9769357495881383,1.0,1.0,5/25,14.55%,PKM;HK1;PGAM1;TPI1;PFKL
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.25304458826620313,-0.5500461491346202,0.9585921325051759,1.0,1.0,3/10,19.87%,ATP7A;KYAT1;KYNU
prerank,positive regulation of exocytosis (GO:0045921),0.20764326139771677,0.5490997561685793,0.9761146496815286,1.0,1.0,13/35,29.17%,UNC13D;HGS;SDCBP;CADPS;PDCD6IP;CADPS2;CLASP1;SNCA;ATP6AP1;CLASP2;RAB7A;VPS4B;RAB27A
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.23868273607517126,0.5483058621474525,0.9781818181818182,1.0,1.0,5/18,21.72%,RAB11A;BRD4;RCC2;MECP2;CDK4
prerank,regulation of mRNA catabolic process (GO:0061013),0.1745456195711632,0.547392817800376,1.0,1.0,1.0,23/121,20.19%,PRR5L;PSMB3;PSMD11;PSMC6;GTPBP1;PSME2;HSPA8;ZFP36L1;DCP2;HSPB1;PSMD8;PSMB10;SERBP1;ELAVL1;PSMA8;ZC3HAV1;YWHAZ;YWHAB;XRN1;PSMD9;SET;EXOSC9;ZFP36L2
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.2637272010669309,0.5472064975391819,0.9376181474480151,1.0,1.0,3/10,16.21%,SPAG5;RCC2;APC
prerank,mitotic spindle assembly (GO:0090307),0.1988485577489623,0.545800703082084,0.9875776397515528,1.0,1.0,6/42,11.70%,KIF2A;RAB11A;MZT1;KIF3B;MAP10;KIF23
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.2358187175462549,-0.5447606222757764,0.9498910675381264,1.0,1.0,6/12,27.99%,IDH2;ACO1;IDH1;IDH3G;ACO2;SIRT4
prerank,defense response to fungus (GO:0050832),0.23635144384839304,0.5447347605089573,0.9581881533101045,1.0,1.0,3/17,20.26%,S100A8;BCL10;PLCG2
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.20982960718187071,-0.5446136345042782,0.9788732394366197,1.0,1.0,4/19,17.98%,AMPD3;GMPR2;DGUOK;POLD2
prerank,response to histamine (GO:0034776),0.2654198080162993,0.5439830501691917,0.9436363636363636,1.0,1.0,4/10,26.19%,GABRB1;GABRB2;AOC1;GABRG2
prerank,positive regulation of lipid storage (GO:0010884),0.23160438383967547,0.5436172408147883,0.9498269896193772,1.0,1.0,1/21,2.97%,SCARB1
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.24384059043859452,0.5434919136653236,0.9463955637707948,1.0,1.0,3/14,23.14%,TNFSF11;ATP6AP1;TRAF6
prerank,mitochondrion disassembly (GO:0061726),0.2140107484737841,0.5429347654715169,0.9813084112149533,1.0,1.0,13/34,24.85%,CTSK;MAP1LC3B;ATG12;WDR45;MAP1LC3A;ATG9B;ATG7;ATG2A;GABARAP;BNIP3;USP30;GABARAPL2;ULK1
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.2604772452128593,0.5413842286766753,0.9387755102040817,1.0,1.0,3/10,22.50%,PSMC6;THRA;PSMC3
prerank,isotype switching (GO:0045190),0.26073102120309716,0.5405109056204354,0.9343971631205674,1.0,1.0,2/10,16.03%,RNF8;MSH2
prerank,polarized epithelial cell differentiation (GO:0030859),0.2458564690023437,0.5396045116350298,0.9578947368421052,1.0,1.0,2/13,8.46%,OPHN1;MSN
prerank,phosphate ion transmembrane transport (GO:0035435),0.25200226663049513,0.5389421896068561,0.9515828677839852,1.0,1.0,4/12,23.37%,XPR1;SLC37A3;SLC37A2;SLC37A1
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.23602014890326084,-0.5377325328642582,0.9848156182212582,1.0,1.0,5/12,34.83%,PIBF1;BRCA1;APOC1;SIRT1;ERLIN1
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.24269915202691988,-0.5376433264281744,0.9621052631578947,1.0,1.0,1/10,4.78%,IVD
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.17289306214640957,0.537020290704562,1.0,1.0,1.0,25/96,26.44%,AGFG1;HHEX;RNPS1;NXT1;CPSF1;MAGOHB;THOC6;NCBP2;NUP54;EIF4E;ZC3H11A;NUP160;NUP153;NUP50;RBM8A;UPF2;NCBP1;NUP42;NUP85;NUP210;NUP188;DHX38;UPF3B;UPF1;CHTOP
prerank,natural killer cell mediated immunity (GO:0002228),-0.21579219566892655,-0.5369173677634779,0.9668874172185431,1.0,1.0,4/15,22.39%,PLEKHM2;RAET1E;LYST;ULBP1
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.22607385079125836,0.5368545558017296,0.9539007092198581,1.0,1.0,18/18,77.42%,DNAAF2;AQP4;RFX3;CFAP53;ODAD4;CABYR;NPHP3;SPEF2;CCDC39;NEK10;OFD1;DNAAF1;DNAAF4;CCDC40;SPA17;SPAG17;ADCY10;ROPN1L
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.21541690557503712,-0.5365910764279864,0.9747126436781609,1.0,1.0,7/16,36.74%,CIRBP;TRA2B;NCL;CELF4;CELF3;SF3B4;NUP98
prerank,ncRNA export from nucleus (GO:0097064),-0.1798479482261775,-0.5365623602864458,0.9971830985915493,1.0,1.0,16/36,38.46%,PHAX;SEH1L;NUP205;TSC1;RAE1;NUP155;TPR;NDC1;NUP35;NUP43;AAAS;NOL6;SSB;NUP98;NUP62;NUP37
prerank,regulation of superoxide anion generation (GO:0032928),-0.22465974896319751,-0.5333672448518193,0.9734513274336283,1.0,1.0,1/14,3.61%,PRKCD
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.19830054423840224,0.5329575038752564,0.9886363636363636,1.0,1.0,13/43,26.09%,MRE11;BABAM1;CDC6;ORC1;TRIM39;HMGA2;HUS1;BRCC3;PABIR1;RAD17;TOPBP1;NABP2;BLM
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.20304056707927454,0.5326338625383579,0.9919743178170144,1.0,1.0,10/38,27.71%,NDUFA2;NDUFA8;NDUFA4;NDUFA12;NDUFB3;NDUFC1;NDUFA10;NDUFA7;NDUFS5;NDUFAB1
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.20181853828926516,-0.5321398467057541,0.9754299754299754,1.0,1.0,6/20,25.79%,APOE;SREBF1;MBTPS1;NR1H4;EPHX2;KPNB1
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.23103073209721853,0.5306196981002964,0.9790575916230366,1.0,1.0,6/20,18.52%,TSNAX;ZC3H7A;TSN;MRPL44;TRIM71;DICER1
prerank,phasic smooth muscle contraction (GO:0014821),0.2543936731107206,0.5285774127039622,0.9405405405405406,1.0,1.0,10/10,74.58%,EDN1;TIFAB;EDN3;EDNRB;EDN2;DRD2;GDNF;HTR1D;HTR2B;PTGER3
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.25147230569501317,0.5265768151700949,0.9484346224677717,1.0,1.0,2/11,15.75%,PANK3;ACAT1
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.25147230569501317,0.5265768151700949,0.9484346224677717,1.0,1.0,2/11,15.75%,PANK3;ACAT1
prerank,coenzyme A biosynthetic process (GO:0015937),0.25147230569501317,0.5265768151700949,0.9484346224677717,1.0,1.0,2/11,15.75%,PANK3;ACAT1
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.18914748423541314,0.5262978998953242,0.9955489614243324,1.0,1.0,19/55,27.54%,PSMB3;PSMD11;PSMC6;PSME2;PSMD8;PSMB10;RBX1;PSMA8;SKP1;PSMD9;PINX1;CUL1;PSMD1;PSMC3;PSMD10;PSME1;PSMB8;PSMD2;PSMA1
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.22079302691264444,0.5260741992273951,0.9741379310344828,1.0,1.0,6/25,22.66%,ZMYND11;BRD4;NELFCD;RNF8;EAF1;EAPP
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.2207199428947248,-0.5252923959645373,0.9710467706013363,1.0,1.0,4/13,16.79%,KDM1A;TWIST1;SNAI1;CD44
prerank,peptidyl-lysine acetylation (GO:0018394),-0.2404916358631068,-0.5243274466128739,0.9663157894736842,1.0,1.0,5/10,33.58%,EP300;CREBBP;SIRT1;KAT5;ESCO1
prerank,RNA interference (GO:0016246),0.23418576265268534,0.5242354177093252,0.9516129032258065,1.0,1.0,4/17,18.52%,TSNAX;TSN;MRPL44;DICER1
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.18324245447793772,0.5236447788807528,0.9940915805022157,1.0,1.0,16/58,22.10%,MRE11;UBE2V2;BABAM1;ZBTB7A;POLB;HMGB2;RNF8;HERC2;SUMO1;BRCC3;POLL;UVRAG;POLA1;ERCC8;DCLRE1C;ERCC4
prerank,7-methylguanosine mRNA capping (GO:0006370),0.2044001607481419,0.5230864308792889,0.9834437086092715,1.0,1.0,8/31,21.60%,GTF2H2;NCBP2;GTF2H4;CMTR2;POLR2J;CMTR1;GTF2H3;NCBP1
prerank,7-methylguanosine RNA capping (GO:0009452),0.2044001607481419,0.5230864308792889,0.9834437086092715,1.0,1.0,8/31,21.60%,GTF2H2;NCBP2;GTF2H4;CMTR2;POLR2J;CMTR1;GTF2H3;NCBP1
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.2163157548509882,0.5218942953636415,0.9744027303754266,1.0,1.0,2/23,14.01%,CALM1;METAP2
prerank,protein localization to phagophore assembly site (GO:0034497),-0.22673851497912684,-0.5217094126510329,0.9831223628691983,1.0,1.0,5/11,35.26%,MFN2;ATG9A;WIPI1;STX17;WIPI2
prerank,response to organonitrogen compound (GO:0010243),-0.16941464422617594,-0.5216816206606647,0.9946380697050938,1.0,1.0,8/38,21.87%,RCN3;PRKN;GLRB;IRAK3;SYVN1;NR1H4;KYNU;DERL1
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.24240295541299586,0.5208598478145685,0.967032967032967,1.0,1.0,7/13,30.26%,AAR2;PRPF8;SART3;SRSF12;DDX20;PRPF31;PRPF6
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.18689106954191664,0.5198624116349421,0.9955089820359282,1.0,1.0,10/49,21.50%,MEF2C;ZFPM1;CBFB;HMGB2;KMT2C;SIN3A;RBBP5;RBM15;CNOT4;KAT2B
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.24130816497262564,0.5175554880426806,0.9626334519572953,1.0,1.0,3/13,22.66%,NELFCD;RNF8;EAPP
prerank,myelin maintenance (GO:0043217),0.24825654534803454,0.5171315408364384,0.9607843137254902,1.0,1.0,3/10,18.78%,ABCD1;DEGS1;ABCD2
prerank,RNA methylation (GO:0001510),0.17898998565890015,0.5168950280726554,0.9985380116959064,1.0,1.0,21/60,27.02%,CBLL1;GTPBP3;TRMT10C;MRM2;TRMT61B;TRMT12;METTL2B;METTL2A;ZC3H13;ALKBH8;CMTR1;TRMT5;RBM15;NSUN6;METTL3;ZCCHC4;PCIF1;TRMO;TARBP1;TRMT10A;TYW3
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.2051784292286242,0.516844172203711,0.9765494137353434,1.0,1.0,7/27,25.54%,AK4;CMPK1;DTYMK;GSR;NME2;TYMS;AK2
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),-0.18153608619186268,-0.5166985476546325,0.9925373134328358,1.0,1.0,6/30,17.76%,NPEPPS;RNF31;HUWE1;HTRA2;ABLIM3;PDCD5
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.24570752991881323,0.5166233630479139,0.9555555555555556,1.0,1.0,3/12,22.66%,NELFCD;RNF8;EAPP
prerank,cellular response to ATP (GO:0071318),-0.21310897743565307,-0.5166034697231865,0.9767441860465116,1.0,1.0,7/14,34.13%,P2RX4;HSP90B1;RYR3;P2RY1;P2RX3;P2RY12;P2RY2
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.2503342086991072,0.5162893444881228,0.9529190207156308,1.0,1.0,5/11,25.79%,LPCAT3;ATL1;VCPIP1;BNIP1;VAPB
prerank,lipid droplet formation (GO:0140042),0.25235036425053103,0.5140752272327225,0.9534883720930233,1.0,1.0,1/10,6.86%,CDS2
prerank,regulation of microtubule-based movement (GO:0060632),-0.22071400585526169,-0.511798713975066,0.9799554565701559,1.0,1.0,3/11,24.61%,NEFH;MAP2;HAP1
prerank,cellular response to leucine (GO:0071233),0.25439566448619366,0.509660090942042,0.9577981651376147,1.0,1.0,2/10,11.83%,SESN3;RPTOR
prerank,response to leucine (GO:0043201),0.25439566448619366,0.509660090942042,0.9577981651376147,1.0,1.0,2/10,11.83%,SESN3;RPTOR
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.24960705250312543,0.5095294661294841,0.9672447013487476,1.0,1.0,1/10,12.29%,GNB1
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.2283869047727352,0.5085747083831832,0.9646017699115044,1.0,1.0,4/15,17.36%,STXBP1;NPS;NLGN1;CNTNAP4
prerank,negative regulation of innate immune response (GO:0045824),0.19718154441406666,0.5080642896792209,0.9875195007800313,0.9998394067986891,1.0,4/34,12.24%,NLRC5;SAMHD1;USP18;TNFAIP3
prerank,establishment of spindle orientation (GO:0051294),0.2082959057764148,0.5075296179875396,0.9726495726495726,0.9995460444630215,1.0,7/28,21.67%,MAP4;CDK5RAP2;ZW10;DCTN1;NSFL1C;CLASP1;NDE1
prerank,mRNA export from nucleus (GO:0006406),0.16177392346021424,0.5057886110892705,1.0,0.9995676060968659,1.0,26/102,26.44%,AGFG1;HHEX;RNPS1;NXT1;CPSF1;MAGOHB;THOC6;NCBP2;NUP54;EIF4E;ZC3H11A;NUP160;NUP153;NUP50;RBM8A;UPF2;NCBP1;NUP42;ENY2;NUP85;NUP210;NUP188;DHX38;UPF3B;UPF1;CHTOP
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.1918586118321809,-0.5045206874073832,0.9885057471264368,1.0,1.0,8/22,30.10%,SMARCB1;WDR43;PHF8;NCL;RASL11A;ERBB2;EIF2AK3;PIH1D1
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.20512750212949826,0.5039788365381516,0.9847715736040609,0.9995834141773557,1.0,11/27,25.45%,PDE12;RNASE1;TRIR;NHP2;XRN1;DICER1;NUDT16;RPP30;RNASE6;KHNYN;ZC3H12A
prerank,androgen metabolic process (GO:0008209),-0.20060361426238,-0.5031093718983219,0.9795918367346939,1.0,1.0,1/18,5.50%,SPP1
prerank,interstrand cross-link repair (GO:0036297),-0.15290124306865444,-0.502866495136487,1.0,1.0,1.0,17/53,32.50%,FANCE;FANCI;FAAP100;NUCKS1;ERCC1;FANCD2;ATRIP;ATR;MCM9;RAD51AP1;USP1;RNF168;NEIL3;FAAP24;FANCL;UBE2T;MCM8
prerank,DNA integrity checkpoint signaling (GO:0031570),0.19332168493341562,0.502633965549899,0.9919871794871795,0.9994805937581475,1.0,15/36,29.48%,HINFP;DNA2;CDC6;FBXO6;HUS1;CDC5L;RAD9B;RAD1;RAD17;TIPRL;CLOCK;TIMELESS;CHEK2;MAP3K20;HUS1B
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.2453372879556895,0.5020168618173713,0.9634369287020109,0.99919406762188,1.0,4/10,22.23%,CTBP1;SET;NOC2L;SNCA
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.22286269947425033,0.5019107757043,0.9616724738675958,0.9987906002559959,1.0,5/16,26.23%,ZFP36L1;TRIM71;ZFP36L2;ZC3H12A;UPF1
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.23882751694702475,0.49759254914459217,0.9645669291338582,0.9994148731249056,1.0,10/10,76.13%,NAF1;ZNHIT3;ZNHIT6;RUVBL1;RUVBL2;NUFIP1;SHQ1;PIH1D1;TAF9;PIH1D2
prerank,tRNA processing (GO:0008033),0.17462208698547607,0.4970207563920195,1.0,0.9991120215091969,1.0,16/61,23.46%,SARS1;CDKAL1;CSTF2;CPSF1;TRMT10C;DTWD2;RTRAF;RPP21;TSEN15;RTCB;THUMPD1;QTRT2;NSUN6;RPP30;CTU2;TSEN34
prerank,regulation of T cell mediated immunity (GO:0002709),-0.2246285920903689,-0.4946537155085607,0.9813664596273292,1.0,1.0,2/10,14.03%,TRPM4;ZBTB1
prerank,UV-damage excision repair (GO:0070914),-0.2164078666546646,-0.4945642020821772,0.9872340425531915,1.0,1.0,3/12,21.76%,DDB2;ERCC1;CUL4B
prerank,tRNA aminoacylation (GO:0043039),0.1881217188803007,0.4928592945641207,0.9887096774193549,0.9996102161319456,1.0,14/37,28.70%,SARS2;SARS1;YARS2;GARS1;GATC;FARSB;CARS1;IARS2;NARS1;HARS1;QRSL1;VARS1;LARS2;MARS2
prerank,protein prenylation (GO:0018342),0.2378238296708212,0.4917660531171459,0.949438202247191,0.9994183720566218,1.0,2/10,17.91%,PGGT1B;RCE1
prerank,V(D)J recombination (GO:0033151),0.23137279517921042,0.48936403274022405,0.9678030303030303,0.9995159574067887,1.0,11/11,76.88%,HMGB2;DCAF1;TCF3;RAG1;XRCC4;RAG2;PRKDC;LIG4;HMGB1;LIG3;LIG1
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.20789364613032588,0.4889639184876734,0.9821109123434705,0.9991692053078256,1.0,5/21,21.72%,RAB11A;BRD4;RCC2;MECP2;CDK4
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.2105162779493376,-0.4885001206310993,0.977924944812362,1.0,1.0,5/13,25.72%,RCL1;NOP14;NOP9;UTP20;BMS1
prerank,histone lysine methylation (GO:0034968),-0.16701978104348006,-0.4863165711934436,1.0,1.0,1.0,11/33,29.96%,SMYD3;EHMT2;ASH2L;TRMT112;EZH2;SETD6;SMYD2;SETMAR;SETD1B;DYDC2;KMT2A
prerank,negative regulation of secretion (GO:0051048),-0.22049962339944765,-0.48451842038500087,0.9781181619256017,1.0,1.0,10/10,77.97%,VAMP3;PTGER3;SPX;CD74;NR1H3;ERBB3;NRG1;TIFAB;EGF;VAMP8
prerank,regulation of spindle assembly (GO:0090169),-0.17398075506868077,-0.48385584007212257,0.989821882951654,1.0,1.0,8/25,27.61%,GPSM2;SENP6;CHMP4C;EML3;HSPA1A;CCSAP;TPR;NUMA1
prerank,cellular response to hydroxyurea (GO:0072711),0.23318313896780027,0.4818564318925708,0.9743119266055046,1.0,1.0,7/10,35.47%,DDX11;NSMCE3;BLM;TIMELESS;DDI2;RTF2;ATRX
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.1957184180302285,-0.4814668456122238,0.9862068965517241,1.0,1.0,7/15,37.93%,ZC3H12B;LACTB2;ZC3H12C;POP7;ZC3H12D;RPP40;NYNRIN
prerank,response to ethanol (GO:0045471),-0.20059438980391658,-0.4795680982525252,0.9840546697038725,1.0,1.0,1/14,5.06%,ADCY7
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.19891836774671356,0.47949842321592945,0.9879310344827587,1.0,1.0,12/22,31.23%,VPS36;VPS25;VPS37A;PLAA;VPS37B;VPS37C;RNF126;RNF115;VPS4B;VPS28;MVB12B;UBAP1
prerank,regulation of chromosome organization (GO:0033044),0.19985273663376846,0.47631924094554123,0.9899328859060402,1.0,1.0,6/22,26.23%,TERF2;SHCBP1L;YLPM1;WAPL;MYC;UPF1
prerank,regulation of transposition (GO:0010528),0.2216143348488551,0.4757609313301486,0.976491862567812,1.0,1.0,1/13,4.94%,PIWIL1
prerank,cellular response to oxygen levels (GO:0071453),0.23079337183027868,0.4743874960987826,0.9675090252707581,0.9999506185532877,1.0,10/10,76.94%,CCDC115;ATP6AP1;ATP6V1A;ATP6V0D1;ATP6V1G1;NDUFS2;ATP6V0A2;TMEM199;PICK1;CPEB4
prerank,protein import into mitochondrial matrix (GO:0030150),0.2039060537553381,0.47223412903053913,0.9894366197183099,0.9999104971432488,1.0,18/18,79.63%,DNAJC19;TOMM20L;TIMM50;TIMM21;TOMM70;GRPEL2;GRPEL1;PAM16;DNLZ;TOMM20;ROMO1;TIMM17A;DNAJC15;TOMM40;TIMM17B;TIMM23;TIMM44;TOMM40L
prerank,regulation of centrosome cycle (GO:0046605),0.19823858221377774,0.4710831981155548,0.9863247863247864,0.9996956119968975,1.0,2/21,7.90%,MARK4;CHMP1B
prerank,positive regulation of double-strand break repair (GO:2000781),0.17773580902522962,0.47032587756234223,0.9953632148377125,0.9993845738720711,1.0,12/39,25.67%,SHLD1;MGMT;WDR48;ACTR2;FANCB;DDX11;SLF1;PARP9;FMN2;ARID2;PNKP;DTX3L
prerank,mitotic cytokinetic process (GO:1902410),0.19990878524575376,0.4642276626209975,0.9829931972789115,0.99996017333676,1.0,11/20,34.76%,CHMP1B;MITD1;PDCD6IP;CHMP2B;VPS4B;CEP55;CHMP3;RHOA;CHMP4A;CHMP4B;CHMP7
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.21227252035610072,0.4641850723538759,0.9840142095914742,0.999534657975014,1.0,5/14,28.14%,NOL9;DDX18;ZNHIT3;RPL7L1;ZNHIT6
prerank,mitochondrion transport along microtubule (GO:0047497),0.21173199190340095,0.46024554133068246,0.9854545454545455,0.9997147822629614,1.0,5/13,31.01%,HIF1A;SPAST;LRPPRC;UBB;SYBU
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.1995048650045654,-0.45892994725157277,0.9868995633187773,1.0,1.0,4/11,39.25%,EXOSC2;PARN;FBLL1;LARP7
prerank,DNA damage checkpoint signaling (GO:0000077),0.186730951440539,0.45890999247948916,0.988255033557047,0.9994864556373285,1.0,9/28,25.80%,HINFP;STK33;FBXO6;HUS1;CDC5L;RAD1;RAD17;TIPRL;CLOCK
prerank,positive regulation of mRNA processing (GO:0050685),-0.17484051088739194,-0.45848860647068795,0.9975609756097561,1.0,1.0,10/21,39.56%,PAF1;CIRBP;TRA2B;NCL;CELF4;DHX36;CELF3;SF3B4;NUP98;CDC73
prerank,neuron fate commitment (GO:0048663),-0.19235688031958154,-0.4584342306747935,0.9978213507625272,1.0,1.0,7/14,34.14%,TGFBR1;ID2;POU3F2;SHH;POU4F1;PAX6;ASCL1
prerank,DNA replication initiation (GO:0006270),-0.15355508370670473,-0.45818547747153837,1.0,1.0,1.0,14/37,33.66%,POLE4;PRIM2;CDC45;DBF4;MCM3;MCM4;POLE2;MCM5;ORC5;ORC2;GMNN;CDC34;MCM8;LRWD1
prerank,P-body assembly (GO:0033962),0.21234249173296627,0.45685835621987514,0.9887005649717514,0.9993741198549957,1.0,4/12,28.06%,EDC3;LSM4;LSM14A;DYNC1H1
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.18646319210324003,-0.4561056833519856,0.995575221238938,1.0,1.0,8/16,39.65%,PTPN22;TNFSF8;LST1;AHR;IKZF3;FGF10;CD22;TNFSF9
prerank,organophosphate catabolic process (GO:0046434),0.22198675819699953,0.45376135152715397,0.980565371024735,0.9993924753377759,1.0,1/11,8.73%,ENPP2
prerank,ribosomal large subunit assembly (GO:0000027),0.1858327044048085,0.45193933693372795,0.9932088285229203,0.9991933966266128,1.0,7/24,27.63%,RPL3;MRPL20;RPL11;RSL24D1;RPL24;RPL6;TRAF7
prerank,tRNA 5'-leader removal (GO:0001682),-0.19016559937581884,-0.4508748007096431,0.9913606911447084,1.0,1.0,6/13,35.70%,PRORP;POP4;RPP25L;POP7;RPP40;SSB
prerank,cell cycle G1/S phase transition (GO:0044843),0.15786668341074395,0.4494273740271353,0.9985315712187959,0.9991092611429496,1.0,16/61,25.08%,MAX;HINFP;EIF4E;PIM2;PLK2;ACVR1;MAP3K11;TRIM71;CDK6;USP29;CUL1;NASP;CDK4;CDKN1B;MYC;CDKN2C
prerank,intermediate filament organization (GO:0045109),0.19822500250564162,0.44619767456027776,0.9931153184165232,0.9991010981484207,1.0,3/17,16.87%,KLHL24;GFAP;DNAJB6
prerank,coenzyme A metabolic process (GO:0015936),-0.18494790467610947,-0.4460082888023088,0.9931972789115646,1.0,1.0,2/14,13.61%,DCAKD;CROT
prerank,estrogen metabolic process (GO:0008210),-0.1827508414634487,-0.4445119104528036,0.9935344827586207,1.0,1.0,6/15,36.52%,CYP1B1;HSD17B2;SULT1A1;HSD17B14;HSD17B1;HSD17B11
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.1778603627511193,-0.4434755381874995,0.9954853273137697,1.0,1.0,5/17,27.00%,ALG1;MPDU1;MVD;DHDDS;SRD5A3
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.19067305409618354,-0.43836068422164043,0.9937106918238994,1.0,1.0,8/12,48.77%,ZBTB1;IL12RB1;CARD9;IL23A;IL12B;IL23R;CLEC6A;IL1B
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.2007858876116361,0.43749500214012416,0.9793233082706767,0.9997395602429308,1.0,7/13,34.73%,BNIP3L;BNIP3;PMAIP1;BAX;BCL2L11;BAD;BMF
prerank,regulation of viral transcription (GO:0046782),0.16292310135715302,0.4348689302639428,0.9984076433121019,0.9995942819570669,1.0,5/39,18.30%,TRIM14;NELFCD;TRIM11;POLR2J;CCNT1
prerank,regulation of chromosome segregation (GO:0051983),-0.1735378256786761,-0.43073555736242436,0.9954441913439636,1.0,1.0,8/16,40.75%,SMC6;CSNK2A1;NUMA1;RAD18;BUB1;KIF2C;AURKB;MKI67
prerank,response to hydroxyurea (GO:0072710),0.2045139014347713,0.42921597121530963,0.9870848708487084,0.9997858826703891,1.0,5/11,29.90%,DDX11;NSMCE3;BLM;TIMELESS;DDI2
prerank,eosinophil chemotaxis (GO:0048245),0.1956931190356606,0.42858786910555857,0.9945553539019963,0.9989868272542912,1.0,14/14,80.45%,CCL1;SCG2;CCL4;CCL26;CCL24;LGALS3;CCL11;CCL3;CCL7;CCL8;CCL5;CX3CL1;CCL2;CCL13
prerank,eosinophil migration (GO:0072677),0.1956931190356606,0.42858786910555857,0.9945553539019963,0.9989868272542912,1.0,14/14,80.45%,CCL1;SCG2;CCL4;CCL26;CCL24;LGALS3;CCL11;CCL3;CCL7;CCL8;CCL5;CX3CL1;CCL2;CCL13
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.19889433774475657,0.4265247817694738,0.9891304347826086,0.9987450968960209,1.0,5/14,28.29%,WDR48;ACTR2;FANCB;ARID2;TIMELESS
prerank,tRNA export from nucleus (GO:0006409),-0.14419284748902006,-0.42489347024245516,1.0,1.0,1.0,14/32,38.46%,SEH1L;NUP205;RAE1;NUP155;TPR;NDC1;NUP35;NUP43;AAAS;NOL6;SSB;NUP98;NUP62;NUP37
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.14419284748902006,-0.42489347024245516,1.0,1.0,1.0,14/32,38.46%,SEH1L;NUP205;RAE1;NUP155;TPR;NDC1;NUP35;NUP43;AAAS;NOL6;SSB;NUP98;NUP62;NUP37
prerank,sensory perception of pain (GO:0019233),0.17509018039597946,0.4227783043060062,0.9946524064171123,0.9986905803018623,1.0,2/21,8.39%,RETREG1;P2RX7
prerank,gas transport (GO:0015669),-0.1926221503398382,-0.42246233678853906,0.9977728285077951,1.0,1.0,1/10,8.99%,CYGB
prerank,T cell activation involved in immune response (GO:0002286),-0.18203651813832827,-0.4202191063635531,0.9936034115138592,0.9997583299049301,1.0,9/12,46.74%,MDK;FCER1G;ICAM1;LILRB1;CD74;ITGAL;F2RL1;IFNK;TNFSF18
prerank,regulation of mitotic spindle assembly (GO:1901673),0.17856774735579828,0.4159398672039582,0.9983164983164983,0.9988856354503152,1.0,8/19,33.79%,CHMP1B;PDCD6IP;CEP97;CHMP2B;VPS4B;DRG1;CHMP3;CHMP4B
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.1668307912540681,0.41201166928864086,0.9983633387888707,0.9987702716648401,1.0,5/25,18.95%,HSPA8;DNAJC7;HSPE1;HSPA9;ERO1A
prerank,phospholipid metabolic process (GO:0006644),0.13944026265096354,0.4067991993042399,1.0,0.9987570766451247,1.0,16/71,26.70%,MBOAT1;PLA2G4B;ENPP2;PIP4K2A;CLN8;PLPPR4;PLPP2;GPX4;PGP;PLAA;LPCAT4;PLPPR3;SMPD1;GPAM;LPCAT1;AGPAT2
prerank,protein localization to condensed chromosome (GO:1903083),0.18973006490955702,0.4033895898812654,0.9945054945054945,0.998569796942287,1.0,3/12,19.53%,BUB3;ZW10;IK
prerank,myeloid dendritic cell activation (GO:0001773),0.18725674827369745,0.3982344009747459,0.9981515711645101,0.9984668674028068,1.0,12/12,81.29%,TGFBR2;DOCK2;BATF2;DHRS2;DCSTAMP;SLAMF1;BATF3;IL4;CAMK4;HMGB1;PYCARD;BATF
prerank,negative regulation of viral release from host cell (GO:1902187),-0.16849770858183188,-0.3975230106004523,0.9976958525345622,1.0,1.0,13/13,83.17%,PML;TRIM8;TRIM5;TRIM21;TRIM35;TRIM13;TRIM15;TRIM32;TRIM28;CHMP3;MID2;TRIM11;TRIM26
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.15779228933818915,-0.3970179337798382,0.9977324263038548,0.9994990184231886,1.0,16/16,84.24%,PDS5B;SGO1;NAA50;DSCC1;PDS5A;RB1;RAD21L1;HASPIN;CDCA5;MAU2;SMC1A;NIPBL;REC8;POGZ;RAD21;BOD1
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",-0.13586490332634635,-0.37601878955597795,1.0,0.9994301293173375,1.0,5/25,23.24%,SRSF4;PRPF3;TRA2B;SRSF10;DBR1
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.14693551054658763,0.36903444350671666,1.0,0.9994233247452565,1.0,9/28,28.08%,SHLD1;SIRT7;ACTR2;HMGA2;PARP9;PNKP;DTX3L;NUDT16L1;CYREN
prerank,positive regulation of telomere capping (GO:1904355),0.1597217050903937,0.35678961902476863,1.0,0.9993335599605252,1.0,7/17,29.26%,MAPK3;MAPK1;MAP2K7;NABP2;PNKP;NEK7;PRKCQ
